data_1rqm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rqm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 120.628 0.251 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.1 t -129.44 179.61 5.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.117 1.767 . . . . 0.0 107.33 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -52.46 -58.97 5.05 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.483 2.313 . . . . 0.0 111.735 -160.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.38 -16.32 60.13 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -102.22 -17.11 16.1 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.959 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -49.11 -55.8 11.11 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 125.203 1.401 . . . . 0.0 108.859 171.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -53.02 -54.54 33.84 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.307 1.843 . . . . 0.0 112.468 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -64.09 -20.93 66.31 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.125 0.57 . . . . 0.0 112.278 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.34 -64.18 1.16 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 167.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.3 pt -58.55 -25.72 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -62.53 -22.33 66.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.29 1.036 . . . . 0.0 113.406 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.12 149.51 51.21 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 119.12 0.873 . . . . 0.0 112.453 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -87.82 53.34 2.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.232 1.413 . . . . 0.0 110.193 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.76 165.9 35.9 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.66 101.09 0.16 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.192 3.261 . . . . 0.0 111.772 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.47 101.71 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 125.369 1.468 . . . . 0.0 107.973 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.9 tt -82.58 112.77 19.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 171.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.59 114.95 39.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.97 93.03 4.65 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -164.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -86.62 112.86 22.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.601 0.761 . . . . 0.0 109.758 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 26.6 p-90 -124.54 -175.68 3.33 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 169.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.52 158.69 43.93 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.202 -0.936 . . . . 0.0 110.096 172.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.42 -1.27 0.5 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.215 1.806 . . . . 0.0 115.598 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.15 -18.96 1.75 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.1 p -72.27 100.65 2.66 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.855 1.207 . . . . 0.0 111.519 -165.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -29.0 -61.81 0.14 Allowed Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.934 1.73 . . . . 0.0 115.067 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.31 -33.67 29.56 Favored 'Trans proline' 0 C--N 1.351 0.658 0 CA-C-N 120.273 2.036 . . . . 0.0 112.985 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.7 p -69.27 -30.35 68.44 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.795 1.179 . . . . 0.0 110.624 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -20.6 65.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.329 0.968 . . . . 0.0 111.654 172.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.1 mtp -99.85 -25.98 14.17 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.323 1.449 . . . . 0.0 111.878 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.7 ttt -81.48 -38.74 25.86 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.727 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.03 -50.73 61.17 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 120.703 1.592 . . . . 0.0 112.534 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.22 -33.25 40.22 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.598 1.532 . . . . 0.0 112.359 172.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.65 -36.63 77.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 120.13 1.332 . . . . 0.0 110.851 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 mt -78.92 -6.47 56.27 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.921 2.489 . . . . 0.0 111.471 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.92 -48.52 13.29 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.738 1.215 . . . . 0.0 108.144 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -60.9 -43.41 98.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.853 0.461 . . . . 0.0 110.022 168.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -63.85 -20.13 65.58 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.543 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.92 -59.4 2.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 121.174 1.806 . . . . 0.0 108.668 166.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.16 -45.43 65.06 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.792 1.237 . . . . 0.0 111.838 -173.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.55 -23.91 29.35 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -169.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.32 36.69 0.83 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.037 1.335 . . . . 0.0 110.626 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.39 -23.42 3.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 -160.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.18 0.07 8.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.349 0.977 . . . . 0.0 112.841 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -76.58 -29.34 56.57 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.432 -0.792 . . . . 0.0 109.946 167.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.22 143.04 42.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 109.249 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.33 136.49 53.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 158.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 t -119.92 134.61 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 160.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.21 90.38 2.03 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -166.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -86.99 143.71 27.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.226 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 152.62 26.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.208 0.913 . . . . 0.0 113.263 171.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -76.45 107.04 8.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.246 1.818 . . . . 0.0 107.683 172.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.6 p -48.41 -43.53 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 126.738 2.015 . . . . 0.0 114.274 -165.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.45 -27.09 68.31 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.872 2.069 . . . . 0.0 112.492 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.4 -28.1 62.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.726 0.81 . . . . 0.0 111.406 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -115.48 83.75 11.21 Favored Pre-proline 0 N--CA 1.457 -0.125 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.53 -25.77 29.32 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.631 1.554 . . . . 0.0 112.207 170.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.7 OUTLIER -61.71 118.44 7.13 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.47 1.108 . . . . 0.0 109.405 -176.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.262 8.8 m 70.23 -20.01 0.2 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.606 2.362 . . . . 0.0 113.366 173.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.431 ' H ' ' C ' ' A' ' 62' ' ' GLU . 97.9 m -54.66 -55.73 26.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.58 1.952 . . . . 0.0 109.011 160.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.5 t -57.59 -41.57 81.44 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.291 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -62.75 -40.81 98.41 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.665 0.786 . . . . 0.0 112.949 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -96.27 16.56 17.98 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.713 0.688 . . . . 0.0 112.773 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.21 25.81 72.24 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 124.129 0.871 . . . . 0.0 112.523 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 30.6 mm -82.14 70.02 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 122.576 1.179 . . . . 0.0 109.558 -165.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 53.3 ttp -120.37 0.78 10.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.739 1.616 . . . . 0.0 109.974 166.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.3 t -88.83 21.94 2.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.102 1.361 . . . . 0.0 112.985 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.45 144.61 83.95 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.529 0.732 . . . . 0.0 112.528 -168.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -69.06 130.64 16.41 Favored 'Cis proline' 0 C--N 1.35 0.606 0 CA-C-N 119.01 0.682 . . . . 0.0 112.734 7.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.9 m -125.26 151.71 45.58 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.862 1.265 . . . . 0.0 108.82 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.2 tt -143.63 105.34 4.32 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -173.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.9 mt -101.1 143.82 13.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 171.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.25 115.89 28.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -113.63 163.39 15.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.827 1.651 . . . . 0.0 111.873 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.41 149.91 13.89 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.466 1.907 . . . . 0.0 107.337 158.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.03 14.67 47.0 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 119.155 0.889 . . . . 0.0 113.496 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.87 -5.99 82.24 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.436 1.494 . . . . 0.0 113.35 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -98.86 121.14 56.93 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 119.174 1.487 . . . . 0.0 110.189 -173.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.09 103.79 1.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.75 2.967 . . . . 0.0 110.048 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.29 -35.94 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 121.815 -0.553 . . . . 0.0 112.071 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -153.54 158.27 41.0 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.592 0.757 . . . . 0.0 110.669 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -147.44 125.22 11.88 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.744 2.018 . . . . 0.0 106.741 -172.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.8 mp -121.83 150.5 41.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.473 1.909 . . . . 0.0 106.802 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.9 pt -145.43 151.97 14.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.613 1.165 . . . . 0.0 109.344 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.12 167.63 24.65 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.404 1.002 . . . . 0.0 111.908 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -75.33 73.94 2.42 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.077 0.951 . . . . 0.0 110.855 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -70.06 138.3 87.33 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.62 163.53 38.63 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.403 2.069 . . . . 0.0 110.634 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.12 -44.8 61.4 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.982 1.313 . . . . 0.0 111.225 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.67 -15.32 63.41 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.093 0.957 . . . . 0.0 112.67 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -102.0 -44.57 5.44 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.208 0.913 . . . . 0.0 109.17 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.51 -59.32 5.63 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.106 1.762 . . . . 0.0 109.636 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -63.55 -24.73 67.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.054 0.843 . . . . 0.0 110.968 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.92 -51.52 15.85 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.854 0.752 . . . . 0.0 110.682 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -62.27 -43.3 99.15 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.7 0.8 . . . . 0.0 110.481 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 tp -78.77 -7.03 57.41 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.725 1.21 . . . . 0.0 112.744 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.07 -33.05 37.46 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.689 1.196 . . . . 0.0 111.085 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.16 11.87 0.1 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.803 2.041 . . . . 0.0 112.711 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.54 -11.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 119.451 -2.031 . . . . 0.0 113.187 158.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.07 -22.57 20.67 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.043 1.337 . . . . 0.0 112.047 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 . . . . . 0 C--O 1.251 1.134 0 C-N-CA 128.591 2.757 . . . . 0.0 110.202 175.613 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 tp . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.797 0.332 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.4 p -146.03 172.27 13.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 128.703 2.801 . . . . 0.0 104.988 170.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -45.45 -61.2 1.78 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.517 2.327 . . . . 0.0 110.855 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.0 -31.95 71.54 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.692 -0.63 . . . . 0.0 112.182 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -78.03 -19.25 54.71 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.287 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -55.51 -60.44 3.43 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.442 1.497 . . . . 0.0 107.572 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -58.81 -45.46 89.88 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 111.793 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -56.85 -36.01 69.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.568 0.622 . . . . 0.0 111.516 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.46 -60.72 2.11 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.873 0.869 . . . . 0.0 110.69 172.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.2 pt -68.98 -2.42 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -168.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -42.76 -39.69 2.55 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.593 1.957 . . . . 0.0 114.91 -172.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 159.25 -176.55 36.04 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 119.322 0.965 . . . . 0.0 113.899 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 65.25 -57.44 0.29 Allowed 'General case' 0 N--CA 1.463 0.196 1 C-N-CA 132.056 4.143 . . . . 0.0 112.543 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.53 150.86 20.61 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.645 -160.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.16 88.5 0.7 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.113 3.209 . . . . 0.0 110.24 170.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.59 149.57 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 170.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.03 167.77 21.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.932 -0.48 . . . . 0.0 110.595 161.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.31 134.46 66.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 124.48 1.112 . . . . 0.0 108.382 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -95.7 99.72 11.53 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 167.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -86.68 112.73 21.92 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 -128.28 176.65 7.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.163 1.385 . . . . 0.0 108.162 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -147.5 149.03 31.86 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.723 1.147 . . . . 0.0 110.789 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.07 -24.46 66.24 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -102.51 -6.99 22.26 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.252 0.933 . . . . 0.0 113.25 -174.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.1 p -66.19 169.94 6.44 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.638 0.732 . . . . 0.0 112.676 -164.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.89 -90.22 1.54 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 165.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.39 -23.16 71.7 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.003 2.469 . . . . 0.0 114.117 -168.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.86 -25.92 68.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.161 0.891 . . . . 0.0 111.682 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -71.8 -17.16 62.18 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.0 0.92 . . . . 0.0 111.632 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.5 mtp -97.39 -39.87 8.98 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.689 1.596 . . . . 0.0 110.211 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.8 tpt -66.84 -44.87 79.94 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-O 117.657 -1.163 . . . . 0.0 109.931 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.86 99.91 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.309 1.413 . . . . 0.0 112.725 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -69.19 -38.63 8.75 Favored 'Trans proline' 0 C--N 1.352 0.747 0 CA-C-N 121.78 1.671 . . . . 0.0 112.837 169.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.97 -34.09 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 120.935 1.698 . . . . 0.0 111.531 177.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.0 -13.23 61.19 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.877 2.471 . . . . 0.0 111.701 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.3 -36.63 34.06 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.564 1.074 . . . . 0.0 110.308 176.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.95 -43.24 99.33 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 169.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -58.57 -45.98 87.89 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.669 0.788 . . . . 0.0 110.479 171.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.06 -49.04 72.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.173 0.897 . . . . 0.0 110.893 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -53.19 60.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.74 1.216 . . . . 0.0 111.087 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.72 48.56 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -164.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -141.98 38.88 1.62 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.748 1.219 . . . . 0.0 110.552 172.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.47 -8.67 2.89 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.009 1.324 . . . . 0.0 113.964 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -92.29 -53.96 4.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.94 2.496 . . . . 0.0 111.425 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -68.34 -26.08 65.42 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 118.719 -0.658 . . . . 0.0 111.248 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.2 m -141.73 171.0 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.436 0.695 . . . . 0.0 110.111 -174.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.9 t -127.48 130.43 49.21 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 160.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.0 p -90.98 173.08 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 158.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.07 153.35 34.91 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 159.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -113.26 137.65 51.17 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 119.29 -0.386 . . . . 0.0 109.992 -169.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pp -149.86 146.88 27.36 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 122.686 1.232 . . . . 0.0 114.288 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -78.64 110.16 13.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.127 2.171 . . . . 0.0 108.025 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.01 -37.1 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.861 1.665 . . . . 0.0 112.929 -166.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.86 -38.62 83.36 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.097 1.359 . . . . 0.0 110.601 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -76.34 -27.31 56.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.629 2.372 . . . . 0.0 112.048 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -116.65 78.21 8.7 Favored Pre-proline 0 N--CA 1.445 -0.703 0 C-N-CA 124.817 1.247 . . . . 0.0 110.461 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.36 -88.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 123.875 3.05 . . . . 0.0 112.313 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 30.96 -39.45 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.893 1 C-N-CA 132.912 4.485 . . . . 0.0 120.367 -159.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -159.52 -7.32 0.06 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 129.466 3.106 . . . . 0.0 112.376 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 m -39.93 -60.4 1.03 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.168 2.187 . . . . 0.0 110.547 164.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.0 t -68.79 -17.39 64.02 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.789 -1.1 . . . . 0.0 113.041 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -77.61 -30.97 52.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.69 1.132 . . . . 0.0 110.112 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -93.51 9.65 35.76 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.438 0.695 . . . . 0.0 111.122 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.52 22.85 75.23 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.846 0.736 . . . . 0.0 112.784 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.8 mm -78.23 77.36 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.753 1.221 . . . . 0.0 109.151 -169.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.81 -2.54 8.77 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.088 1.355 . . . . 0.0 110.363 167.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 p -82.87 43.64 0.86 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.177 2.591 . . . . 0.0 111.485 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.11 145.84 94.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 O-C-N 121.7 -0.625 . . . . 0.0 111.697 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.21 127.0 8.89 Favored 'Cis proline' 0 N--CA 1.459 -0.512 0 CA-C-N 119.153 0.733 . . . . 0.0 110.797 0.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.0 m -116.84 148.07 41.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 tt -136.96 126.64 25.42 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.9 mt -128.85 141.56 46.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mp -106.94 142.7 36.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.843 1.657 . . . . 0.0 109.474 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -134.68 150.09 50.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.357 1.463 . . . . 0.0 109.309 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.66 163.88 32.19 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 159.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.02 8.55 8.55 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 118.453 -1.193 . . . . 0.0 115.287 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.34 2.49 60.39 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 119.134 1.467 . . . . 0.0 113.156 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -126.57 135.91 27.93 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 119.346 1.573 . . . . 0.0 110.813 -168.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.44 117.2 5.02 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.48 2.786 . . . . 0.0 110.376 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.03 -46.01 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -156.55 164.5 38.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.867 0.758 . . . . 0.0 111.365 -173.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -136.28 147.98 47.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.483 1.913 . . . . 0.0 109.414 -171.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -122.14 154.05 37.92 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.833 1.653 . . . . 0.0 107.845 158.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 pt -141.32 137.74 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.671 1.988 . . . . 0.0 106.129 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.42 168.31 35.61 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.922 0.772 . . . . 0.0 112.921 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -80.4 83.64 6.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.529 1.131 . . . . 0.0 108.952 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -88.66 134.68 33.5 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.53 160.41 48.1 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.28 1.32 . . . . 0.0 109.793 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -41.67 80.79 Favored 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 123.803 0.841 . . . . 0.0 111.512 -175.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.79 -19.99 60.54 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -95.39 -49.75 5.31 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.888 1.222 . . . . 0.0 109.364 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.31 -59.17 5.74 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 124.499 1.12 . . . . 0.0 110.62 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -65.9 -18.44 65.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.075 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.25 -51.6 12.89 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.148 0.885 . . . . 0.0 110.307 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -53.32 -43.17 67.4 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.852 0.861 . . . . 0.0 110.831 175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 mp -86.85 -0.77 57.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.597 1.559 . . . . 0.0 113.167 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.04 -34.29 69.91 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 119.431 1.014 . . . . 0.0 111.622 -172.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -63.26 -12.56 30.0 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.195 1.398 . . . . 0.0 113.96 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.4 m -128.59 9.73 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 126.245 1.818 . . . . 0.0 111.633 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -124.95 -4.55 7.51 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.924 1.689 . . . . 0.0 113.122 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 126.895 2.078 . . . . 0.0 108.708 164.761 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.1 p -142.86 163.97 31.35 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 129.145 2.978 . . . . 0.0 104.998 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.41 -40.14 81.63 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.601 1.16 . . . . 0.0 113.124 -168.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.52 65.84 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.633 -0.667 . . . . 0.0 112.358 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -94.49 -34.75 12.58 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.201 1.4 . . . . 0.0 110.549 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -50.6 -62.39 1.63 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 126.847 2.059 . . . . 0.0 109.201 173.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -57.29 -46.03 83.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.277 0.489 . . . . 0.0 110.781 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -70.62 -21.53 62.63 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.4 -62.01 1.71 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.212 0.915 . . . . 0.0 109.538 165.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.1 pt -62.46 -21.71 27.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.514 1.126 . . . . 0.0 113.776 -167.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -64.37 -23.92 67.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.93 0.892 . . . . 0.0 112.807 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.35 170.16 54.52 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 118.864 0.756 . . . . 0.0 112.058 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -82.83 -22.62 34.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.601 1.56 . . . . 0.0 112.798 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.46 48.73 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 123.408 0.528 . . . . 0.0 112.219 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.3 91.3 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 124.186 3.257 . . . . 0.0 111.317 173.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.67 131.43 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 mp -118.57 136.94 53.58 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.55 116.63 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -72.72 107.52 5.22 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 124.105 0.878 . . . . 0.0 109.025 163.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -89.03 108.15 19.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 164.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -126.44 -177.92 4.16 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.31 159.84 40.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.376 -0.827 . . . . 0.0 108.876 168.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.77 -15.67 22.01 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.63 -31.25 17.62 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.458 1.026 . . . . 0.0 113.354 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.9 p -72.8 160.67 31.81 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.684 1.129 . . . . 0.0 111.151 -168.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.43 -79.55 1.47 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.018 0.818 . . . . 0.0 112.515 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.15 -15.89 51.93 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.621 2.881 . . . . 0.0 113.701 -172.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.1 p -52.81 -35.97 57.75 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.248 0.619 . . . . 0.0 111.786 167.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -70.38 -13.94 62.35 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.753 0.706 . . . . 0.0 112.563 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.2 mtm -95.91 -20.08 19.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.078 1.351 . . . . 0.0 111.63 170.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.5 ttt -79.85 -39.27 30.99 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 108.913 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.01 -52.48 46.94 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.742 1.217 . . . . 0.0 113.326 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.65 -30.88 34.14 Favored 'Trans proline' 0 C--N 1.352 0.711 0 CA-C-N 121.987 1.745 . . . . 0.0 112.26 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.17 -38.3 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.636 1.107 . . . . 0.0 109.887 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 mp -69.99 -26.93 64.31 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.6 1.96 . . . . 0.0 112.196 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -69.52 -46.76 65.79 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.252 0.933 . . . . 0.0 109.156 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -61.93 -41.23 97.7 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.069 0.548 . . . . 0.0 110.591 173.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.29 -50.53 73.29 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.286 1.035 . . . . 0.0 110.915 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.25 -48.24 79.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.725 0.81 . . . . 0.0 110.16 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -58.27 -50.03 75.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.254 0.621 . . . . 0.0 110.941 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.7 -23.14 50.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.96 52.86 0.69 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.348 1.459 . . . . 0.0 109.876 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.26 -17.63 54.43 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -95.43 -49.6 5.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.595 2.358 . . . . 0.0 111.549 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -67.11 -24.62 65.95 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.151 -170.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.22 149.43 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 119.139 0.881 . . . . 0.0 111.074 -172.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.344 2.9 t -110.57 84.9 2.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 123.11 1.433 . . . . 0.0 109.3 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.14 139.14 19.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.967 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.52 166.56 22.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.201 2.2 . . . . 0.0 107.976 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -136.22 144.57 44.96 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 122.406 0.282 . . . . 0.0 111.377 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -145.86 142.7 29.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.368 0.604 . . . . 0.0 111.539 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -83.13 98.51 9.37 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.98 -27.73 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.613 -163.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -65.01 -24.87 67.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.867 2.467 . . . . 0.0 112.306 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -91.89 -32.26 15.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.069 1.347 . . . . 0.0 110.238 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -116.94 74.87 7.12 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.643 1.177 . . . . 0.0 109.839 -170.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.15 -12.65 14.3 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.152 3.235 . . . . 0.0 113.514 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 64' ' ' THR . 7.0 tp10 -72.9 142.6 47.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.131 0.878 . . . . 0.0 109.315 174.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m 60.07 -29.36 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 131.46 3.904 . . . . 0.0 113.458 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.522 ' H ' ' C ' ' A' ' 62' ' ' GLU . 21.2 m -50.11 -59.6 3.76 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.018 2.927 . . . . 0.0 108.737 161.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -70.93 -10.14 59.12 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 117.725 -1.131 . . . . 0.0 112.674 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -85.87 -39.21 17.26 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.852 1.205 . . . . 0.0 111.266 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -92.99 6.85 46.44 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.538 0.608 . . . . 0.0 112.242 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.89 34.5 77.28 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.861 0.755 . . . . 0.0 111.926 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.7 mm -72.17 85.31 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.078 1.751 . . . . 0.0 109.259 -171.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.8 tpp -143.11 51.85 1.38 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.557 1.543 . . . . 0.0 109.654 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.2 m -156.81 42.41 0.36 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.145 -1.597 . . . . 0.0 111.812 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.2 pt -70.73 151.93 95.24 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 121.767 -0.583 . . . . 0.0 112.564 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.49 129.2 6.64 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 119.379 0.814 . . . . 0.0 110.755 -5.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.1 m -121.44 140.93 51.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -123.53 120.39 32.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 171.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.6 mt -121.24 142.77 35.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 tt -108.11 121.54 45.05 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 176.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -118.37 156.77 28.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.151 0.98 . . . . 0.0 111.221 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -163.14 158.97 22.48 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 125.535 1.534 . . . . 0.0 108.745 161.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.26 16.05 25.61 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.919 0.771 . . . . 0.0 113.984 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.22 -5.82 83.95 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.122 -1.377 . . . . 0.0 114.017 -173.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.97 149.97 44.24 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 120.186 1.993 . . . . 0.0 111.617 -174.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.17 128.03 6.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.352 2.702 . . . . 0.0 110.296 170.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.3 -41.86 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.579 -0.701 . . . . 0.0 110.34 168.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -164.91 169.85 16.02 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.827 0.851 . . . . 0.0 111.22 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -136.31 146.93 47.17 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.729 2.411 . . . . 0.0 108.941 -170.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.8 151.52 37.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.651 1.981 . . . . 0.0 106.897 159.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.06 147.9 26.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.005 1.722 . . . . 0.0 107.298 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.31 169.4 21.14 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 122.022 0.79 . . . . 0.0 112.081 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -74.01 89.05 1.91 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -86.87 137.38 33.52 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 159.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.4 165.95 30.85 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.322 2.015 . . . . 0.0 111.451 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -46.27 -48.67 18.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.724 1.61 . . . . 0.0 112.144 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -52.78 -47.09 67.77 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.113 1.365 . . . . 0.0 111.644 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -38.51 72.3 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 124.341 1.056 . . . . 0.0 108.578 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 -54.53 30.2 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.218 1.007 . . . . 0.0 109.514 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.22 -40.23 85.18 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.66 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.78 -51.96 65.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.524 1.056 . . . . 0.0 111.414 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -62.81 -27.69 69.49 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.77 0.828 . . . . 0.0 112.419 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 mp -106.66 3.36 26.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.716 1.207 . . . . 0.0 111.905 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.58 -29.97 60.0 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.543 1.137 . . . . 0.0 112.567 -174.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -62.53 -14.86 46.71 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.1 p -117.55 -7.03 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 119.651 1.114 . . . . 0.0 111.686 172.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.52 -11.87 26.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.548 1.139 . . . . 0.0 112.068 172.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.739 2.016 . . . . 0.0 110.135 165.875 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.3 mt . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 122.364 1.078 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.5 m -150.2 -129.4 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 102.581 -3.118 . . . . 0.0 102.581 172.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -86.61 -67.42 0.82 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.117 1.767 . . . . 0.0 111.248 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.6 -35.87 77.19 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.271 -0.893 . . . . 0.0 111.359 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -67.01 -31.33 71.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.728 0.811 . . . . 0.0 109.671 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -58.88 -57.25 13.86 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.819 0.736 . . . . 0.0 109.623 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -59.74 -46.52 88.9 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.54 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -63.29 -17.21 62.27 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.71 -59.28 2.48 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.807 0.843 . . . . 0.0 110.585 166.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.6 pt -67.59 -18.84 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -169.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -49.08 -34.45 13.76 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.157 1.783 . . . . 0.0 112.996 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.61 138.56 2.88 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 112.042 -0.423 . . . . 0.0 112.042 168.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.54 -102.97 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.9 -130.54 2.76 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 127.691 2.567 . . . . 0.0 106.752 165.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.95 93.45 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.272 2.648 . . . . 0.0 111.703 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.2 141.17 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 167.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.2 mt -137.33 158.99 43.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.04 141.31 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -96.06 110.39 22.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 158.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -93.71 109.68 21.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 167.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -134.25 -176.52 4.23 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.072 1.749 . . . . 0.0 108.098 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.37 166.3 33.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.643 1.577 . . . . 0.0 107.386 168.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.5 -29.08 69.76 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -31.86 17.75 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -169.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 p -71.51 102.4 2.69 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.713 0.688 . . . . 0.0 111.999 -162.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -34.14 -61.01 0.54 Allowed Glycine 0 CA--C 1.539 1.534 0 C-N-CA 126.017 1.77 . . . . 0.0 114.912 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.82 -32.86 28.6 Favored 'Trans proline' 0 C--N 1.35 0.646 0 CA-C-N 120.241 2.02 . . . . 0.0 112.512 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.4 p -67.73 -35.59 79.03 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 119.315 0.961 . . . . 0.0 110.258 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -62.35 -15.92 51.34 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.855 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 75.9 mtm -104.11 -14.2 15.97 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.564 1.145 . . . . 0.0 112.876 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.407 ' SD ' ' HA ' ' A' ' 90' ' ' TYR . 14.9 ttt -94.11 -40.67 9.93 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.284 1.434 . . . . 0.0 109.547 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.82 -49.42 86.85 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 117.738 -1.125 . . . . 0.0 112.466 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.76 -33.6 53.34 Favored 'Trans proline' 0 C--N 1.354 0.841 0 CA-C-N 121.888 1.71 . . . . 0.0 112.086 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.88 -42.27 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 118.447 0.567 . . . . 0.0 109.513 174.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.47 -24.58 64.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.014 1.725 . . . . 0.0 112.319 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.453 ' CD ' ' HZ3' ' A' ' 54' ' ' LYS . 2.0 tp10 -68.88 -48.25 63.85 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.418 1.008 . . . . 0.0 109.624 177.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -62.88 -45.23 93.53 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -55.16 -48.17 74.11 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 122.931 0.492 . . . . 0.0 110.439 175.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.07 -55.04 37.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.385 1.074 . . . . 0.0 110.73 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -52.82 -46.75 67.86 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.848 0.859 . . . . 0.0 110.602 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.53 -16.53 10.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -150.13 48.82 0.91 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.535 1.134 . . . . 0.0 110.559 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -25.64 66.58 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -97.68 -54.1 3.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.233 1.413 . . . . 0.0 112.465 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -53.79 -29.7 41.5 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.603 0.761 . . . . 0.0 112.378 -171.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 m -134.29 141.56 43.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.319 1.9 t -92.56 73.45 5.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 123.191 1.472 . . . . 0.0 107.723 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.79 164.26 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.307 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.6 179.9 8.75 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.806 0.843 . . . . 0.0 110.119 170.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.453 ' HZ3' ' CD ' ' A' ' 40' ' ' GLU . 7.6 ttpm? -139.63 134.44 32.06 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.53 159.79 43.28 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.999 0.812 . . . . 0.0 112.351 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -82.38 123.38 29.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.314 0.646 . . . . 0.0 109.408 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.6 p -62.34 -29.59 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.182 0.993 . . . . 0.0 112.824 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.62 -36.34 70.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.642 0.777 . . . . 0.0 110.8 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.54 -34.85 74.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.178 2.191 . . . . 0.0 112.181 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -111.1 85.15 5.04 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 123.953 0.901 . . . . 0.0 109.393 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.3 -24.12 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.086 2.524 . . . . 0.0 112.816 172.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' C ' ' HG1' ' A' ' 63' ' ' THR . 49.3 mt-10 -70.07 117.66 11.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.021 1.328 . . . . 0.0 109.978 -178.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.422 ' HG1' ' C ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER 89.36 -40.71 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 129.784 3.233 . . . . 0.0 109.906 -176.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.2 m -52.16 -60.54 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.163 2.185 . . . . 0.0 110.353 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.3 t -57.94 -44.26 86.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.709 0.404 . . . . 0.0 109.938 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -60.15 -27.92 67.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.965 1.306 . . . . 0.0 112.913 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.33 14.65 22.62 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.8 0.727 . . . . 0.0 111.465 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.07 26.5 73.32 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 121.55 -0.719 . . . . 0.0 113.135 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.3 mm -75.86 79.16 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.346 1.458 . . . . 0.0 109.014 -171.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.6 ttm -128.24 3.39 5.77 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.305 1.442 . . . . 0.0 110.962 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 t -90.82 23.88 2.95 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.088 1.355 . . . . 0.0 113.121 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.407 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -57.95 145.06 73.54 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.782 0.833 . . . . 0.0 113.161 -168.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 55.7 Cg_endo -69.09 132.24 20.78 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.034 0.691 . . . . 0.0 112.19 8.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.5 m -122.22 153.28 39.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 tt -144.44 104.44 4.07 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.734 2.014 . . . . 0.0 106.22 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.9 mt -102.19 133.17 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.66 109.68 21.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.095 2.158 . . . . 0.0 105.652 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -105.04 156.96 17.57 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -152.87 146.28 24.89 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 159.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.81 35.84 4.55 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.874 1.226 . . . . 0.0 115.215 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.77 -3.22 62.67 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 118.701 1.251 . . . . 0.0 114.791 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -123.61 130.88 24.32 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 119.652 1.726 . . . . 0.0 110.977 -168.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.48 101.69 1.39 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.778 2.986 . . . . 0.0 109.803 169.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -42.42 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.859 0.864 . . . . 0.0 111.094 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.405 ' HZ1' ' CG ' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -159.37 168.41 26.4 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.168 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.74 163.45 30.14 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.352 0.596 . . . . 0.0 111.489 160.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -117.88 148.31 42.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.838 2.055 . . . . 0.0 105.784 170.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.6 pt -139.56 140.26 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 125.151 1.38 . . . . 0.0 107.885 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.68 161.63 8.57 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.76 0.695 . . . . 0.0 111.781 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.407 ' HA ' ' SD ' ' A' ' 35' ' ' MET . 10.6 t80 -66.73 98.88 0.56 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.574 1.55 . . . . 0.0 112.385 -170.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -93.01 140.6 23.43 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 168.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.15 163.5 38.53 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.487 2.125 . . . . 0.0 110.308 168.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.67 -46.04 70.5 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 123.843 0.857 . . . . 0.0 111.879 -174.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -49.63 -43.36 46.66 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.801 1.24 . . . . 0.0 111.159 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -88.35 -42.61 12.09 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.442 1.097 . . . . 0.0 109.061 -166.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.83 -62.46 1.85 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.99 1.316 . . . . 0.0 109.31 173.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -57.3 -38.13 73.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.608 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.29 82.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.615 1.098 . . . . 0.0 110.574 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -66.99 -21.88 65.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.77 -7.24 27.9 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.204 1.802 . . . . 0.0 113.287 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.71 -29.46 66.7 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.088 1.755 . . . . 0.0 112.532 -167.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.405 ' CG ' ' HZ1' ' A' ' 85' ' ' LYS . 7.0 p-10 -63.48 -5.54 3.88 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.073 1.749 . . . . 0.0 113.886 173.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.4 -1.07 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.124 0.874 . . . . 0.0 112.687 167.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.19 -12.51 15.71 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.247 1.419 . . . . 0.0 113.316 174.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 . . . . . 0 C--O 1.248 1.003 0 C-N-CA 126.461 1.904 . . . . 0.0 107.395 159.126 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tp . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 121.625 0.726 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.48 171.04 15.16 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 -173.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -45.38 -58.89 3.0 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 127.562 2.345 . . . . 0.0 112.758 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.66 96.89 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.531 -0.731 . . . . 0.0 111.341 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -68.05 -26.97 66.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.395 1.078 . . . . 0.0 110.314 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -65.18 -6.44 9.34 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 125.128 1.371 . . . . 0.0 112.431 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -121.19 -56.15 1.93 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 162.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -67.89 -12.6 61.01 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -168.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.26 -3.87 13.79 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.593 1.157 . . . . 0.0 113.044 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.423 HG13 ' H ' ' A' ' 15' ' ' GLN . 11.7 pt -91.83 -105.95 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 158.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.423 ' H ' HG13 ' A' ' 14' ' ' ILE . 3.1 pt20 47.95 -10.26 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.77 1 C-N-CA 131.859 4.064 . . . . 0.0 118.881 174.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.27 179.94 17.48 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.144 1.831 . . . . 0.0 112.29 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.14 -11.43 57.94 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.087 1.755 . . . . 0.0 112.869 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.4 150.02 51.7 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.72 97.42 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.036 2.491 . . . . 0.0 110.34 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.1 t -105.33 140.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.95 136.44 46.11 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.793 0.806 . . . . 0.0 110.206 172.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.87 120.99 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 126.707 2.003 . . . . 0.0 105.965 -170.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.02 92.06 4.22 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -77.97 113.77 16.19 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.028 0.931 . . . . 0.0 108.9 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -131.97 -174.21 3.36 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 170.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.46 167.67 26.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.642 1.577 . . . . 0.0 107.584 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.9 -8.89 32.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.357 1.244 . . . . 0.0 114.357 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -110.53 -21.49 12.12 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -172.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 p -77.87 45.55 0.52 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -158.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 29.3 -95.17 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 C-N-CA 128.782 3.086 . . . . 0.0 114.213 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.07 -21.68 60.2 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.41 2.74 . . . . 0.0 114.538 -176.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.1 p -56.97 -32.37 65.99 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.448 1.476 . . . . 0.0 111.436 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -72.25 -18.91 61.78 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.751 1.22 . . . . 0.0 112.182 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -98.73 -18.11 18.18 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.086 1.354 . . . . 0.0 111.251 173.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.8 ttt -74.2 -37.62 63.84 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.602 1.561 . . . . 0.0 109.377 168.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.77 -51.56 45.3 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.495 -1.241 . . . . 0.0 113.171 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.68 -33.4 13.15 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 121.739 1.657 . . . . 0.0 113.051 171.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -28.89 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 121.258 1.844 . . . . 0.0 110.777 175.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.43 -13.1 61.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.765 2.026 . . . . 0.0 112.711 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -79.42 -40.7 29.37 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.682 1.128 . . . . 0.0 108.982 171.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.44 -16.89 64.45 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.733 0.813 . . . . 0.0 111.383 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -83.13 -43.89 15.72 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.426 1.09 . . . . 0.0 111.43 169.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.68 -48.66 49.47 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.938 0.895 . . . . 0.0 110.871 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -54.95 -43.0 73.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.458 1.103 . . . . 0.0 111.765 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.21 -12.49 28.71 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.551 1.141 . . . . 0.0 113.369 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -156.01 49.88 0.52 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.544 1.137 . . . . 0.0 110.056 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.07 -47.45 53.6 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.959 0.904 . . . . 0.0 112.459 -170.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -124.65 -6.2 7.5 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 171.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -55.07 -31.15 60.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.177 1.391 . . . . 0.0 111.765 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.26 177.26 6.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.676 1.19 . . . . 0.0 109.321 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 m -117.18 96.92 5.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.817 1.247 . . . . 0.0 107.741 164.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.77 149.25 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 160.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.58 109.03 3.98 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.432 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -88.32 145.5 25.8 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.767 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -154.38 157.29 38.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.659 0.784 . . . . 0.0 112.374 173.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -76.81 106.19 8.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.688 1.595 . . . . 0.0 109.187 174.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 p -64.1 -28.9 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.015 0.926 . . . . 0.0 112.685 -173.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.54 -30.25 71.28 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.341 1.056 . . . . 0.0 110.891 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -98.44 -20.45 17.11 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.578 1.951 . . . . 0.0 112.062 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -104.76 92.52 5.19 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.115 167.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.69 -17.95 22.69 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.062 1.841 . . . . 0.0 113.533 167.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.5 OUTLIER -64.7 113.63 3.89 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.568 1.147 . . . . 0.0 109.282 -173.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.303 17.6 m 66.13 -14.69 0.14 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.329 2.651 . . . . 0.0 113.63 176.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 62' ' ' GLU . 95.4 m -50.41 -55.24 16.64 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.321 1.848 . . . . 0.0 108.486 158.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -72.01 -6.79 44.75 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 117.847 -1.073 . . . . 0.0 113.103 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.77 -52.84 4.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.403 1.001 . . . . 0.0 109.364 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -81.2 16.87 1.42 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.159 0.89 . . . . 0.0 112.43 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.32 32.02 80.75 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 121.558 -0.714 . . . . 0.0 111.775 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.3 mm -77.43 81.3 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.538 1.135 . . . . 0.0 108.083 -172.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -117.88 14.4 14.21 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.783 1.633 . . . . 0.0 112.472 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.1 m -154.78 158.98 40.31 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.74 -1.225 . . . . 0.0 109.802 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.8 pt -155.05 162.51 27.07 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 129.28 3.032 . . . . 0.0 107.568 -171.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.2 127.59 7.24 Favored 'Cis proline' 0 C--N 1.349 0.565 0 CA-C-N 119.952 1.018 . . . . 0.0 110.653 -6.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.3 m -124.56 136.34 53.89 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.325 1.05 . . . . 0.0 108.797 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 tt -130.01 117.56 20.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.9 mt -126.38 129.65 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 tt -96.67 126.32 41.75 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.62 153.44 39.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.594 1.157 . . . . 0.0 110.613 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -158.56 153.37 24.89 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 124.757 1.223 . . . . 0.0 108.434 158.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.86 11.47 24.26 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 119.424 -0.653 . . . . 0.0 113.355 -169.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.65 0.58 89.95 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 118.345 1.072 . . . . 0.0 113.717 -170.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -107.82 136.16 19.74 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 119.34 1.57 . . . . 0.0 109.691 -173.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.99 110.31 3.02 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.361 2.707 . . . . 0.0 110.965 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.79 -37.19 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.629 1.572 . . . . 0.0 110.981 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -154.68 157.32 37.93 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.865 0.866 . . . . 0.0 109.108 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -141.24 127.73 20.03 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 126.937 2.095 . . . . 0.0 105.989 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mp -122.58 139.77 53.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.429 1.891 . . . . 0.0 106.03 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.09 121.86 29.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.207 1.403 . . . . 0.0 108.248 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.02 172.7 23.46 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.128 1.347 . . . . 0.0 112.507 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -69.7 85.22 0.46 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.285 1.034 . . . . 0.0 108.473 171.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.98 120.99 77.11 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 169.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -65.96 160.6 43.52 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.288 1.325 . . . . 0.0 109.92 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.44 -52.46 13.05 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 125.264 1.426 . . . . 0.0 112.558 -172.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -59.77 -25.95 65.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.911 1.284 . . . . 0.0 112.673 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -88.12 -42.18 12.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.033 0.933 . . . . 0.0 109.849 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.32 -60.83 3.0 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.658 1.983 . . . . 0.0 110.384 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -57.8 -33.45 68.59 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.189 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.05 -48.7 62.17 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 119.616 1.098 . . . . 0.0 111.119 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.0 tp-100 -63.25 -38.26 90.47 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.243 0.617 . . . . 0.0 111.33 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.86 -1.4 56.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.034 0.933 . . . . 0.0 112.912 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.46 -38.95 66.97 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 124.235 1.014 . . . . 0.0 112.798 -165.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -69.83 -6.47 32.67 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.647 1.112 . . . . 0.0 113.305 -176.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.28 1.29 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.654 1.182 . . . . 0.0 111.934 170.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -124.78 -4.03 7.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.005 1.722 . . . . 0.0 113.384 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.119 0 C-N-CA 126.792 2.037 . . . . 0.0 110.38 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.465 0.288 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -138.15 -178.65 5.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 164.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.31 -60.37 3.2 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.989 2.115 . . . . 0.0 112.777 -161.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.94 -34.53 77.67 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -77.04 -19.14 57.56 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.914 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -57.18 -59.73 4.66 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.529 1.059 . . . . 0.0 109.759 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -42.6 99.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.589 0.356 . . . . 0.0 110.48 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.64 -26.7 61.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.159 0.584 . . . . 0.0 112.149 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.74 -26.94 19.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.828 -1.082 . . . . 0.0 112.655 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.486 HG13 ' H ' ' A' ' 15' ' ' GLN 0.279 11.3 pt -75.22 -91.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.95 0.795 . . . . 0.0 109.517 171.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.486 ' H ' HG13 ' A' ' 14' ' ' ILE . 13.9 pt20 45.85 -17.77 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.758 1 C-N-CA 133.207 4.603 . . . . 0.0 119.632 174.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.02 -179.06 25.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.757 1.162 . . . . 0.0 112.887 -159.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -81.46 -13.57 58.04 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.85 2.06 . . . . 0.0 114.207 -167.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.93 156.04 41.28 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 118.577 0.626 . . . . 0.0 112.036 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.15 81.96 1.11 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.778 2.985 . . . . 0.0 110.466 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.4 t -87.81 138.11 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.8 tt -133.75 141.27 47.44 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.91 125.63 58.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -170.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.71 96.85 6.2 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.747 1.219 . . . . 0.0 108.218 175.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -75.11 115.78 15.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -117.49 176.76 5.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 168.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.62 161.22 40.99 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.294 -0.879 . . . . 0.0 110.392 174.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.31 15.06 0.48 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.321 1.049 . . . . 0.0 113.579 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.411 ' CG ' ' N ' ' A' ' 29' ' ' CYS . 2.2 p90 -136.82 -61.72 0.66 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.215 1.006 . . . . 0.0 108.553 168.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.411 ' N ' ' CG ' ' A' ' 28' ' ' TRP . 16.3 p 44.16 -62.95 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 1 C-N-CA 132.024 4.13 . . . . 0.0 117.525 178.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.76 -103.83 3.06 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.951 1.739 . . . . 0.0 109.802 -161.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -60.19 -21.12 64.96 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.451 2.767 . . . . 0.0 115.15 -171.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -60.75 -25.3 66.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.947 1.248 . . . . 0.0 111.466 173.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -22.3 65.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.394 0.997 . . . . 0.0 111.932 174.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 84.0 mtp -98.54 -25.0 14.9 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 125.946 1.698 . . . . 0.0 111.429 176.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.2 ttt -83.38 -36.37 24.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 117.521 -1.228 . . . . 0.0 109.109 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.87 -51.13 57.24 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.871 1.669 . . . . 0.0 112.482 175.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -62.41 -39.43 46.28 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 121.444 1.551 . . . . 0.0 112.422 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.25 -20.67 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 119.981 1.264 . . . . 0.0 112.071 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.84 -17.39 24.15 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.242 1.817 . . . . 0.0 111.612 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.04 -45.84 69.41 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 167.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -53.83 -50.14 66.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.954 1.301 . . . . 0.0 110.151 167.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.86 -51.39 67.72 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.095 0.558 . . . . 0.0 110.974 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.57 -55.85 19.4 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.881 0.872 . . . . 0.0 110.532 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.68 -43.6 85.18 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.672 0.608 . . . . 0.0 111.217 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.79 -21.31 10.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -147.63 40.94 1.02 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.481 1.112 . . . . 0.0 111.003 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.52 -37.17 16.91 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.951 1.7 . . . . 0.0 115.275 -162.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -132.26 6.27 4.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -66.24 -34.58 78.33 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.527 -0.733 . . . . 0.0 109.825 166.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.65 171.64 5.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.338 0.6 OUTLIER -118.62 97.81 5.92 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 159.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 p -84.89 159.76 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.2 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.38 156.92 44.07 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 162.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -123.03 138.09 54.77 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 172.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pp -150.87 150.83 31.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.867 0.467 . . . . 0.0 110.956 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -82.79 116.57 22.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.81 -27.86 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.8 0.84 . . . . 0.0 112.142 -175.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -67.63 -31.45 71.47 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.683 0.793 . . . . 0.0 111.0 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -83.97 -24.82 30.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.034 0.934 . . . . 0.0 111.907 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -113.84 86.63 11.23 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.309 1.043 . . . . 0.0 109.856 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.03 -24.51 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.124 2.55 . . . . 0.0 113.752 171.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -69.23 131.16 44.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.788 1.176 . . . . 0.0 109.808 -177.179 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.9 m 69.68 -31.8 0.22 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.42 2.688 . . . . 0.0 112.453 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 62' ' ' GLU . 94.1 m -53.51 -54.74 32.93 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.471 1.909 . . . . 0.0 109.721 170.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.6 t -70.03 -1.94 11.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.766 -1.111 . . . . 0.0 113.157 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -106.69 -35.09 7.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.663 1.12 . . . . 0.0 111.339 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -99.1 14.93 27.55 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.794 0.725 . . . . 0.0 112.119 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.99 33.53 85.81 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 123.486 0.565 . . . . 0.0 111.899 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.7 mm -74.3 80.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.416 1.486 . . . . 0.0 108.312 -171.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 21.7 ttt -138.89 40.12 2.15 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.255 1.422 . . . . 0.0 109.642 -176.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.2 m -155.11 61.41 0.64 Allowed 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.468 -1.395 . . . . 0.0 109.565 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.48 153.79 81.54 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.686 173.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -67.32 126.08 7.45 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 CA-C-N 119.206 0.752 . . . . 0.0 110.544 -5.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -114.53 130.49 56.76 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.99 119.6 30.02 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -173.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.52 148.7 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -121.98 132.97 54.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -121.35 155.1 35.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.064 1.346 . . . . 0.0 110.842 -173.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -164.62 151.39 11.04 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.333 1.453 . . . . 0.0 109.229 158.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.03 15.81 50.88 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.652 0.644 . . . . 0.0 112.353 -165.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.02 -3.59 28.26 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.843 -0.976 . . . . 0.0 113.862 -166.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.74 133.56 39.41 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 119.522 1.661 . . . . 0.0 108.821 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.45 95.82 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.272 2.648 . . . . 0.0 109.299 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 m -61.14 -35.56 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 O-C-N 121.656 -0.653 . . . . 0.0 111.917 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.88 159.85 43.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.012 0.434 . . . . 0.0 111.636 159.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.13 140.92 48.93 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 127.538 2.335 . . . . 0.0 107.303 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -123.39 152.59 41.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 127.702 2.401 . . . . 0.0 107.625 168.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.73 126.18 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.82 163.75 39.14 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.607 1.099 . . . . 0.0 113.101 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -61.82 134.05 56.23 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.057 1.343 . . . . 0.0 110.535 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -137.91 144.01 42.24 Favored Pre-proline 0 C--O 1.242 0.671 0 C-N-CA 124.89 1.276 . . . . 0.0 107.608 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.94 157.27 57.76 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.192 1.928 . . . . 0.0 109.155 169.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.559 ' N ' ' HZ2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -61.54 -38.47 87.57 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.149 -0.97 . . . . 0.0 110.779 -175.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.22 -21.37 13.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.059 0.944 . . . . 0.0 113.02 174.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -97.92 -50.91 4.24 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 119.49 1.041 . . . . 0.0 110.454 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.74 -58.9 6.32 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.837 1.655 . . . . 0.0 109.527 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.52 -30.77 68.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.931 1.292 . . . . 0.0 110.657 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.71 -46.25 32.14 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.547 0.612 . . . . 0.0 110.965 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.7 tp-100 -64.75 -31.22 72.35 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.424 1.09 . . . . 0.0 111.19 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.24 2.17 56.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.345 1.058 . . . . 0.0 112.511 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.18 -19.04 61.13 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -19.79 62.88 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.066 1.757 . . . . 0.0 111.672 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.31 -7.23 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 125.779 1.632 . . . . 0.0 111.783 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.05 5.96 28.52 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.557 1.543 . . . . 0.0 112.78 167.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.962 0 C-N-CA 126.157 1.783 . . . . 0.0 109.618 165.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 tp . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 121.339 0.59 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 t -142.64 -127.67 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -98.79 -62.22 1.27 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.982 1.313 . . . . 0.0 109.49 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.94 79.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.62 1.168 . . . . 0.0 111.008 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -72.24 -24.54 61.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.335 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -71.45 -48.83 46.94 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.07 -32.98 74.74 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.949 -0.548 . . . . 0.0 112.3 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -64.85 -50.32 67.1 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.166 0.894 . . . . 0.0 110.2 167.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.74 -48.21 72.86 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.143 0.883 . . . . 0.0 111.372 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt -63.01 -1.98 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -52.23 -31.6 32.83 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.233 1.379 . . . . 0.0 111.909 171.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.99 -133.28 13.98 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 116.531 1.372 . . . . 0.0 116.531 158.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.6 t70 64.29 -50.16 0.29 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 130.221 3.408 . . . . 0.0 111.303 -158.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.4 160.68 46.0 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.68 107.04 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.19 2.593 . . . . 0.0 110.956 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.3 t -94.52 107.02 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.97 153.59 22.06 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 164.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.26 150.88 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 164.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -110.7 104.62 13.31 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.411 ' CE2' HG22 ' A' ' 69' ' ' ILE . 79.0 m-85 -89.31 108.2 19.49 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 164.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -131.49 -176.39 4.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.528 1.531 . . . . 0.0 107.019 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.18 171.25 20.25 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.692 1.197 . . . . 0.0 108.132 164.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.52 80.61 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.52 -23.91 18.94 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -163.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.9 p -75.6 40.19 0.18 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.298 1.839 . . . . 0.0 115.256 -159.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 42.48 -99.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 127.718 2.58 . . . . 0.0 113.974 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -57.52 -23.48 56.51 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.528 2.819 . . . . 0.0 114.396 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.9 p -56.91 -34.63 68.13 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.511 1.05 . . . . 0.0 111.417 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -71.12 -8.0 50.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.357 1.063 . . . . 0.0 112.359 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.7 mtm -106.88 -12.3 15.51 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.81 1.644 . . . . 0.0 112.222 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -40.42 11.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.813 2.045 . . . . 0.0 108.851 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.34 -56.23 19.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.233 1.413 . . . . 0.0 112.177 170.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.57 -25.01 69.79 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.143 1.801 . . . . 0.0 113.017 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.1 t -68.78 -46.35 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.365 0.984 . . . . 0.0 109.677 170.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 mp -61.15 -36.2 79.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.698 1.599 . . . . 0.0 111.901 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.18 -7.64 38.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.218 2.207 . . . . 0.0 112.099 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -109.81 -50.72 2.95 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.368 1.467 . . . . 0.0 109.47 168.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.452 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 47.4 t80 -45.45 -51.76 11.07 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 125.811 1.645 . . . . 0.0 112.22 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.15 -63.09 1.24 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.601 1.161 . . . . 0.0 110.369 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.88 -33.77 74.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.61 1.564 . . . . 0.0 111.993 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.77 -19.4 27.79 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -140.7 48.5 1.72 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.142 1.377 . . . . 0.0 109.028 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.24 -37.44 16.1 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.077 1.351 . . . . 0.0 114.259 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -130.32 3.22 4.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -65.46 -36.78 84.9 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.679 1.127 . . . . 0.0 109.094 159.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.6 m -111.09 174.27 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.248 1.019 . . . . 0.0 108.696 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.4 134.72 48.87 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 158.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.6 p -137.01 161.06 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.552 1.141 . . . . 0.0 109.827 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -165.09 166.35 19.23 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.275 171.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.15 148.1 42.67 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.52 137.05 36.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 125.812 1.945 . . . . 0.0 111.403 169.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -75.21 101.11 4.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 p -61.56 -25.3 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.373 1.069 . . . . 0.0 112.374 -166.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.01 -18.79 61.31 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.367 1.867 . . . . 0.0 112.649 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -114.97 -43.62 3.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 127.68 2.392 . . . . 0.0 109.887 -171.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -114.93 81.88 7.92 Favored Pre-proline 0 N--CA 1.443 -0.795 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.2 -68.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.235 2.623 . . . . 0.0 111.828 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 29.32 99.34 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.357 2.663 . . . . 0.0 115.586 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.263 38.6 m 67.71 -8.39 0.52 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.748 1.219 . . . . 0.0 113.165 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -49.36 -50.14 41.3 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.488 -1.382 . . . . 0.0 111.173 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.9 t -71.75 -3.68 23.37 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 117.657 -1.163 . . . . 0.0 112.778 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -95.6 -32.05 12.99 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.731 1.15 . . . . 0.0 111.68 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -110.48 0.74 17.89 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.82 35.91 43.89 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.263 0.935 . . . . 0.0 112.399 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.411 HG22 ' CE2' ' A' ' 24' ' ' PHE . 42.8 mm -82.17 48.88 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.376 1.47 . . . . 0.0 111.778 -163.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 18.0 ttt -88.32 2.35 52.66 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.754 1.222 . . . . 0.0 110.348 163.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 p -72.77 13.97 0.32 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.202 2.201 . . . . 0.0 114.907 -176.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.41 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -65.16 144.75 99.1 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 123.907 0.883 . . . . 0.0 112.014 -165.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 57.5 Cg_endo -65.94 132.09 15.42 Favored 'Cis proline' 0 C--N 1.35 0.622 0 CA-C-N 119.268 0.774 . . . . 0.0 111.398 2.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.5 m -131.44 141.1 49.75 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.563 0.745 . . . . 0.0 109.144 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -135.87 98.92 4.02 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.1 mt -88.29 145.99 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.35 99.21 7.04 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -96.47 160.83 14.2 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.552 1.941 . . . . 0.0 109.685 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -157.78 39.02 0.27 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 158.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 82' ' ' GLU . . . 159.39 52.38 0.01 OUTLIER Glycine 0 N--CA 1.463 0.468 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 169.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.4 -25.53 0.58 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.31 1.91 . . . . 0.0 112.677 -168.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 80' ' ' GLY . 42.0 tt0 -91.72 131.71 35.04 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.43 1.892 . . . . 0.0 110.028 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.85 126.55 7.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.988 3.125 . . . . 0.0 110.78 170.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.8 -38.4 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 121.661 -0.65 . . . . 0.0 110.448 165.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -154.1 172.07 18.11 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 118.623 0.647 . . . . 0.0 111.233 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -138.35 136.15 36.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.196 1.799 . . . . 0.0 108.032 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.25 141.29 43.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.19 2.196 . . . . 0.0 105.851 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 pt -139.78 152.32 22.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.575 1.15 . . . . 0.0 108.838 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.19 168.1 6.86 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.838 0.732 . . . . 0.0 111.65 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -81.61 75.08 8.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.723 -0.869 . . . . 0.0 110.563 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -75.42 122.9 88.19 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 158.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -71.84 173.75 12.24 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.089 1.859 . . . . 0.0 110.7 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.452 ' HE2' ' OE1' ' A' ' 97' ' ' GLU . 22.8 tptm -31.8 -59.12 0.27 Allowed 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 127.561 2.344 . . . . 0.0 112.483 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.72 -49.81 64.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.802 1.313 . . . . 0.0 111.643 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -74.22 -42.01 60.44 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.496 1.118 . . . . 0.0 110.033 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 tt -59.78 -62.46 1.86 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.594 1.558 . . . . 0.0 108.983 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.452 ' OE1' ' HE2' ' A' ' 93' ' ' LYS . 11.3 tt0 -66.09 -25.92 67.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.224 1.41 . . . . 0.0 111.102 -177.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.93 -52.48 24.18 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.212 0.915 . . . . 0.0 110.412 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -59.7 -40.0 86.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.391 0.541 . . . . 0.0 111.367 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.27 -0.66 50.57 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.797 1.239 . . . . 0.0 112.764 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.6 -28.97 66.09 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.363 0.983 . . . . 0.0 112.142 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -69.67 -3.71 16.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.626 1.17 . . . . 0.0 113.488 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.88 -15.58 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.156 0.889 . . . . 0.0 112.416 164.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.37 -9.98 50.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.015 0.926 . . . . 0.0 113.204 173.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 C-N-CA 125.641 1.576 . . . . 0.0 110.622 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tp . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.5 m -150.02 157.2 42.9 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -46.51 -53.4 11.34 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 127.172 2.189 . . . . 0.0 113.207 -168.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.03 93.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.051 0.929 . . . . 0.0 111.746 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -69.91 -18.47 63.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.124 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -58.12 -60.9 3.03 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.252 0.621 . . . . 0.0 110.242 172.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -63.47 -39.64 95.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.322 -0.37 . . . . 0.0 110.56 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -63.65 -27.99 69.61 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.609 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.64 -60.39 2.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.659 1.118 . . . . 0.0 109.517 168.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.8 pt -64.89 -23.28 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -167.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -59.53 -30.09 68.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 164.16 104.39 0.18 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.316 0.962 . . . . 0.0 110.734 -168.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -160.93 -65.03 0.06 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.614 1.566 . . . . 0.0 109.778 -169.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.22 -161.39 32.48 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 -164.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.44 112.48 1.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.491 2.127 . . . . 0.0 108.855 167.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.7 t -110.3 141.16 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 125.501 1.521 . . . . 0.0 107.199 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.1 tp -145.2 111.33 5.59 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 118.028 0.377 . . . . 0.0 110.469 -167.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.4 t -112.83 121.99 66.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 118.957 0.799 . . . . 0.0 109.436 -163.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -82.36 106.76 14.5 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.49 105.3 16.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 162.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.3 p-90 -117.95 -179.44 3.76 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 166.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.76 152.04 32.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 120.505 -1.372 . . . . 0.0 110.336 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -23.9 66.7 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.93 -13.27 29.09 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 p -71.55 178.25 3.61 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.214 0.605 . . . . 0.0 112.386 -164.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.97 -93.5 1.87 Allowed Glycine 0 CA--C 1.538 1.489 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 164.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -66.85 -21.27 50.87 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.381 2.721 . . . . 0.0 114.133 -166.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -30.37 68.81 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.521 0.6 . . . . 0.0 111.225 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 -71.8 -13.16 61.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.501 1.12 . . . . 0.0 111.981 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 76.4 mtm -98.6 -37.2 9.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.105 1.362 . . . . 0.0 111.089 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.8 ttt -67.44 -43.02 82.13 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.874 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.22 -50.64 74.58 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 119.956 1.253 . . . . 0.0 113.284 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.93 -33.43 26.35 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.849 1.696 . . . . 0.0 112.684 170.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -29.56 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 120.093 1.315 . . . . 0.0 112.018 173.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.7 mt -82.98 -23.9 33.17 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.667 2.387 . . . . 0.0 110.904 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -70.05 -35.93 74.62 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.824 0.738 . . . . 0.0 110.6 171.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.03 -35.43 61.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.134 0.879 . . . . 0.0 111.107 174.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -55.02 -46.06 75.21 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.326 0.65 . . . . 0.0 109.549 166.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.12 -51.68 68.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.427 -0.796 . . . . 0.0 111.274 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.93 -46.46 74.93 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.445 0.698 . . . . 0.0 110.311 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.4 -16.07 59.42 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -138.89 28.55 2.35 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.058 1.343 . . . . 0.0 112.271 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.46 65.79 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -164.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -95.38 -45.61 7.05 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.304 2.642 . . . . 0.0 111.316 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -66.51 -19.61 65.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.785 1.634 . . . . 0.0 113.029 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.35 143.16 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 119.14 0.882 . . . . 0.0 110.058 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.8 m -78.01 60.07 2.3 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.724 1.61 . . . . 0.0 107.743 168.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 p -71.3 151.09 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.03 169.51 24.4 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -144.32 125.7 14.81 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -168.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.39 154.51 43.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.838 1.304 . . . . 0.0 114.112 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -87.57 105.22 17.18 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.26 -14.65 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 121.382 -0.824 . . . . 0.0 112.207 -172.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.93 -35.79 82.3 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.197 1.399 . . . . 0.0 111.643 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -74.47 -33.1 62.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.287 1.035 . . . . 0.0 110.638 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -111.43 87.43 7.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.115 0.966 . . . . 0.0 111.985 -164.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -80.95 -19.82 8.02 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.64 2.893 . . . . 0.0 113.951 168.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.5 OUTLIER -71.61 128.88 37.26 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.645 1.111 . . . . 0.0 109.649 -177.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.0 m 68.54 -28.79 0.16 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.807 2.443 . . . . 0.0 112.696 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 62' ' ' GLU . 30.2 m -53.14 -55.71 21.97 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.03 1.732 . . . . 0.0 109.649 167.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -70.6 -4.01 21.08 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 117.917 -1.04 . . . . 0.0 112.855 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -94.39 -34.25 12.84 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.563 1.074 . . . . 0.0 110.714 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -106.06 11.36 31.57 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.64 0.655 . . . . 0.0 112.117 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.22 35.23 90.1 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 123.939 0.78 . . . . 0.0 111.553 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.58 87.98 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.993 0.901 . . . . 0.0 109.979 -168.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.2 ttt -125.81 -1.35 7.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.514 1.525 . . . . 0.0 110.74 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.1 p -72.95 23.27 0.06 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.706 2.402 . . . . 0.0 114.824 -169.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.4 pt -68.61 150.87 97.53 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -159.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.86 130.19 9.15 Favored 'Cis proline' 0 C--N 1.353 0.766 0 CA-C-N 118.89 0.639 . . . . 0.0 110.682 -7.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.1 m -114.14 130.56 56.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.9 tt -120.12 109.95 16.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -119.08 132.88 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tt -102.56 137.95 40.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -135.18 163.99 28.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.386 1.874 . . . . 0.0 108.757 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -153.86 140.92 19.36 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 158.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 39.13 53.46 2.64 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 126.219 1.866 . . . . 0.0 114.49 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.1 -7.24 78.85 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.842 1.21 . . . . 0.0 114.338 176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.19 123.7 36.09 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 119.453 1.626 . . . . 0.0 110.049 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -71.65 135.38 25.98 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.099 2.532 . . . . 0.0 109.89 169.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.9 t -100.4 -56.14 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.625 1.17 . . . . 0.0 110.033 -173.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -155.56 163.9 39.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.743 0.701 . . . . 0.0 109.975 170.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -120.86 132.27 54.89 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.811 2.044 . . . . 0.0 107.267 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.53 144.93 38.63 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.97 2.508 . . . . 0.0 106.411 169.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.8 pt -139.64 120.11 14.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.497 1.119 . . . . 0.0 109.622 -170.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.83 168.86 42.34 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.073 0.844 . . . . 0.0 111.905 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.74 81.08 1.57 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.792 1.637 . . . . 0.0 110.501 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -68.63 133.73 90.64 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.31 159.73 52.02 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.496 1.464 . . . . 0.0 109.532 165.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.51 -41.03 72.54 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 123.446 0.699 . . . . 0.0 112.748 -170.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.83 -29.72 68.45 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.012 0.925 . . . . 0.0 112.667 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.5 -47.28 11.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.345 1.858 . . . . 0.0 107.496 178.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.34 -62.48 1.81 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.139 2.176 . . . . 0.0 109.846 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -30.19 71.33 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 117.607 -1.187 . . . . 0.0 110.602 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.49 -26.41 64.54 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 122.044 2.202 . . . . 0.0 111.679 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.03 -17.26 61.0 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 167.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 tp -128.42 -9.0 5.19 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -159.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.88 -15.88 24.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.136 2.174 . . . . 0.0 112.702 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -72.81 -20.26 61.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.494 1.118 . . . . 0.0 113.261 170.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.51 -6.69 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.149 1.78 . . . . 0.0 112.746 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.6 6.09 49.82 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.196 1.798 . . . . 0.0 109.808 158.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 C--O 1.25 1.082 0 C-N-CA 124.653 1.181 . . . . 0.0 109.717 163.679 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.528 0.108 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.0 p -134.96 -62.01 0.74 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.778 0.799 . . . . 0.0 110.528 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 8' ' ' ALA . 39.0 p-10 -179.3 -78.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.468 1.907 . . . . 0.0 108.807 -159.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.446 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . -61.69 -38.44 87.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.984 0.913 . . . . 0.0 109.66 172.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -75.82 -21.53 57.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.362 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -67.58 -55.87 11.69 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 173.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -63.02 -35.63 80.85 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.39 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -58.11 -46.3 85.79 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.801 0.728 . . . . 0.0 110.638 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.34 -40.7 96.39 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.026 -0.988 . . . . 0.0 112.567 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . 0.257 11.8 pt -72.22 -67.31 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 118.851 0.75 . . . . 0.0 111.613 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 37.78 -13.39 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.601 1 C-N-CA 134.905 5.282 . . . . 0.0 120.359 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 174.1 -159.93 29.47 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 120.78 1.627 . . . . 0.0 116.049 -166.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.52 -9.37 56.49 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.211 3.004 . . . . 0.0 115.835 -161.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.52 164.2 54.03 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 119.093 0.86 . . . . 0.0 112.967 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.33 110.25 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.293 2.662 . . . . 0.0 107.775 166.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.416 ' HA ' ' HB ' ' A' ' 51' ' ' THR . 60.1 t -122.2 142.54 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 pp -133.5 155.85 48.82 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.161 0.505 . . . . 0.0 110.156 168.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.55 124.2 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.605 1.562 . . . . 0.0 107.612 -173.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.01 100.9 13.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.676 1.59 . . . . 0.0 107.967 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -89.71 109.77 20.72 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.915 0.886 . . . . 0.0 108.979 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -137.4 -171.86 3.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.97 170.19 21.08 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.196 1.398 . . . . 0.0 107.454 169.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.38 -14.65 62.42 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.53 -24.11 9.43 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -166.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 p -70.94 34.59 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 127.275 2.23 . . . . 0.0 116.51 -160.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 52.3 -110.21 1.11 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.523 1.535 . . . . 0.0 113.372 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.11 -14.94 31.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.085 3.19 . . . . 0.0 114.921 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 17.5 p -54.54 -30.96 55.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.988 0.813 . . . . 0.0 111.856 165.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -71.69 -6.21 39.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.161 0.984 . . . . 0.0 112.923 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.6 mtm -108.82 -30.41 8.16 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.974 1.709 . . . . 0.0 111.371 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.3 tpt -75.07 -43.91 50.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.227 1.811 . . . . 0.0 109.406 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.0 95.41 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 116.806 -1.569 . . . . 0.0 112.09 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -63.7 -34.68 61.66 Favored 'Trans proline' 0 C--N 1.352 0.728 0 CA-C-N 122.432 1.904 . . . . 0.0 112.54 173.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.29 -33.39 63.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 119.728 1.149 . . . . 0.0 110.983 174.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mp -75.92 -23.08 55.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.715 1.606 . . . . 0.0 111.672 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.404 ' CD ' ' HZ2' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -66.04 -44.8 83.54 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 124.331 1.052 . . . . 0.0 109.425 169.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.466 ' OE2' ' HE3' ' A' ' 93' ' ' LYS . 19.0 tt0 -59.22 -48.88 79.99 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 172.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -52.33 -49.48 64.18 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 122.665 0.386 . . . . 0.0 110.748 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.1 -51.93 58.45 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.971 0.908 . . . . 0.0 111.33 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.15 -47.51 75.0 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.366 0.667 . . . . 0.0 109.992 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.14 -17.09 64.19 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -136.0 14.42 3.33 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -168.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -42.5 -46.03 4.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.912 1.685 . . . . 0.0 113.366 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -86.0 -13.46 47.47 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -94.29 -21.93 18.7 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.69 -0.631 . . . . 0.0 111.483 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.47 137.45 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 122.207 1.003 . . . . 0.0 109.803 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.416 ' HB ' ' HA ' ' A' ' 20' ' ' VAL . 3.5 m -77.75 86.84 4.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.319 1.848 . . . . 0.0 107.16 -175.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.4 t -80.44 159.72 4.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -176.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.01 158.85 25.64 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 162.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HZ2' ' CD ' ' A' ' 40' ' ' GLU . 77.9 tttt -135.92 129.38 32.15 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -166.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.67 151.72 34.17 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 122.525 1.155 . . . . 0.0 113.227 -174.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -87.17 103.96 15.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.286 1.835 . . . . 0.0 107.503 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.21 -24.29 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.279 1.032 . . . . 0.0 113.513 -165.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.43 -42.89 78.24 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.881 0.872 . . . . 0.0 110.708 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -81.81 -18.22 44.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.364 2.266 . . . . 0.0 111.914 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -109.59 78.68 1.2 Allowed Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.849 1.66 . . . . 0.0 109.805 173.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.08 -18.06 14.73 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.269 2.646 . . . . 0.0 112.481 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 64' ' ' THR . 4.4 tp10 -64.71 125.75 25.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.143 1.377 . . . . 0.0 109.619 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.2 m 66.53 -29.56 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.932 3.293 . . . . 0.0 112.492 -174.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.48 ' H ' ' C ' ' A' ' 62' ' ' GLU . 24.5 m -52.36 -54.05 36.82 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.815 2.046 . . . . 0.0 110.587 172.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.8 t -62.03 -41.92 98.62 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.166 0.292 . . . . 0.0 110.508 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -60.91 -42.4 97.99 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.993 0.917 . . . . 0.0 111.87 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -96.63 5.52 50.56 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.4 33.48 72.83 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 119.224 0.92 . . . . 0.0 112.125 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.5 mm -75.75 82.37 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.599 1.56 . . . . 0.0 110.118 -166.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 93.4 mtp -122.47 -3.29 8.87 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.625 1.17 . . . . 0.0 111.688 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.1 t -84.69 21.93 1.43 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.733 1.213 . . . . 0.0 113.998 -166.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.409 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 26.2 pt -56.05 144.1 60.29 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.108 1.363 . . . . 0.0 112.935 -170.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.409 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 57.1 Cg_endo -65.74 139.25 40.79 Favored 'Cis proline' 0 C--N 1.35 0.637 0 CA-C-O 121.99 0.746 . . . . 0.0 111.085 -1.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -138.09 149.19 45.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.6 tt -135.03 123.41 23.24 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.267 -2.124 . . . . 0.0 105.267 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.1 mt -124.84 147.67 29.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tt -129.35 124.04 33.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.044 0.937 . . . . 0.0 108.897 -168.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -116.31 152.11 34.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.242 1.817 . . . . 0.0 110.398 -171.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 148.94 26.33 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 125.34 1.456 . . . . 0.0 107.38 158.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.15 20.78 71.4 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -168.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.95 3.3 55.42 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.478 -1.179 . . . . 0.0 114.044 -171.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -120.39 139.34 28.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 119.589 1.694 . . . . 0.0 109.454 -170.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.63 125.91 9.21 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.011 2.474 . . . . 0.0 111.775 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -78.33 -43.48 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 123.78 0.832 . . . . 0.0 110.781 175.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -158.77 169.97 23.19 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.022 0.929 . . . . 0.0 109.864 -174.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -137.02 157.22 47.21 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.84 1.256 . . . . 0.0 111.13 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -123.36 145.26 48.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 127.947 2.499 . . . . 0.0 106.087 169.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.6 pt -138.79 156.14 28.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 124.756 1.223 . . . . 0.0 109.058 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.07 179.08 11.17 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -71.4 126.15 28.89 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -126.23 134.5 26.03 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 165.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.99 159.15 47.82 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.167 1.245 . . . . 0.0 110.011 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.466 ' HE3' ' OE2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -49.51 -36.96 24.78 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 125.293 1.437 . . . . 0.0 112.686 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -58.7 -50.11 75.11 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.649 1.58 . . . . 0.0 110.973 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -74.39 -36.73 63.51 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.874 1.269 . . . . 0.0 109.378 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.79 -63.28 1.25 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.471 1.108 . . . . 0.0 108.04 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.36 -31.69 73.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 118.379 -0.82 . . . . 0.0 110.754 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.76 -44.03 78.44 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.694 0.679 . . . . 0.0 110.75 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -67.15 -38.26 85.19 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 118.24 0.473 . . . . 0.0 111.493 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.15 -6.43 59.0 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.958 0.903 . . . . 0.0 112.997 -173.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.66 -33.2 15.0 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.954 1.701 . . . . 0.0 114.201 -175.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.16 -6.56 9.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.64 1.564 . . . . 0.0 114.17 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.36 2.92 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.261 0.937 . . . . 0.0 113.108 166.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.32 -13.5 13.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.469 1.107 . . . . 0.0 112.403 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 127.777 2.431 . . . . 0.0 109.478 165.497 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.5 t -149.3 -128.82 0.05 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -84.65 -70.72 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 120.224 1.375 . . . . 0.0 110.937 164.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.55 82.34 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.349 0.977 . . . . 0.0 111.433 -171.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -76.0 -14.42 60.23 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.898 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -67.3 -68.28 0.39 Allowed 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 172.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.7 -48.79 69.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.463 0.705 . . . . 0.0 110.411 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -68.29 -19.48 64.7 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.145 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.38 -58.78 3.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.157 1.344 . . . . 0.0 110.669 164.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.9 pt -62.11 -21.8 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -168.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -64.94 -20.34 66.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.462 1.105 . . . . 0.0 113.589 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.04 166.54 48.58 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 119.662 1.119 . . . . 0.0 111.606 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.59 -4.18 57.95 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.14 148.53 50.95 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 120.707 -1.246 . . . . 0.0 110.03 171.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -62.76 96.6 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.78 2.32 . . . . 0.0 109.137 167.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 t -99.03 115.5 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 125.187 1.395 . . . . 0.0 107.85 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tt -113.43 119.82 38.91 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 126.052 1.741 . . . . 0.0 108.475 -168.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.9 t -109.3 110.73 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 126.218 1.807 . . . . 0.0 109.034 -168.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -82.2 98.77 8.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.924 0.784 . . . . 0.0 109.832 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -81.32 112.91 19.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 164.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -134.3 -174.04 3.44 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.64 166.3 32.37 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.886 1.275 . . . . 0.0 108.603 167.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.76 65.85 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.6 -30.26 11.87 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -170.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.02 98.97 3.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.613 0.642 . . . . 0.0 111.113 -164.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -25.47 -66.17 0.05 OUTLIER Glycine 0 CA--C 1.541 1.714 0 C-N-CA 126.385 1.945 . . . . 0.0 115.255 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.26 -30.98 23.69 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.311 2.008 . . . . 0.0 113.181 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 p -67.71 -34.6 77.19 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 119.34 0.973 . . . . 0.0 110.158 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -66.67 -12.13 56.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.49 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.9 mtp -97.97 -37.95 9.58 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.88 1.272 . . . . 0.0 111.526 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.1 ttt -74.17 -39.01 63.52 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.009 0.923 . . . . 0.0 110.781 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.58 -52.16 75.61 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 117.826 -1.083 . . . . 0.0 111.349 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.41 -34.61 65.22 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.844 1.694 . . . . 0.0 112.113 172.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.32 -31.38 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 119.65 1.113 . . . . 0.0 111.606 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mp -79.48 -26.17 41.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.196 2.198 . . . . 0.0 111.96 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.82 -44.37 93.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.79 1.177 . . . . 0.0 108.983 171.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -63.09 -45.62 91.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.854 0.462 . . . . 0.0 110.254 172.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -58.68 -38.29 77.89 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 122.017 -0.427 . . . . 0.0 111.158 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.37 -54.39 47.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.213 1.005 . . . . 0.0 109.445 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -51.57 62.11 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.597 0.759 . . . . 0.0 109.841 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.18 -11.94 10.99 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -174.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -136.09 17.42 3.23 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.449 1.099 . . . . 0.0 113.021 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.55 -20.63 1.23 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -158.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -133.74 8.22 3.84 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 173.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -80.94 -23.38 38.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.517 1.053 . . . . 0.0 110.51 161.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.56 176.07 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.226 1.01 . . . . 0.0 110.529 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 73.4 m -115.02 88.06 2.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.2 2.2 . . . . 0.0 107.157 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 t -80.81 149.28 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.06 167.52 29.54 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 162.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -134.09 150.11 51.15 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.027 175.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -154.87 157.85 38.46 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 125.196 1.56 . . . . 0.0 112.863 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -86.16 104.89 16.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.018 1.327 . . . . 0.0 107.661 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.8 p -49.27 -35.56 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.011 1.324 . . . . 0.0 113.488 -166.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -55.12 -37.21 66.61 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.684 1.594 . . . . 0.0 112.718 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.72 -22.12 65.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.649 1.58 . . . . 0.0 113.393 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -117.06 82.71 14.08 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 125.912 1.685 . . . . 0.0 108.594 -172.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.71 -31.19 3.38 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.037 1.825 . . . . 0.0 111.978 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 64' ' ' THR . 2.6 pp20? -63.68 140.79 58.91 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.54 0.736 . . . . 0.0 110.073 177.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.9 m 66.79 -33.3 0.2 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 128.253 2.621 . . . . 0.0 113.079 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.47 ' H ' ' C ' ' A' ' 62' ' ' GLU . 16.4 m -64.81 -56.33 14.15 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 128.559 2.744 . . . . 0.0 109.305 172.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -69.08 -11.79 61.11 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.115 -0.945 . . . . 0.0 112.667 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.97 -55.18 5.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.226 0.921 . . . . 0.0 109.166 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -87.66 10.72 17.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.533 0.606 . . . . 0.0 112.308 -167.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.42 24.96 62.07 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.044 1.307 . . . . 0.0 113.163 173.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.1 mm -83.4 79.08 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 122.489 1.138 . . . . 0.0 110.205 -162.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -115.69 -6.37 12.15 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.475 166.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.1 p -84.71 24.48 1.02 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.255 1.822 . . . . 0.0 113.742 -164.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.74 155.44 93.5 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 122.844 0.457 . . . . 0.0 111.483 -163.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.44 130.19 12.11 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 119.859 0.985 . . . . 0.0 111.38 6.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.0 m -118.85 143.13 47.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -124.18 100.52 6.75 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.3 mt -97.72 144.26 11.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 tt -111.89 125.77 54.39 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 164.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -118.99 161.66 19.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.213 1.805 . . . . 0.0 110.542 -173.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -162.57 147.3 12.04 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 124.837 1.255 . . . . 0.0 109.035 158.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.42 20.34 44.49 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.521 -0.6 . . . . 0.0 113.66 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.82 -10.27 57.47 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.401 1.476 . . . . 0.0 113.854 -171.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -83.87 125.21 73.64 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 119.26 1.53 . . . . 0.0 109.277 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.49 94.5 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.167 2.578 . . . . 0.0 108.782 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 m -60.73 -37.32 75.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.565 -0.709 . . . . 0.0 111.697 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 100' ' ' LEU . 18.9 pttm -166.26 165.02 17.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.162 1.385 . . . . 0.0 109.019 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.16 158.37 43.76 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.54 0.736 . . . . 0.0 112.214 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.11 153.42 23.17 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 160.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.1 140.35 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 126.101 1.76 . . . . 0.0 106.684 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.65 165.62 5.93 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.778 0.704 . . . . 0.0 111.782 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.34 96.97 0.12 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.56 1.144 . . . . 0.0 110.298 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -93.3 131.82 31.91 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 167.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.59 161.83 41.81 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.011 1.808 . . . . 0.0 109.863 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -40.15 66.7 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.342 0.657 . . . . 0.0 112.372 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -59.84 -24.75 64.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.428 1.091 . . . . 0.0 113.192 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.4 tp-100 -95.98 -44.09 7.51 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.835 1.254 . . . . 0.0 109.12 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -67.57 0.25 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.909 2.484 . . . . 0.0 108.671 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.58 -37.89 85.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 117.963 -1.018 . . . . 0.0 108.703 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.88 99.77 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.69 1.132 . . . . 0.0 111.906 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -69.67 -20.54 63.57 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.876 0.471 . . . . 0.0 112.177 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.482 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 1.1 tp -105.88 -10.22 16.76 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.118 1.367 . . . . 0.0 112.693 -171.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.23 -7.33 5.81 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.776 2.831 . . . . 0.0 114.48 -173.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -84.6 -13.34 51.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.089 1.756 . . . . 0.0 112.457 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.23 -16.17 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.092 0.86 . . . . 0.0 111.097 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -82.14 -6.07 58.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 121.626 -0.672 . . . . 0.0 112.226 162.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 . . . . . 0 C--O 1.245 0.836 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 158.721 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.402 ' C ' ' HG1' ' A' ' 6' ' ' THR . 32.4 mt . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.402 ' HG1' ' C ' ' A' ' 5' ' ' LEU . 49.1 m -152.66 -32.72 0.13 Allowed 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.387 -1.445 . . . . 0.0 113.187 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -171.6 -79.9 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 125.989 1.716 . . . . 0.0 106.654 160.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.84 -27.28 63.05 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 121.013 -1.054 . . . . 0.0 112.303 173.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -72.99 -21.63 60.81 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.063 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.28 1.71 0.71 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.638 1.975 . . . . 0.0 112.264 168.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -126.9 -50.15 1.46 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.039 1.335 . . . . 0.0 109.783 168.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -53.71 -35.64 61.36 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.163 0.985 . . . . 0.0 112.284 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.35 -45.86 24.7 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.982 0.81 . . . . 0.0 110.024 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.53 -23.61 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 117.732 -1.128 . . . . 0.0 112.236 -170.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -50.17 -35.11 24.85 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.813 1.245 . . . . 0.0 113.728 -164.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.78 122.69 0.97 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 166.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -156.25 -71.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.883 0.873 . . . . 0.0 110.081 -170.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 149.21 -166.67 29.51 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -161.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.86 89.44 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.649 2.899 . . . . 0.0 110.958 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t -70.45 146.22 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 126.89 2.076 . . . . 0.0 108.479 169.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -144.8 123.58 12.63 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.835 1.654 . . . . 0.0 107.685 -170.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.49 140.88 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 119.508 1.049 . . . . 0.0 111.43 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -98.95 104.16 16.18 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.933 0.893 . . . . 0.0 109.356 159.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -85.15 108.33 17.65 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 166.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -130.82 -172.47 2.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.224 1.41 . . . . 0.0 107.92 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.62 165.97 29.74 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 125.749 1.619 . . . . 0.0 107.878 168.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.42 -14.29 55.9 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -174.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -108.04 -23.85 11.83 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -74.31 93.35 2.37 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.195 0.907 . . . . 0.0 111.449 -165.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -24.49 -63.98 0.05 OUTLIER Glycine 0 CA--C 1.542 1.723 0 C-N-CA 126.377 1.941 . . . . 0.0 115.495 173.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.99 -36.3 22.87 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.562 2.174 . . . . 0.0 113.382 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 p -63.32 -37.14 86.09 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.792 1.178 . . . . 0.0 110.103 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.53 -20.28 64.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.647 0.779 . . . . 0.0 112.043 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.4 mtm -101.27 -14.05 17.82 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.968 1.307 . . . . 0.0 112.749 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.9 ttt -93.28 -39.21 11.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.668 1.587 . . . . 0.0 109.776 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.15 -48.44 92.17 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 117.413 -1.279 . . . . 0.0 112.025 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.64 -33.48 45.01 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 121.862 1.701 . . . . 0.0 112.411 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -40.66 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.457 1.026 . . . . 0.0 109.873 174.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.9 mp -66.46 -20.23 65.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.085 1.754 . . . . 0.0 112.166 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.62 -51.33 28.78 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.222 0.919 . . . . 0.0 109.888 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.69 -43.03 97.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.271 0.628 . . . . 0.0 110.438 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -51.55 -57.36 9.31 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.633 1.173 . . . . 0.0 110.317 169.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.91 -52.06 65.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.65 -0.691 . . . . 0.0 111.156 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -55.22 -42.88 73.91 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.042 0.937 . . . . 0.0 110.804 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.0 -15.67 24.41 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -146.88 56.22 1.13 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.193 1.397 . . . . 0.0 109.819 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.07 64.57 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -169.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -134.98 -2.11 2.61 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -63.7 -32.19 73.61 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.884 -1.135 . . . . 0.0 109.464 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.02 165.11 24.51 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 124.336 1.054 . . . . 0.0 110.252 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.6 m -107.96 88.8 2.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.778 2.031 . . . . 0.0 108.681 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 t -71.73 158.17 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.668 0.787 . . . . 0.0 110.291 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.13 155.04 34.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.903 1.681 . . . . 0.0 106.801 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -139.62 128.91 24.01 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.42 150.69 35.13 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.198 0.936 . . . . 0.0 111.825 -175.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.97 128.12 34.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 167.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.34 -34.06 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.04 -42.94 75.67 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.265 1.426 . . . . 0.0 110.717 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.32 -35.78 67.97 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.361 2.265 . . . . 0.0 112.487 176.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.39 80.49 4.59 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.271 1.029 . . . . 0.0 110.769 -172.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.12 -28.54 23.39 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.734 2.29 . . . . 0.0 114.185 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.43 ' C ' ' H ' ' A' ' 64' ' ' THR . 9.8 tp10 -52.49 117.22 2.71 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.027 1.331 . . . . 0.0 110.944 177.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.256 21.7 m 68.13 -21.35 0.13 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 129.202 3.001 . . . . 0.0 113.336 174.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.43 ' H ' ' C ' ' A' ' 62' ' ' GLU . 51.9 m -53.28 -52.47 58.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.003 1.721 . . . . 0.0 108.833 162.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -69.96 -3.33 15.65 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 117.722 -1.133 . . . . 0.0 113.266 176.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -100.94 -38.44 8.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.769 1.168 . . . . 0.0 110.595 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -92.63 7.67 42.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.702 0.683 . . . . 0.0 111.831 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.86 34.2 81.87 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 123.714 0.673 . . . . 0.0 111.739 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 26.2 mm -77.92 71.31 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.3 1.44 . . . . 0.0 109.002 -170.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 53.6 ttm -95.05 -18.48 20.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.431 1.092 . . . . 0.0 110.292 161.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.3 t -62.22 128.01 34.06 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.588 1.155 . . . . 0.0 108.67 167.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.8 pt -146.44 156.11 49.51 Favored Pre-proline 0 N--CA 1.443 -0.818 0 C-N-CA 126.829 2.052 . . . . 0.0 107.531 159.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.36 130.1 9.57 Favored 'Cis proline' 0 N--CA 1.453 -0.91 0 CA-C-N 119.733 0.94 . . . . 0.0 110.467 -9.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.7 m -123.78 149.3 45.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tt -135.12 134.58 40.38 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.3 mt -131.67 144.12 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.19 136.75 48.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 168.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -133.26 169.48 16.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.334 1.854 . . . . 0.0 110.909 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.474 ' HE3' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -153.69 155.81 36.68 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.376 1.871 . . . . 0.0 106.204 158.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.02 37.58 4.34 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 124.579 1.085 . . . . 0.0 115.795 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.24 17.81 80.14 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.735 1.16 . . . . 0.0 115.1 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -139.64 135.5 16.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.052 1.341 . . . . 0.0 108.9 -168.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.09 170.84 16.01 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.066 2.511 . . . . 0.0 113.097 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.13 -7.53 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.848 1.659 . . . . 0.0 112.081 173.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 161.15 170.75 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 1 C-N-CA 132.088 4.155 . . . . 0.0 108.763 164.15 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -129.5 142.87 50.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.492 1.917 . . . . 0.0 107.639 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.77 145.41 48.07 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 128.926 2.89 . . . . 0.0 106.299 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.69 135.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -173.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.68 165.18 41.03 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 123.772 0.701 . . . . 0.0 112.311 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -77.48 69.33 3.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.917 1.287 . . . . 0.0 111.486 -174.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -76.86 131.81 72.68 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.79 168.09 19.53 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.086 2.524 . . . . 0.0 110.988 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -45.59 76.01 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 123.846 0.858 . . . . 0.0 110.45 -174.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.76 -12.09 59.83 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.323 1.049 . . . . 0.0 112.386 -174.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.13 -55.76 2.68 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.476 1.511 . . . . 0.0 108.155 172.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 tt -54.38 -60.73 2.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.844 2.058 . . . . 0.0 110.315 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -65.51 -20.99 66.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.565 1.146 . . . . 0.0 111.845 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.16 -48.1 31.52 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.487 1.04 . . . . 0.0 109.623 170.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -59.41 -32.08 69.85 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.846 1.258 . . . . 0.0 112.104 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tp -97.71 0.52 47.17 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.669 1.988 . . . . 0.0 112.379 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.07 -29.42 68.55 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.992 0.917 . . . . 0.0 112.529 -169.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -65.85 -12.82 57.38 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.99 4.53 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.814 0.846 . . . . 0.0 112.226 173.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -112.28 -6.42 14.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.528 1.131 . . . . 0.0 112.853 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.539 1.936 . . . . 0.0 108.966 159.24 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.1 m -149.43 163.12 38.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -42.79 -55.28 3.72 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.437 3.095 . . . . 0.0 113.624 -164.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.32 91.95 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.369 0.604 . . . . 0.0 111.792 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.71 -18.1 58.71 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.059 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.34 -61.92 2.14 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.749 1.159 . . . . 0.0 108.745 174.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.39 -39.74 84.35 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.577 0.351 . . . . 0.0 110.781 -177.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -74.84 -16.44 60.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.62 0.768 . . . . 0.0 112.701 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.22 -57.36 3.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.352 0.978 . . . . 0.0 109.321 168.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.2 pt -59.32 -24.35 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -170.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -67.4 -17.62 64.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.615 1.166 . . . . 0.0 113.198 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.42 165.01 47.5 Favored Glycine 0 C--N 1.342 0.909 0 C-N-CA 124.127 0.87 . . . . 0.0 112.124 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -80.29 -42.48 23.01 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.382 1.473 . . . . 0.0 111.956 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.27 164.06 54.88 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 123.371 0.51 . . . . 0.0 112.681 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.2 100.63 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.775 2.984 . . . . 0.0 112.006 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.1 t -90.18 121.99 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 C-N-CA 125.986 1.714 . . . . 0.0 108.116 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 tt -118.95 112.16 19.26 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.132 0.973 . . . . 0.0 109.312 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -91.49 127.85 43.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -92.08 101.93 14.47 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 164.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -87.19 111.69 21.23 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 14.5 p-90 -135.29 178.49 6.99 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.772 1.229 . . . . 0.0 110.491 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.73 167.49 30.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.982 1.313 . . . . 0.0 110.798 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.77 -4.65 41.73 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.11 -16.0 7.6 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -174.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.8 p -75.45 36.93 0.13 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.836 1.654 . . . . 0.0 114.287 -165.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 33.39 -97.94 0.01 OUTLIER Glycine 0 CA--C 1.536 1.381 0 C-N-CA 128.913 3.149 . . . . 0.0 114.464 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.67 -15.76 33.14 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.751 2.967 . . . . 0.0 115.053 -175.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.3 p -54.4 -32.33 56.95 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.347 0.976 . . . . 0.0 111.96 167.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttp85 -67.03 -12.03 58.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.771 0.828 . . . . 0.0 112.66 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.5 mtp -110.09 -20.4 12.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.716 1.606 . . . . 0.0 111.846 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.4 ttt -80.61 -44.31 19.12 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 124.52 1.128 . . . . 0.0 109.412 170.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.66 -47.6 78.43 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 116.802 -1.571 . . . . 0.0 113.528 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.25 -29.9 25.55 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.098 1.865 . . . . 0.0 112.719 171.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.8 -30.12 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 120.216 1.371 . . . . 0.0 111.007 171.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.3 mt -80.02 -18.04 51.24 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.959 1.704 . . . . 0.0 111.212 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.83 -41.92 58.99 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.057 0.943 . . . . 0.0 110.299 162.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.87 -15.51 62.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.676 1.19 . . . . 0.0 111.498 171.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -85.29 -49.0 8.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.221 1.808 . . . . 0.0 109.025 167.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.29 -32.22 66.42 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.17 -0.919 . . . . 0.0 113.363 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.29 -57.35 5.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.03 1.286 . . . . 0.0 110.919 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.68 -22.47 35.04 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -159.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.9 30.21 1.18 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.886 1.275 . . . . 0.0 111.114 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -20.29 -63.4 0.02 OUTLIER 'General case' 0 C--N 1.341 0.196 0 C-N-CA 128.94 2.896 . . . . 0.0 115.314 -170.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -108.12 8.1 27.94 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -169.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -70.88 -26.06 63.07 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.982 0.81 . . . . 0.0 109.682 158.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.79 170.26 15.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.192 0.997 . . . . 0.0 110.9 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.267 10.7 t -124.91 103.64 8.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 158.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.6 t -70.08 155.75 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.09 111.42 3.91 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -89.19 130.72 35.57 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -172.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.37 143.15 24.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.927 0.87 . . . . 0.0 112.77 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -81.14 117.69 21.91 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.1 p -51.8 -32.2 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.503 1.121 . . . . 0.0 113.801 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -67.79 -29.76 69.03 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.191 1.797 . . . . 0.0 112.488 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -23.77 60.69 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.979 1.312 . . . . 0.0 112.462 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -126.21 87.36 56.32 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 125.237 1.415 . . . . 0.0 109.735 -163.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.55 -29.87 15.72 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.875 2.383 . . . . 0.0 113.712 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 64' ' ' THR . 8.3 tp10 -73.8 137.55 43.93 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.741 1.155 . . . . 0.0 110.73 -173.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.7 m 64.09 -31.01 0.11 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 130.123 3.369 . . . . 0.0 112.822 -169.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.474 ' H ' ' C ' ' A' ' 62' ' ' GLU . 52.2 m -58.08 -57.35 13.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.572 1.949 . . . . 0.0 109.45 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -57.78 -46.25 84.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.053 0.541 . . . . 0.0 109.874 178.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -58.39 -35.59 72.25 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.024 0.93 . . . . 0.0 112.758 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -100.55 9.83 42.01 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.191 0.597 . . . . 0.0 112.118 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.24 29.05 74.34 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 119.1 0.864 . . . . 0.0 112.927 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mm -77.13 81.38 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.333 1.453 . . . . 0.0 109.915 -166.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.6 mmt -123.89 -0.98 8.41 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.726 1.61 . . . . 0.0 111.103 166.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.4 t -77.9 30.07 0.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.161 1.785 . . . . 0.0 113.077 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.96 148.44 98.4 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.384 0.538 . . . . 0.0 111.828 -172.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -66.36 128.74 9.56 Favored 'Cis proline' 0 C--N 1.35 0.635 0 CA-C-N 119.73 0.939 . . . . 0.0 111.493 4.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.1 m -123.76 151.87 42.79 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 122.207 1.003 . . . . 0.0 108.838 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.9 tt -131.87 130.21 41.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 mt -130.28 141.24 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 165.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.72 119.55 39.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 175.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -117.32 161.22 19.86 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.979 2.112 . . . . 0.0 112.391 -175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.41 157.33 19.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.65 2.38 . . . . 0.0 108.668 159.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.42 14.83 14.28 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.94 1.257 . . . . 0.0 115.394 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.87 -6.02 58.38 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.625 1.584 . . . . 0.0 113.543 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -129.01 157.44 75.84 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 119.183 1.492 . . . . 0.0 110.689 -170.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.74 166.78 24.96 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.31 2.007 . . . . 0.0 111.55 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.44 -34.8 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.734 1.214 . . . . 0.0 108.505 158.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -162.02 165.77 26.88 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.495 1.118 . . . . 0.0 109.978 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -136.45 143.26 43.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.937 2.495 . . . . 0.0 106.397 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.7 mt -132.55 153.4 51.01 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.618 1.567 . . . . 0.0 108.194 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.2 pt -143.85 143.61 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.052 1.341 . . . . 0.0 108.075 -173.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.64 161.94 26.36 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.783 0.706 . . . . 0.0 111.903 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -75.25 78.55 2.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.083 0.953 . . . . 0.0 111.526 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -69.63 140.86 89.79 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 166.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.85 160.25 49.98 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.748 1.632 . . . . 0.0 110.404 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.91 -45.88 42.13 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.93 1.292 . . . . 0.0 112.814 -171.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -74.09 -25.1 59.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.455 -172.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -73.8 -37.67 64.85 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -61.26 2.78 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.165 1.386 . . . . 0.0 108.813 175.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -64.94 -25.78 68.02 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.22 -0.895 . . . . 0.0 112.229 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.21 -53.88 12.89 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.856 0.753 . . . . 0.0 110.494 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -62.19 -35.07 77.74 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.148 0.579 . . . . 0.0 112.302 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.83 1.85 56.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.645 1.178 . . . . 0.0 112.751 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.15 -31.97 54.0 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 120.082 1.31 . . . . 0.0 113.511 -174.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -65.4 -14.41 60.82 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.954 0.901 . . . . 0.0 113.295 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 66.0 t -109.06 -5.57 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.574 1.55 . . . . 0.0 110.858 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.47 -5.85 14.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.791 1.236 . . . . 0.0 112.741 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.099 0 C-N-CA 126.946 2.099 . . . . 0.0 110.552 164.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.0 mt . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.0 m -125.17 -88.53 0.59 Allowed 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -140.03 -66.25 0.45 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.858 0.863 . . . . 0.0 109.132 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.68 -30.83 45.28 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.666 -0.646 . . . . 0.0 111.912 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -72.32 -26.3 61.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.103 0.561 . . . . 0.0 110.688 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -58.0 -62.83 1.53 Allowed 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.021 0.929 . . . . 0.0 109.678 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -60.39 -42.43 95.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.841 0.456 . . . . 0.0 110.502 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -64.12 -25.65 68.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.66 1.184 . . . . 0.0 112.962 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.08 -61.53 1.97 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.232 0.924 . . . . 0.0 110.058 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.2 pt -59.07 -20.34 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -167.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -60.67 -19.05 57.36 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.344 1.458 . . . . 0.0 113.321 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.95 157.51 48.6 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 119.452 1.024 . . . . 0.0 111.631 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -76.94 -36.28 56.69 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.846 1.659 . . . . 0.0 111.443 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.22 161.97 47.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 123.814 0.721 . . . . 0.0 111.721 177.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.29 107.88 0.74 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.591 2.86 . . . . 0.0 110.948 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.4 t -98.45 141.96 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 167.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.53 153.5 44.91 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 118.565 0.62 . . . . 0.0 111.033 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.02 126.85 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -80.12 121.2 25.26 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.953 0.783 . . . . 0.0 108.915 161.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -98.26 107.16 19.56 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.045 0.938 . . . . 0.0 108.684 163.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -124.08 -177.7 3.85 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.905 1.282 . . . . 0.0 107.992 172.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.61 165.96 33.21 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.971 1.308 . . . . 0.0 108.832 170.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.66 -3.04 7.9 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -174.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -117.27 -24.58 7.39 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.81 1.187 . . . . 0.0 114.155 -175.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.73 93.79 2.63 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.196 0.907 . . . . 0.0 111.845 -163.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -19.32 -71.11 0.01 OUTLIER Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.538 2.018 . . . . 0.0 115.567 173.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.17 -29.46 47.48 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.16 2.574 . . . . 0.0 114.303 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.9 p -64.66 -27.7 69.11 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.513 1.051 . . . . 0.0 110.771 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -19.57 65.96 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.405 173.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -101.95 -23.89 14.07 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.935 1.294 . . . . 0.0 112.486 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.0 tpt -75.99 -47.28 25.54 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 125.917 1.687 . . . . 0.0 108.494 173.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.73 -48.15 70.43 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 120.133 1.333 . . . . 0.0 113.617 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.78 -33.02 21.88 Favored 'Trans proline' 0 C--N 1.352 0.741 0 CA-C-N 122.061 1.772 . . . . 0.0 112.53 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.49 -35.13 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.856 1.207 . . . . 0.0 110.526 173.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.3 mt -72.14 -21.7 61.42 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 125.929 1.692 . . . . 0.0 111.199 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.27 -52.68 31.11 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 170.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -71.34 -19.91 62.24 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -67.08 -60.06 2.94 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.044 1.338 . . . . 0.0 108.963 165.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.74 -49.55 65.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.821 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -53.93 -42.41 68.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.81 1.244 . . . . 0.0 111.262 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.35 -15.27 62.38 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -158.43 57.65 0.45 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.074 1.349 . . . . 0.0 109.462 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.02 -14.51 62.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.596 0.758 . . . . 0.0 112.086 -172.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -109.37 -55.22 2.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.383 3.473 . . . . 0.0 110.646 -172.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -53.72 -31.47 48.3 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 126.268 1.827 . . . . 0.0 112.444 -172.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 m -130.13 150.52 34.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.3 m -82.79 71.62 9.88 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 172.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.76 147.56 7.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 124.397 1.079 . . . . 0.0 109.936 175.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.65 163.02 40.01 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.186 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -128.26 143.14 51.0 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 123.736 0.648 . . . . 0.0 110.904 159.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 pp -146.29 154.34 41.58 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 124.974 1.421 . . . . 0.0 109.515 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -77.54 129.24 35.41 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 p -68.06 -20.39 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.174 -0.953 . . . . 0.0 112.003 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.75 -17.38 55.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.593 0.757 . . . . 0.0 111.266 172.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.23 -34.5 21.99 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.3 1.84 . . . . 0.0 110.147 173.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -106.4 93.43 8.26 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 124.825 1.25 . . . . 0.0 111.264 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.18 -25.71 9.81 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.976 2.451 . . . . 0.0 113.75 164.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 64' ' ' THR . 8.1 tp10 -58.89 119.24 6.84 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.752 1.16 . . . . 0.0 111.169 -177.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.268 16.4 m 63.58 -15.64 0.07 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.281 2.232 . . . . 0.0 113.795 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.438 ' H ' ' C ' ' A' ' 62' ' ' GLU . 27.7 m -53.03 -56.06 18.97 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.102 1.361 . . . . 0.0 108.844 167.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.6 t -72.18 0.39 9.87 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 117.821 -1.085 . . . . 0.0 112.899 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -108.3 -36.05 6.37 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.454 1.101 . . . . 0.0 111.177 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -104.06 10.0 36.21 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.033 0.833 . . . . 0.0 111.108 -175.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.62 32.11 59.84 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 123.918 0.77 . . . . 0.0 112.249 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.9 mm -75.23 83.25 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.999 0.919 . . . . 0.0 109.617 -170.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.2 ttp -128.07 -10.34 5.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.401 1.08 . . . . 0.0 111.342 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.4 t -87.22 56.62 4.06 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.428 1.091 . . . . 0.0 109.36 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.6 pt -81.96 148.43 60.67 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.183 -174.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.77 125.02 6.16 Favored 'Cis proline' 0 C--N 1.35 0.62 0 CA-C-N 119.589 0.889 . . . . 0.0 110.925 -0.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.8 m -109.22 143.91 38.04 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.6 tt -129.4 132.93 47.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 171.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.1 mt -130.43 144.9 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.29 132.96 56.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.85 163.03 30.0 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.454 1.902 . . . . 0.0 111.778 -169.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.47 148.47 18.06 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 125.696 1.598 . . . . 0.0 108.554 157.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.87 19.99 38.98 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 123.904 0.764 . . . . 0.0 113.101 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.91 -7.4 51.2 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.197 1.38 . . . . 0.0 113.971 -170.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -84.3 118.9 72.33 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 119.297 1.548 . . . . 0.0 108.751 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.15 109.09 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.37 2.713 . . . . 0.0 109.853 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 m -71.1 -37.27 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.641 -0.662 . . . . 0.0 111.428 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -156.98 160.62 39.21 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.199 0.6 . . . . 0.0 111.846 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -128.8 142.55 50.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.713 2.405 . . . . 0.0 107.526 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.09 149.95 41.38 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.999 2.12 . . . . 0.0 107.044 165.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.47 132.52 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.353 1.461 . . . . 0.0 107.102 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.16 166.92 26.85 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.405 1.002 . . . . 0.0 112.135 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -76.83 74.56 3.46 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.505 1.122 . . . . 0.0 109.409 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -76.81 122.83 87.17 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 171.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.25 166.72 22.38 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.756 1.637 . . . . 0.0 110.441 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.402 ' HE3' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -47.98 -50.52 27.14 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.895 1.278 . . . . 0.0 112.412 -175.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.48 -19.71 65.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.73 -56.07 3.45 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.8 tt -55.99 -60.52 3.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.505 1.922 . . . . 0.0 109.394 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.402 ' OE1' ' HE3' ' A' ' 93' ' ' LYS . 6.3 tt0 -68.67 -17.4 64.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.493 1.117 . . . . 0.0 111.392 -176.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.84 -52.13 9.38 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 119.472 1.033 . . . . 0.0 110.069 166.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -60.5 -27.52 67.65 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.966 0.907 . . . . 0.0 112.047 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.94 0.39 41.08 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.37 1.868 . . . . 0.0 112.988 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.89 -34.53 67.97 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.978 0.911 . . . . 0.0 112.746 -171.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -66.02 -11.92 51.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.508 1.523 . . . . 0.0 113.45 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.16 8.89 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.197 1.399 . . . . 0.0 111.552 171.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.2 -0.23 12.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.513 1.525 . . . . 0.0 113.529 169.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.363 1.865 . . . . 0.0 108.797 172.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.215 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.5 p -117.35 -89.0 0.59 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 158.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 8' ' ' ALA . 9.1 p-10 -142.84 -73.24 0.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.416 1.486 . . . . 0.0 108.014 -159.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.502 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . -54.14 -32.24 54.7 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.042 0.937 . . . . 0.0 111.291 170.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -81.7 -15.6 53.91 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 119.238 -0.985 . . . . 0.0 112.089 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -66.89 -54.13 25.25 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.145 0.884 . . . . 0.0 109.143 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -65.78 -23.05 66.63 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.604 0.761 . . . . 0.0 111.694 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -73.64 -49.11 27.64 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.152 0.887 . . . . 0.0 110.844 167.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.61 -39.57 91.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.962 0.801 . . . . 0.0 111.801 -171.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.0 tt -58.26 -22.16 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.21 1.404 . . . . 0.0 113.38 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -56.06 -36.75 68.43 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.478 1.511 . . . . 0.0 113.874 -159.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.49 133.92 2.0 Allowed Glycine 0 C--N 1.334 0.428 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 -170.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -174.74 -55.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.836 1.654 . . . . 0.0 107.964 -166.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.73 -157.65 27.47 Favored Glycine 0 CA--C 1.534 1.281 0 N-CA-C 105.064 -3.214 . . . . 0.0 105.064 -158.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.17 103.66 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.205 2.604 . . . . 0.0 111.347 168.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.4 t -88.99 127.42 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 168.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 tt -132.19 122.99 26.15 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -172.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.99 119.74 62.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -172.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -97.07 94.13 6.98 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -176.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -82.46 110.63 17.75 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.133 1.373 . . . . 0.0 108.871 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 16.5 p-90 -125.82 177.07 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.25 164.35 32.59 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.753 1.221 . . . . 0.0 108.953 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.58 -8.74 56.71 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -123.86 -13.88 7.3 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.7 p -70.22 39.19 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -158.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 42.87 -99.03 0.01 OUTLIER Glycine 0 CA--C 1.536 1.389 0 C-N-CA 127.572 2.51 . . . . 0.0 114.764 169.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -58.58 -19.02 42.88 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.862 3.041 . . . . 0.0 114.166 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 14.9 p -60.03 -22.68 62.95 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 119.188 0.904 . . . . 0.0 112.235 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -14.94 61.72 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.12 1.327 . . . . 0.0 112.451 173.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.2 mtm -100.43 -32.46 10.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.647 1.579 . . . . 0.0 111.054 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.2 ttt -72.91 -43.18 62.72 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-O 117.811 -1.09 . . . . 0.0 109.142 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.59 -45.97 85.41 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 116.595 -1.669 . . . . 0.0 113.213 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.5 -45.51 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.628 1.552 . . . . 0.0 111.79 167.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -30.17 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 121.71 2.05 . . . . 0.0 112.133 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 mt -68.7 -13.01 62.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 128.667 2.787 . . . . 0.0 112.252 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.88 -46.38 8.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.296 1.038 . . . . 0.0 109.851 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.89 -40.78 70.13 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.519 1.054 . . . . 0.0 110.665 165.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.447 ' CE1' HD22 ' A' ' 96' ' ' LEU . 79.0 t80 -56.14 -60.07 4.02 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.922 0.889 . . . . 0.0 110.235 171.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.69 -49.68 67.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.632 0.651 . . . . 0.0 111.861 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.1 -48.52 64.7 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.514 1.526 . . . . 0.0 110.547 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.93 -12.6 11.77 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -150.61 61.85 0.94 Allowed 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.268 1.427 . . . . 0.0 108.502 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.04 -45.41 64.67 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.634 1.574 . . . . 0.0 111.413 -169.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -136.41 9.75 3.19 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -61.94 -32.84 73.3 Favored 'General case' 0 C--N 1.345 0.403 0 O-C-N 121.413 -0.805 . . . . 0.0 110.201 163.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.0 m -119.71 143.37 31.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.341 1.1 t -82.21 73.59 9.24 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 124.259 1.981 . . . . 0.0 106.596 166.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.4 148.28 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 113.642 -1.617 . . . . 0.0 107.957 165.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.82 158.8 44.58 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.099 1.36 . . . . 0.0 107.631 170.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -133.05 124.82 28.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.76 152.13 46.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.67 1.224 . . . . 0.0 113.054 -177.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -85.22 110.17 18.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.051 1.74 . . . . 0.0 108.835 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.99 -26.19 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.039 0.936 . . . . 0.0 112.754 -173.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -70.78 -22.69 62.34 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 126.547 1.939 . . . . 0.0 111.182 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.61 -38.74 13.72 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.589 1.156 . . . . 0.0 111.021 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -105.05 106.43 55.52 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.705 -169.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.89 -22.42 6.24 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.047 2.498 . . . . 0.0 114.316 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.462 ' C ' ' H ' ' A' ' 64' ' ' THR . 7.4 tp10 -66.41 118.55 10.22 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.325 0.966 . . . . 0.0 108.766 -173.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.272 25.9 m 67.65 -17.75 0.15 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.817 2.847 . . . . 0.0 112.659 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.462 ' H ' ' C ' ' A' ' 62' ' ' GLU . 31.1 m -54.5 -54.9 34.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.125 1.77 . . . . 0.0 108.895 160.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -57.97 -46.8 84.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.55 0.74 . . . . 0.0 110.356 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -55.06 -35.37 64.46 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.543 1.137 . . . . 0.0 112.899 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -111.09 14.75 21.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.232 0.613 . . . . 0.0 112.258 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.39 31.2 80.07 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 118.962 0.801 . . . . 0.0 113.114 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.7 mm -76.54 81.98 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.102 1.361 . . . . 0.0 110.288 -165.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.6 mmt -130.27 3.82 4.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.19 1.396 . . . . 0.0 111.424 165.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 t -78.89 37.44 0.3 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.232 1.813 . . . . 0.0 110.966 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.74 151.27 76.71 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 121.324 -0.86 . . . . 0.0 111.427 -169.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.7 123.98 4.06 Favored 'Cis proline' 0 C--N 1.349 0.583 0 CA-C-N 119.861 0.986 . . . . 0.0 111.107 4.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.3 m -118.69 154.22 33.08 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 tt -146.3 122.7 10.99 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 104.673 -2.344 . . . . 0.0 104.673 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.8 mt -123.37 139.08 51.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 119.55 39.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.569 1.948 . . . . 0.0 105.822 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -122.26 169.16 11.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.797 2.439 . . . . 0.0 108.062 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.502 ' C ' ' HE3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -153.33 40.13 0.52 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.344 -0.847 . . . . 0.0 112.417 -179.718 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.92 87.41 1.91 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -167.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.69 -23.35 3.02 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 130.585 3.945 . . . . 0.0 114.422 160.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -131.94 149.3 72.95 Favored Pre-proline 0 N--CA 1.445 -0.69 0 C-N-CA 125.379 1.472 . . . . 0.0 110.182 -171.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.12 159.94 30.05 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.848 2.366 . . . . 0.0 111.043 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -38.67 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.239 1.416 . . . . 0.0 110.383 165.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.432 ' HZ3' ' CG ' ' A' ' 102' ' ' ASP . 18.1 pttm -161.11 171.91 17.7 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 119.317 0.962 . . . . 0.0 111.381 174.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -139.05 150.38 45.7 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.24 2.216 . . . . 0.0 108.649 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.76 150.61 40.12 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.148 1.779 . . . . 0.0 107.632 161.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.9 pt -143.33 137.36 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 126.269 1.827 . . . . 0.0 108.082 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.55 167.37 18.01 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.163 0.887 . . . . 0.0 111.762 -174.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -57.01 110.72 0.87 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.906 0.883 . . . . 0.0 111.183 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -101.33 133.84 20.66 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 160.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.97 158.14 58.2 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 CA-C-N 120.287 1.138 . . . . 0.0 109.161 164.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.35 -52.52 2.7 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.149 1.78 . . . . 0.0 110.843 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.19 -31.66 69.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.017 1.727 . . . . 0.0 113.103 -175.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -85.31 -47.27 10.19 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 119.244 0.929 . . . . 0.0 109.906 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.447 HD22 ' CE1' ' A' ' 42' ' ' PHE . 1.3 tt -56.53 -61.89 2.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.305 2.642 . . . . 0.0 108.999 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -63.24 -29.26 70.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.585 1.154 . . . . 0.0 110.827 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.64 -49.15 33.75 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.39 0.995 . . . . 0.0 110.732 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -56.86 -43.24 80.99 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.479 0.712 . . . . 0.0 110.828 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.68 -0.27 55.95 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.51 1.124 . . . . 0.0 113.324 -176.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.16 -28.82 63.12 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.232 1.413 . . . . 0.0 113.4 -170.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.432 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 14.8 p-10 -63.25 -22.09 66.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.15 0.98 . . . . 0.0 113.393 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.11 -15.87 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 118.862 0.756 . . . . 0.0 111.14 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -10.38 56.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.01 1.324 . . . . 0.0 112.49 169.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.249 1.042 0 C-N-CA 129.608 3.163 . . . . 0.0 111.182 161.929 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 mt . . . . . 0 C--O 1.23 0.068 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.9 p -127.01 170.13 12.62 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 163.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -53.39 -55.52 24.34 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 127.886 2.475 . . . . 0.0 111.412 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.4 81.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.226 0.611 . . . . 0.0 110.084 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -75.09 -20.23 59.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.248 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -58.36 -63.93 1.1 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.14 -46.81 89.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.017 0.527 . . . . 0.0 110.787 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.23 -20.02 65.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.094 -174.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.14 -58.13 3.09 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.4 1.0 . . . . 0.0 110.213 165.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.2 pt -62.41 -20.05 23.8 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -169.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -57.36 -24.62 56.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.137 0.975 . . . . 0.0 113.038 172.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.24 112.57 0.26 Allowed Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -157.96 -75.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.489 1.515 . . . . 0.0 109.137 -175.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.69 -166.25 30.75 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 -159.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.32 83.87 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.703 3.602 . . . . 0.0 112.226 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.7 t -94.06 124.12 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 125.743 1.617 . . . . 0.0 106.848 171.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.74 146.64 44.6 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.52 0.676 . . . . 0.0 111.964 170.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.3 t -131.54 108.41 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -161.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -83.46 100.75 10.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.345 1.058 . . . . 0.0 109.155 174.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -78.54 108.61 12.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 166.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -123.17 176.06 6.29 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.39 155.73 31.03 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 120.884 -1.135 . . . . 0.0 110.825 166.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.49 -12.81 61.21 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -173.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.69 -12.37 31.63 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.572 1.078 . . . . 0.0 112.772 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.4 p -67.24 173.72 3.7 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.436 0.636 . . . . 0.0 112.469 -164.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.35 -86.63 1.89 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 162.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.24 -20.78 55.64 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.96 2.44 . . . . 0.0 114.336 -167.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.67 -33.66 68.57 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.8 1.182 . . . . 0.0 111.128 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -74.05 -11.82 60.44 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.572 -0.727 . . . . 0.0 112.516 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.6 ptm -104.23 -21.64 13.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.923 1.289 . . . . 0.0 112.079 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.1 ttt -83.82 -44.4 14.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.89 1.676 . . . . 0.0 108.969 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.2 -47.26 82.56 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 117.541 -1.219 . . . . 0.0 113.324 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.87 -31.48 38.4 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.918 1.721 . . . . 0.0 112.445 172.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.23 -39.03 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.813 1.188 . . . . 0.0 110.511 172.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.8 mt -69.23 -20.01 63.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.227 1.411 . . . . 0.0 111.831 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -69.98 -45.57 67.07 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.673 0.789 . . . . 0.0 110.092 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -62.1 -44.28 96.99 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.529 0.331 . . . . 0.0 110.289 171.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.22 -44.9 84.17 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.772 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.72 -53.51 46.75 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.054 0.942 . . . . 0.0 110.745 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.01 -46.8 87.28 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.184 0.994 . . . . 0.0 111.069 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.8 -26.57 14.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.051 1.341 . . . . 0.0 114.414 -173.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.05 29.67 4.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.415 1.486 . . . . 0.0 111.826 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -14.26 -61.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 131.421 3.888 . . . . 0.0 116.028 -172.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -114.08 -14.53 12.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.386 1.874 . . . . 0.0 113.134 -168.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -66.42 -31.96 73.04 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.231 0.923 . . . . 0.0 110.276 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.12 171.56 17.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 122.706 0.402 . . . . 0.0 110.216 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.5 t -124.45 137.77 54.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.102 0.477 . . . . 0.0 110.005 172.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.86 154.74 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 125.255 1.422 . . . . 0.0 107.313 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.95 138.04 20.35 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -117.45 136.46 53.18 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 118.898 0.772 . . . . 0.0 109.338 170.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -144.38 146.46 32.54 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.175 0.988 . . . . 0.0 113.446 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -75.16 104.14 5.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.007 1.723 . . . . 0.0 107.826 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.7 p -70.15 -20.56 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -166.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.87 -43.08 90.78 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.076 1.35 . . . . 0.0 110.566 169.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -89.23 -25.36 21.78 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.636 1.974 . . . . 0.0 112.316 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -105.33 90.08 3.65 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 118.404 0.547 . . . . 0.0 111.24 164.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.9 -12.67 17.82 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.872 2.381 . . . . 0.0 114.042 166.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -72.87 129.17 37.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.667 1.121 . . . . 0.0 109.078 -176.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.5 m 64.33 -25.12 0.08 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.943 3.297 . . . . 0.0 112.466 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.53 ' H ' ' C ' ' A' ' 62' ' ' GLU . 41.7 m -50.31 -61.59 2.08 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 128.328 2.651 . . . . 0.0 109.214 165.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.1 t -57.45 -46.49 83.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.95 0.5 . . . . 0.0 109.881 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -58.59 -38.58 78.25 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.4 1.08 . . . . 0.0 112.451 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -95.22 12.0 30.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.848 0.749 . . . . 0.0 111.461 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.36 25.64 73.65 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 118.78 0.718 . . . . 0.0 112.635 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.8 mm -73.65 94.89 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.86 1.264 . . . . 0.0 109.312 -169.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.14 -21.37 3.61 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.366 1.466 . . . . 0.0 110.861 175.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 p -81.58 47.76 1.1 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.115 2.566 . . . . 0.0 112.333 -162.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 pt -76.16 153.53 84.39 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -169.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -62.85 128.27 6.06 Favored 'Cis proline' 0 C--N 1.351 0.693 0 N-CA-C 110.238 -0.716 . . . . 0.0 110.238 -7.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 m -115.41 132.64 56.56 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tt -125.43 116.82 22.44 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 mt -120.17 143.03 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 tt -118.9 119.83 35.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -111.48 166.91 10.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.577 1.951 . . . . 0.0 110.356 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -161.67 127.75 3.72 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 126.22 1.808 . . . . 0.0 106.714 158.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 47.8 42.87 22.25 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.633 0.635 . . . . 0.0 113.771 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.12 -7.05 82.63 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 117.859 -1.523 . . . . 0.0 115.146 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -101.03 104.34 31.54 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 120.094 1.947 . . . . 0.0 111.243 -173.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.88 90.25 1.09 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.799 3.0 . . . . 0.0 111.189 171.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 m -63.45 -21.35 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.04 158.03 34.04 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.896 0.878 . . . . 0.0 110.699 160.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -118.36 136.5 53.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.126 2.17 . . . . 0.0 105.958 163.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.07 147.53 41.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.182 2.193 . . . . 0.0 105.637 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.4 pt -140.9 142.67 29.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.779 1.231 . . . . 0.0 107.987 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.21 167.3 27.76 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 123.892 0.745 . . . . 0.0 111.658 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -72.22 79.09 0.97 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.892 0.877 . . . . 0.0 110.088 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -76.45 129.63 79.28 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 162.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -68.45 167.8 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.053 1.835 . . . . 0.0 109.832 175.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.36 -42.56 61.41 Favored 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 123.595 0.758 . . . . 0.0 110.245 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -75.14 -2.34 27.28 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.758 1.223 . . . . 0.0 111.505 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -112.13 -49.56 2.96 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 125.845 1.658 . . . . 0.0 109.221 172.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.0 tt -52.04 -66.44 0.38 Allowed 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 127.2 2.2 . . . . 0.0 110.418 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -63.55 -20.65 65.81 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.69 1.196 . . . . 0.0 111.952 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.67 -48.09 41.98 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.533 1.06 . . . . 0.0 110.665 172.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -59.49 -51.16 71.04 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.928 0.891 . . . . 0.0 110.223 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 mt -75.04 -5.36 43.65 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 126.129 1.771 . . . . 0.0 112.753 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.62 -26.71 34.56 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 124.541 1.136 . . . . 0.0 111.632 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -6.49 9.14 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.802 1.241 . . . . 0.0 113.657 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.62 -14.14 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 162.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.05 -7.86 59.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.211 -0.931 . . . . 0.0 112.249 170.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 C--O 1.247 0.956 0 C-N-CA 127.398 2.279 . . . . 0.0 108.154 158.858 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 N--CA 1.462 0.171 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.0 p -112.42 -105.63 0.38 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 167.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -126.06 -64.72 1.03 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.095 2.158 . . . . 0.0 108.932 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.63 -30.63 61.29 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.764 -0.585 . . . . 0.0 112.075 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.04 -22.59 59.5 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.163 -0.446 . . . . 0.0 111.254 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -64.06 -58.7 5.89 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.841 0.746 . . . . 0.0 109.829 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -59.59 -34.98 73.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.833 0.453 . . . . 0.0 110.978 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -62.82 -53.31 56.27 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.901 -0.499 . . . . 0.0 110.685 171.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.95 -43.99 97.92 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.423 0.689 . . . . 0.0 111.654 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 pt -59.95 -23.59 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -11.06 60.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.542 0.737 . . . . 0.0 111.85 177.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.06 131.19 48.28 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 174.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -87.0 35.65 0.7 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.635 0.774 . . . . 0.0 112.702 -165.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -142.13 179.93 19.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.398 1.475 . . . . 0.0 110.238 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.57 93.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.296 3.331 . . . . 0.0 111.585 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.0 t -100.34 126.42 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 127.35 2.26 . . . . 0.0 106.078 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 tp -126.77 120.92 30.51 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.866 -0.521 . . . . 0.0 110.275 -167.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -100.4 133.65 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 118.698 0.681 . . . . 0.0 109.92 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -93.2 107.86 19.59 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 159.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -82.7 111.96 19.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 162.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -119.71 -174.36 2.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -147.6 161.42 41.18 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 121.394 -0.817 . . . . 0.0 111.508 168.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.83 6.38 0.24 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.433 1.493 . . . . 0.0 115.02 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.42 ' CG ' ' N ' ' A' ' 29' ' ' CYS . 3.5 p90 -124.31 -66.72 0.96 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 163.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 28' ' ' TRP . 16.4 t 36.16 -91.52 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 129.896 3.278 . . . . 0.0 114.614 175.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.66 -91.54 0.56 Allowed Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.624 1.583 . . . . 0.0 111.074 -172.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.07 -19.24 68.5 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.99 3.127 . . . . 0.0 115.066 -168.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 p -51.51 -35.21 39.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.83 0.741 . . . . 0.0 111.722 165.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -66.13 -14.26 61.5 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.547 1.067 . . . . 0.0 112.54 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.8 mtp -105.57 -15.58 14.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.295 1.838 . . . . 0.0 111.407 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.6 ttt -93.95 -34.93 12.88 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 126.322 1.849 . . . . 0.0 109.227 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.26 -50.62 63.21 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.651 1.58 . . . . 0.0 113.02 171.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.91 -35.48 55.29 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 122.127 1.796 . . . . 0.0 111.815 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -61.79 -39.82 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 118.809 0.731 . . . . 0.0 110.079 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.6 mp -68.3 -32.09 71.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.936 2.094 . . . . 0.0 112.211 174.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -68.5 -49.87 56.42 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.026 0.931 . . . . 0.0 108.957 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.422 ' CD ' ' HZ1' ' A' ' 93' ' ' LYS . 37.3 mt-10 -56.51 -47.7 78.79 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.277 0.56 . . . . 0.0 110.274 172.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -58.18 -42.98 87.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.646 1.178 . . . . 0.0 111.051 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.27 59.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.367 1.067 . . . . 0.0 110.218 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -52.61 -45.87 66.76 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.503 0.592 . . . . 0.0 110.589 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.82 -10.68 58.18 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -139.09 3.72 2.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -168.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -24.32 -52.96 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 129.318 3.047 . . . . 0.0 116.258 -158.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . 0.27 2.8 m-20 -125.32 10.7 8.03 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -70.68 -26.63 63.52 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 119.556 1.071 . . . . 0.0 108.665 158.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.79 174.32 12.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 126.12 1.768 . . . . 0.0 110.023 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.262 0.7 OUTLIER -137.51 112.71 9.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 159.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.04 159.17 2.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.228 0.537 . . . . 0.0 109.897 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.2 171.86 15.77 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.57 0.748 . . . . 0.0 109.177 172.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -139.69 131.49 27.52 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -170.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.43 151.25 33.7 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -85.12 115.7 23.07 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.441 1.896 . . . . 0.0 108.494 -178.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 p -64.99 -24.14 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.254 1.022 . . . . 0.0 113.017 -172.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.08 63.7 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.396 1.478 . . . . 0.0 109.988 174.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -65.06 -32.67 74.5 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.079 1.351 . . . . 0.0 111.947 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -110.08 87.32 5.81 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.206 1.002 . . . . 0.0 111.633 -174.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.61 -25.68 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.151 2.567 . . . . 0.0 114.445 170.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.493 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -73.22 137.89 45.26 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 120.49 1.495 . . . . 0.0 109.481 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.293 49.3 m 67.53 -23.97 0.12 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 129.495 3.118 . . . . 0.0 111.751 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.493 ' H ' ' C ' ' A' ' 62' ' ' GLU . 41.2 m -63.76 -71.9 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 127.917 2.487 . . . . 0.0 110.153 169.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -64.55 -28.4 69.61 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -59.0 -24.68 62.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.334 1.854 . . . . 0.0 111.856 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -120.91 13.51 11.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.85 1.26 . . . . 0.0 111.257 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.85 25.01 71.73 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 121.341 -0.849 . . . . 0.0 113.514 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.2 mm -68.21 93.89 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.99 1.316 . . . . 0.0 110.167 -171.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -128.37 -13.22 4.96 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.101 1.36 . . . . 0.0 112.063 171.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.7 t -81.84 53.24 2.12 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.994 1.318 . . . . 0.0 111.457 -173.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.7 pt -70.84 153.03 95.01 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.188 0.995 . . . . 0.0 112.343 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.92 129.92 7.82 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 CA-C-N 119.087 0.71 . . . . 0.0 110.506 -8.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.7 m -112.83 141.85 46.17 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.4 tt -133.19 105.26 6.91 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.6 mt -109.12 128.86 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.1 110.83 22.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 169.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -103.18 156.53 17.64 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.543 1.137 . . . . 0.0 109.462 170.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 127.16 11.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 163.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.84 27.39 59.21 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 118.321 0.51 . . . . 0.0 113.523 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.38 -12.58 69.35 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.959 1.743 . . . . 0.0 113.763 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -90.6 118.36 68.64 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 119.366 1.583 . . . . 0.0 109.689 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 85.01 1.18 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.582 2.855 . . . . 0.0 109.72 171.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -64.82 -38.82 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.344 1.057 . . . . 0.0 111.995 -176.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -142.28 156.05 45.26 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.483 1.038 . . . . 0.0 110.684 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.99 135.48 32.77 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.856 1.663 . . . . 0.0 107.952 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -122.01 146.71 46.9 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.356 2.262 . . . . 0.0 106.797 174.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.3 pt -143.23 119.17 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 124.598 1.159 . . . . 0.0 109.233 -169.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.9 170.57 41.63 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.491 1.52 . . . . 0.0 110.798 -169.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -66.44 93.12 0.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.868 1.267 . . . . 0.0 110.43 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -74.63 131.77 79.26 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 168.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.47 166.57 21.31 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.584 1.522 . . . . 0.0 109.593 165.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.422 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -54.56 -47.48 73.2 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -177.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.1 -15.11 20.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.53 2.332 . . . . 0.0 113.181 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -101.35 -56.05 2.39 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 125.418 1.487 . . . . 0.0 108.703 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.48 -58.07 8.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.593 1.957 . . . . 0.0 109.782 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -26.94 68.61 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.247 1.019 . . . . 0.0 110.946 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.34 -44.87 42.87 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.505 1.048 . . . . 0.0 110.714 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -49.73 76.57 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.255 1.022 . . . . 0.0 109.967 172.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.83 -2.52 57.85 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.464 ' C ' ' H ' ' A' ' 103' ' ' VAL . . . -49.18 -34.45 14.54 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 119.429 1.013 . . . . 0.0 110.42 168.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.6 29.02 0.08 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.562 2.345 . . . . 0.0 112.16 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.464 ' H ' ' C ' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -154.35 -24.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.9 2.08 . . . . 0.0 111.204 158.657 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.15 -10.84 59.73 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.978 0.911 . . . . 0.0 112.343 172.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.258 0 C-N-CA 127.195 2.198 . . . . 0.0 109.167 165.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 121.806 0.812 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.5 p -130.35 178.29 6.7 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 159.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -58.4 -57.99 10.47 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.614 1.566 . . . . 0.0 110.466 169.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.01 79.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.668 -0.645 . . . . 0.0 110.699 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -84.15 -19.32 34.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.949 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -58.74 -56.58 20.35 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 167.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -63.18 -46.07 88.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.748 0.819 . . . . 0.0 109.715 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.593 HE21 ' NE2' ' A' ' 15' ' ' GLN . 9.5 tp60 -63.47 -30.62 71.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.945 0.793 . . . . 0.0 112.336 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.22 -60.48 2.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.422 1.01 . . . . 0.0 110.048 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.37 -10.04 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.593 ' NE2' HE21 ' A' ' 12' ' ' GLN . 20.9 pt20 -46.58 -36.1 6.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.502 1.521 . . . . 0.0 112.818 -174.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.85 113.85 1.66 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 124.131 0.872 . . . . 0.0 112.808 165.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -152.56 -102.89 0.05 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 164.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.74 -138.13 6.37 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.545 1.545 . . . . 0.0 111.742 -168.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.75 85.87 0.92 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.371 3.381 . . . . 0.0 113.05 -167.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.3 t -97.26 140.32 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 170.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.19 124.43 20.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 O-C-N 121.689 -0.632 . . . . 0.0 109.411 164.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.92 142.44 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 172.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.8 89.27 3.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.502 1.144 . . . . 0.0 108.983 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -76.19 114.58 15.02 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.614 1.166 . . . . 0.0 109.27 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 16.4 p-90 -127.93 -171.52 2.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 168.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.77 160.38 41.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.082 -1.011 . . . . 0.0 110.393 169.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.6 -29.17 64.28 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.568 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.61 -26.95 16.87 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 p -71.66 164.98 24.93 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.221 0.919 . . . . 0.0 113.438 -159.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.84 -82.36 1.4 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.279 1.418 . . . . 0.0 112.653 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -60.7 -20.96 67.84 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.466 2.778 . . . . 0.0 113.077 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 17.7 p -59.21 -27.28 65.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.148 172.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.3 mtt85 -76.61 -12.76 60.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 120.477 1.489 . . . . 0.0 112.864 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 86.7 mtp -95.09 -33.0 12.84 Favored 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 124.843 1.257 . . . . 0.0 110.296 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.6 ttt -78.0 -36.18 49.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.416 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.67 -51.8 66.55 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.198 -1.382 . . . . 0.0 112.203 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.83 -38.14 40.85 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 121.735 1.655 . . . . 0.0 111.848 171.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.78 -14.36 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 119.576 1.08 . . . . 0.0 112.163 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.38 -16.36 18.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 128.669 2.788 . . . . 0.0 111.816 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.36 -40.7 29.56 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.672 1.123 . . . . 0.0 109.449 168.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -52.41 -51.02 61.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.739 0.816 . . . . 0.0 109.034 163.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.449 ' CD1' ' HE2' ' A' ' 93' ' ' LYS . 2.3 t80 -57.93 -48.77 78.95 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-O 118.652 -0.689 . . . . 0.0 110.889 177.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.81 -59.82 3.03 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.95 1.3 . . . . 0.0 109.63 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -60.21 -44.7 94.94 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 124.806 1.316 . . . . 0.0 111.343 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.56 -15.09 2.49 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.652 1.181 . . . . 0.0 113.939 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.97 35.37 1.75 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.46 1.104 . . . . 0.0 112.713 174.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.79 -37.54 8.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.83 1.652 . . . . 0.0 115.195 -165.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.4 7.74 4.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.737 1.215 . . . . 0.0 111.362 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -83.99 -27.13 28.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.719 1.607 . . . . 0.0 110.554 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.97 171.63 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.819 1.248 . . . . 0.0 108.788 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.306 6.6 t -110.49 85.95 2.21 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 123.529 1.633 . . . . 0.0 108.631 164.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -70.02 154.95 7.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.409 163.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.55 120.41 3.93 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.085 169.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -94.0 146.47 23.91 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.073 0.233 . . . . 0.0 111.405 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.97 154.51 35.12 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.638 0.732 . . . . 0.0 112.082 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -86.31 96.39 9.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.597 1.959 . . . . 0.0 107.885 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.1 p -66.22 -20.3 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 121.371 -0.831 . . . . 0.0 113.068 -167.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.5 -28.46 63.45 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.97 1.708 . . . . 0.0 111.676 170.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -109.44 -16.83 13.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.446 2.298 . . . . 0.0 111.821 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -112.53 79.67 3.22 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.217 1.807 . . . . 0.0 110.85 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.57 -88.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.572 2.848 . . . . 0.0 109.984 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 46.74 -17.12 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 131.344 3.858 . . . . 0.0 121.206 167.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.8 m 178.2 -25.43 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 130.806 3.642 . . . . 0.0 110.782 -171.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.2 m -44.39 -61.55 1.48 Allowed 'General case' 0 N--CA 1.458 -0.075 0 C-N-CA 127.574 2.35 . . . . 0.0 110.621 173.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -57.94 -45.66 86.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.777 0.831 . . . . 0.0 109.659 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -60.44 -28.12 68.04 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.075 1.35 . . . . 0.0 112.949 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -112.45 12.08 19.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.915 0.779 . . . . 0.0 111.571 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.33 24.58 74.96 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 121.334 -0.854 . . . . 0.0 114.203 173.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.8 mm -80.82 46.54 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 126.79 2.036 . . . . 0.0 111.269 -167.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.0 ttt -83.39 -8.25 59.43 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.237 -0.914 . . . . 0.0 110.17 162.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.2 p -75.77 16.52 0.39 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.251 2.22 . . . . 0.0 115.054 -164.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.4 pt -61.31 145.49 90.35 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.001 0.92 . . . . 0.0 112.361 -165.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.57 135.53 29.29 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 118.25 0.411 . . . . 0.0 111.544 -1.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.6 m -133.44 140.6 47.39 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.049 0.94 . . . . 0.0 110.075 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt -135.65 99.13 4.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.028 1.731 . . . . 0.0 106.757 -170.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.8 mt -95.17 130.56 43.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.46 123.28 35.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 171.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -113.82 148.45 36.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 172.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -152.36 154.71 36.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 163.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.53 15.47 1.25 Allowed Glycine 0 CA--C 1.541 1.713 0 N-CA-C 117.134 1.614 . . . . 0.0 117.134 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.83 15.88 38.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-N 119.69 1.745 . . . . 0.0 112.995 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -134.97 128.0 18.49 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.195 1.398 . . . . 0.0 109.555 -167.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.83 87.32 1.41 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.914 3.076 . . . . 0.0 109.646 171.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 m -63.75 -36.3 76.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 O-C-N 121.503 -0.748 . . . . 0.0 112.456 -174.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 167.05 31.57 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 122.905 0.482 . . . . 0.0 111.106 170.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -134.66 134.06 40.74 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.3 1.84 . . . . 0.0 107.881 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -106.49 149.72 26.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.801 1.64 . . . . 0.0 107.529 167.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 pt -143.32 144.18 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.398 1.479 . . . . 0.0 107.831 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.81 169.52 19.03 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.947 0.784 . . . . 0.0 112.796 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -72.74 73.82 1.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.553 1.541 . . . . 0.0 111.167 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -75.28 136.03 72.51 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 165.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.36 166.01 29.76 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.202 1.935 . . . . 0.0 110.863 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.449 ' HE2' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -49.46 -50.61 40.42 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.68 1.192 . . . . 0.0 111.865 -177.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -52.63 -33.73 48.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.226 1.41 . . . . 0.0 112.964 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.459 HE22 ' NE2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -83.59 -47.83 10.87 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 tt -61.03 -56.84 16.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.433 1.493 . . . . 0.0 110.338 -175.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -55.66 -33.56 64.19 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.456 1.502 . . . . 0.0 110.337 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.86 -50.22 17.79 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 118.232 0.469 . . . . 0.0 110.268 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.459 ' NE2' HE22 ' A' ' 95' ' ' GLN . 1.9 tp-100 -59.62 -41.06 89.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.553 0.741 . . . . 0.0 110.82 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.87 -0.02 54.26 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.365 1.466 . . . . 0.0 113.108 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.53 -27.5 16.78 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.236 1.015 . . . . 0.0 113.332 -174.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.38 0.16 1.6 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.372 1.442 . . . . 0.0 113.686 176.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.273 0.4 OUTLIER -129.97 4.17 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 161.262 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.81 -13.59 16.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.242 1.017 . . . . 0.0 112.13 171.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.896 2.078 . . . . 0.0 109.964 170.304 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.3 tp . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.435 ' H ' ' HB2' ' A' ' 9' ' ' ASN . 67.2 p -130.15 -100.97 0.31 Allowed 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 170.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -133.73 -71.18 0.51 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.273 1.429 . . . . 0.0 110.123 -158.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.01 -42.28 37.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.499 0.72 . . . . 0.0 110.253 163.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.435 ' HB2' ' H ' ' A' ' 6' ' ' THR . 72.3 m-80 -69.74 -26.95 64.56 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.327 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -61.51 -67.06 0.44 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.051 0.841 . . . . 0.0 109.028 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -63.21 -35.8 81.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 121.482 -0.087 . . . . 0.0 110.843 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.91 -8.0 56.58 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 118.228 -0.892 . . . . 0.0 113.144 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.95 -49.21 5.9 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 120.36 1.437 . . . . 0.0 110.784 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.3 pt -59.94 -19.38 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -174.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -17.73 60.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.446 1.498 . . . . 0.0 113.686 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.59 146.19 48.18 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 119.175 0.898 . . . . 0.0 111.259 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -76.4 -23.36 54.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.321 1.048 . . . . 0.0 113.658 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.57 -174.26 40.0 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.132 0.872 . . . . 0.0 112.571 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.72 87.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.506 3.47 . . . . 0.0 111.86 172.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.68 138.1 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 162.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.47 163.0 39.02 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.742 -0.599 . . . . 0.0 110.318 168.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.41 126.87 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 123.994 0.918 . . . . 0.0 108.672 -173.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -80.13 114.88 19.37 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 158.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -100.03 108.88 21.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 25.5 p-90 -125.2 179.43 5.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.287 1.435 . . . . 0.0 107.249 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.25 162.73 40.71 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.496 1.118 . . . . 0.0 109.815 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.85 -9.27 50.48 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -16.38 5.6 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -174.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.4 p -74.4 38.13 0.11 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -159.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 37.62 -102.98 0.02 OUTLIER Glycine 0 CA--C 1.54 1.614 0 C-N-CA 127.665 2.555 . . . . 0.0 114.344 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.93 -17.77 39.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.015 3.144 . . . . 0.0 115.131 -175.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.2 p -53.27 -36.7 61.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.502 1.046 . . . . 0.0 111.323 168.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.2 ttt-85 -67.36 -8.85 35.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.204 1.002 . . . . 0.0 112.545 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 64.8 mtm -107.34 -14.74 14.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.503 1.521 . . . . 0.0 112.473 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.5 ttt -96.55 -36.41 10.77 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.633 1.173 . . . . 0.0 109.428 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.15 -47.81 86.82 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.648 1.179 . . . . 0.0 112.162 174.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.81 -31.28 48.58 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 121.995 1.748 . . . . 0.0 112.699 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.8 -33.74 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 119.437 1.017 . . . . 0.0 110.567 173.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -31.04 62.14 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.184 1.794 . . . . 0.0 111.614 173.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -71.15 -40.18 71.48 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.431 1.014 . . . . 0.0 109.613 172.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -62.58 -43.29 99.17 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 171.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -56.47 -42.7 78.67 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.286 1.035 . . . . 0.0 111.633 172.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.81 -55.12 36.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.183 0.993 . . . . 0.0 110.565 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.38 -47.54 72.55 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.548 1.139 . . . . 0.0 110.097 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.26 -13.69 60.8 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -133.98 17.22 3.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.567 1.076 . . . . 0.0 113.147 -173.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.75 -31.95 5.36 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.846 2.058 . . . . 0.0 115.469 -159.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -124.06 -3.28 8.09 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.963 0.905 . . . . 0.0 113.383 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.425 ' HZ3' ' C ' ' A' ' 105' ' ' GLN . 28.6 ttmt -78.63 -39.05 38.23 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.99 1.268 . . . . 0.0 110.436 166.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 m -124.45 166.45 19.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.302 5.6 t -120.63 91.59 3.57 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.415 1.102 . . . . 0.0 108.501 172.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 p -98.54 116.61 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 125.065 1.346 . . . . 0.0 110.99 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.38 98.13 5.32 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.311 -159.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.1 140.82 49.1 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.873 -173.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pp -153.67 167.69 28.72 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 124.423 1.077 . . . . 0.0 112.758 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -95.97 112.05 23.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.914 1.686 . . . . 0.0 109.388 -173.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.72 -23.67 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.314 0.645 . . . . 0.0 111.967 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -75.42 -3.04 31.48 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.452 1.501 . . . . 0.0 111.776 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -135.26 -38.59 0.76 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.708 2.003 . . . . 0.0 111.743 -166.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -88.33 119.03 70.13 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 118.95 0.795 . . . . 0.0 109.513 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -90.55 -21.54 0.81 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.504 2.803 . . . . 0.0 113.804 164.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 64' ' ' THR . 7.5 tp10 -61.4 111.74 1.9 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.306 1.442 . . . . 0.0 112.002 -170.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m 68.75 -30.58 0.18 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.625 2.77 . . . . 0.0 111.851 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.479 ' H ' ' C ' ' A' ' 62' ' ' GLU . 57.5 m -51.73 -51.35 56.85 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 128.49 2.716 . . . . 0.0 110.463 171.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.5 t -57.73 -50.14 74.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.355 0.662 . . . . 0.0 110.191 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.3 tp60 -56.62 -44.5 81.25 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.693 0.797 . . . . 0.0 111.9 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -88.61 11.54 17.11 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 119.138 -0.458 . . . . 0.0 112.028 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.61 29.31 71.45 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 124.413 1.006 . . . . 0.0 112.391 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.3 mm -79.97 82.0 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.138 0.975 . . . . 0.0 109.579 -162.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.0 ttm -123.42 -6.02 8.2 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.657 1.583 . . . . 0.0 111.111 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.2 t -83.16 26.17 0.65 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.679 1.192 . . . . 0.0 113.744 -167.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.86 151.46 89.16 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -165.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.8 129.84 10.76 Favored 'Cis proline' 0 C--N 1.353 0.784 0 CA-C-N 119.379 0.814 . . . . 0.0 111.44 2.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.8 m -121.37 152.68 38.73 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.0 tt -132.37 130.32 40.54 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 171.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.3 mt -120.78 132.62 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 167.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.47 141.0 28.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.795 2.038 . . . . 0.0 105.982 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -142.52 161.89 36.89 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.993 2.117 . . . . 0.0 111.346 -175.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.74 153.34 14.66 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.203 1.801 . . . . 0.0 108.776 158.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.68 15.69 54.47 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.676 1.131 . . . . 0.0 114.536 167.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.16 -10.36 71.72 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.24 1.4 . . . . 0.0 112.837 -175.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -97.55 159.73 30.4 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 118.729 1.265 . . . . 0.0 109.181 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -69.76 -175.46 1.16 Allowed 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 122.5 2.133 . . . . 0.0 111.193 159.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.07 -46.45 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.309 1.843 . . . . 0.0 108.738 159.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.436 ' HZ3' ' CG ' ' A' ' 102' ' ' ASP . 75.9 mttt -145.57 148.01 32.71 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.665 1.186 . . . . 0.0 107.973 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -117.32 131.99 56.69 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 163.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -125.48 141.03 52.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.1 141.18 29.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 124.022 0.929 . . . . 0.0 108.799 -170.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.18 164.87 39.6 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.586 1.089 . . . . 0.0 111.42 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.58 78.58 2.58 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.3 0.571 . . . . 0.0 110.006 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -71.01 133.82 85.8 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.23 167.58 21.68 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.874 1.716 . . . . 0.0 111.367 176.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -44.78 73.9 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.081 1.352 . . . . 0.0 110.792 -172.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -51.33 -44.9 62.11 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.69 2.396 . . . . 0.0 111.063 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -42.59 53.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.1 1.76 . . . . 0.0 108.049 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -61.74 2.11 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.655 1.582 . . . . 0.0 108.827 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.78 -39.09 83.72 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.585 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.41 82.78 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.267 1.394 . . . . 0.0 111.713 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -78.0 -21.75 50.37 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.16 -1.78 13.58 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.467 1.107 . . . . 0.0 112.808 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.38 -36.19 42.16 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.776 1.63 . . . . 0.0 112.604 -175.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.436 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 10.1 p-10 -64.31 -11.29 30.58 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.182 1.393 . . . . 0.0 114.091 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.81 -8.5 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 119.459 1.027 . . . . 0.0 112.071 168.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.27 -10.25 26.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.392 1.477 . . . . 0.0 112.899 175.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.425 ' C ' ' HZ3' ' A' ' 49' ' ' LYS . 10.7 tt0 . . . . . 0 C--O 1.246 0.899 0 C-N-CA 126.167 1.787 . . . . 0.0 110.212 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 tp . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 121.842 0.83 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.3 m -166.89 170.59 12.07 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.871 3.668 . . . . 0.0 101.958 172.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -43.38 -59.85 1.95 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 128.725 2.81 . . . . 0.0 112.781 -166.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.05 91.66 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.319 0.58 . . . . 0.0 111.189 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -72.07 -21.79 61.46 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.139 -0.458 . . . . 0.0 111.777 -177.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.26 -60.02 3.98 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -60.53 -46.06 91.55 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.442 -0.789 . . . . 0.0 111.184 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -62.67 -26.31 68.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.314 0.961 . . . . 0.0 112.71 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.94 -63.47 1.25 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.066 0.848 . . . . 0.0 109.485 165.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 pt -66.95 -13.52 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -166.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -58.54 -20.74 48.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.993 1.317 . . . . 0.0 113.975 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.43 -112.14 0.26 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 107.849 -2.1 . . . . 0.0 107.849 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 t0 62.4 -12.83 0.07 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 130.039 3.336 . . . . 0.0 117.677 158.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.83 -166.85 16.89 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.512 1.053 . . . . 0.0 111.889 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -55.66 101.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.946 3.098 . . . . 0.0 111.235 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -94.77 140.83 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 108.361 -175.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -130.43 143.14 50.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 173.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.69 108.3 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 63.3 t0 -75.91 98.52 4.24 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.41 ' CE1' HG22 ' A' ' 69' ' ' ILE . 78.0 m-85 -84.3 105.53 15.21 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -124.8 -177.15 3.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.96 162.09 41.48 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.222 -0.924 . . . . 0.0 110.552 171.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.35 -5.42 2.43 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.66 -20.96 10.99 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.591 1.087 . . . . 0.0 113.765 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.9 p -73.83 161.67 29.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.912 1.233 . . . . 0.0 110.347 -173.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.78 -84.86 1.74 Allowed Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.559 -0.579 . . . . 0.0 112.552 -173.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.15 -16.55 55.52 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.339 2.693 . . . . 0.0 113.448 -171.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.0 p -49.78 -40.84 42.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.848 0.859 . . . . 0.0 111.586 166.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -12.35 61.55 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.145 0.578 . . . . 0.0 112.257 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.5 mtm -100.99 -15.73 17.38 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.322 1.449 . . . . 0.0 112.057 173.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.8 ttt -85.32 -42.62 14.43 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 125.485 1.514 . . . . 0.0 108.444 172.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.09 -50.4 36.99 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.359 -1.305 . . . . 0.0 113.419 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.14 -36.1 30.52 Favored 'Trans proline' 0 C--N 1.353 0.766 0 CA-C-N 121.845 1.695 . . . . 0.0 112.17 173.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.97 -35.48 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.306 0.957 . . . . 0.0 110.304 173.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.84 -17.55 57.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.631 1.973 . . . . 0.0 111.847 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.26 -48.86 18.73 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 167.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -61.55 -26.18 67.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.602 0.761 . . . . 0.0 111.33 173.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -65.25 -63.19 1.16 Allowed 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 125.182 1.393 . . . . 0.0 107.879 170.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.77 -46.16 67.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.173 -0.442 . . . . 0.0 112.046 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.93 -34.79 56.94 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.245 1.418 . . . . 0.0 111.781 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.91 -14.45 61.06 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -162.18 63.38 0.23 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.341 1.456 . . . . 0.0 108.995 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.66 71.39 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -166.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -131.74 -1.31 3.82 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -168.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -64.46 -39.63 94.19 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.928 1.24 . . . . 0.0 108.866 161.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.01 170.9 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.697 1.199 . . . . 0.0 108.094 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 t -128.41 74.81 1.58 Allowed 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 123.989 1.852 . . . . 0.0 106.556 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 p -82.78 160.34 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.787 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.67 174.11 15.05 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.185 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 28.1 mttp -131.99 144.39 50.76 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 123.331 0.653 . . . . 0.0 110.509 176.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.97 163.4 39.77 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.788 1.305 . . . . 0.0 114.297 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -91.45 105.33 17.68 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.101 1.76 . . . . 0.0 108.716 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.94 -21.78 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.664 0.786 . . . . 0.0 112.669 -172.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -67.69 -22.43 65.28 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.303 1.041 . . . . 0.0 111.612 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -114.09 -21.64 10.43 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.744 2.017 . . . . 0.0 111.829 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -100.32 94.23 3.23 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.235 1.414 . . . . 0.0 109.924 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.19 -27.74 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.038 2.492 . . . . 0.0 113.524 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -74.84 103.76 5.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.275 0.943 . . . . 0.0 110.751 -172.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m 104.88 -32.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 130.868 3.667 . . . . 0.0 109.471 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -52.82 -52.82 55.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.888 1.275 . . . . 0.0 109.714 167.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 t -70.9 -7.43 45.7 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.228 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -87.73 -33.22 18.78 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.998 1.272 . . . . 0.0 111.12 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -120.12 2.41 10.92 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.62 38.34 51.25 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 119.134 0.879 . . . . 0.0 111.801 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.41 HG22 ' CE1' ' A' ' 24' ' ' PHE . 39.3 mm -75.51 83.67 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.973 1.309 . . . . 0.0 110.498 -166.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -119.58 -6.55 10.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.058 1.343 . . . . 0.0 112.544 172.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 m -77.14 34.41 0.16 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.929 2.092 . . . . 0.0 113.362 -168.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.0 pt -74.76 151.06 86.7 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -162.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.88 130.65 12.23 Favored 'Cis proline' 0 C--N 1.351 0.685 0 CA-C-N 119.047 0.695 . . . . 0.0 110.745 -3.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -119.07 144.12 46.76 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.6 tp -132.36 113.92 13.75 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mt -111.42 142.9 22.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.99 118.56 37.02 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.762 2.025 . . . . 0.0 106.875 -176.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -130.72 176.38 8.24 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.239 1.016 . . . . 0.0 110.433 175.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.88 145.83 17.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 158.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 37.61 41.79 0.89 Allowed Glycine 0 CA--C 1.54 1.637 0 N-CA-C 115.974 1.15 . . . . 0.0 115.974 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.29 -12.63 68.67 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.77 1.652 . . . . 0.0 115.545 177.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -95.43 120.52 63.63 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 120.601 2.2 . . . . 0.0 110.768 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.82 148.71 46.65 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.124 1.883 . . . . 0.0 109.487 163.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.94 -44.54 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.68 0.792 . . . . 0.0 111.914 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -159.56 171.62 19.31 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.72 1.145 . . . . 0.0 110.061 171.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.29 156.21 46.54 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.016 1.726 . . . . 0.0 110.133 -174.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.4 mt -137.01 139.54 41.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.04 134.23 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 -170.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.02 162.68 37.92 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.796 0.712 . . . . 0.0 111.63 -175.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -75.29 75.78 2.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.363 1.065 . . . . 0.0 110.923 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -75.31 140.43 72.72 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 167.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 170.13 19.46 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.592 2.195 . . . . 0.0 111.692 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.83 -46.39 41.98 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.006 1.323 . . . . 0.0 111.945 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -56.94 -43.75 81.84 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.913 1.285 . . . . 0.0 110.95 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.73 -36.49 70.48 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.403 0.681 . . . . 0.0 109.251 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -60.03 3.52 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.415 1.086 . . . . 0.0 108.552 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -62.35 -32.87 73.72 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.102 0.561 . . . . 0.0 110.377 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.74 -53.68 10.99 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.355 0.525 . . . . 0.0 111.009 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.5 -35.87 81.89 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 118.477 0.581 . . . . 0.0 111.089 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.63 -1.14 57.75 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.913 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -50.32 -31.33 14.15 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 125.224 1.41 . . . . 0.0 113.588 -172.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -22.64 58.6 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.399 1.08 . . . . 0.0 112.32 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.55 -8.25 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.809 0.844 . . . . 0.0 111.444 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.89 -10.4 28.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.19 1.396 . . . . 0.0 112.487 171.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 . . . . . 0 C--O 1.249 1.069 0 C-N-CA 126.104 1.761 . . . . 0.0 110.898 171.904 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.341 0 CA-C-O 121.015 0.436 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.0 t -131.78 -50.74 0.97 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.092 0.957 . . . . 0.0 111.53 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 174.27 -68.9 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 127.9 2.48 . . . . 0.0 105.179 171.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.67 -33.5 64.16 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.881 -0.512 . . . . 0.0 111.836 177.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -17.39 61.26 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 119.105 -0.474 . . . . 0.0 111.25 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.69 -64.45 0.89 Allowed 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.88 -44.42 94.21 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.974 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.8 -28.01 65.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.468 1.031 . . . . 0.0 113.013 -177.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.9 -58.9 2.68 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.974 0.91 . . . . 0.0 110.723 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.6 pt -62.08 -23.13 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.936 -171.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -57.71 -31.99 66.94 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.393 1.077 . . . . 0.0 111.688 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.5 102.08 0.15 Allowed Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -165.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -153.36 -69.55 0.15 Allowed 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 128.294 2.638 . . . . 0.0 105.539 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.46 -114.65 0.98 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 106.957 -2.457 . . . . 0.0 106.957 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.79 76.94 3.53 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.21 3.273 . . . . 0.0 112.564 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.96 130.14 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.87 113.89 26.17 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 159.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.09 125.01 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.1 94.73 5.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 124.12 0.888 . . . . 0.0 110.337 -174.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -83.08 109.27 16.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -126.93 175.02 8.38 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -140.14 150.2 43.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.773 0.715 . . . . 0.0 110.52 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.9 -26.26 58.69 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.764 0.825 . . . . 0.0 113.023 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.11 -25.88 16.96 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.0 p -69.75 157.64 36.93 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.372 0.987 . . . . 0.0 111.467 -160.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.75 -86.11 1.16 Allowed Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.318 -172.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.87 -18.83 66.73 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.13 2.553 . . . . 0.0 113.918 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 p -53.67 -35.47 61.1 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.24 0.473 . . . . 0.0 111.23 168.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -69.31 -16.42 63.55 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.381 -0.824 . . . . 0.0 112.336 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.78 -12.32 20.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.597 1.559 . . . . 0.0 112.119 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.8 ttt -93.14 -35.13 13.34 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 126.415 1.886 . . . . 0.0 108.773 175.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.82 -50.45 43.81 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.034 1.734 . . . . 0.0 112.894 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.05 -36.76 46.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 121.81 1.682 . . . . 0.0 111.585 172.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.02 -22.84 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 119.851 1.205 . . . . 0.0 111.314 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.81 -35.06 24.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.776 2.43 . . . . 0.0 111.8 175.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.12 -42.71 93.65 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 169.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -65.79 -15.41 62.85 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.306 1.443 . . . . 0.0 112.368 170.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -82.63 -47.82 11.64 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 120.636 -1.29 . . . . 0.0 109.214 170.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.55 81.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.551 1.14 . . . . 0.0 110.573 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -58.7 -53.12 61.98 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.575 0.75 . . . . 0.0 110.959 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.7 -14.67 54.3 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -162.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 51.39 0.79 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.369 1.868 . . . . 0.0 108.428 172.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.63 -14.02 7.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.412 1.085 . . . . 0.0 113.679 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -88.87 -51.28 5.72 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.596 2.358 . . . . 0.0 111.864 174.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -73.33 -16.73 61.35 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 117.439 -1.267 . . . . 0.0 112.244 -168.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.09 166.56 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 121.128 1.785 . . . . 0.0 113.102 -170.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.1 t -119.46 122.75 42.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.75 0.786 . . . . 0.0 109.146 159.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.97 152.13 5.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 158.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.35 99.7 3.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -95.14 143.38 26.62 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 122.783 0.433 . . . . 0.0 110.714 -169.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -141.73 145.36 34.75 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.299 0.571 . . . . 0.0 110.755 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -82.22 90.0 6.57 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 173.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.1 p -62.01 -15.04 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 125.275 1.43 . . . . 0.0 112.468 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -65.85 -20.0 66.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.809 2.444 . . . . 0.0 112.766 169.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -131.06 -23.43 2.46 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.067 2.147 . . . . 0.0 111.696 -167.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -116.28 77.85 7.71 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.402 1.881 . . . . 0.0 109.176 -169.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.92 -4.82 16.08 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.608 3.539 . . . . 0.0 116.675 -170.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.515 ' C ' ' H ' ' A' ' 64' ' ' THR . 5.6 tp10 -59.93 135.25 57.64 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.976 1.716 . . . . 0.0 109.979 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m 59.26 -14.64 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.925 3.29 . . . . 0.0 112.847 -176.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.515 ' H ' ' C ' ' A' ' 62' ' ' GLU . 96.9 m -63.44 -54.26 39.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 126.259 1.824 . . . . 0.0 109.221 -175.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -73.02 1.12 9.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.543 1.137 . . . . 0.0 112.704 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -107.01 -39.66 5.68 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.622 1.169 . . . . 0.0 110.627 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -104.27 5.24 34.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.587 1.155 . . . . 0.0 110.734 -176.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.81 38.67 49.28 Favored Glycine 0 C--N 1.343 0.941 0 C-N-CA 124.243 0.925 . . . . 0.0 112.158 174.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.9 mm -78.83 76.44 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.965 1.306 . . . . 0.0 109.734 -167.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 70.7 mtm -106.54 -14.88 14.93 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.935 1.294 . . . . 0.0 111.478 173.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.4 m -82.61 23.73 0.77 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.165 1.786 . . . . 0.0 114.022 -159.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.3 pt -71.31 155.79 92.47 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.317 1.047 . . . . 0.0 112.943 -158.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.74 127.86 5.64 Favored 'Cis proline' 0 C--N 1.352 0.711 0 CA-C-N 119.666 0.916 . . . . 0.0 110.687 -3.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -114.32 136.4 53.01 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 tt -131.72 92.99 3.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -174.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.7 mt -94.52 144.37 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tt -110.84 120.33 42.03 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -110.44 148.38 32.16 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -141.27 111.63 6.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 170.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 39.54 59.17 1.98 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.58 2.038 . . . . 0.0 112.942 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.66 -20.32 51.05 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.636 1.588 . . . . 0.0 114.03 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.74 109.41 59.36 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 119.452 1.626 . . . . 0.0 111.359 -166.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.31 92.78 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.855 3.037 . . . . 0.0 110.731 169.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 m -65.54 -40.78 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.582 -0.699 . . . . 0.0 112.644 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HZ1' ' CD2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -158.76 167.19 30.14 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.09 0.956 . . . . 0.0 110.248 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -136.11 133.21 37.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.905 2.082 . . . . 0.0 107.607 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.413 ' CD2' ' HZ1' ' A' ' 85' ' ' LYS . 3.1 mm? -101.12 154.2 18.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 158.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.3 pt -141.35 143.93 27.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 106.872 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.55 172.34 20.19 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 121.983 0.768 . . . . 0.0 112.191 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -74.75 79.62 2.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.934 0.894 . . . . 0.0 110.784 -176.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -72.36 127.69 89.82 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 161.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.41 163.55 36.14 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.712 1.608 . . . . 0.0 109.779 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -45.35 12.32 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.81 1.244 . . . . 0.0 111.041 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -59.92 -24.7 64.55 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.191 1.396 . . . . 0.0 113.908 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -100.12 -46.95 5.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.707 1.203 . . . . 0.0 108.624 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 tt -52.64 -62.93 1.33 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.873 2.069 . . . . 0.0 108.892 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -59.14 -34.92 72.63 Favored 'General case' 0 C--N 1.337 0.043 0 C-N-CA 125.025 1.33 . . . . 0.0 110.469 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.62 -42.04 71.44 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.064 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -41.89 85.41 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.411 0.55 . . . . 0.0 109.798 173.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.77 -4.04 25.45 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.958 1.703 . . . . 0.0 113.337 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.47 -25.07 9.16 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.842 1.257 . . . . 0.0 113.132 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -7.43 9.41 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 121.091 1.769 . . . . 0.0 113.975 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.49 -1.55 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 121.431 -0.793 . . . . 0.0 112.845 168.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -105.77 -10.98 16.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.44 1.096 . . . . 0.0 113.094 174.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 C--O 1.251 1.15 0 C-N-CA 127.017 2.127 . . . . 0.0 109.81 162.87 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.2 m -60.48 175.74 0.42 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.517 2.327 . . . . 0.0 110.883 169.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.64 -165.44 2.06 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.895 1.678 . . . . 0.0 107.507 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.8 m -44.35 136.36 4.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.817 2.047 . . . . 0.0 112.933 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.71 172.92 12.04 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.023 1.729 . . . . 0.0 111.102 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.1 t -129.44 179.61 5.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.117 1.767 . . . . 0.0 107.33 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -52.46 -58.97 5.05 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.483 2.313 . . . . 0.0 111.735 -160.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.38 -16.32 60.13 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -102.22 -17.11 16.1 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.959 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -49.11 -55.8 11.11 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 125.203 1.401 . . . . 0.0 108.859 171.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -53.02 -54.54 33.84 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.307 1.843 . . . . 0.0 112.468 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -64.09 -20.93 66.31 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.125 0.57 . . . . 0.0 112.278 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.34 -64.18 1.16 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 167.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.3 pt -58.55 -25.72 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -62.53 -22.33 66.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.29 1.036 . . . . 0.0 113.406 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.12 149.51 51.21 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 119.12 0.873 . . . . 0.0 112.453 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -87.82 53.34 2.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.232 1.413 . . . . 0.0 110.193 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.76 165.9 35.9 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.66 101.09 0.16 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.192 3.261 . . . . 0.0 111.772 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.47 101.71 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 125.369 1.468 . . . . 0.0 107.973 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.9 tt -82.58 112.77 19.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 171.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.59 114.95 39.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.97 93.03 4.65 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -164.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -86.62 112.86 22.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.601 0.761 . . . . 0.0 109.758 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 26.6 p-90 -124.54 -175.68 3.33 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 169.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.52 158.69 43.93 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.202 -0.936 . . . . 0.0 110.096 172.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.42 -1.27 0.5 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.215 1.806 . . . . 0.0 115.598 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.15 -18.96 1.75 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.1 p -72.27 100.65 2.66 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.855 1.207 . . . . 0.0 111.519 -165.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -29.0 -61.81 0.14 Allowed Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.934 1.73 . . . . 0.0 115.067 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.31 -33.67 29.56 Favored 'Trans proline' 0 C--N 1.351 0.658 0 CA-C-N 120.273 2.036 . . . . 0.0 112.985 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.7 p -69.27 -30.35 68.44 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.795 1.179 . . . . 0.0 110.624 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -20.6 65.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.329 0.968 . . . . 0.0 111.654 172.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.1 mtp -99.85 -25.98 14.17 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.323 1.449 . . . . 0.0 111.878 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.7 ttt -81.48 -38.74 25.86 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.727 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.03 -50.73 61.17 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 120.703 1.592 . . . . 0.0 112.534 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.22 -33.25 40.22 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.598 1.532 . . . . 0.0 112.359 172.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.65 -36.63 77.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 120.13 1.332 . . . . 0.0 110.851 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.2 mt -78.92 -6.47 56.27 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.921 2.489 . . . . 0.0 111.471 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.92 -48.52 13.29 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.738 1.215 . . . . 0.0 108.144 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -60.9 -43.41 98.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.853 0.461 . . . . 0.0 110.022 168.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -63.85 -20.13 65.58 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.543 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.92 -59.4 2.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 121.174 1.806 . . . . 0.0 108.668 166.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.16 -45.43 65.06 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.792 1.237 . . . . 0.0 111.838 -173.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.55 -23.91 29.35 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -169.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.32 36.69 0.83 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.037 1.335 . . . . 0.0 110.626 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.39 -23.42 3.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 -160.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.18 0.07 8.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.349 0.977 . . . . 0.0 112.841 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -76.58 -29.34 56.57 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.432 -0.792 . . . . 0.0 109.946 167.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.22 143.04 42.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 109.249 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.33 136.49 53.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 158.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 t -119.92 134.61 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 160.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.21 90.38 2.03 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -166.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -86.99 143.71 27.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.226 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 152.62 26.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.208 0.913 . . . . 0.0 113.263 171.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -76.45 107.04 8.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.246 1.818 . . . . 0.0 107.683 172.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.6 p -48.41 -43.53 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 126.738 2.015 . . . . 0.0 114.274 -165.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.45 -27.09 68.31 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.872 2.069 . . . . 0.0 112.492 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.4 -28.1 62.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.726 0.81 . . . . 0.0 111.406 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -115.48 83.75 11.21 Favored Pre-proline 0 N--CA 1.457 -0.125 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.53 -25.77 29.32 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.631 1.554 . . . . 0.0 112.207 170.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.7 OUTLIER -61.71 118.44 7.13 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.47 1.108 . . . . 0.0 109.405 -176.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.262 8.8 m 70.23 -20.01 0.2 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.606 2.362 . . . . 0.0 113.366 173.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.431 ' H ' ' C ' ' A' ' 62' ' ' GLU . 97.9 m -54.66 -55.73 26.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.58 1.952 . . . . 0.0 109.011 160.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.5 t -57.59 -41.57 81.44 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.291 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -62.75 -40.81 98.41 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.665 0.786 . . . . 0.0 112.949 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -96.27 16.56 17.98 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.713 0.688 . . . . 0.0 112.773 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.21 25.81 72.24 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 124.129 0.871 . . . . 0.0 112.523 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 30.6 mm -82.14 70.02 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 122.576 1.179 . . . . 0.0 109.558 -165.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 53.3 ttp -120.37 0.78 10.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.739 1.616 . . . . 0.0 109.974 166.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.3 t -88.83 21.94 2.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.102 1.361 . . . . 0.0 112.985 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.45 144.61 83.95 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.529 0.732 . . . . 0.0 112.528 -168.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -69.06 130.64 16.41 Favored 'Cis proline' 0 C--N 1.35 0.606 0 CA-C-N 119.01 0.682 . . . . 0.0 112.734 7.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.9 m -125.26 151.71 45.58 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.862 1.265 . . . . 0.0 108.82 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.2 tt -143.63 105.34 4.32 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -173.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.9 mt -101.1 143.82 13.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 171.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.25 115.89 28.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -113.63 163.39 15.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.827 1.651 . . . . 0.0 111.873 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.41 149.91 13.89 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.466 1.907 . . . . 0.0 107.337 158.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.03 14.67 47.0 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 119.155 0.889 . . . . 0.0 113.496 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.87 -5.99 82.24 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.436 1.494 . . . . 0.0 113.35 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -98.86 121.14 56.93 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 119.174 1.487 . . . . 0.0 110.189 -173.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.09 103.79 1.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.75 2.967 . . . . 0.0 110.048 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.29 -35.94 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 121.815 -0.553 . . . . 0.0 112.071 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -153.54 158.27 41.0 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.592 0.757 . . . . 0.0 110.669 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -147.44 125.22 11.88 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.744 2.018 . . . . 0.0 106.741 -172.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.8 mp -121.83 150.5 41.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.473 1.909 . . . . 0.0 106.802 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.9 pt -145.43 151.97 14.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.613 1.165 . . . . 0.0 109.344 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.12 167.63 24.65 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.404 1.002 . . . . 0.0 111.908 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -75.33 73.94 2.42 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.077 0.951 . . . . 0.0 110.855 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -70.06 138.3 87.33 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.62 163.53 38.63 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.403 2.069 . . . . 0.0 110.634 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.12 -44.8 61.4 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.982 1.313 . . . . 0.0 111.225 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.67 -15.32 63.41 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.093 0.957 . . . . 0.0 112.67 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -102.0 -44.57 5.44 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.208 0.913 . . . . 0.0 109.17 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.51 -59.32 5.63 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.106 1.762 . . . . 0.0 109.636 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -63.55 -24.73 67.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.054 0.843 . . . . 0.0 110.968 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.92 -51.52 15.85 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.854 0.752 . . . . 0.0 110.682 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -62.27 -43.3 99.15 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.7 0.8 . . . . 0.0 110.481 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 tp -78.77 -7.03 57.41 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.725 1.21 . . . . 0.0 112.744 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.07 -33.05 37.46 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.689 1.196 . . . . 0.0 111.085 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.16 11.87 0.1 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.803 2.041 . . . . 0.0 112.711 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.54 -11.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 119.451 -2.031 . . . . 0.0 113.187 158.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.07 -22.57 20.67 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.043 1.337 . . . . 0.0 112.047 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 . . . . . 0 C--O 1.251 1.134 0 C-N-CA 128.591 2.757 . . . . 0.0 110.202 175.613 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 117.371 -1.299 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.8 m 82.69 140.54 0.07 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.436 2.695 . . . . 0.0 113.092 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.4 ttm -157.55 171.81 19.68 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.326 1.85 . . . . 0.0 109.082 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 m -70.99 162.41 29.45 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.889 -1.132 . . . . 0.0 109.264 162.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 tp -136.79 165.08 26.77 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.964 0.906 . . . . 0.0 110.629 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.4 p -146.03 172.27 13.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 128.703 2.801 . . . . 0.0 104.988 170.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -45.45 -61.2 1.78 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.517 2.327 . . . . 0.0 110.855 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.0 -31.95 71.54 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.692 -0.63 . . . . 0.0 112.182 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -78.03 -19.25 54.71 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.287 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -55.51 -60.44 3.43 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.442 1.497 . . . . 0.0 107.572 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -58.81 -45.46 89.88 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 111.793 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -56.85 -36.01 69.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.568 0.622 . . . . 0.0 111.516 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.46 -60.72 2.11 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.873 0.869 . . . . 0.0 110.69 172.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.2 pt -68.98 -2.42 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -168.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -42.76 -39.69 2.55 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.593 1.957 . . . . 0.0 114.91 -172.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 159.25 -176.55 36.04 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 119.322 0.965 . . . . 0.0 113.899 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 65.25 -57.44 0.29 Allowed 'General case' 0 N--CA 1.463 0.196 1 C-N-CA 132.056 4.143 . . . . 0.0 112.543 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.53 150.86 20.61 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.645 -160.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.16 88.5 0.7 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.113 3.209 . . . . 0.0 110.24 170.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.59 149.57 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 170.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.03 167.77 21.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.932 -0.48 . . . . 0.0 110.595 161.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.31 134.46 66.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 124.48 1.112 . . . . 0.0 108.382 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -95.7 99.72 11.53 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 167.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -86.68 112.73 21.92 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 -128.28 176.65 7.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.163 1.385 . . . . 0.0 108.162 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -147.5 149.03 31.86 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.723 1.147 . . . . 0.0 110.789 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.07 -24.46 66.24 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -102.51 -6.99 22.26 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.252 0.933 . . . . 0.0 113.25 -174.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.1 p -66.19 169.94 6.44 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.638 0.732 . . . . 0.0 112.676 -164.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.89 -90.22 1.54 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 165.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.39 -23.16 71.7 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.003 2.469 . . . . 0.0 114.117 -168.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.86 -25.92 68.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.161 0.891 . . . . 0.0 111.682 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -71.8 -17.16 62.18 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.0 0.92 . . . . 0.0 111.632 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.5 mtp -97.39 -39.87 8.98 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.689 1.596 . . . . 0.0 110.211 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.8 tpt -66.84 -44.87 79.94 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-O 117.657 -1.163 . . . . 0.0 109.931 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.86 99.91 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.309 1.413 . . . . 0.0 112.725 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -69.19 -38.63 8.75 Favored 'Trans proline' 0 C--N 1.352 0.747 0 CA-C-N 121.78 1.671 . . . . 0.0 112.837 169.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.97 -34.09 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 120.935 1.698 . . . . 0.0 111.531 177.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.0 -13.23 61.19 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.877 2.471 . . . . 0.0 111.701 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.3 -36.63 34.06 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.564 1.074 . . . . 0.0 110.308 176.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.95 -43.24 99.33 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 169.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -58.57 -45.98 87.89 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.669 0.788 . . . . 0.0 110.479 171.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.06 -49.04 72.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.173 0.897 . . . . 0.0 110.893 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -53.19 60.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.74 1.216 . . . . 0.0 111.087 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.72 48.56 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -164.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -141.98 38.88 1.62 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.748 1.219 . . . . 0.0 110.552 172.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.47 -8.67 2.89 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.009 1.324 . . . . 0.0 113.964 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -92.29 -53.96 4.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.94 2.496 . . . . 0.0 111.425 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -68.34 -26.08 65.42 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 118.719 -0.658 . . . . 0.0 111.248 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.2 m -141.73 171.0 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.436 0.695 . . . . 0.0 110.111 -174.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.9 t -127.48 130.43 49.21 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 160.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.0 p -90.98 173.08 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 158.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.07 153.35 34.91 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 159.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -113.26 137.65 51.17 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 119.29 -0.386 . . . . 0.0 109.992 -169.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pp -149.86 146.88 27.36 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 122.686 1.232 . . . . 0.0 114.288 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -78.64 110.16 13.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.127 2.171 . . . . 0.0 108.025 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.01 -37.1 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.861 1.665 . . . . 0.0 112.929 -166.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.86 -38.62 83.36 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.097 1.359 . . . . 0.0 110.601 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -76.34 -27.31 56.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.629 2.372 . . . . 0.0 112.048 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -116.65 78.21 8.7 Favored Pre-proline 0 N--CA 1.445 -0.703 0 C-N-CA 124.817 1.247 . . . . 0.0 110.461 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.36 -88.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 123.875 3.05 . . . . 0.0 112.313 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 30.96 -39.45 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.893 1 C-N-CA 132.912 4.485 . . . . 0.0 120.367 -159.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -159.52 -7.32 0.06 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 129.466 3.106 . . . . 0.0 112.376 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 m -39.93 -60.4 1.03 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.168 2.187 . . . . 0.0 110.547 164.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.0 t -68.79 -17.39 64.02 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.789 -1.1 . . . . 0.0 113.041 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -77.61 -30.97 52.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.69 1.132 . . . . 0.0 110.112 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -93.51 9.65 35.76 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.438 0.695 . . . . 0.0 111.122 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.52 22.85 75.23 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.846 0.736 . . . . 0.0 112.784 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.8 mm -78.23 77.36 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.753 1.221 . . . . 0.0 109.151 -169.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.81 -2.54 8.77 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.088 1.355 . . . . 0.0 110.363 167.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 p -82.87 43.64 0.86 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.177 2.591 . . . . 0.0 111.485 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.11 145.84 94.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 O-C-N 121.7 -0.625 . . . . 0.0 111.697 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.21 127.0 8.89 Favored 'Cis proline' 0 N--CA 1.459 -0.512 0 CA-C-N 119.153 0.733 . . . . 0.0 110.797 0.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.0 m -116.84 148.07 41.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 tt -136.96 126.64 25.42 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.9 mt -128.85 141.56 46.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mp -106.94 142.7 36.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.843 1.657 . . . . 0.0 109.474 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -134.68 150.09 50.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.357 1.463 . . . . 0.0 109.309 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.66 163.88 32.19 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 159.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.02 8.55 8.55 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 118.453 -1.193 . . . . 0.0 115.287 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.34 2.49 60.39 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 119.134 1.467 . . . . 0.0 113.156 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -126.57 135.91 27.93 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 119.346 1.573 . . . . 0.0 110.813 -168.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.44 117.2 5.02 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.48 2.786 . . . . 0.0 110.376 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.03 -46.01 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -156.55 164.5 38.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.867 0.758 . . . . 0.0 111.365 -173.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -136.28 147.98 47.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.483 1.913 . . . . 0.0 109.414 -171.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -122.14 154.05 37.92 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.833 1.653 . . . . 0.0 107.845 158.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 pt -141.32 137.74 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.671 1.988 . . . . 0.0 106.129 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.42 168.31 35.61 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.922 0.772 . . . . 0.0 112.921 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -80.4 83.64 6.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.529 1.131 . . . . 0.0 108.952 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -88.66 134.68 33.5 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.53 160.41 48.1 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.28 1.32 . . . . 0.0 109.793 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -41.67 80.79 Favored 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 123.803 0.841 . . . . 0.0 111.512 -175.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.79 -19.99 60.54 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -95.39 -49.75 5.31 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.888 1.222 . . . . 0.0 109.364 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.31 -59.17 5.74 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 124.499 1.12 . . . . 0.0 110.62 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -65.9 -18.44 65.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.075 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.25 -51.6 12.89 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.148 0.885 . . . . 0.0 110.307 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -53.32 -43.17 67.4 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.852 0.861 . . . . 0.0 110.831 175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 mp -86.85 -0.77 57.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.597 1.559 . . . . 0.0 113.167 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.04 -34.29 69.91 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 119.431 1.014 . . . . 0.0 111.622 -172.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -63.26 -12.56 30.0 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.195 1.398 . . . . 0.0 113.96 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.4 m -128.59 9.73 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 126.245 1.818 . . . . 0.0 111.633 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -124.95 -4.55 7.51 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.924 1.689 . . . . 0.0 113.122 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 126.895 2.078 . . . . 0.0 108.708 164.761 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.662 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -65.96 -9.08 26.71 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.047 1.339 . . . . 0.0 113.698 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.51 -146.33 0.43 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.833 1.653 . . . . 0.0 110.633 167.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.0 m -67.85 122.17 17.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.31 1.044 . . . . 0.0 108.848 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 tt -134.17 161.67 34.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.956 1.702 . . . . 0.0 109.136 -163.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.1 p -142.86 163.97 31.35 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 129.145 2.978 . . . . 0.0 104.998 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.41 -40.14 81.63 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.601 1.16 . . . . 0.0 113.124 -168.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.52 65.84 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.633 -0.667 . . . . 0.0 112.358 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -94.49 -34.75 12.58 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.201 1.4 . . . . 0.0 110.549 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -50.6 -62.39 1.63 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 126.847 2.059 . . . . 0.0 109.201 173.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -57.29 -46.03 83.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.277 0.489 . . . . 0.0 110.781 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -70.62 -21.53 62.63 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.4 -62.01 1.71 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.212 0.915 . . . . 0.0 109.538 165.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.1 pt -62.46 -21.71 27.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.514 1.126 . . . . 0.0 113.776 -167.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -64.37 -23.92 67.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.93 0.892 . . . . 0.0 112.807 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.35 170.16 54.52 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 118.864 0.756 . . . . 0.0 112.058 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -82.83 -22.62 34.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.601 1.56 . . . . 0.0 112.798 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.46 48.73 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 123.408 0.528 . . . . 0.0 112.219 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.3 91.3 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 124.186 3.257 . . . . 0.0 111.317 173.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.67 131.43 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 mp -118.57 136.94 53.58 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.55 116.63 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -72.72 107.52 5.22 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 124.105 0.878 . . . . 0.0 109.025 163.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -89.03 108.15 19.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 164.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -126.44 -177.92 4.16 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.31 159.84 40.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.376 -0.827 . . . . 0.0 108.876 168.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.77 -15.67 22.01 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.63 -31.25 17.62 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.458 1.026 . . . . 0.0 113.354 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.9 p -72.8 160.67 31.81 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.684 1.129 . . . . 0.0 111.151 -168.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.43 -79.55 1.47 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.018 0.818 . . . . 0.0 112.515 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.15 -15.89 51.93 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.621 2.881 . . . . 0.0 113.701 -172.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.1 p -52.81 -35.97 57.75 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.248 0.619 . . . . 0.0 111.786 167.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -70.38 -13.94 62.35 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.753 0.706 . . . . 0.0 112.563 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.2 mtm -95.91 -20.08 19.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.078 1.351 . . . . 0.0 111.63 170.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.5 ttt -79.85 -39.27 30.99 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 108.913 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.01 -52.48 46.94 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.742 1.217 . . . . 0.0 113.326 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.65 -30.88 34.14 Favored 'Trans proline' 0 C--N 1.352 0.711 0 CA-C-N 121.987 1.745 . . . . 0.0 112.26 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.17 -38.3 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.636 1.107 . . . . 0.0 109.887 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 mp -69.99 -26.93 64.31 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.6 1.96 . . . . 0.0 112.196 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -69.52 -46.76 65.79 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.252 0.933 . . . . 0.0 109.156 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -61.93 -41.23 97.7 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.069 0.548 . . . . 0.0 110.591 173.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.29 -50.53 73.29 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.286 1.035 . . . . 0.0 110.915 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.25 -48.24 79.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.725 0.81 . . . . 0.0 110.16 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -58.27 -50.03 75.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.254 0.621 . . . . 0.0 110.941 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.7 -23.14 50.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.96 52.86 0.69 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.348 1.459 . . . . 0.0 109.876 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.26 -17.63 54.43 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -95.43 -49.6 5.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.595 2.358 . . . . 0.0 111.549 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -67.11 -24.62 65.95 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.151 -170.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.22 149.43 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 119.139 0.881 . . . . 0.0 111.074 -172.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.344 2.9 t -110.57 84.9 2.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 123.11 1.433 . . . . 0.0 109.3 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.14 139.14 19.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.967 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.52 166.56 22.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.201 2.2 . . . . 0.0 107.976 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -136.22 144.57 44.96 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 122.406 0.282 . . . . 0.0 111.377 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -145.86 142.7 29.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.368 0.604 . . . . 0.0 111.539 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -83.13 98.51 9.37 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.98 -27.73 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.613 -163.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -65.01 -24.87 67.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.867 2.467 . . . . 0.0 112.306 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -91.89 -32.26 15.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.069 1.347 . . . . 0.0 110.238 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -116.94 74.87 7.12 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.643 1.177 . . . . 0.0 109.839 -170.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.15 -12.65 14.3 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.152 3.235 . . . . 0.0 113.514 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 64' ' ' THR . 7.0 tp10 -72.9 142.6 47.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.131 0.878 . . . . 0.0 109.315 174.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m 60.07 -29.36 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 131.46 3.904 . . . . 0.0 113.458 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.522 ' H ' ' C ' ' A' ' 62' ' ' GLU . 21.2 m -50.11 -59.6 3.76 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.018 2.927 . . . . 0.0 108.737 161.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -70.93 -10.14 59.12 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 117.725 -1.131 . . . . 0.0 112.674 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -85.87 -39.21 17.26 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.852 1.205 . . . . 0.0 111.266 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -92.99 6.85 46.44 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.538 0.608 . . . . 0.0 112.242 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.89 34.5 77.28 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.861 0.755 . . . . 0.0 111.926 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.7 mm -72.17 85.31 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.078 1.751 . . . . 0.0 109.259 -171.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.8 tpp -143.11 51.85 1.38 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.557 1.543 . . . . 0.0 109.654 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.2 m -156.81 42.41 0.36 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.145 -1.597 . . . . 0.0 111.812 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.2 pt -70.73 151.93 95.24 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 121.767 -0.583 . . . . 0.0 112.564 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.49 129.2 6.64 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 119.379 0.814 . . . . 0.0 110.755 -5.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.1 m -121.44 140.93 51.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -123.53 120.39 32.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 171.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.6 mt -121.24 142.77 35.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 tt -108.11 121.54 45.05 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 176.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -118.37 156.77 28.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.151 0.98 . . . . 0.0 111.221 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -163.14 158.97 22.48 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 125.535 1.534 . . . . 0.0 108.745 161.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.26 16.05 25.61 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.919 0.771 . . . . 0.0 113.984 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.22 -5.82 83.95 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.122 -1.377 . . . . 0.0 114.017 -173.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.97 149.97 44.24 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 120.186 1.993 . . . . 0.0 111.617 -174.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.17 128.03 6.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.352 2.702 . . . . 0.0 110.296 170.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.3 -41.86 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.579 -0.701 . . . . 0.0 110.34 168.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -164.91 169.85 16.02 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.827 0.851 . . . . 0.0 111.22 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -136.31 146.93 47.17 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.729 2.411 . . . . 0.0 108.941 -170.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.8 151.52 37.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.651 1.981 . . . . 0.0 106.897 159.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.06 147.9 26.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.005 1.722 . . . . 0.0 107.298 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.31 169.4 21.14 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 122.022 0.79 . . . . 0.0 112.081 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -74.01 89.05 1.91 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -86.87 137.38 33.52 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 159.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.4 165.95 30.85 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.322 2.015 . . . . 0.0 111.451 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -46.27 -48.67 18.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.724 1.61 . . . . 0.0 112.144 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -52.78 -47.09 67.77 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.113 1.365 . . . . 0.0 111.644 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -38.51 72.3 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 124.341 1.056 . . . . 0.0 108.578 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 -54.53 30.2 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.218 1.007 . . . . 0.0 109.514 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.22 -40.23 85.18 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.66 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.78 -51.96 65.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.524 1.056 . . . . 0.0 111.414 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -62.81 -27.69 69.49 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.77 0.828 . . . . 0.0 112.419 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 mp -106.66 3.36 26.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.716 1.207 . . . . 0.0 111.905 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.58 -29.97 60.0 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.543 1.137 . . . . 0.0 112.567 -174.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -62.53 -14.86 46.71 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.1 p -117.55 -7.03 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 119.651 1.114 . . . . 0.0 111.686 172.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.52 -11.87 26.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.548 1.139 . . . . 0.0 112.068 172.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.739 2.016 . . . . 0.0 110.135 165.875 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.4 p -50.86 144.44 8.5 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -159.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.4 ttm -139.33 159.93 41.0 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.686 1.595 . . . . 0.0 107.533 168.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.4 m -76.03 146.09 39.73 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 163.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.74 173.08 7.43 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 122.364 1.078 . . . . 0.0 109.541 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.5 m -150.2 -129.4 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 102.581 -3.118 . . . . 0.0 102.581 172.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -86.61 -67.42 0.82 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.117 1.767 . . . . 0.0 111.248 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.6 -35.87 77.19 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.271 -0.893 . . . . 0.0 111.359 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -67.01 -31.33 71.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.728 0.811 . . . . 0.0 109.671 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -58.88 -57.25 13.86 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.819 0.736 . . . . 0.0 109.623 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -59.74 -46.52 88.9 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.54 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -63.29 -17.21 62.27 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.71 -59.28 2.48 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.807 0.843 . . . . 0.0 110.585 166.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.6 pt -67.59 -18.84 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -169.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -49.08 -34.45 13.76 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.157 1.783 . . . . 0.0 112.996 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.61 138.56 2.88 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 112.042 -0.423 . . . . 0.0 112.042 168.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.54 -102.97 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.9 -130.54 2.76 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 127.691 2.567 . . . . 0.0 106.752 165.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.95 93.45 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.272 2.648 . . . . 0.0 111.703 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.2 141.17 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 167.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.2 mt -137.33 158.99 43.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.04 141.31 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -96.06 110.39 22.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 158.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -93.71 109.68 21.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 167.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -134.25 -176.52 4.23 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.072 1.749 . . . . 0.0 108.098 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.37 166.3 33.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.643 1.577 . . . . 0.0 107.386 168.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.5 -29.08 69.76 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -31.86 17.75 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -169.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 p -71.51 102.4 2.69 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.713 0.688 . . . . 0.0 111.999 -162.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -34.14 -61.01 0.54 Allowed Glycine 0 CA--C 1.539 1.534 0 C-N-CA 126.017 1.77 . . . . 0.0 114.912 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.82 -32.86 28.6 Favored 'Trans proline' 0 C--N 1.35 0.646 0 CA-C-N 120.241 2.02 . . . . 0.0 112.512 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.4 p -67.73 -35.59 79.03 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 119.315 0.961 . . . . 0.0 110.258 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -62.35 -15.92 51.34 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.855 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 75.9 mtm -104.11 -14.2 15.97 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.564 1.145 . . . . 0.0 112.876 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.407 ' SD ' ' HA ' ' A' ' 90' ' ' TYR . 14.9 ttt -94.11 -40.67 9.93 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.284 1.434 . . . . 0.0 109.547 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.82 -49.42 86.85 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 117.738 -1.125 . . . . 0.0 112.466 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.76 -33.6 53.34 Favored 'Trans proline' 0 C--N 1.354 0.841 0 CA-C-N 121.888 1.71 . . . . 0.0 112.086 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.88 -42.27 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 118.447 0.567 . . . . 0.0 109.513 174.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.47 -24.58 64.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.014 1.725 . . . . 0.0 112.319 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.453 ' CD ' ' HZ3' ' A' ' 54' ' ' LYS . 2.0 tp10 -68.88 -48.25 63.85 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.418 1.008 . . . . 0.0 109.624 177.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -62.88 -45.23 93.53 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -55.16 -48.17 74.11 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 122.931 0.492 . . . . 0.0 110.439 175.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.07 -55.04 37.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.385 1.074 . . . . 0.0 110.73 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -52.82 -46.75 67.86 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.848 0.859 . . . . 0.0 110.602 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.53 -16.53 10.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -150.13 48.82 0.91 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.535 1.134 . . . . 0.0 110.559 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -25.64 66.58 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -97.68 -54.1 3.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.233 1.413 . . . . 0.0 112.465 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -53.79 -29.7 41.5 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.603 0.761 . . . . 0.0 112.378 -171.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 m -134.29 141.56 43.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.319 1.9 t -92.56 73.45 5.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 123.191 1.472 . . . . 0.0 107.723 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.79 164.26 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.307 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.6 179.9 8.75 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.806 0.843 . . . . 0.0 110.119 170.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.453 ' HZ3' ' CD ' ' A' ' 40' ' ' GLU . 7.6 ttpm? -139.63 134.44 32.06 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.53 159.79 43.28 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.999 0.812 . . . . 0.0 112.351 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -82.38 123.38 29.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.314 0.646 . . . . 0.0 109.408 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.6 p -62.34 -29.59 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.182 0.993 . . . . 0.0 112.824 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.62 -36.34 70.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.642 0.777 . . . . 0.0 110.8 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.54 -34.85 74.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.178 2.191 . . . . 0.0 112.181 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -111.1 85.15 5.04 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 123.953 0.901 . . . . 0.0 109.393 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.3 -24.12 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.086 2.524 . . . . 0.0 112.816 172.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' C ' ' HG1' ' A' ' 63' ' ' THR . 49.3 mt-10 -70.07 117.66 11.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.021 1.328 . . . . 0.0 109.978 -178.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.422 ' HG1' ' C ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER 89.36 -40.71 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 129.784 3.233 . . . . 0.0 109.906 -176.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.2 m -52.16 -60.54 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.163 2.185 . . . . 0.0 110.353 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.3 t -57.94 -44.26 86.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.709 0.404 . . . . 0.0 109.938 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -60.15 -27.92 67.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.965 1.306 . . . . 0.0 112.913 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.33 14.65 22.62 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.8 0.727 . . . . 0.0 111.465 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.07 26.5 73.32 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 121.55 -0.719 . . . . 0.0 113.135 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.3 mm -75.86 79.16 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.346 1.458 . . . . 0.0 109.014 -171.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.6 ttm -128.24 3.39 5.77 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.305 1.442 . . . . 0.0 110.962 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 t -90.82 23.88 2.95 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.088 1.355 . . . . 0.0 113.121 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.407 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -57.95 145.06 73.54 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.782 0.833 . . . . 0.0 113.161 -168.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 55.7 Cg_endo -69.09 132.24 20.78 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.034 0.691 . . . . 0.0 112.19 8.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.5 m -122.22 153.28 39.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 tt -144.44 104.44 4.07 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.734 2.014 . . . . 0.0 106.22 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.9 mt -102.19 133.17 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.66 109.68 21.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.095 2.158 . . . . 0.0 105.652 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -105.04 156.96 17.57 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -152.87 146.28 24.89 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 159.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.81 35.84 4.55 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.874 1.226 . . . . 0.0 115.215 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.77 -3.22 62.67 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 118.701 1.251 . . . . 0.0 114.791 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -123.61 130.88 24.32 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 119.652 1.726 . . . . 0.0 110.977 -168.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.48 101.69 1.39 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.778 2.986 . . . . 0.0 109.803 169.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -42.42 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.859 0.864 . . . . 0.0 111.094 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.405 ' HZ1' ' CG ' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -159.37 168.41 26.4 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.168 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.74 163.45 30.14 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.352 0.596 . . . . 0.0 111.489 160.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -117.88 148.31 42.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.838 2.055 . . . . 0.0 105.784 170.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.6 pt -139.56 140.26 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 125.151 1.38 . . . . 0.0 107.885 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.68 161.63 8.57 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.76 0.695 . . . . 0.0 111.781 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.407 ' HA ' ' SD ' ' A' ' 35' ' ' MET . 10.6 t80 -66.73 98.88 0.56 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.574 1.55 . . . . 0.0 112.385 -170.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -93.01 140.6 23.43 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 168.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.15 163.5 38.53 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.487 2.125 . . . . 0.0 110.308 168.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.67 -46.04 70.5 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 123.843 0.857 . . . . 0.0 111.879 -174.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -49.63 -43.36 46.66 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.801 1.24 . . . . 0.0 111.159 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -88.35 -42.61 12.09 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.442 1.097 . . . . 0.0 109.061 -166.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.83 -62.46 1.85 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.99 1.316 . . . . 0.0 109.31 173.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -57.3 -38.13 73.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.608 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.29 82.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.615 1.098 . . . . 0.0 110.574 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -66.99 -21.88 65.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.77 -7.24 27.9 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.204 1.802 . . . . 0.0 113.287 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.71 -29.46 66.7 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.088 1.755 . . . . 0.0 112.532 -167.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.405 ' CG ' ' HZ1' ' A' ' 85' ' ' LYS . 7.0 p-10 -63.48 -5.54 3.88 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.073 1.749 . . . . 0.0 113.886 173.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.4 -1.07 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.124 0.874 . . . . 0.0 112.687 167.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.19 -12.51 15.71 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.247 1.419 . . . . 0.0 113.316 174.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 . . . . . 0 C--O 1.248 1.003 0 C-N-CA 126.461 1.904 . . . . 0.0 107.395 159.126 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 119.73 -0.176 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.3 m -64.79 153.75 39.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.838 0.855 . . . . 0.0 112.074 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.4 ttp -142.5 172.66 12.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.827 1.251 . . . . 0.0 107.837 159.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -77.19 154.73 32.81 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 159.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tp -113.96 164.94 13.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.625 0.726 . . . . 0.0 109.845 173.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.48 171.04 15.16 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 -173.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -45.38 -58.89 3.0 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 127.562 2.345 . . . . 0.0 112.758 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.66 96.89 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.531 -0.731 . . . . 0.0 111.341 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -68.05 -26.97 66.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.395 1.078 . . . . 0.0 110.314 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -65.18 -6.44 9.34 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 125.128 1.371 . . . . 0.0 112.431 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -121.19 -56.15 1.93 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 162.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -67.89 -12.6 61.01 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -168.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.26 -3.87 13.79 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.593 1.157 . . . . 0.0 113.044 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.423 HG13 ' H ' ' A' ' 15' ' ' GLN . 11.7 pt -91.83 -105.95 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 158.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.423 ' H ' HG13 ' A' ' 14' ' ' ILE . 3.1 pt20 47.95 -10.26 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.77 1 C-N-CA 131.859 4.064 . . . . 0.0 118.881 174.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.27 179.94 17.48 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.144 1.831 . . . . 0.0 112.29 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.14 -11.43 57.94 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.087 1.755 . . . . 0.0 112.869 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.4 150.02 51.7 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.72 97.42 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.036 2.491 . . . . 0.0 110.34 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.1 t -105.33 140.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.95 136.44 46.11 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.793 0.806 . . . . 0.0 110.206 172.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.87 120.99 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 126.707 2.003 . . . . 0.0 105.965 -170.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.02 92.06 4.22 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -77.97 113.77 16.19 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.028 0.931 . . . . 0.0 108.9 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -131.97 -174.21 3.36 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 170.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.46 167.67 26.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.642 1.577 . . . . 0.0 107.584 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.9 -8.89 32.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.357 1.244 . . . . 0.0 114.357 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -110.53 -21.49 12.12 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -172.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.7 p -77.87 45.55 0.52 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -158.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 29.3 -95.17 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 C-N-CA 128.782 3.086 . . . . 0.0 114.213 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.07 -21.68 60.2 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.41 2.74 . . . . 0.0 114.538 -176.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.1 p -56.97 -32.37 65.99 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.448 1.476 . . . . 0.0 111.436 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -72.25 -18.91 61.78 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.751 1.22 . . . . 0.0 112.182 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -98.73 -18.11 18.18 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.086 1.354 . . . . 0.0 111.251 173.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.8 ttt -74.2 -37.62 63.84 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.602 1.561 . . . . 0.0 109.377 168.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.77 -51.56 45.3 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.495 -1.241 . . . . 0.0 113.171 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.68 -33.4 13.15 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 121.739 1.657 . . . . 0.0 113.051 171.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -28.89 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 121.258 1.844 . . . . 0.0 110.777 175.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.43 -13.1 61.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.765 2.026 . . . . 0.0 112.711 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -79.42 -40.7 29.37 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.682 1.128 . . . . 0.0 108.982 171.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.44 -16.89 64.45 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.733 0.813 . . . . 0.0 111.383 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -83.13 -43.89 15.72 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.426 1.09 . . . . 0.0 111.43 169.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.68 -48.66 49.47 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.938 0.895 . . . . 0.0 110.871 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -54.95 -43.0 73.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.458 1.103 . . . . 0.0 111.765 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.21 -12.49 28.71 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.551 1.141 . . . . 0.0 113.369 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -156.01 49.88 0.52 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.544 1.137 . . . . 0.0 110.056 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.07 -47.45 53.6 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.959 0.904 . . . . 0.0 112.459 -170.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -124.65 -6.2 7.5 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 171.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -55.07 -31.15 60.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.177 1.391 . . . . 0.0 111.765 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.26 177.26 6.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.676 1.19 . . . . 0.0 109.321 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 m -117.18 96.92 5.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.817 1.247 . . . . 0.0 107.741 164.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.77 149.25 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 160.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.58 109.03 3.98 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.432 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -88.32 145.5 25.8 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.767 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -154.38 157.29 38.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.659 0.784 . . . . 0.0 112.374 173.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -76.81 106.19 8.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.688 1.595 . . . . 0.0 109.187 174.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 p -64.1 -28.9 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.015 0.926 . . . . 0.0 112.685 -173.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.54 -30.25 71.28 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.341 1.056 . . . . 0.0 110.891 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -98.44 -20.45 17.11 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.578 1.951 . . . . 0.0 112.062 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -104.76 92.52 5.19 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.115 167.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.69 -17.95 22.69 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.062 1.841 . . . . 0.0 113.533 167.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.5 OUTLIER -64.7 113.63 3.89 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.568 1.147 . . . . 0.0 109.282 -173.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.303 17.6 m 66.13 -14.69 0.14 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.329 2.651 . . . . 0.0 113.63 176.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 62' ' ' GLU . 95.4 m -50.41 -55.24 16.64 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.321 1.848 . . . . 0.0 108.486 158.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -72.01 -6.79 44.75 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 117.847 -1.073 . . . . 0.0 113.103 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.77 -52.84 4.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.403 1.001 . . . . 0.0 109.364 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -81.2 16.87 1.42 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.159 0.89 . . . . 0.0 112.43 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.32 32.02 80.75 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 121.558 -0.714 . . . . 0.0 111.775 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.3 mm -77.43 81.3 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.538 1.135 . . . . 0.0 108.083 -172.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -117.88 14.4 14.21 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.783 1.633 . . . . 0.0 112.472 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.1 m -154.78 158.98 40.31 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.74 -1.225 . . . . 0.0 109.802 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.8 pt -155.05 162.51 27.07 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 129.28 3.032 . . . . 0.0 107.568 -171.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.2 127.59 7.24 Favored 'Cis proline' 0 C--N 1.349 0.565 0 CA-C-N 119.952 1.018 . . . . 0.0 110.653 -6.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.3 m -124.56 136.34 53.89 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.325 1.05 . . . . 0.0 108.797 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 tt -130.01 117.56 20.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.9 mt -126.38 129.65 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 tt -96.67 126.32 41.75 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.62 153.44 39.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.594 1.157 . . . . 0.0 110.613 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -158.56 153.37 24.89 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 124.757 1.223 . . . . 0.0 108.434 158.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.86 11.47 24.26 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 119.424 -0.653 . . . . 0.0 113.355 -169.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.65 0.58 89.95 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 118.345 1.072 . . . . 0.0 113.717 -170.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -107.82 136.16 19.74 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 119.34 1.57 . . . . 0.0 109.691 -173.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.99 110.31 3.02 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.361 2.707 . . . . 0.0 110.965 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.79 -37.19 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.629 1.572 . . . . 0.0 110.981 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -154.68 157.32 37.93 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.865 0.866 . . . . 0.0 109.108 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -141.24 127.73 20.03 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 126.937 2.095 . . . . 0.0 105.989 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mp -122.58 139.77 53.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.429 1.891 . . . . 0.0 106.03 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.09 121.86 29.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.207 1.403 . . . . 0.0 108.248 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.02 172.7 23.46 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.128 1.347 . . . . 0.0 112.507 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -69.7 85.22 0.46 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.285 1.034 . . . . 0.0 108.473 171.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.98 120.99 77.11 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 169.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -65.96 160.6 43.52 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.288 1.325 . . . . 0.0 109.92 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.44 -52.46 13.05 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 125.264 1.426 . . . . 0.0 112.558 -172.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -59.77 -25.95 65.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.911 1.284 . . . . 0.0 112.673 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -88.12 -42.18 12.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.033 0.933 . . . . 0.0 109.849 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.32 -60.83 3.0 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.658 1.983 . . . . 0.0 110.384 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -57.8 -33.45 68.59 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.189 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.05 -48.7 62.17 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 119.616 1.098 . . . . 0.0 111.119 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.0 tp-100 -63.25 -38.26 90.47 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.243 0.617 . . . . 0.0 111.33 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.86 -1.4 56.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.034 0.933 . . . . 0.0 112.912 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.46 -38.95 66.97 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 124.235 1.014 . . . . 0.0 112.798 -165.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -69.83 -6.47 32.67 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.647 1.112 . . . . 0.0 113.305 -176.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.28 1.29 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.654 1.182 . . . . 0.0 111.934 170.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -124.78 -4.03 7.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.005 1.722 . . . . 0.0 113.384 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.119 0 C-N-CA 126.792 2.037 . . . . 0.0 110.38 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.1 m -147.68 144.29 28.24 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 120.732 -1.23 . . . . 0.0 109.093 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.9 mtt -145.97 177.39 8.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.678 1.591 . . . . 0.0 109.256 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.4 m -93.85 160.84 14.56 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 161.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.8 mt -133.27 165.37 24.97 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.654 0.781 . . . . 0.0 109.444 171.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -138.15 -178.65 5.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 164.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.31 -60.37 3.2 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.989 2.115 . . . . 0.0 112.777 -161.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.94 -34.53 77.67 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -77.04 -19.14 57.56 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.914 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -57.18 -59.73 4.66 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.529 1.059 . . . . 0.0 109.759 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -42.6 99.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.589 0.356 . . . . 0.0 110.48 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.64 -26.7 61.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.159 0.584 . . . . 0.0 112.149 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.74 -26.94 19.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.828 -1.082 . . . . 0.0 112.655 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.486 HG13 ' H ' ' A' ' 15' ' ' GLN 0.279 11.3 pt -75.22 -91.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.95 0.795 . . . . 0.0 109.517 171.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.486 ' H ' HG13 ' A' ' 14' ' ' ILE . 13.9 pt20 45.85 -17.77 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.758 1 C-N-CA 133.207 4.603 . . . . 0.0 119.632 174.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.02 -179.06 25.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.757 1.162 . . . . 0.0 112.887 -159.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -81.46 -13.57 58.04 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.85 2.06 . . . . 0.0 114.207 -167.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.93 156.04 41.28 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 118.577 0.626 . . . . 0.0 112.036 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.15 81.96 1.11 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.778 2.985 . . . . 0.0 110.466 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.4 t -87.81 138.11 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.8 tt -133.75 141.27 47.44 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.91 125.63 58.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -170.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.71 96.85 6.2 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.747 1.219 . . . . 0.0 108.218 175.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -75.11 115.78 15.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -117.49 176.76 5.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 168.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.62 161.22 40.99 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.294 -0.879 . . . . 0.0 110.392 174.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.31 15.06 0.48 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.321 1.049 . . . . 0.0 113.579 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.411 ' CG ' ' N ' ' A' ' 29' ' ' CYS . 2.2 p90 -136.82 -61.72 0.66 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.215 1.006 . . . . 0.0 108.553 168.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.411 ' N ' ' CG ' ' A' ' 28' ' ' TRP . 16.3 p 44.16 -62.95 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 1 C-N-CA 132.024 4.13 . . . . 0.0 117.525 178.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.76 -103.83 3.06 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.951 1.739 . . . . 0.0 109.802 -161.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -60.19 -21.12 64.96 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.451 2.767 . . . . 0.0 115.15 -171.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -60.75 -25.3 66.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.947 1.248 . . . . 0.0 111.466 173.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -22.3 65.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.394 0.997 . . . . 0.0 111.932 174.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 84.0 mtp -98.54 -25.0 14.9 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 125.946 1.698 . . . . 0.0 111.429 176.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.2 ttt -83.38 -36.37 24.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 117.521 -1.228 . . . . 0.0 109.109 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.87 -51.13 57.24 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.871 1.669 . . . . 0.0 112.482 175.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -62.41 -39.43 46.28 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 121.444 1.551 . . . . 0.0 112.422 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.25 -20.67 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 119.981 1.264 . . . . 0.0 112.071 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.84 -17.39 24.15 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.242 1.817 . . . . 0.0 111.612 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.04 -45.84 69.41 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 167.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -53.83 -50.14 66.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.954 1.301 . . . . 0.0 110.151 167.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.86 -51.39 67.72 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.095 0.558 . . . . 0.0 110.974 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.57 -55.85 19.4 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.881 0.872 . . . . 0.0 110.532 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.68 -43.6 85.18 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.672 0.608 . . . . 0.0 111.217 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.79 -21.31 10.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -147.63 40.94 1.02 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.481 1.112 . . . . 0.0 111.003 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.52 -37.17 16.91 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.951 1.7 . . . . 0.0 115.275 -162.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -132.26 6.27 4.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -66.24 -34.58 78.33 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.527 -0.733 . . . . 0.0 109.825 166.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.65 171.64 5.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.338 0.6 OUTLIER -118.62 97.81 5.92 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 159.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 p -84.89 159.76 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.2 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.38 156.92 44.07 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 162.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -123.03 138.09 54.77 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 172.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pp -150.87 150.83 31.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.867 0.467 . . . . 0.0 110.956 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -82.79 116.57 22.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.81 -27.86 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.8 0.84 . . . . 0.0 112.142 -175.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -67.63 -31.45 71.47 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.683 0.793 . . . . 0.0 111.0 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -83.97 -24.82 30.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.034 0.934 . . . . 0.0 111.907 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -113.84 86.63 11.23 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.309 1.043 . . . . 0.0 109.856 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.03 -24.51 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.124 2.55 . . . . 0.0 113.752 171.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -69.23 131.16 44.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.788 1.176 . . . . 0.0 109.808 -177.179 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.9 m 69.68 -31.8 0.22 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.42 2.688 . . . . 0.0 112.453 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 62' ' ' GLU . 94.1 m -53.51 -54.74 32.93 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.471 1.909 . . . . 0.0 109.721 170.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.6 t -70.03 -1.94 11.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.766 -1.111 . . . . 0.0 113.157 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -106.69 -35.09 7.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.663 1.12 . . . . 0.0 111.339 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -99.1 14.93 27.55 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.794 0.725 . . . . 0.0 112.119 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.99 33.53 85.81 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 123.486 0.565 . . . . 0.0 111.899 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.7 mm -74.3 80.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.416 1.486 . . . . 0.0 108.312 -171.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 21.7 ttt -138.89 40.12 2.15 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.255 1.422 . . . . 0.0 109.642 -176.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.2 m -155.11 61.41 0.64 Allowed 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.468 -1.395 . . . . 0.0 109.565 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.48 153.79 81.54 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.686 173.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -67.32 126.08 7.45 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 CA-C-N 119.206 0.752 . . . . 0.0 110.544 -5.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -114.53 130.49 56.76 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.99 119.6 30.02 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -173.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.52 148.7 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -121.98 132.97 54.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -121.35 155.1 35.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.064 1.346 . . . . 0.0 110.842 -173.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -164.62 151.39 11.04 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.333 1.453 . . . . 0.0 109.229 158.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.03 15.81 50.88 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.652 0.644 . . . . 0.0 112.353 -165.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.02 -3.59 28.26 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.843 -0.976 . . . . 0.0 113.862 -166.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.74 133.56 39.41 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 119.522 1.661 . . . . 0.0 108.821 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.45 95.82 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.272 2.648 . . . . 0.0 109.299 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 m -61.14 -35.56 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 O-C-N 121.656 -0.653 . . . . 0.0 111.917 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.88 159.85 43.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.012 0.434 . . . . 0.0 111.636 159.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.13 140.92 48.93 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 127.538 2.335 . . . . 0.0 107.303 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -123.39 152.59 41.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 127.702 2.401 . . . . 0.0 107.625 168.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.73 126.18 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.82 163.75 39.14 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.607 1.099 . . . . 0.0 113.101 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -61.82 134.05 56.23 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.057 1.343 . . . . 0.0 110.535 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -137.91 144.01 42.24 Favored Pre-proline 0 C--O 1.242 0.671 0 C-N-CA 124.89 1.276 . . . . 0.0 107.608 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.94 157.27 57.76 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.192 1.928 . . . . 0.0 109.155 169.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.559 ' N ' ' HZ2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -61.54 -38.47 87.57 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.149 -0.97 . . . . 0.0 110.779 -175.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.22 -21.37 13.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.059 0.944 . . . . 0.0 113.02 174.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -97.92 -50.91 4.24 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 119.49 1.041 . . . . 0.0 110.454 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.74 -58.9 6.32 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.837 1.655 . . . . 0.0 109.527 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.52 -30.77 68.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.931 1.292 . . . . 0.0 110.657 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.71 -46.25 32.14 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.547 0.612 . . . . 0.0 110.965 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.7 tp-100 -64.75 -31.22 72.35 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.424 1.09 . . . . 0.0 111.19 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.24 2.17 56.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.345 1.058 . . . . 0.0 112.511 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.18 -19.04 61.13 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -19.79 62.88 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.066 1.757 . . . . 0.0 111.672 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.31 -7.23 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 125.779 1.632 . . . . 0.0 111.783 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.05 5.96 28.52 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.557 1.543 . . . . 0.0 112.78 167.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.962 0 C-N-CA 126.157 1.783 . . . . 0.0 109.618 165.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 110.793 -0.077 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.0 m -122.03 140.15 52.84 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 171.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.9 tpt -148.07 176.12 10.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.968 1.307 . . . . 0.0 109.131 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.2 m -99.8 141.32 32.77 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 168.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 tp -113.85 163.1 15.52 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.339 0.59 . . . . 0.0 110.307 -173.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 t -142.64 -127.67 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -98.79 -62.22 1.27 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.982 1.313 . . . . 0.0 109.49 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.94 79.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.62 1.168 . . . . 0.0 111.008 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -72.24 -24.54 61.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.335 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -71.45 -48.83 46.94 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.07 -32.98 74.74 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.949 -0.548 . . . . 0.0 112.3 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -64.85 -50.32 67.1 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.166 0.894 . . . . 0.0 110.2 167.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.74 -48.21 72.86 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.143 0.883 . . . . 0.0 111.372 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt -63.01 -1.98 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -52.23 -31.6 32.83 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.233 1.379 . . . . 0.0 111.909 171.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.99 -133.28 13.98 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 116.531 1.372 . . . . 0.0 116.531 158.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.6 t70 64.29 -50.16 0.29 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 130.221 3.408 . . . . 0.0 111.303 -158.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.4 160.68 46.0 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.68 107.04 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.19 2.593 . . . . 0.0 110.956 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 50.3 t -94.52 107.02 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.97 153.59 22.06 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 164.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.26 150.88 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 164.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -110.7 104.62 13.31 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.411 ' CE2' HG22 ' A' ' 69' ' ' ILE . 79.0 m-85 -89.31 108.2 19.49 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 164.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -131.49 -176.39 4.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.528 1.531 . . . . 0.0 107.019 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.18 171.25 20.25 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.692 1.197 . . . . 0.0 108.132 164.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.52 80.61 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.52 -23.91 18.94 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -163.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.9 p -75.6 40.19 0.18 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.298 1.839 . . . . 0.0 115.256 -159.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 42.48 -99.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 127.718 2.58 . . . . 0.0 113.974 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -57.52 -23.48 56.51 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.528 2.819 . . . . 0.0 114.396 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.9 p -56.91 -34.63 68.13 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.511 1.05 . . . . 0.0 111.417 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -71.12 -8.0 50.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.357 1.063 . . . . 0.0 112.359 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.7 mtm -106.88 -12.3 15.51 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.81 1.644 . . . . 0.0 112.222 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -40.42 11.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.813 2.045 . . . . 0.0 108.851 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.34 -56.23 19.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.233 1.413 . . . . 0.0 112.177 170.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.57 -25.01 69.79 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.143 1.801 . . . . 0.0 113.017 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.1 t -68.78 -46.35 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.365 0.984 . . . . 0.0 109.677 170.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 mp -61.15 -36.2 79.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.698 1.599 . . . . 0.0 111.901 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.18 -7.64 38.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.218 2.207 . . . . 0.0 112.099 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -109.81 -50.72 2.95 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.368 1.467 . . . . 0.0 109.47 168.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.452 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 47.4 t80 -45.45 -51.76 11.07 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 125.811 1.645 . . . . 0.0 112.22 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.15 -63.09 1.24 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.601 1.161 . . . . 0.0 110.369 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.88 -33.77 74.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.61 1.564 . . . . 0.0 111.993 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.77 -19.4 27.79 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -140.7 48.5 1.72 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.142 1.377 . . . . 0.0 109.028 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.24 -37.44 16.1 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.077 1.351 . . . . 0.0 114.259 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -130.32 3.22 4.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -65.46 -36.78 84.9 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.679 1.127 . . . . 0.0 109.094 159.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.6 m -111.09 174.27 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.248 1.019 . . . . 0.0 108.696 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.4 134.72 48.87 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 158.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.6 p -137.01 161.06 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.552 1.141 . . . . 0.0 109.827 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -165.09 166.35 19.23 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.275 171.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.15 148.1 42.67 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.52 137.05 36.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 125.812 1.945 . . . . 0.0 111.403 169.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -75.21 101.11 4.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 p -61.56 -25.3 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.373 1.069 . . . . 0.0 112.374 -166.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.01 -18.79 61.31 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.367 1.867 . . . . 0.0 112.649 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -114.97 -43.62 3.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 127.68 2.392 . . . . 0.0 109.887 -171.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -114.93 81.88 7.92 Favored Pre-proline 0 N--CA 1.443 -0.795 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.2 -68.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.235 2.623 . . . . 0.0 111.828 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 29.32 99.34 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.357 2.663 . . . . 0.0 115.586 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.263 38.6 m 67.71 -8.39 0.52 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.748 1.219 . . . . 0.0 113.165 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -49.36 -50.14 41.3 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.488 -1.382 . . . . 0.0 111.173 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.9 t -71.75 -3.68 23.37 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 117.657 -1.163 . . . . 0.0 112.778 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -95.6 -32.05 12.99 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.731 1.15 . . . . 0.0 111.68 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -110.48 0.74 17.89 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.82 35.91 43.89 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.263 0.935 . . . . 0.0 112.399 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.411 HG22 ' CE2' ' A' ' 24' ' ' PHE . 42.8 mm -82.17 48.88 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.376 1.47 . . . . 0.0 111.778 -163.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 18.0 ttt -88.32 2.35 52.66 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.754 1.222 . . . . 0.0 110.348 163.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 p -72.77 13.97 0.32 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.202 2.201 . . . . 0.0 114.907 -176.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.41 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -65.16 144.75 99.1 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 123.907 0.883 . . . . 0.0 112.014 -165.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 57.5 Cg_endo -65.94 132.09 15.42 Favored 'Cis proline' 0 C--N 1.35 0.622 0 CA-C-N 119.268 0.774 . . . . 0.0 111.398 2.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.5 m -131.44 141.1 49.75 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.563 0.745 . . . . 0.0 109.144 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -135.87 98.92 4.02 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.1 mt -88.29 145.99 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.35 99.21 7.04 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -96.47 160.83 14.2 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.552 1.941 . . . . 0.0 109.685 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -157.78 39.02 0.27 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 158.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 82' ' ' GLU . . . 159.39 52.38 0.01 OUTLIER Glycine 0 N--CA 1.463 0.468 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 169.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.4 -25.53 0.58 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.31 1.91 . . . . 0.0 112.677 -168.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 80' ' ' GLY . 42.0 tt0 -91.72 131.71 35.04 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.43 1.892 . . . . 0.0 110.028 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.85 126.55 7.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.988 3.125 . . . . 0.0 110.78 170.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.8 -38.4 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 121.661 -0.65 . . . . 0.0 110.448 165.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -154.1 172.07 18.11 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 118.623 0.647 . . . . 0.0 111.233 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -138.35 136.15 36.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.196 1.799 . . . . 0.0 108.032 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.25 141.29 43.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.19 2.196 . . . . 0.0 105.851 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 pt -139.78 152.32 22.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.575 1.15 . . . . 0.0 108.838 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.19 168.1 6.86 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.838 0.732 . . . . 0.0 111.65 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -81.61 75.08 8.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.723 -0.869 . . . . 0.0 110.563 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -75.42 122.9 88.19 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 158.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -71.84 173.75 12.24 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.089 1.859 . . . . 0.0 110.7 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.452 ' HE2' ' OE1' ' A' ' 97' ' ' GLU . 22.8 tptm -31.8 -59.12 0.27 Allowed 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 127.561 2.344 . . . . 0.0 112.483 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.72 -49.81 64.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.802 1.313 . . . . 0.0 111.643 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -74.22 -42.01 60.44 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.496 1.118 . . . . 0.0 110.033 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 tt -59.78 -62.46 1.86 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.594 1.558 . . . . 0.0 108.983 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.452 ' OE1' ' HE2' ' A' ' 93' ' ' LYS . 11.3 tt0 -66.09 -25.92 67.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.224 1.41 . . . . 0.0 111.102 -177.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.93 -52.48 24.18 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.212 0.915 . . . . 0.0 110.412 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -59.7 -40.0 86.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.391 0.541 . . . . 0.0 111.367 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.27 -0.66 50.57 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.797 1.239 . . . . 0.0 112.764 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.6 -28.97 66.09 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.363 0.983 . . . . 0.0 112.142 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -69.67 -3.71 16.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.626 1.17 . . . . 0.0 113.488 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.88 -15.58 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.156 0.889 . . . . 0.0 112.416 164.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.37 -9.98 50.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.015 0.926 . . . . 0.0 113.204 173.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 C-N-CA 125.641 1.576 . . . . 0.0 110.622 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 m 87.35 168.71 0.06 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.078 1.351 . . . . 0.0 113.657 152.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.405 ' C ' ' HG1' ' A' ' 4' ' ' THR . 16.5 ttt 72.92 -21.14 0.25 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 129.57 3.148 . . . . 0.0 116.001 170.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.405 ' HG1' ' C ' ' A' ' 3' ' ' MET . 54.8 m -155.33 156.97 36.42 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.759 1.624 . . . . 0.0 109.215 176.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tp -146.01 170.32 16.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 127.728 2.411 . . . . 0.0 106.934 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.5 m -150.02 157.2 42.9 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -46.51 -53.4 11.34 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 127.172 2.189 . . . . 0.0 113.207 -168.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.03 93.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.051 0.929 . . . . 0.0 111.746 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -69.91 -18.47 63.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.124 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -58.12 -60.9 3.03 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.252 0.621 . . . . 0.0 110.242 172.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -63.47 -39.64 95.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.322 -0.37 . . . . 0.0 110.56 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -63.65 -27.99 69.61 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.609 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.64 -60.39 2.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.659 1.118 . . . . 0.0 109.517 168.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.8 pt -64.89 -23.28 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -167.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -59.53 -30.09 68.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 164.16 104.39 0.18 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.316 0.962 . . . . 0.0 110.734 -168.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -160.93 -65.03 0.06 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.614 1.566 . . . . 0.0 109.778 -169.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.22 -161.39 32.48 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 -164.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.44 112.48 1.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.491 2.127 . . . . 0.0 108.855 167.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.7 t -110.3 141.16 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 125.501 1.521 . . . . 0.0 107.199 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.1 tp -145.2 111.33 5.59 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 118.028 0.377 . . . . 0.0 110.469 -167.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.4 t -112.83 121.99 66.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 118.957 0.799 . . . . 0.0 109.436 -163.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -82.36 106.76 14.5 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.49 105.3 16.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 162.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.3 p-90 -117.95 -179.44 3.76 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 166.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.76 152.04 32.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 120.505 -1.372 . . . . 0.0 110.336 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -23.9 66.7 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.93 -13.27 29.09 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 p -71.55 178.25 3.61 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.214 0.605 . . . . 0.0 112.386 -164.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.97 -93.5 1.87 Allowed Glycine 0 CA--C 1.538 1.489 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 164.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -66.85 -21.27 50.87 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.381 2.721 . . . . 0.0 114.133 -166.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -30.37 68.81 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.521 0.6 . . . . 0.0 111.225 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 -71.8 -13.16 61.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.501 1.12 . . . . 0.0 111.981 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 76.4 mtm -98.6 -37.2 9.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.105 1.362 . . . . 0.0 111.089 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.8 ttt -67.44 -43.02 82.13 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.874 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.22 -50.64 74.58 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 119.956 1.253 . . . . 0.0 113.284 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.93 -33.43 26.35 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.849 1.696 . . . . 0.0 112.684 170.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -29.56 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 120.093 1.315 . . . . 0.0 112.018 173.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.7 mt -82.98 -23.9 33.17 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.667 2.387 . . . . 0.0 110.904 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -70.05 -35.93 74.62 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.824 0.738 . . . . 0.0 110.6 171.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.03 -35.43 61.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.134 0.879 . . . . 0.0 111.107 174.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -55.02 -46.06 75.21 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.326 0.65 . . . . 0.0 109.549 166.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.12 -51.68 68.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.427 -0.796 . . . . 0.0 111.274 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.93 -46.46 74.93 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.445 0.698 . . . . 0.0 110.311 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.4 -16.07 59.42 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -138.89 28.55 2.35 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.058 1.343 . . . . 0.0 112.271 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.46 65.79 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -164.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -95.38 -45.61 7.05 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.304 2.642 . . . . 0.0 111.316 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -66.51 -19.61 65.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.785 1.634 . . . . 0.0 113.029 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.35 143.16 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 119.14 0.882 . . . . 0.0 110.058 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.8 m -78.01 60.07 2.3 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.724 1.61 . . . . 0.0 107.743 168.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 p -71.3 151.09 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.03 169.51 24.4 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -144.32 125.7 14.81 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -168.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.39 154.51 43.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.838 1.304 . . . . 0.0 114.112 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -87.57 105.22 17.18 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.26 -14.65 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 121.382 -0.824 . . . . 0.0 112.207 -172.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.93 -35.79 82.3 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.197 1.399 . . . . 0.0 111.643 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -74.47 -33.1 62.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.287 1.035 . . . . 0.0 110.638 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -111.43 87.43 7.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.115 0.966 . . . . 0.0 111.985 -164.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -80.95 -19.82 8.02 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.64 2.893 . . . . 0.0 113.951 168.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.5 OUTLIER -71.61 128.88 37.26 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.645 1.111 . . . . 0.0 109.649 -177.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.0 m 68.54 -28.79 0.16 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.807 2.443 . . . . 0.0 112.696 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 62' ' ' GLU . 30.2 m -53.14 -55.71 21.97 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.03 1.732 . . . . 0.0 109.649 167.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -70.6 -4.01 21.08 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 117.917 -1.04 . . . . 0.0 112.855 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -94.39 -34.25 12.84 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.563 1.074 . . . . 0.0 110.714 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -106.06 11.36 31.57 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.64 0.655 . . . . 0.0 112.117 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.22 35.23 90.1 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 123.939 0.78 . . . . 0.0 111.553 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.58 87.98 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.993 0.901 . . . . 0.0 109.979 -168.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.2 ttt -125.81 -1.35 7.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.514 1.525 . . . . 0.0 110.74 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.1 p -72.95 23.27 0.06 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.706 2.402 . . . . 0.0 114.824 -169.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.4 pt -68.61 150.87 97.53 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -159.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.86 130.19 9.15 Favored 'Cis proline' 0 C--N 1.353 0.766 0 CA-C-N 118.89 0.639 . . . . 0.0 110.682 -7.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.1 m -114.14 130.56 56.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.9 tt -120.12 109.95 16.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -119.08 132.88 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tt -102.56 137.95 40.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -135.18 163.99 28.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.386 1.874 . . . . 0.0 108.757 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -153.86 140.92 19.36 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 158.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 39.13 53.46 2.64 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 126.219 1.866 . . . . 0.0 114.49 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.1 -7.24 78.85 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.842 1.21 . . . . 0.0 114.338 176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.19 123.7 36.09 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 119.453 1.626 . . . . 0.0 110.049 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -71.65 135.38 25.98 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.099 2.532 . . . . 0.0 109.89 169.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.9 t -100.4 -56.14 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.625 1.17 . . . . 0.0 110.033 -173.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -155.56 163.9 39.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.743 0.701 . . . . 0.0 109.975 170.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -120.86 132.27 54.89 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.811 2.044 . . . . 0.0 107.267 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.53 144.93 38.63 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.97 2.508 . . . . 0.0 106.411 169.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.8 pt -139.64 120.11 14.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.497 1.119 . . . . 0.0 109.622 -170.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.83 168.86 42.34 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.073 0.844 . . . . 0.0 111.905 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.74 81.08 1.57 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.792 1.637 . . . . 0.0 110.501 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -68.63 133.73 90.64 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.31 159.73 52.02 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.496 1.464 . . . . 0.0 109.532 165.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.51 -41.03 72.54 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 123.446 0.699 . . . . 0.0 112.748 -170.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.83 -29.72 68.45 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.012 0.925 . . . . 0.0 112.667 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.5 -47.28 11.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.345 1.858 . . . . 0.0 107.496 178.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.34 -62.48 1.81 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.139 2.176 . . . . 0.0 109.846 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -30.19 71.33 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 117.607 -1.187 . . . . 0.0 110.602 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.49 -26.41 64.54 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 122.044 2.202 . . . . 0.0 111.679 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.03 -17.26 61.0 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 167.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 tp -128.42 -9.0 5.19 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -159.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.88 -15.88 24.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.136 2.174 . . . . 0.0 112.702 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -72.81 -20.26 61.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.494 1.118 . . . . 0.0 113.261 170.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.51 -6.69 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.149 1.78 . . . . 0.0 112.746 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.6 6.09 49.82 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.196 1.798 . . . . 0.0 109.808 158.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 C--O 1.25 1.082 0 C-N-CA 124.653 1.181 . . . . 0.0 109.717 163.679 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 118.94 -0.552 . . . . 0.0 112.279 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 t -155.04 12.97 0.38 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.771 0.829 . . . . 0.0 112.166 -166.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.6 ttt -121.68 161.09 23.14 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -158.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -67.16 143.67 56.45 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.062 1.745 . . . . 0.0 109.735 161.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 mp -131.27 160.82 33.79 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.219 1.008 . . . . 0.0 110.267 -170.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.0 p -134.96 -62.01 0.74 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.778 0.799 . . . . 0.0 110.528 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 8' ' ' ALA . 39.0 p-10 -179.3 -78.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.468 1.907 . . . . 0.0 108.807 -159.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.446 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . -61.69 -38.44 87.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.984 0.913 . . . . 0.0 109.66 172.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -75.82 -21.53 57.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.362 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -67.58 -55.87 11.69 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 173.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -63.02 -35.63 80.85 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.39 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -58.11 -46.3 85.79 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.801 0.728 . . . . 0.0 110.638 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.34 -40.7 96.39 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.026 -0.988 . . . . 0.0 112.567 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . 0.257 11.8 pt -72.22 -67.31 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 118.851 0.75 . . . . 0.0 111.613 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 37.78 -13.39 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.601 1 C-N-CA 134.905 5.282 . . . . 0.0 120.359 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 174.1 -159.93 29.47 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 120.78 1.627 . . . . 0.0 116.049 -166.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.52 -9.37 56.49 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.211 3.004 . . . . 0.0 115.835 -161.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.52 164.2 54.03 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 119.093 0.86 . . . . 0.0 112.967 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.33 110.25 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.293 2.662 . . . . 0.0 107.775 166.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.416 ' HA ' ' HB ' ' A' ' 51' ' ' THR . 60.1 t -122.2 142.54 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 pp -133.5 155.85 48.82 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.161 0.505 . . . . 0.0 110.156 168.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.55 124.2 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.605 1.562 . . . . 0.0 107.612 -173.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.01 100.9 13.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.676 1.59 . . . . 0.0 107.967 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -89.71 109.77 20.72 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.915 0.886 . . . . 0.0 108.979 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -137.4 -171.86 3.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.97 170.19 21.08 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.196 1.398 . . . . 0.0 107.454 169.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.38 -14.65 62.42 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.53 -24.11 9.43 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -166.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 p -70.94 34.59 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 127.275 2.23 . . . . 0.0 116.51 -160.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 52.3 -110.21 1.11 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.523 1.535 . . . . 0.0 113.372 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.11 -14.94 31.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.085 3.19 . . . . 0.0 114.921 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 17.5 p -54.54 -30.96 55.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.988 0.813 . . . . 0.0 111.856 165.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -71.69 -6.21 39.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.161 0.984 . . . . 0.0 112.923 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.6 mtm -108.82 -30.41 8.16 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.974 1.709 . . . . 0.0 111.371 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.3 tpt -75.07 -43.91 50.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.227 1.811 . . . . 0.0 109.406 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.0 95.41 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 116.806 -1.569 . . . . 0.0 112.09 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -63.7 -34.68 61.66 Favored 'Trans proline' 0 C--N 1.352 0.728 0 CA-C-N 122.432 1.904 . . . . 0.0 112.54 173.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.29 -33.39 63.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 119.728 1.149 . . . . 0.0 110.983 174.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mp -75.92 -23.08 55.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.715 1.606 . . . . 0.0 111.672 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.404 ' CD ' ' HZ2' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -66.04 -44.8 83.54 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 124.331 1.052 . . . . 0.0 109.425 169.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.466 ' OE2' ' HE3' ' A' ' 93' ' ' LYS . 19.0 tt0 -59.22 -48.88 79.99 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 172.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -52.33 -49.48 64.18 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 122.665 0.386 . . . . 0.0 110.748 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.1 -51.93 58.45 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.971 0.908 . . . . 0.0 111.33 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.15 -47.51 75.0 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.366 0.667 . . . . 0.0 109.992 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.14 -17.09 64.19 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -136.0 14.42 3.33 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -168.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -42.5 -46.03 4.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.912 1.685 . . . . 0.0 113.366 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -86.0 -13.46 47.47 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -94.29 -21.93 18.7 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.69 -0.631 . . . . 0.0 111.483 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.47 137.45 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 122.207 1.003 . . . . 0.0 109.803 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.416 ' HB ' ' HA ' ' A' ' 20' ' ' VAL . 3.5 m -77.75 86.84 4.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.319 1.848 . . . . 0.0 107.16 -175.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.4 t -80.44 159.72 4.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -176.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.01 158.85 25.64 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 162.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HZ2' ' CD ' ' A' ' 40' ' ' GLU . 77.9 tttt -135.92 129.38 32.15 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -166.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.67 151.72 34.17 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 122.525 1.155 . . . . 0.0 113.227 -174.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -87.17 103.96 15.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.286 1.835 . . . . 0.0 107.503 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.21 -24.29 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.279 1.032 . . . . 0.0 113.513 -165.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.43 -42.89 78.24 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.881 0.872 . . . . 0.0 110.708 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -81.81 -18.22 44.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.364 2.266 . . . . 0.0 111.914 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -109.59 78.68 1.2 Allowed Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.849 1.66 . . . . 0.0 109.805 173.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.08 -18.06 14.73 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.269 2.646 . . . . 0.0 112.481 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 64' ' ' THR . 4.4 tp10 -64.71 125.75 25.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.143 1.377 . . . . 0.0 109.619 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.2 m 66.53 -29.56 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.932 3.293 . . . . 0.0 112.492 -174.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.48 ' H ' ' C ' ' A' ' 62' ' ' GLU . 24.5 m -52.36 -54.05 36.82 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.815 2.046 . . . . 0.0 110.587 172.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.8 t -62.03 -41.92 98.62 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.166 0.292 . . . . 0.0 110.508 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -60.91 -42.4 97.99 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.993 0.917 . . . . 0.0 111.87 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -96.63 5.52 50.56 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.4 33.48 72.83 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 119.224 0.92 . . . . 0.0 112.125 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.5 mm -75.75 82.37 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.599 1.56 . . . . 0.0 110.118 -166.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 93.4 mtp -122.47 -3.29 8.87 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.625 1.17 . . . . 0.0 111.688 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.1 t -84.69 21.93 1.43 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.733 1.213 . . . . 0.0 113.998 -166.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.409 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 26.2 pt -56.05 144.1 60.29 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.108 1.363 . . . . 0.0 112.935 -170.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.409 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 57.1 Cg_endo -65.74 139.25 40.79 Favored 'Cis proline' 0 C--N 1.35 0.637 0 CA-C-O 121.99 0.746 . . . . 0.0 111.085 -1.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -138.09 149.19 45.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.6 tt -135.03 123.41 23.24 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.267 -2.124 . . . . 0.0 105.267 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.1 mt -124.84 147.67 29.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tt -129.35 124.04 33.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.044 0.937 . . . . 0.0 108.897 -168.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -116.31 152.11 34.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.242 1.817 . . . . 0.0 110.398 -171.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 148.94 26.33 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 125.34 1.456 . . . . 0.0 107.38 158.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.15 20.78 71.4 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -168.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.95 3.3 55.42 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.478 -1.179 . . . . 0.0 114.044 -171.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -120.39 139.34 28.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 119.589 1.694 . . . . 0.0 109.454 -170.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.63 125.91 9.21 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.011 2.474 . . . . 0.0 111.775 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -78.33 -43.48 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 123.78 0.832 . . . . 0.0 110.781 175.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -158.77 169.97 23.19 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.022 0.929 . . . . 0.0 109.864 -174.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -137.02 157.22 47.21 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.84 1.256 . . . . 0.0 111.13 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -123.36 145.26 48.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 127.947 2.499 . . . . 0.0 106.087 169.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.6 pt -138.79 156.14 28.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 124.756 1.223 . . . . 0.0 109.058 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.07 179.08 11.17 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -71.4 126.15 28.89 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -126.23 134.5 26.03 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 165.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.99 159.15 47.82 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.167 1.245 . . . . 0.0 110.011 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.466 ' HE3' ' OE2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -49.51 -36.96 24.78 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 125.293 1.437 . . . . 0.0 112.686 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -58.7 -50.11 75.11 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.649 1.58 . . . . 0.0 110.973 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -74.39 -36.73 63.51 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.874 1.269 . . . . 0.0 109.378 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.79 -63.28 1.25 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.471 1.108 . . . . 0.0 108.04 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.36 -31.69 73.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 118.379 -0.82 . . . . 0.0 110.754 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.76 -44.03 78.44 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.694 0.679 . . . . 0.0 110.75 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -67.15 -38.26 85.19 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 118.24 0.473 . . . . 0.0 111.493 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.15 -6.43 59.0 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.958 0.903 . . . . 0.0 112.997 -173.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.66 -33.2 15.0 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.954 1.701 . . . . 0.0 114.201 -175.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.16 -6.56 9.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.64 1.564 . . . . 0.0 114.17 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.36 2.92 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.261 0.937 . . . . 0.0 113.108 166.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.32 -13.5 13.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.469 1.107 . . . . 0.0 112.403 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 127.777 2.431 . . . . 0.0 109.478 165.497 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 121.4 0.619 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 61.3 m -144.06 149.46 36.66 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 120.938 -1.101 . . . . 0.0 108.05 165.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.29 -178.61 6.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.99 1.316 . . . . 0.0 109.835 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.0 m -108.47 144.17 36.44 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 161.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.85 161.93 15.31 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.5 t -149.3 -128.82 0.05 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -84.65 -70.72 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 120.224 1.375 . . . . 0.0 110.937 164.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.55 82.34 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.349 0.977 . . . . 0.0 111.433 -171.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -76.0 -14.42 60.23 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.898 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -67.3 -68.28 0.39 Allowed 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 172.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.7 -48.79 69.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.463 0.705 . . . . 0.0 110.411 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -68.29 -19.48 64.7 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.145 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.38 -58.78 3.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.157 1.344 . . . . 0.0 110.669 164.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.9 pt -62.11 -21.8 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -168.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -64.94 -20.34 66.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.462 1.105 . . . . 0.0 113.589 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.04 166.54 48.58 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 119.662 1.119 . . . . 0.0 111.606 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.59 -4.18 57.95 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.14 148.53 50.95 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 120.707 -1.246 . . . . 0.0 110.03 171.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -62.76 96.6 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.78 2.32 . . . . 0.0 109.137 167.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 t -99.03 115.5 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 125.187 1.395 . . . . 0.0 107.85 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tt -113.43 119.82 38.91 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 126.052 1.741 . . . . 0.0 108.475 -168.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.9 t -109.3 110.73 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 126.218 1.807 . . . . 0.0 109.034 -168.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -82.2 98.77 8.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.924 0.784 . . . . 0.0 109.832 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -81.32 112.91 19.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 164.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -134.3 -174.04 3.44 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.64 166.3 32.37 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.886 1.275 . . . . 0.0 108.603 167.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.76 65.85 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.6 -30.26 11.87 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -170.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.02 98.97 3.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.613 0.642 . . . . 0.0 111.113 -164.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -25.47 -66.17 0.05 OUTLIER Glycine 0 CA--C 1.541 1.714 0 C-N-CA 126.385 1.945 . . . . 0.0 115.255 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.26 -30.98 23.69 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.311 2.008 . . . . 0.0 113.181 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 p -67.71 -34.6 77.19 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 119.34 0.973 . . . . 0.0 110.158 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -66.67 -12.13 56.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.49 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.9 mtp -97.97 -37.95 9.58 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.88 1.272 . . . . 0.0 111.526 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.1 ttt -74.17 -39.01 63.52 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.009 0.923 . . . . 0.0 110.781 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.58 -52.16 75.61 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 117.826 -1.083 . . . . 0.0 111.349 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.41 -34.61 65.22 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.844 1.694 . . . . 0.0 112.113 172.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.32 -31.38 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 119.65 1.113 . . . . 0.0 111.606 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mp -79.48 -26.17 41.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.196 2.198 . . . . 0.0 111.96 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.82 -44.37 93.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.79 1.177 . . . . 0.0 108.983 171.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -63.09 -45.62 91.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.854 0.462 . . . . 0.0 110.254 172.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -58.68 -38.29 77.89 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 122.017 -0.427 . . . . 0.0 111.158 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.37 -54.39 47.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.213 1.005 . . . . 0.0 109.445 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -51.57 62.11 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.597 0.759 . . . . 0.0 109.841 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.18 -11.94 10.99 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -174.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -136.09 17.42 3.23 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.449 1.099 . . . . 0.0 113.021 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.55 -20.63 1.23 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -158.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -133.74 8.22 3.84 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 173.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -80.94 -23.38 38.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.517 1.053 . . . . 0.0 110.51 161.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.56 176.07 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.226 1.01 . . . . 0.0 110.529 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 73.4 m -115.02 88.06 2.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.2 2.2 . . . . 0.0 107.157 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 t -80.81 149.28 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.06 167.52 29.54 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 162.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -134.09 150.11 51.15 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.027 175.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -154.87 157.85 38.46 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 125.196 1.56 . . . . 0.0 112.863 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -86.16 104.89 16.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.018 1.327 . . . . 0.0 107.661 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.8 p -49.27 -35.56 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.011 1.324 . . . . 0.0 113.488 -166.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -55.12 -37.21 66.61 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.684 1.594 . . . . 0.0 112.718 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.72 -22.12 65.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.649 1.58 . . . . 0.0 113.393 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -117.06 82.71 14.08 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 125.912 1.685 . . . . 0.0 108.594 -172.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.71 -31.19 3.38 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.037 1.825 . . . . 0.0 111.978 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 64' ' ' THR . 2.6 pp20? -63.68 140.79 58.91 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.54 0.736 . . . . 0.0 110.073 177.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.9 m 66.79 -33.3 0.2 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 128.253 2.621 . . . . 0.0 113.079 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.47 ' H ' ' C ' ' A' ' 62' ' ' GLU . 16.4 m -64.81 -56.33 14.15 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 128.559 2.744 . . . . 0.0 109.305 172.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -69.08 -11.79 61.11 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.115 -0.945 . . . . 0.0 112.667 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.97 -55.18 5.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.226 0.921 . . . . 0.0 109.166 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -87.66 10.72 17.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.533 0.606 . . . . 0.0 112.308 -167.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.42 24.96 62.07 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.044 1.307 . . . . 0.0 113.163 173.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.1 mm -83.4 79.08 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 122.489 1.138 . . . . 0.0 110.205 -162.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -115.69 -6.37 12.15 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.475 166.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.1 p -84.71 24.48 1.02 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.255 1.822 . . . . 0.0 113.742 -164.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.74 155.44 93.5 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 122.844 0.457 . . . . 0.0 111.483 -163.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.44 130.19 12.11 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 119.859 0.985 . . . . 0.0 111.38 6.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.0 m -118.85 143.13 47.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -124.18 100.52 6.75 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.3 mt -97.72 144.26 11.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 tt -111.89 125.77 54.39 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 164.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -118.99 161.66 19.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.213 1.805 . . . . 0.0 110.542 -173.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -162.57 147.3 12.04 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 124.837 1.255 . . . . 0.0 109.035 158.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.42 20.34 44.49 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.521 -0.6 . . . . 0.0 113.66 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.82 -10.27 57.47 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.401 1.476 . . . . 0.0 113.854 -171.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -83.87 125.21 73.64 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 119.26 1.53 . . . . 0.0 109.277 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.49 94.5 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.167 2.578 . . . . 0.0 108.782 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 m -60.73 -37.32 75.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.565 -0.709 . . . . 0.0 111.697 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 100' ' ' LEU . 18.9 pttm -166.26 165.02 17.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.162 1.385 . . . . 0.0 109.019 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.16 158.37 43.76 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.54 0.736 . . . . 0.0 112.214 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.11 153.42 23.17 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 160.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.1 140.35 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 126.101 1.76 . . . . 0.0 106.684 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.65 165.62 5.93 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.778 0.704 . . . . 0.0 111.782 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.34 96.97 0.12 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.56 1.144 . . . . 0.0 110.298 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -93.3 131.82 31.91 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 167.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.59 161.83 41.81 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.011 1.808 . . . . 0.0 109.863 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -40.15 66.7 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.342 0.657 . . . . 0.0 112.372 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -59.84 -24.75 64.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.428 1.091 . . . . 0.0 113.192 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.4 tp-100 -95.98 -44.09 7.51 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.835 1.254 . . . . 0.0 109.12 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -67.57 0.25 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.909 2.484 . . . . 0.0 108.671 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.58 -37.89 85.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 117.963 -1.018 . . . . 0.0 108.703 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.88 99.77 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.69 1.132 . . . . 0.0 111.906 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -69.67 -20.54 63.57 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.876 0.471 . . . . 0.0 112.177 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.482 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 1.1 tp -105.88 -10.22 16.76 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.118 1.367 . . . . 0.0 112.693 -171.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.23 -7.33 5.81 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.776 2.831 . . . . 0.0 114.48 -173.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -84.6 -13.34 51.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.089 1.756 . . . . 0.0 112.457 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.23 -16.17 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.092 0.86 . . . . 0.0 111.097 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -82.14 -6.07 58.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 121.626 -0.672 . . . . 0.0 112.226 162.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 . . . . . 0 C--O 1.245 0.836 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 158.721 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 121.462 0.648 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.1 m -153.55 139.42 18.1 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 119.396 -2.065 . . . . 0.0 106.404 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 52.5 ttm -149.12 119.31 7.25 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -65.76 92.97 0.16 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.114 0.966 . . . . 0.0 110.525 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.402 ' C ' ' HG1' ' A' ' 6' ' ' THR . 32.4 mt -53.43 146.98 11.45 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 161.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.402 ' HG1' ' C ' ' A' ' 5' ' ' LEU . 49.1 m -152.66 -32.72 0.13 Allowed 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.387 -1.445 . . . . 0.0 113.187 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -171.6 -79.9 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 125.989 1.716 . . . . 0.0 106.654 160.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.84 -27.28 63.05 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 121.013 -1.054 . . . . 0.0 112.303 173.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -72.99 -21.63 60.81 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.063 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.28 1.71 0.71 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.638 1.975 . . . . 0.0 112.264 168.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -126.9 -50.15 1.46 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.039 1.335 . . . . 0.0 109.783 168.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -53.71 -35.64 61.36 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.163 0.985 . . . . 0.0 112.284 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.35 -45.86 24.7 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.982 0.81 . . . . 0.0 110.024 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.53 -23.61 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 117.732 -1.128 . . . . 0.0 112.236 -170.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -50.17 -35.11 24.85 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.813 1.245 . . . . 0.0 113.728 -164.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.78 122.69 0.97 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 166.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -156.25 -71.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.883 0.873 . . . . 0.0 110.081 -170.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 149.21 -166.67 29.51 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -161.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.86 89.44 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.649 2.899 . . . . 0.0 110.958 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t -70.45 146.22 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 126.89 2.076 . . . . 0.0 108.479 169.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -144.8 123.58 12.63 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.835 1.654 . . . . 0.0 107.685 -170.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.49 140.88 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 119.508 1.049 . . . . 0.0 111.43 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -98.95 104.16 16.18 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.933 0.893 . . . . 0.0 109.356 159.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -85.15 108.33 17.65 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 166.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -130.82 -172.47 2.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.224 1.41 . . . . 0.0 107.92 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.62 165.97 29.74 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 125.749 1.619 . . . . 0.0 107.878 168.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.42 -14.29 55.9 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -174.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -108.04 -23.85 11.83 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -74.31 93.35 2.37 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.195 0.907 . . . . 0.0 111.449 -165.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -24.49 -63.98 0.05 OUTLIER Glycine 0 CA--C 1.542 1.723 0 C-N-CA 126.377 1.941 . . . . 0.0 115.495 173.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.99 -36.3 22.87 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.562 2.174 . . . . 0.0 113.382 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 p -63.32 -37.14 86.09 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.792 1.178 . . . . 0.0 110.103 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.53 -20.28 64.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.647 0.779 . . . . 0.0 112.043 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.4 mtm -101.27 -14.05 17.82 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.968 1.307 . . . . 0.0 112.749 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.9 ttt -93.28 -39.21 11.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.668 1.587 . . . . 0.0 109.776 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.15 -48.44 92.17 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 117.413 -1.279 . . . . 0.0 112.025 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.64 -33.48 45.01 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 121.862 1.701 . . . . 0.0 112.411 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -40.66 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.457 1.026 . . . . 0.0 109.873 174.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.9 mp -66.46 -20.23 65.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.085 1.754 . . . . 0.0 112.166 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.62 -51.33 28.78 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.222 0.919 . . . . 0.0 109.888 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.69 -43.03 97.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.271 0.628 . . . . 0.0 110.438 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -51.55 -57.36 9.31 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.633 1.173 . . . . 0.0 110.317 169.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.91 -52.06 65.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.65 -0.691 . . . . 0.0 111.156 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -55.22 -42.88 73.91 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.042 0.937 . . . . 0.0 110.804 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.0 -15.67 24.41 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -146.88 56.22 1.13 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.193 1.397 . . . . 0.0 109.819 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.07 64.57 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -169.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -134.98 -2.11 2.61 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -63.7 -32.19 73.61 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.884 -1.135 . . . . 0.0 109.464 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.02 165.11 24.51 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 124.336 1.054 . . . . 0.0 110.252 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.6 m -107.96 88.8 2.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.778 2.031 . . . . 0.0 108.681 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 t -71.73 158.17 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.668 0.787 . . . . 0.0 110.291 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.13 155.04 34.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.903 1.681 . . . . 0.0 106.801 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -139.62 128.91 24.01 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.42 150.69 35.13 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.198 0.936 . . . . 0.0 111.825 -175.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.97 128.12 34.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 167.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.34 -34.06 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.04 -42.94 75.67 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.265 1.426 . . . . 0.0 110.717 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.32 -35.78 67.97 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.361 2.265 . . . . 0.0 112.487 176.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.39 80.49 4.59 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.271 1.029 . . . . 0.0 110.769 -172.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.12 -28.54 23.39 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.734 2.29 . . . . 0.0 114.185 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.43 ' C ' ' H ' ' A' ' 64' ' ' THR . 9.8 tp10 -52.49 117.22 2.71 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.027 1.331 . . . . 0.0 110.944 177.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.256 21.7 m 68.13 -21.35 0.13 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 129.202 3.001 . . . . 0.0 113.336 174.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.43 ' H ' ' C ' ' A' ' 62' ' ' GLU . 51.9 m -53.28 -52.47 58.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.003 1.721 . . . . 0.0 108.833 162.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -69.96 -3.33 15.65 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 117.722 -1.133 . . . . 0.0 113.266 176.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -100.94 -38.44 8.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.769 1.168 . . . . 0.0 110.595 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -92.63 7.67 42.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.702 0.683 . . . . 0.0 111.831 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.86 34.2 81.87 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 123.714 0.673 . . . . 0.0 111.739 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 26.2 mm -77.92 71.31 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.3 1.44 . . . . 0.0 109.002 -170.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 53.6 ttm -95.05 -18.48 20.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.431 1.092 . . . . 0.0 110.292 161.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.3 t -62.22 128.01 34.06 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.588 1.155 . . . . 0.0 108.67 167.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.8 pt -146.44 156.11 49.51 Favored Pre-proline 0 N--CA 1.443 -0.818 0 C-N-CA 126.829 2.052 . . . . 0.0 107.531 159.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.36 130.1 9.57 Favored 'Cis proline' 0 N--CA 1.453 -0.91 0 CA-C-N 119.733 0.94 . . . . 0.0 110.467 -9.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.7 m -123.78 149.3 45.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tt -135.12 134.58 40.38 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.3 mt -131.67 144.12 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.19 136.75 48.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 168.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -133.26 169.48 16.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.334 1.854 . . . . 0.0 110.909 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.474 ' HE3' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -153.69 155.81 36.68 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.376 1.871 . . . . 0.0 106.204 158.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.02 37.58 4.34 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 124.579 1.085 . . . . 0.0 115.795 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.24 17.81 80.14 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.735 1.16 . . . . 0.0 115.1 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -139.64 135.5 16.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.052 1.341 . . . . 0.0 108.9 -168.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.09 170.84 16.01 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.066 2.511 . . . . 0.0 113.097 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.13 -7.53 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.848 1.659 . . . . 0.0 112.081 173.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 161.15 170.75 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 1 C-N-CA 132.088 4.155 . . . . 0.0 108.763 164.15 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -129.5 142.87 50.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.492 1.917 . . . . 0.0 107.639 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.77 145.41 48.07 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 128.926 2.89 . . . . 0.0 106.299 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.69 135.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -173.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.68 165.18 41.03 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 123.772 0.701 . . . . 0.0 112.311 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -77.48 69.33 3.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.917 1.287 . . . . 0.0 111.486 -174.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -76.86 131.81 72.68 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.79 168.09 19.53 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.086 2.524 . . . . 0.0 110.988 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -45.59 76.01 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 123.846 0.858 . . . . 0.0 110.45 -174.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.76 -12.09 59.83 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.323 1.049 . . . . 0.0 112.386 -174.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.13 -55.76 2.68 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.476 1.511 . . . . 0.0 108.155 172.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 tt -54.38 -60.73 2.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.844 2.058 . . . . 0.0 110.315 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -65.51 -20.99 66.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.565 1.146 . . . . 0.0 111.845 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.16 -48.1 31.52 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.487 1.04 . . . . 0.0 109.623 170.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -59.41 -32.08 69.85 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.846 1.258 . . . . 0.0 112.104 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tp -97.71 0.52 47.17 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.669 1.988 . . . . 0.0 112.379 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.07 -29.42 68.55 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.992 0.917 . . . . 0.0 112.529 -169.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -65.85 -12.82 57.38 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.99 4.53 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.814 0.846 . . . . 0.0 112.226 173.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -112.28 -6.42 14.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.528 1.131 . . . . 0.0 112.853 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.539 1.936 . . . . 0.0 108.966 159.24 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.252 0.549 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.0 m -149.42 153.47 37.38 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 164.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.29 -178.29 7.03 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.568 1.147 . . . . 0.0 108.404 166.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.3 m -81.14 159.49 24.64 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 163.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.3 tp -132.08 162.13 31.56 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.881 1.272 . . . . 0.0 107.961 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.1 m -149.43 163.12 38.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -42.79 -55.28 3.72 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.437 3.095 . . . . 0.0 113.624 -164.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.32 91.95 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.369 0.604 . . . . 0.0 111.792 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.71 -18.1 58.71 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.059 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.34 -61.92 2.14 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.749 1.159 . . . . 0.0 108.745 174.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.39 -39.74 84.35 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.577 0.351 . . . . 0.0 110.781 -177.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -74.84 -16.44 60.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.62 0.768 . . . . 0.0 112.701 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.22 -57.36 3.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.352 0.978 . . . . 0.0 109.321 168.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.2 pt -59.32 -24.35 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -170.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -67.4 -17.62 64.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.615 1.166 . . . . 0.0 113.198 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.42 165.01 47.5 Favored Glycine 0 C--N 1.342 0.909 0 C-N-CA 124.127 0.87 . . . . 0.0 112.124 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -80.29 -42.48 23.01 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.382 1.473 . . . . 0.0 111.956 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.27 164.06 54.88 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 123.371 0.51 . . . . 0.0 112.681 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.2 100.63 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.775 2.984 . . . . 0.0 112.006 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.1 t -90.18 121.99 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 C-N-CA 125.986 1.714 . . . . 0.0 108.116 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 tt -118.95 112.16 19.26 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.132 0.973 . . . . 0.0 109.312 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -91.49 127.85 43.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -92.08 101.93 14.47 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 164.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -87.19 111.69 21.23 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 14.5 p-90 -135.29 178.49 6.99 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.772 1.229 . . . . 0.0 110.491 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.73 167.49 30.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.982 1.313 . . . . 0.0 110.798 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.77 -4.65 41.73 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.11 -16.0 7.6 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -174.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.8 p -75.45 36.93 0.13 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.836 1.654 . . . . 0.0 114.287 -165.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 33.39 -97.94 0.01 OUTLIER Glycine 0 CA--C 1.536 1.381 0 C-N-CA 128.913 3.149 . . . . 0.0 114.464 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.67 -15.76 33.14 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.751 2.967 . . . . 0.0 115.053 -175.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.3 p -54.4 -32.33 56.95 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.347 0.976 . . . . 0.0 111.96 167.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttp85 -67.03 -12.03 58.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.771 0.828 . . . . 0.0 112.66 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.5 mtp -110.09 -20.4 12.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.716 1.606 . . . . 0.0 111.846 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.4 ttt -80.61 -44.31 19.12 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 124.52 1.128 . . . . 0.0 109.412 170.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.66 -47.6 78.43 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 116.802 -1.571 . . . . 0.0 113.528 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.25 -29.9 25.55 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.098 1.865 . . . . 0.0 112.719 171.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.8 -30.12 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 120.216 1.371 . . . . 0.0 111.007 171.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.3 mt -80.02 -18.04 51.24 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.959 1.704 . . . . 0.0 111.212 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.83 -41.92 58.99 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.057 0.943 . . . . 0.0 110.299 162.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.87 -15.51 62.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.676 1.19 . . . . 0.0 111.498 171.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -85.29 -49.0 8.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.221 1.808 . . . . 0.0 109.025 167.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.29 -32.22 66.42 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.17 -0.919 . . . . 0.0 113.363 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.29 -57.35 5.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.03 1.286 . . . . 0.0 110.919 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.68 -22.47 35.04 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -159.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.9 30.21 1.18 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.886 1.275 . . . . 0.0 111.114 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -20.29 -63.4 0.02 OUTLIER 'General case' 0 C--N 1.341 0.196 0 C-N-CA 128.94 2.896 . . . . 0.0 115.314 -170.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -108.12 8.1 27.94 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -169.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -70.88 -26.06 63.07 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.982 0.81 . . . . 0.0 109.682 158.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.79 170.26 15.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.192 0.997 . . . . 0.0 110.9 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.267 10.7 t -124.91 103.64 8.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 158.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.6 t -70.08 155.75 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.09 111.42 3.91 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -89.19 130.72 35.57 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -172.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.37 143.15 24.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.927 0.87 . . . . 0.0 112.77 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -81.14 117.69 21.91 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.1 p -51.8 -32.2 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.503 1.121 . . . . 0.0 113.801 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -67.79 -29.76 69.03 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.191 1.797 . . . . 0.0 112.488 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -23.77 60.69 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.979 1.312 . . . . 0.0 112.462 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -126.21 87.36 56.32 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 125.237 1.415 . . . . 0.0 109.735 -163.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.55 -29.87 15.72 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.875 2.383 . . . . 0.0 113.712 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 64' ' ' THR . 8.3 tp10 -73.8 137.55 43.93 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.741 1.155 . . . . 0.0 110.73 -173.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.7 m 64.09 -31.01 0.11 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 130.123 3.369 . . . . 0.0 112.822 -169.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.474 ' H ' ' C ' ' A' ' 62' ' ' GLU . 52.2 m -58.08 -57.35 13.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.572 1.949 . . . . 0.0 109.45 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -57.78 -46.25 84.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.053 0.541 . . . . 0.0 109.874 178.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -58.39 -35.59 72.25 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.024 0.93 . . . . 0.0 112.758 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -100.55 9.83 42.01 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.191 0.597 . . . . 0.0 112.118 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.24 29.05 74.34 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 119.1 0.864 . . . . 0.0 112.927 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mm -77.13 81.38 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.333 1.453 . . . . 0.0 109.915 -166.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.6 mmt -123.89 -0.98 8.41 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.726 1.61 . . . . 0.0 111.103 166.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.4 t -77.9 30.07 0.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.161 1.785 . . . . 0.0 113.077 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.96 148.44 98.4 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.384 0.538 . . . . 0.0 111.828 -172.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -66.36 128.74 9.56 Favored 'Cis proline' 0 C--N 1.35 0.635 0 CA-C-N 119.73 0.939 . . . . 0.0 111.493 4.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.1 m -123.76 151.87 42.79 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 122.207 1.003 . . . . 0.0 108.838 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.9 tt -131.87 130.21 41.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 mt -130.28 141.24 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 165.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.72 119.55 39.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 175.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -117.32 161.22 19.86 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.979 2.112 . . . . 0.0 112.391 -175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.41 157.33 19.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.65 2.38 . . . . 0.0 108.668 159.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.42 14.83 14.28 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.94 1.257 . . . . 0.0 115.394 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.87 -6.02 58.38 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.625 1.584 . . . . 0.0 113.543 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -129.01 157.44 75.84 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 119.183 1.492 . . . . 0.0 110.689 -170.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.74 166.78 24.96 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.31 2.007 . . . . 0.0 111.55 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.44 -34.8 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.734 1.214 . . . . 0.0 108.505 158.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -162.02 165.77 26.88 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.495 1.118 . . . . 0.0 109.978 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -136.45 143.26 43.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.937 2.495 . . . . 0.0 106.397 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.7 mt -132.55 153.4 51.01 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.618 1.567 . . . . 0.0 108.194 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.2 pt -143.85 143.61 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.052 1.341 . . . . 0.0 108.075 -173.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.64 161.94 26.36 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.783 0.706 . . . . 0.0 111.903 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -75.25 78.55 2.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.083 0.953 . . . . 0.0 111.526 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -69.63 140.86 89.79 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 166.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.85 160.25 49.98 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.748 1.632 . . . . 0.0 110.404 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.91 -45.88 42.13 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.93 1.292 . . . . 0.0 112.814 -171.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -74.09 -25.1 59.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.455 -172.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -73.8 -37.67 64.85 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -61.26 2.78 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.165 1.386 . . . . 0.0 108.813 175.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -64.94 -25.78 68.02 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.22 -0.895 . . . . 0.0 112.229 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.21 -53.88 12.89 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.856 0.753 . . . . 0.0 110.494 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -62.19 -35.07 77.74 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.148 0.579 . . . . 0.0 112.302 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.83 1.85 56.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.645 1.178 . . . . 0.0 112.751 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.15 -31.97 54.0 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 120.082 1.31 . . . . 0.0 113.511 -174.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -65.4 -14.41 60.82 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.954 0.901 . . . . 0.0 113.295 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 66.0 t -109.06 -5.57 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.574 1.55 . . . . 0.0 110.858 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.47 -5.85 14.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.791 1.236 . . . . 0.0 112.741 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.099 0 C-N-CA 126.946 2.099 . . . . 0.0 110.552 164.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.3 m -114.09 125.2 53.71 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -173.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.8 ttp -149.58 -0.46 0.47 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.319 0.7 OUTLIER 57.18 176.0 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.934 1.294 . . . . 0.0 112.569 -170.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.0 mt -142.75 172.25 12.94 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.664 1.985 . . . . 0.0 107.938 -167.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.0 m -125.17 -88.53 0.59 Allowed 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -140.03 -66.25 0.45 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.858 0.863 . . . . 0.0 109.132 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.68 -30.83 45.28 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.666 -0.646 . . . . 0.0 111.912 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -72.32 -26.3 61.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.103 0.561 . . . . 0.0 110.688 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -58.0 -62.83 1.53 Allowed 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.021 0.929 . . . . 0.0 109.678 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -60.39 -42.43 95.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.841 0.456 . . . . 0.0 110.502 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -64.12 -25.65 68.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.66 1.184 . . . . 0.0 112.962 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.08 -61.53 1.97 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.232 0.924 . . . . 0.0 110.058 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.2 pt -59.07 -20.34 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -167.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -60.67 -19.05 57.36 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.344 1.458 . . . . 0.0 113.321 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.95 157.51 48.6 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 119.452 1.024 . . . . 0.0 111.631 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -76.94 -36.28 56.69 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.846 1.659 . . . . 0.0 111.443 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.22 161.97 47.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 123.814 0.721 . . . . 0.0 111.721 177.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.29 107.88 0.74 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.591 2.86 . . . . 0.0 110.948 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.4 t -98.45 141.96 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 167.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.53 153.5 44.91 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 118.565 0.62 . . . . 0.0 111.033 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.02 126.85 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -80.12 121.2 25.26 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.953 0.783 . . . . 0.0 108.915 161.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -98.26 107.16 19.56 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.045 0.938 . . . . 0.0 108.684 163.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -124.08 -177.7 3.85 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.905 1.282 . . . . 0.0 107.992 172.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.61 165.96 33.21 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.971 1.308 . . . . 0.0 108.832 170.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.66 -3.04 7.9 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -174.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -117.27 -24.58 7.39 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.81 1.187 . . . . 0.0 114.155 -175.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.73 93.79 2.63 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.196 0.907 . . . . 0.0 111.845 -163.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -19.32 -71.11 0.01 OUTLIER Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.538 2.018 . . . . 0.0 115.567 173.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.17 -29.46 47.48 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.16 2.574 . . . . 0.0 114.303 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.9 p -64.66 -27.7 69.11 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.513 1.051 . . . . 0.0 110.771 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -19.57 65.96 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.405 173.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -101.95 -23.89 14.07 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.935 1.294 . . . . 0.0 112.486 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.0 tpt -75.99 -47.28 25.54 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 125.917 1.687 . . . . 0.0 108.494 173.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.73 -48.15 70.43 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 120.133 1.333 . . . . 0.0 113.617 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.78 -33.02 21.88 Favored 'Trans proline' 0 C--N 1.352 0.741 0 CA-C-N 122.061 1.772 . . . . 0.0 112.53 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.49 -35.13 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.856 1.207 . . . . 0.0 110.526 173.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.3 mt -72.14 -21.7 61.42 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 125.929 1.692 . . . . 0.0 111.199 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.27 -52.68 31.11 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 170.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -71.34 -19.91 62.24 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -67.08 -60.06 2.94 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.044 1.338 . . . . 0.0 108.963 165.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.74 -49.55 65.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.821 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -53.93 -42.41 68.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.81 1.244 . . . . 0.0 111.262 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.35 -15.27 62.38 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -158.43 57.65 0.45 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.074 1.349 . . . . 0.0 109.462 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.02 -14.51 62.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.596 0.758 . . . . 0.0 112.086 -172.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -109.37 -55.22 2.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.383 3.473 . . . . 0.0 110.646 -172.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -53.72 -31.47 48.3 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 126.268 1.827 . . . . 0.0 112.444 -172.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 m -130.13 150.52 34.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.3 m -82.79 71.62 9.88 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 172.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.76 147.56 7.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 124.397 1.079 . . . . 0.0 109.936 175.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.65 163.02 40.01 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.186 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -128.26 143.14 51.0 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 123.736 0.648 . . . . 0.0 110.904 159.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 pp -146.29 154.34 41.58 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 124.974 1.421 . . . . 0.0 109.515 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -77.54 129.24 35.41 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 p -68.06 -20.39 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.174 -0.953 . . . . 0.0 112.003 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.75 -17.38 55.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.593 0.757 . . . . 0.0 111.266 172.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.23 -34.5 21.99 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.3 1.84 . . . . 0.0 110.147 173.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -106.4 93.43 8.26 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 124.825 1.25 . . . . 0.0 111.264 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.18 -25.71 9.81 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.976 2.451 . . . . 0.0 113.75 164.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 64' ' ' THR . 8.1 tp10 -58.89 119.24 6.84 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.752 1.16 . . . . 0.0 111.169 -177.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.268 16.4 m 63.58 -15.64 0.07 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.281 2.232 . . . . 0.0 113.795 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.438 ' H ' ' C ' ' A' ' 62' ' ' GLU . 27.7 m -53.03 -56.06 18.97 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.102 1.361 . . . . 0.0 108.844 167.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.6 t -72.18 0.39 9.87 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 117.821 -1.085 . . . . 0.0 112.899 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -108.3 -36.05 6.37 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.454 1.101 . . . . 0.0 111.177 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -104.06 10.0 36.21 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.033 0.833 . . . . 0.0 111.108 -175.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.62 32.11 59.84 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 123.918 0.77 . . . . 0.0 112.249 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.9 mm -75.23 83.25 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.999 0.919 . . . . 0.0 109.617 -170.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.2 ttp -128.07 -10.34 5.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.401 1.08 . . . . 0.0 111.342 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.4 t -87.22 56.62 4.06 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.428 1.091 . . . . 0.0 109.36 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.6 pt -81.96 148.43 60.67 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.183 -174.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.77 125.02 6.16 Favored 'Cis proline' 0 C--N 1.35 0.62 0 CA-C-N 119.589 0.889 . . . . 0.0 110.925 -0.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.8 m -109.22 143.91 38.04 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.6 tt -129.4 132.93 47.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 171.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.1 mt -130.43 144.9 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.29 132.96 56.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.85 163.03 30.0 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.454 1.902 . . . . 0.0 111.778 -169.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.47 148.47 18.06 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 125.696 1.598 . . . . 0.0 108.554 157.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.87 19.99 38.98 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 123.904 0.764 . . . . 0.0 113.101 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.91 -7.4 51.2 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.197 1.38 . . . . 0.0 113.971 -170.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -84.3 118.9 72.33 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 119.297 1.548 . . . . 0.0 108.751 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.15 109.09 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.37 2.713 . . . . 0.0 109.853 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 m -71.1 -37.27 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.641 -0.662 . . . . 0.0 111.428 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -156.98 160.62 39.21 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.199 0.6 . . . . 0.0 111.846 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -128.8 142.55 50.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.713 2.405 . . . . 0.0 107.526 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.09 149.95 41.38 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.999 2.12 . . . . 0.0 107.044 165.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.47 132.52 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.353 1.461 . . . . 0.0 107.102 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.16 166.92 26.85 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.405 1.002 . . . . 0.0 112.135 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -76.83 74.56 3.46 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.505 1.122 . . . . 0.0 109.409 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -76.81 122.83 87.17 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 171.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.25 166.72 22.38 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.756 1.637 . . . . 0.0 110.441 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.402 ' HE3' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -47.98 -50.52 27.14 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.895 1.278 . . . . 0.0 112.412 -175.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.48 -19.71 65.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.73 -56.07 3.45 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.8 tt -55.99 -60.52 3.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.505 1.922 . . . . 0.0 109.394 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.402 ' OE1' ' HE3' ' A' ' 93' ' ' LYS . 6.3 tt0 -68.67 -17.4 64.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.493 1.117 . . . . 0.0 111.392 -176.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.84 -52.13 9.38 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 119.472 1.033 . . . . 0.0 110.069 166.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -60.5 -27.52 67.65 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.966 0.907 . . . . 0.0 112.047 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.94 0.39 41.08 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.37 1.868 . . . . 0.0 112.988 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.89 -34.53 67.97 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.978 0.911 . . . . 0.0 112.746 -171.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -66.02 -11.92 51.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.508 1.523 . . . . 0.0 113.45 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.16 8.89 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.197 1.399 . . . . 0.0 111.552 171.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.2 -0.23 12.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.513 1.525 . . . . 0.0 113.529 169.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.363 1.865 . . . . 0.0 108.797 172.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.2 m 114.19 60.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 1 C-N-CA 133.372 4.669 . . . . 0.0 106.563 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.5 mtt -74.36 137.03 42.52 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.1 m -72.14 81.5 0.98 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 165.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.23 159.04 31.97 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.613 0.765 . . . . 0.0 109.635 175.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.5 p -117.35 -89.0 0.59 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 158.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 8' ' ' ALA . 9.1 p-10 -142.84 -73.24 0.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.416 1.486 . . . . 0.0 108.014 -159.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.502 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . -54.14 -32.24 54.7 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.042 0.937 . . . . 0.0 111.291 170.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -81.7 -15.6 53.91 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 119.238 -0.985 . . . . 0.0 112.089 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -66.89 -54.13 25.25 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.145 0.884 . . . . 0.0 109.143 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -65.78 -23.05 66.63 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.604 0.761 . . . . 0.0 111.694 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -73.64 -49.11 27.64 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.152 0.887 . . . . 0.0 110.844 167.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.61 -39.57 91.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.962 0.801 . . . . 0.0 111.801 -171.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.0 tt -58.26 -22.16 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.21 1.404 . . . . 0.0 113.38 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -56.06 -36.75 68.43 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.478 1.511 . . . . 0.0 113.874 -159.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.49 133.92 2.0 Allowed Glycine 0 C--N 1.334 0.428 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 -170.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -174.74 -55.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.836 1.654 . . . . 0.0 107.964 -166.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.73 -157.65 27.47 Favored Glycine 0 CA--C 1.534 1.281 0 N-CA-C 105.064 -3.214 . . . . 0.0 105.064 -158.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.17 103.66 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.205 2.604 . . . . 0.0 111.347 168.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.4 t -88.99 127.42 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 168.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 tt -132.19 122.99 26.15 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -172.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.99 119.74 62.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -172.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -97.07 94.13 6.98 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -176.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -82.46 110.63 17.75 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.133 1.373 . . . . 0.0 108.871 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 16.5 p-90 -125.82 177.07 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.25 164.35 32.59 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.753 1.221 . . . . 0.0 108.953 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.58 -8.74 56.71 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -123.86 -13.88 7.3 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.7 p -70.22 39.19 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -158.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 42.87 -99.03 0.01 OUTLIER Glycine 0 CA--C 1.536 1.389 0 C-N-CA 127.572 2.51 . . . . 0.0 114.764 169.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -58.58 -19.02 42.88 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.862 3.041 . . . . 0.0 114.166 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 14.9 p -60.03 -22.68 62.95 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 119.188 0.904 . . . . 0.0 112.235 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -14.94 61.72 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.12 1.327 . . . . 0.0 112.451 173.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.2 mtm -100.43 -32.46 10.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.647 1.579 . . . . 0.0 111.054 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.2 ttt -72.91 -43.18 62.72 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-O 117.811 -1.09 . . . . 0.0 109.142 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.59 -45.97 85.41 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 116.595 -1.669 . . . . 0.0 113.213 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.5 -45.51 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.628 1.552 . . . . 0.0 111.79 167.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -30.17 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 121.71 2.05 . . . . 0.0 112.133 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 mt -68.7 -13.01 62.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 128.667 2.787 . . . . 0.0 112.252 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.88 -46.38 8.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.296 1.038 . . . . 0.0 109.851 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.89 -40.78 70.13 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.519 1.054 . . . . 0.0 110.665 165.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.447 ' CE1' HD22 ' A' ' 96' ' ' LEU . 79.0 t80 -56.14 -60.07 4.02 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.922 0.889 . . . . 0.0 110.235 171.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.69 -49.68 67.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.632 0.651 . . . . 0.0 111.861 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.1 -48.52 64.7 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.514 1.526 . . . . 0.0 110.547 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.93 -12.6 11.77 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -150.61 61.85 0.94 Allowed 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.268 1.427 . . . . 0.0 108.502 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.04 -45.41 64.67 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.634 1.574 . . . . 0.0 111.413 -169.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -136.41 9.75 3.19 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -61.94 -32.84 73.3 Favored 'General case' 0 C--N 1.345 0.403 0 O-C-N 121.413 -0.805 . . . . 0.0 110.201 163.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.0 m -119.71 143.37 31.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.341 1.1 t -82.21 73.59 9.24 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 124.259 1.981 . . . . 0.0 106.596 166.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.4 148.28 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 113.642 -1.617 . . . . 0.0 107.957 165.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.82 158.8 44.58 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.099 1.36 . . . . 0.0 107.631 170.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -133.05 124.82 28.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.76 152.13 46.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.67 1.224 . . . . 0.0 113.054 -177.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -85.22 110.17 18.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.051 1.74 . . . . 0.0 108.835 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.99 -26.19 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.039 0.936 . . . . 0.0 112.754 -173.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -70.78 -22.69 62.34 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 126.547 1.939 . . . . 0.0 111.182 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.61 -38.74 13.72 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.589 1.156 . . . . 0.0 111.021 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -105.05 106.43 55.52 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.705 -169.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.89 -22.42 6.24 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.047 2.498 . . . . 0.0 114.316 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.462 ' C ' ' H ' ' A' ' 64' ' ' THR . 7.4 tp10 -66.41 118.55 10.22 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.325 0.966 . . . . 0.0 108.766 -173.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.272 25.9 m 67.65 -17.75 0.15 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.817 2.847 . . . . 0.0 112.659 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.462 ' H ' ' C ' ' A' ' 62' ' ' GLU . 31.1 m -54.5 -54.9 34.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.125 1.77 . . . . 0.0 108.895 160.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -57.97 -46.8 84.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.55 0.74 . . . . 0.0 110.356 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -55.06 -35.37 64.46 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.543 1.137 . . . . 0.0 112.899 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -111.09 14.75 21.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.232 0.613 . . . . 0.0 112.258 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.39 31.2 80.07 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 118.962 0.801 . . . . 0.0 113.114 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.7 mm -76.54 81.98 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.102 1.361 . . . . 0.0 110.288 -165.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.6 mmt -130.27 3.82 4.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.19 1.396 . . . . 0.0 111.424 165.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 t -78.89 37.44 0.3 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.232 1.813 . . . . 0.0 110.966 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.74 151.27 76.71 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 121.324 -0.86 . . . . 0.0 111.427 -169.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.7 123.98 4.06 Favored 'Cis proline' 0 C--N 1.349 0.583 0 CA-C-N 119.861 0.986 . . . . 0.0 111.107 4.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.3 m -118.69 154.22 33.08 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 tt -146.3 122.7 10.99 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 104.673 -2.344 . . . . 0.0 104.673 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.8 mt -123.37 139.08 51.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 119.55 39.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.569 1.948 . . . . 0.0 105.822 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -122.26 169.16 11.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.797 2.439 . . . . 0.0 108.062 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.502 ' C ' ' HE3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -153.33 40.13 0.52 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.344 -0.847 . . . . 0.0 112.417 -179.718 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.92 87.41 1.91 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -167.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.69 -23.35 3.02 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 130.585 3.945 . . . . 0.0 114.422 160.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -131.94 149.3 72.95 Favored Pre-proline 0 N--CA 1.445 -0.69 0 C-N-CA 125.379 1.472 . . . . 0.0 110.182 -171.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.12 159.94 30.05 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.848 2.366 . . . . 0.0 111.043 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -38.67 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.239 1.416 . . . . 0.0 110.383 165.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.432 ' HZ3' ' CG ' ' A' ' 102' ' ' ASP . 18.1 pttm -161.11 171.91 17.7 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 119.317 0.962 . . . . 0.0 111.381 174.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -139.05 150.38 45.7 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.24 2.216 . . . . 0.0 108.649 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.76 150.61 40.12 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.148 1.779 . . . . 0.0 107.632 161.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.9 pt -143.33 137.36 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 126.269 1.827 . . . . 0.0 108.082 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.55 167.37 18.01 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.163 0.887 . . . . 0.0 111.762 -174.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -57.01 110.72 0.87 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.906 0.883 . . . . 0.0 111.183 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -101.33 133.84 20.66 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 160.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.97 158.14 58.2 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 CA-C-N 120.287 1.138 . . . . 0.0 109.161 164.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.35 -52.52 2.7 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.149 1.78 . . . . 0.0 110.843 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.19 -31.66 69.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.017 1.727 . . . . 0.0 113.103 -175.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -85.31 -47.27 10.19 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 119.244 0.929 . . . . 0.0 109.906 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.447 HD22 ' CE1' ' A' ' 42' ' ' PHE . 1.3 tt -56.53 -61.89 2.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.305 2.642 . . . . 0.0 108.999 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -63.24 -29.26 70.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.585 1.154 . . . . 0.0 110.827 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.64 -49.15 33.75 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.39 0.995 . . . . 0.0 110.732 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -56.86 -43.24 80.99 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.479 0.712 . . . . 0.0 110.828 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.68 -0.27 55.95 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.51 1.124 . . . . 0.0 113.324 -176.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.16 -28.82 63.12 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.232 1.413 . . . . 0.0 113.4 -170.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.432 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 14.8 p-10 -63.25 -22.09 66.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.15 0.98 . . . . 0.0 113.393 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.11 -15.87 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 118.862 0.756 . . . . 0.0 111.14 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -10.38 56.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.01 1.324 . . . . 0.0 112.49 169.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.249 1.042 0 C-N-CA 129.608 3.163 . . . . 0.0 111.182 161.929 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.741 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.2 t -79.18 -165.92 0.84 Allowed 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 153.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.63 5.63 0.61 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 174.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -134.75 158.88 43.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.423 1.089 . . . . 0.0 108.899 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 mt -140.34 170.39 15.89 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 125.335 1.454 . . . . 0.0 109.621 170.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.9 p -127.01 170.13 12.62 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 163.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -53.39 -55.52 24.34 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 127.886 2.475 . . . . 0.0 111.412 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.4 81.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.226 0.611 . . . . 0.0 110.084 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -75.09 -20.23 59.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.248 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -58.36 -63.93 1.1 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.14 -46.81 89.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.017 0.527 . . . . 0.0 110.787 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.23 -20.02 65.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.094 -174.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.14 -58.13 3.09 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.4 1.0 . . . . 0.0 110.213 165.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.2 pt -62.41 -20.05 23.8 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -169.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -57.36 -24.62 56.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.137 0.975 . . . . 0.0 113.038 172.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.24 112.57 0.26 Allowed Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -157.96 -75.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.489 1.515 . . . . 0.0 109.137 -175.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.69 -166.25 30.75 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 -159.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.32 83.87 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.703 3.602 . . . . 0.0 112.226 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.7 t -94.06 124.12 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 125.743 1.617 . . . . 0.0 106.848 171.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.74 146.64 44.6 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.52 0.676 . . . . 0.0 111.964 170.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.3 t -131.54 108.41 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -161.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -83.46 100.75 10.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.345 1.058 . . . . 0.0 109.155 174.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -78.54 108.61 12.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 166.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -123.17 176.06 6.29 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.39 155.73 31.03 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 120.884 -1.135 . . . . 0.0 110.825 166.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.49 -12.81 61.21 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -173.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.69 -12.37 31.63 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.572 1.078 . . . . 0.0 112.772 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.4 p -67.24 173.72 3.7 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.436 0.636 . . . . 0.0 112.469 -164.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.35 -86.63 1.89 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 162.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.24 -20.78 55.64 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.96 2.44 . . . . 0.0 114.336 -167.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.67 -33.66 68.57 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.8 1.182 . . . . 0.0 111.128 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -74.05 -11.82 60.44 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.572 -0.727 . . . . 0.0 112.516 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.6 ptm -104.23 -21.64 13.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.923 1.289 . . . . 0.0 112.079 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.1 ttt -83.82 -44.4 14.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.89 1.676 . . . . 0.0 108.969 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.2 -47.26 82.56 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 117.541 -1.219 . . . . 0.0 113.324 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.87 -31.48 38.4 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.918 1.721 . . . . 0.0 112.445 172.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.23 -39.03 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.813 1.188 . . . . 0.0 110.511 172.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.8 mt -69.23 -20.01 63.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.227 1.411 . . . . 0.0 111.831 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -69.98 -45.57 67.07 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.673 0.789 . . . . 0.0 110.092 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -62.1 -44.28 96.99 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.529 0.331 . . . . 0.0 110.289 171.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.22 -44.9 84.17 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.772 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.72 -53.51 46.75 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.054 0.942 . . . . 0.0 110.745 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.01 -46.8 87.28 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.184 0.994 . . . . 0.0 111.069 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.8 -26.57 14.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.051 1.341 . . . . 0.0 114.414 -173.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.05 29.67 4.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.415 1.486 . . . . 0.0 111.826 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -14.26 -61.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 131.421 3.888 . . . . 0.0 116.028 -172.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -114.08 -14.53 12.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.386 1.874 . . . . 0.0 113.134 -168.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -66.42 -31.96 73.04 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.231 0.923 . . . . 0.0 110.276 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.12 171.56 17.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 122.706 0.402 . . . . 0.0 110.216 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.5 t -124.45 137.77 54.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.102 0.477 . . . . 0.0 110.005 172.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.86 154.74 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 125.255 1.422 . . . . 0.0 107.313 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.95 138.04 20.35 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -117.45 136.46 53.18 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 118.898 0.772 . . . . 0.0 109.338 170.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -144.38 146.46 32.54 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.175 0.988 . . . . 0.0 113.446 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -75.16 104.14 5.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.007 1.723 . . . . 0.0 107.826 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.7 p -70.15 -20.56 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -166.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.87 -43.08 90.78 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.076 1.35 . . . . 0.0 110.566 169.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -89.23 -25.36 21.78 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.636 1.974 . . . . 0.0 112.316 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -105.33 90.08 3.65 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 118.404 0.547 . . . . 0.0 111.24 164.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.9 -12.67 17.82 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.872 2.381 . . . . 0.0 114.042 166.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -72.87 129.17 37.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.667 1.121 . . . . 0.0 109.078 -176.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.5 m 64.33 -25.12 0.08 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.943 3.297 . . . . 0.0 112.466 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.53 ' H ' ' C ' ' A' ' 62' ' ' GLU . 41.7 m -50.31 -61.59 2.08 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 128.328 2.651 . . . . 0.0 109.214 165.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.1 t -57.45 -46.49 83.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.95 0.5 . . . . 0.0 109.881 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -58.59 -38.58 78.25 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.4 1.08 . . . . 0.0 112.451 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -95.22 12.0 30.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.848 0.749 . . . . 0.0 111.461 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.36 25.64 73.65 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 118.78 0.718 . . . . 0.0 112.635 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.8 mm -73.65 94.89 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.86 1.264 . . . . 0.0 109.312 -169.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.14 -21.37 3.61 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.366 1.466 . . . . 0.0 110.861 175.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 p -81.58 47.76 1.1 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.115 2.566 . . . . 0.0 112.333 -162.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 pt -76.16 153.53 84.39 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -169.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -62.85 128.27 6.06 Favored 'Cis proline' 0 C--N 1.351 0.693 0 N-CA-C 110.238 -0.716 . . . . 0.0 110.238 -7.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 m -115.41 132.64 56.56 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tt -125.43 116.82 22.44 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 mt -120.17 143.03 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 tt -118.9 119.83 35.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -111.48 166.91 10.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.577 1.951 . . . . 0.0 110.356 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -161.67 127.75 3.72 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 126.22 1.808 . . . . 0.0 106.714 158.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 47.8 42.87 22.25 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.633 0.635 . . . . 0.0 113.771 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.12 -7.05 82.63 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 117.859 -1.523 . . . . 0.0 115.146 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -101.03 104.34 31.54 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 120.094 1.947 . . . . 0.0 111.243 -173.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.88 90.25 1.09 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.799 3.0 . . . . 0.0 111.189 171.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 m -63.45 -21.35 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.04 158.03 34.04 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.896 0.878 . . . . 0.0 110.699 160.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -118.36 136.5 53.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.126 2.17 . . . . 0.0 105.958 163.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.07 147.53 41.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.182 2.193 . . . . 0.0 105.637 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.4 pt -140.9 142.67 29.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.779 1.231 . . . . 0.0 107.987 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.21 167.3 27.76 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 123.892 0.745 . . . . 0.0 111.658 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -72.22 79.09 0.97 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.892 0.877 . . . . 0.0 110.088 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -76.45 129.63 79.28 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 162.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -68.45 167.8 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.053 1.835 . . . . 0.0 109.832 175.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.36 -42.56 61.41 Favored 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 123.595 0.758 . . . . 0.0 110.245 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -75.14 -2.34 27.28 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.758 1.223 . . . . 0.0 111.505 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -112.13 -49.56 2.96 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 125.845 1.658 . . . . 0.0 109.221 172.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.0 tt -52.04 -66.44 0.38 Allowed 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 127.2 2.2 . . . . 0.0 110.418 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -63.55 -20.65 65.81 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.69 1.196 . . . . 0.0 111.952 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.67 -48.09 41.98 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.533 1.06 . . . . 0.0 110.665 172.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -59.49 -51.16 71.04 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.928 0.891 . . . . 0.0 110.223 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 mt -75.04 -5.36 43.65 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 126.129 1.771 . . . . 0.0 112.753 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.62 -26.71 34.56 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 124.541 1.136 . . . . 0.0 111.632 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -6.49 9.14 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.802 1.241 . . . . 0.0 113.657 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.62 -14.14 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 162.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.05 -7.86 59.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.211 -0.931 . . . . 0.0 112.249 170.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 C--O 1.247 0.956 0 C-N-CA 127.398 2.279 . . . . 0.0 108.154 158.858 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.2 m -149.78 153.03 36.17 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 120.018 -1.677 . . . . 0.0 107.743 168.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.3 mtt -138.19 -175.2 4.02 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.588 1.955 . . . . 0.0 109.44 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.7 m -151.83 154.54 36.38 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 171.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.7 mt -140.33 169.53 17.5 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.029 0.932 . . . . 0.0 109.652 -159.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.0 p -112.42 -105.63 0.38 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 167.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -126.06 -64.72 1.03 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.095 2.158 . . . . 0.0 108.932 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.63 -30.63 61.29 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.764 -0.585 . . . . 0.0 112.075 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.04 -22.59 59.5 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.163 -0.446 . . . . 0.0 111.254 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -64.06 -58.7 5.89 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.841 0.746 . . . . 0.0 109.829 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -59.59 -34.98 73.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.833 0.453 . . . . 0.0 110.978 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -62.82 -53.31 56.27 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.901 -0.499 . . . . 0.0 110.685 171.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.95 -43.99 97.92 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.423 0.689 . . . . 0.0 111.654 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 pt -59.95 -23.59 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -11.06 60.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.542 0.737 . . . . 0.0 111.85 177.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.06 131.19 48.28 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 174.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -87.0 35.65 0.7 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.635 0.774 . . . . 0.0 112.702 -165.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -142.13 179.93 19.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.398 1.475 . . . . 0.0 110.238 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.57 93.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.296 3.331 . . . . 0.0 111.585 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.0 t -100.34 126.42 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 127.35 2.26 . . . . 0.0 106.078 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 tp -126.77 120.92 30.51 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.866 -0.521 . . . . 0.0 110.275 -167.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -100.4 133.65 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 118.698 0.681 . . . . 0.0 109.92 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -93.2 107.86 19.59 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 159.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -82.7 111.96 19.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 162.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -119.71 -174.36 2.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -147.6 161.42 41.18 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 121.394 -0.817 . . . . 0.0 111.508 168.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.83 6.38 0.24 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.433 1.493 . . . . 0.0 115.02 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.42 ' CG ' ' N ' ' A' ' 29' ' ' CYS . 3.5 p90 -124.31 -66.72 0.96 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 163.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 28' ' ' TRP . 16.4 t 36.16 -91.52 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 129.896 3.278 . . . . 0.0 114.614 175.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.66 -91.54 0.56 Allowed Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.624 1.583 . . . . 0.0 111.074 -172.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.07 -19.24 68.5 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.99 3.127 . . . . 0.0 115.066 -168.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 p -51.51 -35.21 39.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.83 0.741 . . . . 0.0 111.722 165.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -66.13 -14.26 61.5 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.547 1.067 . . . . 0.0 112.54 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.8 mtp -105.57 -15.58 14.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.295 1.838 . . . . 0.0 111.407 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.6 ttt -93.95 -34.93 12.88 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 126.322 1.849 . . . . 0.0 109.227 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.26 -50.62 63.21 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.651 1.58 . . . . 0.0 113.02 171.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.91 -35.48 55.29 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 122.127 1.796 . . . . 0.0 111.815 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -61.79 -39.82 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 118.809 0.731 . . . . 0.0 110.079 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.6 mp -68.3 -32.09 71.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.936 2.094 . . . . 0.0 112.211 174.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -68.5 -49.87 56.42 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.026 0.931 . . . . 0.0 108.957 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.422 ' CD ' ' HZ1' ' A' ' 93' ' ' LYS . 37.3 mt-10 -56.51 -47.7 78.79 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.277 0.56 . . . . 0.0 110.274 172.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -58.18 -42.98 87.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.646 1.178 . . . . 0.0 111.051 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.27 59.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.367 1.067 . . . . 0.0 110.218 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -52.61 -45.87 66.76 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.503 0.592 . . . . 0.0 110.589 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.82 -10.68 58.18 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -139.09 3.72 2.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -168.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -24.32 -52.96 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 129.318 3.047 . . . . 0.0 116.258 -158.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . 0.27 2.8 m-20 -125.32 10.7 8.03 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -70.68 -26.63 63.52 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 119.556 1.071 . . . . 0.0 108.665 158.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.79 174.32 12.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 126.12 1.768 . . . . 0.0 110.023 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.262 0.7 OUTLIER -137.51 112.71 9.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 159.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.04 159.17 2.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.228 0.537 . . . . 0.0 109.897 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.2 171.86 15.77 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.57 0.748 . . . . 0.0 109.177 172.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -139.69 131.49 27.52 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -170.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.43 151.25 33.7 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -85.12 115.7 23.07 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.441 1.896 . . . . 0.0 108.494 -178.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 p -64.99 -24.14 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.254 1.022 . . . . 0.0 113.017 -172.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.08 63.7 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.396 1.478 . . . . 0.0 109.988 174.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -65.06 -32.67 74.5 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.079 1.351 . . . . 0.0 111.947 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -110.08 87.32 5.81 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.206 1.002 . . . . 0.0 111.633 -174.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.61 -25.68 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.151 2.567 . . . . 0.0 114.445 170.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.493 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -73.22 137.89 45.26 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 120.49 1.495 . . . . 0.0 109.481 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.293 49.3 m 67.53 -23.97 0.12 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 129.495 3.118 . . . . 0.0 111.751 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.493 ' H ' ' C ' ' A' ' 62' ' ' GLU . 41.2 m -63.76 -71.9 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 127.917 2.487 . . . . 0.0 110.153 169.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -64.55 -28.4 69.61 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -59.0 -24.68 62.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.334 1.854 . . . . 0.0 111.856 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -120.91 13.51 11.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.85 1.26 . . . . 0.0 111.257 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.85 25.01 71.73 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 121.341 -0.849 . . . . 0.0 113.514 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.2 mm -68.21 93.89 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.99 1.316 . . . . 0.0 110.167 -171.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -128.37 -13.22 4.96 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.101 1.36 . . . . 0.0 112.063 171.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.7 t -81.84 53.24 2.12 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.994 1.318 . . . . 0.0 111.457 -173.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.7 pt -70.84 153.03 95.01 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.188 0.995 . . . . 0.0 112.343 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.92 129.92 7.82 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 CA-C-N 119.087 0.71 . . . . 0.0 110.506 -8.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.7 m -112.83 141.85 46.17 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.4 tt -133.19 105.26 6.91 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.6 mt -109.12 128.86 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.1 110.83 22.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 169.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -103.18 156.53 17.64 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.543 1.137 . . . . 0.0 109.462 170.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 127.16 11.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 163.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.84 27.39 59.21 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 118.321 0.51 . . . . 0.0 113.523 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.38 -12.58 69.35 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.959 1.743 . . . . 0.0 113.763 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -90.6 118.36 68.64 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 119.366 1.583 . . . . 0.0 109.689 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 85.01 1.18 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.582 2.855 . . . . 0.0 109.72 171.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -64.82 -38.82 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.344 1.057 . . . . 0.0 111.995 -176.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -142.28 156.05 45.26 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.483 1.038 . . . . 0.0 110.684 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.99 135.48 32.77 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.856 1.663 . . . . 0.0 107.952 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -122.01 146.71 46.9 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.356 2.262 . . . . 0.0 106.797 174.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.3 pt -143.23 119.17 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 124.598 1.159 . . . . 0.0 109.233 -169.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.9 170.57 41.63 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.491 1.52 . . . . 0.0 110.798 -169.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -66.44 93.12 0.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.868 1.267 . . . . 0.0 110.43 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -74.63 131.77 79.26 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 168.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.47 166.57 21.31 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.584 1.522 . . . . 0.0 109.593 165.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.422 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -54.56 -47.48 73.2 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -177.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.1 -15.11 20.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.53 2.332 . . . . 0.0 113.181 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -101.35 -56.05 2.39 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 125.418 1.487 . . . . 0.0 108.703 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.48 -58.07 8.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.593 1.957 . . . . 0.0 109.782 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -26.94 68.61 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.247 1.019 . . . . 0.0 110.946 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.34 -44.87 42.87 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.505 1.048 . . . . 0.0 110.714 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -49.73 76.57 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.255 1.022 . . . . 0.0 109.967 172.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.83 -2.52 57.85 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.464 ' C ' ' H ' ' A' ' 103' ' ' VAL . . . -49.18 -34.45 14.54 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 119.429 1.013 . . . . 0.0 110.42 168.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.6 29.02 0.08 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.562 2.345 . . . . 0.0 112.16 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.464 ' H ' ' C ' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -154.35 -24.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.9 2.08 . . . . 0.0 111.204 158.657 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.15 -10.84 59.73 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.978 0.911 . . . . 0.0 112.343 172.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.258 0 C-N-CA 127.195 2.198 . . . . 0.0 109.167 165.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 118.844 -0.598 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . 0.268 6.1 t 54.91 -162.8 0.14 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.548 1.939 . . . . 0.0 115.059 159.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . 0.289 13.2 ttt 137.24 -136.54 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 1 C-N-CA 135.283 5.433 . . . . 0.0 106.673 179.075 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.4 m -56.43 137.24 53.31 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.682 1.593 . . . . 0.0 112.672 -168.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tp -90.63 175.23 7.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.153 1.781 . . . . 0.0 111.403 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.5 p -130.35 178.29 6.7 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 159.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -58.4 -57.99 10.47 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.614 1.566 . . . . 0.0 110.466 169.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.01 79.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.668 -0.645 . . . . 0.0 110.699 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -84.15 -19.32 34.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.949 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -58.74 -56.58 20.35 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 167.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -63.18 -46.07 88.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.748 0.819 . . . . 0.0 109.715 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.593 HE21 ' NE2' ' A' ' 15' ' ' GLN . 9.5 tp60 -63.47 -30.62 71.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.945 0.793 . . . . 0.0 112.336 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.22 -60.48 2.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.422 1.01 . . . . 0.0 110.048 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.37 -10.04 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.593 ' NE2' HE21 ' A' ' 12' ' ' GLN . 20.9 pt20 -46.58 -36.1 6.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.502 1.521 . . . . 0.0 112.818 -174.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.85 113.85 1.66 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 124.131 0.872 . . . . 0.0 112.808 165.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -152.56 -102.89 0.05 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 164.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.74 -138.13 6.37 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.545 1.545 . . . . 0.0 111.742 -168.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.75 85.87 0.92 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.371 3.381 . . . . 0.0 113.05 -167.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.3 t -97.26 140.32 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 170.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.19 124.43 20.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 O-C-N 121.689 -0.632 . . . . 0.0 109.411 164.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.92 142.44 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 172.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.8 89.27 3.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.502 1.144 . . . . 0.0 108.983 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -76.19 114.58 15.02 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.614 1.166 . . . . 0.0 109.27 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 16.4 p-90 -127.93 -171.52 2.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 168.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.77 160.38 41.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.082 -1.011 . . . . 0.0 110.393 169.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.6 -29.17 64.28 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.568 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.61 -26.95 16.87 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 p -71.66 164.98 24.93 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.221 0.919 . . . . 0.0 113.438 -159.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.84 -82.36 1.4 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.279 1.418 . . . . 0.0 112.653 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -60.7 -20.96 67.84 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.466 2.778 . . . . 0.0 113.077 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 17.7 p -59.21 -27.28 65.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.148 172.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.3 mtt85 -76.61 -12.76 60.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 120.477 1.489 . . . . 0.0 112.864 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 86.7 mtp -95.09 -33.0 12.84 Favored 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 124.843 1.257 . . . . 0.0 110.296 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.6 ttt -78.0 -36.18 49.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.416 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.67 -51.8 66.55 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.198 -1.382 . . . . 0.0 112.203 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.83 -38.14 40.85 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 121.735 1.655 . . . . 0.0 111.848 171.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.78 -14.36 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 119.576 1.08 . . . . 0.0 112.163 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.38 -16.36 18.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 128.669 2.788 . . . . 0.0 111.816 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.36 -40.7 29.56 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.672 1.123 . . . . 0.0 109.449 168.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -52.41 -51.02 61.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.739 0.816 . . . . 0.0 109.034 163.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.449 ' CD1' ' HE2' ' A' ' 93' ' ' LYS . 2.3 t80 -57.93 -48.77 78.95 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-O 118.652 -0.689 . . . . 0.0 110.889 177.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.81 -59.82 3.03 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.95 1.3 . . . . 0.0 109.63 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -60.21 -44.7 94.94 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 124.806 1.316 . . . . 0.0 111.343 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.56 -15.09 2.49 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.652 1.181 . . . . 0.0 113.939 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.97 35.37 1.75 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.46 1.104 . . . . 0.0 112.713 174.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.79 -37.54 8.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.83 1.652 . . . . 0.0 115.195 -165.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.4 7.74 4.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.737 1.215 . . . . 0.0 111.362 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -83.99 -27.13 28.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.719 1.607 . . . . 0.0 110.554 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.97 171.63 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.819 1.248 . . . . 0.0 108.788 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.306 6.6 t -110.49 85.95 2.21 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 123.529 1.633 . . . . 0.0 108.631 164.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -70.02 154.95 7.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.409 163.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.55 120.41 3.93 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.085 169.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -94.0 146.47 23.91 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.073 0.233 . . . . 0.0 111.405 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.97 154.51 35.12 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.638 0.732 . . . . 0.0 112.082 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -86.31 96.39 9.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.597 1.959 . . . . 0.0 107.885 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.1 p -66.22 -20.3 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 121.371 -0.831 . . . . 0.0 113.068 -167.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.5 -28.46 63.45 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.97 1.708 . . . . 0.0 111.676 170.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -109.44 -16.83 13.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.446 2.298 . . . . 0.0 111.821 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -112.53 79.67 3.22 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.217 1.807 . . . . 0.0 110.85 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.57 -88.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.572 2.848 . . . . 0.0 109.984 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 46.74 -17.12 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 131.344 3.858 . . . . 0.0 121.206 167.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.8 m 178.2 -25.43 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 130.806 3.642 . . . . 0.0 110.782 -171.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.2 m -44.39 -61.55 1.48 Allowed 'General case' 0 N--CA 1.458 -0.075 0 C-N-CA 127.574 2.35 . . . . 0.0 110.621 173.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -57.94 -45.66 86.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.777 0.831 . . . . 0.0 109.659 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -60.44 -28.12 68.04 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.075 1.35 . . . . 0.0 112.949 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -112.45 12.08 19.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.915 0.779 . . . . 0.0 111.571 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.33 24.58 74.96 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 121.334 -0.854 . . . . 0.0 114.203 173.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.8 mm -80.82 46.54 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 126.79 2.036 . . . . 0.0 111.269 -167.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.0 ttt -83.39 -8.25 59.43 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.237 -0.914 . . . . 0.0 110.17 162.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.2 p -75.77 16.52 0.39 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.251 2.22 . . . . 0.0 115.054 -164.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.4 pt -61.31 145.49 90.35 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.001 0.92 . . . . 0.0 112.361 -165.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.57 135.53 29.29 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 118.25 0.411 . . . . 0.0 111.544 -1.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.6 m -133.44 140.6 47.39 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.049 0.94 . . . . 0.0 110.075 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt -135.65 99.13 4.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.028 1.731 . . . . 0.0 106.757 -170.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.8 mt -95.17 130.56 43.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.46 123.28 35.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 171.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -113.82 148.45 36.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 172.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -152.36 154.71 36.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 163.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.53 15.47 1.25 Allowed Glycine 0 CA--C 1.541 1.713 0 N-CA-C 117.134 1.614 . . . . 0.0 117.134 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.83 15.88 38.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-N 119.69 1.745 . . . . 0.0 112.995 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -134.97 128.0 18.49 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.195 1.398 . . . . 0.0 109.555 -167.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.83 87.32 1.41 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.914 3.076 . . . . 0.0 109.646 171.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 m -63.75 -36.3 76.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 O-C-N 121.503 -0.748 . . . . 0.0 112.456 -174.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 167.05 31.57 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 122.905 0.482 . . . . 0.0 111.106 170.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -134.66 134.06 40.74 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.3 1.84 . . . . 0.0 107.881 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -106.49 149.72 26.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.801 1.64 . . . . 0.0 107.529 167.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 pt -143.32 144.18 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.398 1.479 . . . . 0.0 107.831 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.81 169.52 19.03 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.947 0.784 . . . . 0.0 112.796 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -72.74 73.82 1.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.553 1.541 . . . . 0.0 111.167 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -75.28 136.03 72.51 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 165.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.36 166.01 29.76 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.202 1.935 . . . . 0.0 110.863 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.449 ' HE2' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -49.46 -50.61 40.42 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.68 1.192 . . . . 0.0 111.865 -177.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -52.63 -33.73 48.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.226 1.41 . . . . 0.0 112.964 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.459 HE22 ' NE2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -83.59 -47.83 10.87 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 tt -61.03 -56.84 16.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.433 1.493 . . . . 0.0 110.338 -175.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -55.66 -33.56 64.19 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.456 1.502 . . . . 0.0 110.337 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.86 -50.22 17.79 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 118.232 0.469 . . . . 0.0 110.268 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.459 ' NE2' HE22 ' A' ' 95' ' ' GLN . 1.9 tp-100 -59.62 -41.06 89.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.553 0.741 . . . . 0.0 110.82 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.87 -0.02 54.26 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.365 1.466 . . . . 0.0 113.108 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.53 -27.5 16.78 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.236 1.015 . . . . 0.0 113.332 -174.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.38 0.16 1.6 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.372 1.442 . . . . 0.0 113.686 176.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.273 0.4 OUTLIER -129.97 4.17 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 161.262 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.81 -13.59 16.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.242 1.017 . . . . 0.0 112.13 171.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.896 2.078 . . . . 0.0 109.964 170.304 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -156.37 174.36 15.52 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 120.225 -1.547 . . . . 0.0 111.436 -175.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.4 mtp -148.84 169.92 19.42 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.607 1.963 . . . . 0.0 108.885 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.1 m -62.46 148.97 43.99 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 159.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.3 tp -119.62 162.99 18.04 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.118 0.967 . . . . 0.0 110.276 -173.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.435 ' H ' ' HB2' ' A' ' 9' ' ' ASN . 67.2 p -130.15 -100.97 0.31 Allowed 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 170.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -133.73 -71.18 0.51 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.273 1.429 . . . . 0.0 110.123 -158.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.01 -42.28 37.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.499 0.72 . . . . 0.0 110.253 163.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.435 ' HB2' ' H ' ' A' ' 6' ' ' THR . 72.3 m-80 -69.74 -26.95 64.56 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.327 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -61.51 -67.06 0.44 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.051 0.841 . . . . 0.0 109.028 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -63.21 -35.8 81.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 121.482 -0.087 . . . . 0.0 110.843 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.91 -8.0 56.58 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 118.228 -0.892 . . . . 0.0 113.144 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.95 -49.21 5.9 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 120.36 1.437 . . . . 0.0 110.784 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.3 pt -59.94 -19.38 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -174.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -17.73 60.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.446 1.498 . . . . 0.0 113.686 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.59 146.19 48.18 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 119.175 0.898 . . . . 0.0 111.259 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -76.4 -23.36 54.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.321 1.048 . . . . 0.0 113.658 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.57 -174.26 40.0 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.132 0.872 . . . . 0.0 112.571 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.72 87.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.506 3.47 . . . . 0.0 111.86 172.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.68 138.1 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 162.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.47 163.0 39.02 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.742 -0.599 . . . . 0.0 110.318 168.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.41 126.87 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 123.994 0.918 . . . . 0.0 108.672 -173.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -80.13 114.88 19.37 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 158.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -100.03 108.88 21.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 25.5 p-90 -125.2 179.43 5.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.287 1.435 . . . . 0.0 107.249 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.25 162.73 40.71 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.496 1.118 . . . . 0.0 109.815 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.85 -9.27 50.48 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -16.38 5.6 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -174.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.4 p -74.4 38.13 0.11 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -159.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 37.62 -102.98 0.02 OUTLIER Glycine 0 CA--C 1.54 1.614 0 C-N-CA 127.665 2.555 . . . . 0.0 114.344 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.93 -17.77 39.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.015 3.144 . . . . 0.0 115.131 -175.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.2 p -53.27 -36.7 61.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.502 1.046 . . . . 0.0 111.323 168.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.2 ttt-85 -67.36 -8.85 35.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.204 1.002 . . . . 0.0 112.545 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 64.8 mtm -107.34 -14.74 14.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.503 1.521 . . . . 0.0 112.473 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.5 ttt -96.55 -36.41 10.77 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.633 1.173 . . . . 0.0 109.428 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.15 -47.81 86.82 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.648 1.179 . . . . 0.0 112.162 174.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.81 -31.28 48.58 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 121.995 1.748 . . . . 0.0 112.699 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.8 -33.74 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 119.437 1.017 . . . . 0.0 110.567 173.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -31.04 62.14 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.184 1.794 . . . . 0.0 111.614 173.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -71.15 -40.18 71.48 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.431 1.014 . . . . 0.0 109.613 172.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -62.58 -43.29 99.17 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 171.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -56.47 -42.7 78.67 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.286 1.035 . . . . 0.0 111.633 172.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.81 -55.12 36.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.183 0.993 . . . . 0.0 110.565 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.38 -47.54 72.55 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.548 1.139 . . . . 0.0 110.097 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.26 -13.69 60.8 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -133.98 17.22 3.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.567 1.076 . . . . 0.0 113.147 -173.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.75 -31.95 5.36 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.846 2.058 . . . . 0.0 115.469 -159.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -124.06 -3.28 8.09 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.963 0.905 . . . . 0.0 113.383 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.425 ' HZ3' ' C ' ' A' ' 105' ' ' GLN . 28.6 ttmt -78.63 -39.05 38.23 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.99 1.268 . . . . 0.0 110.436 166.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 m -124.45 166.45 19.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.302 5.6 t -120.63 91.59 3.57 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.415 1.102 . . . . 0.0 108.501 172.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 p -98.54 116.61 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 125.065 1.346 . . . . 0.0 110.99 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.38 98.13 5.32 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.311 -159.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.1 140.82 49.1 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.873 -173.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pp -153.67 167.69 28.72 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 124.423 1.077 . . . . 0.0 112.758 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -95.97 112.05 23.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.914 1.686 . . . . 0.0 109.388 -173.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.72 -23.67 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.314 0.645 . . . . 0.0 111.967 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -75.42 -3.04 31.48 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.452 1.501 . . . . 0.0 111.776 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -135.26 -38.59 0.76 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.708 2.003 . . . . 0.0 111.743 -166.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -88.33 119.03 70.13 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 118.95 0.795 . . . . 0.0 109.513 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -90.55 -21.54 0.81 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.504 2.803 . . . . 0.0 113.804 164.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 64' ' ' THR . 7.5 tp10 -61.4 111.74 1.9 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.306 1.442 . . . . 0.0 112.002 -170.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m 68.75 -30.58 0.18 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.625 2.77 . . . . 0.0 111.851 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.479 ' H ' ' C ' ' A' ' 62' ' ' GLU . 57.5 m -51.73 -51.35 56.85 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 128.49 2.716 . . . . 0.0 110.463 171.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.5 t -57.73 -50.14 74.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.355 0.662 . . . . 0.0 110.191 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.3 tp60 -56.62 -44.5 81.25 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.693 0.797 . . . . 0.0 111.9 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -88.61 11.54 17.11 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 119.138 -0.458 . . . . 0.0 112.028 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.61 29.31 71.45 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 124.413 1.006 . . . . 0.0 112.391 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.3 mm -79.97 82.0 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.138 0.975 . . . . 0.0 109.579 -162.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.0 ttm -123.42 -6.02 8.2 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.657 1.583 . . . . 0.0 111.111 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.2 t -83.16 26.17 0.65 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.679 1.192 . . . . 0.0 113.744 -167.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.86 151.46 89.16 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -165.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.8 129.84 10.76 Favored 'Cis proline' 0 C--N 1.353 0.784 0 CA-C-N 119.379 0.814 . . . . 0.0 111.44 2.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.8 m -121.37 152.68 38.73 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.0 tt -132.37 130.32 40.54 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 171.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.3 mt -120.78 132.62 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 167.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.47 141.0 28.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.795 2.038 . . . . 0.0 105.982 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -142.52 161.89 36.89 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.993 2.117 . . . . 0.0 111.346 -175.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.74 153.34 14.66 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.203 1.801 . . . . 0.0 108.776 158.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.68 15.69 54.47 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.676 1.131 . . . . 0.0 114.536 167.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.16 -10.36 71.72 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.24 1.4 . . . . 0.0 112.837 -175.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -97.55 159.73 30.4 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 118.729 1.265 . . . . 0.0 109.181 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -69.76 -175.46 1.16 Allowed 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 122.5 2.133 . . . . 0.0 111.193 159.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.07 -46.45 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.309 1.843 . . . . 0.0 108.738 159.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.436 ' HZ3' ' CG ' ' A' ' 102' ' ' ASP . 75.9 mttt -145.57 148.01 32.71 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.665 1.186 . . . . 0.0 107.973 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -117.32 131.99 56.69 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 163.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -125.48 141.03 52.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.1 141.18 29.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 124.022 0.929 . . . . 0.0 108.799 -170.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.18 164.87 39.6 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.586 1.089 . . . . 0.0 111.42 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.58 78.58 2.58 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.3 0.571 . . . . 0.0 110.006 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -71.01 133.82 85.8 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.23 167.58 21.68 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.874 1.716 . . . . 0.0 111.367 176.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -44.78 73.9 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.081 1.352 . . . . 0.0 110.792 -172.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -51.33 -44.9 62.11 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.69 2.396 . . . . 0.0 111.063 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -42.59 53.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.1 1.76 . . . . 0.0 108.049 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -61.74 2.11 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.655 1.582 . . . . 0.0 108.827 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.78 -39.09 83.72 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.585 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.41 82.78 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.267 1.394 . . . . 0.0 111.713 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -78.0 -21.75 50.37 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.16 -1.78 13.58 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.467 1.107 . . . . 0.0 112.808 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.38 -36.19 42.16 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.776 1.63 . . . . 0.0 112.604 -175.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.436 ' CG ' ' HZ3' ' A' ' 85' ' ' LYS . 10.1 p-10 -64.31 -11.29 30.58 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.182 1.393 . . . . 0.0 114.091 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.81 -8.5 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 119.459 1.027 . . . . 0.0 112.071 168.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.27 -10.25 26.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.392 1.477 . . . . 0.0 112.899 175.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.425 ' C ' ' HZ3' ' A' ' 49' ' ' LYS . 10.7 tt0 . . . . . 0 C--O 1.246 0.899 0 C-N-CA 126.167 1.787 . . . . 0.0 110.212 172.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.476 ' HA ' ' HB ' ' A' ' 51' ' ' THR . . . . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.0 m -51.93 127.06 20.07 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.139 1.376 . . . . 0.0 112.846 -170.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.1 ptm -164.45 -179.89 6.3 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.516 1.526 . . . . 0.0 109.613 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -69.4 154.56 41.84 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.179 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 tp -123.84 159.68 29.07 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.842 0.83 . . . . 0.0 111.226 -177.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.3 m -166.89 170.59 12.07 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.871 3.668 . . . . 0.0 101.958 172.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -43.38 -59.85 1.95 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 128.725 2.81 . . . . 0.0 112.781 -166.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.05 91.66 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.319 0.58 . . . . 0.0 111.189 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -72.07 -21.79 61.46 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.139 -0.458 . . . . 0.0 111.777 -177.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.26 -60.02 3.98 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -60.53 -46.06 91.55 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.442 -0.789 . . . . 0.0 111.184 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -62.67 -26.31 68.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.314 0.961 . . . . 0.0 112.71 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.94 -63.47 1.25 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.066 0.848 . . . . 0.0 109.485 165.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 pt -66.95 -13.52 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -166.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -58.54 -20.74 48.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.993 1.317 . . . . 0.0 113.975 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.43 -112.14 0.26 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 107.849 -2.1 . . . . 0.0 107.849 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 t0 62.4 -12.83 0.07 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 130.039 3.336 . . . . 0.0 117.677 158.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.83 -166.85 16.89 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.512 1.053 . . . . 0.0 111.889 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -55.66 101.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.946 3.098 . . . . 0.0 111.235 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -94.77 140.83 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 108.361 -175.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -130.43 143.14 50.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 173.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.69 108.3 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 63.3 t0 -75.91 98.52 4.24 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.41 ' CE1' HG22 ' A' ' 69' ' ' ILE . 78.0 m-85 -84.3 105.53 15.21 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -124.8 -177.15 3.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.96 162.09 41.48 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.222 -0.924 . . . . 0.0 110.552 171.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.35 -5.42 2.43 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.66 -20.96 10.99 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.591 1.087 . . . . 0.0 113.765 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.9 p -73.83 161.67 29.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.912 1.233 . . . . 0.0 110.347 -173.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.78 -84.86 1.74 Allowed Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.559 -0.579 . . . . 0.0 112.552 -173.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.15 -16.55 55.52 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.339 2.693 . . . . 0.0 113.448 -171.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.0 p -49.78 -40.84 42.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.848 0.859 . . . . 0.0 111.586 166.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -12.35 61.55 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.145 0.578 . . . . 0.0 112.257 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.5 mtm -100.99 -15.73 17.38 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.322 1.449 . . . . 0.0 112.057 173.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.8 ttt -85.32 -42.62 14.43 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 125.485 1.514 . . . . 0.0 108.444 172.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.09 -50.4 36.99 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.359 -1.305 . . . . 0.0 113.419 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.14 -36.1 30.52 Favored 'Trans proline' 0 C--N 1.353 0.766 0 CA-C-N 121.845 1.695 . . . . 0.0 112.17 173.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.97 -35.48 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.306 0.957 . . . . 0.0 110.304 173.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.84 -17.55 57.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.631 1.973 . . . . 0.0 111.847 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.26 -48.86 18.73 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 167.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -61.55 -26.18 67.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.602 0.761 . . . . 0.0 111.33 173.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -65.25 -63.19 1.16 Allowed 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 125.182 1.393 . . . . 0.0 107.879 170.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.77 -46.16 67.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.173 -0.442 . . . . 0.0 112.046 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.93 -34.79 56.94 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.245 1.418 . . . . 0.0 111.781 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.91 -14.45 61.06 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -162.18 63.38 0.23 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.341 1.456 . . . . 0.0 108.995 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.66 71.39 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -166.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -131.74 -1.31 3.82 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -168.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -64.46 -39.63 94.19 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.928 1.24 . . . . 0.0 108.866 161.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.01 170.9 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.697 1.199 . . . . 0.0 108.094 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 1' ' ' ALA . 2.6 t -128.41 74.81 1.58 Allowed 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 123.989 1.852 . . . . 0.0 106.556 177.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 p -82.78 160.34 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.787 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.67 174.11 15.05 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.185 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 28.1 mttp -131.99 144.39 50.76 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 123.331 0.653 . . . . 0.0 110.509 176.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.97 163.4 39.77 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.788 1.305 . . . . 0.0 114.297 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -91.45 105.33 17.68 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.101 1.76 . . . . 0.0 108.716 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.94 -21.78 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.664 0.786 . . . . 0.0 112.669 -172.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -67.69 -22.43 65.28 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.303 1.041 . . . . 0.0 111.612 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -114.09 -21.64 10.43 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.744 2.017 . . . . 0.0 111.829 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -100.32 94.23 3.23 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.235 1.414 . . . . 0.0 109.924 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.19 -27.74 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.038 2.492 . . . . 0.0 113.524 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -74.84 103.76 5.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.275 0.943 . . . . 0.0 110.751 -172.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m 104.88 -32.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 130.868 3.667 . . . . 0.0 109.471 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -52.82 -52.82 55.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.888 1.275 . . . . 0.0 109.714 167.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 t -70.9 -7.43 45.7 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.228 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -87.73 -33.22 18.78 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.998 1.272 . . . . 0.0 111.12 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -120.12 2.41 10.92 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.62 38.34 51.25 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 119.134 0.879 . . . . 0.0 111.801 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.41 HG22 ' CE1' ' A' ' 24' ' ' PHE . 39.3 mm -75.51 83.67 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.973 1.309 . . . . 0.0 110.498 -166.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -119.58 -6.55 10.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.058 1.343 . . . . 0.0 112.544 172.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 m -77.14 34.41 0.16 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.929 2.092 . . . . 0.0 113.362 -168.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.0 pt -74.76 151.06 86.7 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -162.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.88 130.65 12.23 Favored 'Cis proline' 0 C--N 1.351 0.685 0 CA-C-N 119.047 0.695 . . . . 0.0 110.745 -3.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -119.07 144.12 46.76 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.6 tp -132.36 113.92 13.75 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mt -111.42 142.9 22.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.99 118.56 37.02 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.762 2.025 . . . . 0.0 106.875 -176.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -130.72 176.38 8.24 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.239 1.016 . . . . 0.0 110.433 175.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.88 145.83 17.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 158.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 37.61 41.79 0.89 Allowed Glycine 0 CA--C 1.54 1.637 0 N-CA-C 115.974 1.15 . . . . 0.0 115.974 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.29 -12.63 68.67 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.77 1.652 . . . . 0.0 115.545 177.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -95.43 120.52 63.63 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 120.601 2.2 . . . . 0.0 110.768 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.82 148.71 46.65 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.124 1.883 . . . . 0.0 109.487 163.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.94 -44.54 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.68 0.792 . . . . 0.0 111.914 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -159.56 171.62 19.31 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.72 1.145 . . . . 0.0 110.061 171.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.29 156.21 46.54 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.016 1.726 . . . . 0.0 110.133 -174.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.4 mt -137.01 139.54 41.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.04 134.23 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 -170.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.02 162.68 37.92 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.796 0.712 . . . . 0.0 111.63 -175.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -75.29 75.78 2.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.363 1.065 . . . . 0.0 110.923 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -75.31 140.43 72.72 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 167.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 170.13 19.46 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.592 2.195 . . . . 0.0 111.692 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.83 -46.39 41.98 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.006 1.323 . . . . 0.0 111.945 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -56.94 -43.75 81.84 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.913 1.285 . . . . 0.0 110.95 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.73 -36.49 70.48 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.403 0.681 . . . . 0.0 109.251 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -60.03 3.52 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.415 1.086 . . . . 0.0 108.552 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -62.35 -32.87 73.72 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.102 0.561 . . . . 0.0 110.377 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.74 -53.68 10.99 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.355 0.525 . . . . 0.0 111.009 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.5 -35.87 81.89 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 118.477 0.581 . . . . 0.0 111.089 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.63 -1.14 57.75 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.913 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -50.32 -31.33 14.15 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 125.224 1.41 . . . . 0.0 113.588 -172.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -22.64 58.6 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.399 1.08 . . . . 0.0 112.32 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.55 -8.25 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.809 0.844 . . . . 0.0 111.444 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.89 -10.4 28.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.19 1.396 . . . . 0.0 112.487 171.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 . . . . . 0 C--O 1.249 1.069 0 C-N-CA 126.104 1.761 . . . . 0.0 110.898 171.904 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 117.002 -1.475 . . . . 0.0 107.8 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.3 m -62.65 -61.09 2.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.311 1.414 . . . . 0.0 112.789 -168.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.4 ttp 48.56 -137.66 0.9 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.785 1.634 . . . . 0.0 110.22 -166.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.4 m -59.01 126.48 27.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.653 1.581 . . . . 0.0 113.34 -159.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.95 171.22 8.9 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.814 2.046 . . . . 0.0 111.207 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.0 t -131.78 -50.74 0.97 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.092 0.957 . . . . 0.0 111.53 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 174.27 -68.9 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 127.9 2.48 . . . . 0.0 105.179 171.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.67 -33.5 64.16 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.881 -0.512 . . . . 0.0 111.836 177.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -17.39 61.26 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 119.105 -0.474 . . . . 0.0 111.25 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.69 -64.45 0.89 Allowed 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.88 -44.42 94.21 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.974 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.8 -28.01 65.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.468 1.031 . . . . 0.0 113.013 -177.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.9 -58.9 2.68 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.974 0.91 . . . . 0.0 110.723 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.6 pt -62.08 -23.13 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.936 -171.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -57.71 -31.99 66.94 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.393 1.077 . . . . 0.0 111.688 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.5 102.08 0.15 Allowed Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -165.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -153.36 -69.55 0.15 Allowed 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 128.294 2.638 . . . . 0.0 105.539 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.46 -114.65 0.98 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 106.957 -2.457 . . . . 0.0 106.957 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.79 76.94 3.53 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.21 3.273 . . . . 0.0 112.564 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.96 130.14 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.87 113.89 26.17 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 159.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.09 125.01 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.1 94.73 5.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 124.12 0.888 . . . . 0.0 110.337 -174.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -83.08 109.27 16.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -126.93 175.02 8.38 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -140.14 150.2 43.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.773 0.715 . . . . 0.0 110.52 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.9 -26.26 58.69 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.764 0.825 . . . . 0.0 113.023 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.11 -25.88 16.96 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.0 p -69.75 157.64 36.93 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.372 0.987 . . . . 0.0 111.467 -160.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.75 -86.11 1.16 Allowed Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.318 -172.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.87 -18.83 66.73 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.13 2.553 . . . . 0.0 113.918 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 p -53.67 -35.47 61.1 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.24 0.473 . . . . 0.0 111.23 168.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -69.31 -16.42 63.55 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.381 -0.824 . . . . 0.0 112.336 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.78 -12.32 20.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.597 1.559 . . . . 0.0 112.119 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.8 ttt -93.14 -35.13 13.34 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 126.415 1.886 . . . . 0.0 108.773 175.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.82 -50.45 43.81 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.034 1.734 . . . . 0.0 112.894 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.05 -36.76 46.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 121.81 1.682 . . . . 0.0 111.585 172.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.02 -22.84 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 119.851 1.205 . . . . 0.0 111.314 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.81 -35.06 24.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.776 2.43 . . . . 0.0 111.8 175.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.12 -42.71 93.65 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 169.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -65.79 -15.41 62.85 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.306 1.443 . . . . 0.0 112.368 170.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -82.63 -47.82 11.64 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 120.636 -1.29 . . . . 0.0 109.214 170.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.55 81.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.551 1.14 . . . . 0.0 110.573 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -58.7 -53.12 61.98 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.575 0.75 . . . . 0.0 110.959 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.7 -14.67 54.3 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -162.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 51.39 0.79 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.369 1.868 . . . . 0.0 108.428 172.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.63 -14.02 7.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.412 1.085 . . . . 0.0 113.679 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -88.87 -51.28 5.72 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.596 2.358 . . . . 0.0 111.864 174.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -73.33 -16.73 61.35 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 117.439 -1.267 . . . . 0.0 112.244 -168.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.09 166.56 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 121.128 1.785 . . . . 0.0 113.102 -170.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.1 t -119.46 122.75 42.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.75 0.786 . . . . 0.0 109.146 159.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.97 152.13 5.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 158.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.35 99.7 3.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -95.14 143.38 26.62 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 122.783 0.433 . . . . 0.0 110.714 -169.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -141.73 145.36 34.75 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.299 0.571 . . . . 0.0 110.755 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -82.22 90.0 6.57 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 173.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.1 p -62.01 -15.04 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 125.275 1.43 . . . . 0.0 112.468 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -65.85 -20.0 66.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.809 2.444 . . . . 0.0 112.766 169.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -131.06 -23.43 2.46 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.067 2.147 . . . . 0.0 111.696 -167.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -116.28 77.85 7.71 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.402 1.881 . . . . 0.0 109.176 -169.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.92 -4.82 16.08 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.608 3.539 . . . . 0.0 116.675 -170.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.515 ' C ' ' H ' ' A' ' 64' ' ' THR . 5.6 tp10 -59.93 135.25 57.64 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.976 1.716 . . . . 0.0 109.979 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m 59.26 -14.64 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.925 3.29 . . . . 0.0 112.847 -176.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.515 ' H ' ' C ' ' A' ' 62' ' ' GLU . 96.9 m -63.44 -54.26 39.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 126.259 1.824 . . . . 0.0 109.221 -175.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -73.02 1.12 9.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.543 1.137 . . . . 0.0 112.704 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -107.01 -39.66 5.68 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.622 1.169 . . . . 0.0 110.627 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -104.27 5.24 34.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.587 1.155 . . . . 0.0 110.734 -176.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.81 38.67 49.28 Favored Glycine 0 C--N 1.343 0.941 0 C-N-CA 124.243 0.925 . . . . 0.0 112.158 174.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.9 mm -78.83 76.44 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.965 1.306 . . . . 0.0 109.734 -167.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 70.7 mtm -106.54 -14.88 14.93 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.935 1.294 . . . . 0.0 111.478 173.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.4 m -82.61 23.73 0.77 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.165 1.786 . . . . 0.0 114.022 -159.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.3 pt -71.31 155.79 92.47 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.317 1.047 . . . . 0.0 112.943 -158.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.74 127.86 5.64 Favored 'Cis proline' 0 C--N 1.352 0.711 0 CA-C-N 119.666 0.916 . . . . 0.0 110.687 -3.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -114.32 136.4 53.01 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 tt -131.72 92.99 3.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -174.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.7 mt -94.52 144.37 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tt -110.84 120.33 42.03 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -110.44 148.38 32.16 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -141.27 111.63 6.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 170.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 39.54 59.17 1.98 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.58 2.038 . . . . 0.0 112.942 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.66 -20.32 51.05 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.636 1.588 . . . . 0.0 114.03 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.74 109.41 59.36 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 119.452 1.626 . . . . 0.0 111.359 -166.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.31 92.78 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.855 3.037 . . . . 0.0 110.731 169.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 m -65.54 -40.78 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.582 -0.699 . . . . 0.0 112.644 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HZ1' ' CD2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -158.76 167.19 30.14 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.09 0.956 . . . . 0.0 110.248 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -136.11 133.21 37.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.905 2.082 . . . . 0.0 107.607 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.413 ' CD2' ' HZ1' ' A' ' 85' ' ' LYS . 3.1 mm? -101.12 154.2 18.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 158.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.3 pt -141.35 143.93 27.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 106.872 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.55 172.34 20.19 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 121.983 0.768 . . . . 0.0 112.191 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -74.75 79.62 2.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.934 0.894 . . . . 0.0 110.784 -176.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -72.36 127.69 89.82 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 161.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.41 163.55 36.14 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.712 1.608 . . . . 0.0 109.779 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -45.35 12.32 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.81 1.244 . . . . 0.0 111.041 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -59.92 -24.7 64.55 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.191 1.396 . . . . 0.0 113.908 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -100.12 -46.95 5.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.707 1.203 . . . . 0.0 108.624 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 tt -52.64 -62.93 1.33 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.873 2.069 . . . . 0.0 108.892 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -59.14 -34.92 72.63 Favored 'General case' 0 C--N 1.337 0.043 0 C-N-CA 125.025 1.33 . . . . 0.0 110.469 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.62 -42.04 71.44 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.064 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -41.89 85.41 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.411 0.55 . . . . 0.0 109.798 173.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.77 -4.04 25.45 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.958 1.703 . . . . 0.0 113.337 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.47 -25.07 9.16 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.842 1.257 . . . . 0.0 113.132 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -7.43 9.41 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 121.091 1.769 . . . . 0.0 113.975 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.49 -1.55 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 121.431 -0.793 . . . . 0.0 112.845 168.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -105.77 -10.98 16.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.44 1.096 . . . . 0.0 113.094 174.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 C--O 1.251 1.15 0 C-N-CA 127.017 2.127 . . . . 0.0 109.81 162.87 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 120.628 0.251 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.1 t -129.44 179.61 5.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.117 1.767 . . . . 0.0 107.33 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -52.46 -58.97 5.05 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.483 2.313 . . . . 0.0 111.735 -160.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.38 -16.32 60.13 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -102.22 -17.11 16.1 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.959 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -49.11 -55.8 11.11 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 125.203 1.401 . . . . 0.0 108.859 171.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -53.02 -54.54 33.84 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.307 1.843 . . . . 0.0 112.468 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -64.09 -20.93 66.31 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.125 0.57 . . . . 0.0 112.278 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.34 -64.18 1.16 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 167.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.3 pt -58.55 -25.72 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -62.53 -22.33 66.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.29 1.036 . . . . 0.0 113.406 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.12 149.51 51.21 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 119.12 0.873 . . . . 0.0 112.453 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -87.82 53.34 2.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.232 1.413 . . . . 0.0 110.193 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.76 165.9 35.9 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.66 101.09 0.16 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.192 3.261 . . . . 0.0 111.772 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.47 101.71 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 125.369 1.468 . . . . 0.0 107.973 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.46 HD22 HG13 ' A' ' 52' ' ' VAL . 4.9 tt -82.58 112.77 19.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 171.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.59 114.95 39.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.97 93.03 4.65 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -164.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 69' ' ' ILE . 52.8 m-85 -86.62 112.86 22.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.601 0.761 . . . . 0.0 109.758 -176.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 26.6 p-90 -124.54 -175.68 3.33 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 169.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.497 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -151.52 158.69 43.93 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.202 -0.936 . . . . 0.0 110.096 172.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.42 -1.27 0.5 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.215 1.806 . . . . 0.0 115.598 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.15 -18.96 1.75 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 26' ' ' ALA . 1.1 p -72.27 100.65 2.66 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.855 1.207 . . . . 0.0 111.519 -165.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -29.0 -61.81 0.14 Allowed Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.934 1.73 . . . . 0.0 115.067 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.31 -33.67 29.56 Favored 'Trans proline' 0 C--N 1.351 0.658 0 CA-C-N 120.273 2.036 . . . . 0.0 112.985 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.7 p -69.27 -30.35 68.44 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.795 1.179 . . . . 0.0 110.624 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -20.6 65.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.329 0.968 . . . . 0.0 111.654 172.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.1 mtp -99.85 -25.98 14.17 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.323 1.449 . . . . 0.0 111.878 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.7 ttt -81.48 -38.74 25.86 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.727 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.03 -50.73 61.17 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 120.703 1.592 . . . . 0.0 112.534 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.22 -33.25 40.22 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.598 1.532 . . . . 0.0 112.359 172.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.65 -36.63 77.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 120.13 1.332 . . . . 0.0 110.851 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 42' ' ' PHE . 54.2 mt -78.92 -6.47 56.27 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.921 2.489 . . . . 0.0 111.471 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.92 -48.52 13.29 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.738 1.215 . . . . 0.0 108.144 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -60.9 -43.41 98.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.853 0.461 . . . . 0.0 110.022 168.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.467 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 33.1 t80 -63.85 -20.13 65.58 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.543 173.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.92 -59.4 2.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 121.174 1.806 . . . . 0.0 108.668 166.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.16 -45.43 65.06 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.792 1.237 . . . . 0.0 111.838 -173.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.55 -23.91 29.35 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -169.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.32 36.69 0.83 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.037 1.335 . . . . 0.0 110.626 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.39 -23.42 3.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 -160.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.18 0.07 8.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.349 0.977 . . . . 0.0 112.841 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -76.58 -29.34 56.57 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.432 -0.792 . . . . 0.0 109.946 167.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.22 143.04 42.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 109.249 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.33 136.49 53.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 158.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.46 HG13 HD22 ' A' ' 21' ' ' LEU . 5.0 t -119.92 134.61 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 160.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.21 90.38 2.03 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -166.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -86.99 143.71 27.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.226 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 152.62 26.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.208 0.913 . . . . 0.0 113.263 171.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -76.45 107.04 8.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.246 1.818 . . . . 0.0 107.683 172.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' A' ' 26' ' ' ALA . 8.6 p -48.41 -43.53 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 126.738 2.015 . . . . 0.0 114.274 -165.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.45 -27.09 68.31 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.872 2.069 . . . . 0.0 112.492 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.4 -28.1 62.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.726 0.81 . . . . 0.0 111.406 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -115.48 83.75 11.21 Favored Pre-proline 0 N--CA 1.457 -0.125 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.53 -25.77 29.32 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.631 1.554 . . . . 0.0 112.207 170.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.71 118.44 7.13 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.47 1.108 . . . . 0.0 109.405 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.262 8.8 m 70.23 -20.01 0.2 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.606 2.362 . . . . 0.0 113.366 173.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.9 m -54.66 -55.73 26.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.58 1.952 . . . . 0.0 109.011 160.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.5 t -57.59 -41.57 81.44 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.291 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -62.75 -40.81 98.41 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.665 0.786 . . . . 0.0 112.949 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -96.27 16.56 17.98 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.713 0.688 . . . . 0.0 112.773 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.21 25.81 72.24 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 124.129 0.871 . . . . 0.0 112.523 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.542 HD12 HG21 ' A' ' 74' ' ' THR . 30.6 mm -82.14 70.02 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 122.576 1.179 . . . . 0.0 109.558 -165.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 53.3 ttp -120.37 0.78 10.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.739 1.616 . . . . 0.0 109.974 166.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.3 t -88.83 21.94 2.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.102 1.361 . . . . 0.0 112.985 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.451 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -59.45 144.61 83.95 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.529 0.732 . . . . 0.0 112.528 -168.011 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 62.6 Cg_endo -69.06 130.64 16.41 Favored 'Cis proline' 0 C--N 1.35 0.606 0 CA-C-N 119.01 0.682 . . . . 0.0 112.734 7.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.542 HG21 HD12 ' A' ' 69' ' ' ILE . 40.9 m -125.26 151.71 45.58 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.862 1.265 . . . . 0.0 108.82 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.2 tt -143.63 105.34 4.32 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -173.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.42 HD11 HD11 ' A' ' 69' ' ' ILE . 23.9 mt -101.1 143.82 13.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 171.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.25 115.89 28.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -113.63 163.39 15.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.827 1.651 . . . . 0.0 111.873 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.456 ' HE3' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -162.41 149.91 13.89 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.466 1.907 . . . . 0.0 107.337 158.202 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.03 14.67 47.0 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 119.155 0.889 . . . . 0.0 113.496 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.87 -5.99 82.24 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.436 1.494 . . . . 0.0 113.35 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -98.86 121.14 56.93 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 119.174 1.487 . . . . 0.0 110.189 -173.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.09 103.79 1.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.75 2.967 . . . . 0.0 110.048 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.456 HG21 ' HE3' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -71.29 -35.94 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 121.815 -0.553 . . . . 0.0 112.071 178.491 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -153.54 158.27 41.0 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.592 0.757 . . . . 0.0 110.669 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -147.44 125.22 11.88 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.744 2.018 . . . . 0.0 106.741 -172.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.8 mp -121.83 150.5 41.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.473 1.909 . . . . 0.0 106.802 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.9 pt -145.43 151.97 14.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.613 1.165 . . . . 0.0 109.344 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.12 167.63 24.65 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.404 1.002 . . . . 0.0 111.908 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -75.33 73.94 2.42 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.077 0.951 . . . . 0.0 110.855 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -70.06 138.3 87.33 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.62 163.53 38.63 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.403 2.069 . . . . 0.0 110.634 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.12 -44.8 61.4 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.982 1.313 . . . . 0.0 111.225 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.67 -15.32 63.41 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.093 0.957 . . . . 0.0 112.67 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -102.0 -44.57 5.44 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.208 0.913 . . . . 0.0 109.17 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.51 -59.32 5.63 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.106 1.762 . . . . 0.0 109.636 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -63.55 -24.73 67.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.054 0.843 . . . . 0.0 110.968 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.92 -51.52 15.85 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.854 0.752 . . . . 0.0 110.682 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -62.27 -43.3 99.15 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.7 0.8 . . . . 0.0 110.481 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 tp -78.77 -7.03 57.41 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.725 1.21 . . . . 0.0 112.744 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.07 -33.05 37.46 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.689 1.196 . . . . 0.0 111.085 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.16 11.87 0.1 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.803 2.041 . . . . 0.0 112.711 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.54 -11.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 119.451 -2.031 . . . . 0.0 113.187 158.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.07 -22.57 20.67 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.043 1.337 . . . . 0.0 112.047 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 . . . . . 0 C--O 1.251 1.134 0 C-N-CA 128.591 2.757 . . . . 0.0 110.202 175.613 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 10' ' ' PHE . 4.2 tp . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.797 0.332 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.4 p -146.03 172.27 13.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 128.703 2.801 . . . . 0.0 104.988 170.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -45.45 -61.2 1.78 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.517 2.327 . . . . 0.0 110.855 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.0 -31.95 71.54 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.692 -0.63 . . . . 0.0 112.182 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -78.03 -19.25 54.71 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.287 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.504 ' HA ' HD21 ' A' ' 5' ' ' LEU . 2.2 t80 -55.51 -60.44 3.43 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.442 1.497 . . . . 0.0 107.572 173.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -58.81 -45.46 89.88 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 111.793 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -56.85 -36.01 69.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.568 0.622 . . . . 0.0 111.516 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.46 -60.72 2.11 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.873 0.869 . . . . 0.0 110.69 172.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.2 pt -68.98 -2.42 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -168.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -42.76 -39.69 2.55 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.593 1.957 . . . . 0.0 114.91 -172.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 159.25 -176.55 36.04 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 119.322 0.965 . . . . 0.0 113.899 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 65.25 -57.44 0.29 Allowed 'General case' 0 N--CA 1.463 0.196 1 C-N-CA 132.056 4.143 . . . . 0.0 112.543 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.53 150.86 20.61 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.645 -160.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.16 88.5 0.7 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.113 3.209 . . . . 0.0 110.24 170.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.59 149.57 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 170.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.03 167.77 21.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.932 -0.48 . . . . 0.0 110.595 161.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.31 134.46 66.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 124.48 1.112 . . . . 0.0 108.382 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 45.4 t0 -95.7 99.72 11.53 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 167.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.484 ' CD1' HG23 ' A' ' 57' ' ' VAL . 37.1 m-85 -86.68 112.73 21.92 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 -128.28 176.65 7.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.163 1.385 . . . . 0.0 108.162 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -147.5 149.03 31.86 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.723 1.147 . . . . 0.0 110.789 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.07 -24.46 66.24 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -102.51 -6.99 22.26 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.252 0.933 . . . . 0.0 113.25 -174.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.1 p -66.19 169.94 6.44 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.638 0.732 . . . . 0.0 112.676 -164.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.89 -90.22 1.54 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 165.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.39 -23.16 71.7 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.003 2.469 . . . . 0.0 114.117 -168.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.86 -25.92 68.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.161 0.891 . . . . 0.0 111.682 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -71.8 -17.16 62.18 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.0 0.92 . . . . 0.0 111.632 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.5 mtp -97.39 -39.87 8.98 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.689 1.596 . . . . 0.0 110.211 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.8 tpt -66.84 -44.87 79.94 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-O 117.657 -1.163 . . . . 0.0 109.931 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.86 99.91 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.309 1.413 . . . . 0.0 112.725 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -69.19 -38.63 8.75 Favored 'Trans proline' 0 C--N 1.352 0.747 0 CA-C-N 121.78 1.671 . . . . 0.0 112.837 169.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.97 -34.09 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 120.935 1.698 . . . . 0.0 111.531 177.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.0 -13.23 61.19 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.877 2.471 . . . . 0.0 111.701 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.3 -36.63 34.06 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.564 1.074 . . . . 0.0 110.308 176.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.95 -43.24 99.33 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 169.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -58.57 -45.98 87.89 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.669 0.788 . . . . 0.0 110.479 171.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.06 -49.04 72.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.173 0.897 . . . . 0.0 110.893 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -53.19 60.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.74 1.216 . . . . 0.0 111.087 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.72 48.56 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -164.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -141.98 38.88 1.62 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.748 1.219 . . . . 0.0 110.552 172.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.47 -8.67 2.89 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.009 1.324 . . . . 0.0 113.964 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -92.29 -53.96 4.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.94 2.496 . . . . 0.0 111.425 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -68.34 -26.08 65.42 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 118.719 -0.658 . . . . 0.0 111.248 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.2 m -141.73 171.0 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.436 0.695 . . . . 0.0 110.111 -174.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.9 t -127.48 130.43 49.21 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 160.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.0 p -90.98 173.08 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 158.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.07 153.35 34.91 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 159.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 17.8 mtpp -113.26 137.65 51.17 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 119.29 -0.386 . . . . 0.0 109.992 -169.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pp -149.86 146.88 27.36 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 122.686 1.232 . . . . 0.0 114.288 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -78.64 110.16 13.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.127 2.171 . . . . 0.0 108.025 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.484 HG23 ' CD1' ' A' ' 24' ' ' PHE . 7.6 p -63.01 -37.1 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.861 1.665 . . . . 0.0 112.929 -166.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.86 -38.62 83.36 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.097 1.359 . . . . 0.0 110.601 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -76.34 -27.31 56.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.629 2.372 . . . . 0.0 112.048 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -116.65 78.21 8.7 Favored Pre-proline 0 N--CA 1.445 -0.703 0 C-N-CA 124.817 1.247 . . . . 0.0 110.461 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.36 -88.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 123.875 3.05 . . . . 0.0 112.313 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 30.96 -39.45 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.893 1 C-N-CA 132.912 4.485 . . . . 0.0 120.367 -159.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -159.52 -7.32 0.06 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 129.466 3.106 . . . . 0.0 112.376 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 m -39.93 -60.4 1.03 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.168 2.187 . . . . 0.0 110.547 164.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.0 t -68.79 -17.39 64.02 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.789 -1.1 . . . . 0.0 113.041 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -77.61 -30.97 52.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.69 1.132 . . . . 0.0 110.112 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -93.51 9.65 35.76 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.438 0.695 . . . . 0.0 111.122 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.52 22.85 75.23 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.846 0.736 . . . . 0.0 112.784 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.443 HG21 ' CZ ' ' A' ' 24' ' ' PHE . 40.8 mm -78.23 77.36 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.753 1.221 . . . . 0.0 109.151 -169.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.81 -2.54 8.77 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.088 1.355 . . . . 0.0 110.363 167.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 p -82.87 43.64 0.86 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.177 2.591 . . . . 0.0 111.485 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.11 145.84 94.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 O-C-N 121.7 -0.625 . . . . 0.0 111.697 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.21 127.0 8.89 Favored 'Cis proline' 0 N--CA 1.459 -0.512 0 CA-C-N 119.153 0.733 . . . . 0.0 110.797 0.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.0 m -116.84 148.07 41.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 tt -136.96 126.64 25.42 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.9 mt -128.85 141.56 46.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.466 HD11 HD21 ' A' ' 100' ' ' LEU . 1.3 mp -106.94 142.7 36.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.843 1.657 . . . . 0.0 109.474 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -134.68 150.09 50.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.357 1.463 . . . . 0.0 109.309 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.66 163.88 32.19 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 159.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.02 8.55 8.55 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 118.453 -1.193 . . . . 0.0 115.287 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.34 2.49 60.39 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 119.134 1.467 . . . . 0.0 113.156 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -126.57 135.91 27.93 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 119.346 1.573 . . . . 0.0 110.813 -168.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.44 117.2 5.02 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.48 2.786 . . . . 0.0 110.376 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.03 -46.01 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -156.55 164.5 38.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.867 0.758 . . . . 0.0 111.365 -173.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -136.28 147.98 47.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.483 1.913 . . . . 0.0 109.414 -171.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -122.14 154.05 37.92 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.833 1.653 . . . . 0.0 107.845 158.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 pt -141.32 137.74 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.671 1.988 . . . . 0.0 106.129 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.42 168.31 35.61 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.922 0.772 . . . . 0.0 112.921 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -80.4 83.64 6.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.529 1.131 . . . . 0.0 108.952 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -88.66 134.68 33.5 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.53 160.41 48.1 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.28 1.32 . . . . 0.0 109.793 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -41.67 80.79 Favored 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 123.803 0.841 . . . . 0.0 111.512 -175.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.79 -19.99 60.54 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -95.39 -49.75 5.31 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.888 1.222 . . . . 0.0 109.364 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.31 -59.17 5.74 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 124.499 1.12 . . . . 0.0 110.62 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -65.9 -18.44 65.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.075 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.25 -51.6 12.89 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.148 0.885 . . . . 0.0 110.307 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -53.32 -43.17 67.4 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.852 0.861 . . . . 0.0 110.831 175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.466 HD21 HD11 ' A' ' 77' ' ' LEU . 1.4 mp -86.85 -0.77 57.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.597 1.559 . . . . 0.0 113.167 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.04 -34.29 69.91 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 119.431 1.014 . . . . 0.0 111.622 -172.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -63.26 -12.56 30.0 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.195 1.398 . . . . 0.0 113.96 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.4 m -128.59 9.73 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 126.245 1.818 . . . . 0.0 111.633 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -124.95 -4.55 7.51 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.924 1.689 . . . . 0.0 113.122 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 126.895 2.078 . . . . 0.0 108.708 164.761 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.1 p -142.86 163.97 31.35 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 129.145 2.978 . . . . 0.0 104.998 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 10' ' ' PHE . 21.5 t70 -58.41 -40.14 81.63 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.601 1.16 . . . . 0.0 113.124 -168.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.52 65.84 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.633 -0.667 . . . . 0.0 112.358 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -94.49 -34.75 12.58 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.201 1.4 . . . . 0.0 110.549 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' A' ' 7' ' ' ASP . 51.8 t80 -50.6 -62.39 1.63 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 126.847 2.059 . . . . 0.0 109.201 173.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -57.29 -46.03 83.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.277 0.489 . . . . 0.0 110.781 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -70.62 -21.53 62.63 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.4 -62.01 1.71 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.212 0.915 . . . . 0.0 109.538 165.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.1 pt -62.46 -21.71 27.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.514 1.126 . . . . 0.0 113.776 -167.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -64.37 -23.92 67.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.93 0.892 . . . . 0.0 112.807 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.35 170.16 54.52 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 118.864 0.756 . . . . 0.0 112.058 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -82.83 -22.62 34.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.601 1.56 . . . . 0.0 112.798 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.46 48.73 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 123.408 0.528 . . . . 0.0 112.219 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HA ' HD21 ' A' ' 77' ' ' LEU . 34.7 Cg_endo -65.3 91.3 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 124.186 3.257 . . . . 0.0 111.317 173.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.67 131.43 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 mp -118.57 136.94 53.58 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.55 116.63 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 26.0 t0 -72.72 107.52 5.22 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 124.105 0.878 . . . . 0.0 109.025 163.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -89.03 108.15 19.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 164.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -126.44 -177.92 4.16 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.31 159.84 40.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.376 -0.827 . . . . 0.0 108.876 168.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.77 -15.67 22.01 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.535 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -89.63 -31.25 17.62 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.458 1.026 . . . . 0.0 113.354 177.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.9 p -72.8 160.67 31.81 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.684 1.129 . . . . 0.0 111.151 -168.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.43 -79.55 1.47 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.018 0.818 . . . . 0.0 112.515 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.15 -15.89 51.93 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.621 2.881 . . . . 0.0 113.701 -172.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.1 p -52.81 -35.97 57.75 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.248 0.619 . . . . 0.0 111.786 167.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -70.38 -13.94 62.35 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.753 0.706 . . . . 0.0 112.563 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.2 mtm -95.91 -20.08 19.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.078 1.351 . . . . 0.0 111.63 170.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.5 ttt -79.85 -39.27 30.99 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 108.913 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.01 -52.48 46.94 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.742 1.217 . . . . 0.0 113.326 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.65 -30.88 34.14 Favored 'Trans proline' 0 C--N 1.352 0.711 0 CA-C-N 121.987 1.745 . . . . 0.0 112.26 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.17 -38.3 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.636 1.107 . . . . 0.0 109.887 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 mp -69.99 -26.93 64.31 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.6 1.96 . . . . 0.0 112.196 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -69.52 -46.76 65.79 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.252 0.933 . . . . 0.0 109.156 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -61.93 -41.23 97.7 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.069 0.548 . . . . 0.0 110.591 173.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.29 -50.53 73.29 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.286 1.035 . . . . 0.0 110.915 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.25 -48.24 79.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.725 0.81 . . . . 0.0 110.16 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -58.27 -50.03 75.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.254 0.621 . . . . 0.0 110.941 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.7 -23.14 50.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.96 52.86 0.69 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.348 1.459 . . . . 0.0 109.876 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.26 -17.63 54.43 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -95.43 -49.6 5.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.595 2.358 . . . . 0.0 111.549 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -67.11 -24.62 65.95 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.151 -170.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.22 149.43 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 119.139 0.881 . . . . 0.0 111.074 -172.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.344 2.9 t -110.57 84.9 2.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 123.11 1.433 . . . . 0.0 109.3 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.14 139.14 19.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.967 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.52 166.56 22.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.201 2.2 . . . . 0.0 107.976 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 23.5 pttp -136.22 144.57 44.96 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 122.406 0.282 . . . . 0.0 111.377 173.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -145.86 142.7 29.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.368 0.604 . . . . 0.0 111.539 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -83.13 98.51 9.37 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.98 -27.73 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.613 -163.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -65.01 -24.87 67.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.867 2.467 . . . . 0.0 112.306 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -91.89 -32.26 15.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.069 1.347 . . . . 0.0 110.238 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -116.94 74.87 7.12 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.643 1.177 . . . . 0.0 109.839 -170.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.15 -12.65 14.3 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.152 3.235 . . . . 0.0 113.514 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.9 142.6 47.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.131 0.878 . . . . 0.0 109.315 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m 60.07 -29.36 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 131.46 3.904 . . . . 0.0 113.458 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.2 m -50.11 -59.6 3.76 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.018 2.927 . . . . 0.0 108.737 161.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -70.93 -10.14 59.12 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 117.725 -1.131 . . . . 0.0 112.674 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -85.87 -39.21 17.26 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.852 1.205 . . . . 0.0 111.266 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -92.99 6.85 46.44 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.538 0.608 . . . . 0.0 112.242 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.89 34.5 77.28 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.861 0.755 . . . . 0.0 111.926 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.7 mm -72.17 85.31 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.078 1.751 . . . . 0.0 109.259 -171.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.8 tpp -143.11 51.85 1.38 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.557 1.543 . . . . 0.0 109.654 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.2 m -156.81 42.41 0.36 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.145 -1.597 . . . . 0.0 111.812 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.535 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 43.2 pt -70.73 151.93 95.24 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 121.767 -0.583 . . . . 0.0 112.564 -174.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 37.8 Cg_endo -62.49 129.2 6.64 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 119.379 0.814 . . . . 0.0 110.755 -5.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.1 m -121.44 140.93 51.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -123.53 120.39 32.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 171.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.6 mt -121.24 142.77 35.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 19' ' ' PRO . 4.4 tt -108.11 121.54 45.05 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.409 ' N ' HD23 ' A' ' 77' ' ' LEU . 80.8 m-85 -118.37 156.77 28.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.151 0.98 . . . . 0.0 111.221 -176.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -163.14 158.97 22.48 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 125.535 1.534 . . . . 0.0 108.745 161.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.26 16.05 25.61 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.919 0.771 . . . . 0.0 113.984 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.22 -5.82 83.95 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.122 -1.377 . . . . 0.0 114.017 -173.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.97 149.97 44.24 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 120.186 1.993 . . . . 0.0 111.617 -174.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.17 128.03 6.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.352 2.702 . . . . 0.0 110.296 170.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.3 -41.86 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.579 -0.701 . . . . 0.0 110.34 168.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -164.91 169.85 16.02 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.827 0.851 . . . . 0.0 111.22 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -136.31 146.93 47.17 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.729 2.411 . . . . 0.0 108.941 -170.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.8 151.52 37.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.651 1.981 . . . . 0.0 106.897 159.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.06 147.9 26.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.005 1.722 . . . . 0.0 107.298 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.31 169.4 21.14 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 122.022 0.79 . . . . 0.0 112.081 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -74.01 89.05 1.91 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -86.87 137.38 33.52 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 159.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.4 165.95 30.85 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.322 2.015 . . . . 0.0 111.451 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -46.27 -48.67 18.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.724 1.61 . . . . 0.0 112.144 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -52.78 -47.09 67.77 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.113 1.365 . . . . 0.0 111.644 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -38.51 72.3 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 124.341 1.056 . . . . 0.0 108.578 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 -54.53 30.2 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.218 1.007 . . . . 0.0 109.514 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.22 -40.23 85.18 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.66 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.78 -51.96 65.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.524 1.056 . . . . 0.0 111.414 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -62.81 -27.69 69.49 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.77 0.828 . . . . 0.0 112.419 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 mp -106.66 3.36 26.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.716 1.207 . . . . 0.0 111.905 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.58 -29.97 60.0 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.543 1.137 . . . . 0.0 112.567 -174.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -62.53 -14.86 46.71 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.422 HG11 ' CD1' ' A' ' 77' ' ' LEU . 2.1 p -117.55 -7.03 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 119.651 1.114 . . . . 0.0 111.686 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.52 -11.87 26.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.548 1.139 . . . . 0.0 112.068 172.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.739 2.016 . . . . 0.0 110.135 165.875 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.3 mt . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 122.364 1.078 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.5 m -150.2 -129.4 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 102.581 -3.118 . . . . 0.0 102.581 172.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -86.61 -67.42 0.82 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.117 1.767 . . . . 0.0 111.248 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.6 -35.87 77.19 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.271 -0.893 . . . . 0.0 111.359 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -67.01 -31.33 71.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.728 0.811 . . . . 0.0 109.671 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -58.88 -57.25 13.86 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.819 0.736 . . . . 0.0 109.623 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -59.74 -46.52 88.9 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.54 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -63.29 -17.21 62.27 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.71 -59.28 2.48 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.807 0.843 . . . . 0.0 110.585 166.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.6 pt -67.59 -18.84 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -169.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -49.08 -34.45 13.76 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.157 1.783 . . . . 0.0 112.996 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.61 138.56 2.88 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 112.042 -0.423 . . . . 0.0 112.042 168.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.54 -102.97 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.9 -130.54 2.76 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 127.691 2.567 . . . . 0.0 106.752 165.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.95 93.45 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.272 2.648 . . . . 0.0 111.703 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.2 141.17 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 167.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.2 mt -137.33 158.99 43.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.04 141.31 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.41 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 54.9 t0 -96.06 110.39 22.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 158.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -93.71 109.68 21.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 167.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -134.25 -176.52 4.23 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.072 1.749 . . . . 0.0 108.098 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.37 166.3 33.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.643 1.577 . . . . 0.0 107.386 168.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.5 -29.08 69.76 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -31.86 17.75 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -169.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 p -71.51 102.4 2.69 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.713 0.688 . . . . 0.0 111.999 -162.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -34.14 -61.01 0.54 Allowed Glycine 0 CA--C 1.539 1.534 0 C-N-CA 126.017 1.77 . . . . 0.0 114.912 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.82 -32.86 28.6 Favored 'Trans proline' 0 C--N 1.35 0.646 0 CA-C-N 120.241 2.02 . . . . 0.0 112.512 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.4 p -67.73 -35.59 79.03 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 119.315 0.961 . . . . 0.0 110.258 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -62.35 -15.92 51.34 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.855 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 75.9 mtm -104.11 -14.2 15.97 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.564 1.145 . . . . 0.0 112.876 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.417 ' SD ' ' HA ' ' A' ' 90' ' ' TYR . 14.9 ttt -94.11 -40.67 9.93 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.284 1.434 . . . . 0.0 109.547 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.82 -49.42 86.85 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 117.738 -1.125 . . . . 0.0 112.466 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.76 -33.6 53.34 Favored 'Trans proline' 0 C--N 1.354 0.841 0 CA-C-N 121.888 1.71 . . . . 0.0 112.086 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.88 -42.27 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 118.447 0.567 . . . . 0.0 109.513 174.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.47 -24.58 64.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.014 1.725 . . . . 0.0 112.319 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -68.88 -48.25 63.85 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.418 1.008 . . . . 0.0 109.624 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -62.88 -45.23 93.53 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -55.16 -48.17 74.11 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 122.931 0.492 . . . . 0.0 110.439 175.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.07 -55.04 37.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.385 1.074 . . . . 0.0 110.73 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -52.82 -46.75 67.86 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.848 0.859 . . . . 0.0 110.602 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.53 -16.53 10.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -150.13 48.82 0.91 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.535 1.134 . . . . 0.0 110.559 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -25.64 66.58 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -97.68 -54.1 3.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.233 1.413 . . . . 0.0 112.465 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -53.79 -29.7 41.5 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.603 0.761 . . . . 0.0 112.378 -171.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 m -134.29 141.56 43.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.319 1.9 t -92.56 73.45 5.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 123.191 1.472 . . . . 0.0 107.723 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.79 164.26 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.307 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.6 179.9 8.75 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.806 0.843 . . . . 0.0 110.119 170.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 7.6 ttpm? -139.63 134.44 32.06 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.53 159.79 43.28 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.999 0.812 . . . . 0.0 112.351 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -82.38 123.38 29.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.314 0.646 . . . . 0.0 109.408 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.6 p -62.34 -29.59 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.182 0.993 . . . . 0.0 112.824 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.62 -36.34 70.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.642 0.777 . . . . 0.0 110.8 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.54 -34.85 74.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.178 2.191 . . . . 0.0 112.181 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -111.1 85.15 5.04 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 123.953 0.901 . . . . 0.0 109.393 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.3 -24.12 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.086 2.524 . . . . 0.0 112.816 172.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.07 117.66 11.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.021 1.328 . . . . 0.0 109.978 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 89.36 -40.71 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 129.784 3.233 . . . . 0.0 109.906 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.2 m -52.16 -60.54 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.163 2.185 . . . . 0.0 110.353 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.3 t -57.94 -44.26 86.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.709 0.404 . . . . 0.0 109.938 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -60.15 -27.92 67.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.965 1.306 . . . . 0.0 112.913 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.33 14.65 22.62 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.8 0.727 . . . . 0.0 111.465 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.07 26.5 73.32 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 121.55 -0.719 . . . . 0.0 113.135 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.3 mm -75.86 79.16 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.346 1.458 . . . . 0.0 109.014 -171.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.6 ttm -128.24 3.39 5.77 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.305 1.442 . . . . 0.0 110.962 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 t -90.82 23.88 2.95 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.088 1.355 . . . . 0.0 113.121 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.492 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -57.95 145.06 73.54 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.782 0.833 . . . . 0.0 113.161 -168.558 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 55.7 Cg_endo -69.09 132.24 20.78 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.034 0.691 . . . . 0.0 112.19 8.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.5 m -122.22 153.28 39.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 tt -144.44 104.44 4.07 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.734 2.014 . . . . 0.0 106.22 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.9 mt -102.19 133.17 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.66 109.68 21.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.095 2.158 . . . . 0.0 105.652 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -105.04 156.96 17.57 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -152.87 146.28 24.89 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 159.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.81 35.84 4.55 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.874 1.226 . . . . 0.0 115.215 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.77 -3.22 62.67 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 118.701 1.251 . . . . 0.0 114.791 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -123.61 130.88 24.32 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 119.652 1.726 . . . . 0.0 110.977 -168.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.48 101.69 1.39 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.778 2.986 . . . . 0.0 109.803 169.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -42.42 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.859 0.864 . . . . 0.0 111.094 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.37 168.41 26.4 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.74 163.45 30.14 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.352 0.596 . . . . 0.0 111.489 160.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 99' ' ' GLN . 2.8 mm? -117.88 148.31 42.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.838 2.055 . . . . 0.0 105.784 170.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.6 pt -139.56 140.26 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 125.151 1.38 . . . . 0.0 107.885 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.68 161.63 8.57 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.76 0.695 . . . . 0.0 111.781 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.417 ' HA ' ' SD ' ' A' ' 35' ' ' MET . 10.6 t80 -66.73 98.88 0.56 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.574 1.55 . . . . 0.0 112.385 -170.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -93.01 140.6 23.43 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 168.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.15 163.5 38.53 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.487 2.125 . . . . 0.0 110.308 168.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.67 -46.04 70.5 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 123.843 0.857 . . . . 0.0 111.879 -174.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -49.63 -43.36 46.66 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.801 1.24 . . . . 0.0 111.159 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -88.35 -42.61 12.09 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.442 1.097 . . . . 0.0 109.061 -166.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.83 -62.46 1.85 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.99 1.316 . . . . 0.0 109.31 173.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -57.3 -38.13 73.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.608 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.29 82.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.615 1.098 . . . . 0.0 110.574 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.439 ' HG2' HD11 ' A' ' 87' ' ' LEU . 4.9 tp60 -66.99 -21.88 65.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.77 -7.24 27.9 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.204 1.802 . . . . 0.0 113.287 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.71 -29.46 66.7 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.088 1.755 . . . . 0.0 112.532 -167.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.48 -5.54 3.88 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.073 1.749 . . . . 0.0 113.886 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.4 -1.07 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.124 0.874 . . . . 0.0 112.687 167.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.19 -12.51 15.71 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.247 1.419 . . . . 0.0 113.316 174.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.4 tp60 . . . . . 0 C--O 1.248 1.003 0 C-N-CA 126.461 1.904 . . . . 0.0 107.395 159.126 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tp . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 121.625 0.726 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.48 171.04 15.16 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 -173.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -45.38 -58.89 3.0 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 127.562 2.345 . . . . 0.0 112.758 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.66 96.89 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.531 -0.731 . . . . 0.0 111.341 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -68.05 -26.97 66.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.395 1.078 . . . . 0.0 110.314 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -65.18 -6.44 9.34 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 125.128 1.371 . . . . 0.0 112.431 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -121.19 -56.15 1.93 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 162.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -67.89 -12.6 61.01 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -168.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.26 -3.87 13.79 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.593 1.157 . . . . 0.0 113.044 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 11.7 pt -91.83 -105.95 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 158.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 47.95 -10.26 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.77 1 C-N-CA 131.859 4.064 . . . . 0.0 118.881 174.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.27 179.94 17.48 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.144 1.831 . . . . 0.0 112.29 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.14 -11.43 57.94 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.087 1.755 . . . . 0.0 112.869 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.4 150.02 51.7 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.72 97.42 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.036 2.491 . . . . 0.0 110.34 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.1 t -105.33 140.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.95 136.44 46.11 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.793 0.806 . . . . 0.0 110.206 172.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.87 120.99 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 126.707 2.003 . . . . 0.0 105.965 -170.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.02 92.06 4.22 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -77.97 113.77 16.19 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.028 0.931 . . . . 0.0 108.9 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -131.97 -174.21 3.36 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 170.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.46 167.67 26.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.642 1.577 . . . . 0.0 107.584 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.9 -8.89 32.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.357 1.244 . . . . 0.0 114.357 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.538 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -110.53 -21.49 12.12 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -172.438 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.437 ' SG ' HD12 ' A' ' 72' ' ' ILE . 3.7 p -77.87 45.55 0.52 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -158.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 29.3 -95.17 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 C-N-CA 128.782 3.086 . . . . 0.0 114.213 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.07 -21.68 60.2 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.41 2.74 . . . . 0.0 114.538 -176.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.1 p -56.97 -32.37 65.99 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.448 1.476 . . . . 0.0 111.436 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -72.25 -18.91 61.78 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.751 1.22 . . . . 0.0 112.182 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -98.73 -18.11 18.18 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.086 1.354 . . . . 0.0 111.251 173.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.8 ttt -74.2 -37.62 63.84 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.602 1.561 . . . . 0.0 109.377 168.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.77 -51.56 45.3 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.495 -1.241 . . . . 0.0 113.171 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.68 -33.4 13.15 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 121.739 1.657 . . . . 0.0 113.051 171.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -28.89 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 121.258 1.844 . . . . 0.0 110.777 175.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.43 -13.1 61.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.765 2.026 . . . . 0.0 112.711 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -79.42 -40.7 29.37 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.682 1.128 . . . . 0.0 108.982 171.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.44 -16.89 64.45 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.733 0.813 . . . . 0.0 111.383 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -83.13 -43.89 15.72 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.426 1.09 . . . . 0.0 111.43 169.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.68 -48.66 49.47 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.938 0.895 . . . . 0.0 110.871 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -54.95 -43.0 73.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.458 1.103 . . . . 0.0 111.765 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.21 -12.49 28.71 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.551 1.141 . . . . 0.0 113.369 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -156.01 49.88 0.52 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.544 1.137 . . . . 0.0 110.056 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.07 -47.45 53.6 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.959 0.904 . . . . 0.0 112.459 -170.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -124.65 -6.2 7.5 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 171.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -55.07 -31.15 60.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.177 1.391 . . . . 0.0 111.765 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.26 177.26 6.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.676 1.19 . . . . 0.0 109.321 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 m -117.18 96.92 5.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.817 1.247 . . . . 0.0 107.741 164.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.77 149.25 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 160.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.58 109.03 3.98 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.432 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -88.32 145.5 25.8 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.767 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -154.38 157.29 38.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.659 0.784 . . . . 0.0 112.374 173.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -76.81 106.19 8.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.688 1.595 . . . . 0.0 109.187 174.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 p -64.1 -28.9 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.015 0.926 . . . . 0.0 112.685 -173.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.54 -30.25 71.28 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.341 1.056 . . . . 0.0 110.891 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -98.44 -20.45 17.11 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.578 1.951 . . . . 0.0 112.062 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -104.76 92.52 5.19 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.115 167.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.69 -17.95 22.69 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.062 1.841 . . . . 0.0 113.533 167.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 113.63 3.89 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.568 1.147 . . . . 0.0 109.282 -173.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.303 17.6 m 66.13 -14.69 0.14 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.329 2.651 . . . . 0.0 113.63 176.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.4 m -50.41 -55.24 16.64 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.321 1.848 . . . . 0.0 108.486 158.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -72.01 -6.79 44.75 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 117.847 -1.073 . . . . 0.0 113.103 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.77 -52.84 4.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.403 1.001 . . . . 0.0 109.364 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -81.2 16.87 1.42 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.159 0.89 . . . . 0.0 112.43 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.32 32.02 80.75 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 121.558 -0.714 . . . . 0.0 111.775 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.3 mm -77.43 81.3 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.538 1.135 . . . . 0.0 108.083 -172.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -117.88 14.4 14.21 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.783 1.633 . . . . 0.0 112.472 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.1 m -154.78 158.98 40.31 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.74 -1.225 . . . . 0.0 109.802 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.538 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 15.8 pt -155.05 162.51 27.07 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 129.28 3.032 . . . . 0.0 107.568 -171.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.2 127.59 7.24 Favored 'Cis proline' 0 C--N 1.349 0.565 0 CA-C-N 119.952 1.018 . . . . 0.0 110.653 -6.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.3 m -124.56 136.34 53.89 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.325 1.05 . . . . 0.0 108.797 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 tt -130.01 117.56 20.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.9 mt -126.38 129.65 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 tt -96.67 126.32 41.75 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.62 153.44 39.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.594 1.157 . . . . 0.0 110.613 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -158.56 153.37 24.89 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 124.757 1.223 . . . . 0.0 108.434 158.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.86 11.47 24.26 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 119.424 -0.653 . . . . 0.0 113.355 -169.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.65 0.58 89.95 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 118.345 1.072 . . . . 0.0 113.717 -170.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -107.82 136.16 19.74 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 119.34 1.57 . . . . 0.0 109.691 -173.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.99 110.31 3.02 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.361 2.707 . . . . 0.0 110.965 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.79 -37.19 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.629 1.572 . . . . 0.0 110.981 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -154.68 157.32 37.93 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.865 0.866 . . . . 0.0 109.108 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -141.24 127.73 20.03 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 126.937 2.095 . . . . 0.0 105.989 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mp -122.58 139.77 53.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.429 1.891 . . . . 0.0 106.03 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.09 121.86 29.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.207 1.403 . . . . 0.0 108.248 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.02 172.7 23.46 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.128 1.347 . . . . 0.0 112.507 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -69.7 85.22 0.46 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.285 1.034 . . . . 0.0 108.473 171.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.98 120.99 77.11 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 169.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -65.96 160.6 43.52 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.288 1.325 . . . . 0.0 109.92 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.44 -52.46 13.05 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 125.264 1.426 . . . . 0.0 112.558 -172.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -59.77 -25.95 65.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.911 1.284 . . . . 0.0 112.673 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -88.12 -42.18 12.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.033 0.933 . . . . 0.0 109.849 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.32 -60.83 3.0 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.658 1.983 . . . . 0.0 110.384 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -57.8 -33.45 68.59 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.189 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.05 -48.7 62.17 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 119.616 1.098 . . . . 0.0 111.119 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.0 tp-100 -63.25 -38.26 90.47 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.243 0.617 . . . . 0.0 111.33 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.86 -1.4 56.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.034 0.933 . . . . 0.0 112.912 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.46 -38.95 66.97 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 124.235 1.014 . . . . 0.0 112.798 -165.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -69.83 -6.47 32.67 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.647 1.112 . . . . 0.0 113.305 -176.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.28 1.29 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.654 1.182 . . . . 0.0 111.934 170.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -124.78 -4.03 7.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.005 1.722 . . . . 0.0 113.384 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.119 0 C-N-CA 126.792 2.037 . . . . 0.0 110.38 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.465 0.288 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -138.15 -178.65 5.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 164.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.31 -60.37 3.2 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.989 2.115 . . . . 0.0 112.777 -161.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.94 -34.53 77.67 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -77.04 -19.14 57.56 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.914 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -57.18 -59.73 4.66 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.529 1.059 . . . . 0.0 109.759 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -42.6 99.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.589 0.356 . . . . 0.0 110.48 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.64 -26.7 61.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.159 0.584 . . . . 0.0 112.149 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.74 -26.94 19.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.828 -1.082 . . . . 0.0 112.655 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.472 HG13 ' H ' ' A' ' 15' ' ' GLN 0.279 11.3 pt -75.22 -91.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.95 0.795 . . . . 0.0 109.517 171.369 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.472 ' H ' HG13 ' A' ' 14' ' ' ILE . 13.9 pt20 45.85 -17.77 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.758 1 C-N-CA 133.207 4.603 . . . . 0.0 119.632 174.645 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.02 -179.06 25.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.757 1.162 . . . . 0.0 112.887 -159.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -81.46 -13.57 58.04 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.85 2.06 . . . . 0.0 114.207 -167.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.93 156.04 41.28 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 118.577 0.626 . . . . 0.0 112.036 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.15 81.96 1.11 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.778 2.985 . . . . 0.0 110.466 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.4 t -87.81 138.11 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.8 tt -133.75 141.27 47.44 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.91 125.63 58.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -170.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.71 96.85 6.2 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.747 1.219 . . . . 0.0 108.218 175.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -75.11 115.78 15.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -117.49 176.76 5.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 168.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.62 161.22 40.99 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.294 -0.879 . . . . 0.0 110.392 174.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.31 15.06 0.48 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.321 1.049 . . . . 0.0 113.579 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.411 ' CG ' ' N ' ' A' ' 29' ' ' CYS . 2.2 p90 -136.82 -61.72 0.66 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.215 1.006 . . . . 0.0 108.553 168.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.411 ' N ' ' CG ' ' A' ' 28' ' ' TRP . 16.3 p 44.16 -62.95 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 1 C-N-CA 132.024 4.13 . . . . 0.0 117.525 178.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.76 -103.83 3.06 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.951 1.739 . . . . 0.0 109.802 -161.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -60.19 -21.12 64.96 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.451 2.767 . . . . 0.0 115.15 -171.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -60.75 -25.3 66.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.947 1.248 . . . . 0.0 111.466 173.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -22.3 65.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.394 0.997 . . . . 0.0 111.932 174.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 84.0 mtp -98.54 -25.0 14.9 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 125.946 1.698 . . . . 0.0 111.429 176.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.2 ttt -83.38 -36.37 24.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 117.521 -1.228 . . . . 0.0 109.109 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.87 -51.13 57.24 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.871 1.669 . . . . 0.0 112.482 175.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -62.41 -39.43 46.28 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 121.444 1.551 . . . . 0.0 112.422 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.25 -20.67 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 119.981 1.264 . . . . 0.0 112.071 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.84 -17.39 24.15 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.242 1.817 . . . . 0.0 111.612 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.04 -45.84 69.41 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 167.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -53.83 -50.14 66.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.954 1.301 . . . . 0.0 110.151 167.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.86 -51.39 67.72 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.095 0.558 . . . . 0.0 110.974 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.57 -55.85 19.4 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.881 0.872 . . . . 0.0 110.532 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.68 -43.6 85.18 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.672 0.608 . . . . 0.0 111.217 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.79 -21.31 10.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -147.63 40.94 1.02 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.481 1.112 . . . . 0.0 111.003 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.52 -37.17 16.91 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.951 1.7 . . . . 0.0 115.275 -162.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -132.26 6.27 4.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -66.24 -34.58 78.33 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.527 -0.733 . . . . 0.0 109.825 166.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.65 171.64 5.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.338 0.6 OUTLIER -118.62 97.81 5.92 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 159.237 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 p -84.89 159.76 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.2 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.38 156.92 44.07 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 162.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -123.03 138.09 54.77 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 172.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pp -150.87 150.83 31.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.867 0.467 . . . . 0.0 110.956 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -82.79 116.57 22.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.81 -27.86 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.8 0.84 . . . . 0.0 112.142 -175.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -67.63 -31.45 71.47 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.683 0.793 . . . . 0.0 111.0 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -83.97 -24.82 30.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.034 0.934 . . . . 0.0 111.907 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -113.84 86.63 11.23 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.309 1.043 . . . . 0.0 109.856 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.03 -24.51 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.124 2.55 . . . . 0.0 113.752 171.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.23 131.16 44.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.788 1.176 . . . . 0.0 109.808 -177.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.9 m 69.68 -31.8 0.22 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.42 2.688 . . . . 0.0 112.453 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.1 m -53.51 -54.74 32.93 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.471 1.909 . . . . 0.0 109.721 170.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.6 t -70.03 -1.94 11.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.766 -1.111 . . . . 0.0 113.157 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -106.69 -35.09 7.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.663 1.12 . . . . 0.0 111.339 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -99.1 14.93 27.55 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.794 0.725 . . . . 0.0 112.119 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.99 33.53 85.81 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 123.486 0.565 . . . . 0.0 111.899 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.7 mm -74.3 80.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.416 1.486 . . . . 0.0 108.312 -171.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 21.7 ttt -138.89 40.12 2.15 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.255 1.422 . . . . 0.0 109.642 -176.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.2 m -155.11 61.41 0.64 Allowed 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.468 -1.395 . . . . 0.0 109.565 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.48 153.79 81.54 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.686 173.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -67.32 126.08 7.45 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 CA-C-N 119.206 0.752 . . . . 0.0 110.544 -5.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -114.53 130.49 56.76 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.99 119.6 30.02 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -173.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.52 148.7 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -121.98 132.97 54.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -121.35 155.1 35.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.064 1.346 . . . . 0.0 110.842 -173.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -164.62 151.39 11.04 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.333 1.453 . . . . 0.0 109.229 158.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.03 15.81 50.88 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.652 0.644 . . . . 0.0 112.353 -165.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.02 -3.59 28.26 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.843 -0.976 . . . . 0.0 113.862 -166.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.74 133.56 39.41 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 119.522 1.661 . . . . 0.0 108.821 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.45 95.82 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.272 2.648 . . . . 0.0 109.299 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 m -61.14 -35.56 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 O-C-N 121.656 -0.653 . . . . 0.0 111.917 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.88 159.85 43.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.012 0.434 . . . . 0.0 111.636 159.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.13 140.92 48.93 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 127.538 2.335 . . . . 0.0 107.303 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.462 HD11 ' HG2' ' A' ' 99' ' ' GLN . 3.6 mm? -123.39 152.59 41.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 127.702 2.401 . . . . 0.0 107.625 168.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.73 126.18 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.82 163.75 39.14 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.607 1.099 . . . . 0.0 113.101 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -61.82 134.05 56.23 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.057 1.343 . . . . 0.0 110.535 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -137.91 144.01 42.24 Favored Pre-proline 0 C--O 1.242 0.671 0 C-N-CA 124.89 1.276 . . . . 0.0 107.608 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.94 157.27 57.76 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.192 1.928 . . . . 0.0 109.155 169.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.54 -38.47 87.57 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.149 -0.97 . . . . 0.0 110.779 -175.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.22 -21.37 13.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.059 0.944 . . . . 0.0 113.02 174.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -97.92 -50.91 4.24 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 119.49 1.041 . . . . 0.0 110.454 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.74 -58.9 6.32 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.837 1.655 . . . . 0.0 109.527 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.52 -30.77 68.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.931 1.292 . . . . 0.0 110.657 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.71 -46.25 32.14 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.547 0.612 . . . . 0.0 110.965 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.462 ' HG2' HD11 ' A' ' 87' ' ' LEU . 12.7 tp-100 -64.75 -31.22 72.35 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.424 1.09 . . . . 0.0 111.19 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.24 2.17 56.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.345 1.058 . . . . 0.0 112.511 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.18 -19.04 61.13 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -19.79 62.88 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.066 1.757 . . . . 0.0 111.672 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.31 -7.23 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 125.779 1.632 . . . . 0.0 111.783 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.05 5.96 28.52 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.557 1.543 . . . . 0.0 112.78 167.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.962 0 C-N-CA 126.157 1.783 . . . . 0.0 109.618 165.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.658 HD13 ' CB ' ' A' ' 53' ' ' ALA . 1.6 tp . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 121.339 0.59 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 t -142.64 -127.67 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -98.79 -62.22 1.27 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.982 1.313 . . . . 0.0 109.49 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.94 79.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.62 1.168 . . . . 0.0 111.008 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -72.24 -24.54 61.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.335 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -71.45 -48.83 46.94 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.07 -32.98 74.74 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.949 -0.548 . . . . 0.0 112.3 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -64.85 -50.32 67.1 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.166 0.894 . . . . 0.0 110.2 167.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.402 ' O ' HG21 ' A' ' 20' ' ' VAL . . . -54.74 -48.21 72.86 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.143 0.883 . . . . 0.0 111.372 -175.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt -63.01 -1.98 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -52.23 -31.6 32.83 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.233 1.379 . . . . 0.0 111.909 171.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.99 -133.28 13.98 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 116.531 1.372 . . . . 0.0 116.531 158.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.6 t70 64.29 -50.16 0.29 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 130.221 3.408 . . . . 0.0 111.303 -158.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.4 160.68 46.0 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.68 107.04 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.19 2.593 . . . . 0.0 110.956 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 13' ' ' ALA . 50.3 t -94.52 107.02 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.97 153.59 22.06 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 164.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.26 150.88 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 164.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -110.7 104.62 13.31 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.43 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 79.0 m-85 -89.31 108.2 19.49 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 164.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -131.49 -176.39 4.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.528 1.531 . . . . 0.0 107.019 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.18 171.25 20.25 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.692 1.197 . . . . 0.0 108.132 164.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.52 80.61 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.52 -23.91 18.94 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -163.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.9 p -75.6 40.19 0.18 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.298 1.839 . . . . 0.0 115.256 -159.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 42.48 -99.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 127.718 2.58 . . . . 0.0 113.974 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -57.52 -23.48 56.51 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.528 2.819 . . . . 0.0 114.396 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.9 p -56.91 -34.63 68.13 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.511 1.05 . . . . 0.0 111.417 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -71.12 -8.0 50.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.357 1.063 . . . . 0.0 112.359 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.7 mtm -106.88 -12.3 15.51 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.81 1.644 . . . . 0.0 112.222 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -40.42 11.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.813 2.045 . . . . 0.0 108.851 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.34 -56.23 19.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.233 1.413 . . . . 0.0 112.177 170.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.57 -25.01 69.79 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.143 1.801 . . . . 0.0 113.017 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.1 t -68.78 -46.35 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.365 0.984 . . . . 0.0 109.677 170.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.47 ' HA ' ' HB3' ' A' ' 42' ' ' PHE . 3.7 mp -61.15 -36.2 79.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.698 1.599 . . . . 0.0 111.901 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.18 -7.64 38.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.218 2.207 . . . . 0.0 112.099 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -109.81 -50.72 2.95 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.368 1.467 . . . . 0.0 109.47 168.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 47.4 t80 -45.45 -51.76 11.07 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 125.811 1.645 . . . . 0.0 112.22 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.15 -63.09 1.24 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.601 1.161 . . . . 0.0 110.369 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.88 -33.77 74.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.61 1.564 . . . . 0.0 111.993 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.77 -19.4 27.79 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -140.7 48.5 1.72 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.142 1.377 . . . . 0.0 109.028 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.24 -37.44 16.1 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.077 1.351 . . . . 0.0 114.259 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -130.32 3.22 4.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -65.46 -36.78 84.9 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.679 1.127 . . . . 0.0 109.094 159.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.6 m -111.09 174.27 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.248 1.019 . . . . 0.0 108.696 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.4 134.72 48.87 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 158.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.6 p -137.01 161.06 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.552 1.141 . . . . 0.0 109.827 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.658 ' CB ' HD13 ' A' ' 5' ' ' LEU . . . -165.09 166.35 19.23 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.275 171.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.15 148.1 42.67 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.52 137.05 36.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 125.812 1.945 . . . . 0.0 111.403 169.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -75.21 101.11 4.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.439 HG11 HG21 ' A' ' 72' ' ' ILE . 2.8 p -61.56 -25.3 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.373 1.069 . . . . 0.0 112.374 -166.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.01 -18.79 61.31 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.367 1.867 . . . . 0.0 112.649 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -114.97 -43.62 3.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 127.68 2.392 . . . . 0.0 109.887 -171.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -114.93 81.88 7.92 Favored Pre-proline 0 N--CA 1.443 -0.795 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.2 -68.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.235 2.623 . . . . 0.0 111.828 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 29.32 99.34 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.357 2.663 . . . . 0.0 115.586 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.263 38.6 m 67.71 -8.39 0.52 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.748 1.219 . . . . 0.0 113.165 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -49.36 -50.14 41.3 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.488 -1.382 . . . . 0.0 111.173 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.9 t -71.75 -3.68 23.37 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 117.657 -1.163 . . . . 0.0 112.778 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -95.6 -32.05 12.99 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.731 1.15 . . . . 0.0 111.68 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -110.48 0.74 17.89 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.82 35.91 43.89 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.263 0.935 . . . . 0.0 112.399 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.43 HG21 ' CZ ' ' A' ' 24' ' ' PHE . 42.8 mm -82.17 48.88 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.376 1.47 . . . . 0.0 111.778 -163.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 18.0 ttt -88.32 2.35 52.66 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.754 1.222 . . . . 0.0 110.348 163.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 p -72.77 13.97 0.32 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.202 2.201 . . . . 0.0 114.907 -176.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.462 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -65.16 144.75 99.1 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 123.907 0.883 . . . . 0.0 112.014 -165.795 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.462 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 57.5 Cg_endo -65.94 132.09 15.42 Favored 'Cis proline' 0 C--N 1.35 0.622 0 CA-C-N 119.268 0.774 . . . . 0.0 111.398 2.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.5 m -131.44 141.1 49.75 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.563 0.745 . . . . 0.0 109.144 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -135.87 98.92 4.02 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.1 mt -88.29 145.99 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.35 99.21 7.04 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -96.47 160.83 14.2 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.552 1.941 . . . . 0.0 109.685 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -157.78 39.02 0.27 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 158.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 82' ' ' GLU . . . 159.39 52.38 0.01 OUTLIER Glycine 0 N--CA 1.463 0.468 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 169.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.4 -25.53 0.58 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.31 1.91 . . . . 0.0 112.677 -168.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 80' ' ' GLY . 42.0 tt0 -91.72 131.71 35.04 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.43 1.892 . . . . 0.0 110.028 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.85 126.55 7.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.988 3.125 . . . . 0.0 110.78 170.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.8 -38.4 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 121.661 -0.65 . . . . 0.0 110.448 165.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -154.1 172.07 18.11 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 118.623 0.647 . . . . 0.0 111.233 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -138.35 136.15 36.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.196 1.799 . . . . 0.0 108.032 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.25 141.29 43.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.19 2.196 . . . . 0.0 105.851 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 pt -139.78 152.32 22.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.575 1.15 . . . . 0.0 108.838 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.19 168.1 6.86 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.838 0.732 . . . . 0.0 111.65 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -81.61 75.08 8.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.723 -0.869 . . . . 0.0 110.563 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -75.42 122.9 88.19 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 158.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -71.84 173.75 12.24 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.089 1.859 . . . . 0.0 110.7 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HE2' ' OE1' ' A' ' 97' ' ' GLU . 22.8 tptm -31.8 -59.12 0.27 Allowed 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 127.561 2.344 . . . . 0.0 112.483 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.72 -49.81 64.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.802 1.313 . . . . 0.0 111.643 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -74.22 -42.01 60.44 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.496 1.118 . . . . 0.0 110.033 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 tt -59.78 -62.46 1.86 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.594 1.558 . . . . 0.0 108.983 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.46 ' OE1' ' HE2' ' A' ' 93' ' ' LYS . 11.3 tt0 -66.09 -25.92 67.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.224 1.41 . . . . 0.0 111.102 -177.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.93 -52.48 24.18 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.212 0.915 . . . . 0.0 110.412 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -59.7 -40.0 86.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.391 0.541 . . . . 0.0 111.367 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.27 -0.66 50.57 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.797 1.239 . . . . 0.0 112.764 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.6 -28.97 66.09 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.363 0.983 . . . . 0.0 112.142 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -69.67 -3.71 16.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.626 1.17 . . . . 0.0 113.488 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.88 -15.58 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.156 0.889 . . . . 0.0 112.416 164.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.37 -9.98 50.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.015 0.926 . . . . 0.0 113.204 173.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 C-N-CA 125.641 1.576 . . . . 0.0 110.622 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.446 HD21 ' HA ' ' A' ' 10' ' ' PHE . 6.0 tp . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.5 m -150.02 157.2 42.9 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -46.51 -53.4 11.34 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 127.172 2.189 . . . . 0.0 113.207 -168.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.03 93.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.051 0.929 . . . . 0.0 111.746 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -69.91 -18.47 63.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.124 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.446 ' HA ' HD21 ' A' ' 5' ' ' LEU . 2.3 t80 -58.12 -60.9 3.03 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.252 0.621 . . . . 0.0 110.242 172.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -63.47 -39.64 95.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.322 -0.37 . . . . 0.0 110.56 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -63.65 -27.99 69.61 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.609 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.64 -60.39 2.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.659 1.118 . . . . 0.0 109.517 168.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.8 pt -64.89 -23.28 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -167.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -59.53 -30.09 68.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 164.16 104.39 0.18 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.316 0.962 . . . . 0.0 110.734 -168.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -160.93 -65.03 0.06 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.614 1.566 . . . . 0.0 109.778 -169.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.22 -161.39 32.48 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 -164.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.44 112.48 1.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.491 2.127 . . . . 0.0 108.855 167.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.7 t -110.3 141.16 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 125.501 1.521 . . . . 0.0 107.199 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.1 tp -145.2 111.33 5.59 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 118.028 0.377 . . . . 0.0 110.469 -167.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.4 t -112.83 121.99 66.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 118.957 0.799 . . . . 0.0 109.436 -163.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 11.4 t0 -82.36 106.76 14.5 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 169.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.49 105.3 16.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 162.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.3 p-90 -117.95 -179.44 3.76 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 166.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.76 152.04 32.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 120.505 -1.372 . . . . 0.0 110.336 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -23.9 66.7 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.93 -13.27 29.09 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 p -71.55 178.25 3.61 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.214 0.605 . . . . 0.0 112.386 -164.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.97 -93.5 1.87 Allowed Glycine 0 CA--C 1.538 1.489 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 164.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -66.85 -21.27 50.87 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.381 2.721 . . . . 0.0 114.133 -166.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -30.37 68.81 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.521 0.6 . . . . 0.0 111.225 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 -71.8 -13.16 61.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.501 1.12 . . . . 0.0 111.981 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 76.4 mtm -98.6 -37.2 9.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.105 1.362 . . . . 0.0 111.089 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.8 ttt -67.44 -43.02 82.13 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.874 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.22 -50.64 74.58 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 119.956 1.253 . . . . 0.0 113.284 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.93 -33.43 26.35 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.849 1.696 . . . . 0.0 112.684 170.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -29.56 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 120.093 1.315 . . . . 0.0 112.018 173.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.7 mt -82.98 -23.9 33.17 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.667 2.387 . . . . 0.0 110.904 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -70.05 -35.93 74.62 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.824 0.738 . . . . 0.0 110.6 171.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.03 -35.43 61.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.134 0.879 . . . . 0.0 111.107 174.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -55.02 -46.06 75.21 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.326 0.65 . . . . 0.0 109.549 166.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.473 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -61.12 -51.68 68.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.427 -0.796 . . . . 0.0 111.274 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.93 -46.46 74.93 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.445 0.698 . . . . 0.0 110.311 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.4 -16.07 59.42 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -138.89 28.55 2.35 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.058 1.343 . . . . 0.0 112.271 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.46 65.79 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -164.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -95.38 -45.61 7.05 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.304 2.642 . . . . 0.0 111.316 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -66.51 -19.61 65.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.785 1.634 . . . . 0.0 113.029 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.35 143.16 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 119.14 0.882 . . . . 0.0 110.058 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.8 m -78.01 60.07 2.3 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.724 1.61 . . . . 0.0 107.743 168.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 43' ' ' ALA . 2.5 p -71.3 151.09 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.03 169.51 24.4 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 16.4 ttpp -144.32 125.7 14.81 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -168.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.39 154.51 43.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.838 1.304 . . . . 0.0 114.112 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -87.57 105.22 17.18 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.26 -14.65 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 121.382 -0.824 . . . . 0.0 112.207 -172.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.93 -35.79 82.3 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.197 1.399 . . . . 0.0 111.643 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -74.47 -33.1 62.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.287 1.035 . . . . 0.0 110.638 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -111.43 87.43 7.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.115 0.966 . . . . 0.0 111.985 -164.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -80.95 -19.82 8.02 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.64 2.893 . . . . 0.0 113.951 168.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.61 128.88 37.26 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.645 1.111 . . . . 0.0 109.649 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.0 m 68.54 -28.79 0.16 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.807 2.443 . . . . 0.0 112.696 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.2 m -53.14 -55.71 21.97 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.03 1.732 . . . . 0.0 109.649 167.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -70.6 -4.01 21.08 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 117.917 -1.04 . . . . 0.0 112.855 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -94.39 -34.25 12.84 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.563 1.074 . . . . 0.0 110.714 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -106.06 11.36 31.57 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.64 0.655 . . . . 0.0 112.117 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.22 35.23 90.1 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 123.939 0.78 . . . . 0.0 111.553 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.58 87.98 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.993 0.901 . . . . 0.0 109.979 -168.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.2 ttt -125.81 -1.35 7.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.514 1.525 . . . . 0.0 110.74 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.1 p -72.95 23.27 0.06 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.706 2.402 . . . . 0.0 114.824 -169.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.412 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 46.4 pt -68.61 150.87 97.53 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -159.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 36.8 Cg_endo -63.86 130.19 9.15 Favored 'Cis proline' 0 C--N 1.353 0.766 0 CA-C-N 118.89 0.639 . . . . 0.0 110.682 -7.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.1 m -114.14 130.56 56.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.9 tt -120.12 109.95 16.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -119.08 132.88 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tt -102.56 137.95 40.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -135.18 163.99 28.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.386 1.874 . . . . 0.0 108.757 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -153.86 140.92 19.36 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 158.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 39.13 53.46 2.64 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 126.219 1.866 . . . . 0.0 114.49 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.1 -7.24 78.85 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.842 1.21 . . . . 0.0 114.338 176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.19 123.7 36.09 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 119.453 1.626 . . . . 0.0 110.049 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -71.65 135.38 25.98 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.099 2.532 . . . . 0.0 109.89 169.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.9 t -100.4 -56.14 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.625 1.17 . . . . 0.0 110.033 -173.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -155.56 163.9 39.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.743 0.701 . . . . 0.0 109.975 170.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -120.86 132.27 54.89 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.811 2.044 . . . . 0.0 107.267 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.53 144.93 38.63 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.97 2.508 . . . . 0.0 106.411 169.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.8 pt -139.64 120.11 14.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.497 1.119 . . . . 0.0 109.622 -170.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.83 168.86 42.34 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.073 0.844 . . . . 0.0 111.905 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.74 81.08 1.57 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.792 1.637 . . . . 0.0 110.501 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -68.63 133.73 90.64 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.31 159.73 52.02 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.496 1.464 . . . . 0.0 109.532 165.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.51 -41.03 72.54 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 123.446 0.699 . . . . 0.0 112.748 -170.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.83 -29.72 68.45 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.012 0.925 . . . . 0.0 112.667 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.5 -47.28 11.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.345 1.858 . . . . 0.0 107.496 178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.34 -62.48 1.81 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.139 2.176 . . . . 0.0 109.846 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -30.19 71.33 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 117.607 -1.187 . . . . 0.0 110.602 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.49 -26.41 64.54 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 122.044 2.202 . . . . 0.0 111.679 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.03 -17.26 61.0 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 167.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 tp -128.42 -9.0 5.19 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -159.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.88 -15.88 24.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.136 2.174 . . . . 0.0 112.702 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -72.81 -20.26 61.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.494 1.118 . . . . 0.0 113.261 170.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.51 -6.69 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.149 1.78 . . . . 0.0 112.746 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.6 6.09 49.82 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.196 1.798 . . . . 0.0 109.808 158.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 C--O 1.25 1.082 0 C-N-CA 124.653 1.181 . . . . 0.0 109.717 163.679 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.66 HD13 ' HB1' ' A' ' 53' ' ' ALA . 1.8 mp . . . . . 0 CA--C 1.528 0.108 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.0 p -134.96 -62.01 0.74 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.778 0.799 . . . . 0.0 110.528 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 8' ' ' ALA . 39.0 p-10 -179.3 -78.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.468 1.907 . . . . 0.0 108.807 -159.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.412 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . -61.69 -38.44 87.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.984 0.913 . . . . 0.0 109.66 172.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -75.82 -21.53 57.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.362 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -67.58 -55.87 11.69 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 173.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -63.02 -35.63 80.85 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.39 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -58.11 -46.3 85.79 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.801 0.728 . . . . 0.0 110.638 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.34 -40.7 96.39 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.026 -0.988 . . . . 0.0 112.567 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . 0.257 11.8 pt -72.22 -67.31 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 118.851 0.75 . . . . 0.0 111.613 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 37.78 -13.39 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.601 1 C-N-CA 134.905 5.282 . . . . 0.0 120.359 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 174.1 -159.93 29.47 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 120.78 1.627 . . . . 0.0 116.049 -166.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.586 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 4.0 m-20 -70.52 -9.37 56.49 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.211 3.004 . . . . 0.0 115.835 -161.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.52 164.2 54.03 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 119.093 0.86 . . . . 0.0 112.967 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.33 110.25 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.293 2.662 . . . . 0.0 107.775 166.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.499 ' HA ' ' HB ' ' A' ' 51' ' ' THR . 60.1 t -122.2 142.54 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.454 HD11 HG13 ' A' ' 52' ' ' VAL . 1.3 pp -133.5 155.85 48.82 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.161 0.505 . . . . 0.0 110.156 168.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.666 HG13 HD11 ' A' ' 55' ' ' LEU . 2.1 t -128.55 124.2 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.605 1.562 . . . . 0.0 107.612 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.01 100.9 13.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.676 1.59 . . . . 0.0 107.967 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.578 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 61.1 m-85 -89.71 109.77 20.72 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.915 0.886 . . . . 0.0 108.979 174.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -137.4 -171.86 3.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.97 170.19 21.08 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.196 1.398 . . . . 0.0 107.454 169.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.38 -14.65 62.42 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CH2' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -113.53 -24.11 9.43 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -166.31 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 p -70.94 34.59 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 127.275 2.23 . . . . 0.0 116.51 -160.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 52.3 -110.21 1.11 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.523 1.535 . . . . 0.0 113.372 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.11 -14.94 31.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.085 3.19 . . . . 0.0 114.921 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 17.5 p -54.54 -30.96 55.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.988 0.813 . . . . 0.0 111.856 165.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -71.69 -6.21 39.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.161 0.984 . . . . 0.0 112.923 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.6 mtm -108.82 -30.41 8.16 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.974 1.709 . . . . 0.0 111.371 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.3 tpt -75.07 -43.91 50.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.227 1.811 . . . . 0.0 109.406 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.0 95.41 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 116.806 -1.569 . . . . 0.0 112.09 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 26.6 Cg_endo -63.7 -34.68 61.66 Favored 'Trans proline' 0 C--N 1.352 0.728 0 CA-C-N 122.432 1.904 . . . . 0.0 112.54 173.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.29 -33.39 63.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 119.728 1.149 . . . . 0.0 110.983 174.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mp -75.92 -23.08 55.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.715 1.606 . . . . 0.0 111.672 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -66.04 -44.8 83.54 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 124.331 1.052 . . . . 0.0 109.425 169.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.469 ' OE2' ' HE3' ' A' ' 93' ' ' LYS . 19.0 tt0 -59.22 -48.88 79.99 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 172.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -52.33 -49.48 64.18 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 122.665 0.386 . . . . 0.0 110.748 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.1 -51.93 58.45 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.971 0.908 . . . . 0.0 111.33 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.15 -47.51 75.0 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.366 0.667 . . . . 0.0 109.992 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.14 -17.09 64.19 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -136.0 14.42 3.33 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -168.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -42.5 -46.03 4.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.912 1.685 . . . . 0.0 113.366 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -86.0 -13.46 47.47 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -94.29 -21.93 18.7 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.69 -0.631 . . . . 0.0 111.483 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.47 137.45 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 122.207 1.003 . . . . 0.0 109.803 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 20' ' ' VAL . 3.5 m -77.75 86.84 4.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.319 1.848 . . . . 0.0 107.16 -175.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.454 HG13 HD11 ' A' ' 21' ' ' LEU . 45.4 t -80.44 159.72 4.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.66 ' HB1' HD13 ' A' ' 5' ' ' LEU . . . -162.01 158.85 25.64 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 162.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -135.92 129.38 32.15 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -166.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.666 HD11 HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -149.67 151.72 34.17 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 122.525 1.155 . . . . 0.0 113.227 -174.295 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -87.17 103.96 15.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.286 1.835 . . . . 0.0 107.503 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.443 HG21 HG22 ' A' ' 69' ' ' ILE . 4.5 p -61.21 -24.29 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.279 1.032 . . . . 0.0 113.513 -165.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.43 -42.89 78.24 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.881 0.872 . . . . 0.0 110.708 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -81.81 -18.22 44.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.364 2.266 . . . . 0.0 111.914 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -109.59 78.68 1.2 Allowed Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.849 1.66 . . . . 0.0 109.805 173.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.08 -18.06 14.73 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.269 2.646 . . . . 0.0 112.481 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.71 125.75 25.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.143 1.377 . . . . 0.0 109.619 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.2 m 66.53 -29.56 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.932 3.293 . . . . 0.0 112.492 -174.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -52.36 -54.05 36.82 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.815 2.046 . . . . 0.0 110.587 172.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.8 t -62.03 -41.92 98.62 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.166 0.292 . . . . 0.0 110.508 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -60.91 -42.4 97.99 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.993 0.917 . . . . 0.0 111.87 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -96.63 5.52 50.56 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.4 33.48 72.83 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 119.224 0.92 . . . . 0.0 112.125 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.578 HG21 ' CZ ' ' A' ' 24' ' ' PHE . 35.5 mm -75.75 82.37 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.599 1.56 . . . . 0.0 110.118 -166.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 93.4 mtp -122.47 -3.29 8.87 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.625 1.17 . . . . 0.0 111.688 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.1 t -84.69 21.93 1.43 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.733 1.213 . . . . 0.0 113.998 -166.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.497 HD11 ' CH2' ' A' ' 28' ' ' TRP . 26.2 pt -56.05 144.1 60.29 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.108 1.363 . . . . 0.0 112.935 -170.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 57.1 Cg_endo -65.74 139.25 40.79 Favored 'Cis proline' 0 C--N 1.35 0.637 0 CA-C-O 121.99 0.746 . . . . 0.0 111.085 -1.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -138.09 149.19 45.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.6 tt -135.03 123.41 23.24 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.267 -2.124 . . . . 0.0 105.267 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.456 HD12 ' CE2' ' A' ' 24' ' ' PHE . 21.1 mt -124.84 147.67 29.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.44 HD12 HD21 ' A' ' 100' ' ' LEU . 6.5 tt -129.35 124.04 33.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.044 0.937 . . . . 0.0 108.897 -168.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -116.31 152.11 34.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.242 1.817 . . . . 0.0 110.398 -171.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 148.94 26.33 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 125.34 1.456 . . . . 0.0 107.38 158.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.586 ' H ' ' HA ' ' A' ' 17' ' ' ASP . . . 67.15 20.78 71.4 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -168.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.95 3.3 55.42 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.478 -1.179 . . . . 0.0 114.044 -171.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -120.39 139.34 28.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 119.589 1.694 . . . . 0.0 109.454 -170.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.63 125.91 9.21 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.011 2.474 . . . . 0.0 111.775 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -78.33 -43.48 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 123.78 0.832 . . . . 0.0 110.781 175.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -158.77 169.97 23.19 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.022 0.929 . . . . 0.0 109.864 -174.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.401 ' CB ' HG12 ' A' ' 76' ' ' ILE . 1.7 pm0 -137.02 157.22 47.21 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.84 1.256 . . . . 0.0 111.13 173.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.43 HD11 ' HG2' ' A' ' 99' ' ' GLN . 4.2 mm? -123.36 145.26 48.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 127.947 2.499 . . . . 0.0 106.087 169.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.6 pt -138.79 156.14 28.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 124.756 1.223 . . . . 0.0 109.058 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.07 179.08 11.17 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -71.4 126.15 28.89 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -126.23 134.5 26.03 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 165.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.99 159.15 47.82 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.167 1.245 . . . . 0.0 110.011 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.469 ' HE3' ' OE2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -49.51 -36.96 24.78 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 125.293 1.437 . . . . 0.0 112.686 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -58.7 -50.11 75.11 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.649 1.58 . . . . 0.0 110.973 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -74.39 -36.73 63.51 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.874 1.269 . . . . 0.0 109.378 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.79 -63.28 1.25 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.471 1.108 . . . . 0.0 108.04 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.36 -31.69 73.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 118.379 -0.82 . . . . 0.0 110.754 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.76 -44.03 78.44 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.694 0.679 . . . . 0.0 110.75 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.43 ' HG2' HD11 ' A' ' 87' ' ' LEU . 9.5 tp-100 -67.15 -38.26 85.19 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 118.24 0.473 . . . . 0.0 111.493 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.44 HD21 HD12 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -86.15 -6.43 59.0 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.958 0.903 . . . . 0.0 112.997 -173.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.66 -33.2 15.0 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.954 1.701 . . . . 0.0 114.201 -175.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.16 -6.56 9.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.64 1.564 . . . . 0.0 114.17 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.36 2.92 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.261 0.937 . . . . 0.0 113.108 166.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.32 -13.5 13.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.469 1.107 . . . . 0.0 112.403 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 127.777 2.431 . . . . 0.0 109.478 165.497 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.416 HD13 ' CB ' ' A' ' 53' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.5 t -149.3 -128.82 0.05 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.457 ' HA ' HD22 ' A' ' 60' ' ' ASN . 18.0 p-10 -84.65 -70.72 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 120.224 1.375 . . . . 0.0 110.937 164.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.55 82.34 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.349 0.977 . . . . 0.0 111.433 -171.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -76.0 -14.42 60.23 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.898 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -67.3 -68.28 0.39 Allowed 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 172.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.7 -48.79 69.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.463 0.705 . . . . 0.0 110.411 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -68.29 -19.48 64.7 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.145 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.38 -58.78 3.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.157 1.344 . . . . 0.0 110.669 164.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.9 pt -62.11 -21.8 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -168.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -64.94 -20.34 66.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.462 1.105 . . . . 0.0 113.589 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.04 166.54 48.58 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 119.662 1.119 . . . . 0.0 111.606 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.59 -4.18 57.95 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.14 148.53 50.95 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 120.707 -1.246 . . . . 0.0 110.03 171.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -62.76 96.6 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.78 2.32 . . . . 0.0 109.137 167.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 t -99.03 115.5 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 125.187 1.395 . . . . 0.0 107.85 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tt -113.43 119.82 38.91 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 126.052 1.741 . . . . 0.0 108.475 -168.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.9 t -109.3 110.73 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 126.218 1.807 . . . . 0.0 109.034 -168.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.445 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 28.2 t0 -82.2 98.77 8.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.924 0.784 . . . . 0.0 109.832 167.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -81.32 112.91 19.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 164.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -134.3 -174.04 3.44 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.64 166.3 32.37 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.886 1.275 . . . . 0.0 108.603 167.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.76 65.85 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.6 -30.26 11.87 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -170.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.02 98.97 3.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.613 0.642 . . . . 0.0 111.113 -164.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -25.47 -66.17 0.05 OUTLIER Glycine 0 CA--C 1.541 1.714 0 C-N-CA 126.385 1.945 . . . . 0.0 115.255 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.26 -30.98 23.69 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.311 2.008 . . . . 0.0 113.181 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 p -67.71 -34.6 77.19 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 119.34 0.973 . . . . 0.0 110.158 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -66.67 -12.13 56.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.49 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.9 mtp -97.97 -37.95 9.58 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.88 1.272 . . . . 0.0 111.526 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.1 ttt -74.17 -39.01 63.52 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.009 0.923 . . . . 0.0 110.781 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.58 -52.16 75.61 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 117.826 -1.083 . . . . 0.0 111.349 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.41 -34.61 65.22 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.844 1.694 . . . . 0.0 112.113 172.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.32 -31.38 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 119.65 1.113 . . . . 0.0 111.606 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mp -79.48 -26.17 41.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.196 2.198 . . . . 0.0 111.96 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.82 -44.37 93.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.79 1.177 . . . . 0.0 108.983 171.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -63.09 -45.62 91.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.854 0.462 . . . . 0.0 110.254 172.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -58.68 -38.29 77.89 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 122.017 -0.427 . . . . 0.0 111.158 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.37 -54.39 47.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.213 1.005 . . . . 0.0 109.445 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -51.57 62.11 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.597 0.759 . . . . 0.0 109.841 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.18 -11.94 10.99 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -174.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -136.09 17.42 3.23 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.449 1.099 . . . . 0.0 113.021 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.55 -20.63 1.23 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -158.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -133.74 8.22 3.84 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 173.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -80.94 -23.38 38.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.517 1.053 . . . . 0.0 110.51 161.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.56 176.07 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.226 1.01 . . . . 0.0 110.529 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 73.4 m -115.02 88.06 2.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.2 2.2 . . . . 0.0 107.157 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 t -80.81 149.28 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.416 ' CB ' HD13 ' A' ' 5' ' ' LEU . . . -154.06 167.52 29.54 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 162.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 39.9 pttt -134.09 150.11 51.15 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.027 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -154.87 157.85 38.46 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 125.196 1.56 . . . . 0.0 112.863 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -86.16 104.89 16.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.018 1.327 . . . . 0.0 107.661 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.8 p -49.27 -35.56 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.011 1.324 . . . . 0.0 113.488 -166.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -55.12 -37.21 66.61 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.684 1.594 . . . . 0.0 112.718 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.72 -22.12 65.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.649 1.58 . . . . 0.0 113.393 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.457 HD22 ' HA ' ' A' ' 7' ' ' ASP . 26.1 t-20 -117.06 82.71 14.08 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 125.912 1.685 . . . . 0.0 108.594 -172.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.71 -31.19 3.38 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.037 1.825 . . . . 0.0 111.978 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -63.68 140.79 58.91 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.54 0.736 . . . . 0.0 110.073 177.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.9 m 66.79 -33.3 0.2 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 128.253 2.621 . . . . 0.0 113.079 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.4 m -64.81 -56.33 14.15 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 128.559 2.744 . . . . 0.0 109.305 172.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -69.08 -11.79 61.11 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.115 -0.945 . . . . 0.0 112.667 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.97 -55.18 5.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.226 0.921 . . . . 0.0 109.166 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -87.66 10.72 17.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.533 0.606 . . . . 0.0 112.308 -167.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.42 24.96 62.07 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.044 1.307 . . . . 0.0 113.163 173.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.1 mm -83.4 79.08 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 122.489 1.138 . . . . 0.0 110.205 -162.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -115.69 -6.37 12.15 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.475 166.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.1 p -84.71 24.48 1.02 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.255 1.822 . . . . 0.0 113.742 -164.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.457 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -69.74 155.44 93.5 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 122.844 0.457 . . . . 0.0 111.483 -163.337 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 55.7 Cg_endo -66.44 130.19 12.11 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 119.859 0.985 . . . . 0.0 111.38 6.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.0 m -118.85 143.13 47.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -124.18 100.52 6.75 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.3 mt -97.72 144.26 11.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 tt -111.89 125.77 54.39 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 164.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -118.99 161.66 19.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.213 1.805 . . . . 0.0 110.542 -173.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -162.57 147.3 12.04 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 124.837 1.255 . . . . 0.0 109.035 158.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.42 20.34 44.49 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.521 -0.6 . . . . 0.0 113.66 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.82 -10.27 57.47 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.401 1.476 . . . . 0.0 113.854 -171.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -83.87 125.21 73.64 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 119.26 1.53 . . . . 0.0 109.277 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.49 94.5 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.167 2.578 . . . . 0.0 108.782 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 m -60.73 -37.32 75.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.565 -0.709 . . . . 0.0 111.697 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.565 ' HE3' ' HA ' ' A' ' 100' ' ' LEU . 18.9 pttm -166.26 165.02 17.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.162 1.385 . . . . 0.0 109.019 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.16 158.37 43.76 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.54 0.736 . . . . 0.0 112.214 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.11 153.42 23.17 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 160.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.1 140.35 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 126.101 1.76 . . . . 0.0 106.684 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.65 165.62 5.93 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.778 0.704 . . . . 0.0 111.782 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.34 96.97 0.12 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.56 1.144 . . . . 0.0 110.298 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -93.3 131.82 31.91 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 167.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.59 161.83 41.81 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.011 1.808 . . . . 0.0 109.863 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -40.15 66.7 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.342 0.657 . . . . 0.0 112.372 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -59.84 -24.75 64.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.428 1.091 . . . . 0.0 113.192 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.4 tp-100 -95.98 -44.09 7.51 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.835 1.254 . . . . 0.0 109.12 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -67.57 0.25 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.909 2.484 . . . . 0.0 108.671 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.58 -37.89 85.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 117.963 -1.018 . . . . 0.0 108.703 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.88 99.77 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.69 1.132 . . . . 0.0 111.906 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -69.67 -20.54 63.57 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.876 0.471 . . . . 0.0 112.177 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.565 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 1.1 tp -105.88 -10.22 16.76 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.118 1.367 . . . . 0.0 112.693 -171.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.23 -7.33 5.81 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.776 2.831 . . . . 0.0 114.48 -173.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -84.6 -13.34 51.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.089 1.756 . . . . 0.0 112.457 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.23 -16.17 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.092 0.86 . . . . 0.0 111.097 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -82.14 -6.07 58.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 121.626 -0.672 . . . . 0.0 112.226 162.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 . . . . . 0 C--O 1.245 0.836 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 158.721 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.52 ' HB2' HD23 ' A' ' 55' ' ' LEU . 32.4 mt . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.1 m -152.66 -32.72 0.13 Allowed 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.387 -1.445 . . . . 0.0 113.187 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -171.6 -79.9 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 125.989 1.716 . . . . 0.0 106.654 160.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.84 -27.28 63.05 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 121.013 -1.054 . . . . 0.0 112.303 173.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 12' ' ' GLN . 12.7 t-20 -72.99 -21.63 60.81 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.063 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.28 1.71 0.71 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.638 1.975 . . . . 0.0 112.264 168.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -126.9 -50.15 1.46 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.039 1.335 . . . . 0.0 109.783 168.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 9' ' ' ASN . 45.6 tt0 -53.71 -35.64 61.36 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.163 0.985 . . . . 0.0 112.284 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.35 -45.86 24.7 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.982 0.81 . . . . 0.0 110.024 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -67.53 -23.61 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 117.732 -1.128 . . . . 0.0 112.236 -170.62 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -50.17 -35.11 24.85 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.813 1.245 . . . . 0.0 113.728 -164.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.78 122.69 0.97 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 166.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -156.25 -71.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.883 0.873 . . . . 0.0 110.081 -170.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 149.21 -166.67 29.51 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -161.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.86 89.44 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.649 2.899 . . . . 0.0 110.958 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t -70.45 146.22 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 126.89 2.076 . . . . 0.0 108.479 169.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -144.8 123.58 12.63 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.835 1.654 . . . . 0.0 107.685 -170.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.49 140.88 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 119.508 1.049 . . . . 0.0 111.43 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.408 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 53.6 t0 -98.95 104.16 16.18 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.933 0.893 . . . . 0.0 109.356 159.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -85.15 108.33 17.65 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 166.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -130.82 -172.47 2.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.224 1.41 . . . . 0.0 107.92 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.62 165.97 29.74 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 125.749 1.619 . . . . 0.0 107.878 168.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.42 -14.29 55.9 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -174.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.64 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -108.04 -23.85 11.83 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.851 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' HD12 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -74.31 93.35 2.37 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.195 0.907 . . . . 0.0 111.449 -165.223 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -24.49 -63.98 0.05 OUTLIER Glycine 0 CA--C 1.542 1.723 0 C-N-CA 126.377 1.941 . . . . 0.0 115.495 173.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.99 -36.3 22.87 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.562 2.174 . . . . 0.0 113.382 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 p -63.32 -37.14 86.09 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.792 1.178 . . . . 0.0 110.103 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.53 -20.28 64.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.647 0.779 . . . . 0.0 112.043 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.4 mtm -101.27 -14.05 17.82 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.968 1.307 . . . . 0.0 112.749 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.9 ttt -93.28 -39.21 11.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.668 1.587 . . . . 0.0 109.776 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.15 -48.44 92.17 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 117.413 -1.279 . . . . 0.0 112.025 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.64 -33.48 45.01 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 121.862 1.701 . . . . 0.0 112.411 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -40.66 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.457 1.026 . . . . 0.0 109.873 174.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 42' ' ' PHE . 4.9 mp -66.46 -20.23 65.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.085 1.754 . . . . 0.0 112.166 176.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.62 -51.33 28.78 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.222 0.919 . . . . 0.0 109.888 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.69 -43.03 97.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.271 0.628 . . . . 0.0 110.438 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 67.0 t80 -51.55 -57.36 9.31 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.633 1.173 . . . . 0.0 110.317 169.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.91 -52.06 65.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.65 -0.691 . . . . 0.0 111.156 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -55.22 -42.88 73.91 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.042 0.937 . . . . 0.0 110.804 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.0 -15.67 24.41 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -146.88 56.22 1.13 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.193 1.397 . . . . 0.0 109.819 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.07 64.57 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -169.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -134.98 -2.11 2.61 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -63.7 -32.19 73.61 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.884 -1.135 . . . . 0.0 109.464 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.02 165.11 24.51 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 124.336 1.054 . . . . 0.0 110.252 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.6 m -107.96 88.8 2.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.778 2.031 . . . . 0.0 108.681 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 t -71.73 158.17 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.668 0.787 . . . . 0.0 110.291 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.13 155.04 34.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.903 1.681 . . . . 0.0 106.801 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 14.8 mtpt -139.62 128.91 24.01 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 5' ' ' LEU . 0.6 OUTLIER -147.42 150.69 35.13 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.198 0.936 . . . . 0.0 111.825 -175.148 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.97 128.12 34.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 167.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.34 -34.06 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.04 -42.94 75.67 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.265 1.426 . . . . 0.0 110.717 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.32 -35.78 67.97 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.361 2.265 . . . . 0.0 112.487 176.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.39 80.49 4.59 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.271 1.029 . . . . 0.0 110.769 -172.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.12 -28.54 23.39 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.734 2.29 . . . . 0.0 114.185 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -52.49 117.22 2.71 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.027 1.331 . . . . 0.0 110.944 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.256 21.7 m 68.13 -21.35 0.13 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 129.202 3.001 . . . . 0.0 113.336 174.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.9 m -53.28 -52.47 58.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.003 1.721 . . . . 0.0 108.833 162.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -69.96 -3.33 15.65 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 117.722 -1.133 . . . . 0.0 113.266 176.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -100.94 -38.44 8.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.769 1.168 . . . . 0.0 110.595 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -92.63 7.67 42.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.702 0.683 . . . . 0.0 111.831 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.86 34.2 81.87 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 123.714 0.673 . . . . 0.0 111.739 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 26.2 mm -77.92 71.31 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.3 1.44 . . . . 0.0 109.002 -170.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 53.6 ttm -95.05 -18.48 20.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.431 1.092 . . . . 0.0 110.292 161.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.3 t -62.22 128.01 34.06 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.588 1.155 . . . . 0.0 108.67 167.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.64 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 14.8 pt -146.44 156.11 49.51 Favored Pre-proline 0 N--CA 1.443 -0.818 0 C-N-CA 126.829 2.052 . . . . 0.0 107.531 159.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.36 130.1 9.57 Favored 'Cis proline' 0 N--CA 1.453 -0.91 0 CA-C-N 119.733 0.94 . . . . 0.0 110.467 -9.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.7 m -123.78 149.3 45.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tt -135.12 134.58 40.38 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.3 mt -131.67 144.12 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.19 136.75 48.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 168.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -133.26 169.48 16.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.334 1.854 . . . . 0.0 110.909 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.457 ' N ' ' HE3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -153.69 155.81 36.68 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.376 1.871 . . . . 0.0 106.204 158.666 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.02 37.58 4.34 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 124.579 1.085 . . . . 0.0 115.795 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.457 ' H ' HG22 ' A' ' 14' ' ' ILE . . . 75.24 17.81 80.14 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.735 1.16 . . . . 0.0 115.1 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -139.64 135.5 16.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.052 1.341 . . . . 0.0 108.9 -168.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.09 170.84 16.01 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.066 2.511 . . . . 0.0 113.097 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.13 -7.53 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.848 1.659 . . . . 0.0 112.081 173.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 161.15 170.75 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 1 C-N-CA 132.088 4.155 . . . . 0.0 108.763 164.15 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -129.5 142.87 50.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.492 1.917 . . . . 0.0 107.639 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.77 145.41 48.07 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 128.926 2.89 . . . . 0.0 106.299 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.69 135.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -173.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.68 165.18 41.03 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 123.772 0.701 . . . . 0.0 112.311 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -77.48 69.33 3.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.917 1.287 . . . . 0.0 111.486 -174.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -76.86 131.81 72.68 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.79 168.09 19.53 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.086 2.524 . . . . 0.0 110.988 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -45.59 76.01 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 123.846 0.858 . . . . 0.0 110.45 -174.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.76 -12.09 59.83 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.323 1.049 . . . . 0.0 112.386 -174.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.13 -55.76 2.68 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.476 1.511 . . . . 0.0 108.155 172.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 tt -54.38 -60.73 2.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.844 2.058 . . . . 0.0 110.315 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -65.51 -20.99 66.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.565 1.146 . . . . 0.0 111.845 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.16 -48.1 31.52 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.487 1.04 . . . . 0.0 109.623 170.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -59.41 -32.08 69.85 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.846 1.258 . . . . 0.0 112.104 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tp -97.71 0.52 47.17 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.669 1.988 . . . . 0.0 112.379 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.07 -29.42 68.55 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.992 0.917 . . . . 0.0 112.529 -169.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -65.85 -12.82 57.38 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.99 4.53 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.814 0.846 . . . . 0.0 112.226 173.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -112.28 -6.42 14.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.528 1.131 . . . . 0.0 112.853 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.539 1.936 . . . . 0.0 108.966 159.24 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.1 m -149.43 163.12 38.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -42.79 -55.28 3.72 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.437 3.095 . . . . 0.0 113.624 -164.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.32 91.95 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.369 0.604 . . . . 0.0 111.792 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.71 -18.1 58.71 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.059 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.34 -61.92 2.14 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.749 1.159 . . . . 0.0 108.745 174.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.417 ' HA ' HG12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -59.39 -39.74 84.35 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.577 0.351 . . . . 0.0 110.781 -177.376 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -74.84 -16.44 60.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.62 0.768 . . . . 0.0 112.701 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.22 -57.36 3.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.352 0.978 . . . . 0.0 109.321 168.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 11' ' ' GLN . 41.2 pt -59.32 -24.35 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -170.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -67.4 -17.62 64.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.615 1.166 . . . . 0.0 113.198 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.42 165.01 47.5 Favored Glycine 0 C--N 1.342 0.909 0 C-N-CA 124.127 0.87 . . . . 0.0 112.124 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -80.29 -42.48 23.01 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.382 1.473 . . . . 0.0 111.956 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.27 164.06 54.88 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 123.371 0.51 . . . . 0.0 112.681 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.2 100.63 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.775 2.984 . . . . 0.0 112.006 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.1 t -90.18 121.99 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 C-N-CA 125.986 1.714 . . . . 0.0 108.116 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 tt -118.95 112.16 19.26 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.132 0.973 . . . . 0.0 109.312 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -91.49 127.85 43.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 62.1 t0 -92.08 101.93 14.47 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 164.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -87.19 111.69 21.23 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 14.5 p-90 -135.29 178.49 6.99 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.772 1.229 . . . . 0.0 110.491 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.73 167.49 30.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.982 1.313 . . . . 0.0 110.798 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.77 -4.65 41.73 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.11 -16.0 7.6 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -174.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.8 p -75.45 36.93 0.13 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.836 1.654 . . . . 0.0 114.287 -165.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 33.39 -97.94 0.01 OUTLIER Glycine 0 CA--C 1.536 1.381 0 C-N-CA 128.913 3.149 . . . . 0.0 114.464 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.67 -15.76 33.14 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.751 2.967 . . . . 0.0 115.053 -175.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.3 p -54.4 -32.33 56.95 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.347 0.976 . . . . 0.0 111.96 167.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttp85 -67.03 -12.03 58.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.771 0.828 . . . . 0.0 112.66 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.5 mtp -110.09 -20.4 12.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.716 1.606 . . . . 0.0 111.846 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.4 ttt -80.61 -44.31 19.12 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 124.52 1.128 . . . . 0.0 109.412 170.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.66 -47.6 78.43 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 116.802 -1.571 . . . . 0.0 113.528 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.25 -29.9 25.55 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.098 1.865 . . . . 0.0 112.719 171.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.8 -30.12 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 120.216 1.371 . . . . 0.0 111.007 171.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.3 mt -80.02 -18.04 51.24 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.959 1.704 . . . . 0.0 111.212 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.83 -41.92 58.99 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.057 0.943 . . . . 0.0 110.299 162.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.87 -15.51 62.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.676 1.19 . . . . 0.0 111.498 171.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.406 ' CE2' HD12 ' A' ' 96' ' ' LEU . 31.9 t80 -85.29 -49.0 8.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.221 1.808 . . . . 0.0 109.025 167.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.29 -32.22 66.42 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.17 -0.919 . . . . 0.0 113.363 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.29 -57.35 5.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.03 1.286 . . . . 0.0 110.919 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.68 -22.47 35.04 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -159.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.9 30.21 1.18 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.886 1.275 . . . . 0.0 111.114 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -20.29 -63.4 0.02 OUTLIER 'General case' 0 C--N 1.341 0.196 0 C-N-CA 128.94 2.896 . . . . 0.0 115.314 -170.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -108.12 8.1 27.94 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -169.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -70.88 -26.06 63.07 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.982 0.81 . . . . 0.0 109.682 158.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.79 170.26 15.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.192 0.997 . . . . 0.0 110.9 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.267 10.7 t -124.91 103.64 8.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 158.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.6 t -70.08 155.75 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.09 111.42 3.91 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 6.0 tttp -89.19 130.72 35.57 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -172.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.37 143.15 24.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.927 0.87 . . . . 0.0 112.77 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -81.14 117.69 21.91 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.1 p -51.8 -32.2 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.503 1.121 . . . . 0.0 113.801 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -67.79 -29.76 69.03 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.191 1.797 . . . . 0.0 112.488 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -23.77 60.69 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.979 1.312 . . . . 0.0 112.462 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -126.21 87.36 56.32 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 125.237 1.415 . . . . 0.0 109.735 -163.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.55 -29.87 15.72 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.875 2.383 . . . . 0.0 113.712 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 64' ' ' THR . 8.3 tp10 -73.8 137.55 43.93 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.741 1.155 . . . . 0.0 110.73 -173.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.7 m 64.09 -31.01 0.11 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 130.123 3.369 . . . . 0.0 112.822 -169.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 62' ' ' GLU . 52.2 m -58.08 -57.35 13.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.572 1.949 . . . . 0.0 109.45 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -57.78 -46.25 84.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.053 0.541 . . . . 0.0 109.874 178.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -58.39 -35.59 72.25 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.024 0.93 . . . . 0.0 112.758 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -100.55 9.83 42.01 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.191 0.597 . . . . 0.0 112.118 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.24 29.05 74.34 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 119.1 0.864 . . . . 0.0 112.927 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mm -77.13 81.38 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.333 1.453 . . . . 0.0 109.915 -166.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.6 mmt -123.89 -0.98 8.41 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.726 1.61 . . . . 0.0 111.103 166.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.4 t -77.9 30.07 0.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.161 1.785 . . . . 0.0 113.077 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.472 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -67.96 148.44 98.4 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.384 0.538 . . . . 0.0 111.828 -172.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 62.3 Cg_endo -66.36 128.74 9.56 Favored 'Cis proline' 0 C--N 1.35 0.635 0 CA-C-N 119.73 0.939 . . . . 0.0 111.493 4.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.1 m -123.76 151.87 42.79 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 122.207 1.003 . . . . 0.0 108.838 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.9 tt -131.87 130.21 41.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 mt -130.28 141.24 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 165.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.72 119.55 39.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 175.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -117.32 161.22 19.86 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.979 2.112 . . . . 0.0 112.391 -175.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.41 157.33 19.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.65 2.38 . . . . 0.0 108.668 159.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.42 14.83 14.28 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.94 1.257 . . . . 0.0 115.394 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.87 -6.02 58.38 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.625 1.584 . . . . 0.0 113.543 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -129.01 157.44 75.84 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 119.183 1.492 . . . . 0.0 110.689 -170.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.74 166.78 24.96 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.31 2.007 . . . . 0.0 111.55 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.44 -34.8 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.734 1.214 . . . . 0.0 108.505 158.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -162.02 165.77 26.88 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.495 1.118 . . . . 0.0 109.978 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -136.45 143.26 43.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.937 2.495 . . . . 0.0 106.397 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.7 mt -132.55 153.4 51.01 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.618 1.567 . . . . 0.0 108.194 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.2 pt -143.85 143.61 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.052 1.341 . . . . 0.0 108.075 -173.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.64 161.94 26.36 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.783 0.706 . . . . 0.0 111.903 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -75.25 78.55 2.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.083 0.953 . . . . 0.0 111.526 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -69.63 140.86 89.79 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 166.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.85 160.25 49.98 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.748 1.632 . . . . 0.0 110.404 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.91 -45.88 42.13 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.93 1.292 . . . . 0.0 112.814 -171.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -74.09 -25.1 59.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.455 -172.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -73.8 -37.67 64.85 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.406 HD12 ' CE2' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -59.0 -61.26 2.78 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.165 1.386 . . . . 0.0 108.813 175.584 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -64.94 -25.78 68.02 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.22 -0.895 . . . . 0.0 112.229 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.21 -53.88 12.89 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.856 0.753 . . . . 0.0 110.494 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -62.19 -35.07 77.74 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.148 0.579 . . . . 0.0 112.302 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.83 1.85 56.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.645 1.178 . . . . 0.0 112.751 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.15 -31.97 54.0 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 120.082 1.31 . . . . 0.0 113.511 -174.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -65.4 -14.41 60.82 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.954 0.901 . . . . 0.0 113.295 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 66.0 t -109.06 -5.57 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.574 1.55 . . . . 0.0 110.858 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.47 -5.85 14.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.791 1.236 . . . . 0.0 112.741 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.099 0 C-N-CA 126.946 2.099 . . . . 0.0 110.552 164.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.708 ' HB2' HD23 ' A' ' 55' ' ' LEU . 58.0 mt . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.0 m -125.17 -88.53 0.59 Allowed 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -140.03 -66.25 0.45 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.858 0.863 . . . . 0.0 109.132 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.68 -30.83 45.28 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.666 -0.646 . . . . 0.0 111.912 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -72.32 -26.3 61.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.103 0.561 . . . . 0.0 110.688 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.423 ' HD2' HD21 ' A' ' 55' ' ' LEU . 50.3 t80 -58.0 -62.83 1.53 Allowed 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.021 0.929 . . . . 0.0 109.678 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.443 ' HA ' HG12 ' A' ' 14' ' ' ILE . 20.9 tt0 -60.39 -42.43 95.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.841 0.456 . . . . 0.0 110.502 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -64.12 -25.65 68.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.66 1.184 . . . . 0.0 112.962 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.08 -61.53 1.97 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.232 0.924 . . . . 0.0 110.058 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 11' ' ' GLN . 43.2 pt -59.07 -20.34 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -167.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -60.67 -19.05 57.36 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.344 1.458 . . . . 0.0 113.321 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.95 157.51 48.6 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 119.452 1.024 . . . . 0.0 111.631 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -76.94 -36.28 56.69 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.846 1.659 . . . . 0.0 111.443 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.22 161.97 47.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 123.814 0.721 . . . . 0.0 111.721 177.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.29 107.88 0.74 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.591 2.86 . . . . 0.0 110.948 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.466 HG22 ' HB ' ' A' ' 51' ' ' THR . 71.4 t -98.45 141.96 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 167.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.53 153.5 44.91 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 118.565 0.62 . . . . 0.0 111.033 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.02 126.85 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 22.4 t0 -80.12 121.2 25.26 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.953 0.783 . . . . 0.0 108.915 161.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.418 ' CD1' HG23 ' A' ' 57' ' ' VAL . 63.6 m-85 -98.26 107.16 19.56 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.045 0.938 . . . . 0.0 108.684 163.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -124.08 -177.7 3.85 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.905 1.282 . . . . 0.0 107.992 172.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.61 165.96 33.21 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.971 1.308 . . . . 0.0 108.832 170.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.66 -3.04 7.9 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -174.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.562 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -117.27 -24.58 7.39 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.81 1.187 . . . . 0.0 114.155 -175.237 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.73 93.79 2.63 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.196 0.907 . . . . 0.0 111.845 -163.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -19.32 -71.11 0.01 OUTLIER Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.538 2.018 . . . . 0.0 115.567 173.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.17 -29.46 47.48 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.16 2.574 . . . . 0.0 114.303 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.9 p -64.66 -27.7 69.11 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.513 1.051 . . . . 0.0 110.771 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -19.57 65.96 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.405 173.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -101.95 -23.89 14.07 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.935 1.294 . . . . 0.0 112.486 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.0 tpt -75.99 -47.28 25.54 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 125.917 1.687 . . . . 0.0 108.494 173.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.73 -48.15 70.43 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 120.133 1.333 . . . . 0.0 113.617 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.78 -33.02 21.88 Favored 'Trans proline' 0 C--N 1.352 0.741 0 CA-C-N 122.061 1.772 . . . . 0.0 112.53 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.49 -35.13 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.856 1.207 . . . . 0.0 110.526 173.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.3 mt -72.14 -21.7 61.42 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 125.929 1.692 . . . . 0.0 111.199 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.27 -52.68 31.11 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 170.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -71.34 -19.91 62.24 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -67.08 -60.06 2.94 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.044 1.338 . . . . 0.0 108.963 165.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.74 -49.55 65.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.821 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -53.93 -42.41 68.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.81 1.244 . . . . 0.0 111.262 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.35 -15.27 62.38 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -158.43 57.65 0.45 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.074 1.349 . . . . 0.0 109.462 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.02 -14.51 62.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.596 0.758 . . . . 0.0 112.086 -172.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -109.37 -55.22 2.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.383 3.473 . . . . 0.0 110.646 -172.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -53.72 -31.47 48.3 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 126.268 1.827 . . . . 0.0 112.444 -172.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 m -130.13 150.52 34.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.466 ' HB ' HG22 ' A' ' 20' ' ' VAL . 97.3 m -82.79 71.62 9.88 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 172.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.76 147.56 7.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 124.397 1.079 . . . . 0.0 109.936 175.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.65 163.02 40.01 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.186 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 51.3 pttt -128.26 143.14 51.0 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 123.736 0.648 . . . . 0.0 110.904 159.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.708 HD23 ' HB2' ' A' ' 5' ' ' LEU . 1.3 pp -146.29 154.34 41.58 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 124.974 1.421 . . . . 0.0 109.515 176.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -77.54 129.24 35.41 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 24' ' ' PHE . 3.3 p -68.06 -20.39 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.174 -0.953 . . . . 0.0 112.003 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.75 -17.38 55.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.593 0.757 . . . . 0.0 111.266 172.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.23 -34.5 21.99 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.3 1.84 . . . . 0.0 110.147 173.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -106.4 93.43 8.26 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 124.825 1.25 . . . . 0.0 111.264 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.18 -25.71 9.81 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.976 2.451 . . . . 0.0 113.75 164.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -58.89 119.24 6.84 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.752 1.16 . . . . 0.0 111.169 -177.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.268 16.4 m 63.58 -15.64 0.07 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.281 2.232 . . . . 0.0 113.795 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.7 m -53.03 -56.06 18.97 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.102 1.361 . . . . 0.0 108.844 167.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.6 t -72.18 0.39 9.87 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 117.821 -1.085 . . . . 0.0 112.899 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -108.3 -36.05 6.37 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.454 1.101 . . . . 0.0 111.177 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -104.06 10.0 36.21 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.033 0.833 . . . . 0.0 111.108 -175.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.62 32.11 59.84 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 123.918 0.77 . . . . 0.0 112.249 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.9 mm -75.23 83.25 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.999 0.919 . . . . 0.0 109.617 -170.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.2 ttp -128.07 -10.34 5.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.401 1.08 . . . . 0.0 111.342 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.4 t -87.22 56.62 4.06 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.428 1.091 . . . . 0.0 109.36 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.562 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 34.6 pt -81.96 148.43 60.67 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.183 -174.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.411 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 57.2 Cg_endo -66.77 125.02 6.16 Favored 'Cis proline' 0 C--N 1.35 0.62 0 CA-C-N 119.589 0.889 . . . . 0.0 110.925 -0.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.8 m -109.22 143.91 38.04 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.6 tt -129.4 132.93 47.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 171.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.1 mt -130.43 144.9 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.29 132.96 56.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.85 163.03 30.0 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.454 1.902 . . . . 0.0 111.778 -169.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.47 148.47 18.06 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 125.696 1.598 . . . . 0.0 108.554 157.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.87 19.99 38.98 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 123.904 0.764 . . . . 0.0 113.101 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.91 -7.4 51.2 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.197 1.38 . . . . 0.0 113.971 -170.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -84.3 118.9 72.33 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 119.297 1.548 . . . . 0.0 108.751 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.15 109.09 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.37 2.713 . . . . 0.0 109.853 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 m -71.1 -37.27 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.641 -0.662 . . . . 0.0 111.428 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -156.98 160.62 39.21 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.199 0.6 . . . . 0.0 111.846 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -128.8 142.55 50.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.713 2.405 . . . . 0.0 107.526 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.407 HD11 ' HG2' ' A' ' 99' ' ' GLN . 4.1 mm? -120.09 149.95 41.38 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.999 2.12 . . . . 0.0 107.044 165.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.47 132.52 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.353 1.461 . . . . 0.0 107.102 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.16 166.92 26.85 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.405 1.002 . . . . 0.0 112.135 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -76.83 74.56 3.46 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.505 1.122 . . . . 0.0 109.409 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -76.81 122.83 87.17 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 171.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.25 166.72 22.38 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.756 1.637 . . . . 0.0 110.441 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.427 ' HE3' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -47.98 -50.52 27.14 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.895 1.278 . . . . 0.0 112.412 -175.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.48 -19.71 65.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.73 -56.07 3.45 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.8 tt -55.99 -60.52 3.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.505 1.922 . . . . 0.0 109.394 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.427 ' OE1' ' HE3' ' A' ' 93' ' ' LYS . 6.3 tt0 -68.67 -17.4 64.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.493 1.117 . . . . 0.0 111.392 -176.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.84 -52.13 9.38 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 119.472 1.033 . . . . 0.0 110.069 166.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.407 ' HG2' HD11 ' A' ' 87' ' ' LEU . 18.6 tp60 -60.5 -27.52 67.65 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.966 0.907 . . . . 0.0 112.047 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.94 0.39 41.08 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.37 1.868 . . . . 0.0 112.988 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.89 -34.53 67.97 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.978 0.911 . . . . 0.0 112.746 -171.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -66.02 -11.92 51.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.508 1.523 . . . . 0.0 113.45 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.16 8.89 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.197 1.399 . . . . 0.0 111.552 171.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.2 -0.23 12.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.513 1.525 . . . . 0.0 113.529 169.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.363 1.865 . . . . 0.0 108.797 172.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.215 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.5 p -117.35 -89.0 0.59 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 158.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 8' ' ' ALA . 9.1 p-10 -142.84 -73.24 0.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.416 1.486 . . . . 0.0 108.014 -159.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.442 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . -54.14 -32.24 54.7 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.042 0.937 . . . . 0.0 111.291 170.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -81.7 -15.6 53.91 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 119.238 -0.985 . . . . 0.0 112.089 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -66.89 -54.13 25.25 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.145 0.884 . . . . 0.0 109.143 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -65.78 -23.05 66.63 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.604 0.761 . . . . 0.0 111.694 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -73.64 -49.11 27.64 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.152 0.887 . . . . 0.0 110.844 167.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.61 -39.57 91.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.962 0.801 . . . . 0.0 111.801 -171.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 14' ' ' ILE . 9.0 tt -58.26 -22.16 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.21 1.404 . . . . 0.0 113.38 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -56.06 -36.75 68.43 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.478 1.511 . . . . 0.0 113.874 -159.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.49 133.92 2.0 Allowed Glycine 0 C--N 1.334 0.428 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 -170.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -174.74 -55.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.836 1.654 . . . . 0.0 107.964 -166.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.73 -157.65 27.47 Favored Glycine 0 CA--C 1.534 1.281 0 N-CA-C 105.064 -3.214 . . . . 0.0 105.064 -158.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.17 103.66 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.205 2.604 . . . . 0.0 111.347 168.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.4 t -88.99 127.42 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 168.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 tt -132.19 122.99 26.15 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -172.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.99 119.74 62.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -172.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -97.07 94.13 6.98 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -176.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.457 ' CD1' HG23 ' A' ' 57' ' ' VAL . 29.9 m-85 -82.46 110.63 17.75 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.133 1.373 . . . . 0.0 108.871 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 16.5 p-90 -125.82 177.07 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.25 164.35 32.59 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.753 1.221 . . . . 0.0 108.953 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.58 -8.74 56.71 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -123.86 -13.88 7.3 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.7 p -70.22 39.19 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -158.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 42.87 -99.03 0.01 OUTLIER Glycine 0 CA--C 1.536 1.389 0 C-N-CA 127.572 2.51 . . . . 0.0 114.764 169.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -58.58 -19.02 42.88 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.862 3.041 . . . . 0.0 114.166 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 14.9 p -60.03 -22.68 62.95 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 119.188 0.904 . . . . 0.0 112.235 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -14.94 61.72 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.12 1.327 . . . . 0.0 112.451 173.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.2 mtm -100.43 -32.46 10.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.647 1.579 . . . . 0.0 111.054 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.2 ttt -72.91 -43.18 62.72 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-O 117.811 -1.09 . . . . 0.0 109.142 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.59 -45.97 85.41 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 116.595 -1.669 . . . . 0.0 113.213 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.5 -45.51 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.628 1.552 . . . . 0.0 111.79 167.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -30.17 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 121.71 2.05 . . . . 0.0 112.133 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 mt -68.7 -13.01 62.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 128.667 2.787 . . . . 0.0 112.252 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.88 -46.38 8.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.296 1.038 . . . . 0.0 109.851 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.89 -40.78 70.13 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.519 1.054 . . . . 0.0 110.665 165.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.456 ' CE1' HD22 ' A' ' 96' ' ' LEU . 79.0 t80 -56.14 -60.07 4.02 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.922 0.889 . . . . 0.0 110.235 171.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.69 -49.68 67.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.632 0.651 . . . . 0.0 111.861 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.1 -48.52 64.7 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.514 1.526 . . . . 0.0 110.547 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.93 -12.6 11.77 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -150.61 61.85 0.94 Allowed 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.268 1.427 . . . . 0.0 108.502 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.04 -45.41 64.67 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.634 1.574 . . . . 0.0 111.413 -169.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -136.41 9.75 3.19 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -61.94 -32.84 73.3 Favored 'General case' 0 C--N 1.345 0.403 0 O-C-N 121.413 -0.805 . . . . 0.0 110.201 163.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.0 m -119.71 143.37 31.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.341 1.1 t -82.21 73.59 9.24 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 124.259 1.981 . . . . 0.0 106.596 166.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.4 148.28 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 113.642 -1.617 . . . . 0.0 107.957 165.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.82 158.8 44.58 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.099 1.36 . . . . 0.0 107.631 170.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -133.05 124.82 28.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.76 152.13 46.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.67 1.224 . . . . 0.0 113.054 -177.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -85.22 110.17 18.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.051 1.74 . . . . 0.0 108.835 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.457 HG23 ' CD1' ' A' ' 24' ' ' PHE . 3.0 p -60.99 -26.19 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.039 0.936 . . . . 0.0 112.754 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -70.78 -22.69 62.34 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 126.547 1.939 . . . . 0.0 111.182 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.61 -38.74 13.72 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.589 1.156 . . . . 0.0 111.021 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -105.05 106.43 55.52 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.705 -169.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.89 -22.42 6.24 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.047 2.498 . . . . 0.0 114.316 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -66.41 118.55 10.22 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.325 0.966 . . . . 0.0 108.766 -173.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.272 25.9 m 67.65 -17.75 0.15 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.817 2.847 . . . . 0.0 112.659 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -54.5 -54.9 34.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.125 1.77 . . . . 0.0 108.895 160.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -57.97 -46.8 84.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.55 0.74 . . . . 0.0 110.356 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -55.06 -35.37 64.46 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.543 1.137 . . . . 0.0 112.899 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -111.09 14.75 21.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.232 0.613 . . . . 0.0 112.258 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.39 31.2 80.07 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 118.962 0.801 . . . . 0.0 113.114 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.7 mm -76.54 81.98 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.102 1.361 . . . . 0.0 110.288 -165.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.6 mmt -130.27 3.82 4.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.19 1.396 . . . . 0.0 111.424 165.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 t -78.89 37.44 0.3 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.232 1.813 . . . . 0.0 110.966 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.479 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -78.74 151.27 76.71 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 121.324 -0.86 . . . . 0.0 111.427 -169.429 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 61.3 Cg_endo -64.7 123.98 4.06 Favored 'Cis proline' 0 C--N 1.349 0.583 0 CA-C-N 119.861 0.986 . . . . 0.0 111.107 4.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.3 m -118.69 154.22 33.08 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 tt -146.3 122.7 10.99 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 104.673 -2.344 . . . . 0.0 104.673 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.8 mt -123.37 139.08 51.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 119.55 39.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.569 1.948 . . . . 0.0 105.822 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -122.26 169.16 11.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.797 2.439 . . . . 0.0 108.062 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.474 ' HE3' ' C ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -153.33 40.13 0.52 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.344 -0.847 . . . . 0.0 112.417 -179.718 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.92 87.41 1.91 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -167.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.69 -23.35 3.02 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 130.585 3.945 . . . . 0.0 114.422 160.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -131.94 149.3 72.95 Favored Pre-proline 0 N--CA 1.445 -0.69 0 C-N-CA 125.379 1.472 . . . . 0.0 110.182 -171.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.12 159.94 30.05 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.848 2.366 . . . . 0.0 111.043 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -38.67 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.239 1.416 . . . . 0.0 110.383 165.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -161.11 171.91 17.7 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 119.317 0.962 . . . . 0.0 111.381 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -139.05 150.38 45.7 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.24 2.216 . . . . 0.0 108.649 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.76 150.61 40.12 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.148 1.779 . . . . 0.0 107.632 161.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.9 pt -143.33 137.36 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 126.269 1.827 . . . . 0.0 108.082 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.55 167.37 18.01 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.163 0.887 . . . . 0.0 111.762 -174.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -57.01 110.72 0.87 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.906 0.883 . . . . 0.0 111.183 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -101.33 133.84 20.66 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 160.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.97 158.14 58.2 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 CA-C-N 120.287 1.138 . . . . 0.0 109.161 164.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.35 -52.52 2.7 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.149 1.78 . . . . 0.0 110.843 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.19 -31.66 69.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.017 1.727 . . . . 0.0 113.103 -175.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -85.31 -47.27 10.19 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 119.244 0.929 . . . . 0.0 109.906 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.456 HD22 ' CE1' ' A' ' 42' ' ' PHE . 1.3 tt -56.53 -61.89 2.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.305 2.642 . . . . 0.0 108.999 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -63.24 -29.26 70.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.585 1.154 . . . . 0.0 110.827 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.64 -49.15 33.75 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.39 0.995 . . . . 0.0 110.732 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -56.86 -43.24 80.99 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.479 0.712 . . . . 0.0 110.828 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.68 -0.27 55.95 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.51 1.124 . . . . 0.0 113.324 -176.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.16 -28.82 63.12 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.232 1.413 . . . . 0.0 113.4 -170.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -63.25 -22.09 66.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.15 0.98 . . . . 0.0 113.393 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.11 -15.87 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 118.862 0.756 . . . . 0.0 111.14 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -10.38 56.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.01 1.324 . . . . 0.0 112.49 169.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.249 1.042 0 C-N-CA 129.608 3.163 . . . . 0.0 111.182 161.929 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 mt . . . . . 0 C--O 1.23 0.068 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.9 p -127.01 170.13 12.62 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 163.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -53.39 -55.52 24.34 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 127.886 2.475 . . . . 0.0 111.412 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.4 81.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.226 0.611 . . . . 0.0 110.084 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -75.09 -20.23 59.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.248 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -58.36 -63.93 1.1 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.14 -46.81 89.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.017 0.527 . . . . 0.0 110.787 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.23 -20.02 65.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.094 -174.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.14 -58.13 3.09 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.4 1.0 . . . . 0.0 110.213 165.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.2 pt -62.41 -20.05 23.8 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -169.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -57.36 -24.62 56.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.137 0.975 . . . . 0.0 113.038 172.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.24 112.57 0.26 Allowed Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -157.96 -75.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.489 1.515 . . . . 0.0 109.137 -175.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.69 -166.25 30.75 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 -159.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.32 83.87 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.703 3.602 . . . . 0.0 112.226 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.7 t -94.06 124.12 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 125.743 1.617 . . . . 0.0 106.848 171.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.74 146.64 44.6 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.52 0.676 . . . . 0.0 111.964 170.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.3 t -131.54 108.41 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -161.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -83.46 100.75 10.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.345 1.058 . . . . 0.0 109.155 174.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -78.54 108.61 12.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 166.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -123.17 176.06 6.29 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.39 155.73 31.03 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 120.884 -1.135 . . . . 0.0 110.825 166.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.49 -12.81 61.21 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -173.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.69 -12.37 31.63 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.572 1.078 . . . . 0.0 112.772 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.4 p -67.24 173.72 3.7 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.436 0.636 . . . . 0.0 112.469 -164.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.35 -86.63 1.89 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 162.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.24 -20.78 55.64 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.96 2.44 . . . . 0.0 114.336 -167.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.67 -33.66 68.57 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.8 1.182 . . . . 0.0 111.128 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -74.05 -11.82 60.44 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.572 -0.727 . . . . 0.0 112.516 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.6 ptm -104.23 -21.64 13.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.923 1.289 . . . . 0.0 112.079 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.1 ttt -83.82 -44.4 14.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.89 1.676 . . . . 0.0 108.969 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.2 -47.26 82.56 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 117.541 -1.219 . . . . 0.0 113.324 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.87 -31.48 38.4 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.918 1.721 . . . . 0.0 112.445 172.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.23 -39.03 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.813 1.188 . . . . 0.0 110.511 172.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.8 mt -69.23 -20.01 63.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.227 1.411 . . . . 0.0 111.831 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -69.98 -45.57 67.07 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.673 0.789 . . . . 0.0 110.092 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -62.1 -44.28 96.99 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.529 0.331 . . . . 0.0 110.289 171.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.22 -44.9 84.17 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.772 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.72 -53.51 46.75 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.054 0.942 . . . . 0.0 110.745 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.01 -46.8 87.28 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.184 0.994 . . . . 0.0 111.069 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.8 -26.57 14.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.051 1.341 . . . . 0.0 114.414 -173.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.05 29.67 4.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.415 1.486 . . . . 0.0 111.826 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -14.26 -61.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 131.421 3.888 . . . . 0.0 116.028 -172.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -114.08 -14.53 12.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.386 1.874 . . . . 0.0 113.134 -168.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -66.42 -31.96 73.04 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.231 0.923 . . . . 0.0 110.276 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.12 171.56 17.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 122.706 0.402 . . . . 0.0 110.216 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.5 t -124.45 137.77 54.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.102 0.477 . . . . 0.0 110.005 172.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.86 154.74 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 125.255 1.422 . . . . 0.0 107.313 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.95 138.04 20.35 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -117.45 136.46 53.18 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 118.898 0.772 . . . . 0.0 109.338 170.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -144.38 146.46 32.54 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.175 0.988 . . . . 0.0 113.446 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -75.16 104.14 5.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.007 1.723 . . . . 0.0 107.826 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.534 HG11 HG21 ' A' ' 72' ' ' ILE . 4.7 p -70.15 -20.56 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -166.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.87 -43.08 90.78 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.076 1.35 . . . . 0.0 110.566 169.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -89.23 -25.36 21.78 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.636 1.974 . . . . 0.0 112.316 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -105.33 90.08 3.65 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 118.404 0.547 . . . . 0.0 111.24 164.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.9 -12.67 17.82 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.872 2.381 . . . . 0.0 114.042 166.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -72.87 129.17 37.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.667 1.121 . . . . 0.0 109.078 -176.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.5 m 64.33 -25.12 0.08 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.943 3.297 . . . . 0.0 112.466 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 62' ' ' GLU . 41.7 m -50.31 -61.59 2.08 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 128.328 2.651 . . . . 0.0 109.214 165.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.1 t -57.45 -46.49 83.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.95 0.5 . . . . 0.0 109.881 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -58.59 -38.58 78.25 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.4 1.08 . . . . 0.0 112.451 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -95.22 12.0 30.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.848 0.749 . . . . 0.0 111.461 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.36 25.64 73.65 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 118.78 0.718 . . . . 0.0 112.635 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.8 mm -73.65 94.89 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.86 1.264 . . . . 0.0 109.312 -169.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.14 -21.37 3.61 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.366 1.466 . . . . 0.0 110.861 175.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 p -81.58 47.76 1.1 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.115 2.566 . . . . 0.0 112.333 -162.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.534 HG21 HG11 ' A' ' 57' ' ' VAL . 45.6 pt -76.16 153.53 84.39 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -169.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.421 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 41.1 Cg_endo -62.85 128.27 6.06 Favored 'Cis proline' 0 C--N 1.351 0.693 0 N-CA-C 110.238 -0.716 . . . . 0.0 110.238 -7.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 m -115.41 132.64 56.56 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tt -125.43 116.82 22.44 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 mt -120.17 143.03 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 tt -118.9 119.83 35.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -111.48 166.91 10.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.577 1.951 . . . . 0.0 110.356 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -161.67 127.75 3.72 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 126.22 1.808 . . . . 0.0 106.714 158.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 47.8 42.87 22.25 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.633 0.635 . . . . 0.0 113.771 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.12 -7.05 82.63 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 117.859 -1.523 . . . . 0.0 115.146 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -101.03 104.34 31.54 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 120.094 1.947 . . . . 0.0 111.243 -173.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.88 90.25 1.09 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.799 3.0 . . . . 0.0 111.189 171.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 m -63.45 -21.35 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.04 158.03 34.04 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.896 0.878 . . . . 0.0 110.699 160.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -118.36 136.5 53.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.126 2.17 . . . . 0.0 105.958 163.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.07 147.53 41.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.182 2.193 . . . . 0.0 105.637 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.4 pt -140.9 142.67 29.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.779 1.231 . . . . 0.0 107.987 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.21 167.3 27.76 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 123.892 0.745 . . . . 0.0 111.658 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -72.22 79.09 0.97 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.892 0.877 . . . . 0.0 110.088 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -76.45 129.63 79.28 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 162.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -68.45 167.8 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.053 1.835 . . . . 0.0 109.832 175.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.36 -42.56 61.41 Favored 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 123.595 0.758 . . . . 0.0 110.245 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -75.14 -2.34 27.28 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.758 1.223 . . . . 0.0 111.505 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -112.13 -49.56 2.96 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 125.845 1.658 . . . . 0.0 109.221 172.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.0 tt -52.04 -66.44 0.38 Allowed 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 127.2 2.2 . . . . 0.0 110.418 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -63.55 -20.65 65.81 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.69 1.196 . . . . 0.0 111.952 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.67 -48.09 41.98 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.533 1.06 . . . . 0.0 110.665 172.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -59.49 -51.16 71.04 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.928 0.891 . . . . 0.0 110.223 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 mt -75.04 -5.36 43.65 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 126.129 1.771 . . . . 0.0 112.753 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.62 -26.71 34.56 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 124.541 1.136 . . . . 0.0 111.632 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -6.49 9.14 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.802 1.241 . . . . 0.0 113.657 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.62 -14.14 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 162.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.05 -7.86 59.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.211 -0.931 . . . . 0.0 112.249 170.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 C--O 1.247 0.956 0 C-N-CA 127.398 2.279 . . . . 0.0 108.154 158.858 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 N--CA 1.462 0.171 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.0 p -112.42 -105.63 0.38 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 167.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -126.06 -64.72 1.03 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.095 2.158 . . . . 0.0 108.932 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.63 -30.63 61.29 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.764 -0.585 . . . . 0.0 112.075 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.04 -22.59 59.5 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.163 -0.446 . . . . 0.0 111.254 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -64.06 -58.7 5.89 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.841 0.746 . . . . 0.0 109.829 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -59.59 -34.98 73.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.833 0.453 . . . . 0.0 110.978 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -62.82 -53.31 56.27 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.901 -0.499 . . . . 0.0 110.685 171.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.95 -43.99 97.92 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.423 0.689 . . . . 0.0 111.654 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 pt -59.95 -23.59 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -11.06 60.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.542 0.737 . . . . 0.0 111.85 177.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.06 131.19 48.28 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 174.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -87.0 35.65 0.7 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.635 0.774 . . . . 0.0 112.702 -165.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -142.13 179.93 19.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.398 1.475 . . . . 0.0 110.238 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.57 93.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.296 3.331 . . . . 0.0 111.585 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.0 t -100.34 126.42 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 127.35 2.26 . . . . 0.0 106.078 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.541 HD11 HD21 ' A' ' 75' ' ' LEU . 15.8 tp -126.77 120.92 30.51 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.866 -0.521 . . . . 0.0 110.275 -167.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -100.4 133.65 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 118.698 0.681 . . . . 0.0 109.92 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -93.2 107.86 19.59 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 159.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.472 ' CD1' HG23 ' A' ' 57' ' ' VAL . 47.5 m-85 -82.7 111.96 19.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 162.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -119.71 -174.36 2.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.506 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -147.6 161.42 41.18 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 121.394 -0.817 . . . . 0.0 111.508 168.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.83 6.38 0.24 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.433 1.493 . . . . 0.0 115.02 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.42 ' CG ' ' N ' ' A' ' 29' ' ' CYS . 3.5 p90 -124.31 -66.72 0.96 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 163.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 28' ' ' TRP . 16.4 t 36.16 -91.52 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 129.896 3.278 . . . . 0.0 114.614 175.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.66 -91.54 0.56 Allowed Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.624 1.583 . . . . 0.0 111.074 -172.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.07 -19.24 68.5 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.99 3.127 . . . . 0.0 115.066 -168.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 p -51.51 -35.21 39.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.83 0.741 . . . . 0.0 111.722 165.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -66.13 -14.26 61.5 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.547 1.067 . . . . 0.0 112.54 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.8 mtp -105.57 -15.58 14.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.295 1.838 . . . . 0.0 111.407 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.6 ttt -93.95 -34.93 12.88 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 126.322 1.849 . . . . 0.0 109.227 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.26 -50.62 63.21 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.651 1.58 . . . . 0.0 113.02 171.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.91 -35.48 55.29 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 122.127 1.796 . . . . 0.0 111.815 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -61.79 -39.82 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 118.809 0.731 . . . . 0.0 110.079 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.6 mp -68.3 -32.09 71.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.936 2.094 . . . . 0.0 112.211 174.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -68.5 -49.87 56.42 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.026 0.931 . . . . 0.0 108.957 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -56.51 -47.7 78.79 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.277 0.56 . . . . 0.0 110.274 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -58.18 -42.98 87.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.646 1.178 . . . . 0.0 111.051 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.27 59.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.367 1.067 . . . . 0.0 110.218 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -52.61 -45.87 66.76 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.503 0.592 . . . . 0.0 110.589 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.82 -10.68 58.18 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -139.09 3.72 2.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -168.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -24.32 -52.96 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 129.318 3.047 . . . . 0.0 116.258 -158.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . 0.27 2.8 m-20 -125.32 10.7 8.03 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -70.68 -26.63 63.52 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 119.556 1.071 . . . . 0.0 108.665 158.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.79 174.32 12.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 126.12 1.768 . . . . 0.0 110.023 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.262 0.7 OUTLIER -137.51 112.71 9.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 159.09 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.04 159.17 2.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.228 0.537 . . . . 0.0 109.897 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.2 171.86 15.77 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.57 0.748 . . . . 0.0 109.177 172.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -139.69 131.49 27.52 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -170.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.43 151.25 33.7 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -85.12 115.7 23.07 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.441 1.896 . . . . 0.0 108.494 -178.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' A' ' 26' ' ' ALA . 2.3 p -64.99 -24.14 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.254 1.022 . . . . 0.0 113.017 -172.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.08 63.7 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.396 1.478 . . . . 0.0 109.988 174.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -65.06 -32.67 74.5 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.079 1.351 . . . . 0.0 111.947 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -110.08 87.32 5.81 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.206 1.002 . . . . 0.0 111.633 -174.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.61 -25.68 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.151 2.567 . . . . 0.0 114.445 170.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -73.22 137.89 45.26 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 120.49 1.495 . . . . 0.0 109.481 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.293 49.3 m 67.53 -23.97 0.12 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 129.495 3.118 . . . . 0.0 111.751 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.432 ' H ' ' C ' ' A' ' 62' ' ' GLU . 41.2 m -63.76 -71.9 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 127.917 2.487 . . . . 0.0 110.153 169.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -64.55 -28.4 69.61 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -59.0 -24.68 62.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.334 1.854 . . . . 0.0 111.856 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -120.91 13.51 11.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.85 1.26 . . . . 0.0 111.257 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.85 25.01 71.73 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 121.341 -0.849 . . . . 0.0 113.514 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.493 HD12 HG21 ' A' ' 74' ' ' THR . 23.2 mm -68.21 93.89 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.99 1.316 . . . . 0.0 110.167 -171.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -128.37 -13.22 4.96 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.101 1.36 . . . . 0.0 112.063 171.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.7 t -81.84 53.24 2.12 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.994 1.318 . . . . 0.0 111.457 -173.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.423 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 23.7 pt -70.84 153.03 95.01 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.188 0.995 . . . . 0.0 112.343 -176.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.423 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 39.7 Cg_endo -62.92 129.92 7.82 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 CA-C-N 119.087 0.71 . . . . 0.0 110.506 -8.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.493 HG21 HD12 ' A' ' 69' ' ' ILE . 24.7 m -112.83 141.85 46.17 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.541 HD21 HD11 ' A' ' 21' ' ' LEU . 5.4 tt -133.19 105.26 6.91 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -172.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.6 mt -109.12 128.86 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.415 HD13 HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -92.1 110.83 22.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 169.236 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -103.18 156.53 17.64 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.543 1.137 . . . . 0.0 109.462 170.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 127.16 11.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 163.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.84 27.39 59.21 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 118.321 0.51 . . . . 0.0 113.523 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.38 -12.58 69.35 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.959 1.743 . . . . 0.0 113.763 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -90.6 118.36 68.64 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 119.366 1.583 . . . . 0.0 109.689 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 85.01 1.18 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.582 2.855 . . . . 0.0 109.72 171.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -64.82 -38.82 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.344 1.057 . . . . 0.0 111.995 -176.7 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -142.28 156.05 45.26 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.483 1.038 . . . . 0.0 110.684 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.99 135.48 32.77 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.856 1.663 . . . . 0.0 107.952 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.1 mm? -122.01 146.71 46.9 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.356 2.262 . . . . 0.0 106.797 174.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.3 pt -143.23 119.17 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 124.598 1.159 . . . . 0.0 109.233 -169.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.9 170.57 41.63 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.491 1.52 . . . . 0.0 110.798 -169.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -66.44 93.12 0.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.868 1.267 . . . . 0.0 110.43 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -74.63 131.77 79.26 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 168.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.47 166.57 21.31 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.584 1.522 . . . . 0.0 109.593 165.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -47.48 73.2 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -177.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.1 -15.11 20.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.53 2.332 . . . . 0.0 113.181 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -101.35 -56.05 2.39 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 125.418 1.487 . . . . 0.0 108.703 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.48 -58.07 8.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.593 1.957 . . . . 0.0 109.782 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -26.94 68.61 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.247 1.019 . . . . 0.0 110.946 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.34 -44.87 42.87 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.505 1.048 . . . . 0.0 110.714 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -49.73 76.57 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.255 1.022 . . . . 0.0 109.967 172.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.83 -2.52 57.85 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.18 -34.45 14.54 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 119.429 1.013 . . . . 0.0 110.42 168.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.6 29.02 0.08 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.562 2.345 . . . . 0.0 112.16 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.35 -24.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.9 2.08 . . . . 0.0 111.204 158.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.15 -10.84 59.73 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.978 0.911 . . . . 0.0 112.343 172.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.258 0 C-N-CA 127.195 2.198 . . . . 0.0 109.167 165.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 53' ' ' ALA . 1.1 tp . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 121.806 0.812 . . . . 0.0 111.403 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.5 p -130.35 178.29 6.7 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 159.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -58.4 -57.99 10.47 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.614 1.566 . . . . 0.0 110.466 169.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.01 79.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.668 -0.645 . . . . 0.0 110.699 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -84.15 -19.32 34.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.949 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.46 ' HA ' HD21 ' A' ' 5' ' ' LEU . 21.9 t80 -58.74 -56.58 20.35 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 167.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -63.18 -46.07 88.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.748 0.819 . . . . 0.0 109.715 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -63.47 -30.62 71.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.945 0.793 . . . . 0.0 112.336 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.22 -60.48 2.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.422 1.01 . . . . 0.0 110.048 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.37 -10.04 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -46.58 -36.1 6.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.502 1.521 . . . . 0.0 112.818 -174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.85 113.85 1.66 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 124.131 0.872 . . . . 0.0 112.808 165.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -152.56 -102.89 0.05 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 164.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.74 -138.13 6.37 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.545 1.545 . . . . 0.0 111.742 -168.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.75 85.87 0.92 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.371 3.381 . . . . 0.0 113.05 -167.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.3 t -97.26 140.32 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 170.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.19 124.43 20.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 O-C-N 121.689 -0.632 . . . . 0.0 109.411 164.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.92 142.44 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 172.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.8 89.27 3.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.502 1.144 . . . . 0.0 108.983 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 69' ' ' ILE . 74.8 m-85 -76.19 114.58 15.02 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.614 1.166 . . . . 0.0 109.27 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 16.4 p-90 -127.93 -171.52 2.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 168.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.77 160.38 41.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.082 -1.011 . . . . 0.0 110.393 169.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.6 -29.17 64.28 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.568 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.474 ' CH2' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -93.61 -26.95 16.87 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 p -71.66 164.98 24.93 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.221 0.919 . . . . 0.0 113.438 -159.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.84 -82.36 1.4 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.279 1.418 . . . . 0.0 112.653 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -60.7 -20.96 67.84 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.466 2.778 . . . . 0.0 113.077 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 17.7 p -59.21 -27.28 65.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.148 172.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.3 mtt85 -76.61 -12.76 60.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 120.477 1.489 . . . . 0.0 112.864 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 86.7 mtp -95.09 -33.0 12.84 Favored 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 124.843 1.257 . . . . 0.0 110.296 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.6 ttt -78.0 -36.18 49.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.416 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.67 -51.8 66.55 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.198 -1.382 . . . . 0.0 112.203 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.83 -38.14 40.85 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 121.735 1.655 . . . . 0.0 111.848 171.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.78 -14.36 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 119.576 1.08 . . . . 0.0 112.163 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.38 -16.36 18.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 128.669 2.788 . . . . 0.0 111.816 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.36 -40.7 29.56 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.672 1.123 . . . . 0.0 109.449 168.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -52.41 -51.02 61.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.739 0.816 . . . . 0.0 109.034 163.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.458 ' CD1' ' HE2' ' A' ' 93' ' ' LYS . 2.3 t80 -57.93 -48.77 78.95 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-O 118.652 -0.689 . . . . 0.0 110.889 177.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.81 -59.82 3.03 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.95 1.3 . . . . 0.0 109.63 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -60.21 -44.7 94.94 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 124.806 1.316 . . . . 0.0 111.343 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.56 -15.09 2.49 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.652 1.181 . . . . 0.0 113.939 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.97 35.37 1.75 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.46 1.104 . . . . 0.0 112.713 174.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.79 -37.54 8.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.83 1.652 . . . . 0.0 115.195 -165.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.4 7.74 4.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.737 1.215 . . . . 0.0 111.362 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -83.99 -27.13 28.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.719 1.607 . . . . 0.0 110.554 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.97 171.63 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.819 1.248 . . . . 0.0 108.788 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.306 6.6 t -110.49 85.95 2.21 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 123.529 1.633 . . . . 0.0 108.631 164.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -70.02 154.95 7.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.409 163.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.494 ' HB3' HD22 ' A' ' 5' ' ' LEU . . . -157.55 120.41 3.93 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.085 169.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -94.0 146.47 23.91 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.073 0.233 . . . . 0.0 111.405 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.97 154.51 35.12 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.638 0.732 . . . . 0.0 112.082 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -86.31 96.39 9.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.597 1.959 . . . . 0.0 107.885 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.401 HG11 HG21 ' A' ' 72' ' ' ILE . 1.1 p -66.22 -20.3 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 121.371 -0.831 . . . . 0.0 113.068 -167.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.5 -28.46 63.45 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.97 1.708 . . . . 0.0 111.676 170.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -109.44 -16.83 13.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.446 2.298 . . . . 0.0 111.821 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -112.53 79.67 3.22 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.217 1.807 . . . . 0.0 110.85 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.57 -88.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.572 2.848 . . . . 0.0 109.984 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 46.74 -17.12 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 131.344 3.858 . . . . 0.0 121.206 167.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.8 m 178.2 -25.43 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 130.806 3.642 . . . . 0.0 110.782 -171.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.404 HG23 ' HB ' ' A' ' 69' ' ' ILE . 37.2 m -44.39 -61.55 1.48 Allowed 'General case' 0 N--CA 1.458 -0.075 0 C-N-CA 127.574 2.35 . . . . 0.0 110.621 173.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -57.94 -45.66 86.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.777 0.831 . . . . 0.0 109.659 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -60.44 -28.12 68.04 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.075 1.35 . . . . 0.0 112.949 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -112.45 12.08 19.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.915 0.779 . . . . 0.0 111.571 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.33 24.58 74.96 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 121.334 -0.854 . . . . 0.0 114.203 173.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.417 HG21 ' CE2' ' A' ' 24' ' ' PHE . 40.8 mm -80.82 46.54 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 126.79 2.036 . . . . 0.0 111.269 -167.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.0 ttt -83.39 -8.25 59.43 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.237 -0.914 . . . . 0.0 110.17 162.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.2 p -75.77 16.52 0.39 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.251 2.22 . . . . 0.0 115.054 -164.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.474 HD11 ' CH2' ' A' ' 28' ' ' TRP . 28.4 pt -61.31 145.49 90.35 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.001 0.92 . . . . 0.0 112.361 -165.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 74.3 Cg_endo -67.57 135.53 29.29 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 118.25 0.411 . . . . 0.0 111.544 -1.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.6 m -133.44 140.6 47.39 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.049 0.94 . . . . 0.0 110.075 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt -135.65 99.13 4.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.028 1.731 . . . . 0.0 106.757 -170.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.8 mt -95.17 130.56 43.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.449 HD12 ' HG ' ' A' ' 100' ' ' LEU . 0.8 OUTLIER -92.46 123.28 35.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 171.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -113.82 148.45 36.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 172.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.608 ' HE3' HG21 ' A' ' 84' ' ' VAL . 12.7 ptpt -152.36 154.71 36.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 163.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.53 15.47 1.25 Allowed Glycine 0 CA--C 1.541 1.713 0 N-CA-C 117.134 1.614 . . . . 0.0 117.134 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.83 15.88 38.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-N 119.69 1.745 . . . . 0.0 112.995 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -134.97 128.0 18.49 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.195 1.398 . . . . 0.0 109.555 -167.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.83 87.32 1.41 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.914 3.076 . . . . 0.0 109.646 171.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.608 HG21 ' HE3' ' A' ' 79' ' ' LYS . 2.6 m -63.75 -36.3 76.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 O-C-N 121.503 -0.748 . . . . 0.0 112.456 -174.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 167.05 31.57 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 122.905 0.482 . . . . 0.0 111.106 170.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -134.66 134.06 40.74 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.3 1.84 . . . . 0.0 107.881 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.484 HD11 ' HG2' ' A' ' 99' ' ' GLN . 4.5 mm? -106.49 149.72 26.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.801 1.64 . . . . 0.0 107.529 167.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 pt -143.32 144.18 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.398 1.479 . . . . 0.0 107.831 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.81 169.52 19.03 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.947 0.784 . . . . 0.0 112.796 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -72.74 73.82 1.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.553 1.541 . . . . 0.0 111.167 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.45 ' HG3' HD12 ' A' ' 87' ' ' LEU . 6.3 mm100 -75.28 136.03 72.51 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 165.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.36 166.01 29.76 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.202 1.935 . . . . 0.0 110.863 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.458 ' HE2' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -49.46 -50.61 40.42 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.68 1.192 . . . . 0.0 111.865 -177.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -52.63 -33.73 48.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.226 1.41 . . . . 0.0 112.964 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.59 -47.83 10.87 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 tt -61.03 -56.84 16.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.433 1.493 . . . . 0.0 110.338 -175.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -55.66 -33.56 64.19 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.456 1.502 . . . . 0.0 110.337 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.86 -50.22 17.79 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 118.232 0.469 . . . . 0.0 110.268 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.484 ' HG2' HD11 ' A' ' 87' ' ' LEU . 13.1 tp60 -59.62 -41.06 89.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.553 0.741 . . . . 0.0 110.82 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.449 ' HG ' HD12 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -85.87 -0.02 54.26 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.365 1.466 . . . . 0.0 113.108 -178.683 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.53 -27.5 16.78 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.236 1.015 . . . . 0.0 113.332 -174.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.38 0.16 1.6 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.372 1.442 . . . . 0.0 113.686 176.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.273 0.4 OUTLIER -129.97 4.17 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 161.262 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.81 -13.59 16.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.242 1.017 . . . . 0.0 112.13 171.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.896 2.078 . . . . 0.0 109.964 170.304 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 10' ' ' PHE . 6.3 tp . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.47 ' H ' ' HB2' ' A' ' 9' ' ' ASN . 67.2 p -130.15 -100.97 0.31 Allowed 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 170.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -133.73 -71.18 0.51 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.273 1.429 . . . . 0.0 110.123 -158.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.01 -42.28 37.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.499 0.72 . . . . 0.0 110.253 163.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.47 ' HB2' ' H ' ' A' ' 6' ' ' THR . 72.3 m-80 -69.74 -26.95 64.56 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.327 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.527 ' HA ' HD21 ' A' ' 5' ' ' LEU . 8.8 t80 -61.51 -67.06 0.44 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.051 0.841 . . . . 0.0 109.028 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -63.21 -35.8 81.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 121.482 -0.087 . . . . 0.0 110.843 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.91 -8.0 56.58 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 118.228 -0.892 . . . . 0.0 113.144 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.95 -49.21 5.9 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 120.36 1.437 . . . . 0.0 110.784 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.3 pt -59.94 -19.38 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -174.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -17.73 60.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.446 1.498 . . . . 0.0 113.686 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.59 146.19 48.18 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 119.175 0.898 . . . . 0.0 111.259 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -76.4 -23.36 54.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.321 1.048 . . . . 0.0 113.658 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.57 -174.26 40.0 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.132 0.872 . . . . 0.0 112.571 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.72 87.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.506 3.47 . . . . 0.0 111.86 172.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.68 138.1 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 162.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.47 163.0 39.02 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.742 -0.599 . . . . 0.0 110.318 168.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.41 126.87 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 123.994 0.918 . . . . 0.0 108.672 -173.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 66.3 t0 -80.13 114.88 19.37 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 158.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -100.03 108.88 21.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 25.5 p-90 -125.2 179.43 5.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.287 1.435 . . . . 0.0 107.249 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.554 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -152.25 162.73 40.71 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.496 1.118 . . . . 0.0 109.815 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.85 -9.27 50.48 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -16.38 5.6 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -174.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 26' ' ' ALA . 6.4 p -74.4 38.13 0.11 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -159.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 37.62 -102.98 0.02 OUTLIER Glycine 0 CA--C 1.54 1.614 0 C-N-CA 127.665 2.555 . . . . 0.0 114.344 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.93 -17.77 39.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.015 3.144 . . . . 0.0 115.131 -175.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.2 p -53.27 -36.7 61.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.502 1.046 . . . . 0.0 111.323 168.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.2 ttt-85 -67.36 -8.85 35.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.204 1.002 . . . . 0.0 112.545 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 64.8 mtm -107.34 -14.74 14.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.503 1.521 . . . . 0.0 112.473 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.5 ttt -96.55 -36.41 10.77 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.633 1.173 . . . . 0.0 109.428 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.15 -47.81 86.82 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.648 1.179 . . . . 0.0 112.162 174.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.81 -31.28 48.58 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 121.995 1.748 . . . . 0.0 112.699 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.8 -33.74 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 119.437 1.017 . . . . 0.0 110.567 173.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -31.04 62.14 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.184 1.794 . . . . 0.0 111.614 173.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -71.15 -40.18 71.48 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.431 1.014 . . . . 0.0 109.613 172.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -62.58 -43.29 99.17 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 171.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -56.47 -42.7 78.67 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.286 1.035 . . . . 0.0 111.633 172.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.81 -55.12 36.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.183 0.993 . . . . 0.0 110.565 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.38 -47.54 72.55 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.548 1.139 . . . . 0.0 110.097 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.26 -13.69 60.8 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -133.98 17.22 3.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.567 1.076 . . . . 0.0 113.147 -173.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.75 -31.95 5.36 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.846 2.058 . . . . 0.0 115.469 -159.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -124.06 -3.28 8.09 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.963 0.905 . . . . 0.0 113.383 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -78.63 -39.05 38.23 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.99 1.268 . . . . 0.0 110.436 166.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 m -124.45 166.45 19.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.302 5.6 t -120.63 91.59 3.57 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.415 1.102 . . . . 0.0 108.501 172.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 p -98.54 116.61 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 125.065 1.346 . . . . 0.0 110.99 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.38 98.13 5.32 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.311 -159.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' H ' ' CD ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -72.1 140.82 49.1 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.873 -173.816 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pp -153.67 167.69 28.72 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 124.423 1.077 . . . . 0.0 112.758 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -95.97 112.05 23.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.914 1.686 . . . . 0.0 109.388 -173.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -64.72 -23.67 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.314 0.645 . . . . 0.0 111.967 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -75.42 -3.04 31.48 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.452 1.501 . . . . 0.0 111.776 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -135.26 -38.59 0.76 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.708 2.003 . . . . 0.0 111.743 -166.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -88.33 119.03 70.13 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 118.95 0.795 . . . . 0.0 109.513 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -90.55 -21.54 0.81 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.504 2.803 . . . . 0.0 113.804 164.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 64' ' ' THR . 7.5 tp10 -61.4 111.74 1.9 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.306 1.442 . . . . 0.0 112.002 -170.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m 68.75 -30.58 0.18 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.625 2.77 . . . . 0.0 111.851 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.407 ' H ' ' C ' ' A' ' 62' ' ' GLU . 57.5 m -51.73 -51.35 56.85 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 128.49 2.716 . . . . 0.0 110.463 171.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.5 t -57.73 -50.14 74.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.355 0.662 . . . . 0.0 110.191 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.3 tp60 -56.62 -44.5 81.25 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.693 0.797 . . . . 0.0 111.9 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -88.61 11.54 17.11 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 119.138 -0.458 . . . . 0.0 112.028 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.61 29.31 71.45 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 124.413 1.006 . . . . 0.0 112.391 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.484 ' CD1' HD11 ' A' ' 76' ' ' ILE . 43.3 mm -79.97 82.0 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.138 0.975 . . . . 0.0 109.579 -162.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.0 ttm -123.42 -6.02 8.2 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.657 1.583 . . . . 0.0 111.111 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.2 t -83.16 26.17 0.65 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.679 1.192 . . . . 0.0 113.744 -167.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.454 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -63.86 151.46 89.16 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -165.222 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 59.6 Cg_endo -65.8 129.84 10.76 Favored 'Cis proline' 0 C--N 1.353 0.784 0 CA-C-N 119.379 0.814 . . . . 0.0 111.44 2.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.8 m -121.37 152.68 38.73 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.0 tt -132.37 130.32 40.54 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 171.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.484 HD11 ' CD1' ' A' ' 69' ' ' ILE . 37.3 mt -120.78 132.62 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 167.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.47 141.0 28.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.795 2.038 . . . . 0.0 105.982 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -142.52 161.89 36.89 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.993 2.117 . . . . 0.0 111.346 -175.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.448 ' CE ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -163.74 153.34 14.66 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.203 1.801 . . . . 0.0 108.776 158.143 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.68 15.69 54.47 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.676 1.131 . . . . 0.0 114.536 167.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.16 -10.36 71.72 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.24 1.4 . . . . 0.0 112.837 -175.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -97.55 159.73 30.4 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 118.729 1.265 . . . . 0.0 109.181 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -69.76 -175.46 1.16 Allowed 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 122.5 2.133 . . . . 0.0 111.193 159.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.448 HG22 ' CE ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -133.07 -46.45 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.309 1.843 . . . . 0.0 108.738 159.161 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.426 ' HZ1' ' CG ' ' A' ' 102' ' ' ASP . 75.9 mttt -145.57 148.01 32.71 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.665 1.186 . . . . 0.0 107.973 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -117.32 131.99 56.69 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 163.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -125.48 141.03 52.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.1 141.18 29.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 124.022 0.929 . . . . 0.0 108.799 -170.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.18 164.87 39.6 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.586 1.089 . . . . 0.0 111.42 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.58 78.58 2.58 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.3 0.571 . . . . 0.0 110.006 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -71.01 133.82 85.8 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.23 167.58 21.68 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.874 1.716 . . . . 0.0 111.367 176.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -44.78 73.9 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.081 1.352 . . . . 0.0 110.792 -172.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -51.33 -44.9 62.11 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.69 2.396 . . . . 0.0 111.063 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -42.59 53.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.1 1.76 . . . . 0.0 108.049 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -61.74 2.11 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.655 1.582 . . . . 0.0 108.827 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.78 -39.09 83.72 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.585 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.41 82.78 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.267 1.394 . . . . 0.0 111.713 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -78.0 -21.75 50.37 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.16 -1.78 13.58 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.467 1.107 . . . . 0.0 112.808 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.38 -36.19 42.16 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.776 1.63 . . . . 0.0 112.604 -175.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.426 ' CG ' ' HZ1' ' A' ' 85' ' ' LYS . 10.1 p-10 -64.31 -11.29 30.58 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.182 1.393 . . . . 0.0 114.091 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.81 -8.5 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 119.459 1.027 . . . . 0.0 112.071 168.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.27 -10.25 26.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.392 1.477 . . . . 0.0 112.899 175.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 C--O 1.246 0.899 0 C-N-CA 126.167 1.787 . . . . 0.0 110.212 172.058 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.446 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 1.6 tp . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 121.842 0.83 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.3 m -166.89 170.59 12.07 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.871 3.668 . . . . 0.0 101.958 172.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -43.38 -59.85 1.95 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 128.725 2.81 . . . . 0.0 112.781 -166.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.05 91.66 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.319 0.58 . . . . 0.0 111.189 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -72.07 -21.79 61.46 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.139 -0.458 . . . . 0.0 111.777 -177.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.26 -60.02 3.98 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -60.53 -46.06 91.55 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.442 -0.789 . . . . 0.0 111.184 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -62.67 -26.31 68.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.314 0.961 . . . . 0.0 112.71 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.94 -63.47 1.25 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.066 0.848 . . . . 0.0 109.485 165.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.77 HG22 HG11 ' A' ' 20' ' ' VAL . 2.9 pt -66.95 -13.52 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -166.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -58.54 -20.74 48.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.993 1.317 . . . . 0.0 113.975 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.43 -112.14 0.26 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 107.849 -2.1 . . . . 0.0 107.849 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 t0 62.4 -12.83 0.07 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 130.039 3.336 . . . . 0.0 117.677 158.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.83 -166.85 16.89 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.512 1.053 . . . . 0.0 111.889 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -55.66 101.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.946 3.098 . . . . 0.0 111.235 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.77 HG11 HG22 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -94.77 140.83 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 108.361 -175.4 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.472 HD11 HD21 ' A' ' 100' ' ' LEU . 3.5 mm? -130.43 143.14 50.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 173.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.69 108.3 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.481 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 63.3 t0 -75.91 98.52 4.24 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 78.0 m-85 -84.3 105.53 15.21 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -124.8 -177.15 3.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.96 162.09 41.48 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.222 -0.924 . . . . 0.0 110.552 171.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.35 -5.42 2.43 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.473 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -113.66 -20.96 10.99 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.591 1.087 . . . . 0.0 113.765 178.548 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.9 p -73.83 161.67 29.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.912 1.233 . . . . 0.0 110.347 -173.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.78 -84.86 1.74 Allowed Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.559 -0.579 . . . . 0.0 112.552 -173.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.15 -16.55 55.52 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.339 2.693 . . . . 0.0 113.448 -171.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.0 p -49.78 -40.84 42.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.848 0.859 . . . . 0.0 111.586 166.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -12.35 61.55 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.145 0.578 . . . . 0.0 112.257 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.5 mtm -100.99 -15.73 17.38 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.322 1.449 . . . . 0.0 112.057 173.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.8 ttt -85.32 -42.62 14.43 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 125.485 1.514 . . . . 0.0 108.444 172.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.09 -50.4 36.99 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.359 -1.305 . . . . 0.0 113.419 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.14 -36.1 30.52 Favored 'Trans proline' 0 C--N 1.353 0.766 0 CA-C-N 121.845 1.695 . . . . 0.0 112.17 173.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.97 -35.48 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.306 0.957 . . . . 0.0 110.304 173.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.84 -17.55 57.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.631 1.973 . . . . 0.0 111.847 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.26 -48.86 18.73 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 167.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -61.55 -26.18 67.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.602 0.761 . . . . 0.0 111.33 173.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.447 ' CE1' HD12 ' A' ' 96' ' ' LEU . 81.2 t80 -65.25 -63.19 1.16 Allowed 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 125.182 1.393 . . . . 0.0 107.879 170.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.77 -46.16 67.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.173 -0.442 . . . . 0.0 112.046 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.93 -34.79 56.94 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.245 1.418 . . . . 0.0 111.781 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.91 -14.45 61.06 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -162.18 63.38 0.23 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.341 1.456 . . . . 0.0 108.995 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.66 71.39 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -166.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -131.74 -1.31 3.82 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -168.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -64.46 -39.63 94.19 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.928 1.24 . . . . 0.0 108.866 161.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.01 170.9 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.697 1.199 . . . . 0.0 108.094 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 t -128.41 74.81 1.58 Allowed 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 123.989 1.852 . . . . 0.0 106.556 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 p -82.78 160.34 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.787 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 5' ' ' LEU . . . -159.67 174.11 15.05 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.185 176.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 28.1 mttp -131.99 144.39 50.76 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 123.331 0.653 . . . . 0.0 110.509 176.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.97 163.4 39.77 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.788 1.305 . . . . 0.0 114.297 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -91.45 105.33 17.68 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.101 1.76 . . . . 0.0 108.716 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.484 HG21 HG22 ' A' ' 69' ' ' ILE . 2.7 p -65.94 -21.78 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.664 0.786 . . . . 0.0 112.669 -172.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -67.69 -22.43 65.28 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.303 1.041 . . . . 0.0 111.612 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -114.09 -21.64 10.43 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.744 2.017 . . . . 0.0 111.829 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -100.32 94.23 3.23 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.235 1.414 . . . . 0.0 109.924 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.19 -27.74 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.038 2.492 . . . . 0.0 113.524 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -74.84 103.76 5.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.275 0.943 . . . . 0.0 110.751 -172.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m 104.88 -32.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 130.868 3.667 . . . . 0.0 109.471 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -52.82 -52.82 55.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.888 1.275 . . . . 0.0 109.714 167.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 t -70.9 -7.43 45.7 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.228 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -87.73 -33.22 18.78 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.998 1.272 . . . . 0.0 111.12 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -120.12 2.41 10.92 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.62 38.34 51.25 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 119.134 0.879 . . . . 0.0 111.801 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.491 HG21 ' CZ ' ' A' ' 24' ' ' PHE . 39.3 mm -75.51 83.67 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.973 1.309 . . . . 0.0 110.498 -166.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -119.58 -6.55 10.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.058 1.343 . . . . 0.0 112.544 172.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 m -77.14 34.41 0.16 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.929 2.092 . . . . 0.0 113.362 -168.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.473 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 34.0 pt -74.76 151.06 86.7 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -162.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 59.3 Cg_endo -65.88 130.65 12.23 Favored 'Cis proline' 0 C--N 1.351 0.685 0 CA-C-N 119.047 0.695 . . . . 0.0 110.745 -3.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -119.07 144.12 46.76 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.6 tp -132.36 113.92 13.75 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mt -111.42 142.9 22.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.99 118.56 37.02 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.762 2.025 . . . . 0.0 106.875 -176.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.432 ' HB2' HG12 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -130.72 176.38 8.24 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.239 1.016 . . . . 0.0 110.433 175.247 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.88 145.83 17.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 158.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 37.61 41.79 0.89 Allowed Glycine 0 CA--C 1.54 1.637 0 N-CA-C 115.974 1.15 . . . . 0.0 115.974 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.29 -12.63 68.67 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.77 1.652 . . . . 0.0 115.545 177.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -95.43 120.52 63.63 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 120.601 2.2 . . . . 0.0 110.768 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.82 148.71 46.65 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.124 1.883 . . . . 0.0 109.487 163.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.94 -44.54 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.68 0.792 . . . . 0.0 111.914 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -159.56 171.62 19.31 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.72 1.145 . . . . 0.0 110.061 171.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.29 156.21 46.54 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.016 1.726 . . . . 0.0 110.133 -174.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.4 mt -137.01 139.54 41.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.04 134.23 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 -170.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.02 162.68 37.92 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.796 0.712 . . . . 0.0 111.63 -175.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -75.29 75.78 2.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.363 1.065 . . . . 0.0 110.923 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -75.31 140.43 72.72 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 167.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 170.13 19.46 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.592 2.195 . . . . 0.0 111.692 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.83 -46.39 41.98 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.006 1.323 . . . . 0.0 111.945 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -56.94 -43.75 81.84 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.913 1.285 . . . . 0.0 110.95 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.73 -36.49 70.48 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.403 0.681 . . . . 0.0 109.251 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.447 HD12 ' CE1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -64.92 -60.03 3.52 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.415 1.086 . . . . 0.0 108.552 179.041 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -62.35 -32.87 73.72 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.102 0.561 . . . . 0.0 110.377 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.74 -53.68 10.99 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.355 0.525 . . . . 0.0 111.009 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.5 -35.87 81.89 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 118.477 0.581 . . . . 0.0 111.089 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.472 HD21 HD11 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -87.63 -1.14 57.75 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.913 -178.388 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -50.32 -31.33 14.15 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 125.224 1.41 . . . . 0.0 113.588 -172.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -22.64 58.6 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.399 1.08 . . . . 0.0 112.32 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.55 -8.25 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.809 0.844 . . . . 0.0 111.444 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.89 -10.4 28.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.19 1.396 . . . . 0.0 112.487 171.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 . . . . . 0 C--O 1.249 1.069 0 C-N-CA 126.104 1.761 . . . . 0.0 110.898 171.904 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.341 0 CA-C-O 121.015 0.436 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.0 t -131.78 -50.74 0.97 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.092 0.957 . . . . 0.0 111.53 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 174.27 -68.9 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 127.9 2.48 . . . . 0.0 105.179 171.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.67 -33.5 64.16 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.881 -0.512 . . . . 0.0 111.836 177.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -17.39 61.26 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 119.105 -0.474 . . . . 0.0 111.25 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.69 -64.45 0.89 Allowed 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -59.88 -44.42 94.21 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.974 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.8 -28.01 65.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.468 1.031 . . . . 0.0 113.013 -177.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.9 -58.9 2.68 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.974 0.91 . . . . 0.0 110.723 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.6 pt -62.08 -23.13 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.936 -171.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -57.71 -31.99 66.94 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.393 1.077 . . . . 0.0 111.688 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.5 102.08 0.15 Allowed Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -165.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -153.36 -69.55 0.15 Allowed 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 128.294 2.638 . . . . 0.0 105.539 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.46 -114.65 0.98 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 106.957 -2.457 . . . . 0.0 106.957 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.79 76.94 3.53 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.21 3.273 . . . . 0.0 112.564 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.96 130.14 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -112.87 113.89 26.17 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 159.373 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.09 125.01 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.1 94.73 5.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 124.12 0.888 . . . . 0.0 110.337 -174.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -83.08 109.27 16.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.416 ' O ' HG12 ' A' ' 57' ' ' VAL . 22.7 p-90 -126.93 175.02 8.38 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -140.14 150.2 43.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.773 0.715 . . . . 0.0 110.52 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.9 -26.26 58.69 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.764 0.825 . . . . 0.0 113.023 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.11 -25.88 16.96 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.0 p -69.75 157.64 36.93 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.372 0.987 . . . . 0.0 111.467 -160.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.75 -86.11 1.16 Allowed Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.318 -172.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.87 -18.83 66.73 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.13 2.553 . . . . 0.0 113.918 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 p -53.67 -35.47 61.1 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.24 0.473 . . . . 0.0 111.23 168.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -69.31 -16.42 63.55 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.381 -0.824 . . . . 0.0 112.336 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.78 -12.32 20.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.597 1.559 . . . . 0.0 112.119 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.8 ttt -93.14 -35.13 13.34 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 126.415 1.886 . . . . 0.0 108.773 175.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.82 -50.45 43.81 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.034 1.734 . . . . 0.0 112.894 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.05 -36.76 46.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 121.81 1.682 . . . . 0.0 111.585 172.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.02 -22.84 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 119.851 1.205 . . . . 0.0 111.314 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.81 -35.06 24.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.776 2.43 . . . . 0.0 111.8 175.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.12 -42.71 93.65 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 169.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -65.79 -15.41 62.85 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.306 1.443 . . . . 0.0 112.368 170.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -82.63 -47.82 11.64 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 120.636 -1.29 . . . . 0.0 109.214 170.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.55 81.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.551 1.14 . . . . 0.0 110.573 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -58.7 -53.12 61.98 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.575 0.75 . . . . 0.0 110.959 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.7 -14.67 54.3 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -162.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 51.39 0.79 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.369 1.868 . . . . 0.0 108.428 172.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.63 -14.02 7.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.412 1.085 . . . . 0.0 113.679 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -88.87 -51.28 5.72 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.596 2.358 . . . . 0.0 111.864 174.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -73.33 -16.73 61.35 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 117.439 -1.267 . . . . 0.0 112.244 -168.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.09 166.56 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 121.128 1.785 . . . . 0.0 113.102 -170.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.1 t -119.46 122.75 42.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.75 0.786 . . . . 0.0 109.146 159.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.411 ' HA ' ' HG ' ' A' ' 21' ' ' LEU . 2.9 t -76.97 152.13 5.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 158.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.35 99.7 3.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -95.14 143.38 26.62 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 122.783 0.433 . . . . 0.0 110.714 -169.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -141.73 145.36 34.75 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.299 0.571 . . . . 0.0 110.755 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -82.22 90.0 6.57 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 173.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 72' ' ' ILE . 6.1 p -62.01 -15.04 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 125.275 1.43 . . . . 0.0 112.468 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -65.85 -20.0 66.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.809 2.444 . . . . 0.0 112.766 169.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -131.06 -23.43 2.46 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.067 2.147 . . . . 0.0 111.696 -167.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -116.28 77.85 7.71 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.402 1.881 . . . . 0.0 109.176 -169.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.92 -4.82 16.08 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.608 3.539 . . . . 0.0 116.675 -170.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.461 ' C ' ' H ' ' A' ' 64' ' ' THR . 5.6 tp10 -59.93 135.25 57.64 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.976 1.716 . . . . 0.0 109.979 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m 59.26 -14.64 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.925 3.29 . . . . 0.0 112.847 -176.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.461 ' H ' ' C ' ' A' ' 62' ' ' GLU . 96.9 m -63.44 -54.26 39.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 126.259 1.824 . . . . 0.0 109.221 -175.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -73.02 1.12 9.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.543 1.137 . . . . 0.0 112.704 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -107.01 -39.66 5.68 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.622 1.169 . . . . 0.0 110.627 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -104.27 5.24 34.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.587 1.155 . . . . 0.0 110.734 -176.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.81 38.67 49.28 Favored Glycine 0 C--N 1.343 0.941 0 C-N-CA 124.243 0.925 . . . . 0.0 112.158 174.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.9 mm -78.83 76.44 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.965 1.306 . . . . 0.0 109.734 -167.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 70.7 mtm -106.54 -14.88 14.93 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.935 1.294 . . . . 0.0 111.478 173.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.4 m -82.61 23.73 0.77 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.165 1.786 . . . . 0.0 114.022 -159.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.546 HG21 HG11 ' A' ' 57' ' ' VAL . 16.3 pt -71.31 155.79 92.47 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.317 1.047 . . . . 0.0 112.943 -158.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 56.7 Cg_endo -62.74 127.86 5.64 Favored 'Cis proline' 0 C--N 1.352 0.711 0 CA-C-N 119.666 0.916 . . . . 0.0 110.687 -3.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -114.32 136.4 53.01 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 tt -131.72 92.99 3.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -174.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.7 mt -94.52 144.37 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.5 HD11 ' HB ' ' A' ' 103' ' ' VAL . 3.3 tt -110.84 120.33 42.03 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -110.44 148.38 32.16 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -141.27 111.63 6.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 170.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 39.54 59.17 1.98 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.58 2.038 . . . . 0.0 112.942 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.66 -20.32 51.05 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.636 1.588 . . . . 0.0 114.03 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.74 109.41 59.36 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 119.452 1.626 . . . . 0.0 111.359 -166.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.31 92.78 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.855 3.037 . . . . 0.0 110.731 169.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 m -65.54 -40.78 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.582 -0.699 . . . . 0.0 112.644 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.404 ' CE ' ' HB2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -158.76 167.19 30.14 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.09 0.956 . . . . 0.0 110.248 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -136.11 133.21 37.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.905 2.082 . . . . 0.0 107.607 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.12 154.2 18.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 158.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.3 pt -141.35 143.93 27.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 106.872 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.55 172.34 20.19 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 121.983 0.768 . . . . 0.0 112.191 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -74.75 79.62 2.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.934 0.894 . . . . 0.0 110.784 -176.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -72.36 127.69 89.82 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 161.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.41 163.55 36.14 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.712 1.608 . . . . 0.0 109.779 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -45.35 12.32 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.81 1.244 . . . . 0.0 111.041 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -59.92 -24.7 64.55 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.191 1.396 . . . . 0.0 113.908 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -100.12 -46.95 5.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.707 1.203 . . . . 0.0 108.624 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 tt -52.64 -62.93 1.33 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.873 2.069 . . . . 0.0 108.892 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -59.14 -34.92 72.63 Favored 'General case' 0 C--N 1.337 0.043 0 C-N-CA 125.025 1.33 . . . . 0.0 110.469 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.62 -42.04 71.44 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.064 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -41.89 85.41 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.411 0.55 . . . . 0.0 109.798 173.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.449 ' HG ' HD12 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -71.77 -4.04 25.45 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.958 1.703 . . . . 0.0 113.337 -178.579 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.47 -25.07 9.16 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.842 1.257 . . . . 0.0 113.132 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -7.43 9.41 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 121.091 1.769 . . . . 0.0 113.975 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.5 ' HB ' HD11 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -127.49 -1.55 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 121.431 -0.793 . . . . 0.0 112.845 168.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -105.77 -10.98 16.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.44 1.096 . . . . 0.0 113.094 174.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 C--O 1.251 1.15 0 C-N-CA 127.017 2.127 . . . . 0.0 109.81 162.87 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.461 ' HB ' HG23 ' A' ' 51' ' ' THR . 7.2 m -60.48 175.74 0.42 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.517 2.327 . . . . 0.0 110.883 169.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.64 -165.44 2.06 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.895 1.678 . . . . 0.0 107.507 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.8 m -44.35 136.36 4.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.817 2.047 . . . . 0.0 112.933 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.71 172.92 12.04 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.023 1.729 . . . . 0.0 111.102 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.1 t -129.44 179.61 5.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.117 1.767 . . . . 0.0 107.33 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -52.46 -58.97 5.05 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.483 2.313 . . . . 0.0 111.735 -160.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.38 -16.32 60.13 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -102.22 -17.11 16.1 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.959 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -49.11 -55.8 11.11 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 125.203 1.401 . . . . 0.0 108.859 171.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -53.02 -54.54 33.84 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.307 1.843 . . . . 0.0 112.468 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -64.09 -20.93 66.31 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.125 0.57 . . . . 0.0 112.278 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.34 -64.18 1.16 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 167.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.3 pt -58.55 -25.72 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -62.53 -22.33 66.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.29 1.036 . . . . 0.0 113.406 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.12 149.51 51.21 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 119.12 0.873 . . . . 0.0 112.453 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -87.82 53.34 2.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.232 1.413 . . . . 0.0 110.193 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.76 165.9 35.9 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.66 101.09 0.16 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.192 3.261 . . . . 0.0 111.772 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.47 101.71 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 125.369 1.468 . . . . 0.0 107.973 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.46 HD22 HG13 ' A' ' 52' ' ' VAL . 4.9 tt -82.58 112.77 19.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 171.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.59 114.95 39.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.97 93.03 4.65 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -164.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 69' ' ' ILE . 52.8 m-85 -86.62 112.86 22.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.601 0.761 . . . . 0.0 109.758 -176.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 26.6 p-90 -124.54 -175.68 3.33 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 169.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.497 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -151.52 158.69 43.93 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.202 -0.936 . . . . 0.0 110.096 172.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.42 -1.27 0.5 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.215 1.806 . . . . 0.0 115.598 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.15 -18.96 1.75 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 26' ' ' ALA . 1.1 p -72.27 100.65 2.66 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.855 1.207 . . . . 0.0 111.519 -165.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -29.0 -61.81 0.14 Allowed Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.934 1.73 . . . . 0.0 115.067 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.31 -33.67 29.56 Favored 'Trans proline' 0 C--N 1.351 0.658 0 CA-C-N 120.273 2.036 . . . . 0.0 112.985 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.7 p -69.27 -30.35 68.44 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.795 1.179 . . . . 0.0 110.624 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -20.6 65.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.329 0.968 . . . . 0.0 111.654 172.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.1 mtp -99.85 -25.98 14.17 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.323 1.449 . . . . 0.0 111.878 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.7 ttt -81.48 -38.74 25.86 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.727 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.03 -50.73 61.17 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 120.703 1.592 . . . . 0.0 112.534 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.22 -33.25 40.22 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.598 1.532 . . . . 0.0 112.359 172.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.65 -36.63 77.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 120.13 1.332 . . . . 0.0 110.851 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 42' ' ' PHE . 54.2 mt -78.92 -6.47 56.27 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.921 2.489 . . . . 0.0 111.471 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.92 -48.52 13.29 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.738 1.215 . . . . 0.0 108.144 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -60.9 -43.41 98.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.853 0.461 . . . . 0.0 110.022 168.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.467 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 33.1 t80 -63.85 -20.13 65.58 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.543 173.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.92 -59.4 2.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 121.174 1.806 . . . . 0.0 108.668 166.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.16 -45.43 65.06 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.792 1.237 . . . . 0.0 111.838 -173.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.55 -23.91 29.35 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -169.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.32 36.69 0.83 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.037 1.335 . . . . 0.0 110.626 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.39 -23.42 3.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 -160.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.18 0.07 8.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.349 0.977 . . . . 0.0 112.841 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -76.58 -29.34 56.57 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.432 -0.792 . . . . 0.0 109.946 167.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.22 143.04 42.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 109.249 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.461 HG23 ' HB ' ' A' ' 2' ' ' THR . 1.0 OUTLIER -68.33 136.49 53.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 158.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.46 HG13 HD22 ' A' ' 21' ' ' LEU . 5.0 t -119.92 134.61 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 160.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.21 90.38 2.03 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -166.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -86.99 143.71 27.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.226 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 152.62 26.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.208 0.913 . . . . 0.0 113.263 171.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -76.45 107.04 8.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.246 1.818 . . . . 0.0 107.683 172.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' A' ' 26' ' ' ALA . 8.6 p -48.41 -43.53 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 126.738 2.015 . . . . 0.0 114.274 -165.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.45 -27.09 68.31 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.872 2.069 . . . . 0.0 112.492 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.4 -28.1 62.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.726 0.81 . . . . 0.0 111.406 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -115.48 83.75 11.21 Favored Pre-proline 0 N--CA 1.457 -0.125 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.53 -25.77 29.32 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.631 1.554 . . . . 0.0 112.207 170.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.71 118.44 7.13 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.47 1.108 . . . . 0.0 109.405 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.262 8.8 m 70.23 -20.01 0.2 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.606 2.362 . . . . 0.0 113.366 173.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.9 m -54.66 -55.73 26.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.58 1.952 . . . . 0.0 109.011 160.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.5 t -57.59 -41.57 81.44 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.291 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -62.75 -40.81 98.41 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.665 0.786 . . . . 0.0 112.949 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -96.27 16.56 17.98 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.713 0.688 . . . . 0.0 112.773 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.21 25.81 72.24 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 124.129 0.871 . . . . 0.0 112.523 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.542 HD12 HG21 ' A' ' 74' ' ' THR . 30.6 mm -82.14 70.02 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 122.576 1.179 . . . . 0.0 109.558 -165.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 53.3 ttp -120.37 0.78 10.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.739 1.616 . . . . 0.0 109.974 166.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.3 t -88.83 21.94 2.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.102 1.361 . . . . 0.0 112.985 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.451 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -59.45 144.61 83.95 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.529 0.732 . . . . 0.0 112.528 -168.011 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 62.6 Cg_endo -69.06 130.64 16.41 Favored 'Cis proline' 0 C--N 1.35 0.606 0 CA-C-N 119.01 0.682 . . . . 0.0 112.734 7.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.542 HG21 HD12 ' A' ' 69' ' ' ILE . 40.9 m -125.26 151.71 45.58 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.862 1.265 . . . . 0.0 108.82 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.2 tt -143.63 105.34 4.32 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -173.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.42 HD11 HD11 ' A' ' 69' ' ' ILE . 23.9 mt -101.1 143.82 13.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 171.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.25 115.89 28.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -113.63 163.39 15.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.827 1.651 . . . . 0.0 111.873 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.456 ' HE3' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -162.41 149.91 13.89 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.466 1.907 . . . . 0.0 107.337 158.202 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.03 14.67 47.0 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 119.155 0.889 . . . . 0.0 113.496 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.87 -5.99 82.24 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.436 1.494 . . . . 0.0 113.35 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -98.86 121.14 56.93 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 119.174 1.487 . . . . 0.0 110.189 -173.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.09 103.79 1.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.75 2.967 . . . . 0.0 110.048 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.456 HG21 ' HE3' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -71.29 -35.94 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 121.815 -0.553 . . . . 0.0 112.071 178.491 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -153.54 158.27 41.0 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.592 0.757 . . . . 0.0 110.669 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -147.44 125.22 11.88 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.744 2.018 . . . . 0.0 106.741 -172.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.8 mp -121.83 150.5 41.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.473 1.909 . . . . 0.0 106.802 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.9 pt -145.43 151.97 14.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.613 1.165 . . . . 0.0 109.344 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.12 167.63 24.65 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.404 1.002 . . . . 0.0 111.908 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -75.33 73.94 2.42 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.077 0.951 . . . . 0.0 110.855 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -70.06 138.3 87.33 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.62 163.53 38.63 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.403 2.069 . . . . 0.0 110.634 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.12 -44.8 61.4 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.982 1.313 . . . . 0.0 111.225 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.67 -15.32 63.41 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.093 0.957 . . . . 0.0 112.67 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -102.0 -44.57 5.44 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.208 0.913 . . . . 0.0 109.17 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.51 -59.32 5.63 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.106 1.762 . . . . 0.0 109.636 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -63.55 -24.73 67.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.054 0.843 . . . . 0.0 110.968 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.92 -51.52 15.85 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.854 0.752 . . . . 0.0 110.682 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -62.27 -43.3 99.15 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.7 0.8 . . . . 0.0 110.481 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 tp -78.77 -7.03 57.41 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.725 1.21 . . . . 0.0 112.744 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.07 -33.05 37.46 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.689 1.196 . . . . 0.0 111.085 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.16 11.87 0.1 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.803 2.041 . . . . 0.0 112.711 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.54 -11.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 119.451 -2.031 . . . . 0.0 113.187 158.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.07 -22.57 20.67 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.043 1.337 . . . . 0.0 112.047 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 . . . . . 0 C--O 1.251 1.134 0 C-N-CA 128.591 2.757 . . . . 0.0 110.202 175.613 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 117.371 -1.299 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.8 m 82.69 140.54 0.07 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.436 2.695 . . . . 0.0 113.092 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.4 ttm -157.55 171.81 19.68 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.326 1.85 . . . . 0.0 109.082 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 m -70.99 162.41 29.45 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.889 -1.132 . . . . 0.0 109.264 162.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 10' ' ' PHE . 4.2 tp -136.79 165.08 26.77 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.964 0.906 . . . . 0.0 110.629 175.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.4 p -146.03 172.27 13.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 128.703 2.801 . . . . 0.0 104.988 170.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -45.45 -61.2 1.78 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.517 2.327 . . . . 0.0 110.855 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.0 -31.95 71.54 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.692 -0.63 . . . . 0.0 112.182 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -78.03 -19.25 54.71 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.287 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.504 ' HA ' HD21 ' A' ' 5' ' ' LEU . 2.2 t80 -55.51 -60.44 3.43 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.442 1.497 . . . . 0.0 107.572 173.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -58.81 -45.46 89.88 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 111.793 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -56.85 -36.01 69.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.568 0.622 . . . . 0.0 111.516 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.46 -60.72 2.11 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.873 0.869 . . . . 0.0 110.69 172.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.2 pt -68.98 -2.42 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -168.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -42.76 -39.69 2.55 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.593 1.957 . . . . 0.0 114.91 -172.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 159.25 -176.55 36.04 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 119.322 0.965 . . . . 0.0 113.899 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 65.25 -57.44 0.29 Allowed 'General case' 0 N--CA 1.463 0.196 1 C-N-CA 132.056 4.143 . . . . 0.0 112.543 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.53 150.86 20.61 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.645 -160.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.16 88.5 0.7 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.113 3.209 . . . . 0.0 110.24 170.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.59 149.57 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 170.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.03 167.77 21.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.932 -0.48 . . . . 0.0 110.595 161.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.31 134.46 66.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 124.48 1.112 . . . . 0.0 108.382 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 45.4 t0 -95.7 99.72 11.53 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 167.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.484 ' CD1' HG23 ' A' ' 57' ' ' VAL . 37.1 m-85 -86.68 112.73 21.92 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 -128.28 176.65 7.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.163 1.385 . . . . 0.0 108.162 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -147.5 149.03 31.86 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.723 1.147 . . . . 0.0 110.789 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.07 -24.46 66.24 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -102.51 -6.99 22.26 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.252 0.933 . . . . 0.0 113.25 -174.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.1 p -66.19 169.94 6.44 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.638 0.732 . . . . 0.0 112.676 -164.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.89 -90.22 1.54 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 165.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.39 -23.16 71.7 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.003 2.469 . . . . 0.0 114.117 -168.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.86 -25.92 68.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.161 0.891 . . . . 0.0 111.682 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -71.8 -17.16 62.18 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.0 0.92 . . . . 0.0 111.632 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.5 mtp -97.39 -39.87 8.98 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.689 1.596 . . . . 0.0 110.211 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.8 tpt -66.84 -44.87 79.94 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-O 117.657 -1.163 . . . . 0.0 109.931 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.86 99.91 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.309 1.413 . . . . 0.0 112.725 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -69.19 -38.63 8.75 Favored 'Trans proline' 0 C--N 1.352 0.747 0 CA-C-N 121.78 1.671 . . . . 0.0 112.837 169.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.97 -34.09 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 120.935 1.698 . . . . 0.0 111.531 177.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.0 -13.23 61.19 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.877 2.471 . . . . 0.0 111.701 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.3 -36.63 34.06 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.564 1.074 . . . . 0.0 110.308 176.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.95 -43.24 99.33 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 169.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -58.57 -45.98 87.89 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.669 0.788 . . . . 0.0 110.479 171.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.06 -49.04 72.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.173 0.897 . . . . 0.0 110.893 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -53.19 60.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.74 1.216 . . . . 0.0 111.087 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.72 48.56 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -164.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -141.98 38.88 1.62 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.748 1.219 . . . . 0.0 110.552 172.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.47 -8.67 2.89 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.009 1.324 . . . . 0.0 113.964 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -92.29 -53.96 4.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.94 2.496 . . . . 0.0 111.425 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -68.34 -26.08 65.42 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 118.719 -0.658 . . . . 0.0 111.248 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.2 m -141.73 171.0 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.436 0.695 . . . . 0.0 110.111 -174.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.9 t -127.48 130.43 49.21 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 160.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.0 p -90.98 173.08 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 158.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.07 153.35 34.91 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 159.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 17.8 mtpp -113.26 137.65 51.17 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 119.29 -0.386 . . . . 0.0 109.992 -169.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pp -149.86 146.88 27.36 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 122.686 1.232 . . . . 0.0 114.288 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -78.64 110.16 13.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.127 2.171 . . . . 0.0 108.025 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.484 HG23 ' CD1' ' A' ' 24' ' ' PHE . 7.6 p -63.01 -37.1 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.861 1.665 . . . . 0.0 112.929 -166.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.86 -38.62 83.36 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.097 1.359 . . . . 0.0 110.601 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -76.34 -27.31 56.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.629 2.372 . . . . 0.0 112.048 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -116.65 78.21 8.7 Favored Pre-proline 0 N--CA 1.445 -0.703 0 C-N-CA 124.817 1.247 . . . . 0.0 110.461 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.36 -88.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 123.875 3.05 . . . . 0.0 112.313 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 30.96 -39.45 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.893 1 C-N-CA 132.912 4.485 . . . . 0.0 120.367 -159.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -159.52 -7.32 0.06 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 129.466 3.106 . . . . 0.0 112.376 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 m -39.93 -60.4 1.03 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.168 2.187 . . . . 0.0 110.547 164.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.0 t -68.79 -17.39 64.02 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.789 -1.1 . . . . 0.0 113.041 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -77.61 -30.97 52.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.69 1.132 . . . . 0.0 110.112 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -93.51 9.65 35.76 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.438 0.695 . . . . 0.0 111.122 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.52 22.85 75.23 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.846 0.736 . . . . 0.0 112.784 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.443 HG21 ' CZ ' ' A' ' 24' ' ' PHE . 40.8 mm -78.23 77.36 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.753 1.221 . . . . 0.0 109.151 -169.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.81 -2.54 8.77 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.088 1.355 . . . . 0.0 110.363 167.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 p -82.87 43.64 0.86 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.177 2.591 . . . . 0.0 111.485 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.11 145.84 94.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 O-C-N 121.7 -0.625 . . . . 0.0 111.697 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.21 127.0 8.89 Favored 'Cis proline' 0 N--CA 1.459 -0.512 0 CA-C-N 119.153 0.733 . . . . 0.0 110.797 0.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.0 m -116.84 148.07 41.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 tt -136.96 126.64 25.42 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.9 mt -128.85 141.56 46.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.466 HD11 HD21 ' A' ' 100' ' ' LEU . 1.3 mp -106.94 142.7 36.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.843 1.657 . . . . 0.0 109.474 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -134.68 150.09 50.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.357 1.463 . . . . 0.0 109.309 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.66 163.88 32.19 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 159.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.02 8.55 8.55 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 118.453 -1.193 . . . . 0.0 115.287 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.34 2.49 60.39 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 119.134 1.467 . . . . 0.0 113.156 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -126.57 135.91 27.93 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 119.346 1.573 . . . . 0.0 110.813 -168.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.44 117.2 5.02 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.48 2.786 . . . . 0.0 110.376 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.03 -46.01 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -156.55 164.5 38.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.867 0.758 . . . . 0.0 111.365 -173.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -136.28 147.98 47.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.483 1.913 . . . . 0.0 109.414 -171.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -122.14 154.05 37.92 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.833 1.653 . . . . 0.0 107.845 158.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 pt -141.32 137.74 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.671 1.988 . . . . 0.0 106.129 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.42 168.31 35.61 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.922 0.772 . . . . 0.0 112.921 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -80.4 83.64 6.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.529 1.131 . . . . 0.0 108.952 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -88.66 134.68 33.5 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.53 160.41 48.1 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.28 1.32 . . . . 0.0 109.793 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -41.67 80.79 Favored 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 123.803 0.841 . . . . 0.0 111.512 -175.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.79 -19.99 60.54 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -95.39 -49.75 5.31 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.888 1.222 . . . . 0.0 109.364 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.31 -59.17 5.74 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 124.499 1.12 . . . . 0.0 110.62 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -65.9 -18.44 65.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.075 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.25 -51.6 12.89 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.148 0.885 . . . . 0.0 110.307 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -53.32 -43.17 67.4 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.852 0.861 . . . . 0.0 110.831 175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.466 HD21 HD11 ' A' ' 77' ' ' LEU . 1.4 mp -86.85 -0.77 57.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.597 1.559 . . . . 0.0 113.167 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.04 -34.29 69.91 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 119.431 1.014 . . . . 0.0 111.622 -172.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -63.26 -12.56 30.0 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.195 1.398 . . . . 0.0 113.96 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.4 m -128.59 9.73 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 126.245 1.818 . . . . 0.0 111.633 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -124.95 -4.55 7.51 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.924 1.689 . . . . 0.0 113.122 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 126.895 2.078 . . . . 0.0 108.708 164.761 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.662 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -65.96 -9.08 26.71 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.047 1.339 . . . . 0.0 113.698 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.51 -146.33 0.43 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.833 1.653 . . . . 0.0 110.633 167.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.0 m -67.85 122.17 17.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.31 1.044 . . . . 0.0 108.848 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 tt -134.17 161.67 34.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.956 1.702 . . . . 0.0 109.136 -163.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.1 p -142.86 163.97 31.35 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 129.145 2.978 . . . . 0.0 104.998 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 10' ' ' PHE . 21.5 t70 -58.41 -40.14 81.63 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.601 1.16 . . . . 0.0 113.124 -168.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.52 65.84 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.633 -0.667 . . . . 0.0 112.358 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -94.49 -34.75 12.58 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.201 1.4 . . . . 0.0 110.549 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' A' ' 7' ' ' ASP . 51.8 t80 -50.6 -62.39 1.63 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 126.847 2.059 . . . . 0.0 109.201 173.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -57.29 -46.03 83.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.277 0.489 . . . . 0.0 110.781 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -70.62 -21.53 62.63 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.4 -62.01 1.71 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.212 0.915 . . . . 0.0 109.538 165.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.1 pt -62.46 -21.71 27.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.514 1.126 . . . . 0.0 113.776 -167.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -64.37 -23.92 67.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.93 0.892 . . . . 0.0 112.807 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.35 170.16 54.52 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 118.864 0.756 . . . . 0.0 112.058 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -82.83 -22.62 34.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.601 1.56 . . . . 0.0 112.798 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.46 48.73 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 123.408 0.528 . . . . 0.0 112.219 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HA ' HD21 ' A' ' 77' ' ' LEU . 34.7 Cg_endo -65.3 91.3 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 124.186 3.257 . . . . 0.0 111.317 173.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.67 131.43 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 mp -118.57 136.94 53.58 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.55 116.63 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 26.0 t0 -72.72 107.52 5.22 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 124.105 0.878 . . . . 0.0 109.025 163.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -89.03 108.15 19.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 164.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -126.44 -177.92 4.16 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.31 159.84 40.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.376 -0.827 . . . . 0.0 108.876 168.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.77 -15.67 22.01 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.535 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -89.63 -31.25 17.62 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.458 1.026 . . . . 0.0 113.354 177.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.9 p -72.8 160.67 31.81 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.684 1.129 . . . . 0.0 111.151 -168.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.43 -79.55 1.47 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.018 0.818 . . . . 0.0 112.515 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.15 -15.89 51.93 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.621 2.881 . . . . 0.0 113.701 -172.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.1 p -52.81 -35.97 57.75 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.248 0.619 . . . . 0.0 111.786 167.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -70.38 -13.94 62.35 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.753 0.706 . . . . 0.0 112.563 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.2 mtm -95.91 -20.08 19.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.078 1.351 . . . . 0.0 111.63 170.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.5 ttt -79.85 -39.27 30.99 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 108.913 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.01 -52.48 46.94 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.742 1.217 . . . . 0.0 113.326 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.65 -30.88 34.14 Favored 'Trans proline' 0 C--N 1.352 0.711 0 CA-C-N 121.987 1.745 . . . . 0.0 112.26 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.17 -38.3 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.636 1.107 . . . . 0.0 109.887 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 mp -69.99 -26.93 64.31 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.6 1.96 . . . . 0.0 112.196 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -69.52 -46.76 65.79 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.252 0.933 . . . . 0.0 109.156 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -61.93 -41.23 97.7 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.069 0.548 . . . . 0.0 110.591 173.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.29 -50.53 73.29 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.286 1.035 . . . . 0.0 110.915 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.25 -48.24 79.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.725 0.81 . . . . 0.0 110.16 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -58.27 -50.03 75.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.254 0.621 . . . . 0.0 110.941 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.7 -23.14 50.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.96 52.86 0.69 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.348 1.459 . . . . 0.0 109.876 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.26 -17.63 54.43 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -95.43 -49.6 5.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.595 2.358 . . . . 0.0 111.549 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -67.11 -24.62 65.95 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.151 -170.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.22 149.43 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 119.139 0.881 . . . . 0.0 111.074 -172.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.344 2.9 t -110.57 84.9 2.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 123.11 1.433 . . . . 0.0 109.3 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.14 139.14 19.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.967 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.52 166.56 22.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.201 2.2 . . . . 0.0 107.976 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 23.5 pttp -136.22 144.57 44.96 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 122.406 0.282 . . . . 0.0 111.377 173.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -145.86 142.7 29.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.368 0.604 . . . . 0.0 111.539 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -83.13 98.51 9.37 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.98 -27.73 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.613 -163.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -65.01 -24.87 67.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.867 2.467 . . . . 0.0 112.306 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -91.89 -32.26 15.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.069 1.347 . . . . 0.0 110.238 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -116.94 74.87 7.12 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.643 1.177 . . . . 0.0 109.839 -170.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.15 -12.65 14.3 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.152 3.235 . . . . 0.0 113.514 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.9 142.6 47.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.131 0.878 . . . . 0.0 109.315 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m 60.07 -29.36 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 131.46 3.904 . . . . 0.0 113.458 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.2 m -50.11 -59.6 3.76 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.018 2.927 . . . . 0.0 108.737 161.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -70.93 -10.14 59.12 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 117.725 -1.131 . . . . 0.0 112.674 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -85.87 -39.21 17.26 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.852 1.205 . . . . 0.0 111.266 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -92.99 6.85 46.44 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.538 0.608 . . . . 0.0 112.242 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.89 34.5 77.28 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.861 0.755 . . . . 0.0 111.926 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.7 mm -72.17 85.31 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.078 1.751 . . . . 0.0 109.259 -171.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.8 tpp -143.11 51.85 1.38 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.557 1.543 . . . . 0.0 109.654 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.2 m -156.81 42.41 0.36 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.145 -1.597 . . . . 0.0 111.812 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.535 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 43.2 pt -70.73 151.93 95.24 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 121.767 -0.583 . . . . 0.0 112.564 -174.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 37.8 Cg_endo -62.49 129.2 6.64 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 119.379 0.814 . . . . 0.0 110.755 -5.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.1 m -121.44 140.93 51.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -123.53 120.39 32.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 171.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.6 mt -121.24 142.77 35.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 19' ' ' PRO . 4.4 tt -108.11 121.54 45.05 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.409 ' N ' HD23 ' A' ' 77' ' ' LEU . 80.8 m-85 -118.37 156.77 28.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.151 0.98 . . . . 0.0 111.221 -176.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -163.14 158.97 22.48 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 125.535 1.534 . . . . 0.0 108.745 161.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.26 16.05 25.61 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.919 0.771 . . . . 0.0 113.984 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.22 -5.82 83.95 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.122 -1.377 . . . . 0.0 114.017 -173.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.97 149.97 44.24 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 120.186 1.993 . . . . 0.0 111.617 -174.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.17 128.03 6.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.352 2.702 . . . . 0.0 110.296 170.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.3 -41.86 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.579 -0.701 . . . . 0.0 110.34 168.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -164.91 169.85 16.02 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.827 0.851 . . . . 0.0 111.22 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -136.31 146.93 47.17 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.729 2.411 . . . . 0.0 108.941 -170.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.8 151.52 37.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.651 1.981 . . . . 0.0 106.897 159.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.06 147.9 26.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.005 1.722 . . . . 0.0 107.298 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.31 169.4 21.14 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 122.022 0.79 . . . . 0.0 112.081 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -74.01 89.05 1.91 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -86.87 137.38 33.52 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 159.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.4 165.95 30.85 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.322 2.015 . . . . 0.0 111.451 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -46.27 -48.67 18.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.724 1.61 . . . . 0.0 112.144 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -52.78 -47.09 67.77 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.113 1.365 . . . . 0.0 111.644 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -38.51 72.3 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 124.341 1.056 . . . . 0.0 108.578 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 -54.53 30.2 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.218 1.007 . . . . 0.0 109.514 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.22 -40.23 85.18 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.66 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.78 -51.96 65.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.524 1.056 . . . . 0.0 111.414 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -62.81 -27.69 69.49 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.77 0.828 . . . . 0.0 112.419 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 mp -106.66 3.36 26.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.716 1.207 . . . . 0.0 111.905 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.58 -29.97 60.0 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.543 1.137 . . . . 0.0 112.567 -174.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -62.53 -14.86 46.71 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.422 HG11 ' CD1' ' A' ' 77' ' ' LEU . 2.1 p -117.55 -7.03 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 119.651 1.114 . . . . 0.0 111.686 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.52 -11.87 26.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.548 1.139 . . . . 0.0 112.068 172.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.739 2.016 . . . . 0.0 110.135 165.875 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.4 p -50.86 144.44 8.5 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -159.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.4 ttm -139.33 159.93 41.0 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.686 1.595 . . . . 0.0 107.533 168.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.4 m -76.03 146.09 39.73 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 163.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.74 173.08 7.43 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 122.364 1.078 . . . . 0.0 109.541 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.5 m -150.2 -129.4 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 102.581 -3.118 . . . . 0.0 102.581 172.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -86.61 -67.42 0.82 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.117 1.767 . . . . 0.0 111.248 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.6 -35.87 77.19 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.271 -0.893 . . . . 0.0 111.359 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -67.01 -31.33 71.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.728 0.811 . . . . 0.0 109.671 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -58.88 -57.25 13.86 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.819 0.736 . . . . 0.0 109.623 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -59.74 -46.52 88.9 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.54 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -63.29 -17.21 62.27 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.71 -59.28 2.48 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.807 0.843 . . . . 0.0 110.585 166.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.6 pt -67.59 -18.84 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -169.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -49.08 -34.45 13.76 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.157 1.783 . . . . 0.0 112.996 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.61 138.56 2.88 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 112.042 -0.423 . . . . 0.0 112.042 168.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.54 -102.97 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.9 -130.54 2.76 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 127.691 2.567 . . . . 0.0 106.752 165.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.95 93.45 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.272 2.648 . . . . 0.0 111.703 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.2 141.17 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 167.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.2 mt -137.33 158.99 43.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.04 141.31 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.41 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 54.9 t0 -96.06 110.39 22.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 158.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -93.71 109.68 21.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 167.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -134.25 -176.52 4.23 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.072 1.749 . . . . 0.0 108.098 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.37 166.3 33.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.643 1.577 . . . . 0.0 107.386 168.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.5 -29.08 69.76 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -31.86 17.75 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -169.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 p -71.51 102.4 2.69 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.713 0.688 . . . . 0.0 111.999 -162.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -34.14 -61.01 0.54 Allowed Glycine 0 CA--C 1.539 1.534 0 C-N-CA 126.017 1.77 . . . . 0.0 114.912 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.82 -32.86 28.6 Favored 'Trans proline' 0 C--N 1.35 0.646 0 CA-C-N 120.241 2.02 . . . . 0.0 112.512 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.4 p -67.73 -35.59 79.03 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 119.315 0.961 . . . . 0.0 110.258 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -62.35 -15.92 51.34 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.855 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 75.9 mtm -104.11 -14.2 15.97 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.564 1.145 . . . . 0.0 112.876 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.417 ' SD ' ' HA ' ' A' ' 90' ' ' TYR . 14.9 ttt -94.11 -40.67 9.93 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.284 1.434 . . . . 0.0 109.547 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.82 -49.42 86.85 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 117.738 -1.125 . . . . 0.0 112.466 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.76 -33.6 53.34 Favored 'Trans proline' 0 C--N 1.354 0.841 0 CA-C-N 121.888 1.71 . . . . 0.0 112.086 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.88 -42.27 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 118.447 0.567 . . . . 0.0 109.513 174.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.47 -24.58 64.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.014 1.725 . . . . 0.0 112.319 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -68.88 -48.25 63.85 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.418 1.008 . . . . 0.0 109.624 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -62.88 -45.23 93.53 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -55.16 -48.17 74.11 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 122.931 0.492 . . . . 0.0 110.439 175.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.07 -55.04 37.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.385 1.074 . . . . 0.0 110.73 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -52.82 -46.75 67.86 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.848 0.859 . . . . 0.0 110.602 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.53 -16.53 10.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -150.13 48.82 0.91 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.535 1.134 . . . . 0.0 110.559 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -25.64 66.58 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -97.68 -54.1 3.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.233 1.413 . . . . 0.0 112.465 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -53.79 -29.7 41.5 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.603 0.761 . . . . 0.0 112.378 -171.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 m -134.29 141.56 43.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.319 1.9 t -92.56 73.45 5.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 123.191 1.472 . . . . 0.0 107.723 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.79 164.26 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.307 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.6 179.9 8.75 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.806 0.843 . . . . 0.0 110.119 170.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 7.6 ttpm? -139.63 134.44 32.06 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.53 159.79 43.28 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.999 0.812 . . . . 0.0 112.351 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -82.38 123.38 29.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.314 0.646 . . . . 0.0 109.408 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.6 p -62.34 -29.59 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.182 0.993 . . . . 0.0 112.824 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.62 -36.34 70.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.642 0.777 . . . . 0.0 110.8 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.54 -34.85 74.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.178 2.191 . . . . 0.0 112.181 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -111.1 85.15 5.04 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 123.953 0.901 . . . . 0.0 109.393 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.3 -24.12 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.086 2.524 . . . . 0.0 112.816 172.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.07 117.66 11.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.021 1.328 . . . . 0.0 109.978 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 89.36 -40.71 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 129.784 3.233 . . . . 0.0 109.906 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.2 m -52.16 -60.54 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.163 2.185 . . . . 0.0 110.353 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.3 t -57.94 -44.26 86.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.709 0.404 . . . . 0.0 109.938 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -60.15 -27.92 67.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.965 1.306 . . . . 0.0 112.913 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.33 14.65 22.62 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.8 0.727 . . . . 0.0 111.465 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.07 26.5 73.32 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 121.55 -0.719 . . . . 0.0 113.135 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.3 mm -75.86 79.16 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.346 1.458 . . . . 0.0 109.014 -171.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.6 ttm -128.24 3.39 5.77 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.305 1.442 . . . . 0.0 110.962 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 t -90.82 23.88 2.95 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.088 1.355 . . . . 0.0 113.121 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.492 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -57.95 145.06 73.54 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.782 0.833 . . . . 0.0 113.161 -168.558 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 55.7 Cg_endo -69.09 132.24 20.78 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.034 0.691 . . . . 0.0 112.19 8.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.5 m -122.22 153.28 39.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 tt -144.44 104.44 4.07 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.734 2.014 . . . . 0.0 106.22 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.9 mt -102.19 133.17 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.66 109.68 21.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.095 2.158 . . . . 0.0 105.652 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -105.04 156.96 17.57 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -152.87 146.28 24.89 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 159.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.81 35.84 4.55 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.874 1.226 . . . . 0.0 115.215 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.77 -3.22 62.67 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 118.701 1.251 . . . . 0.0 114.791 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -123.61 130.88 24.32 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 119.652 1.726 . . . . 0.0 110.977 -168.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.48 101.69 1.39 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.778 2.986 . . . . 0.0 109.803 169.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -42.42 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.859 0.864 . . . . 0.0 111.094 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.37 168.41 26.4 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.74 163.45 30.14 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.352 0.596 . . . . 0.0 111.489 160.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 99' ' ' GLN . 2.8 mm? -117.88 148.31 42.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.838 2.055 . . . . 0.0 105.784 170.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.6 pt -139.56 140.26 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 125.151 1.38 . . . . 0.0 107.885 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.68 161.63 8.57 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.76 0.695 . . . . 0.0 111.781 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.417 ' HA ' ' SD ' ' A' ' 35' ' ' MET . 10.6 t80 -66.73 98.88 0.56 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.574 1.55 . . . . 0.0 112.385 -170.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -93.01 140.6 23.43 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 168.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.15 163.5 38.53 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.487 2.125 . . . . 0.0 110.308 168.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.67 -46.04 70.5 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 123.843 0.857 . . . . 0.0 111.879 -174.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -49.63 -43.36 46.66 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.801 1.24 . . . . 0.0 111.159 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -88.35 -42.61 12.09 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.442 1.097 . . . . 0.0 109.061 -166.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.83 -62.46 1.85 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.99 1.316 . . . . 0.0 109.31 173.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -57.3 -38.13 73.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.608 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.29 82.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.615 1.098 . . . . 0.0 110.574 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.439 ' HG2' HD11 ' A' ' 87' ' ' LEU . 4.9 tp60 -66.99 -21.88 65.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.77 -7.24 27.9 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.204 1.802 . . . . 0.0 113.287 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.71 -29.46 66.7 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.088 1.755 . . . . 0.0 112.532 -167.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.48 -5.54 3.88 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.073 1.749 . . . . 0.0 113.886 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.4 -1.07 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.124 0.874 . . . . 0.0 112.687 167.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.19 -12.51 15.71 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.247 1.419 . . . . 0.0 113.316 174.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.4 tp60 . . . . . 0 C--O 1.248 1.003 0 C-N-CA 126.461 1.904 . . . . 0.0 107.395 159.126 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 119.73 -0.176 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.3 m -64.79 153.75 39.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.838 0.855 . . . . 0.0 112.074 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.4 ttp -142.5 172.66 12.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.827 1.251 . . . . 0.0 107.837 159.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -77.19 154.73 32.81 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 159.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tp -113.96 164.94 13.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.625 0.726 . . . . 0.0 109.845 173.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.48 171.04 15.16 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 -173.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -45.38 -58.89 3.0 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 127.562 2.345 . . . . 0.0 112.758 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.66 96.89 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.531 -0.731 . . . . 0.0 111.341 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -68.05 -26.97 66.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.395 1.078 . . . . 0.0 110.314 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -65.18 -6.44 9.34 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 125.128 1.371 . . . . 0.0 112.431 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -121.19 -56.15 1.93 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 162.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -67.89 -12.6 61.01 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -168.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.26 -3.87 13.79 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.593 1.157 . . . . 0.0 113.044 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 11.7 pt -91.83 -105.95 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 158.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 47.95 -10.26 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.77 1 C-N-CA 131.859 4.064 . . . . 0.0 118.881 174.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.27 179.94 17.48 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.144 1.831 . . . . 0.0 112.29 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.14 -11.43 57.94 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.087 1.755 . . . . 0.0 112.869 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.4 150.02 51.7 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.72 97.42 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.036 2.491 . . . . 0.0 110.34 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.1 t -105.33 140.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.95 136.44 46.11 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.793 0.806 . . . . 0.0 110.206 172.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.87 120.99 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 126.707 2.003 . . . . 0.0 105.965 -170.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.02 92.06 4.22 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -77.97 113.77 16.19 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.028 0.931 . . . . 0.0 108.9 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -131.97 -174.21 3.36 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 170.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.46 167.67 26.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.642 1.577 . . . . 0.0 107.584 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.9 -8.89 32.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.357 1.244 . . . . 0.0 114.357 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.538 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -110.53 -21.49 12.12 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -172.438 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.437 ' SG ' HD12 ' A' ' 72' ' ' ILE . 3.7 p -77.87 45.55 0.52 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -158.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 29.3 -95.17 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 C-N-CA 128.782 3.086 . . . . 0.0 114.213 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.07 -21.68 60.2 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.41 2.74 . . . . 0.0 114.538 -176.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.1 p -56.97 -32.37 65.99 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.448 1.476 . . . . 0.0 111.436 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -72.25 -18.91 61.78 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.751 1.22 . . . . 0.0 112.182 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -98.73 -18.11 18.18 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.086 1.354 . . . . 0.0 111.251 173.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.8 ttt -74.2 -37.62 63.84 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.602 1.561 . . . . 0.0 109.377 168.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.77 -51.56 45.3 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.495 -1.241 . . . . 0.0 113.171 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.68 -33.4 13.15 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 121.739 1.657 . . . . 0.0 113.051 171.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -28.89 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 121.258 1.844 . . . . 0.0 110.777 175.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.43 -13.1 61.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.765 2.026 . . . . 0.0 112.711 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -79.42 -40.7 29.37 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.682 1.128 . . . . 0.0 108.982 171.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.44 -16.89 64.45 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.733 0.813 . . . . 0.0 111.383 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -83.13 -43.89 15.72 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.426 1.09 . . . . 0.0 111.43 169.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.68 -48.66 49.47 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.938 0.895 . . . . 0.0 110.871 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -54.95 -43.0 73.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.458 1.103 . . . . 0.0 111.765 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.21 -12.49 28.71 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.551 1.141 . . . . 0.0 113.369 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -156.01 49.88 0.52 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.544 1.137 . . . . 0.0 110.056 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.07 -47.45 53.6 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.959 0.904 . . . . 0.0 112.459 -170.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -124.65 -6.2 7.5 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 171.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -55.07 -31.15 60.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.177 1.391 . . . . 0.0 111.765 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.26 177.26 6.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.676 1.19 . . . . 0.0 109.321 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 m -117.18 96.92 5.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.817 1.247 . . . . 0.0 107.741 164.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.77 149.25 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 160.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.58 109.03 3.98 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.432 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -88.32 145.5 25.8 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.767 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -154.38 157.29 38.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.659 0.784 . . . . 0.0 112.374 173.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -76.81 106.19 8.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.688 1.595 . . . . 0.0 109.187 174.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 p -64.1 -28.9 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.015 0.926 . . . . 0.0 112.685 -173.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.54 -30.25 71.28 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.341 1.056 . . . . 0.0 110.891 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -98.44 -20.45 17.11 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.578 1.951 . . . . 0.0 112.062 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -104.76 92.52 5.19 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.115 167.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.69 -17.95 22.69 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.062 1.841 . . . . 0.0 113.533 167.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 113.63 3.89 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.568 1.147 . . . . 0.0 109.282 -173.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.303 17.6 m 66.13 -14.69 0.14 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.329 2.651 . . . . 0.0 113.63 176.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.4 m -50.41 -55.24 16.64 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.321 1.848 . . . . 0.0 108.486 158.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -72.01 -6.79 44.75 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 117.847 -1.073 . . . . 0.0 113.103 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.77 -52.84 4.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.403 1.001 . . . . 0.0 109.364 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -81.2 16.87 1.42 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.159 0.89 . . . . 0.0 112.43 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.32 32.02 80.75 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 121.558 -0.714 . . . . 0.0 111.775 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.3 mm -77.43 81.3 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.538 1.135 . . . . 0.0 108.083 -172.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -117.88 14.4 14.21 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.783 1.633 . . . . 0.0 112.472 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.1 m -154.78 158.98 40.31 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.74 -1.225 . . . . 0.0 109.802 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.538 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 15.8 pt -155.05 162.51 27.07 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 129.28 3.032 . . . . 0.0 107.568 -171.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.2 127.59 7.24 Favored 'Cis proline' 0 C--N 1.349 0.565 0 CA-C-N 119.952 1.018 . . . . 0.0 110.653 -6.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.3 m -124.56 136.34 53.89 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.325 1.05 . . . . 0.0 108.797 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 tt -130.01 117.56 20.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.9 mt -126.38 129.65 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 tt -96.67 126.32 41.75 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.62 153.44 39.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.594 1.157 . . . . 0.0 110.613 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -158.56 153.37 24.89 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 124.757 1.223 . . . . 0.0 108.434 158.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.86 11.47 24.26 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 119.424 -0.653 . . . . 0.0 113.355 -169.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.65 0.58 89.95 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 118.345 1.072 . . . . 0.0 113.717 -170.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -107.82 136.16 19.74 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 119.34 1.57 . . . . 0.0 109.691 -173.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.99 110.31 3.02 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.361 2.707 . . . . 0.0 110.965 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.79 -37.19 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.629 1.572 . . . . 0.0 110.981 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -154.68 157.32 37.93 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.865 0.866 . . . . 0.0 109.108 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -141.24 127.73 20.03 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 126.937 2.095 . . . . 0.0 105.989 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mp -122.58 139.77 53.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.429 1.891 . . . . 0.0 106.03 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.09 121.86 29.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.207 1.403 . . . . 0.0 108.248 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.02 172.7 23.46 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.128 1.347 . . . . 0.0 112.507 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -69.7 85.22 0.46 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.285 1.034 . . . . 0.0 108.473 171.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.98 120.99 77.11 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 169.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -65.96 160.6 43.52 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.288 1.325 . . . . 0.0 109.92 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.44 -52.46 13.05 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 125.264 1.426 . . . . 0.0 112.558 -172.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -59.77 -25.95 65.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.911 1.284 . . . . 0.0 112.673 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -88.12 -42.18 12.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.033 0.933 . . . . 0.0 109.849 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.32 -60.83 3.0 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.658 1.983 . . . . 0.0 110.384 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -57.8 -33.45 68.59 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.189 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.05 -48.7 62.17 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 119.616 1.098 . . . . 0.0 111.119 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.0 tp-100 -63.25 -38.26 90.47 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.243 0.617 . . . . 0.0 111.33 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.86 -1.4 56.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.034 0.933 . . . . 0.0 112.912 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.46 -38.95 66.97 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 124.235 1.014 . . . . 0.0 112.798 -165.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -69.83 -6.47 32.67 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.647 1.112 . . . . 0.0 113.305 -176.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.28 1.29 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.654 1.182 . . . . 0.0 111.934 170.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -124.78 -4.03 7.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.005 1.722 . . . . 0.0 113.384 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.119 0 C-N-CA 126.792 2.037 . . . . 0.0 110.38 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.1 m -147.68 144.29 28.24 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 120.732 -1.23 . . . . 0.0 109.093 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.9 mtt -145.97 177.39 8.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.678 1.591 . . . . 0.0 109.256 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.4 m -93.85 160.84 14.56 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 161.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.8 mt -133.27 165.37 24.97 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.654 0.781 . . . . 0.0 109.444 171.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -138.15 -178.65 5.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 164.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.31 -60.37 3.2 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.989 2.115 . . . . 0.0 112.777 -161.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.94 -34.53 77.67 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -77.04 -19.14 57.56 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.914 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -57.18 -59.73 4.66 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.529 1.059 . . . . 0.0 109.759 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -42.6 99.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.589 0.356 . . . . 0.0 110.48 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.64 -26.7 61.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.159 0.584 . . . . 0.0 112.149 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.74 -26.94 19.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.828 -1.082 . . . . 0.0 112.655 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.472 HG13 ' H ' ' A' ' 15' ' ' GLN 0.279 11.3 pt -75.22 -91.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.95 0.795 . . . . 0.0 109.517 171.369 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.472 ' H ' HG13 ' A' ' 14' ' ' ILE . 13.9 pt20 45.85 -17.77 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.758 1 C-N-CA 133.207 4.603 . . . . 0.0 119.632 174.645 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.02 -179.06 25.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.757 1.162 . . . . 0.0 112.887 -159.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -81.46 -13.57 58.04 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.85 2.06 . . . . 0.0 114.207 -167.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.93 156.04 41.28 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 118.577 0.626 . . . . 0.0 112.036 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.15 81.96 1.11 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.778 2.985 . . . . 0.0 110.466 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.4 t -87.81 138.11 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.8 tt -133.75 141.27 47.44 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.91 125.63 58.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -170.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.71 96.85 6.2 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.747 1.219 . . . . 0.0 108.218 175.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -75.11 115.78 15.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -117.49 176.76 5.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 168.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.62 161.22 40.99 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.294 -0.879 . . . . 0.0 110.392 174.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.31 15.06 0.48 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.321 1.049 . . . . 0.0 113.579 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.411 ' CG ' ' N ' ' A' ' 29' ' ' CYS . 2.2 p90 -136.82 -61.72 0.66 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.215 1.006 . . . . 0.0 108.553 168.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.411 ' N ' ' CG ' ' A' ' 28' ' ' TRP . 16.3 p 44.16 -62.95 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 1 C-N-CA 132.024 4.13 . . . . 0.0 117.525 178.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.76 -103.83 3.06 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.951 1.739 . . . . 0.0 109.802 -161.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -60.19 -21.12 64.96 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.451 2.767 . . . . 0.0 115.15 -171.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -60.75 -25.3 66.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.947 1.248 . . . . 0.0 111.466 173.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -22.3 65.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.394 0.997 . . . . 0.0 111.932 174.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 84.0 mtp -98.54 -25.0 14.9 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 125.946 1.698 . . . . 0.0 111.429 176.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.2 ttt -83.38 -36.37 24.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 117.521 -1.228 . . . . 0.0 109.109 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.87 -51.13 57.24 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.871 1.669 . . . . 0.0 112.482 175.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -62.41 -39.43 46.28 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 121.444 1.551 . . . . 0.0 112.422 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.25 -20.67 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 119.981 1.264 . . . . 0.0 112.071 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.84 -17.39 24.15 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.242 1.817 . . . . 0.0 111.612 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.04 -45.84 69.41 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 167.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -53.83 -50.14 66.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.954 1.301 . . . . 0.0 110.151 167.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.86 -51.39 67.72 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.095 0.558 . . . . 0.0 110.974 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.57 -55.85 19.4 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.881 0.872 . . . . 0.0 110.532 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.68 -43.6 85.18 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.672 0.608 . . . . 0.0 111.217 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.79 -21.31 10.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -147.63 40.94 1.02 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.481 1.112 . . . . 0.0 111.003 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.52 -37.17 16.91 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.951 1.7 . . . . 0.0 115.275 -162.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -132.26 6.27 4.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -66.24 -34.58 78.33 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.527 -0.733 . . . . 0.0 109.825 166.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.65 171.64 5.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.338 0.6 OUTLIER -118.62 97.81 5.92 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 159.237 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 p -84.89 159.76 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.2 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.38 156.92 44.07 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 162.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -123.03 138.09 54.77 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 172.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pp -150.87 150.83 31.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.867 0.467 . . . . 0.0 110.956 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -82.79 116.57 22.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.81 -27.86 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.8 0.84 . . . . 0.0 112.142 -175.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -67.63 -31.45 71.47 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.683 0.793 . . . . 0.0 111.0 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -83.97 -24.82 30.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.034 0.934 . . . . 0.0 111.907 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -113.84 86.63 11.23 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.309 1.043 . . . . 0.0 109.856 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.03 -24.51 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.124 2.55 . . . . 0.0 113.752 171.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.23 131.16 44.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.788 1.176 . . . . 0.0 109.808 -177.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.9 m 69.68 -31.8 0.22 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.42 2.688 . . . . 0.0 112.453 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.1 m -53.51 -54.74 32.93 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.471 1.909 . . . . 0.0 109.721 170.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.6 t -70.03 -1.94 11.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.766 -1.111 . . . . 0.0 113.157 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -106.69 -35.09 7.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.663 1.12 . . . . 0.0 111.339 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -99.1 14.93 27.55 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.794 0.725 . . . . 0.0 112.119 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.99 33.53 85.81 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 123.486 0.565 . . . . 0.0 111.899 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.7 mm -74.3 80.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.416 1.486 . . . . 0.0 108.312 -171.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 21.7 ttt -138.89 40.12 2.15 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.255 1.422 . . . . 0.0 109.642 -176.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.2 m -155.11 61.41 0.64 Allowed 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.468 -1.395 . . . . 0.0 109.565 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.48 153.79 81.54 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.686 173.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -67.32 126.08 7.45 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 CA-C-N 119.206 0.752 . . . . 0.0 110.544 -5.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -114.53 130.49 56.76 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.99 119.6 30.02 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -173.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.52 148.7 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -121.98 132.97 54.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -121.35 155.1 35.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.064 1.346 . . . . 0.0 110.842 -173.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -164.62 151.39 11.04 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.333 1.453 . . . . 0.0 109.229 158.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.03 15.81 50.88 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.652 0.644 . . . . 0.0 112.353 -165.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.02 -3.59 28.26 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.843 -0.976 . . . . 0.0 113.862 -166.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.74 133.56 39.41 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 119.522 1.661 . . . . 0.0 108.821 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.45 95.82 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.272 2.648 . . . . 0.0 109.299 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 m -61.14 -35.56 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 O-C-N 121.656 -0.653 . . . . 0.0 111.917 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.88 159.85 43.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.012 0.434 . . . . 0.0 111.636 159.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.13 140.92 48.93 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 127.538 2.335 . . . . 0.0 107.303 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.462 HD11 ' HG2' ' A' ' 99' ' ' GLN . 3.6 mm? -123.39 152.59 41.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 127.702 2.401 . . . . 0.0 107.625 168.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.73 126.18 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.82 163.75 39.14 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.607 1.099 . . . . 0.0 113.101 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -61.82 134.05 56.23 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.057 1.343 . . . . 0.0 110.535 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -137.91 144.01 42.24 Favored Pre-proline 0 C--O 1.242 0.671 0 C-N-CA 124.89 1.276 . . . . 0.0 107.608 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.94 157.27 57.76 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.192 1.928 . . . . 0.0 109.155 169.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.54 -38.47 87.57 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.149 -0.97 . . . . 0.0 110.779 -175.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.22 -21.37 13.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.059 0.944 . . . . 0.0 113.02 174.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -97.92 -50.91 4.24 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 119.49 1.041 . . . . 0.0 110.454 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.74 -58.9 6.32 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.837 1.655 . . . . 0.0 109.527 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.52 -30.77 68.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.931 1.292 . . . . 0.0 110.657 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.71 -46.25 32.14 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.547 0.612 . . . . 0.0 110.965 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.462 ' HG2' HD11 ' A' ' 87' ' ' LEU . 12.7 tp-100 -64.75 -31.22 72.35 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.424 1.09 . . . . 0.0 111.19 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.24 2.17 56.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.345 1.058 . . . . 0.0 112.511 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.18 -19.04 61.13 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -19.79 62.88 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.066 1.757 . . . . 0.0 111.672 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.31 -7.23 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 125.779 1.632 . . . . 0.0 111.783 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.05 5.96 28.52 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.557 1.543 . . . . 0.0 112.78 167.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.962 0 C-N-CA 126.157 1.783 . . . . 0.0 109.618 165.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 110.793 -0.077 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.0 m -122.03 140.15 52.84 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 171.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.9 tpt -148.07 176.12 10.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.968 1.307 . . . . 0.0 109.131 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.2 m -99.8 141.32 32.77 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 168.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.658 HD13 ' CB ' ' A' ' 53' ' ' ALA . 1.6 tp -113.85 163.1 15.52 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.339 0.59 . . . . 0.0 110.307 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 t -142.64 -127.67 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -98.79 -62.22 1.27 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.982 1.313 . . . . 0.0 109.49 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.94 79.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.62 1.168 . . . . 0.0 111.008 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -72.24 -24.54 61.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.335 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -71.45 -48.83 46.94 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.07 -32.98 74.74 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.949 -0.548 . . . . 0.0 112.3 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -64.85 -50.32 67.1 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.166 0.894 . . . . 0.0 110.2 167.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.402 ' O ' HG21 ' A' ' 20' ' ' VAL . . . -54.74 -48.21 72.86 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.143 0.883 . . . . 0.0 111.372 -175.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt -63.01 -1.98 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -52.23 -31.6 32.83 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.233 1.379 . . . . 0.0 111.909 171.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.99 -133.28 13.98 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 116.531 1.372 . . . . 0.0 116.531 158.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.6 t70 64.29 -50.16 0.29 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 130.221 3.408 . . . . 0.0 111.303 -158.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.4 160.68 46.0 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.68 107.04 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.19 2.593 . . . . 0.0 110.956 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 13' ' ' ALA . 50.3 t -94.52 107.02 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.97 153.59 22.06 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 164.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.26 150.88 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 164.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -110.7 104.62 13.31 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.43 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 79.0 m-85 -89.31 108.2 19.49 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 164.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -131.49 -176.39 4.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.528 1.531 . . . . 0.0 107.019 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.18 171.25 20.25 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.692 1.197 . . . . 0.0 108.132 164.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.52 80.61 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.52 -23.91 18.94 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -163.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.9 p -75.6 40.19 0.18 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.298 1.839 . . . . 0.0 115.256 -159.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 42.48 -99.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 127.718 2.58 . . . . 0.0 113.974 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -57.52 -23.48 56.51 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.528 2.819 . . . . 0.0 114.396 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.9 p -56.91 -34.63 68.13 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.511 1.05 . . . . 0.0 111.417 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -71.12 -8.0 50.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.357 1.063 . . . . 0.0 112.359 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.7 mtm -106.88 -12.3 15.51 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.81 1.644 . . . . 0.0 112.222 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -40.42 11.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.813 2.045 . . . . 0.0 108.851 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.34 -56.23 19.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.233 1.413 . . . . 0.0 112.177 170.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.57 -25.01 69.79 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.143 1.801 . . . . 0.0 113.017 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.1 t -68.78 -46.35 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.365 0.984 . . . . 0.0 109.677 170.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.47 ' HA ' ' HB3' ' A' ' 42' ' ' PHE . 3.7 mp -61.15 -36.2 79.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.698 1.599 . . . . 0.0 111.901 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.18 -7.64 38.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.218 2.207 . . . . 0.0 112.099 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -109.81 -50.72 2.95 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.368 1.467 . . . . 0.0 109.47 168.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 47.4 t80 -45.45 -51.76 11.07 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 125.811 1.645 . . . . 0.0 112.22 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.15 -63.09 1.24 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.601 1.161 . . . . 0.0 110.369 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.88 -33.77 74.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.61 1.564 . . . . 0.0 111.993 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.77 -19.4 27.79 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -140.7 48.5 1.72 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.142 1.377 . . . . 0.0 109.028 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.24 -37.44 16.1 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.077 1.351 . . . . 0.0 114.259 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -130.32 3.22 4.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -65.46 -36.78 84.9 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.679 1.127 . . . . 0.0 109.094 159.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.6 m -111.09 174.27 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.248 1.019 . . . . 0.0 108.696 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.4 134.72 48.87 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 158.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.6 p -137.01 161.06 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.552 1.141 . . . . 0.0 109.827 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.658 ' CB ' HD13 ' A' ' 5' ' ' LEU . . . -165.09 166.35 19.23 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.275 171.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.15 148.1 42.67 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.52 137.05 36.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 125.812 1.945 . . . . 0.0 111.403 169.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -75.21 101.11 4.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.439 HG11 HG21 ' A' ' 72' ' ' ILE . 2.8 p -61.56 -25.3 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.373 1.069 . . . . 0.0 112.374 -166.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.01 -18.79 61.31 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.367 1.867 . . . . 0.0 112.649 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -114.97 -43.62 3.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 127.68 2.392 . . . . 0.0 109.887 -171.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -114.93 81.88 7.92 Favored Pre-proline 0 N--CA 1.443 -0.795 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.2 -68.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.235 2.623 . . . . 0.0 111.828 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 29.32 99.34 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.357 2.663 . . . . 0.0 115.586 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.263 38.6 m 67.71 -8.39 0.52 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.748 1.219 . . . . 0.0 113.165 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -49.36 -50.14 41.3 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.488 -1.382 . . . . 0.0 111.173 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.9 t -71.75 -3.68 23.37 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 117.657 -1.163 . . . . 0.0 112.778 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -95.6 -32.05 12.99 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.731 1.15 . . . . 0.0 111.68 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -110.48 0.74 17.89 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.82 35.91 43.89 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.263 0.935 . . . . 0.0 112.399 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.43 HG21 ' CZ ' ' A' ' 24' ' ' PHE . 42.8 mm -82.17 48.88 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.376 1.47 . . . . 0.0 111.778 -163.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 18.0 ttt -88.32 2.35 52.66 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.754 1.222 . . . . 0.0 110.348 163.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 p -72.77 13.97 0.32 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.202 2.201 . . . . 0.0 114.907 -176.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.462 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -65.16 144.75 99.1 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 123.907 0.883 . . . . 0.0 112.014 -165.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.462 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 57.5 Cg_endo -65.94 132.09 15.42 Favored 'Cis proline' 0 C--N 1.35 0.622 0 CA-C-N 119.268 0.774 . . . . 0.0 111.398 2.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.5 m -131.44 141.1 49.75 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.563 0.745 . . . . 0.0 109.144 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -135.87 98.92 4.02 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.1 mt -88.29 145.99 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.35 99.21 7.04 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -96.47 160.83 14.2 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.552 1.941 . . . . 0.0 109.685 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -157.78 39.02 0.27 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 158.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 82' ' ' GLU . . . 159.39 52.38 0.01 OUTLIER Glycine 0 N--CA 1.463 0.468 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 169.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.4 -25.53 0.58 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.31 1.91 . . . . 0.0 112.677 -168.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 80' ' ' GLY . 42.0 tt0 -91.72 131.71 35.04 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.43 1.892 . . . . 0.0 110.028 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.85 126.55 7.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.988 3.125 . . . . 0.0 110.78 170.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.8 -38.4 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 121.661 -0.65 . . . . 0.0 110.448 165.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -154.1 172.07 18.11 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 118.623 0.647 . . . . 0.0 111.233 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -138.35 136.15 36.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.196 1.799 . . . . 0.0 108.032 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.25 141.29 43.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.19 2.196 . . . . 0.0 105.851 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 pt -139.78 152.32 22.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.575 1.15 . . . . 0.0 108.838 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.19 168.1 6.86 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.838 0.732 . . . . 0.0 111.65 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -81.61 75.08 8.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.723 -0.869 . . . . 0.0 110.563 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -75.42 122.9 88.19 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 158.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -71.84 173.75 12.24 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.089 1.859 . . . . 0.0 110.7 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HE2' ' OE1' ' A' ' 97' ' ' GLU . 22.8 tptm -31.8 -59.12 0.27 Allowed 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 127.561 2.344 . . . . 0.0 112.483 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.72 -49.81 64.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.802 1.313 . . . . 0.0 111.643 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -74.22 -42.01 60.44 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.496 1.118 . . . . 0.0 110.033 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 tt -59.78 -62.46 1.86 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.594 1.558 . . . . 0.0 108.983 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.46 ' OE1' ' HE2' ' A' ' 93' ' ' LYS . 11.3 tt0 -66.09 -25.92 67.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.224 1.41 . . . . 0.0 111.102 -177.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.93 -52.48 24.18 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.212 0.915 . . . . 0.0 110.412 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -59.7 -40.0 86.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.391 0.541 . . . . 0.0 111.367 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.27 -0.66 50.57 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.797 1.239 . . . . 0.0 112.764 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.6 -28.97 66.09 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.363 0.983 . . . . 0.0 112.142 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -69.67 -3.71 16.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.626 1.17 . . . . 0.0 113.488 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.88 -15.58 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.156 0.889 . . . . 0.0 112.416 164.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.37 -9.98 50.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.015 0.926 . . . . 0.0 113.204 173.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 C-N-CA 125.641 1.576 . . . . 0.0 110.622 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 m 87.35 168.71 0.06 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.078 1.351 . . . . 0.0 113.657 152.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.5 ttt 72.92 -21.14 0.25 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 129.57 3.148 . . . . 0.0 116.001 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.8 m -155.33 156.97 36.42 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.759 1.624 . . . . 0.0 109.215 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.446 HD21 ' HA ' ' A' ' 10' ' ' PHE . 6.0 tp -146.01 170.32 16.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 127.728 2.411 . . . . 0.0 106.934 175.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.5 m -150.02 157.2 42.9 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -46.51 -53.4 11.34 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 127.172 2.189 . . . . 0.0 113.207 -168.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.03 93.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.051 0.929 . . . . 0.0 111.746 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -69.91 -18.47 63.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.124 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.446 ' HA ' HD21 ' A' ' 5' ' ' LEU . 2.3 t80 -58.12 -60.9 3.03 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.252 0.621 . . . . 0.0 110.242 172.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -63.47 -39.64 95.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.322 -0.37 . . . . 0.0 110.56 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -63.65 -27.99 69.61 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.609 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.64 -60.39 2.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.659 1.118 . . . . 0.0 109.517 168.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.8 pt -64.89 -23.28 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -167.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -59.53 -30.09 68.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 164.16 104.39 0.18 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.316 0.962 . . . . 0.0 110.734 -168.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -160.93 -65.03 0.06 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.614 1.566 . . . . 0.0 109.778 -169.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.22 -161.39 32.48 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 -164.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.44 112.48 1.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.491 2.127 . . . . 0.0 108.855 167.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.7 t -110.3 141.16 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 125.501 1.521 . . . . 0.0 107.199 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.1 tp -145.2 111.33 5.59 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 118.028 0.377 . . . . 0.0 110.469 -167.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.4 t -112.83 121.99 66.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 118.957 0.799 . . . . 0.0 109.436 -163.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 11.4 t0 -82.36 106.76 14.5 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 169.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.49 105.3 16.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 162.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.3 p-90 -117.95 -179.44 3.76 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 166.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.76 152.04 32.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 120.505 -1.372 . . . . 0.0 110.336 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -23.9 66.7 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.93 -13.27 29.09 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 p -71.55 178.25 3.61 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.214 0.605 . . . . 0.0 112.386 -164.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.97 -93.5 1.87 Allowed Glycine 0 CA--C 1.538 1.489 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 164.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -66.85 -21.27 50.87 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.381 2.721 . . . . 0.0 114.133 -166.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -30.37 68.81 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.521 0.6 . . . . 0.0 111.225 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 -71.8 -13.16 61.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.501 1.12 . . . . 0.0 111.981 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 76.4 mtm -98.6 -37.2 9.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.105 1.362 . . . . 0.0 111.089 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.8 ttt -67.44 -43.02 82.13 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.874 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.22 -50.64 74.58 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 119.956 1.253 . . . . 0.0 113.284 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.93 -33.43 26.35 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.849 1.696 . . . . 0.0 112.684 170.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -29.56 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 120.093 1.315 . . . . 0.0 112.018 173.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.7 mt -82.98 -23.9 33.17 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.667 2.387 . . . . 0.0 110.904 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -70.05 -35.93 74.62 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.824 0.738 . . . . 0.0 110.6 171.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.03 -35.43 61.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.134 0.879 . . . . 0.0 111.107 174.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -55.02 -46.06 75.21 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.326 0.65 . . . . 0.0 109.549 166.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.473 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -61.12 -51.68 68.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.427 -0.796 . . . . 0.0 111.274 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.93 -46.46 74.93 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.445 0.698 . . . . 0.0 110.311 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.4 -16.07 59.42 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -138.89 28.55 2.35 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.058 1.343 . . . . 0.0 112.271 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.46 65.79 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -164.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -95.38 -45.61 7.05 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.304 2.642 . . . . 0.0 111.316 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -66.51 -19.61 65.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.785 1.634 . . . . 0.0 113.029 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.35 143.16 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 119.14 0.882 . . . . 0.0 110.058 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.8 m -78.01 60.07 2.3 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.724 1.61 . . . . 0.0 107.743 168.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 43' ' ' ALA . 2.5 p -71.3 151.09 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.03 169.51 24.4 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 16.4 ttpp -144.32 125.7 14.81 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -168.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.39 154.51 43.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.838 1.304 . . . . 0.0 114.112 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -87.57 105.22 17.18 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.26 -14.65 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 121.382 -0.824 . . . . 0.0 112.207 -172.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.93 -35.79 82.3 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.197 1.399 . . . . 0.0 111.643 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -74.47 -33.1 62.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.287 1.035 . . . . 0.0 110.638 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -111.43 87.43 7.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.115 0.966 . . . . 0.0 111.985 -164.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -80.95 -19.82 8.02 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.64 2.893 . . . . 0.0 113.951 168.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.61 128.88 37.26 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.645 1.111 . . . . 0.0 109.649 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.0 m 68.54 -28.79 0.16 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.807 2.443 . . . . 0.0 112.696 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.2 m -53.14 -55.71 21.97 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.03 1.732 . . . . 0.0 109.649 167.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -70.6 -4.01 21.08 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 117.917 -1.04 . . . . 0.0 112.855 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -94.39 -34.25 12.84 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.563 1.074 . . . . 0.0 110.714 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -106.06 11.36 31.57 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.64 0.655 . . . . 0.0 112.117 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.22 35.23 90.1 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 123.939 0.78 . . . . 0.0 111.553 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.58 87.98 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.993 0.901 . . . . 0.0 109.979 -168.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.2 ttt -125.81 -1.35 7.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.514 1.525 . . . . 0.0 110.74 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.1 p -72.95 23.27 0.06 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.706 2.402 . . . . 0.0 114.824 -169.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.412 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 46.4 pt -68.61 150.87 97.53 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -159.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 36.8 Cg_endo -63.86 130.19 9.15 Favored 'Cis proline' 0 C--N 1.353 0.766 0 CA-C-N 118.89 0.639 . . . . 0.0 110.682 -7.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.1 m -114.14 130.56 56.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.9 tt -120.12 109.95 16.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -119.08 132.88 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tt -102.56 137.95 40.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -135.18 163.99 28.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.386 1.874 . . . . 0.0 108.757 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -153.86 140.92 19.36 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 158.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 39.13 53.46 2.64 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 126.219 1.866 . . . . 0.0 114.49 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.1 -7.24 78.85 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.842 1.21 . . . . 0.0 114.338 176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.19 123.7 36.09 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 119.453 1.626 . . . . 0.0 110.049 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -71.65 135.38 25.98 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.099 2.532 . . . . 0.0 109.89 169.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.9 t -100.4 -56.14 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.625 1.17 . . . . 0.0 110.033 -173.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -155.56 163.9 39.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.743 0.701 . . . . 0.0 109.975 170.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -120.86 132.27 54.89 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.811 2.044 . . . . 0.0 107.267 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.53 144.93 38.63 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.97 2.508 . . . . 0.0 106.411 169.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.8 pt -139.64 120.11 14.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.497 1.119 . . . . 0.0 109.622 -170.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.83 168.86 42.34 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.073 0.844 . . . . 0.0 111.905 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.74 81.08 1.57 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.792 1.637 . . . . 0.0 110.501 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -68.63 133.73 90.64 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.31 159.73 52.02 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.496 1.464 . . . . 0.0 109.532 165.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.51 -41.03 72.54 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 123.446 0.699 . . . . 0.0 112.748 -170.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.83 -29.72 68.45 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.012 0.925 . . . . 0.0 112.667 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.5 -47.28 11.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.345 1.858 . . . . 0.0 107.496 178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.34 -62.48 1.81 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.139 2.176 . . . . 0.0 109.846 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -30.19 71.33 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 117.607 -1.187 . . . . 0.0 110.602 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.49 -26.41 64.54 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 122.044 2.202 . . . . 0.0 111.679 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.03 -17.26 61.0 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 167.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 tp -128.42 -9.0 5.19 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -159.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.88 -15.88 24.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.136 2.174 . . . . 0.0 112.702 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -72.81 -20.26 61.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.494 1.118 . . . . 0.0 113.261 170.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.51 -6.69 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.149 1.78 . . . . 0.0 112.746 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.6 6.09 49.82 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.196 1.798 . . . . 0.0 109.808 158.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 C--O 1.25 1.082 0 C-N-CA 124.653 1.181 . . . . 0.0 109.717 163.679 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 51' ' ' THR . . . . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 118.94 -0.552 . . . . 0.0 112.279 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 t -155.04 12.97 0.38 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.771 0.829 . . . . 0.0 112.166 -166.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.6 ttt -121.68 161.09 23.14 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -158.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -67.16 143.67 56.45 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.062 1.745 . . . . 0.0 109.735 161.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.66 HD13 ' HB1' ' A' ' 53' ' ' ALA . 1.8 mp -131.27 160.82 33.79 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.219 1.008 . . . . 0.0 110.267 -170.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.0 p -134.96 -62.01 0.74 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.778 0.799 . . . . 0.0 110.528 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 8' ' ' ALA . 39.0 p-10 -179.3 -78.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.468 1.907 . . . . 0.0 108.807 -159.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.412 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . -61.69 -38.44 87.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.984 0.913 . . . . 0.0 109.66 172.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -75.82 -21.53 57.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.362 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -67.58 -55.87 11.69 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 173.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -63.02 -35.63 80.85 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.39 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -58.11 -46.3 85.79 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.801 0.728 . . . . 0.0 110.638 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.34 -40.7 96.39 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.026 -0.988 . . . . 0.0 112.567 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . 0.257 11.8 pt -72.22 -67.31 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 118.851 0.75 . . . . 0.0 111.613 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 37.78 -13.39 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.601 1 C-N-CA 134.905 5.282 . . . . 0.0 120.359 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 174.1 -159.93 29.47 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 120.78 1.627 . . . . 0.0 116.049 -166.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.586 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 4.0 m-20 -70.52 -9.37 56.49 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.211 3.004 . . . . 0.0 115.835 -161.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.52 164.2 54.03 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 119.093 0.86 . . . . 0.0 112.967 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.33 110.25 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.293 2.662 . . . . 0.0 107.775 166.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.499 ' HA ' ' HB ' ' A' ' 51' ' ' THR . 60.1 t -122.2 142.54 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.454 HD11 HG13 ' A' ' 52' ' ' VAL . 1.3 pp -133.5 155.85 48.82 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.161 0.505 . . . . 0.0 110.156 168.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.666 HG13 HD11 ' A' ' 55' ' ' LEU . 2.1 t -128.55 124.2 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.605 1.562 . . . . 0.0 107.612 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.01 100.9 13.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.676 1.59 . . . . 0.0 107.967 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.578 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 61.1 m-85 -89.71 109.77 20.72 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.915 0.886 . . . . 0.0 108.979 174.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -137.4 -171.86 3.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.97 170.19 21.08 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.196 1.398 . . . . 0.0 107.454 169.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.38 -14.65 62.42 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CH2' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -113.53 -24.11 9.43 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -166.31 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 p -70.94 34.59 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 127.275 2.23 . . . . 0.0 116.51 -160.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 52.3 -110.21 1.11 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.523 1.535 . . . . 0.0 113.372 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.11 -14.94 31.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.085 3.19 . . . . 0.0 114.921 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 17.5 p -54.54 -30.96 55.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.988 0.813 . . . . 0.0 111.856 165.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -71.69 -6.21 39.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.161 0.984 . . . . 0.0 112.923 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.6 mtm -108.82 -30.41 8.16 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.974 1.709 . . . . 0.0 111.371 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.3 tpt -75.07 -43.91 50.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.227 1.811 . . . . 0.0 109.406 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.0 95.41 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 116.806 -1.569 . . . . 0.0 112.09 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 26.6 Cg_endo -63.7 -34.68 61.66 Favored 'Trans proline' 0 C--N 1.352 0.728 0 CA-C-N 122.432 1.904 . . . . 0.0 112.54 173.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.29 -33.39 63.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 119.728 1.149 . . . . 0.0 110.983 174.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mp -75.92 -23.08 55.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.715 1.606 . . . . 0.0 111.672 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -66.04 -44.8 83.54 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 124.331 1.052 . . . . 0.0 109.425 169.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.469 ' OE2' ' HE3' ' A' ' 93' ' ' LYS . 19.0 tt0 -59.22 -48.88 79.99 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 172.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -52.33 -49.48 64.18 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 122.665 0.386 . . . . 0.0 110.748 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.1 -51.93 58.45 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.971 0.908 . . . . 0.0 111.33 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.15 -47.51 75.0 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.366 0.667 . . . . 0.0 109.992 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.14 -17.09 64.19 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -136.0 14.42 3.33 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -168.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -42.5 -46.03 4.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.912 1.685 . . . . 0.0 113.366 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -86.0 -13.46 47.47 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -94.29 -21.93 18.7 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.69 -0.631 . . . . 0.0 111.483 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.47 137.45 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 122.207 1.003 . . . . 0.0 109.803 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 20' ' ' VAL . 3.5 m -77.75 86.84 4.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.319 1.848 . . . . 0.0 107.16 -175.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.454 HG13 HD11 ' A' ' 21' ' ' LEU . 45.4 t -80.44 159.72 4.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.66 ' HB1' HD13 ' A' ' 5' ' ' LEU . . . -162.01 158.85 25.64 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 162.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -135.92 129.38 32.15 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -166.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.666 HD11 HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -149.67 151.72 34.17 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 122.525 1.155 . . . . 0.0 113.227 -174.295 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -87.17 103.96 15.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.286 1.835 . . . . 0.0 107.503 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.443 HG21 HG22 ' A' ' 69' ' ' ILE . 4.5 p -61.21 -24.29 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.279 1.032 . . . . 0.0 113.513 -165.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.43 -42.89 78.24 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.881 0.872 . . . . 0.0 110.708 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -81.81 -18.22 44.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.364 2.266 . . . . 0.0 111.914 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -109.59 78.68 1.2 Allowed Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.849 1.66 . . . . 0.0 109.805 173.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.08 -18.06 14.73 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.269 2.646 . . . . 0.0 112.481 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.71 125.75 25.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.143 1.377 . . . . 0.0 109.619 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.2 m 66.53 -29.56 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.932 3.293 . . . . 0.0 112.492 -174.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -52.36 -54.05 36.82 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.815 2.046 . . . . 0.0 110.587 172.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.8 t -62.03 -41.92 98.62 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.166 0.292 . . . . 0.0 110.508 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -60.91 -42.4 97.99 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.993 0.917 . . . . 0.0 111.87 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -96.63 5.52 50.56 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.4 33.48 72.83 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 119.224 0.92 . . . . 0.0 112.125 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.578 HG21 ' CZ ' ' A' ' 24' ' ' PHE . 35.5 mm -75.75 82.37 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.599 1.56 . . . . 0.0 110.118 -166.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 93.4 mtp -122.47 -3.29 8.87 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.625 1.17 . . . . 0.0 111.688 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.1 t -84.69 21.93 1.43 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.733 1.213 . . . . 0.0 113.998 -166.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.497 HD11 ' CH2' ' A' ' 28' ' ' TRP . 26.2 pt -56.05 144.1 60.29 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.108 1.363 . . . . 0.0 112.935 -170.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 57.1 Cg_endo -65.74 139.25 40.79 Favored 'Cis proline' 0 C--N 1.35 0.637 0 CA-C-O 121.99 0.746 . . . . 0.0 111.085 -1.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -138.09 149.19 45.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.6 tt -135.03 123.41 23.24 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.267 -2.124 . . . . 0.0 105.267 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.456 HD12 ' CE2' ' A' ' 24' ' ' PHE . 21.1 mt -124.84 147.67 29.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.44 HD12 HD21 ' A' ' 100' ' ' LEU . 6.5 tt -129.35 124.04 33.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.044 0.937 . . . . 0.0 108.897 -168.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -116.31 152.11 34.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.242 1.817 . . . . 0.0 110.398 -171.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 148.94 26.33 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 125.34 1.456 . . . . 0.0 107.38 158.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.586 ' H ' ' HA ' ' A' ' 17' ' ' ASP . . . 67.15 20.78 71.4 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -168.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.95 3.3 55.42 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.478 -1.179 . . . . 0.0 114.044 -171.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -120.39 139.34 28.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 119.589 1.694 . . . . 0.0 109.454 -170.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.63 125.91 9.21 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.011 2.474 . . . . 0.0 111.775 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -78.33 -43.48 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 123.78 0.832 . . . . 0.0 110.781 175.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -158.77 169.97 23.19 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.022 0.929 . . . . 0.0 109.864 -174.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.401 ' CB ' HG12 ' A' ' 76' ' ' ILE . 1.7 pm0 -137.02 157.22 47.21 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.84 1.256 . . . . 0.0 111.13 173.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.43 HD11 ' HG2' ' A' ' 99' ' ' GLN . 4.2 mm? -123.36 145.26 48.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 127.947 2.499 . . . . 0.0 106.087 169.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.6 pt -138.79 156.14 28.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 124.756 1.223 . . . . 0.0 109.058 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.07 179.08 11.17 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -71.4 126.15 28.89 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -126.23 134.5 26.03 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 165.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.99 159.15 47.82 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.167 1.245 . . . . 0.0 110.011 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.469 ' HE3' ' OE2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -49.51 -36.96 24.78 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 125.293 1.437 . . . . 0.0 112.686 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -58.7 -50.11 75.11 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.649 1.58 . . . . 0.0 110.973 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -74.39 -36.73 63.51 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.874 1.269 . . . . 0.0 109.378 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.79 -63.28 1.25 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.471 1.108 . . . . 0.0 108.04 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.36 -31.69 73.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 118.379 -0.82 . . . . 0.0 110.754 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.76 -44.03 78.44 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.694 0.679 . . . . 0.0 110.75 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.43 ' HG2' HD11 ' A' ' 87' ' ' LEU . 9.5 tp-100 -67.15 -38.26 85.19 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 118.24 0.473 . . . . 0.0 111.493 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.44 HD21 HD12 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -86.15 -6.43 59.0 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.958 0.903 . . . . 0.0 112.997 -173.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.66 -33.2 15.0 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.954 1.701 . . . . 0.0 114.201 -175.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.16 -6.56 9.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.64 1.564 . . . . 0.0 114.17 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.36 2.92 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.261 0.937 . . . . 0.0 113.108 166.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.32 -13.5 13.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.469 1.107 . . . . 0.0 112.403 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 127.777 2.431 . . . . 0.0 109.478 165.497 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 121.4 0.619 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 61.3 m -144.06 149.46 36.66 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 120.938 -1.101 . . . . 0.0 108.05 165.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.29 -178.61 6.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.99 1.316 . . . . 0.0 109.835 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.0 m -108.47 144.17 36.44 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 161.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.416 HD13 ' CB ' ' A' ' 53' ' ' ALA . 1.0 OUTLIER -110.85 161.93 15.31 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.5 t -149.3 -128.82 0.05 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.457 ' HA ' HD22 ' A' ' 60' ' ' ASN . 18.0 p-10 -84.65 -70.72 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 120.224 1.375 . . . . 0.0 110.937 164.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.55 82.34 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.349 0.977 . . . . 0.0 111.433 -171.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -76.0 -14.42 60.23 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.898 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -67.3 -68.28 0.39 Allowed 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 172.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.7 -48.79 69.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.463 0.705 . . . . 0.0 110.411 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -68.29 -19.48 64.7 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.145 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.38 -58.78 3.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.157 1.344 . . . . 0.0 110.669 164.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.9 pt -62.11 -21.8 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -168.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -64.94 -20.34 66.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.462 1.105 . . . . 0.0 113.589 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.04 166.54 48.58 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 119.662 1.119 . . . . 0.0 111.606 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.59 -4.18 57.95 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.14 148.53 50.95 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 120.707 -1.246 . . . . 0.0 110.03 171.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -62.76 96.6 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.78 2.32 . . . . 0.0 109.137 167.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 t -99.03 115.5 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 125.187 1.395 . . . . 0.0 107.85 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tt -113.43 119.82 38.91 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 126.052 1.741 . . . . 0.0 108.475 -168.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.9 t -109.3 110.73 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 126.218 1.807 . . . . 0.0 109.034 -168.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.445 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 28.2 t0 -82.2 98.77 8.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.924 0.784 . . . . 0.0 109.832 167.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -81.32 112.91 19.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 164.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -134.3 -174.04 3.44 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.64 166.3 32.37 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.886 1.275 . . . . 0.0 108.603 167.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.76 65.85 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.6 -30.26 11.87 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -170.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.02 98.97 3.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.613 0.642 . . . . 0.0 111.113 -164.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -25.47 -66.17 0.05 OUTLIER Glycine 0 CA--C 1.541 1.714 0 C-N-CA 126.385 1.945 . . . . 0.0 115.255 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.26 -30.98 23.69 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.311 2.008 . . . . 0.0 113.181 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 p -67.71 -34.6 77.19 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 119.34 0.973 . . . . 0.0 110.158 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -66.67 -12.13 56.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.49 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.9 mtp -97.97 -37.95 9.58 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.88 1.272 . . . . 0.0 111.526 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.1 ttt -74.17 -39.01 63.52 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.009 0.923 . . . . 0.0 110.781 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.58 -52.16 75.61 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 117.826 -1.083 . . . . 0.0 111.349 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.41 -34.61 65.22 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.844 1.694 . . . . 0.0 112.113 172.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.32 -31.38 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 119.65 1.113 . . . . 0.0 111.606 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mp -79.48 -26.17 41.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.196 2.198 . . . . 0.0 111.96 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.82 -44.37 93.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.79 1.177 . . . . 0.0 108.983 171.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -63.09 -45.62 91.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.854 0.462 . . . . 0.0 110.254 172.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -58.68 -38.29 77.89 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 122.017 -0.427 . . . . 0.0 111.158 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.37 -54.39 47.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.213 1.005 . . . . 0.0 109.445 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -51.57 62.11 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.597 0.759 . . . . 0.0 109.841 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.18 -11.94 10.99 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -174.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -136.09 17.42 3.23 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.449 1.099 . . . . 0.0 113.021 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.55 -20.63 1.23 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -158.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -133.74 8.22 3.84 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 173.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -80.94 -23.38 38.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.517 1.053 . . . . 0.0 110.51 161.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.56 176.07 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.226 1.01 . . . . 0.0 110.529 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 73.4 m -115.02 88.06 2.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.2 2.2 . . . . 0.0 107.157 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 t -80.81 149.28 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.416 ' CB ' HD13 ' A' ' 5' ' ' LEU . . . -154.06 167.52 29.54 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 162.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 39.9 pttt -134.09 150.11 51.15 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.027 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -154.87 157.85 38.46 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 125.196 1.56 . . . . 0.0 112.863 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -86.16 104.89 16.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.018 1.327 . . . . 0.0 107.661 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.8 p -49.27 -35.56 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.011 1.324 . . . . 0.0 113.488 -166.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -55.12 -37.21 66.61 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.684 1.594 . . . . 0.0 112.718 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.72 -22.12 65.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.649 1.58 . . . . 0.0 113.393 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.457 HD22 ' HA ' ' A' ' 7' ' ' ASP . 26.1 t-20 -117.06 82.71 14.08 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 125.912 1.685 . . . . 0.0 108.594 -172.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.71 -31.19 3.38 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.037 1.825 . . . . 0.0 111.978 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -63.68 140.79 58.91 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.54 0.736 . . . . 0.0 110.073 177.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.9 m 66.79 -33.3 0.2 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 128.253 2.621 . . . . 0.0 113.079 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.4 m -64.81 -56.33 14.15 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 128.559 2.744 . . . . 0.0 109.305 172.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -69.08 -11.79 61.11 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.115 -0.945 . . . . 0.0 112.667 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.97 -55.18 5.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.226 0.921 . . . . 0.0 109.166 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -87.66 10.72 17.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.533 0.606 . . . . 0.0 112.308 -167.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.42 24.96 62.07 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.044 1.307 . . . . 0.0 113.163 173.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.1 mm -83.4 79.08 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 122.489 1.138 . . . . 0.0 110.205 -162.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -115.69 -6.37 12.15 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.475 166.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.1 p -84.71 24.48 1.02 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.255 1.822 . . . . 0.0 113.742 -164.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.457 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -69.74 155.44 93.5 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 122.844 0.457 . . . . 0.0 111.483 -163.337 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 55.7 Cg_endo -66.44 130.19 12.11 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 119.859 0.985 . . . . 0.0 111.38 6.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.0 m -118.85 143.13 47.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -124.18 100.52 6.75 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.3 mt -97.72 144.26 11.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 tt -111.89 125.77 54.39 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 164.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -118.99 161.66 19.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.213 1.805 . . . . 0.0 110.542 -173.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -162.57 147.3 12.04 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 124.837 1.255 . . . . 0.0 109.035 158.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.42 20.34 44.49 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.521 -0.6 . . . . 0.0 113.66 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.82 -10.27 57.47 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.401 1.476 . . . . 0.0 113.854 -171.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -83.87 125.21 73.64 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 119.26 1.53 . . . . 0.0 109.277 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.49 94.5 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.167 2.578 . . . . 0.0 108.782 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 m -60.73 -37.32 75.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.565 -0.709 . . . . 0.0 111.697 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.565 ' HE3' ' HA ' ' A' ' 100' ' ' LEU . 18.9 pttm -166.26 165.02 17.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.162 1.385 . . . . 0.0 109.019 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.16 158.37 43.76 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.54 0.736 . . . . 0.0 112.214 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.11 153.42 23.17 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 160.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.1 140.35 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 126.101 1.76 . . . . 0.0 106.684 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.65 165.62 5.93 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.778 0.704 . . . . 0.0 111.782 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.34 96.97 0.12 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.56 1.144 . . . . 0.0 110.298 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -93.3 131.82 31.91 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 167.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.59 161.83 41.81 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.011 1.808 . . . . 0.0 109.863 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -40.15 66.7 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.342 0.657 . . . . 0.0 112.372 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -59.84 -24.75 64.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.428 1.091 . . . . 0.0 113.192 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.4 tp-100 -95.98 -44.09 7.51 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.835 1.254 . . . . 0.0 109.12 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -67.57 0.25 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.909 2.484 . . . . 0.0 108.671 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.58 -37.89 85.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 117.963 -1.018 . . . . 0.0 108.703 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.88 99.77 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.69 1.132 . . . . 0.0 111.906 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -69.67 -20.54 63.57 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.876 0.471 . . . . 0.0 112.177 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.565 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 1.1 tp -105.88 -10.22 16.76 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.118 1.367 . . . . 0.0 112.693 -171.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.23 -7.33 5.81 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.776 2.831 . . . . 0.0 114.48 -173.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -84.6 -13.34 51.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.089 1.756 . . . . 0.0 112.457 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.23 -16.17 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.092 0.86 . . . . 0.0 111.097 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -82.14 -6.07 58.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 121.626 -0.672 . . . . 0.0 112.226 162.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 . . . . . 0 C--O 1.245 0.836 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 158.721 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 121.462 0.648 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.1 m -153.55 139.42 18.1 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 119.396 -2.065 . . . . 0.0 106.404 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 52.5 ttm -149.12 119.31 7.25 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -65.76 92.97 0.16 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.114 0.966 . . . . 0.0 110.525 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.52 ' HB2' HD23 ' A' ' 55' ' ' LEU . 32.4 mt -53.43 146.98 11.45 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 161.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.1 m -152.66 -32.72 0.13 Allowed 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.387 -1.445 . . . . 0.0 113.187 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -171.6 -79.9 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 125.989 1.716 . . . . 0.0 106.654 160.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.84 -27.28 63.05 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 121.013 -1.054 . . . . 0.0 112.303 173.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 12' ' ' GLN . 12.7 t-20 -72.99 -21.63 60.81 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.063 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.28 1.71 0.71 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.638 1.975 . . . . 0.0 112.264 168.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -126.9 -50.15 1.46 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.039 1.335 . . . . 0.0 109.783 168.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 9' ' ' ASN . 45.6 tt0 -53.71 -35.64 61.36 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.163 0.985 . . . . 0.0 112.284 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.35 -45.86 24.7 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.982 0.81 . . . . 0.0 110.024 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -67.53 -23.61 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 117.732 -1.128 . . . . 0.0 112.236 -170.62 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -50.17 -35.11 24.85 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.813 1.245 . . . . 0.0 113.728 -164.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.78 122.69 0.97 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 166.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -156.25 -71.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.883 0.873 . . . . 0.0 110.081 -170.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 149.21 -166.67 29.51 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -161.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.86 89.44 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.649 2.899 . . . . 0.0 110.958 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t -70.45 146.22 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 126.89 2.076 . . . . 0.0 108.479 169.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -144.8 123.58 12.63 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.835 1.654 . . . . 0.0 107.685 -170.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.49 140.88 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 119.508 1.049 . . . . 0.0 111.43 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.408 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 53.6 t0 -98.95 104.16 16.18 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.933 0.893 . . . . 0.0 109.356 159.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -85.15 108.33 17.65 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 166.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -130.82 -172.47 2.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.224 1.41 . . . . 0.0 107.92 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.62 165.97 29.74 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 125.749 1.619 . . . . 0.0 107.878 168.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.42 -14.29 55.9 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -174.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.64 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -108.04 -23.85 11.83 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.851 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' HD12 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -74.31 93.35 2.37 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.195 0.907 . . . . 0.0 111.449 -165.223 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -24.49 -63.98 0.05 OUTLIER Glycine 0 CA--C 1.542 1.723 0 C-N-CA 126.377 1.941 . . . . 0.0 115.495 173.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.99 -36.3 22.87 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.562 2.174 . . . . 0.0 113.382 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 p -63.32 -37.14 86.09 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.792 1.178 . . . . 0.0 110.103 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.53 -20.28 64.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.647 0.779 . . . . 0.0 112.043 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.4 mtm -101.27 -14.05 17.82 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.968 1.307 . . . . 0.0 112.749 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.9 ttt -93.28 -39.21 11.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.668 1.587 . . . . 0.0 109.776 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.15 -48.44 92.17 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 117.413 -1.279 . . . . 0.0 112.025 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.64 -33.48 45.01 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 121.862 1.701 . . . . 0.0 112.411 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -40.66 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.457 1.026 . . . . 0.0 109.873 174.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 42' ' ' PHE . 4.9 mp -66.46 -20.23 65.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.085 1.754 . . . . 0.0 112.166 176.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.62 -51.33 28.78 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.222 0.919 . . . . 0.0 109.888 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.69 -43.03 97.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.271 0.628 . . . . 0.0 110.438 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 67.0 t80 -51.55 -57.36 9.31 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.633 1.173 . . . . 0.0 110.317 169.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.91 -52.06 65.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.65 -0.691 . . . . 0.0 111.156 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -55.22 -42.88 73.91 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.042 0.937 . . . . 0.0 110.804 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.0 -15.67 24.41 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -146.88 56.22 1.13 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.193 1.397 . . . . 0.0 109.819 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.07 64.57 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -169.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -134.98 -2.11 2.61 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -63.7 -32.19 73.61 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.884 -1.135 . . . . 0.0 109.464 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.02 165.11 24.51 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 124.336 1.054 . . . . 0.0 110.252 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.6 m -107.96 88.8 2.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.778 2.031 . . . . 0.0 108.681 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 t -71.73 158.17 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.668 0.787 . . . . 0.0 110.291 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.13 155.04 34.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.903 1.681 . . . . 0.0 106.801 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 14.8 mtpt -139.62 128.91 24.01 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 5' ' ' LEU . 0.6 OUTLIER -147.42 150.69 35.13 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.198 0.936 . . . . 0.0 111.825 -175.148 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.97 128.12 34.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 167.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.34 -34.06 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.04 -42.94 75.67 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.265 1.426 . . . . 0.0 110.717 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.32 -35.78 67.97 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.361 2.265 . . . . 0.0 112.487 176.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.39 80.49 4.59 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.271 1.029 . . . . 0.0 110.769 -172.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.12 -28.54 23.39 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.734 2.29 . . . . 0.0 114.185 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -52.49 117.22 2.71 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.027 1.331 . . . . 0.0 110.944 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.256 21.7 m 68.13 -21.35 0.13 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 129.202 3.001 . . . . 0.0 113.336 174.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.9 m -53.28 -52.47 58.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.003 1.721 . . . . 0.0 108.833 162.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -69.96 -3.33 15.65 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 117.722 -1.133 . . . . 0.0 113.266 176.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -100.94 -38.44 8.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.769 1.168 . . . . 0.0 110.595 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -92.63 7.67 42.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.702 0.683 . . . . 0.0 111.831 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.86 34.2 81.87 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 123.714 0.673 . . . . 0.0 111.739 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 26.2 mm -77.92 71.31 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.3 1.44 . . . . 0.0 109.002 -170.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 53.6 ttm -95.05 -18.48 20.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.431 1.092 . . . . 0.0 110.292 161.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.3 t -62.22 128.01 34.06 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.588 1.155 . . . . 0.0 108.67 167.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.64 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 14.8 pt -146.44 156.11 49.51 Favored Pre-proline 0 N--CA 1.443 -0.818 0 C-N-CA 126.829 2.052 . . . . 0.0 107.531 159.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.36 130.1 9.57 Favored 'Cis proline' 0 N--CA 1.453 -0.91 0 CA-C-N 119.733 0.94 . . . . 0.0 110.467 -9.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.7 m -123.78 149.3 45.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tt -135.12 134.58 40.38 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.3 mt -131.67 144.12 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.19 136.75 48.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 168.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -133.26 169.48 16.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.334 1.854 . . . . 0.0 110.909 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.457 ' N ' ' HE3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -153.69 155.81 36.68 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.376 1.871 . . . . 0.0 106.204 158.666 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.02 37.58 4.34 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 124.579 1.085 . . . . 0.0 115.795 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.457 ' H ' HG22 ' A' ' 14' ' ' ILE . . . 75.24 17.81 80.14 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.735 1.16 . . . . 0.0 115.1 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -139.64 135.5 16.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.052 1.341 . . . . 0.0 108.9 -168.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.09 170.84 16.01 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.066 2.511 . . . . 0.0 113.097 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.13 -7.53 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.848 1.659 . . . . 0.0 112.081 173.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 161.15 170.75 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 1 C-N-CA 132.088 4.155 . . . . 0.0 108.763 164.15 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -129.5 142.87 50.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.492 1.917 . . . . 0.0 107.639 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.77 145.41 48.07 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 128.926 2.89 . . . . 0.0 106.299 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.69 135.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -173.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.68 165.18 41.03 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 123.772 0.701 . . . . 0.0 112.311 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -77.48 69.33 3.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.917 1.287 . . . . 0.0 111.486 -174.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -76.86 131.81 72.68 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.79 168.09 19.53 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.086 2.524 . . . . 0.0 110.988 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -45.59 76.01 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 123.846 0.858 . . . . 0.0 110.45 -174.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.76 -12.09 59.83 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.323 1.049 . . . . 0.0 112.386 -174.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.13 -55.76 2.68 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.476 1.511 . . . . 0.0 108.155 172.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 tt -54.38 -60.73 2.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.844 2.058 . . . . 0.0 110.315 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -65.51 -20.99 66.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.565 1.146 . . . . 0.0 111.845 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.16 -48.1 31.52 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.487 1.04 . . . . 0.0 109.623 170.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -59.41 -32.08 69.85 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.846 1.258 . . . . 0.0 112.104 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tp -97.71 0.52 47.17 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.669 1.988 . . . . 0.0 112.379 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.07 -29.42 68.55 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.992 0.917 . . . . 0.0 112.529 -169.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -65.85 -12.82 57.38 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.99 4.53 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.814 0.846 . . . . 0.0 112.226 173.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -112.28 -6.42 14.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.528 1.131 . . . . 0.0 112.853 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.539 1.936 . . . . 0.0 108.966 159.24 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.252 0.549 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.0 m -149.42 153.47 37.38 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 164.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.29 -178.29 7.03 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.568 1.147 . . . . 0.0 108.404 166.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.3 m -81.14 159.49 24.64 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 163.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.3 tp -132.08 162.13 31.56 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.881 1.272 . . . . 0.0 107.961 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.1 m -149.43 163.12 38.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -42.79 -55.28 3.72 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.437 3.095 . . . . 0.0 113.624 -164.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.32 91.95 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.369 0.604 . . . . 0.0 111.792 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.71 -18.1 58.71 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.059 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.34 -61.92 2.14 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.749 1.159 . . . . 0.0 108.745 174.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.417 ' HA ' HG12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -59.39 -39.74 84.35 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.577 0.351 . . . . 0.0 110.781 -177.376 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -74.84 -16.44 60.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.62 0.768 . . . . 0.0 112.701 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.22 -57.36 3.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.352 0.978 . . . . 0.0 109.321 168.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 11' ' ' GLN . 41.2 pt -59.32 -24.35 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -170.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -67.4 -17.62 64.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.615 1.166 . . . . 0.0 113.198 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.42 165.01 47.5 Favored Glycine 0 C--N 1.342 0.909 0 C-N-CA 124.127 0.87 . . . . 0.0 112.124 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -80.29 -42.48 23.01 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.382 1.473 . . . . 0.0 111.956 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.27 164.06 54.88 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 123.371 0.51 . . . . 0.0 112.681 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.2 100.63 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.775 2.984 . . . . 0.0 112.006 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.1 t -90.18 121.99 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 C-N-CA 125.986 1.714 . . . . 0.0 108.116 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 tt -118.95 112.16 19.26 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.132 0.973 . . . . 0.0 109.312 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -91.49 127.85 43.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 62.1 t0 -92.08 101.93 14.47 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 164.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -87.19 111.69 21.23 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 14.5 p-90 -135.29 178.49 6.99 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.772 1.229 . . . . 0.0 110.491 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.73 167.49 30.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.982 1.313 . . . . 0.0 110.798 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.77 -4.65 41.73 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.11 -16.0 7.6 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -174.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.8 p -75.45 36.93 0.13 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.836 1.654 . . . . 0.0 114.287 -165.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 33.39 -97.94 0.01 OUTLIER Glycine 0 CA--C 1.536 1.381 0 C-N-CA 128.913 3.149 . . . . 0.0 114.464 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.67 -15.76 33.14 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.751 2.967 . . . . 0.0 115.053 -175.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.3 p -54.4 -32.33 56.95 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.347 0.976 . . . . 0.0 111.96 167.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttp85 -67.03 -12.03 58.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.771 0.828 . . . . 0.0 112.66 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.5 mtp -110.09 -20.4 12.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.716 1.606 . . . . 0.0 111.846 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.4 ttt -80.61 -44.31 19.12 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 124.52 1.128 . . . . 0.0 109.412 170.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.66 -47.6 78.43 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 116.802 -1.571 . . . . 0.0 113.528 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.25 -29.9 25.55 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.098 1.865 . . . . 0.0 112.719 171.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.8 -30.12 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 120.216 1.371 . . . . 0.0 111.007 171.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.3 mt -80.02 -18.04 51.24 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.959 1.704 . . . . 0.0 111.212 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.83 -41.92 58.99 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.057 0.943 . . . . 0.0 110.299 162.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.87 -15.51 62.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.676 1.19 . . . . 0.0 111.498 171.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.406 ' CE2' HD12 ' A' ' 96' ' ' LEU . 31.9 t80 -85.29 -49.0 8.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.221 1.808 . . . . 0.0 109.025 167.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.29 -32.22 66.42 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.17 -0.919 . . . . 0.0 113.363 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.29 -57.35 5.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.03 1.286 . . . . 0.0 110.919 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.68 -22.47 35.04 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -159.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.9 30.21 1.18 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.886 1.275 . . . . 0.0 111.114 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -20.29 -63.4 0.02 OUTLIER 'General case' 0 C--N 1.341 0.196 0 C-N-CA 128.94 2.896 . . . . 0.0 115.314 -170.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -108.12 8.1 27.94 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -169.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -70.88 -26.06 63.07 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.982 0.81 . . . . 0.0 109.682 158.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.79 170.26 15.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.192 0.997 . . . . 0.0 110.9 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.267 10.7 t -124.91 103.64 8.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 158.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.6 t -70.08 155.75 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.09 111.42 3.91 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 6.0 tttp -89.19 130.72 35.57 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -172.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.37 143.15 24.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.927 0.87 . . . . 0.0 112.77 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -81.14 117.69 21.91 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.1 p -51.8 -32.2 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.503 1.121 . . . . 0.0 113.801 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -67.79 -29.76 69.03 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.191 1.797 . . . . 0.0 112.488 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -23.77 60.69 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.979 1.312 . . . . 0.0 112.462 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -126.21 87.36 56.32 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 125.237 1.415 . . . . 0.0 109.735 -163.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.55 -29.87 15.72 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.875 2.383 . . . . 0.0 113.712 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 64' ' ' THR . 8.3 tp10 -73.8 137.55 43.93 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.741 1.155 . . . . 0.0 110.73 -173.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.7 m 64.09 -31.01 0.11 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 130.123 3.369 . . . . 0.0 112.822 -169.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 62' ' ' GLU . 52.2 m -58.08 -57.35 13.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.572 1.949 . . . . 0.0 109.45 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -57.78 -46.25 84.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.053 0.541 . . . . 0.0 109.874 178.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -58.39 -35.59 72.25 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.024 0.93 . . . . 0.0 112.758 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -100.55 9.83 42.01 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.191 0.597 . . . . 0.0 112.118 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.24 29.05 74.34 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 119.1 0.864 . . . . 0.0 112.927 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mm -77.13 81.38 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.333 1.453 . . . . 0.0 109.915 -166.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.6 mmt -123.89 -0.98 8.41 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.726 1.61 . . . . 0.0 111.103 166.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.4 t -77.9 30.07 0.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.161 1.785 . . . . 0.0 113.077 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.472 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -67.96 148.44 98.4 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.384 0.538 . . . . 0.0 111.828 -172.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 62.3 Cg_endo -66.36 128.74 9.56 Favored 'Cis proline' 0 C--N 1.35 0.635 0 CA-C-N 119.73 0.939 . . . . 0.0 111.493 4.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.1 m -123.76 151.87 42.79 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 122.207 1.003 . . . . 0.0 108.838 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.9 tt -131.87 130.21 41.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 mt -130.28 141.24 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 165.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.72 119.55 39.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 175.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -117.32 161.22 19.86 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.979 2.112 . . . . 0.0 112.391 -175.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.41 157.33 19.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.65 2.38 . . . . 0.0 108.668 159.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.42 14.83 14.28 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.94 1.257 . . . . 0.0 115.394 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.87 -6.02 58.38 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.625 1.584 . . . . 0.0 113.543 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -129.01 157.44 75.84 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 119.183 1.492 . . . . 0.0 110.689 -170.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.74 166.78 24.96 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.31 2.007 . . . . 0.0 111.55 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.44 -34.8 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.734 1.214 . . . . 0.0 108.505 158.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -162.02 165.77 26.88 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.495 1.118 . . . . 0.0 109.978 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -136.45 143.26 43.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.937 2.495 . . . . 0.0 106.397 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.7 mt -132.55 153.4 51.01 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.618 1.567 . . . . 0.0 108.194 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.2 pt -143.85 143.61 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.052 1.341 . . . . 0.0 108.075 -173.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.64 161.94 26.36 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.783 0.706 . . . . 0.0 111.903 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -75.25 78.55 2.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.083 0.953 . . . . 0.0 111.526 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -69.63 140.86 89.79 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 166.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.85 160.25 49.98 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.748 1.632 . . . . 0.0 110.404 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.91 -45.88 42.13 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.93 1.292 . . . . 0.0 112.814 -171.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -74.09 -25.1 59.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.455 -172.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -73.8 -37.67 64.85 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.406 HD12 ' CE2' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -59.0 -61.26 2.78 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.165 1.386 . . . . 0.0 108.813 175.584 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -64.94 -25.78 68.02 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.22 -0.895 . . . . 0.0 112.229 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.21 -53.88 12.89 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.856 0.753 . . . . 0.0 110.494 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -62.19 -35.07 77.74 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.148 0.579 . . . . 0.0 112.302 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.83 1.85 56.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.645 1.178 . . . . 0.0 112.751 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.15 -31.97 54.0 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 120.082 1.31 . . . . 0.0 113.511 -174.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -65.4 -14.41 60.82 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.954 0.901 . . . . 0.0 113.295 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 66.0 t -109.06 -5.57 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.574 1.55 . . . . 0.0 110.858 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.47 -5.85 14.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.791 1.236 . . . . 0.0 112.741 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.099 0 C-N-CA 126.946 2.099 . . . . 0.0 110.552 164.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.3 m -114.09 125.2 53.71 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -173.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.8 ttp -149.58 -0.46 0.47 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.319 0.7 OUTLIER 57.18 176.0 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.934 1.294 . . . . 0.0 112.569 -170.117 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.708 ' HB2' HD23 ' A' ' 55' ' ' LEU . 58.0 mt -142.75 172.25 12.94 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.664 1.985 . . . . 0.0 107.938 -167.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.0 m -125.17 -88.53 0.59 Allowed 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -140.03 -66.25 0.45 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.858 0.863 . . . . 0.0 109.132 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.68 -30.83 45.28 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.666 -0.646 . . . . 0.0 111.912 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -72.32 -26.3 61.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.103 0.561 . . . . 0.0 110.688 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.423 ' HD2' HD21 ' A' ' 55' ' ' LEU . 50.3 t80 -58.0 -62.83 1.53 Allowed 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.021 0.929 . . . . 0.0 109.678 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.443 ' HA ' HG12 ' A' ' 14' ' ' ILE . 20.9 tt0 -60.39 -42.43 95.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.841 0.456 . . . . 0.0 110.502 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -64.12 -25.65 68.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.66 1.184 . . . . 0.0 112.962 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.08 -61.53 1.97 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.232 0.924 . . . . 0.0 110.058 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 11' ' ' GLN . 43.2 pt -59.07 -20.34 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -167.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -60.67 -19.05 57.36 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.344 1.458 . . . . 0.0 113.321 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.95 157.51 48.6 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 119.452 1.024 . . . . 0.0 111.631 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -76.94 -36.28 56.69 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.846 1.659 . . . . 0.0 111.443 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.22 161.97 47.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 123.814 0.721 . . . . 0.0 111.721 177.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.29 107.88 0.74 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.591 2.86 . . . . 0.0 110.948 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.466 HG22 ' HB ' ' A' ' 51' ' ' THR . 71.4 t -98.45 141.96 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 167.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.53 153.5 44.91 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 118.565 0.62 . . . . 0.0 111.033 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.02 126.85 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 22.4 t0 -80.12 121.2 25.26 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.953 0.783 . . . . 0.0 108.915 161.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.418 ' CD1' HG23 ' A' ' 57' ' ' VAL . 63.6 m-85 -98.26 107.16 19.56 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.045 0.938 . . . . 0.0 108.684 163.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -124.08 -177.7 3.85 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.905 1.282 . . . . 0.0 107.992 172.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.61 165.96 33.21 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.971 1.308 . . . . 0.0 108.832 170.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.66 -3.04 7.9 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -174.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.562 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -117.27 -24.58 7.39 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.81 1.187 . . . . 0.0 114.155 -175.237 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.73 93.79 2.63 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.196 0.907 . . . . 0.0 111.845 -163.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -19.32 -71.11 0.01 OUTLIER Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.538 2.018 . . . . 0.0 115.567 173.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.17 -29.46 47.48 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.16 2.574 . . . . 0.0 114.303 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.9 p -64.66 -27.7 69.11 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.513 1.051 . . . . 0.0 110.771 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -19.57 65.96 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.405 173.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -101.95 -23.89 14.07 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.935 1.294 . . . . 0.0 112.486 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.0 tpt -75.99 -47.28 25.54 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 125.917 1.687 . . . . 0.0 108.494 173.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.73 -48.15 70.43 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 120.133 1.333 . . . . 0.0 113.617 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.78 -33.02 21.88 Favored 'Trans proline' 0 C--N 1.352 0.741 0 CA-C-N 122.061 1.772 . . . . 0.0 112.53 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.49 -35.13 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.856 1.207 . . . . 0.0 110.526 173.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.3 mt -72.14 -21.7 61.42 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 125.929 1.692 . . . . 0.0 111.199 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.27 -52.68 31.11 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 170.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -71.34 -19.91 62.24 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -67.08 -60.06 2.94 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.044 1.338 . . . . 0.0 108.963 165.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.74 -49.55 65.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.821 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -53.93 -42.41 68.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.81 1.244 . . . . 0.0 111.262 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.35 -15.27 62.38 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -158.43 57.65 0.45 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.074 1.349 . . . . 0.0 109.462 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.02 -14.51 62.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.596 0.758 . . . . 0.0 112.086 -172.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -109.37 -55.22 2.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.383 3.473 . . . . 0.0 110.646 -172.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -53.72 -31.47 48.3 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 126.268 1.827 . . . . 0.0 112.444 -172.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 m -130.13 150.52 34.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.466 ' HB ' HG22 ' A' ' 20' ' ' VAL . 97.3 m -82.79 71.62 9.88 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 172.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.76 147.56 7.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 124.397 1.079 . . . . 0.0 109.936 175.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.65 163.02 40.01 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.186 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 51.3 pttt -128.26 143.14 51.0 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 123.736 0.648 . . . . 0.0 110.904 159.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.708 HD23 ' HB2' ' A' ' 5' ' ' LEU . 1.3 pp -146.29 154.34 41.58 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 124.974 1.421 . . . . 0.0 109.515 176.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -77.54 129.24 35.41 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 24' ' ' PHE . 3.3 p -68.06 -20.39 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.174 -0.953 . . . . 0.0 112.003 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.75 -17.38 55.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.593 0.757 . . . . 0.0 111.266 172.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.23 -34.5 21.99 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.3 1.84 . . . . 0.0 110.147 173.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -106.4 93.43 8.26 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 124.825 1.25 . . . . 0.0 111.264 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.18 -25.71 9.81 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.976 2.451 . . . . 0.0 113.75 164.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -58.89 119.24 6.84 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.752 1.16 . . . . 0.0 111.169 -177.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.268 16.4 m 63.58 -15.64 0.07 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.281 2.232 . . . . 0.0 113.795 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.7 m -53.03 -56.06 18.97 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.102 1.361 . . . . 0.0 108.844 167.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.6 t -72.18 0.39 9.87 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 117.821 -1.085 . . . . 0.0 112.899 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -108.3 -36.05 6.37 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.454 1.101 . . . . 0.0 111.177 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -104.06 10.0 36.21 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.033 0.833 . . . . 0.0 111.108 -175.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.62 32.11 59.84 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 123.918 0.77 . . . . 0.0 112.249 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.9 mm -75.23 83.25 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.999 0.919 . . . . 0.0 109.617 -170.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.2 ttp -128.07 -10.34 5.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.401 1.08 . . . . 0.0 111.342 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.4 t -87.22 56.62 4.06 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.428 1.091 . . . . 0.0 109.36 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.562 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 34.6 pt -81.96 148.43 60.67 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.183 -174.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.411 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 57.2 Cg_endo -66.77 125.02 6.16 Favored 'Cis proline' 0 C--N 1.35 0.62 0 CA-C-N 119.589 0.889 . . . . 0.0 110.925 -0.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.8 m -109.22 143.91 38.04 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.6 tt -129.4 132.93 47.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 171.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.1 mt -130.43 144.9 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.29 132.96 56.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.85 163.03 30.0 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.454 1.902 . . . . 0.0 111.778 -169.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.47 148.47 18.06 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 125.696 1.598 . . . . 0.0 108.554 157.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.87 19.99 38.98 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 123.904 0.764 . . . . 0.0 113.101 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.91 -7.4 51.2 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.197 1.38 . . . . 0.0 113.971 -170.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -84.3 118.9 72.33 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 119.297 1.548 . . . . 0.0 108.751 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.15 109.09 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.37 2.713 . . . . 0.0 109.853 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 m -71.1 -37.27 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.641 -0.662 . . . . 0.0 111.428 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -156.98 160.62 39.21 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.199 0.6 . . . . 0.0 111.846 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -128.8 142.55 50.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.713 2.405 . . . . 0.0 107.526 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.407 HD11 ' HG2' ' A' ' 99' ' ' GLN . 4.1 mm? -120.09 149.95 41.38 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.999 2.12 . . . . 0.0 107.044 165.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.47 132.52 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.353 1.461 . . . . 0.0 107.102 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.16 166.92 26.85 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.405 1.002 . . . . 0.0 112.135 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -76.83 74.56 3.46 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.505 1.122 . . . . 0.0 109.409 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -76.81 122.83 87.17 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 171.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.25 166.72 22.38 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.756 1.637 . . . . 0.0 110.441 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.427 ' HE3' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -47.98 -50.52 27.14 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.895 1.278 . . . . 0.0 112.412 -175.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.48 -19.71 65.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.73 -56.07 3.45 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.8 tt -55.99 -60.52 3.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.505 1.922 . . . . 0.0 109.394 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.427 ' OE1' ' HE3' ' A' ' 93' ' ' LYS . 6.3 tt0 -68.67 -17.4 64.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.493 1.117 . . . . 0.0 111.392 -176.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.84 -52.13 9.38 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 119.472 1.033 . . . . 0.0 110.069 166.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.407 ' HG2' HD11 ' A' ' 87' ' ' LEU . 18.6 tp60 -60.5 -27.52 67.65 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.966 0.907 . . . . 0.0 112.047 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.94 0.39 41.08 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.37 1.868 . . . . 0.0 112.988 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.89 -34.53 67.97 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.978 0.911 . . . . 0.0 112.746 -171.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -66.02 -11.92 51.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.508 1.523 . . . . 0.0 113.45 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.16 8.89 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.197 1.399 . . . . 0.0 111.552 171.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.2 -0.23 12.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.513 1.525 . . . . 0.0 113.529 169.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.363 1.865 . . . . 0.0 108.797 172.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.2 m 114.19 60.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 1 C-N-CA 133.372 4.669 . . . . 0.0 106.563 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.5 mtt -74.36 137.03 42.52 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.1 m -72.14 81.5 0.98 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 165.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.23 159.04 31.97 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.613 0.765 . . . . 0.0 109.635 175.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.5 p -117.35 -89.0 0.59 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 158.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 8' ' ' ALA . 9.1 p-10 -142.84 -73.24 0.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.416 1.486 . . . . 0.0 108.014 -159.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.442 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . -54.14 -32.24 54.7 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.042 0.937 . . . . 0.0 111.291 170.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -81.7 -15.6 53.91 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 119.238 -0.985 . . . . 0.0 112.089 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -66.89 -54.13 25.25 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.145 0.884 . . . . 0.0 109.143 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -65.78 -23.05 66.63 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.604 0.761 . . . . 0.0 111.694 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -73.64 -49.11 27.64 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.152 0.887 . . . . 0.0 110.844 167.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.61 -39.57 91.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.962 0.801 . . . . 0.0 111.801 -171.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 14' ' ' ILE . 9.0 tt -58.26 -22.16 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.21 1.404 . . . . 0.0 113.38 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -56.06 -36.75 68.43 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.478 1.511 . . . . 0.0 113.874 -159.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.49 133.92 2.0 Allowed Glycine 0 C--N 1.334 0.428 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 -170.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -174.74 -55.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.836 1.654 . . . . 0.0 107.964 -166.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.73 -157.65 27.47 Favored Glycine 0 CA--C 1.534 1.281 0 N-CA-C 105.064 -3.214 . . . . 0.0 105.064 -158.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.17 103.66 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.205 2.604 . . . . 0.0 111.347 168.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.4 t -88.99 127.42 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 168.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 tt -132.19 122.99 26.15 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -172.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.99 119.74 62.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -172.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -97.07 94.13 6.98 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -176.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.457 ' CD1' HG23 ' A' ' 57' ' ' VAL . 29.9 m-85 -82.46 110.63 17.75 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.133 1.373 . . . . 0.0 108.871 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 16.5 p-90 -125.82 177.07 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.25 164.35 32.59 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.753 1.221 . . . . 0.0 108.953 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.58 -8.74 56.71 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -123.86 -13.88 7.3 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.7 p -70.22 39.19 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -158.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 42.87 -99.03 0.01 OUTLIER Glycine 0 CA--C 1.536 1.389 0 C-N-CA 127.572 2.51 . . . . 0.0 114.764 169.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -58.58 -19.02 42.88 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.862 3.041 . . . . 0.0 114.166 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 14.9 p -60.03 -22.68 62.95 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 119.188 0.904 . . . . 0.0 112.235 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -14.94 61.72 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.12 1.327 . . . . 0.0 112.451 173.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.2 mtm -100.43 -32.46 10.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.647 1.579 . . . . 0.0 111.054 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.2 ttt -72.91 -43.18 62.72 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-O 117.811 -1.09 . . . . 0.0 109.142 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.59 -45.97 85.41 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 116.595 -1.669 . . . . 0.0 113.213 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.5 -45.51 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.628 1.552 . . . . 0.0 111.79 167.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -30.17 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 121.71 2.05 . . . . 0.0 112.133 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 mt -68.7 -13.01 62.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 128.667 2.787 . . . . 0.0 112.252 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.88 -46.38 8.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.296 1.038 . . . . 0.0 109.851 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.89 -40.78 70.13 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.519 1.054 . . . . 0.0 110.665 165.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.456 ' CE1' HD22 ' A' ' 96' ' ' LEU . 79.0 t80 -56.14 -60.07 4.02 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.922 0.889 . . . . 0.0 110.235 171.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.69 -49.68 67.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.632 0.651 . . . . 0.0 111.861 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.1 -48.52 64.7 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.514 1.526 . . . . 0.0 110.547 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.93 -12.6 11.77 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -150.61 61.85 0.94 Allowed 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.268 1.427 . . . . 0.0 108.502 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.04 -45.41 64.67 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.634 1.574 . . . . 0.0 111.413 -169.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -136.41 9.75 3.19 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -61.94 -32.84 73.3 Favored 'General case' 0 C--N 1.345 0.403 0 O-C-N 121.413 -0.805 . . . . 0.0 110.201 163.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.0 m -119.71 143.37 31.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.341 1.1 t -82.21 73.59 9.24 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 124.259 1.981 . . . . 0.0 106.596 166.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.4 148.28 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 113.642 -1.617 . . . . 0.0 107.957 165.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.82 158.8 44.58 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.099 1.36 . . . . 0.0 107.631 170.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -133.05 124.82 28.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.76 152.13 46.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.67 1.224 . . . . 0.0 113.054 -177.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -85.22 110.17 18.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.051 1.74 . . . . 0.0 108.835 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.457 HG23 ' CD1' ' A' ' 24' ' ' PHE . 3.0 p -60.99 -26.19 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.039 0.936 . . . . 0.0 112.754 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -70.78 -22.69 62.34 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 126.547 1.939 . . . . 0.0 111.182 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.61 -38.74 13.72 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.589 1.156 . . . . 0.0 111.021 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -105.05 106.43 55.52 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.705 -169.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.89 -22.42 6.24 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.047 2.498 . . . . 0.0 114.316 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -66.41 118.55 10.22 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.325 0.966 . . . . 0.0 108.766 -173.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.272 25.9 m 67.65 -17.75 0.15 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.817 2.847 . . . . 0.0 112.659 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -54.5 -54.9 34.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.125 1.77 . . . . 0.0 108.895 160.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -57.97 -46.8 84.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.55 0.74 . . . . 0.0 110.356 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -55.06 -35.37 64.46 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.543 1.137 . . . . 0.0 112.899 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -111.09 14.75 21.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.232 0.613 . . . . 0.0 112.258 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.39 31.2 80.07 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 118.962 0.801 . . . . 0.0 113.114 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.7 mm -76.54 81.98 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.102 1.361 . . . . 0.0 110.288 -165.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.6 mmt -130.27 3.82 4.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.19 1.396 . . . . 0.0 111.424 165.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 t -78.89 37.44 0.3 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.232 1.813 . . . . 0.0 110.966 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.479 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -78.74 151.27 76.71 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 121.324 -0.86 . . . . 0.0 111.427 -169.429 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 61.3 Cg_endo -64.7 123.98 4.06 Favored 'Cis proline' 0 C--N 1.349 0.583 0 CA-C-N 119.861 0.986 . . . . 0.0 111.107 4.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.3 m -118.69 154.22 33.08 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 tt -146.3 122.7 10.99 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 104.673 -2.344 . . . . 0.0 104.673 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.8 mt -123.37 139.08 51.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 119.55 39.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.569 1.948 . . . . 0.0 105.822 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -122.26 169.16 11.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.797 2.439 . . . . 0.0 108.062 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.474 ' HE3' ' C ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -153.33 40.13 0.52 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.344 -0.847 . . . . 0.0 112.417 -179.718 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.92 87.41 1.91 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -167.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.69 -23.35 3.02 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 130.585 3.945 . . . . 0.0 114.422 160.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -131.94 149.3 72.95 Favored Pre-proline 0 N--CA 1.445 -0.69 0 C-N-CA 125.379 1.472 . . . . 0.0 110.182 -171.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.12 159.94 30.05 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.848 2.366 . . . . 0.0 111.043 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -38.67 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.239 1.416 . . . . 0.0 110.383 165.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -161.11 171.91 17.7 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 119.317 0.962 . . . . 0.0 111.381 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -139.05 150.38 45.7 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.24 2.216 . . . . 0.0 108.649 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.76 150.61 40.12 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.148 1.779 . . . . 0.0 107.632 161.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.9 pt -143.33 137.36 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 126.269 1.827 . . . . 0.0 108.082 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.55 167.37 18.01 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.163 0.887 . . . . 0.0 111.762 -174.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -57.01 110.72 0.87 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.906 0.883 . . . . 0.0 111.183 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -101.33 133.84 20.66 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 160.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.97 158.14 58.2 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 CA-C-N 120.287 1.138 . . . . 0.0 109.161 164.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.35 -52.52 2.7 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.149 1.78 . . . . 0.0 110.843 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.19 -31.66 69.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.017 1.727 . . . . 0.0 113.103 -175.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -85.31 -47.27 10.19 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 119.244 0.929 . . . . 0.0 109.906 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.456 HD22 ' CE1' ' A' ' 42' ' ' PHE . 1.3 tt -56.53 -61.89 2.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.305 2.642 . . . . 0.0 108.999 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -63.24 -29.26 70.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.585 1.154 . . . . 0.0 110.827 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.64 -49.15 33.75 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.39 0.995 . . . . 0.0 110.732 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -56.86 -43.24 80.99 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.479 0.712 . . . . 0.0 110.828 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.68 -0.27 55.95 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.51 1.124 . . . . 0.0 113.324 -176.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.16 -28.82 63.12 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.232 1.413 . . . . 0.0 113.4 -170.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -63.25 -22.09 66.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.15 0.98 . . . . 0.0 113.393 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.11 -15.87 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 118.862 0.756 . . . . 0.0 111.14 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -10.38 56.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.01 1.324 . . . . 0.0 112.49 169.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.249 1.042 0 C-N-CA 129.608 3.163 . . . . 0.0 111.182 161.929 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 51' ' ' THR . . . . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.2 t -79.18 -165.92 0.84 Allowed 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 153.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.63 5.63 0.61 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 174.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -134.75 158.88 43.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.423 1.089 . . . . 0.0 108.899 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 mt -140.34 170.39 15.89 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 125.335 1.454 . . . . 0.0 109.621 170.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.9 p -127.01 170.13 12.62 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 163.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -53.39 -55.52 24.34 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 127.886 2.475 . . . . 0.0 111.412 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.4 81.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.226 0.611 . . . . 0.0 110.084 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -75.09 -20.23 59.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.248 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -58.36 -63.93 1.1 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.14 -46.81 89.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.017 0.527 . . . . 0.0 110.787 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.23 -20.02 65.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.094 -174.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.14 -58.13 3.09 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.4 1.0 . . . . 0.0 110.213 165.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.2 pt -62.41 -20.05 23.8 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -169.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -57.36 -24.62 56.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.137 0.975 . . . . 0.0 113.038 172.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.24 112.57 0.26 Allowed Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -157.96 -75.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.489 1.515 . . . . 0.0 109.137 -175.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.69 -166.25 30.75 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 -159.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.32 83.87 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.703 3.602 . . . . 0.0 112.226 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.7 t -94.06 124.12 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 125.743 1.617 . . . . 0.0 106.848 171.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.74 146.64 44.6 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.52 0.676 . . . . 0.0 111.964 170.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.3 t -131.54 108.41 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -161.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -83.46 100.75 10.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.345 1.058 . . . . 0.0 109.155 174.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -78.54 108.61 12.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 166.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -123.17 176.06 6.29 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.39 155.73 31.03 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 120.884 -1.135 . . . . 0.0 110.825 166.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.49 -12.81 61.21 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -173.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.69 -12.37 31.63 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.572 1.078 . . . . 0.0 112.772 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.4 p -67.24 173.72 3.7 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.436 0.636 . . . . 0.0 112.469 -164.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.35 -86.63 1.89 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 162.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.24 -20.78 55.64 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.96 2.44 . . . . 0.0 114.336 -167.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.67 -33.66 68.57 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.8 1.182 . . . . 0.0 111.128 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -74.05 -11.82 60.44 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.572 -0.727 . . . . 0.0 112.516 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.6 ptm -104.23 -21.64 13.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.923 1.289 . . . . 0.0 112.079 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.1 ttt -83.82 -44.4 14.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.89 1.676 . . . . 0.0 108.969 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.2 -47.26 82.56 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 117.541 -1.219 . . . . 0.0 113.324 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.87 -31.48 38.4 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.918 1.721 . . . . 0.0 112.445 172.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.23 -39.03 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.813 1.188 . . . . 0.0 110.511 172.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.8 mt -69.23 -20.01 63.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.227 1.411 . . . . 0.0 111.831 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -69.98 -45.57 67.07 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.673 0.789 . . . . 0.0 110.092 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -62.1 -44.28 96.99 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.529 0.331 . . . . 0.0 110.289 171.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.22 -44.9 84.17 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.772 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.72 -53.51 46.75 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.054 0.942 . . . . 0.0 110.745 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.01 -46.8 87.28 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.184 0.994 . . . . 0.0 111.069 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.8 -26.57 14.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.051 1.341 . . . . 0.0 114.414 -173.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.05 29.67 4.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.415 1.486 . . . . 0.0 111.826 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -14.26 -61.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 131.421 3.888 . . . . 0.0 116.028 -172.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -114.08 -14.53 12.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.386 1.874 . . . . 0.0 113.134 -168.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -66.42 -31.96 73.04 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.231 0.923 . . . . 0.0 110.276 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.12 171.56 17.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 122.706 0.402 . . . . 0.0 110.216 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 1' ' ' ALA . 3.5 t -124.45 137.77 54.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.102 0.477 . . . . 0.0 110.005 172.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.86 154.74 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 125.255 1.422 . . . . 0.0 107.313 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.95 138.04 20.35 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -117.45 136.46 53.18 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 118.898 0.772 . . . . 0.0 109.338 170.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -144.38 146.46 32.54 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.175 0.988 . . . . 0.0 113.446 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -75.16 104.14 5.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.007 1.723 . . . . 0.0 107.826 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.534 HG11 HG21 ' A' ' 72' ' ' ILE . 4.7 p -70.15 -20.56 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -166.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.87 -43.08 90.78 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.076 1.35 . . . . 0.0 110.566 169.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -89.23 -25.36 21.78 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.636 1.974 . . . . 0.0 112.316 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -105.33 90.08 3.65 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 118.404 0.547 . . . . 0.0 111.24 164.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.9 -12.67 17.82 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.872 2.381 . . . . 0.0 114.042 166.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -72.87 129.17 37.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.667 1.121 . . . . 0.0 109.078 -176.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.5 m 64.33 -25.12 0.08 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.943 3.297 . . . . 0.0 112.466 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 62' ' ' GLU . 41.7 m -50.31 -61.59 2.08 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 128.328 2.651 . . . . 0.0 109.214 165.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.1 t -57.45 -46.49 83.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.95 0.5 . . . . 0.0 109.881 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -58.59 -38.58 78.25 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.4 1.08 . . . . 0.0 112.451 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -95.22 12.0 30.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.848 0.749 . . . . 0.0 111.461 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.36 25.64 73.65 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 118.78 0.718 . . . . 0.0 112.635 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.8 mm -73.65 94.89 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.86 1.264 . . . . 0.0 109.312 -169.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.14 -21.37 3.61 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.366 1.466 . . . . 0.0 110.861 175.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 p -81.58 47.76 1.1 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.115 2.566 . . . . 0.0 112.333 -162.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.534 HG21 HG11 ' A' ' 57' ' ' VAL . 45.6 pt -76.16 153.53 84.39 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -169.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.421 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 41.1 Cg_endo -62.85 128.27 6.06 Favored 'Cis proline' 0 C--N 1.351 0.693 0 N-CA-C 110.238 -0.716 . . . . 0.0 110.238 -7.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 m -115.41 132.64 56.56 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tt -125.43 116.82 22.44 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 mt -120.17 143.03 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 tt -118.9 119.83 35.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -111.48 166.91 10.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.577 1.951 . . . . 0.0 110.356 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -161.67 127.75 3.72 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 126.22 1.808 . . . . 0.0 106.714 158.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 47.8 42.87 22.25 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.633 0.635 . . . . 0.0 113.771 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.12 -7.05 82.63 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 117.859 -1.523 . . . . 0.0 115.146 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -101.03 104.34 31.54 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 120.094 1.947 . . . . 0.0 111.243 -173.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.88 90.25 1.09 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.799 3.0 . . . . 0.0 111.189 171.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 m -63.45 -21.35 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.04 158.03 34.04 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.896 0.878 . . . . 0.0 110.699 160.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -118.36 136.5 53.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.126 2.17 . . . . 0.0 105.958 163.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.07 147.53 41.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.182 2.193 . . . . 0.0 105.637 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.4 pt -140.9 142.67 29.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.779 1.231 . . . . 0.0 107.987 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.21 167.3 27.76 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 123.892 0.745 . . . . 0.0 111.658 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -72.22 79.09 0.97 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.892 0.877 . . . . 0.0 110.088 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -76.45 129.63 79.28 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 162.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -68.45 167.8 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.053 1.835 . . . . 0.0 109.832 175.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.36 -42.56 61.41 Favored 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 123.595 0.758 . . . . 0.0 110.245 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -75.14 -2.34 27.28 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.758 1.223 . . . . 0.0 111.505 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -112.13 -49.56 2.96 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 125.845 1.658 . . . . 0.0 109.221 172.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.0 tt -52.04 -66.44 0.38 Allowed 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 127.2 2.2 . . . . 0.0 110.418 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -63.55 -20.65 65.81 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.69 1.196 . . . . 0.0 111.952 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.67 -48.09 41.98 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.533 1.06 . . . . 0.0 110.665 172.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -59.49 -51.16 71.04 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.928 0.891 . . . . 0.0 110.223 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 mt -75.04 -5.36 43.65 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 126.129 1.771 . . . . 0.0 112.753 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.62 -26.71 34.56 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 124.541 1.136 . . . . 0.0 111.632 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -6.49 9.14 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.802 1.241 . . . . 0.0 113.657 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.62 -14.14 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 162.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.05 -7.86 59.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.211 -0.931 . . . . 0.0 112.249 170.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 C--O 1.247 0.956 0 C-N-CA 127.398 2.279 . . . . 0.0 108.154 158.858 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.2 m -149.78 153.03 36.17 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 120.018 -1.677 . . . . 0.0 107.743 168.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.3 mtt -138.19 -175.2 4.02 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.588 1.955 . . . . 0.0 109.44 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.7 m -151.83 154.54 36.38 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 171.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.7 mt -140.33 169.53 17.5 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.029 0.932 . . . . 0.0 109.652 -159.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.0 p -112.42 -105.63 0.38 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 167.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -126.06 -64.72 1.03 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.095 2.158 . . . . 0.0 108.932 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.63 -30.63 61.29 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.764 -0.585 . . . . 0.0 112.075 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.04 -22.59 59.5 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.163 -0.446 . . . . 0.0 111.254 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -64.06 -58.7 5.89 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.841 0.746 . . . . 0.0 109.829 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -59.59 -34.98 73.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.833 0.453 . . . . 0.0 110.978 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -62.82 -53.31 56.27 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.901 -0.499 . . . . 0.0 110.685 171.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.95 -43.99 97.92 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.423 0.689 . . . . 0.0 111.654 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 pt -59.95 -23.59 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -11.06 60.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.542 0.737 . . . . 0.0 111.85 177.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.06 131.19 48.28 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 174.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -87.0 35.65 0.7 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.635 0.774 . . . . 0.0 112.702 -165.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -142.13 179.93 19.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.398 1.475 . . . . 0.0 110.238 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.57 93.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.296 3.331 . . . . 0.0 111.585 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.0 t -100.34 126.42 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 127.35 2.26 . . . . 0.0 106.078 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.541 HD11 HD21 ' A' ' 75' ' ' LEU . 15.8 tp -126.77 120.92 30.51 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.866 -0.521 . . . . 0.0 110.275 -167.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -100.4 133.65 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 118.698 0.681 . . . . 0.0 109.92 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -93.2 107.86 19.59 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 159.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.472 ' CD1' HG23 ' A' ' 57' ' ' VAL . 47.5 m-85 -82.7 111.96 19.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 162.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -119.71 -174.36 2.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.506 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -147.6 161.42 41.18 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 121.394 -0.817 . . . . 0.0 111.508 168.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.83 6.38 0.24 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.433 1.493 . . . . 0.0 115.02 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.42 ' CG ' ' N ' ' A' ' 29' ' ' CYS . 3.5 p90 -124.31 -66.72 0.96 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 163.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 28' ' ' TRP . 16.4 t 36.16 -91.52 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 129.896 3.278 . . . . 0.0 114.614 175.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.66 -91.54 0.56 Allowed Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.624 1.583 . . . . 0.0 111.074 -172.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.07 -19.24 68.5 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.99 3.127 . . . . 0.0 115.066 -168.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 p -51.51 -35.21 39.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.83 0.741 . . . . 0.0 111.722 165.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -66.13 -14.26 61.5 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.547 1.067 . . . . 0.0 112.54 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.8 mtp -105.57 -15.58 14.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.295 1.838 . . . . 0.0 111.407 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.6 ttt -93.95 -34.93 12.88 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 126.322 1.849 . . . . 0.0 109.227 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.26 -50.62 63.21 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.651 1.58 . . . . 0.0 113.02 171.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.91 -35.48 55.29 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 122.127 1.796 . . . . 0.0 111.815 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -61.79 -39.82 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 118.809 0.731 . . . . 0.0 110.079 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.6 mp -68.3 -32.09 71.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.936 2.094 . . . . 0.0 112.211 174.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -68.5 -49.87 56.42 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.026 0.931 . . . . 0.0 108.957 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -56.51 -47.7 78.79 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.277 0.56 . . . . 0.0 110.274 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -58.18 -42.98 87.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.646 1.178 . . . . 0.0 111.051 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.27 59.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.367 1.067 . . . . 0.0 110.218 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -52.61 -45.87 66.76 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.503 0.592 . . . . 0.0 110.589 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.82 -10.68 58.18 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -139.09 3.72 2.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -168.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -24.32 -52.96 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 129.318 3.047 . . . . 0.0 116.258 -158.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . 0.27 2.8 m-20 -125.32 10.7 8.03 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -70.68 -26.63 63.52 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 119.556 1.071 . . . . 0.0 108.665 158.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.79 174.32 12.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 126.12 1.768 . . . . 0.0 110.023 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.262 0.7 OUTLIER -137.51 112.71 9.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 159.09 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.04 159.17 2.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.228 0.537 . . . . 0.0 109.897 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.2 171.86 15.77 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.57 0.748 . . . . 0.0 109.177 172.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -139.69 131.49 27.52 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -170.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.43 151.25 33.7 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -85.12 115.7 23.07 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.441 1.896 . . . . 0.0 108.494 -178.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' A' ' 26' ' ' ALA . 2.3 p -64.99 -24.14 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.254 1.022 . . . . 0.0 113.017 -172.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.08 63.7 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.396 1.478 . . . . 0.0 109.988 174.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -65.06 -32.67 74.5 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.079 1.351 . . . . 0.0 111.947 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -110.08 87.32 5.81 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.206 1.002 . . . . 0.0 111.633 -174.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.61 -25.68 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.151 2.567 . . . . 0.0 114.445 170.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -73.22 137.89 45.26 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 120.49 1.495 . . . . 0.0 109.481 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.293 49.3 m 67.53 -23.97 0.12 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 129.495 3.118 . . . . 0.0 111.751 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.432 ' H ' ' C ' ' A' ' 62' ' ' GLU . 41.2 m -63.76 -71.9 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 127.917 2.487 . . . . 0.0 110.153 169.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -64.55 -28.4 69.61 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -59.0 -24.68 62.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.334 1.854 . . . . 0.0 111.856 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -120.91 13.51 11.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.85 1.26 . . . . 0.0 111.257 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.85 25.01 71.73 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 121.341 -0.849 . . . . 0.0 113.514 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.493 HD12 HG21 ' A' ' 74' ' ' THR . 23.2 mm -68.21 93.89 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.99 1.316 . . . . 0.0 110.167 -171.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -128.37 -13.22 4.96 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.101 1.36 . . . . 0.0 112.063 171.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.7 t -81.84 53.24 2.12 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.994 1.318 . . . . 0.0 111.457 -173.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.423 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 23.7 pt -70.84 153.03 95.01 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.188 0.995 . . . . 0.0 112.343 -176.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.423 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 39.7 Cg_endo -62.92 129.92 7.82 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 CA-C-N 119.087 0.71 . . . . 0.0 110.506 -8.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.493 HG21 HD12 ' A' ' 69' ' ' ILE . 24.7 m -112.83 141.85 46.17 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.541 HD21 HD11 ' A' ' 21' ' ' LEU . 5.4 tt -133.19 105.26 6.91 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -172.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.6 mt -109.12 128.86 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.415 HD13 HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -92.1 110.83 22.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 169.236 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -103.18 156.53 17.64 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.543 1.137 . . . . 0.0 109.462 170.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 127.16 11.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 163.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.84 27.39 59.21 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 118.321 0.51 . . . . 0.0 113.523 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.38 -12.58 69.35 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.959 1.743 . . . . 0.0 113.763 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -90.6 118.36 68.64 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 119.366 1.583 . . . . 0.0 109.689 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 85.01 1.18 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.582 2.855 . . . . 0.0 109.72 171.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -64.82 -38.82 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.344 1.057 . . . . 0.0 111.995 -176.7 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -142.28 156.05 45.26 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.483 1.038 . . . . 0.0 110.684 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.99 135.48 32.77 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.856 1.663 . . . . 0.0 107.952 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.1 mm? -122.01 146.71 46.9 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.356 2.262 . . . . 0.0 106.797 174.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.3 pt -143.23 119.17 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 124.598 1.159 . . . . 0.0 109.233 -169.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.9 170.57 41.63 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.491 1.52 . . . . 0.0 110.798 -169.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -66.44 93.12 0.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.868 1.267 . . . . 0.0 110.43 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -74.63 131.77 79.26 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 168.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.47 166.57 21.31 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.584 1.522 . . . . 0.0 109.593 165.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -47.48 73.2 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -177.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.1 -15.11 20.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.53 2.332 . . . . 0.0 113.181 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -101.35 -56.05 2.39 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 125.418 1.487 . . . . 0.0 108.703 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.48 -58.07 8.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.593 1.957 . . . . 0.0 109.782 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -26.94 68.61 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.247 1.019 . . . . 0.0 110.946 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.34 -44.87 42.87 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.505 1.048 . . . . 0.0 110.714 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -49.73 76.57 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.255 1.022 . . . . 0.0 109.967 172.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.83 -2.52 57.85 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.18 -34.45 14.54 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 119.429 1.013 . . . . 0.0 110.42 168.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.6 29.02 0.08 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.562 2.345 . . . . 0.0 112.16 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.35 -24.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.9 2.08 . . . . 0.0 111.204 158.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.15 -10.84 59.73 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.978 0.911 . . . . 0.0 112.343 172.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.258 0 C-N-CA 127.195 2.198 . . . . 0.0 109.167 165.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 118.844 -0.598 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . 0.268 6.1 t 54.91 -162.8 0.14 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.548 1.939 . . . . 0.0 115.059 159.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . 0.289 13.2 ttt 137.24 -136.54 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 1 C-N-CA 135.283 5.433 . . . . 0.0 106.673 179.075 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.4 m -56.43 137.24 53.31 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.682 1.593 . . . . 0.0 112.672 -168.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 53' ' ' ALA . 1.1 tp -90.63 175.23 7.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.153 1.781 . . . . 0.0 111.403 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.5 p -130.35 178.29 6.7 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 159.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -58.4 -57.99 10.47 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.614 1.566 . . . . 0.0 110.466 169.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.01 79.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.668 -0.645 . . . . 0.0 110.699 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -84.15 -19.32 34.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.949 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.46 ' HA ' HD21 ' A' ' 5' ' ' LEU . 21.9 t80 -58.74 -56.58 20.35 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 167.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -63.18 -46.07 88.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.748 0.819 . . . . 0.0 109.715 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -63.47 -30.62 71.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.945 0.793 . . . . 0.0 112.336 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.22 -60.48 2.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.422 1.01 . . . . 0.0 110.048 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.37 -10.04 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -46.58 -36.1 6.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.502 1.521 . . . . 0.0 112.818 -174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.85 113.85 1.66 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 124.131 0.872 . . . . 0.0 112.808 165.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -152.56 -102.89 0.05 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 164.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.74 -138.13 6.37 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.545 1.545 . . . . 0.0 111.742 -168.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.75 85.87 0.92 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.371 3.381 . . . . 0.0 113.05 -167.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.3 t -97.26 140.32 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 170.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.19 124.43 20.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 O-C-N 121.689 -0.632 . . . . 0.0 109.411 164.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.92 142.44 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 172.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.8 89.27 3.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.502 1.144 . . . . 0.0 108.983 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 69' ' ' ILE . 74.8 m-85 -76.19 114.58 15.02 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.614 1.166 . . . . 0.0 109.27 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 16.4 p-90 -127.93 -171.52 2.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 168.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.77 160.38 41.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.082 -1.011 . . . . 0.0 110.393 169.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.6 -29.17 64.28 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.568 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.474 ' CH2' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -93.61 -26.95 16.87 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 p -71.66 164.98 24.93 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.221 0.919 . . . . 0.0 113.438 -159.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.84 -82.36 1.4 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.279 1.418 . . . . 0.0 112.653 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -60.7 -20.96 67.84 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.466 2.778 . . . . 0.0 113.077 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 17.7 p -59.21 -27.28 65.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.148 172.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.3 mtt85 -76.61 -12.76 60.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 120.477 1.489 . . . . 0.0 112.864 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 86.7 mtp -95.09 -33.0 12.84 Favored 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 124.843 1.257 . . . . 0.0 110.296 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.6 ttt -78.0 -36.18 49.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.416 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.67 -51.8 66.55 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.198 -1.382 . . . . 0.0 112.203 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.83 -38.14 40.85 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 121.735 1.655 . . . . 0.0 111.848 171.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.78 -14.36 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 119.576 1.08 . . . . 0.0 112.163 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.38 -16.36 18.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 128.669 2.788 . . . . 0.0 111.816 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.36 -40.7 29.56 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.672 1.123 . . . . 0.0 109.449 168.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -52.41 -51.02 61.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.739 0.816 . . . . 0.0 109.034 163.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.458 ' CD1' ' HE2' ' A' ' 93' ' ' LYS . 2.3 t80 -57.93 -48.77 78.95 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-O 118.652 -0.689 . . . . 0.0 110.889 177.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.81 -59.82 3.03 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.95 1.3 . . . . 0.0 109.63 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -60.21 -44.7 94.94 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 124.806 1.316 . . . . 0.0 111.343 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.56 -15.09 2.49 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.652 1.181 . . . . 0.0 113.939 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.97 35.37 1.75 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.46 1.104 . . . . 0.0 112.713 174.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.79 -37.54 8.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.83 1.652 . . . . 0.0 115.195 -165.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.4 7.74 4.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.737 1.215 . . . . 0.0 111.362 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -83.99 -27.13 28.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.719 1.607 . . . . 0.0 110.554 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.97 171.63 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.819 1.248 . . . . 0.0 108.788 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.306 6.6 t -110.49 85.95 2.21 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 123.529 1.633 . . . . 0.0 108.631 164.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -70.02 154.95 7.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.409 163.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.494 ' HB3' HD22 ' A' ' 5' ' ' LEU . . . -157.55 120.41 3.93 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.085 169.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -94.0 146.47 23.91 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.073 0.233 . . . . 0.0 111.405 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.97 154.51 35.12 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.638 0.732 . . . . 0.0 112.082 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -86.31 96.39 9.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.597 1.959 . . . . 0.0 107.885 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.401 HG11 HG21 ' A' ' 72' ' ' ILE . 1.1 p -66.22 -20.3 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 121.371 -0.831 . . . . 0.0 113.068 -167.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.5 -28.46 63.45 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.97 1.708 . . . . 0.0 111.676 170.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -109.44 -16.83 13.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.446 2.298 . . . . 0.0 111.821 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -112.53 79.67 3.22 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.217 1.807 . . . . 0.0 110.85 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.57 -88.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.572 2.848 . . . . 0.0 109.984 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 46.74 -17.12 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 131.344 3.858 . . . . 0.0 121.206 167.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.8 m 178.2 -25.43 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 130.806 3.642 . . . . 0.0 110.782 -171.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.404 HG23 ' HB ' ' A' ' 69' ' ' ILE . 37.2 m -44.39 -61.55 1.48 Allowed 'General case' 0 N--CA 1.458 -0.075 0 C-N-CA 127.574 2.35 . . . . 0.0 110.621 173.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -57.94 -45.66 86.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.777 0.831 . . . . 0.0 109.659 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -60.44 -28.12 68.04 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.075 1.35 . . . . 0.0 112.949 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -112.45 12.08 19.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.915 0.779 . . . . 0.0 111.571 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.33 24.58 74.96 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 121.334 -0.854 . . . . 0.0 114.203 173.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.417 HG21 ' CE2' ' A' ' 24' ' ' PHE . 40.8 mm -80.82 46.54 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 126.79 2.036 . . . . 0.0 111.269 -167.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.0 ttt -83.39 -8.25 59.43 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.237 -0.914 . . . . 0.0 110.17 162.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.2 p -75.77 16.52 0.39 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.251 2.22 . . . . 0.0 115.054 -164.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.474 HD11 ' CH2' ' A' ' 28' ' ' TRP . 28.4 pt -61.31 145.49 90.35 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.001 0.92 . . . . 0.0 112.361 -165.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 74.3 Cg_endo -67.57 135.53 29.29 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 118.25 0.411 . . . . 0.0 111.544 -1.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.6 m -133.44 140.6 47.39 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.049 0.94 . . . . 0.0 110.075 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt -135.65 99.13 4.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.028 1.731 . . . . 0.0 106.757 -170.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.8 mt -95.17 130.56 43.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.449 HD12 ' HG ' ' A' ' 100' ' ' LEU . 0.8 OUTLIER -92.46 123.28 35.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 171.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -113.82 148.45 36.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 172.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.608 ' HE3' HG21 ' A' ' 84' ' ' VAL . 12.7 ptpt -152.36 154.71 36.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 163.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.53 15.47 1.25 Allowed Glycine 0 CA--C 1.541 1.713 0 N-CA-C 117.134 1.614 . . . . 0.0 117.134 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.83 15.88 38.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-N 119.69 1.745 . . . . 0.0 112.995 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -134.97 128.0 18.49 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.195 1.398 . . . . 0.0 109.555 -167.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.83 87.32 1.41 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.914 3.076 . . . . 0.0 109.646 171.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.608 HG21 ' HE3' ' A' ' 79' ' ' LYS . 2.6 m -63.75 -36.3 76.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 O-C-N 121.503 -0.748 . . . . 0.0 112.456 -174.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 167.05 31.57 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 122.905 0.482 . . . . 0.0 111.106 170.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -134.66 134.06 40.74 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.3 1.84 . . . . 0.0 107.881 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.484 HD11 ' HG2' ' A' ' 99' ' ' GLN . 4.5 mm? -106.49 149.72 26.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.801 1.64 . . . . 0.0 107.529 167.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 pt -143.32 144.18 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.398 1.479 . . . . 0.0 107.831 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.81 169.52 19.03 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.947 0.784 . . . . 0.0 112.796 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -72.74 73.82 1.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.553 1.541 . . . . 0.0 111.167 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.45 ' HG3' HD12 ' A' ' 87' ' ' LEU . 6.3 mm100 -75.28 136.03 72.51 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 165.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.36 166.01 29.76 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.202 1.935 . . . . 0.0 110.863 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.458 ' HE2' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -49.46 -50.61 40.42 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.68 1.192 . . . . 0.0 111.865 -177.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -52.63 -33.73 48.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.226 1.41 . . . . 0.0 112.964 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.59 -47.83 10.87 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 tt -61.03 -56.84 16.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.433 1.493 . . . . 0.0 110.338 -175.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -55.66 -33.56 64.19 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.456 1.502 . . . . 0.0 110.337 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.86 -50.22 17.79 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 118.232 0.469 . . . . 0.0 110.268 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.484 ' HG2' HD11 ' A' ' 87' ' ' LEU . 13.1 tp60 -59.62 -41.06 89.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.553 0.741 . . . . 0.0 110.82 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.449 ' HG ' HD12 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -85.87 -0.02 54.26 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.365 1.466 . . . . 0.0 113.108 -178.683 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.53 -27.5 16.78 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.236 1.015 . . . . 0.0 113.332 -174.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.38 0.16 1.6 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.372 1.442 . . . . 0.0 113.686 176.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.273 0.4 OUTLIER -129.97 4.17 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 161.262 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.81 -13.59 16.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.242 1.017 . . . . 0.0 112.13 171.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.896 2.078 . . . . 0.0 109.964 170.304 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -156.37 174.36 15.52 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 120.225 -1.547 . . . . 0.0 111.436 -175.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.4 mtp -148.84 169.92 19.42 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.607 1.963 . . . . 0.0 108.885 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.1 m -62.46 148.97 43.99 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 159.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 10' ' ' PHE . 6.3 tp -119.62 162.99 18.04 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.118 0.967 . . . . 0.0 110.276 -173.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.47 ' H ' ' HB2' ' A' ' 9' ' ' ASN . 67.2 p -130.15 -100.97 0.31 Allowed 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 170.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -133.73 -71.18 0.51 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.273 1.429 . . . . 0.0 110.123 -158.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.01 -42.28 37.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.499 0.72 . . . . 0.0 110.253 163.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.47 ' HB2' ' H ' ' A' ' 6' ' ' THR . 72.3 m-80 -69.74 -26.95 64.56 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.327 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.527 ' HA ' HD21 ' A' ' 5' ' ' LEU . 8.8 t80 -61.51 -67.06 0.44 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.051 0.841 . . . . 0.0 109.028 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -63.21 -35.8 81.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 121.482 -0.087 . . . . 0.0 110.843 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.91 -8.0 56.58 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 118.228 -0.892 . . . . 0.0 113.144 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.95 -49.21 5.9 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 120.36 1.437 . . . . 0.0 110.784 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.3 pt -59.94 -19.38 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -174.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -17.73 60.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.446 1.498 . . . . 0.0 113.686 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.59 146.19 48.18 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 119.175 0.898 . . . . 0.0 111.259 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -76.4 -23.36 54.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.321 1.048 . . . . 0.0 113.658 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.57 -174.26 40.0 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.132 0.872 . . . . 0.0 112.571 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.72 87.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.506 3.47 . . . . 0.0 111.86 172.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.68 138.1 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 162.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.47 163.0 39.02 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.742 -0.599 . . . . 0.0 110.318 168.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.41 126.87 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 123.994 0.918 . . . . 0.0 108.672 -173.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 66.3 t0 -80.13 114.88 19.37 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 158.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -100.03 108.88 21.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 25.5 p-90 -125.2 179.43 5.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.287 1.435 . . . . 0.0 107.249 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.554 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -152.25 162.73 40.71 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.496 1.118 . . . . 0.0 109.815 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.85 -9.27 50.48 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -16.38 5.6 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -174.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 26' ' ' ALA . 6.4 p -74.4 38.13 0.11 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -159.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 37.62 -102.98 0.02 OUTLIER Glycine 0 CA--C 1.54 1.614 0 C-N-CA 127.665 2.555 . . . . 0.0 114.344 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.93 -17.77 39.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.015 3.144 . . . . 0.0 115.131 -175.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.2 p -53.27 -36.7 61.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.502 1.046 . . . . 0.0 111.323 168.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.2 ttt-85 -67.36 -8.85 35.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.204 1.002 . . . . 0.0 112.545 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 64.8 mtm -107.34 -14.74 14.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.503 1.521 . . . . 0.0 112.473 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.5 ttt -96.55 -36.41 10.77 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.633 1.173 . . . . 0.0 109.428 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.15 -47.81 86.82 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.648 1.179 . . . . 0.0 112.162 174.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.81 -31.28 48.58 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 121.995 1.748 . . . . 0.0 112.699 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.8 -33.74 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 119.437 1.017 . . . . 0.0 110.567 173.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -31.04 62.14 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.184 1.794 . . . . 0.0 111.614 173.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -71.15 -40.18 71.48 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.431 1.014 . . . . 0.0 109.613 172.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -62.58 -43.29 99.17 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 171.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -56.47 -42.7 78.67 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.286 1.035 . . . . 0.0 111.633 172.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.81 -55.12 36.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.183 0.993 . . . . 0.0 110.565 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.38 -47.54 72.55 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.548 1.139 . . . . 0.0 110.097 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.26 -13.69 60.8 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -133.98 17.22 3.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.567 1.076 . . . . 0.0 113.147 -173.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.75 -31.95 5.36 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.846 2.058 . . . . 0.0 115.469 -159.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -124.06 -3.28 8.09 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.963 0.905 . . . . 0.0 113.383 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -78.63 -39.05 38.23 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.99 1.268 . . . . 0.0 110.436 166.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 m -124.45 166.45 19.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.302 5.6 t -120.63 91.59 3.57 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.415 1.102 . . . . 0.0 108.501 172.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 p -98.54 116.61 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 125.065 1.346 . . . . 0.0 110.99 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.38 98.13 5.32 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.311 -159.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' H ' ' CD ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -72.1 140.82 49.1 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.873 -173.816 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pp -153.67 167.69 28.72 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 124.423 1.077 . . . . 0.0 112.758 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -95.97 112.05 23.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.914 1.686 . . . . 0.0 109.388 -173.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -64.72 -23.67 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.314 0.645 . . . . 0.0 111.967 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -75.42 -3.04 31.48 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.452 1.501 . . . . 0.0 111.776 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -135.26 -38.59 0.76 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.708 2.003 . . . . 0.0 111.743 -166.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -88.33 119.03 70.13 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 118.95 0.795 . . . . 0.0 109.513 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -90.55 -21.54 0.81 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.504 2.803 . . . . 0.0 113.804 164.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 64' ' ' THR . 7.5 tp10 -61.4 111.74 1.9 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.306 1.442 . . . . 0.0 112.002 -170.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m 68.75 -30.58 0.18 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.625 2.77 . . . . 0.0 111.851 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.407 ' H ' ' C ' ' A' ' 62' ' ' GLU . 57.5 m -51.73 -51.35 56.85 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 128.49 2.716 . . . . 0.0 110.463 171.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.5 t -57.73 -50.14 74.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.355 0.662 . . . . 0.0 110.191 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.3 tp60 -56.62 -44.5 81.25 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.693 0.797 . . . . 0.0 111.9 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -88.61 11.54 17.11 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 119.138 -0.458 . . . . 0.0 112.028 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.61 29.31 71.45 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 124.413 1.006 . . . . 0.0 112.391 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.484 ' CD1' HD11 ' A' ' 76' ' ' ILE . 43.3 mm -79.97 82.0 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.138 0.975 . . . . 0.0 109.579 -162.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.0 ttm -123.42 -6.02 8.2 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.657 1.583 . . . . 0.0 111.111 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.2 t -83.16 26.17 0.65 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.679 1.192 . . . . 0.0 113.744 -167.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.454 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -63.86 151.46 89.16 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -165.222 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 59.6 Cg_endo -65.8 129.84 10.76 Favored 'Cis proline' 0 C--N 1.353 0.784 0 CA-C-N 119.379 0.814 . . . . 0.0 111.44 2.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.8 m -121.37 152.68 38.73 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.0 tt -132.37 130.32 40.54 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 171.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.484 HD11 ' CD1' ' A' ' 69' ' ' ILE . 37.3 mt -120.78 132.62 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 167.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.47 141.0 28.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.795 2.038 . . . . 0.0 105.982 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -142.52 161.89 36.89 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.993 2.117 . . . . 0.0 111.346 -175.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.448 ' CE ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -163.74 153.34 14.66 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.203 1.801 . . . . 0.0 108.776 158.143 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.68 15.69 54.47 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.676 1.131 . . . . 0.0 114.536 167.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.16 -10.36 71.72 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.24 1.4 . . . . 0.0 112.837 -175.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -97.55 159.73 30.4 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 118.729 1.265 . . . . 0.0 109.181 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -69.76 -175.46 1.16 Allowed 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 122.5 2.133 . . . . 0.0 111.193 159.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.448 HG22 ' CE ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -133.07 -46.45 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.309 1.843 . . . . 0.0 108.738 159.161 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.426 ' HZ1' ' CG ' ' A' ' 102' ' ' ASP . 75.9 mttt -145.57 148.01 32.71 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.665 1.186 . . . . 0.0 107.973 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -117.32 131.99 56.69 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 163.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -125.48 141.03 52.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.1 141.18 29.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 124.022 0.929 . . . . 0.0 108.799 -170.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.18 164.87 39.6 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.586 1.089 . . . . 0.0 111.42 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.58 78.58 2.58 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.3 0.571 . . . . 0.0 110.006 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -71.01 133.82 85.8 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.23 167.58 21.68 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.874 1.716 . . . . 0.0 111.367 176.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -44.78 73.9 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.081 1.352 . . . . 0.0 110.792 -172.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -51.33 -44.9 62.11 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.69 2.396 . . . . 0.0 111.063 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -42.59 53.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.1 1.76 . . . . 0.0 108.049 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -61.74 2.11 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.655 1.582 . . . . 0.0 108.827 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.78 -39.09 83.72 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.585 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.41 82.78 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.267 1.394 . . . . 0.0 111.713 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -78.0 -21.75 50.37 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.16 -1.78 13.58 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.467 1.107 . . . . 0.0 112.808 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.38 -36.19 42.16 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.776 1.63 . . . . 0.0 112.604 -175.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.426 ' CG ' ' HZ1' ' A' ' 85' ' ' LYS . 10.1 p-10 -64.31 -11.29 30.58 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.182 1.393 . . . . 0.0 114.091 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.81 -8.5 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 119.459 1.027 . . . . 0.0 112.071 168.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.27 -10.25 26.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.392 1.477 . . . . 0.0 112.899 175.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 C--O 1.246 0.899 0 C-N-CA 126.167 1.787 . . . . 0.0 110.212 172.058 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 51' ' ' THR . . . . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.0 m -51.93 127.06 20.07 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.139 1.376 . . . . 0.0 112.846 -170.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.1 ptm -164.45 -179.89 6.3 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.516 1.526 . . . . 0.0 109.613 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -69.4 154.56 41.84 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.179 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.446 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 1.6 tp -123.84 159.68 29.07 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.842 0.83 . . . . 0.0 111.226 -177.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.3 m -166.89 170.59 12.07 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.871 3.668 . . . . 0.0 101.958 172.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -43.38 -59.85 1.95 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 128.725 2.81 . . . . 0.0 112.781 -166.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.05 91.66 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.319 0.58 . . . . 0.0 111.189 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -72.07 -21.79 61.46 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.139 -0.458 . . . . 0.0 111.777 -177.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.26 -60.02 3.98 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -60.53 -46.06 91.55 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.442 -0.789 . . . . 0.0 111.184 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -62.67 -26.31 68.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.314 0.961 . . . . 0.0 112.71 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.94 -63.47 1.25 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.066 0.848 . . . . 0.0 109.485 165.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.77 HG22 HG11 ' A' ' 20' ' ' VAL . 2.9 pt -66.95 -13.52 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -166.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -58.54 -20.74 48.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.993 1.317 . . . . 0.0 113.975 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.43 -112.14 0.26 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 107.849 -2.1 . . . . 0.0 107.849 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 t0 62.4 -12.83 0.07 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 130.039 3.336 . . . . 0.0 117.677 158.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.83 -166.85 16.89 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.512 1.053 . . . . 0.0 111.889 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -55.66 101.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.946 3.098 . . . . 0.0 111.235 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.77 HG11 HG22 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -94.77 140.83 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 108.361 -175.4 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.472 HD11 HD21 ' A' ' 100' ' ' LEU . 3.5 mm? -130.43 143.14 50.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 173.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.69 108.3 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.481 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 63.3 t0 -75.91 98.52 4.24 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 78.0 m-85 -84.3 105.53 15.21 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -124.8 -177.15 3.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.96 162.09 41.48 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.222 -0.924 . . . . 0.0 110.552 171.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.35 -5.42 2.43 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.473 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -113.66 -20.96 10.99 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.591 1.087 . . . . 0.0 113.765 178.548 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.9 p -73.83 161.67 29.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.912 1.233 . . . . 0.0 110.347 -173.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.78 -84.86 1.74 Allowed Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.559 -0.579 . . . . 0.0 112.552 -173.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.15 -16.55 55.52 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.339 2.693 . . . . 0.0 113.448 -171.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.0 p -49.78 -40.84 42.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.848 0.859 . . . . 0.0 111.586 166.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -12.35 61.55 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.145 0.578 . . . . 0.0 112.257 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.5 mtm -100.99 -15.73 17.38 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.322 1.449 . . . . 0.0 112.057 173.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.8 ttt -85.32 -42.62 14.43 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 125.485 1.514 . . . . 0.0 108.444 172.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.09 -50.4 36.99 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.359 -1.305 . . . . 0.0 113.419 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.14 -36.1 30.52 Favored 'Trans proline' 0 C--N 1.353 0.766 0 CA-C-N 121.845 1.695 . . . . 0.0 112.17 173.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.97 -35.48 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.306 0.957 . . . . 0.0 110.304 173.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.84 -17.55 57.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.631 1.973 . . . . 0.0 111.847 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.26 -48.86 18.73 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 167.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -61.55 -26.18 67.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.602 0.761 . . . . 0.0 111.33 173.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.447 ' CE1' HD12 ' A' ' 96' ' ' LEU . 81.2 t80 -65.25 -63.19 1.16 Allowed 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 125.182 1.393 . . . . 0.0 107.879 170.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.77 -46.16 67.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.173 -0.442 . . . . 0.0 112.046 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.93 -34.79 56.94 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.245 1.418 . . . . 0.0 111.781 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.91 -14.45 61.06 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -162.18 63.38 0.23 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.341 1.456 . . . . 0.0 108.995 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.66 71.39 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -166.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -131.74 -1.31 3.82 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -168.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -64.46 -39.63 94.19 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.928 1.24 . . . . 0.0 108.866 161.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.01 170.9 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.697 1.199 . . . . 0.0 108.094 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.463 ' HB ' ' HA ' ' A' ' 1' ' ' ALA . 2.6 t -128.41 74.81 1.58 Allowed 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 123.989 1.852 . . . . 0.0 106.556 177.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 p -82.78 160.34 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.787 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 5' ' ' LEU . . . -159.67 174.11 15.05 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.185 176.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 28.1 mttp -131.99 144.39 50.76 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 123.331 0.653 . . . . 0.0 110.509 176.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.97 163.4 39.77 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.788 1.305 . . . . 0.0 114.297 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -91.45 105.33 17.68 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.101 1.76 . . . . 0.0 108.716 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.484 HG21 HG22 ' A' ' 69' ' ' ILE . 2.7 p -65.94 -21.78 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.664 0.786 . . . . 0.0 112.669 -172.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -67.69 -22.43 65.28 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.303 1.041 . . . . 0.0 111.612 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -114.09 -21.64 10.43 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.744 2.017 . . . . 0.0 111.829 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -100.32 94.23 3.23 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.235 1.414 . . . . 0.0 109.924 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.19 -27.74 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.038 2.492 . . . . 0.0 113.524 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -74.84 103.76 5.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.275 0.943 . . . . 0.0 110.751 -172.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m 104.88 -32.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 130.868 3.667 . . . . 0.0 109.471 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -52.82 -52.82 55.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.888 1.275 . . . . 0.0 109.714 167.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 t -70.9 -7.43 45.7 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.228 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -87.73 -33.22 18.78 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.998 1.272 . . . . 0.0 111.12 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -120.12 2.41 10.92 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.62 38.34 51.25 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 119.134 0.879 . . . . 0.0 111.801 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.491 HG21 ' CZ ' ' A' ' 24' ' ' PHE . 39.3 mm -75.51 83.67 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.973 1.309 . . . . 0.0 110.498 -166.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -119.58 -6.55 10.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.058 1.343 . . . . 0.0 112.544 172.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 m -77.14 34.41 0.16 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.929 2.092 . . . . 0.0 113.362 -168.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.473 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 34.0 pt -74.76 151.06 86.7 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -162.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 59.3 Cg_endo -65.88 130.65 12.23 Favored 'Cis proline' 0 C--N 1.351 0.685 0 CA-C-N 119.047 0.695 . . . . 0.0 110.745 -3.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -119.07 144.12 46.76 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.6 tp -132.36 113.92 13.75 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mt -111.42 142.9 22.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.99 118.56 37.02 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.762 2.025 . . . . 0.0 106.875 -176.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.432 ' HB2' HG12 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -130.72 176.38 8.24 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.239 1.016 . . . . 0.0 110.433 175.247 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.88 145.83 17.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 158.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 37.61 41.79 0.89 Allowed Glycine 0 CA--C 1.54 1.637 0 N-CA-C 115.974 1.15 . . . . 0.0 115.974 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.29 -12.63 68.67 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.77 1.652 . . . . 0.0 115.545 177.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -95.43 120.52 63.63 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 120.601 2.2 . . . . 0.0 110.768 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.82 148.71 46.65 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.124 1.883 . . . . 0.0 109.487 163.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.94 -44.54 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.68 0.792 . . . . 0.0 111.914 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -159.56 171.62 19.31 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.72 1.145 . . . . 0.0 110.061 171.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.29 156.21 46.54 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.016 1.726 . . . . 0.0 110.133 -174.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.4 mt -137.01 139.54 41.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.04 134.23 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 -170.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.02 162.68 37.92 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.796 0.712 . . . . 0.0 111.63 -175.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -75.29 75.78 2.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.363 1.065 . . . . 0.0 110.923 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -75.31 140.43 72.72 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 167.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 170.13 19.46 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.592 2.195 . . . . 0.0 111.692 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.83 -46.39 41.98 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.006 1.323 . . . . 0.0 111.945 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -56.94 -43.75 81.84 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.913 1.285 . . . . 0.0 110.95 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.73 -36.49 70.48 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.403 0.681 . . . . 0.0 109.251 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.447 HD12 ' CE1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -64.92 -60.03 3.52 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.415 1.086 . . . . 0.0 108.552 179.041 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -62.35 -32.87 73.72 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.102 0.561 . . . . 0.0 110.377 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.74 -53.68 10.99 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.355 0.525 . . . . 0.0 111.009 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.5 -35.87 81.89 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 118.477 0.581 . . . . 0.0 111.089 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.472 HD21 HD11 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -87.63 -1.14 57.75 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.913 -178.388 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -50.32 -31.33 14.15 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 125.224 1.41 . . . . 0.0 113.588 -172.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -22.64 58.6 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.399 1.08 . . . . 0.0 112.32 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.55 -8.25 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.809 0.844 . . . . 0.0 111.444 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.89 -10.4 28.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.19 1.396 . . . . 0.0 112.487 171.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 . . . . . 0 C--O 1.249 1.069 0 C-N-CA 126.104 1.761 . . . . 0.0 110.898 171.904 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 117.002 -1.475 . . . . 0.0 107.8 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.3 m -62.65 -61.09 2.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.311 1.414 . . . . 0.0 112.789 -168.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.4 ttp 48.56 -137.66 0.9 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.785 1.634 . . . . 0.0 110.22 -166.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.4 m -59.01 126.48 27.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.653 1.581 . . . . 0.0 113.34 -159.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.95 171.22 8.9 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.814 2.046 . . . . 0.0 111.207 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.0 t -131.78 -50.74 0.97 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.092 0.957 . . . . 0.0 111.53 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 174.27 -68.9 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 127.9 2.48 . . . . 0.0 105.179 171.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.67 -33.5 64.16 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.881 -0.512 . . . . 0.0 111.836 177.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -17.39 61.26 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 119.105 -0.474 . . . . 0.0 111.25 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.69 -64.45 0.89 Allowed 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -59.88 -44.42 94.21 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.974 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.8 -28.01 65.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.468 1.031 . . . . 0.0 113.013 -177.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.9 -58.9 2.68 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.974 0.91 . . . . 0.0 110.723 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.6 pt -62.08 -23.13 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.936 -171.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -57.71 -31.99 66.94 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.393 1.077 . . . . 0.0 111.688 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.5 102.08 0.15 Allowed Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -165.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -153.36 -69.55 0.15 Allowed 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 128.294 2.638 . . . . 0.0 105.539 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.46 -114.65 0.98 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 106.957 -2.457 . . . . 0.0 106.957 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.79 76.94 3.53 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.21 3.273 . . . . 0.0 112.564 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.96 130.14 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -112.87 113.89 26.17 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 159.373 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.09 125.01 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.1 94.73 5.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 124.12 0.888 . . . . 0.0 110.337 -174.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -83.08 109.27 16.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.416 ' O ' HG12 ' A' ' 57' ' ' VAL . 22.7 p-90 -126.93 175.02 8.38 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -140.14 150.2 43.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.773 0.715 . . . . 0.0 110.52 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.9 -26.26 58.69 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.764 0.825 . . . . 0.0 113.023 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.11 -25.88 16.96 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.0 p -69.75 157.64 36.93 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.372 0.987 . . . . 0.0 111.467 -160.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.75 -86.11 1.16 Allowed Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.318 -172.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.87 -18.83 66.73 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.13 2.553 . . . . 0.0 113.918 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 p -53.67 -35.47 61.1 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.24 0.473 . . . . 0.0 111.23 168.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -69.31 -16.42 63.55 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.381 -0.824 . . . . 0.0 112.336 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.78 -12.32 20.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.597 1.559 . . . . 0.0 112.119 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.8 ttt -93.14 -35.13 13.34 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 126.415 1.886 . . . . 0.0 108.773 175.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.82 -50.45 43.81 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.034 1.734 . . . . 0.0 112.894 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.05 -36.76 46.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 121.81 1.682 . . . . 0.0 111.585 172.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.02 -22.84 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 119.851 1.205 . . . . 0.0 111.314 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.81 -35.06 24.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.776 2.43 . . . . 0.0 111.8 175.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.12 -42.71 93.65 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 169.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -65.79 -15.41 62.85 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.306 1.443 . . . . 0.0 112.368 170.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -82.63 -47.82 11.64 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 120.636 -1.29 . . . . 0.0 109.214 170.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.55 81.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.551 1.14 . . . . 0.0 110.573 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -58.7 -53.12 61.98 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.575 0.75 . . . . 0.0 110.959 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.7 -14.67 54.3 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -162.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 51.39 0.79 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.369 1.868 . . . . 0.0 108.428 172.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.63 -14.02 7.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.412 1.085 . . . . 0.0 113.679 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -88.87 -51.28 5.72 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.596 2.358 . . . . 0.0 111.864 174.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -73.33 -16.73 61.35 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 117.439 -1.267 . . . . 0.0 112.244 -168.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.09 166.56 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 121.128 1.785 . . . . 0.0 113.102 -170.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.1 t -119.46 122.75 42.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.75 0.786 . . . . 0.0 109.146 159.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.411 ' HA ' ' HG ' ' A' ' 21' ' ' LEU . 2.9 t -76.97 152.13 5.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 158.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.35 99.7 3.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -95.14 143.38 26.62 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 122.783 0.433 . . . . 0.0 110.714 -169.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -141.73 145.36 34.75 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.299 0.571 . . . . 0.0 110.755 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -82.22 90.0 6.57 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 173.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 72' ' ' ILE . 6.1 p -62.01 -15.04 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 125.275 1.43 . . . . 0.0 112.468 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -65.85 -20.0 66.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.809 2.444 . . . . 0.0 112.766 169.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -131.06 -23.43 2.46 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.067 2.147 . . . . 0.0 111.696 -167.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -116.28 77.85 7.71 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.402 1.881 . . . . 0.0 109.176 -169.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.92 -4.82 16.08 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.608 3.539 . . . . 0.0 116.675 -170.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.461 ' C ' ' H ' ' A' ' 64' ' ' THR . 5.6 tp10 -59.93 135.25 57.64 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.976 1.716 . . . . 0.0 109.979 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m 59.26 -14.64 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.925 3.29 . . . . 0.0 112.847 -176.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.461 ' H ' ' C ' ' A' ' 62' ' ' GLU . 96.9 m -63.44 -54.26 39.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 126.259 1.824 . . . . 0.0 109.221 -175.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -73.02 1.12 9.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.543 1.137 . . . . 0.0 112.704 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -107.01 -39.66 5.68 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.622 1.169 . . . . 0.0 110.627 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -104.27 5.24 34.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.587 1.155 . . . . 0.0 110.734 -176.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.81 38.67 49.28 Favored Glycine 0 C--N 1.343 0.941 0 C-N-CA 124.243 0.925 . . . . 0.0 112.158 174.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.9 mm -78.83 76.44 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.965 1.306 . . . . 0.0 109.734 -167.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 70.7 mtm -106.54 -14.88 14.93 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.935 1.294 . . . . 0.0 111.478 173.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.4 m -82.61 23.73 0.77 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.165 1.786 . . . . 0.0 114.022 -159.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.546 HG21 HG11 ' A' ' 57' ' ' VAL . 16.3 pt -71.31 155.79 92.47 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.317 1.047 . . . . 0.0 112.943 -158.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 56.7 Cg_endo -62.74 127.86 5.64 Favored 'Cis proline' 0 C--N 1.352 0.711 0 CA-C-N 119.666 0.916 . . . . 0.0 110.687 -3.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -114.32 136.4 53.01 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 tt -131.72 92.99 3.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -174.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.7 mt -94.52 144.37 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.5 HD11 ' HB ' ' A' ' 103' ' ' VAL . 3.3 tt -110.84 120.33 42.03 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -110.44 148.38 32.16 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -141.27 111.63 6.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 170.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 39.54 59.17 1.98 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.58 2.038 . . . . 0.0 112.942 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.66 -20.32 51.05 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.636 1.588 . . . . 0.0 114.03 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.74 109.41 59.36 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 119.452 1.626 . . . . 0.0 111.359 -166.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.31 92.78 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.855 3.037 . . . . 0.0 110.731 169.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 m -65.54 -40.78 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.582 -0.699 . . . . 0.0 112.644 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.404 ' CE ' ' HB2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -158.76 167.19 30.14 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.09 0.956 . . . . 0.0 110.248 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -136.11 133.21 37.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.905 2.082 . . . . 0.0 107.607 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.12 154.2 18.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 158.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.3 pt -141.35 143.93 27.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 106.872 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.55 172.34 20.19 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 121.983 0.768 . . . . 0.0 112.191 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -74.75 79.62 2.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.934 0.894 . . . . 0.0 110.784 -176.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -72.36 127.69 89.82 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 161.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.41 163.55 36.14 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.712 1.608 . . . . 0.0 109.779 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -45.35 12.32 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.81 1.244 . . . . 0.0 111.041 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -59.92 -24.7 64.55 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.191 1.396 . . . . 0.0 113.908 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -100.12 -46.95 5.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.707 1.203 . . . . 0.0 108.624 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 tt -52.64 -62.93 1.33 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.873 2.069 . . . . 0.0 108.892 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -59.14 -34.92 72.63 Favored 'General case' 0 C--N 1.337 0.043 0 C-N-CA 125.025 1.33 . . . . 0.0 110.469 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.62 -42.04 71.44 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.064 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -41.89 85.41 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.411 0.55 . . . . 0.0 109.798 173.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.449 ' HG ' HD12 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -71.77 -4.04 25.45 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.958 1.703 . . . . 0.0 113.337 -178.579 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.47 -25.07 9.16 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.842 1.257 . . . . 0.0 113.132 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -7.43 9.41 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 121.091 1.769 . . . . 0.0 113.975 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.5 ' HB ' HD11 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -127.49 -1.55 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 121.431 -0.793 . . . . 0.0 112.845 168.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -105.77 -10.98 16.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.44 1.096 . . . . 0.0 113.094 174.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 C--O 1.251 1.15 0 C-N-CA 127.017 2.127 . . . . 0.0 109.81 162.87 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 120.628 0.251 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.1 t -129.44 179.61 5.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.117 1.767 . . . . 0.0 107.33 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -52.46 -58.97 5.05 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.483 2.313 . . . . 0.0 111.735 -160.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.38 -16.32 60.13 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -102.22 -17.11 16.1 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.959 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -49.11 -55.8 11.11 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 125.203 1.401 . . . . 0.0 108.859 171.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -53.02 -54.54 33.84 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.307 1.843 . . . . 0.0 112.468 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -64.09 -20.93 66.31 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.125 0.57 . . . . 0.0 112.278 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.34 -64.18 1.16 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 167.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.3 pt -58.55 -25.72 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -62.53 -22.33 66.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.29 1.036 . . . . 0.0 113.406 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.12 149.51 51.21 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 119.12 0.873 . . . . 0.0 112.453 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -87.82 53.34 2.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.232 1.413 . . . . 0.0 110.193 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.76 165.9 35.9 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.66 101.09 0.16 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.192 3.261 . . . . 0.0 111.772 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.47 101.71 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 125.369 1.468 . . . . 0.0 107.973 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.46 HD22 HG13 ' A' ' 52' ' ' VAL . 4.9 tt -82.58 112.77 19.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 171.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.59 114.95 39.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.97 93.03 4.65 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -164.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 69' ' ' ILE . 52.8 m-85 -86.62 112.86 22.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.601 0.761 . . . . 0.0 109.758 -176.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 26.6 p-90 -124.54 -175.68 3.33 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 169.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.497 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -151.52 158.69 43.93 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.202 -0.936 . . . . 0.0 110.096 172.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.42 -1.27 0.5 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.215 1.806 . . . . 0.0 115.598 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.15 -18.96 1.75 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 26' ' ' ALA . 1.1 p -72.27 100.65 2.66 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.855 1.207 . . . . 0.0 111.519 -165.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -29.0 -61.81 0.14 Allowed Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.934 1.73 . . . . 0.0 115.067 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.31 -33.67 29.56 Favored 'Trans proline' 0 C--N 1.351 0.658 0 CA-C-N 120.273 2.036 . . . . 0.0 112.985 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.7 p -69.27 -30.35 68.44 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.795 1.179 . . . . 0.0 110.624 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -20.6 65.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.329 0.968 . . . . 0.0 111.654 172.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.1 mtp -99.85 -25.98 14.17 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.323 1.449 . . . . 0.0 111.878 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.7 ttt -81.48 -38.74 25.86 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.727 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.03 -50.73 61.17 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 120.703 1.592 . . . . 0.0 112.534 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.22 -33.25 40.22 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.598 1.532 . . . . 0.0 112.359 172.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.65 -36.63 77.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 120.13 1.332 . . . . 0.0 110.851 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 42' ' ' PHE . 54.2 mt -78.92 -6.47 56.27 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.921 2.489 . . . . 0.0 111.471 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.92 -48.52 13.29 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.738 1.215 . . . . 0.0 108.144 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -60.9 -43.41 98.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.853 0.461 . . . . 0.0 110.022 168.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.467 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 33.1 t80 -63.85 -20.13 65.58 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.543 173.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.92 -59.4 2.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 121.174 1.806 . . . . 0.0 108.668 166.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.16 -45.43 65.06 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.792 1.237 . . . . 0.0 111.838 -173.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.55 -23.91 29.35 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -169.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.32 36.69 0.83 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.037 1.335 . . . . 0.0 110.626 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.39 -23.42 3.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 -160.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.18 0.07 8.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.349 0.977 . . . . 0.0 112.841 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -76.58 -29.34 56.57 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.432 -0.792 . . . . 0.0 109.946 167.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.22 143.04 42.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 109.249 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.33 136.49 53.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 158.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.46 HG13 HD22 ' A' ' 21' ' ' LEU . 5.0 t -119.92 134.61 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 160.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.21 90.38 2.03 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -166.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -86.99 143.71 27.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.226 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 152.62 26.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.208 0.913 . . . . 0.0 113.263 171.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -76.45 107.04 8.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.246 1.818 . . . . 0.0 107.683 172.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' A' ' 26' ' ' ALA . 8.6 p -48.41 -43.53 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 126.738 2.015 . . . . 0.0 114.274 -165.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.45 -27.09 68.31 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.872 2.069 . . . . 0.0 112.492 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.4 -28.1 62.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.726 0.81 . . . . 0.0 111.406 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -115.48 83.75 11.21 Favored Pre-proline 0 N--CA 1.457 -0.125 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.53 -25.77 29.32 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.631 1.554 . . . . 0.0 112.207 170.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.71 118.44 7.13 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.47 1.108 . . . . 0.0 109.405 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.262 8.8 m 70.23 -20.01 0.2 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.606 2.362 . . . . 0.0 113.366 173.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.9 m -54.66 -55.73 26.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.58 1.952 . . . . 0.0 109.011 160.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.5 t -57.59 -41.57 81.44 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.291 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -62.75 -40.81 98.41 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.665 0.786 . . . . 0.0 112.949 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -96.27 16.56 17.98 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.713 0.688 . . . . 0.0 112.773 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.21 25.81 72.24 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 124.129 0.871 . . . . 0.0 112.523 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.542 HD12 HG21 ' A' ' 74' ' ' THR . 30.6 mm -82.14 70.02 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 122.576 1.179 . . . . 0.0 109.558 -165.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 53.3 ttp -120.37 0.78 10.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.739 1.616 . . . . 0.0 109.974 166.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.3 t -88.83 21.94 2.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.102 1.361 . . . . 0.0 112.985 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.451 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -59.45 144.61 83.95 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.529 0.732 . . . . 0.0 112.528 -168.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 62.6 Cg_endo -69.06 130.64 16.41 Favored 'Cis proline' 0 C--N 1.35 0.606 0 CA-C-N 119.01 0.682 . . . . 0.0 112.734 7.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.542 HG21 HD12 ' A' ' 69' ' ' ILE . 40.9 m -125.26 151.71 45.58 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.862 1.265 . . . . 0.0 108.82 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.2 tt -143.63 105.34 4.32 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -173.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.42 HD11 HD11 ' A' ' 69' ' ' ILE . 23.9 mt -101.1 143.82 13.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 171.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.25 115.89 28.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -113.63 163.39 15.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.827 1.651 . . . . 0.0 111.873 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.456 ' HE3' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -162.41 149.91 13.89 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.466 1.907 . . . . 0.0 107.337 158.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.03 14.67 47.0 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 119.155 0.889 . . . . 0.0 113.496 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.87 -5.99 82.24 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.436 1.494 . . . . 0.0 113.35 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -98.86 121.14 56.93 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 119.174 1.487 . . . . 0.0 110.189 -173.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.09 103.79 1.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.75 2.967 . . . . 0.0 110.048 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.456 HG21 ' HE3' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -71.29 -35.94 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 121.815 -0.553 . . . . 0.0 112.071 178.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -153.54 158.27 41.0 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.592 0.757 . . . . 0.0 110.669 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -147.44 125.22 11.88 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.744 2.018 . . . . 0.0 106.741 -172.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.8 mp -121.83 150.5 41.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.473 1.909 . . . . 0.0 106.802 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.9 pt -145.43 151.97 14.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.613 1.165 . . . . 0.0 109.344 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.12 167.63 24.65 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.404 1.002 . . . . 0.0 111.908 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -75.33 73.94 2.42 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.077 0.951 . . . . 0.0 110.855 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -70.06 138.3 87.33 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.62 163.53 38.63 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.403 2.069 . . . . 0.0 110.634 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.12 -44.8 61.4 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.982 1.313 . . . . 0.0 111.225 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.67 -15.32 63.41 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.093 0.957 . . . . 0.0 112.67 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -102.0 -44.57 5.44 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.208 0.913 . . . . 0.0 109.17 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.51 -59.32 5.63 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.106 1.762 . . . . 0.0 109.636 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -63.55 -24.73 67.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.054 0.843 . . . . 0.0 110.968 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.92 -51.52 15.85 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.854 0.752 . . . . 0.0 110.682 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -62.27 -43.3 99.15 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.7 0.8 . . . . 0.0 110.481 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 tp -78.77 -7.03 57.41 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.725 1.21 . . . . 0.0 112.744 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.07 -33.05 37.46 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.689 1.196 . . . . 0.0 111.085 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.16 11.87 0.1 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.803 2.041 . . . . 0.0 112.711 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.54 -11.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 119.451 -2.031 . . . . 0.0 113.187 158.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.07 -22.57 20.67 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.043 1.337 . . . . 0.0 112.047 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 . . . . . 0 C--O 1.251 1.134 0 C-N-CA 128.591 2.757 . . . . 0.0 110.202 175.613 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 10' ' ' PHE . 4.2 tp . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.797 0.332 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.4 p -146.03 172.27 13.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 128.703 2.801 . . . . 0.0 104.988 170.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -45.45 -61.2 1.78 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.517 2.327 . . . . 0.0 110.855 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.0 -31.95 71.54 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.692 -0.63 . . . . 0.0 112.182 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -78.03 -19.25 54.71 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.287 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.504 ' HA ' HD21 ' A' ' 5' ' ' LEU . 2.2 t80 -55.51 -60.44 3.43 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.442 1.497 . . . . 0.0 107.572 173.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -58.81 -45.46 89.88 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 111.793 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -56.85 -36.01 69.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.568 0.622 . . . . 0.0 111.516 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.46 -60.72 2.11 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.873 0.869 . . . . 0.0 110.69 172.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.2 pt -68.98 -2.42 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -168.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -42.76 -39.69 2.55 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.593 1.957 . . . . 0.0 114.91 -172.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 159.25 -176.55 36.04 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 119.322 0.965 . . . . 0.0 113.899 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 65.25 -57.44 0.29 Allowed 'General case' 0 N--CA 1.463 0.196 1 C-N-CA 132.056 4.143 . . . . 0.0 112.543 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.53 150.86 20.61 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.645 -160.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.16 88.5 0.7 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.113 3.209 . . . . 0.0 110.24 170.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.59 149.57 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 170.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.03 167.77 21.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.932 -0.48 . . . . 0.0 110.595 161.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.31 134.46 66.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 124.48 1.112 . . . . 0.0 108.382 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 45.4 t0 -95.7 99.72 11.53 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 167.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.484 ' CD1' HG23 ' A' ' 57' ' ' VAL . 37.1 m-85 -86.68 112.73 21.92 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 -128.28 176.65 7.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.163 1.385 . . . . 0.0 108.162 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -147.5 149.03 31.86 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.723 1.147 . . . . 0.0 110.789 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.07 -24.46 66.24 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -102.51 -6.99 22.26 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.252 0.933 . . . . 0.0 113.25 -174.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.1 p -66.19 169.94 6.44 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.638 0.732 . . . . 0.0 112.676 -164.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.89 -90.22 1.54 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 165.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.39 -23.16 71.7 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.003 2.469 . . . . 0.0 114.117 -168.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.86 -25.92 68.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.161 0.891 . . . . 0.0 111.682 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -71.8 -17.16 62.18 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.0 0.92 . . . . 0.0 111.632 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.5 mtp -97.39 -39.87 8.98 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.689 1.596 . . . . 0.0 110.211 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.8 tpt -66.84 -44.87 79.94 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-O 117.657 -1.163 . . . . 0.0 109.931 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.86 99.91 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.309 1.413 . . . . 0.0 112.725 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -69.19 -38.63 8.75 Favored 'Trans proline' 0 C--N 1.352 0.747 0 CA-C-N 121.78 1.671 . . . . 0.0 112.837 169.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.97 -34.09 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 120.935 1.698 . . . . 0.0 111.531 177.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.0 -13.23 61.19 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.877 2.471 . . . . 0.0 111.701 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.3 -36.63 34.06 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.564 1.074 . . . . 0.0 110.308 176.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.95 -43.24 99.33 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 169.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -58.57 -45.98 87.89 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.669 0.788 . . . . 0.0 110.479 171.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.06 -49.04 72.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.173 0.897 . . . . 0.0 110.893 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -53.19 60.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.74 1.216 . . . . 0.0 111.087 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.72 48.56 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -164.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -141.98 38.88 1.62 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.748 1.219 . . . . 0.0 110.552 172.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.47 -8.67 2.89 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.009 1.324 . . . . 0.0 113.964 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -92.29 -53.96 4.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.94 2.496 . . . . 0.0 111.425 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -68.34 -26.08 65.42 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 118.719 -0.658 . . . . 0.0 111.248 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.2 m -141.73 171.0 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.436 0.695 . . . . 0.0 110.111 -174.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.9 t -127.48 130.43 49.21 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 160.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.0 p -90.98 173.08 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 158.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.07 153.35 34.91 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 159.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 17.8 mtpp -113.26 137.65 51.17 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 119.29 -0.386 . . . . 0.0 109.992 -169.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pp -149.86 146.88 27.36 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 122.686 1.232 . . . . 0.0 114.288 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -78.64 110.16 13.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.127 2.171 . . . . 0.0 108.025 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.484 HG23 ' CD1' ' A' ' 24' ' ' PHE . 7.6 p -63.01 -37.1 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.861 1.665 . . . . 0.0 112.929 -166.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.86 -38.62 83.36 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.097 1.359 . . . . 0.0 110.601 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -76.34 -27.31 56.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.629 2.372 . . . . 0.0 112.048 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -116.65 78.21 8.7 Favored Pre-proline 0 N--CA 1.445 -0.703 0 C-N-CA 124.817 1.247 . . . . 0.0 110.461 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.36 -88.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 123.875 3.05 . . . . 0.0 112.313 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 30.96 -39.45 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.893 1 C-N-CA 132.912 4.485 . . . . 0.0 120.367 -159.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -159.52 -7.32 0.06 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 129.466 3.106 . . . . 0.0 112.376 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 m -39.93 -60.4 1.03 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.168 2.187 . . . . 0.0 110.547 164.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.0 t -68.79 -17.39 64.02 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.789 -1.1 . . . . 0.0 113.041 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -77.61 -30.97 52.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.69 1.132 . . . . 0.0 110.112 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -93.51 9.65 35.76 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.438 0.695 . . . . 0.0 111.122 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.52 22.85 75.23 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.846 0.736 . . . . 0.0 112.784 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.443 HG21 ' CZ ' ' A' ' 24' ' ' PHE . 40.8 mm -78.23 77.36 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.753 1.221 . . . . 0.0 109.151 -169.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.81 -2.54 8.77 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.088 1.355 . . . . 0.0 110.363 167.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 p -82.87 43.64 0.86 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.177 2.591 . . . . 0.0 111.485 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.11 145.84 94.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 O-C-N 121.7 -0.625 . . . . 0.0 111.697 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.21 127.0 8.89 Favored 'Cis proline' 0 N--CA 1.459 -0.512 0 CA-C-N 119.153 0.733 . . . . 0.0 110.797 0.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.0 m -116.84 148.07 41.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 tt -136.96 126.64 25.42 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.9 mt -128.85 141.56 46.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.466 HD11 HD21 ' A' ' 100' ' ' LEU . 1.3 mp -106.94 142.7 36.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.843 1.657 . . . . 0.0 109.474 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -134.68 150.09 50.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.357 1.463 . . . . 0.0 109.309 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.66 163.88 32.19 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 159.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.02 8.55 8.55 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 118.453 -1.193 . . . . 0.0 115.287 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.34 2.49 60.39 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 119.134 1.467 . . . . 0.0 113.156 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -126.57 135.91 27.93 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 119.346 1.573 . . . . 0.0 110.813 -168.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.44 117.2 5.02 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.48 2.786 . . . . 0.0 110.376 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.03 -46.01 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -156.55 164.5 38.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.867 0.758 . . . . 0.0 111.365 -173.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -136.28 147.98 47.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.483 1.913 . . . . 0.0 109.414 -171.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -122.14 154.05 37.92 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.833 1.653 . . . . 0.0 107.845 158.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 pt -141.32 137.74 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.671 1.988 . . . . 0.0 106.129 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.42 168.31 35.61 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.922 0.772 . . . . 0.0 112.921 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -80.4 83.64 6.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.529 1.131 . . . . 0.0 108.952 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -88.66 134.68 33.5 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.53 160.41 48.1 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.28 1.32 . . . . 0.0 109.793 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -41.67 80.79 Favored 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 123.803 0.841 . . . . 0.0 111.512 -175.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.79 -19.99 60.54 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -95.39 -49.75 5.31 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.888 1.222 . . . . 0.0 109.364 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.31 -59.17 5.74 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 124.499 1.12 . . . . 0.0 110.62 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -65.9 -18.44 65.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.075 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.25 -51.6 12.89 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.148 0.885 . . . . 0.0 110.307 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -53.32 -43.17 67.4 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.852 0.861 . . . . 0.0 110.831 175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.466 HD21 HD11 ' A' ' 77' ' ' LEU . 1.4 mp -86.85 -0.77 57.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.597 1.559 . . . . 0.0 113.167 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.04 -34.29 69.91 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 119.431 1.014 . . . . 0.0 111.622 -172.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -63.26 -12.56 30.0 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.195 1.398 . . . . 0.0 113.96 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.4 m -128.59 9.73 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 126.245 1.818 . . . . 0.0 111.633 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -124.95 -4.55 7.51 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.924 1.689 . . . . 0.0 113.122 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 126.895 2.078 . . . . 0.0 108.708 164.761 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.1 p -142.86 163.97 31.35 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 129.145 2.978 . . . . 0.0 104.998 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 10' ' ' PHE . 21.5 t70 -58.41 -40.14 81.63 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.601 1.16 . . . . 0.0 113.124 -168.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.52 65.84 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.633 -0.667 . . . . 0.0 112.358 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -94.49 -34.75 12.58 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.201 1.4 . . . . 0.0 110.549 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' A' ' 7' ' ' ASP . 51.8 t80 -50.6 -62.39 1.63 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 126.847 2.059 . . . . 0.0 109.201 173.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -57.29 -46.03 83.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.277 0.489 . . . . 0.0 110.781 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -70.62 -21.53 62.63 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.4 -62.01 1.71 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.212 0.915 . . . . 0.0 109.538 165.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.1 pt -62.46 -21.71 27.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.514 1.126 . . . . 0.0 113.776 -167.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -64.37 -23.92 67.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.93 0.892 . . . . 0.0 112.807 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.35 170.16 54.52 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 118.864 0.756 . . . . 0.0 112.058 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -82.83 -22.62 34.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.601 1.56 . . . . 0.0 112.798 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.46 48.73 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 123.408 0.528 . . . . 0.0 112.219 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HA ' HD21 ' A' ' 77' ' ' LEU . 34.7 Cg_endo -65.3 91.3 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 124.186 3.257 . . . . 0.0 111.317 173.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.67 131.43 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 mp -118.57 136.94 53.58 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.55 116.63 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 26.0 t0 -72.72 107.52 5.22 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 124.105 0.878 . . . . 0.0 109.025 163.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -89.03 108.15 19.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 164.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -126.44 -177.92 4.16 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.31 159.84 40.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.376 -0.827 . . . . 0.0 108.876 168.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.77 -15.67 22.01 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.535 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -89.63 -31.25 17.62 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.458 1.026 . . . . 0.0 113.354 177.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.9 p -72.8 160.67 31.81 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.684 1.129 . . . . 0.0 111.151 -168.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.43 -79.55 1.47 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.018 0.818 . . . . 0.0 112.515 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.15 -15.89 51.93 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.621 2.881 . . . . 0.0 113.701 -172.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.1 p -52.81 -35.97 57.75 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.248 0.619 . . . . 0.0 111.786 167.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -70.38 -13.94 62.35 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.753 0.706 . . . . 0.0 112.563 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.2 mtm -95.91 -20.08 19.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.078 1.351 . . . . 0.0 111.63 170.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.5 ttt -79.85 -39.27 30.99 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 108.913 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.01 -52.48 46.94 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.742 1.217 . . . . 0.0 113.326 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.65 -30.88 34.14 Favored 'Trans proline' 0 C--N 1.352 0.711 0 CA-C-N 121.987 1.745 . . . . 0.0 112.26 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.17 -38.3 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.636 1.107 . . . . 0.0 109.887 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 mp -69.99 -26.93 64.31 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.6 1.96 . . . . 0.0 112.196 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -69.52 -46.76 65.79 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.252 0.933 . . . . 0.0 109.156 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -61.93 -41.23 97.7 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.069 0.548 . . . . 0.0 110.591 173.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.29 -50.53 73.29 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.286 1.035 . . . . 0.0 110.915 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.25 -48.24 79.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.725 0.81 . . . . 0.0 110.16 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -58.27 -50.03 75.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.254 0.621 . . . . 0.0 110.941 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.7 -23.14 50.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.96 52.86 0.69 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.348 1.459 . . . . 0.0 109.876 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.26 -17.63 54.43 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -95.43 -49.6 5.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.595 2.358 . . . . 0.0 111.549 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -67.11 -24.62 65.95 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.151 -170.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.22 149.43 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 119.139 0.881 . . . . 0.0 111.074 -172.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.344 2.9 t -110.57 84.9 2.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 123.11 1.433 . . . . 0.0 109.3 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.14 139.14 19.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.967 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.52 166.56 22.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.201 2.2 . . . . 0.0 107.976 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 23.5 pttp -136.22 144.57 44.96 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 122.406 0.282 . . . . 0.0 111.377 173.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -145.86 142.7 29.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.368 0.604 . . . . 0.0 111.539 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -83.13 98.51 9.37 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.98 -27.73 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.613 -163.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -65.01 -24.87 67.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.867 2.467 . . . . 0.0 112.306 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -91.89 -32.26 15.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.069 1.347 . . . . 0.0 110.238 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -116.94 74.87 7.12 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.643 1.177 . . . . 0.0 109.839 -170.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.15 -12.65 14.3 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.152 3.235 . . . . 0.0 113.514 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.9 142.6 47.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.131 0.878 . . . . 0.0 109.315 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m 60.07 -29.36 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 131.46 3.904 . . . . 0.0 113.458 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.2 m -50.11 -59.6 3.76 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.018 2.927 . . . . 0.0 108.737 161.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -70.93 -10.14 59.12 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 117.725 -1.131 . . . . 0.0 112.674 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -85.87 -39.21 17.26 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.852 1.205 . . . . 0.0 111.266 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -92.99 6.85 46.44 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.538 0.608 . . . . 0.0 112.242 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.89 34.5 77.28 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.861 0.755 . . . . 0.0 111.926 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.7 mm -72.17 85.31 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.078 1.751 . . . . 0.0 109.259 -171.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.8 tpp -143.11 51.85 1.38 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.557 1.543 . . . . 0.0 109.654 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.2 m -156.81 42.41 0.36 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.145 -1.597 . . . . 0.0 111.812 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.535 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 43.2 pt -70.73 151.93 95.24 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 121.767 -0.583 . . . . 0.0 112.564 -174.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 37.8 Cg_endo -62.49 129.2 6.64 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 119.379 0.814 . . . . 0.0 110.755 -5.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.1 m -121.44 140.93 51.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -123.53 120.39 32.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 171.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.6 mt -121.24 142.77 35.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 19' ' ' PRO . 4.4 tt -108.11 121.54 45.05 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.409 ' N ' HD23 ' A' ' 77' ' ' LEU . 80.8 m-85 -118.37 156.77 28.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.151 0.98 . . . . 0.0 111.221 -176.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -163.14 158.97 22.48 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 125.535 1.534 . . . . 0.0 108.745 161.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.26 16.05 25.61 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.919 0.771 . . . . 0.0 113.984 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.22 -5.82 83.95 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.122 -1.377 . . . . 0.0 114.017 -173.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.97 149.97 44.24 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 120.186 1.993 . . . . 0.0 111.617 -174.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.17 128.03 6.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.352 2.702 . . . . 0.0 110.296 170.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.3 -41.86 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.579 -0.701 . . . . 0.0 110.34 168.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -164.91 169.85 16.02 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.827 0.851 . . . . 0.0 111.22 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -136.31 146.93 47.17 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.729 2.411 . . . . 0.0 108.941 -170.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.8 151.52 37.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.651 1.981 . . . . 0.0 106.897 159.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.06 147.9 26.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.005 1.722 . . . . 0.0 107.298 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.31 169.4 21.14 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 122.022 0.79 . . . . 0.0 112.081 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -74.01 89.05 1.91 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -86.87 137.38 33.52 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 159.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.4 165.95 30.85 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.322 2.015 . . . . 0.0 111.451 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -46.27 -48.67 18.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.724 1.61 . . . . 0.0 112.144 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -52.78 -47.09 67.77 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.113 1.365 . . . . 0.0 111.644 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -38.51 72.3 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 124.341 1.056 . . . . 0.0 108.578 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 -54.53 30.2 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.218 1.007 . . . . 0.0 109.514 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.22 -40.23 85.18 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.66 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.78 -51.96 65.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.524 1.056 . . . . 0.0 111.414 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -62.81 -27.69 69.49 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.77 0.828 . . . . 0.0 112.419 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 mp -106.66 3.36 26.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.716 1.207 . . . . 0.0 111.905 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.58 -29.97 60.0 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.543 1.137 . . . . 0.0 112.567 -174.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -62.53 -14.86 46.71 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.422 HG11 ' CD1' ' A' ' 77' ' ' LEU . 2.1 p -117.55 -7.03 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 119.651 1.114 . . . . 0.0 111.686 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.52 -11.87 26.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.548 1.139 . . . . 0.0 112.068 172.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.739 2.016 . . . . 0.0 110.135 165.875 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.3 mt . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 122.364 1.078 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.5 m -150.2 -129.4 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 102.581 -3.118 . . . . 0.0 102.581 172.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -86.61 -67.42 0.82 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.117 1.767 . . . . 0.0 111.248 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.6 -35.87 77.19 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.271 -0.893 . . . . 0.0 111.359 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -67.01 -31.33 71.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.728 0.811 . . . . 0.0 109.671 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -58.88 -57.25 13.86 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.819 0.736 . . . . 0.0 109.623 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -59.74 -46.52 88.9 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.54 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -63.29 -17.21 62.27 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.71 -59.28 2.48 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.807 0.843 . . . . 0.0 110.585 166.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.6 pt -67.59 -18.84 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -169.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -49.08 -34.45 13.76 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.157 1.783 . . . . 0.0 112.996 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.61 138.56 2.88 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 112.042 -0.423 . . . . 0.0 112.042 168.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.54 -102.97 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.9 -130.54 2.76 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 127.691 2.567 . . . . 0.0 106.752 165.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.95 93.45 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.272 2.648 . . . . 0.0 111.703 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.2 141.17 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 167.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.2 mt -137.33 158.99 43.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.04 141.31 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.41 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 54.9 t0 -96.06 110.39 22.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 158.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -93.71 109.68 21.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 167.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -134.25 -176.52 4.23 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.072 1.749 . . . . 0.0 108.098 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.37 166.3 33.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.643 1.577 . . . . 0.0 107.386 168.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.5 -29.08 69.76 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -31.86 17.75 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -169.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 p -71.51 102.4 2.69 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.713 0.688 . . . . 0.0 111.999 -162.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -34.14 -61.01 0.54 Allowed Glycine 0 CA--C 1.539 1.534 0 C-N-CA 126.017 1.77 . . . . 0.0 114.912 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.82 -32.86 28.6 Favored 'Trans proline' 0 C--N 1.35 0.646 0 CA-C-N 120.241 2.02 . . . . 0.0 112.512 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.4 p -67.73 -35.59 79.03 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 119.315 0.961 . . . . 0.0 110.258 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -62.35 -15.92 51.34 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.855 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 75.9 mtm -104.11 -14.2 15.97 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.564 1.145 . . . . 0.0 112.876 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.417 ' SD ' ' HA ' ' A' ' 90' ' ' TYR . 14.9 ttt -94.11 -40.67 9.93 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.284 1.434 . . . . 0.0 109.547 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.82 -49.42 86.85 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 117.738 -1.125 . . . . 0.0 112.466 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.76 -33.6 53.34 Favored 'Trans proline' 0 C--N 1.354 0.841 0 CA-C-N 121.888 1.71 . . . . 0.0 112.086 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.88 -42.27 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 118.447 0.567 . . . . 0.0 109.513 174.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.47 -24.58 64.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.014 1.725 . . . . 0.0 112.319 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -68.88 -48.25 63.85 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.418 1.008 . . . . 0.0 109.624 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -62.88 -45.23 93.53 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -55.16 -48.17 74.11 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 122.931 0.492 . . . . 0.0 110.439 175.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.07 -55.04 37.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.385 1.074 . . . . 0.0 110.73 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -52.82 -46.75 67.86 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.848 0.859 . . . . 0.0 110.602 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.53 -16.53 10.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -150.13 48.82 0.91 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.535 1.134 . . . . 0.0 110.559 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -25.64 66.58 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -97.68 -54.1 3.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.233 1.413 . . . . 0.0 112.465 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -53.79 -29.7 41.5 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.603 0.761 . . . . 0.0 112.378 -171.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 m -134.29 141.56 43.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.319 1.9 t -92.56 73.45 5.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 123.191 1.472 . . . . 0.0 107.723 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.79 164.26 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.307 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.6 179.9 8.75 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.806 0.843 . . . . 0.0 110.119 170.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 7.6 ttpm? -139.63 134.44 32.06 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.53 159.79 43.28 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.999 0.812 . . . . 0.0 112.351 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -82.38 123.38 29.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.314 0.646 . . . . 0.0 109.408 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.6 p -62.34 -29.59 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.182 0.993 . . . . 0.0 112.824 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.62 -36.34 70.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.642 0.777 . . . . 0.0 110.8 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.54 -34.85 74.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.178 2.191 . . . . 0.0 112.181 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -111.1 85.15 5.04 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 123.953 0.901 . . . . 0.0 109.393 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.3 -24.12 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.086 2.524 . . . . 0.0 112.816 172.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.07 117.66 11.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.021 1.328 . . . . 0.0 109.978 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 89.36 -40.71 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 129.784 3.233 . . . . 0.0 109.906 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.2 m -52.16 -60.54 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.163 2.185 . . . . 0.0 110.353 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.3 t -57.94 -44.26 86.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.709 0.404 . . . . 0.0 109.938 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -60.15 -27.92 67.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.965 1.306 . . . . 0.0 112.913 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.33 14.65 22.62 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.8 0.727 . . . . 0.0 111.465 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.07 26.5 73.32 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 121.55 -0.719 . . . . 0.0 113.135 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.3 mm -75.86 79.16 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.346 1.458 . . . . 0.0 109.014 -171.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.6 ttm -128.24 3.39 5.77 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.305 1.442 . . . . 0.0 110.962 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 t -90.82 23.88 2.95 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.088 1.355 . . . . 0.0 113.121 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.492 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -57.95 145.06 73.54 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.782 0.833 . . . . 0.0 113.161 -168.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 55.7 Cg_endo -69.09 132.24 20.78 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.034 0.691 . . . . 0.0 112.19 8.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.5 m -122.22 153.28 39.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 tt -144.44 104.44 4.07 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.734 2.014 . . . . 0.0 106.22 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.9 mt -102.19 133.17 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.66 109.68 21.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.095 2.158 . . . . 0.0 105.652 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -105.04 156.96 17.57 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -152.87 146.28 24.89 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 159.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.81 35.84 4.55 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.874 1.226 . . . . 0.0 115.215 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.77 -3.22 62.67 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 118.701 1.251 . . . . 0.0 114.791 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -123.61 130.88 24.32 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 119.652 1.726 . . . . 0.0 110.977 -168.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.48 101.69 1.39 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.778 2.986 . . . . 0.0 109.803 169.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -42.42 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.859 0.864 . . . . 0.0 111.094 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.37 168.41 26.4 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.74 163.45 30.14 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.352 0.596 . . . . 0.0 111.489 160.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 99' ' ' GLN . 2.8 mm? -117.88 148.31 42.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.838 2.055 . . . . 0.0 105.784 170.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.6 pt -139.56 140.26 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 125.151 1.38 . . . . 0.0 107.885 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.68 161.63 8.57 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.76 0.695 . . . . 0.0 111.781 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.417 ' HA ' ' SD ' ' A' ' 35' ' ' MET . 10.6 t80 -66.73 98.88 0.56 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.574 1.55 . . . . 0.0 112.385 -170.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -93.01 140.6 23.43 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 168.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.15 163.5 38.53 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.487 2.125 . . . . 0.0 110.308 168.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.67 -46.04 70.5 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 123.843 0.857 . . . . 0.0 111.879 -174.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -49.63 -43.36 46.66 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.801 1.24 . . . . 0.0 111.159 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -88.35 -42.61 12.09 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.442 1.097 . . . . 0.0 109.061 -166.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.83 -62.46 1.85 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.99 1.316 . . . . 0.0 109.31 173.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -57.3 -38.13 73.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.608 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.29 82.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.615 1.098 . . . . 0.0 110.574 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.439 ' HG2' HD11 ' A' ' 87' ' ' LEU . 4.9 tp60 -66.99 -21.88 65.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.77 -7.24 27.9 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.204 1.802 . . . . 0.0 113.287 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.71 -29.46 66.7 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.088 1.755 . . . . 0.0 112.532 -167.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.48 -5.54 3.88 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.073 1.749 . . . . 0.0 113.886 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.4 -1.07 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.124 0.874 . . . . 0.0 112.687 167.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.19 -12.51 15.71 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.247 1.419 . . . . 0.0 113.316 174.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 . . . . . 0 C--O 1.248 1.003 0 C-N-CA 126.461 1.904 . . . . 0.0 107.395 159.126 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tp . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 121.625 0.726 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.48 171.04 15.16 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 -173.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -45.38 -58.89 3.0 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 127.562 2.345 . . . . 0.0 112.758 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.66 96.89 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.531 -0.731 . . . . 0.0 111.341 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -68.05 -26.97 66.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.395 1.078 . . . . 0.0 110.314 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -65.18 -6.44 9.34 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 125.128 1.371 . . . . 0.0 112.431 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -121.19 -56.15 1.93 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 162.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -67.89 -12.6 61.01 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -168.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.26 -3.87 13.79 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.593 1.157 . . . . 0.0 113.044 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 11.7 pt -91.83 -105.95 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 158.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 47.95 -10.26 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.77 1 C-N-CA 131.859 4.064 . . . . 0.0 118.881 174.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.27 179.94 17.48 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.144 1.831 . . . . 0.0 112.29 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.14 -11.43 57.94 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.087 1.755 . . . . 0.0 112.869 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.4 150.02 51.7 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.72 97.42 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.036 2.491 . . . . 0.0 110.34 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.1 t -105.33 140.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.95 136.44 46.11 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.793 0.806 . . . . 0.0 110.206 172.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.87 120.99 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 126.707 2.003 . . . . 0.0 105.965 -170.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.02 92.06 4.22 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -77.97 113.77 16.19 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.028 0.931 . . . . 0.0 108.9 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -131.97 -174.21 3.36 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 170.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.46 167.67 26.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.642 1.577 . . . . 0.0 107.584 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.9 -8.89 32.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.357 1.244 . . . . 0.0 114.357 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.538 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -110.53 -21.49 12.12 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -172.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.437 ' SG ' HD12 ' A' ' 72' ' ' ILE . 3.7 p -77.87 45.55 0.52 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -158.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 29.3 -95.17 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 C-N-CA 128.782 3.086 . . . . 0.0 114.213 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.07 -21.68 60.2 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.41 2.74 . . . . 0.0 114.538 -176.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.1 p -56.97 -32.37 65.99 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.448 1.476 . . . . 0.0 111.436 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -72.25 -18.91 61.78 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.751 1.22 . . . . 0.0 112.182 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -98.73 -18.11 18.18 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.086 1.354 . . . . 0.0 111.251 173.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.8 ttt -74.2 -37.62 63.84 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.602 1.561 . . . . 0.0 109.377 168.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.77 -51.56 45.3 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.495 -1.241 . . . . 0.0 113.171 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.68 -33.4 13.15 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 121.739 1.657 . . . . 0.0 113.051 171.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -28.89 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 121.258 1.844 . . . . 0.0 110.777 175.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.43 -13.1 61.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.765 2.026 . . . . 0.0 112.711 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -79.42 -40.7 29.37 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.682 1.128 . . . . 0.0 108.982 171.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.44 -16.89 64.45 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.733 0.813 . . . . 0.0 111.383 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -83.13 -43.89 15.72 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.426 1.09 . . . . 0.0 111.43 169.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.68 -48.66 49.47 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.938 0.895 . . . . 0.0 110.871 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -54.95 -43.0 73.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.458 1.103 . . . . 0.0 111.765 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.21 -12.49 28.71 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.551 1.141 . . . . 0.0 113.369 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -156.01 49.88 0.52 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.544 1.137 . . . . 0.0 110.056 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.07 -47.45 53.6 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.959 0.904 . . . . 0.0 112.459 -170.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -124.65 -6.2 7.5 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 171.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -55.07 -31.15 60.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.177 1.391 . . . . 0.0 111.765 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.26 177.26 6.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.676 1.19 . . . . 0.0 109.321 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 m -117.18 96.92 5.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.817 1.247 . . . . 0.0 107.741 164.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.77 149.25 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 160.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.58 109.03 3.98 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.432 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -88.32 145.5 25.8 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.767 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -154.38 157.29 38.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.659 0.784 . . . . 0.0 112.374 173.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -76.81 106.19 8.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.688 1.595 . . . . 0.0 109.187 174.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 p -64.1 -28.9 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.015 0.926 . . . . 0.0 112.685 -173.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.54 -30.25 71.28 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.341 1.056 . . . . 0.0 110.891 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -98.44 -20.45 17.11 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.578 1.951 . . . . 0.0 112.062 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -104.76 92.52 5.19 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.115 167.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.69 -17.95 22.69 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.062 1.841 . . . . 0.0 113.533 167.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 113.63 3.89 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.568 1.147 . . . . 0.0 109.282 -173.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.303 17.6 m 66.13 -14.69 0.14 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.329 2.651 . . . . 0.0 113.63 176.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.4 m -50.41 -55.24 16.64 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.321 1.848 . . . . 0.0 108.486 158.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -72.01 -6.79 44.75 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 117.847 -1.073 . . . . 0.0 113.103 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.77 -52.84 4.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.403 1.001 . . . . 0.0 109.364 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -81.2 16.87 1.42 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.159 0.89 . . . . 0.0 112.43 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.32 32.02 80.75 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 121.558 -0.714 . . . . 0.0 111.775 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.3 mm -77.43 81.3 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.538 1.135 . . . . 0.0 108.083 -172.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -117.88 14.4 14.21 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.783 1.633 . . . . 0.0 112.472 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.1 m -154.78 158.98 40.31 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.74 -1.225 . . . . 0.0 109.802 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.538 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 15.8 pt -155.05 162.51 27.07 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 129.28 3.032 . . . . 0.0 107.568 -171.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.2 127.59 7.24 Favored 'Cis proline' 0 C--N 1.349 0.565 0 CA-C-N 119.952 1.018 . . . . 0.0 110.653 -6.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.3 m -124.56 136.34 53.89 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.325 1.05 . . . . 0.0 108.797 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 tt -130.01 117.56 20.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.9 mt -126.38 129.65 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 tt -96.67 126.32 41.75 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.62 153.44 39.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.594 1.157 . . . . 0.0 110.613 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -158.56 153.37 24.89 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 124.757 1.223 . . . . 0.0 108.434 158.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.86 11.47 24.26 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 119.424 -0.653 . . . . 0.0 113.355 -169.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.65 0.58 89.95 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 118.345 1.072 . . . . 0.0 113.717 -170.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -107.82 136.16 19.74 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 119.34 1.57 . . . . 0.0 109.691 -173.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.99 110.31 3.02 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.361 2.707 . . . . 0.0 110.965 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.79 -37.19 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.629 1.572 . . . . 0.0 110.981 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -154.68 157.32 37.93 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.865 0.866 . . . . 0.0 109.108 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -141.24 127.73 20.03 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 126.937 2.095 . . . . 0.0 105.989 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mp -122.58 139.77 53.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.429 1.891 . . . . 0.0 106.03 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.09 121.86 29.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.207 1.403 . . . . 0.0 108.248 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.02 172.7 23.46 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.128 1.347 . . . . 0.0 112.507 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -69.7 85.22 0.46 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.285 1.034 . . . . 0.0 108.473 171.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.98 120.99 77.11 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 169.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -65.96 160.6 43.52 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.288 1.325 . . . . 0.0 109.92 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.44 -52.46 13.05 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 125.264 1.426 . . . . 0.0 112.558 -172.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -59.77 -25.95 65.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.911 1.284 . . . . 0.0 112.673 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -88.12 -42.18 12.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.033 0.933 . . . . 0.0 109.849 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.32 -60.83 3.0 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.658 1.983 . . . . 0.0 110.384 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -57.8 -33.45 68.59 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.189 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.05 -48.7 62.17 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 119.616 1.098 . . . . 0.0 111.119 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.0 tp-100 -63.25 -38.26 90.47 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.243 0.617 . . . . 0.0 111.33 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.86 -1.4 56.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.034 0.933 . . . . 0.0 112.912 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.46 -38.95 66.97 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 124.235 1.014 . . . . 0.0 112.798 -165.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -69.83 -6.47 32.67 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.647 1.112 . . . . 0.0 113.305 -176.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.28 1.29 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.654 1.182 . . . . 0.0 111.934 170.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -124.78 -4.03 7.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.005 1.722 . . . . 0.0 113.384 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.119 0 C-N-CA 126.792 2.037 . . . . 0.0 110.38 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.465 0.288 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -138.15 -178.65 5.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 164.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.31 -60.37 3.2 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.989 2.115 . . . . 0.0 112.777 -161.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.94 -34.53 77.67 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -77.04 -19.14 57.56 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.914 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -57.18 -59.73 4.66 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.529 1.059 . . . . 0.0 109.759 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -42.6 99.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.589 0.356 . . . . 0.0 110.48 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.64 -26.7 61.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.159 0.584 . . . . 0.0 112.149 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.74 -26.94 19.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.828 -1.082 . . . . 0.0 112.655 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.472 HG13 ' H ' ' A' ' 15' ' ' GLN 0.279 11.3 pt -75.22 -91.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.95 0.795 . . . . 0.0 109.517 171.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.472 ' H ' HG13 ' A' ' 14' ' ' ILE . 13.9 pt20 45.85 -17.77 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.758 1 C-N-CA 133.207 4.603 . . . . 0.0 119.632 174.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.02 -179.06 25.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.757 1.162 . . . . 0.0 112.887 -159.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -81.46 -13.57 58.04 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.85 2.06 . . . . 0.0 114.207 -167.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.93 156.04 41.28 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 118.577 0.626 . . . . 0.0 112.036 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.15 81.96 1.11 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.778 2.985 . . . . 0.0 110.466 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.4 t -87.81 138.11 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.8 tt -133.75 141.27 47.44 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.91 125.63 58.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -170.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.71 96.85 6.2 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.747 1.219 . . . . 0.0 108.218 175.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -75.11 115.78 15.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -117.49 176.76 5.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 168.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.62 161.22 40.99 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.294 -0.879 . . . . 0.0 110.392 174.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.31 15.06 0.48 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.321 1.049 . . . . 0.0 113.579 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.411 ' CG ' ' N ' ' A' ' 29' ' ' CYS . 2.2 p90 -136.82 -61.72 0.66 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.215 1.006 . . . . 0.0 108.553 168.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.411 ' N ' ' CG ' ' A' ' 28' ' ' TRP . 16.3 p 44.16 -62.95 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 1 C-N-CA 132.024 4.13 . . . . 0.0 117.525 178.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.76 -103.83 3.06 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.951 1.739 . . . . 0.0 109.802 -161.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -60.19 -21.12 64.96 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.451 2.767 . . . . 0.0 115.15 -171.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -60.75 -25.3 66.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.947 1.248 . . . . 0.0 111.466 173.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -22.3 65.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.394 0.997 . . . . 0.0 111.932 174.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 84.0 mtp -98.54 -25.0 14.9 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 125.946 1.698 . . . . 0.0 111.429 176.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.2 ttt -83.38 -36.37 24.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 117.521 -1.228 . . . . 0.0 109.109 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.87 -51.13 57.24 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.871 1.669 . . . . 0.0 112.482 175.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -62.41 -39.43 46.28 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 121.444 1.551 . . . . 0.0 112.422 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.25 -20.67 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 119.981 1.264 . . . . 0.0 112.071 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.84 -17.39 24.15 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.242 1.817 . . . . 0.0 111.612 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.04 -45.84 69.41 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 167.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -53.83 -50.14 66.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.954 1.301 . . . . 0.0 110.151 167.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.86 -51.39 67.72 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.095 0.558 . . . . 0.0 110.974 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.57 -55.85 19.4 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.881 0.872 . . . . 0.0 110.532 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.68 -43.6 85.18 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.672 0.608 . . . . 0.0 111.217 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.79 -21.31 10.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -147.63 40.94 1.02 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.481 1.112 . . . . 0.0 111.003 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.52 -37.17 16.91 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.951 1.7 . . . . 0.0 115.275 -162.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -132.26 6.27 4.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -66.24 -34.58 78.33 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.527 -0.733 . . . . 0.0 109.825 166.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.65 171.64 5.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.338 0.6 OUTLIER -118.62 97.81 5.92 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 159.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 p -84.89 159.76 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.2 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.38 156.92 44.07 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 162.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -123.03 138.09 54.77 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 172.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pp -150.87 150.83 31.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.867 0.467 . . . . 0.0 110.956 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -82.79 116.57 22.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.81 -27.86 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.8 0.84 . . . . 0.0 112.142 -175.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -67.63 -31.45 71.47 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.683 0.793 . . . . 0.0 111.0 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -83.97 -24.82 30.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.034 0.934 . . . . 0.0 111.907 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -113.84 86.63 11.23 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.309 1.043 . . . . 0.0 109.856 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.03 -24.51 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.124 2.55 . . . . 0.0 113.752 171.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.23 131.16 44.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.788 1.176 . . . . 0.0 109.808 -177.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.9 m 69.68 -31.8 0.22 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.42 2.688 . . . . 0.0 112.453 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.1 m -53.51 -54.74 32.93 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.471 1.909 . . . . 0.0 109.721 170.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.6 t -70.03 -1.94 11.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.766 -1.111 . . . . 0.0 113.157 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -106.69 -35.09 7.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.663 1.12 . . . . 0.0 111.339 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -99.1 14.93 27.55 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.794 0.725 . . . . 0.0 112.119 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.99 33.53 85.81 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 123.486 0.565 . . . . 0.0 111.899 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.7 mm -74.3 80.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.416 1.486 . . . . 0.0 108.312 -171.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 21.7 ttt -138.89 40.12 2.15 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.255 1.422 . . . . 0.0 109.642 -176.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.2 m -155.11 61.41 0.64 Allowed 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.468 -1.395 . . . . 0.0 109.565 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.48 153.79 81.54 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.686 173.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -67.32 126.08 7.45 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 CA-C-N 119.206 0.752 . . . . 0.0 110.544 -5.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -114.53 130.49 56.76 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.99 119.6 30.02 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -173.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.52 148.7 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -121.98 132.97 54.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -121.35 155.1 35.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.064 1.346 . . . . 0.0 110.842 -173.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -164.62 151.39 11.04 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.333 1.453 . . . . 0.0 109.229 158.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.03 15.81 50.88 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.652 0.644 . . . . 0.0 112.353 -165.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.02 -3.59 28.26 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.843 -0.976 . . . . 0.0 113.862 -166.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.74 133.56 39.41 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 119.522 1.661 . . . . 0.0 108.821 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.45 95.82 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.272 2.648 . . . . 0.0 109.299 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 m -61.14 -35.56 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 O-C-N 121.656 -0.653 . . . . 0.0 111.917 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.88 159.85 43.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.012 0.434 . . . . 0.0 111.636 159.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.13 140.92 48.93 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 127.538 2.335 . . . . 0.0 107.303 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.462 HD11 ' HG2' ' A' ' 99' ' ' GLN . 3.6 mm? -123.39 152.59 41.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 127.702 2.401 . . . . 0.0 107.625 168.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.73 126.18 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.82 163.75 39.14 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.607 1.099 . . . . 0.0 113.101 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -61.82 134.05 56.23 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.057 1.343 . . . . 0.0 110.535 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -137.91 144.01 42.24 Favored Pre-proline 0 C--O 1.242 0.671 0 C-N-CA 124.89 1.276 . . . . 0.0 107.608 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.94 157.27 57.76 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.192 1.928 . . . . 0.0 109.155 169.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.54 -38.47 87.57 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.149 -0.97 . . . . 0.0 110.779 -175.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.22 -21.37 13.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.059 0.944 . . . . 0.0 113.02 174.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -97.92 -50.91 4.24 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 119.49 1.041 . . . . 0.0 110.454 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.74 -58.9 6.32 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.837 1.655 . . . . 0.0 109.527 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.52 -30.77 68.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.931 1.292 . . . . 0.0 110.657 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.71 -46.25 32.14 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.547 0.612 . . . . 0.0 110.965 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.462 ' HG2' HD11 ' A' ' 87' ' ' LEU . 12.7 tp-100 -64.75 -31.22 72.35 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.424 1.09 . . . . 0.0 111.19 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.24 2.17 56.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.345 1.058 . . . . 0.0 112.511 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.18 -19.04 61.13 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -19.79 62.88 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.066 1.757 . . . . 0.0 111.672 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.31 -7.23 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 125.779 1.632 . . . . 0.0 111.783 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.05 5.96 28.52 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.557 1.543 . . . . 0.0 112.78 167.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.962 0 C-N-CA 126.157 1.783 . . . . 0.0 109.618 165.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.658 HD13 ' CB ' ' A' ' 53' ' ' ALA . 1.6 tp . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 121.339 0.59 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 t -142.64 -127.67 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -98.79 -62.22 1.27 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.982 1.313 . . . . 0.0 109.49 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.94 79.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.62 1.168 . . . . 0.0 111.008 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -72.24 -24.54 61.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.335 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -71.45 -48.83 46.94 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.07 -32.98 74.74 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.949 -0.548 . . . . 0.0 112.3 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -64.85 -50.32 67.1 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.166 0.894 . . . . 0.0 110.2 167.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.402 ' O ' HG21 ' A' ' 20' ' ' VAL . . . -54.74 -48.21 72.86 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.143 0.883 . . . . 0.0 111.372 -175.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt -63.01 -1.98 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -52.23 -31.6 32.83 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.233 1.379 . . . . 0.0 111.909 171.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.99 -133.28 13.98 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 116.531 1.372 . . . . 0.0 116.531 158.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.6 t70 64.29 -50.16 0.29 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 130.221 3.408 . . . . 0.0 111.303 -158.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.4 160.68 46.0 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.68 107.04 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.19 2.593 . . . . 0.0 110.956 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 13' ' ' ALA . 50.3 t -94.52 107.02 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.97 153.59 22.06 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 164.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.26 150.88 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 164.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -110.7 104.62 13.31 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.43 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 79.0 m-85 -89.31 108.2 19.49 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 164.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -131.49 -176.39 4.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.528 1.531 . . . . 0.0 107.019 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.18 171.25 20.25 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.692 1.197 . . . . 0.0 108.132 164.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.52 80.61 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.52 -23.91 18.94 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -163.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.9 p -75.6 40.19 0.18 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.298 1.839 . . . . 0.0 115.256 -159.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 42.48 -99.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 127.718 2.58 . . . . 0.0 113.974 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -57.52 -23.48 56.51 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.528 2.819 . . . . 0.0 114.396 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.9 p -56.91 -34.63 68.13 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.511 1.05 . . . . 0.0 111.417 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -71.12 -8.0 50.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.357 1.063 . . . . 0.0 112.359 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.7 mtm -106.88 -12.3 15.51 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.81 1.644 . . . . 0.0 112.222 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -40.42 11.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.813 2.045 . . . . 0.0 108.851 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.34 -56.23 19.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.233 1.413 . . . . 0.0 112.177 170.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.57 -25.01 69.79 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.143 1.801 . . . . 0.0 113.017 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.1 t -68.78 -46.35 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.365 0.984 . . . . 0.0 109.677 170.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.47 ' HA ' ' HB3' ' A' ' 42' ' ' PHE . 3.7 mp -61.15 -36.2 79.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.698 1.599 . . . . 0.0 111.901 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.18 -7.64 38.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.218 2.207 . . . . 0.0 112.099 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -109.81 -50.72 2.95 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.368 1.467 . . . . 0.0 109.47 168.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 47.4 t80 -45.45 -51.76 11.07 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 125.811 1.645 . . . . 0.0 112.22 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.15 -63.09 1.24 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.601 1.161 . . . . 0.0 110.369 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.88 -33.77 74.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.61 1.564 . . . . 0.0 111.993 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.77 -19.4 27.79 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -140.7 48.5 1.72 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.142 1.377 . . . . 0.0 109.028 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.24 -37.44 16.1 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.077 1.351 . . . . 0.0 114.259 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -130.32 3.22 4.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -65.46 -36.78 84.9 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.679 1.127 . . . . 0.0 109.094 159.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.6 m -111.09 174.27 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.248 1.019 . . . . 0.0 108.696 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.4 134.72 48.87 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 158.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.6 p -137.01 161.06 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.552 1.141 . . . . 0.0 109.827 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.658 ' CB ' HD13 ' A' ' 5' ' ' LEU . . . -165.09 166.35 19.23 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.275 171.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.15 148.1 42.67 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.52 137.05 36.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 125.812 1.945 . . . . 0.0 111.403 169.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -75.21 101.11 4.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.439 HG11 HG21 ' A' ' 72' ' ' ILE . 2.8 p -61.56 -25.3 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.373 1.069 . . . . 0.0 112.374 -166.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.01 -18.79 61.31 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.367 1.867 . . . . 0.0 112.649 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -114.97 -43.62 3.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 127.68 2.392 . . . . 0.0 109.887 -171.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -114.93 81.88 7.92 Favored Pre-proline 0 N--CA 1.443 -0.795 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.2 -68.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.235 2.623 . . . . 0.0 111.828 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 29.32 99.34 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.357 2.663 . . . . 0.0 115.586 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.263 38.6 m 67.71 -8.39 0.52 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.748 1.219 . . . . 0.0 113.165 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -49.36 -50.14 41.3 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.488 -1.382 . . . . 0.0 111.173 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.9 t -71.75 -3.68 23.37 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 117.657 -1.163 . . . . 0.0 112.778 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -95.6 -32.05 12.99 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.731 1.15 . . . . 0.0 111.68 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -110.48 0.74 17.89 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.82 35.91 43.89 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.263 0.935 . . . . 0.0 112.399 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.43 HG21 ' CZ ' ' A' ' 24' ' ' PHE . 42.8 mm -82.17 48.88 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.376 1.47 . . . . 0.0 111.778 -163.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 18.0 ttt -88.32 2.35 52.66 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.754 1.222 . . . . 0.0 110.348 163.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 p -72.77 13.97 0.32 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.202 2.201 . . . . 0.0 114.907 -176.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.462 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -65.16 144.75 99.1 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 123.907 0.883 . . . . 0.0 112.014 -165.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.462 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 57.5 Cg_endo -65.94 132.09 15.42 Favored 'Cis proline' 0 C--N 1.35 0.622 0 CA-C-N 119.268 0.774 . . . . 0.0 111.398 2.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.5 m -131.44 141.1 49.75 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.563 0.745 . . . . 0.0 109.144 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -135.87 98.92 4.02 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.1 mt -88.29 145.99 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.35 99.21 7.04 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -96.47 160.83 14.2 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.552 1.941 . . . . 0.0 109.685 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -157.78 39.02 0.27 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 158.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 82' ' ' GLU . . . 159.39 52.38 0.01 OUTLIER Glycine 0 N--CA 1.463 0.468 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 169.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.4 -25.53 0.58 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.31 1.91 . . . . 0.0 112.677 -168.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 80' ' ' GLY . 42.0 tt0 -91.72 131.71 35.04 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.43 1.892 . . . . 0.0 110.028 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.85 126.55 7.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.988 3.125 . . . . 0.0 110.78 170.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.8 -38.4 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 121.661 -0.65 . . . . 0.0 110.448 165.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -154.1 172.07 18.11 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 118.623 0.647 . . . . 0.0 111.233 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -138.35 136.15 36.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.196 1.799 . . . . 0.0 108.032 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.25 141.29 43.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.19 2.196 . . . . 0.0 105.851 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 pt -139.78 152.32 22.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.575 1.15 . . . . 0.0 108.838 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.19 168.1 6.86 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.838 0.732 . . . . 0.0 111.65 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -81.61 75.08 8.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.723 -0.869 . . . . 0.0 110.563 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -75.42 122.9 88.19 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 158.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -71.84 173.75 12.24 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.089 1.859 . . . . 0.0 110.7 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HE2' ' OE1' ' A' ' 97' ' ' GLU . 22.8 tptm -31.8 -59.12 0.27 Allowed 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 127.561 2.344 . . . . 0.0 112.483 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.72 -49.81 64.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.802 1.313 . . . . 0.0 111.643 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -74.22 -42.01 60.44 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.496 1.118 . . . . 0.0 110.033 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 tt -59.78 -62.46 1.86 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.594 1.558 . . . . 0.0 108.983 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.46 ' OE1' ' HE2' ' A' ' 93' ' ' LYS . 11.3 tt0 -66.09 -25.92 67.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.224 1.41 . . . . 0.0 111.102 -177.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.93 -52.48 24.18 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.212 0.915 . . . . 0.0 110.412 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -59.7 -40.0 86.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.391 0.541 . . . . 0.0 111.367 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.27 -0.66 50.57 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.797 1.239 . . . . 0.0 112.764 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.6 -28.97 66.09 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.363 0.983 . . . . 0.0 112.142 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -69.67 -3.71 16.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.626 1.17 . . . . 0.0 113.488 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.88 -15.58 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.156 0.889 . . . . 0.0 112.416 164.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.37 -9.98 50.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.015 0.926 . . . . 0.0 113.204 173.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 C-N-CA 125.641 1.576 . . . . 0.0 110.622 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.446 HD21 ' HA ' ' A' ' 10' ' ' PHE . 6.0 tp . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.5 m -150.02 157.2 42.9 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -46.51 -53.4 11.34 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 127.172 2.189 . . . . 0.0 113.207 -168.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.03 93.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.051 0.929 . . . . 0.0 111.746 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -69.91 -18.47 63.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.124 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.446 ' HA ' HD21 ' A' ' 5' ' ' LEU . 2.3 t80 -58.12 -60.9 3.03 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.252 0.621 . . . . 0.0 110.242 172.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -63.47 -39.64 95.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.322 -0.37 . . . . 0.0 110.56 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -63.65 -27.99 69.61 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.609 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.64 -60.39 2.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.659 1.118 . . . . 0.0 109.517 168.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.8 pt -64.89 -23.28 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -167.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -59.53 -30.09 68.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 164.16 104.39 0.18 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.316 0.962 . . . . 0.0 110.734 -168.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -160.93 -65.03 0.06 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.614 1.566 . . . . 0.0 109.778 -169.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.22 -161.39 32.48 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 -164.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.44 112.48 1.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.491 2.127 . . . . 0.0 108.855 167.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.7 t -110.3 141.16 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 125.501 1.521 . . . . 0.0 107.199 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.1 tp -145.2 111.33 5.59 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 118.028 0.377 . . . . 0.0 110.469 -167.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.4 t -112.83 121.99 66.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 118.957 0.799 . . . . 0.0 109.436 -163.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 11.4 t0 -82.36 106.76 14.5 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 169.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.49 105.3 16.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 162.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.3 p-90 -117.95 -179.44 3.76 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 166.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.76 152.04 32.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 120.505 -1.372 . . . . 0.0 110.336 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -23.9 66.7 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.93 -13.27 29.09 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 p -71.55 178.25 3.61 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.214 0.605 . . . . 0.0 112.386 -164.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.97 -93.5 1.87 Allowed Glycine 0 CA--C 1.538 1.489 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 164.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -66.85 -21.27 50.87 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.381 2.721 . . . . 0.0 114.133 -166.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -30.37 68.81 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.521 0.6 . . . . 0.0 111.225 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 -71.8 -13.16 61.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.501 1.12 . . . . 0.0 111.981 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 76.4 mtm -98.6 -37.2 9.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.105 1.362 . . . . 0.0 111.089 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.8 ttt -67.44 -43.02 82.13 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.874 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.22 -50.64 74.58 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 119.956 1.253 . . . . 0.0 113.284 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.93 -33.43 26.35 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.849 1.696 . . . . 0.0 112.684 170.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -29.56 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 120.093 1.315 . . . . 0.0 112.018 173.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.7 mt -82.98 -23.9 33.17 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.667 2.387 . . . . 0.0 110.904 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -70.05 -35.93 74.62 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.824 0.738 . . . . 0.0 110.6 171.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.03 -35.43 61.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.134 0.879 . . . . 0.0 111.107 174.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -55.02 -46.06 75.21 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.326 0.65 . . . . 0.0 109.549 166.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.473 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -61.12 -51.68 68.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.427 -0.796 . . . . 0.0 111.274 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.93 -46.46 74.93 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.445 0.698 . . . . 0.0 110.311 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.4 -16.07 59.42 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -138.89 28.55 2.35 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.058 1.343 . . . . 0.0 112.271 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.46 65.79 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -164.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -95.38 -45.61 7.05 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.304 2.642 . . . . 0.0 111.316 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -66.51 -19.61 65.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.785 1.634 . . . . 0.0 113.029 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.35 143.16 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 119.14 0.882 . . . . 0.0 110.058 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.8 m -78.01 60.07 2.3 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.724 1.61 . . . . 0.0 107.743 168.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 43' ' ' ALA . 2.5 p -71.3 151.09 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.03 169.51 24.4 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 16.4 ttpp -144.32 125.7 14.81 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -168.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.39 154.51 43.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.838 1.304 . . . . 0.0 114.112 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -87.57 105.22 17.18 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.26 -14.65 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 121.382 -0.824 . . . . 0.0 112.207 -172.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.93 -35.79 82.3 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.197 1.399 . . . . 0.0 111.643 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -74.47 -33.1 62.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.287 1.035 . . . . 0.0 110.638 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -111.43 87.43 7.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.115 0.966 . . . . 0.0 111.985 -164.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -80.95 -19.82 8.02 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.64 2.893 . . . . 0.0 113.951 168.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.61 128.88 37.26 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.645 1.111 . . . . 0.0 109.649 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.0 m 68.54 -28.79 0.16 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.807 2.443 . . . . 0.0 112.696 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.2 m -53.14 -55.71 21.97 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.03 1.732 . . . . 0.0 109.649 167.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -70.6 -4.01 21.08 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 117.917 -1.04 . . . . 0.0 112.855 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -94.39 -34.25 12.84 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.563 1.074 . . . . 0.0 110.714 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -106.06 11.36 31.57 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.64 0.655 . . . . 0.0 112.117 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.22 35.23 90.1 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 123.939 0.78 . . . . 0.0 111.553 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.58 87.98 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.993 0.901 . . . . 0.0 109.979 -168.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.2 ttt -125.81 -1.35 7.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.514 1.525 . . . . 0.0 110.74 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.1 p -72.95 23.27 0.06 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.706 2.402 . . . . 0.0 114.824 -169.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.412 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 46.4 pt -68.61 150.87 97.53 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -159.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 36.8 Cg_endo -63.86 130.19 9.15 Favored 'Cis proline' 0 C--N 1.353 0.766 0 CA-C-N 118.89 0.639 . . . . 0.0 110.682 -7.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.1 m -114.14 130.56 56.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.9 tt -120.12 109.95 16.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -119.08 132.88 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tt -102.56 137.95 40.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -135.18 163.99 28.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.386 1.874 . . . . 0.0 108.757 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -153.86 140.92 19.36 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 158.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 39.13 53.46 2.64 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 126.219 1.866 . . . . 0.0 114.49 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.1 -7.24 78.85 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.842 1.21 . . . . 0.0 114.338 176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.19 123.7 36.09 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 119.453 1.626 . . . . 0.0 110.049 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -71.65 135.38 25.98 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.099 2.532 . . . . 0.0 109.89 169.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.9 t -100.4 -56.14 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.625 1.17 . . . . 0.0 110.033 -173.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -155.56 163.9 39.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.743 0.701 . . . . 0.0 109.975 170.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -120.86 132.27 54.89 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.811 2.044 . . . . 0.0 107.267 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.53 144.93 38.63 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.97 2.508 . . . . 0.0 106.411 169.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.8 pt -139.64 120.11 14.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.497 1.119 . . . . 0.0 109.622 -170.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.83 168.86 42.34 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.073 0.844 . . . . 0.0 111.905 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.74 81.08 1.57 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.792 1.637 . . . . 0.0 110.501 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -68.63 133.73 90.64 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.31 159.73 52.02 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.496 1.464 . . . . 0.0 109.532 165.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.51 -41.03 72.54 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 123.446 0.699 . . . . 0.0 112.748 -170.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.83 -29.72 68.45 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.012 0.925 . . . . 0.0 112.667 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.5 -47.28 11.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.345 1.858 . . . . 0.0 107.496 178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.34 -62.48 1.81 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.139 2.176 . . . . 0.0 109.846 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -30.19 71.33 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 117.607 -1.187 . . . . 0.0 110.602 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.49 -26.41 64.54 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 122.044 2.202 . . . . 0.0 111.679 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.03 -17.26 61.0 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 167.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 tp -128.42 -9.0 5.19 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -159.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.88 -15.88 24.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.136 2.174 . . . . 0.0 112.702 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -72.81 -20.26 61.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.494 1.118 . . . . 0.0 113.261 170.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.51 -6.69 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.149 1.78 . . . . 0.0 112.746 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.6 6.09 49.82 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.196 1.798 . . . . 0.0 109.808 158.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 C--O 1.25 1.082 0 C-N-CA 124.653 1.181 . . . . 0.0 109.717 163.679 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.66 HD13 ' HB1' ' A' ' 53' ' ' ALA . 1.8 mp . . . . . 0 CA--C 1.528 0.108 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.0 p -134.96 -62.01 0.74 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.778 0.799 . . . . 0.0 110.528 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 8' ' ' ALA . 39.0 p-10 -179.3 -78.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.468 1.907 . . . . 0.0 108.807 -159.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.412 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . -61.69 -38.44 87.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.984 0.913 . . . . 0.0 109.66 172.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -75.82 -21.53 57.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.362 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -67.58 -55.87 11.69 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 173.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -63.02 -35.63 80.85 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.39 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -58.11 -46.3 85.79 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.801 0.728 . . . . 0.0 110.638 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.34 -40.7 96.39 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.026 -0.988 . . . . 0.0 112.567 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . 0.257 11.8 pt -72.22 -67.31 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 118.851 0.75 . . . . 0.0 111.613 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 37.78 -13.39 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.601 1 C-N-CA 134.905 5.282 . . . . 0.0 120.359 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 174.1 -159.93 29.47 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 120.78 1.627 . . . . 0.0 116.049 -166.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.586 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 4.0 m-20 -70.52 -9.37 56.49 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.211 3.004 . . . . 0.0 115.835 -161.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.52 164.2 54.03 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 119.093 0.86 . . . . 0.0 112.967 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.33 110.25 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.293 2.662 . . . . 0.0 107.775 166.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.499 ' HA ' ' HB ' ' A' ' 51' ' ' THR . 60.1 t -122.2 142.54 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.454 HD11 HG13 ' A' ' 52' ' ' VAL . 1.3 pp -133.5 155.85 48.82 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.161 0.505 . . . . 0.0 110.156 168.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.666 HG13 HD11 ' A' ' 55' ' ' LEU . 2.1 t -128.55 124.2 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.605 1.562 . . . . 0.0 107.612 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.01 100.9 13.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.676 1.59 . . . . 0.0 107.967 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.578 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 61.1 m-85 -89.71 109.77 20.72 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.915 0.886 . . . . 0.0 108.979 174.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -137.4 -171.86 3.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.97 170.19 21.08 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.196 1.398 . . . . 0.0 107.454 169.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.38 -14.65 62.42 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CH2' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -113.53 -24.11 9.43 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -166.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 p -70.94 34.59 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 127.275 2.23 . . . . 0.0 116.51 -160.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 52.3 -110.21 1.11 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.523 1.535 . . . . 0.0 113.372 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.11 -14.94 31.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.085 3.19 . . . . 0.0 114.921 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 17.5 p -54.54 -30.96 55.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.988 0.813 . . . . 0.0 111.856 165.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -71.69 -6.21 39.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.161 0.984 . . . . 0.0 112.923 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.6 mtm -108.82 -30.41 8.16 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.974 1.709 . . . . 0.0 111.371 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.3 tpt -75.07 -43.91 50.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.227 1.811 . . . . 0.0 109.406 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.0 95.41 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 116.806 -1.569 . . . . 0.0 112.09 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 26.6 Cg_endo -63.7 -34.68 61.66 Favored 'Trans proline' 0 C--N 1.352 0.728 0 CA-C-N 122.432 1.904 . . . . 0.0 112.54 173.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.29 -33.39 63.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 119.728 1.149 . . . . 0.0 110.983 174.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mp -75.92 -23.08 55.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.715 1.606 . . . . 0.0 111.672 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -66.04 -44.8 83.54 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 124.331 1.052 . . . . 0.0 109.425 169.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.469 ' OE2' ' HE3' ' A' ' 93' ' ' LYS . 19.0 tt0 -59.22 -48.88 79.99 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 172.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -52.33 -49.48 64.18 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 122.665 0.386 . . . . 0.0 110.748 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.1 -51.93 58.45 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.971 0.908 . . . . 0.0 111.33 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.15 -47.51 75.0 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.366 0.667 . . . . 0.0 109.992 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.14 -17.09 64.19 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -136.0 14.42 3.33 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -168.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -42.5 -46.03 4.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.912 1.685 . . . . 0.0 113.366 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -86.0 -13.46 47.47 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -94.29 -21.93 18.7 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.69 -0.631 . . . . 0.0 111.483 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.47 137.45 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 122.207 1.003 . . . . 0.0 109.803 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 20' ' ' VAL . 3.5 m -77.75 86.84 4.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.319 1.848 . . . . 0.0 107.16 -175.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.454 HG13 HD11 ' A' ' 21' ' ' LEU . 45.4 t -80.44 159.72 4.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.66 ' HB1' HD13 ' A' ' 5' ' ' LEU . . . -162.01 158.85 25.64 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 162.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -135.92 129.38 32.15 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -166.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.666 HD11 HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -149.67 151.72 34.17 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 122.525 1.155 . . . . 0.0 113.227 -174.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -87.17 103.96 15.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.286 1.835 . . . . 0.0 107.503 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.443 HG21 HG22 ' A' ' 69' ' ' ILE . 4.5 p -61.21 -24.29 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.279 1.032 . . . . 0.0 113.513 -165.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.43 -42.89 78.24 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.881 0.872 . . . . 0.0 110.708 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -81.81 -18.22 44.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.364 2.266 . . . . 0.0 111.914 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -109.59 78.68 1.2 Allowed Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.849 1.66 . . . . 0.0 109.805 173.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.08 -18.06 14.73 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.269 2.646 . . . . 0.0 112.481 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.71 125.75 25.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.143 1.377 . . . . 0.0 109.619 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.2 m 66.53 -29.56 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.932 3.293 . . . . 0.0 112.492 -174.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -52.36 -54.05 36.82 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.815 2.046 . . . . 0.0 110.587 172.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.8 t -62.03 -41.92 98.62 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.166 0.292 . . . . 0.0 110.508 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -60.91 -42.4 97.99 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.993 0.917 . . . . 0.0 111.87 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -96.63 5.52 50.56 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.4 33.48 72.83 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 119.224 0.92 . . . . 0.0 112.125 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.578 HG21 ' CZ ' ' A' ' 24' ' ' PHE . 35.5 mm -75.75 82.37 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.599 1.56 . . . . 0.0 110.118 -166.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 93.4 mtp -122.47 -3.29 8.87 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.625 1.17 . . . . 0.0 111.688 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.1 t -84.69 21.93 1.43 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.733 1.213 . . . . 0.0 113.998 -166.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.497 HD11 ' CH2' ' A' ' 28' ' ' TRP . 26.2 pt -56.05 144.1 60.29 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.108 1.363 . . . . 0.0 112.935 -170.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 57.1 Cg_endo -65.74 139.25 40.79 Favored 'Cis proline' 0 C--N 1.35 0.637 0 CA-C-O 121.99 0.746 . . . . 0.0 111.085 -1.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -138.09 149.19 45.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.6 tt -135.03 123.41 23.24 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.267 -2.124 . . . . 0.0 105.267 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.456 HD12 ' CE2' ' A' ' 24' ' ' PHE . 21.1 mt -124.84 147.67 29.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.44 HD12 HD21 ' A' ' 100' ' ' LEU . 6.5 tt -129.35 124.04 33.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.044 0.937 . . . . 0.0 108.897 -168.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -116.31 152.11 34.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.242 1.817 . . . . 0.0 110.398 -171.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 148.94 26.33 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 125.34 1.456 . . . . 0.0 107.38 158.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.586 ' H ' ' HA ' ' A' ' 17' ' ' ASP . . . 67.15 20.78 71.4 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -168.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.95 3.3 55.42 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.478 -1.179 . . . . 0.0 114.044 -171.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -120.39 139.34 28.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 119.589 1.694 . . . . 0.0 109.454 -170.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.63 125.91 9.21 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.011 2.474 . . . . 0.0 111.775 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -78.33 -43.48 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 123.78 0.832 . . . . 0.0 110.781 175.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -158.77 169.97 23.19 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.022 0.929 . . . . 0.0 109.864 -174.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.401 ' CB ' HG12 ' A' ' 76' ' ' ILE . 1.7 pm0 -137.02 157.22 47.21 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.84 1.256 . . . . 0.0 111.13 173.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.43 HD11 ' HG2' ' A' ' 99' ' ' GLN . 4.2 mm? -123.36 145.26 48.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 127.947 2.499 . . . . 0.0 106.087 169.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.6 pt -138.79 156.14 28.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 124.756 1.223 . . . . 0.0 109.058 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.07 179.08 11.17 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -71.4 126.15 28.89 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -126.23 134.5 26.03 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 165.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.99 159.15 47.82 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.167 1.245 . . . . 0.0 110.011 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.469 ' HE3' ' OE2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -49.51 -36.96 24.78 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 125.293 1.437 . . . . 0.0 112.686 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -58.7 -50.11 75.11 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.649 1.58 . . . . 0.0 110.973 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -74.39 -36.73 63.51 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.874 1.269 . . . . 0.0 109.378 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.79 -63.28 1.25 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.471 1.108 . . . . 0.0 108.04 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.36 -31.69 73.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 118.379 -0.82 . . . . 0.0 110.754 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.76 -44.03 78.44 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.694 0.679 . . . . 0.0 110.75 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.43 ' HG2' HD11 ' A' ' 87' ' ' LEU . 9.5 tp-100 -67.15 -38.26 85.19 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 118.24 0.473 . . . . 0.0 111.493 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.44 HD21 HD12 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -86.15 -6.43 59.0 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.958 0.903 . . . . 0.0 112.997 -173.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.66 -33.2 15.0 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.954 1.701 . . . . 0.0 114.201 -175.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.16 -6.56 9.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.64 1.564 . . . . 0.0 114.17 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.36 2.92 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.261 0.937 . . . . 0.0 113.108 166.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.32 -13.5 13.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.469 1.107 . . . . 0.0 112.403 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 127.777 2.431 . . . . 0.0 109.478 165.497 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.416 HD13 ' CB ' ' A' ' 53' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.5 t -149.3 -128.82 0.05 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.457 ' HA ' HD22 ' A' ' 60' ' ' ASN . 18.0 p-10 -84.65 -70.72 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 120.224 1.375 . . . . 0.0 110.937 164.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.55 82.34 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.349 0.977 . . . . 0.0 111.433 -171.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -76.0 -14.42 60.23 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.898 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -67.3 -68.28 0.39 Allowed 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 172.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.7 -48.79 69.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.463 0.705 . . . . 0.0 110.411 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -68.29 -19.48 64.7 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.145 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.38 -58.78 3.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.157 1.344 . . . . 0.0 110.669 164.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.9 pt -62.11 -21.8 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -168.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -64.94 -20.34 66.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.462 1.105 . . . . 0.0 113.589 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.04 166.54 48.58 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 119.662 1.119 . . . . 0.0 111.606 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.59 -4.18 57.95 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.14 148.53 50.95 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 120.707 -1.246 . . . . 0.0 110.03 171.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -62.76 96.6 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.78 2.32 . . . . 0.0 109.137 167.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 t -99.03 115.5 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 125.187 1.395 . . . . 0.0 107.85 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tt -113.43 119.82 38.91 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 126.052 1.741 . . . . 0.0 108.475 -168.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.9 t -109.3 110.73 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 126.218 1.807 . . . . 0.0 109.034 -168.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.445 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 28.2 t0 -82.2 98.77 8.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.924 0.784 . . . . 0.0 109.832 167.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -81.32 112.91 19.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 164.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -134.3 -174.04 3.44 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.64 166.3 32.37 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.886 1.275 . . . . 0.0 108.603 167.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.76 65.85 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.6 -30.26 11.87 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -170.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.02 98.97 3.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.613 0.642 . . . . 0.0 111.113 -164.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -25.47 -66.17 0.05 OUTLIER Glycine 0 CA--C 1.541 1.714 0 C-N-CA 126.385 1.945 . . . . 0.0 115.255 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.26 -30.98 23.69 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.311 2.008 . . . . 0.0 113.181 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 p -67.71 -34.6 77.19 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 119.34 0.973 . . . . 0.0 110.158 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -66.67 -12.13 56.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.49 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.9 mtp -97.97 -37.95 9.58 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.88 1.272 . . . . 0.0 111.526 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.1 ttt -74.17 -39.01 63.52 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.009 0.923 . . . . 0.0 110.781 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.58 -52.16 75.61 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 117.826 -1.083 . . . . 0.0 111.349 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.41 -34.61 65.22 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.844 1.694 . . . . 0.0 112.113 172.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.32 -31.38 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 119.65 1.113 . . . . 0.0 111.606 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mp -79.48 -26.17 41.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.196 2.198 . . . . 0.0 111.96 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.82 -44.37 93.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.79 1.177 . . . . 0.0 108.983 171.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -63.09 -45.62 91.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.854 0.462 . . . . 0.0 110.254 172.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -58.68 -38.29 77.89 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 122.017 -0.427 . . . . 0.0 111.158 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.37 -54.39 47.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.213 1.005 . . . . 0.0 109.445 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -51.57 62.11 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.597 0.759 . . . . 0.0 109.841 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.18 -11.94 10.99 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -174.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -136.09 17.42 3.23 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.449 1.099 . . . . 0.0 113.021 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.55 -20.63 1.23 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -158.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -133.74 8.22 3.84 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 173.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -80.94 -23.38 38.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.517 1.053 . . . . 0.0 110.51 161.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.56 176.07 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.226 1.01 . . . . 0.0 110.529 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 73.4 m -115.02 88.06 2.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.2 2.2 . . . . 0.0 107.157 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 t -80.81 149.28 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.416 ' CB ' HD13 ' A' ' 5' ' ' LEU . . . -154.06 167.52 29.54 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 162.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 39.9 pttt -134.09 150.11 51.15 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.027 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -154.87 157.85 38.46 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 125.196 1.56 . . . . 0.0 112.863 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -86.16 104.89 16.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.018 1.327 . . . . 0.0 107.661 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.8 p -49.27 -35.56 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.011 1.324 . . . . 0.0 113.488 -166.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -55.12 -37.21 66.61 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.684 1.594 . . . . 0.0 112.718 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.72 -22.12 65.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.649 1.58 . . . . 0.0 113.393 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.457 HD22 ' HA ' ' A' ' 7' ' ' ASP . 26.1 t-20 -117.06 82.71 14.08 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 125.912 1.685 . . . . 0.0 108.594 -172.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.71 -31.19 3.38 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.037 1.825 . . . . 0.0 111.978 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -63.68 140.79 58.91 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.54 0.736 . . . . 0.0 110.073 177.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.9 m 66.79 -33.3 0.2 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 128.253 2.621 . . . . 0.0 113.079 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.4 m -64.81 -56.33 14.15 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 128.559 2.744 . . . . 0.0 109.305 172.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -69.08 -11.79 61.11 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.115 -0.945 . . . . 0.0 112.667 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.97 -55.18 5.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.226 0.921 . . . . 0.0 109.166 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -87.66 10.72 17.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.533 0.606 . . . . 0.0 112.308 -167.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.42 24.96 62.07 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.044 1.307 . . . . 0.0 113.163 173.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.1 mm -83.4 79.08 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 122.489 1.138 . . . . 0.0 110.205 -162.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -115.69 -6.37 12.15 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.475 166.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.1 p -84.71 24.48 1.02 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.255 1.822 . . . . 0.0 113.742 -164.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.457 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -69.74 155.44 93.5 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 122.844 0.457 . . . . 0.0 111.483 -163.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 55.7 Cg_endo -66.44 130.19 12.11 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 119.859 0.985 . . . . 0.0 111.38 6.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.0 m -118.85 143.13 47.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -124.18 100.52 6.75 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.3 mt -97.72 144.26 11.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 tt -111.89 125.77 54.39 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 164.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -118.99 161.66 19.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.213 1.805 . . . . 0.0 110.542 -173.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -162.57 147.3 12.04 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 124.837 1.255 . . . . 0.0 109.035 158.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.42 20.34 44.49 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.521 -0.6 . . . . 0.0 113.66 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.82 -10.27 57.47 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.401 1.476 . . . . 0.0 113.854 -171.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -83.87 125.21 73.64 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 119.26 1.53 . . . . 0.0 109.277 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.49 94.5 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.167 2.578 . . . . 0.0 108.782 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 m -60.73 -37.32 75.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.565 -0.709 . . . . 0.0 111.697 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.565 ' HE3' ' HA ' ' A' ' 100' ' ' LEU . 18.9 pttm -166.26 165.02 17.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.162 1.385 . . . . 0.0 109.019 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.16 158.37 43.76 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.54 0.736 . . . . 0.0 112.214 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.11 153.42 23.17 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 160.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.1 140.35 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 126.101 1.76 . . . . 0.0 106.684 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.65 165.62 5.93 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.778 0.704 . . . . 0.0 111.782 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.34 96.97 0.12 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.56 1.144 . . . . 0.0 110.298 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -93.3 131.82 31.91 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 167.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.59 161.83 41.81 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.011 1.808 . . . . 0.0 109.863 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -40.15 66.7 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.342 0.657 . . . . 0.0 112.372 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -59.84 -24.75 64.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.428 1.091 . . . . 0.0 113.192 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.4 tp-100 -95.98 -44.09 7.51 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.835 1.254 . . . . 0.0 109.12 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -67.57 0.25 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.909 2.484 . . . . 0.0 108.671 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.58 -37.89 85.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 117.963 -1.018 . . . . 0.0 108.703 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.88 99.77 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.69 1.132 . . . . 0.0 111.906 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -69.67 -20.54 63.57 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.876 0.471 . . . . 0.0 112.177 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.565 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 1.1 tp -105.88 -10.22 16.76 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.118 1.367 . . . . 0.0 112.693 -171.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.23 -7.33 5.81 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.776 2.831 . . . . 0.0 114.48 -173.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -84.6 -13.34 51.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.089 1.756 . . . . 0.0 112.457 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.23 -16.17 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.092 0.86 . . . . 0.0 111.097 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -82.14 -6.07 58.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 121.626 -0.672 . . . . 0.0 112.226 162.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 . . . . . 0 C--O 1.245 0.836 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 158.721 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.52 ' HB2' HD23 ' A' ' 55' ' ' LEU . 32.4 mt . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.1 m -152.66 -32.72 0.13 Allowed 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.387 -1.445 . . . . 0.0 113.187 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -171.6 -79.9 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 125.989 1.716 . . . . 0.0 106.654 160.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.84 -27.28 63.05 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 121.013 -1.054 . . . . 0.0 112.303 173.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 12' ' ' GLN . 12.7 t-20 -72.99 -21.63 60.81 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.063 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.28 1.71 0.71 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.638 1.975 . . . . 0.0 112.264 168.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -126.9 -50.15 1.46 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.039 1.335 . . . . 0.0 109.783 168.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 9' ' ' ASN . 45.6 tt0 -53.71 -35.64 61.36 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.163 0.985 . . . . 0.0 112.284 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.35 -45.86 24.7 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.982 0.81 . . . . 0.0 110.024 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -67.53 -23.61 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 117.732 -1.128 . . . . 0.0 112.236 -170.62 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -50.17 -35.11 24.85 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.813 1.245 . . . . 0.0 113.728 -164.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.78 122.69 0.97 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 166.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -156.25 -71.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.883 0.873 . . . . 0.0 110.081 -170.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 149.21 -166.67 29.51 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -161.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.86 89.44 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.649 2.899 . . . . 0.0 110.958 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t -70.45 146.22 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 126.89 2.076 . . . . 0.0 108.479 169.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -144.8 123.58 12.63 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.835 1.654 . . . . 0.0 107.685 -170.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.49 140.88 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 119.508 1.049 . . . . 0.0 111.43 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.408 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 53.6 t0 -98.95 104.16 16.18 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.933 0.893 . . . . 0.0 109.356 159.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -85.15 108.33 17.65 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 166.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -130.82 -172.47 2.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.224 1.41 . . . . 0.0 107.92 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.62 165.97 29.74 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 125.749 1.619 . . . . 0.0 107.878 168.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.42 -14.29 55.9 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -174.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.64 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -108.04 -23.85 11.83 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' HD12 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -74.31 93.35 2.37 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.195 0.907 . . . . 0.0 111.449 -165.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -24.49 -63.98 0.05 OUTLIER Glycine 0 CA--C 1.542 1.723 0 C-N-CA 126.377 1.941 . . . . 0.0 115.495 173.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.99 -36.3 22.87 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.562 2.174 . . . . 0.0 113.382 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 p -63.32 -37.14 86.09 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.792 1.178 . . . . 0.0 110.103 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.53 -20.28 64.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.647 0.779 . . . . 0.0 112.043 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.4 mtm -101.27 -14.05 17.82 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.968 1.307 . . . . 0.0 112.749 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.9 ttt -93.28 -39.21 11.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.668 1.587 . . . . 0.0 109.776 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.15 -48.44 92.17 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 117.413 -1.279 . . . . 0.0 112.025 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.64 -33.48 45.01 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 121.862 1.701 . . . . 0.0 112.411 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -40.66 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.457 1.026 . . . . 0.0 109.873 174.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 42' ' ' PHE . 4.9 mp -66.46 -20.23 65.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.085 1.754 . . . . 0.0 112.166 176.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.62 -51.33 28.78 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.222 0.919 . . . . 0.0 109.888 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.69 -43.03 97.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.271 0.628 . . . . 0.0 110.438 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 67.0 t80 -51.55 -57.36 9.31 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.633 1.173 . . . . 0.0 110.317 169.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.91 -52.06 65.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.65 -0.691 . . . . 0.0 111.156 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -55.22 -42.88 73.91 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.042 0.937 . . . . 0.0 110.804 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.0 -15.67 24.41 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -146.88 56.22 1.13 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.193 1.397 . . . . 0.0 109.819 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.07 64.57 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -169.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -134.98 -2.11 2.61 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -63.7 -32.19 73.61 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.884 -1.135 . . . . 0.0 109.464 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.02 165.11 24.51 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 124.336 1.054 . . . . 0.0 110.252 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.6 m -107.96 88.8 2.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.778 2.031 . . . . 0.0 108.681 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 t -71.73 158.17 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.668 0.787 . . . . 0.0 110.291 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.13 155.04 34.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.903 1.681 . . . . 0.0 106.801 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 14.8 mtpt -139.62 128.91 24.01 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 5' ' ' LEU . 0.6 OUTLIER -147.42 150.69 35.13 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.198 0.936 . . . . 0.0 111.825 -175.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.97 128.12 34.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 167.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.34 -34.06 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.04 -42.94 75.67 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.265 1.426 . . . . 0.0 110.717 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.32 -35.78 67.97 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.361 2.265 . . . . 0.0 112.487 176.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.39 80.49 4.59 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.271 1.029 . . . . 0.0 110.769 -172.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.12 -28.54 23.39 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.734 2.29 . . . . 0.0 114.185 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -52.49 117.22 2.71 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.027 1.331 . . . . 0.0 110.944 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.256 21.7 m 68.13 -21.35 0.13 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 129.202 3.001 . . . . 0.0 113.336 174.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.9 m -53.28 -52.47 58.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.003 1.721 . . . . 0.0 108.833 162.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -69.96 -3.33 15.65 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 117.722 -1.133 . . . . 0.0 113.266 176.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -100.94 -38.44 8.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.769 1.168 . . . . 0.0 110.595 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -92.63 7.67 42.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.702 0.683 . . . . 0.0 111.831 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.86 34.2 81.87 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 123.714 0.673 . . . . 0.0 111.739 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 26.2 mm -77.92 71.31 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.3 1.44 . . . . 0.0 109.002 -170.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 53.6 ttm -95.05 -18.48 20.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.431 1.092 . . . . 0.0 110.292 161.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.3 t -62.22 128.01 34.06 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.588 1.155 . . . . 0.0 108.67 167.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.64 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 14.8 pt -146.44 156.11 49.51 Favored Pre-proline 0 N--CA 1.443 -0.818 0 C-N-CA 126.829 2.052 . . . . 0.0 107.531 159.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.36 130.1 9.57 Favored 'Cis proline' 0 N--CA 1.453 -0.91 0 CA-C-N 119.733 0.94 . . . . 0.0 110.467 -9.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.7 m -123.78 149.3 45.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tt -135.12 134.58 40.38 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.3 mt -131.67 144.12 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.19 136.75 48.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 168.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -133.26 169.48 16.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.334 1.854 . . . . 0.0 110.909 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.457 ' HE3' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -153.69 155.81 36.68 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.376 1.871 . . . . 0.0 106.204 158.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.02 37.58 4.34 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 124.579 1.085 . . . . 0.0 115.795 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.457 ' H ' HG22 ' A' ' 14' ' ' ILE . . . 75.24 17.81 80.14 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.735 1.16 . . . . 0.0 115.1 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -139.64 135.5 16.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.052 1.341 . . . . 0.0 108.9 -168.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.09 170.84 16.01 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.066 2.511 . . . . 0.0 113.097 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.13 -7.53 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.848 1.659 . . . . 0.0 112.081 173.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 161.15 170.75 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 1 C-N-CA 132.088 4.155 . . . . 0.0 108.763 164.15 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -129.5 142.87 50.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.492 1.917 . . . . 0.0 107.639 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.77 145.41 48.07 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 128.926 2.89 . . . . 0.0 106.299 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.69 135.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -173.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.68 165.18 41.03 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 123.772 0.701 . . . . 0.0 112.311 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -77.48 69.33 3.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.917 1.287 . . . . 0.0 111.486 -174.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -76.86 131.81 72.68 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.79 168.09 19.53 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.086 2.524 . . . . 0.0 110.988 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -45.59 76.01 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 123.846 0.858 . . . . 0.0 110.45 -174.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.76 -12.09 59.83 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.323 1.049 . . . . 0.0 112.386 -174.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.13 -55.76 2.68 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.476 1.511 . . . . 0.0 108.155 172.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 tt -54.38 -60.73 2.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.844 2.058 . . . . 0.0 110.315 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -65.51 -20.99 66.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.565 1.146 . . . . 0.0 111.845 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.16 -48.1 31.52 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.487 1.04 . . . . 0.0 109.623 170.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -59.41 -32.08 69.85 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.846 1.258 . . . . 0.0 112.104 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tp -97.71 0.52 47.17 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.669 1.988 . . . . 0.0 112.379 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.07 -29.42 68.55 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.992 0.917 . . . . 0.0 112.529 -169.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -65.85 -12.82 57.38 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.99 4.53 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.814 0.846 . . . . 0.0 112.226 173.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -112.28 -6.42 14.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.528 1.131 . . . . 0.0 112.853 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.539 1.936 . . . . 0.0 108.966 159.24 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.1 m -149.43 163.12 38.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -42.79 -55.28 3.72 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.437 3.095 . . . . 0.0 113.624 -164.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.32 91.95 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.369 0.604 . . . . 0.0 111.792 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.71 -18.1 58.71 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.059 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.34 -61.92 2.14 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.749 1.159 . . . . 0.0 108.745 174.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.417 ' HA ' HG12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -59.39 -39.74 84.35 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.577 0.351 . . . . 0.0 110.781 -177.376 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -74.84 -16.44 60.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.62 0.768 . . . . 0.0 112.701 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.22 -57.36 3.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.352 0.978 . . . . 0.0 109.321 168.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 11' ' ' GLN . 41.2 pt -59.32 -24.35 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -170.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -67.4 -17.62 64.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.615 1.166 . . . . 0.0 113.198 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.42 165.01 47.5 Favored Glycine 0 C--N 1.342 0.909 0 C-N-CA 124.127 0.87 . . . . 0.0 112.124 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -80.29 -42.48 23.01 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.382 1.473 . . . . 0.0 111.956 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.27 164.06 54.88 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 123.371 0.51 . . . . 0.0 112.681 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.2 100.63 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.775 2.984 . . . . 0.0 112.006 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.1 t -90.18 121.99 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 C-N-CA 125.986 1.714 . . . . 0.0 108.116 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 tt -118.95 112.16 19.26 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.132 0.973 . . . . 0.0 109.312 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -91.49 127.85 43.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 62.1 t0 -92.08 101.93 14.47 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 164.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -87.19 111.69 21.23 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 14.5 p-90 -135.29 178.49 6.99 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.772 1.229 . . . . 0.0 110.491 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.73 167.49 30.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.982 1.313 . . . . 0.0 110.798 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.77 -4.65 41.73 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.11 -16.0 7.6 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -174.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.8 p -75.45 36.93 0.13 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.836 1.654 . . . . 0.0 114.287 -165.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 33.39 -97.94 0.01 OUTLIER Glycine 0 CA--C 1.536 1.381 0 C-N-CA 128.913 3.149 . . . . 0.0 114.464 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.67 -15.76 33.14 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.751 2.967 . . . . 0.0 115.053 -175.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.3 p -54.4 -32.33 56.95 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.347 0.976 . . . . 0.0 111.96 167.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttp85 -67.03 -12.03 58.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.771 0.828 . . . . 0.0 112.66 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.5 mtp -110.09 -20.4 12.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.716 1.606 . . . . 0.0 111.846 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.4 ttt -80.61 -44.31 19.12 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 124.52 1.128 . . . . 0.0 109.412 170.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.66 -47.6 78.43 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 116.802 -1.571 . . . . 0.0 113.528 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.25 -29.9 25.55 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.098 1.865 . . . . 0.0 112.719 171.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.8 -30.12 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 120.216 1.371 . . . . 0.0 111.007 171.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.3 mt -80.02 -18.04 51.24 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.959 1.704 . . . . 0.0 111.212 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.83 -41.92 58.99 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.057 0.943 . . . . 0.0 110.299 162.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.87 -15.51 62.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.676 1.19 . . . . 0.0 111.498 171.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.406 ' CE2' HD12 ' A' ' 96' ' ' LEU . 31.9 t80 -85.29 -49.0 8.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.221 1.808 . . . . 0.0 109.025 167.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.29 -32.22 66.42 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.17 -0.919 . . . . 0.0 113.363 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.29 -57.35 5.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.03 1.286 . . . . 0.0 110.919 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.68 -22.47 35.04 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -159.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.9 30.21 1.18 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.886 1.275 . . . . 0.0 111.114 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -20.29 -63.4 0.02 OUTLIER 'General case' 0 C--N 1.341 0.196 0 C-N-CA 128.94 2.896 . . . . 0.0 115.314 -170.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -108.12 8.1 27.94 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -169.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -70.88 -26.06 63.07 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.982 0.81 . . . . 0.0 109.682 158.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.79 170.26 15.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.192 0.997 . . . . 0.0 110.9 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.267 10.7 t -124.91 103.64 8.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 158.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.6 t -70.08 155.75 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.09 111.42 3.91 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 6.0 tttp -89.19 130.72 35.57 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -172.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.37 143.15 24.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.927 0.87 . . . . 0.0 112.77 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -81.14 117.69 21.91 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.1 p -51.8 -32.2 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.503 1.121 . . . . 0.0 113.801 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -67.79 -29.76 69.03 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.191 1.797 . . . . 0.0 112.488 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -23.77 60.69 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.979 1.312 . . . . 0.0 112.462 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -126.21 87.36 56.32 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 125.237 1.415 . . . . 0.0 109.735 -163.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.55 -29.87 15.72 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.875 2.383 . . . . 0.0 113.712 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 64' ' ' THR . 8.3 tp10 -73.8 137.55 43.93 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.741 1.155 . . . . 0.0 110.73 -173.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.7 m 64.09 -31.01 0.11 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 130.123 3.369 . . . . 0.0 112.822 -169.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 62' ' ' GLU . 52.2 m -58.08 -57.35 13.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.572 1.949 . . . . 0.0 109.45 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -57.78 -46.25 84.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.053 0.541 . . . . 0.0 109.874 178.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -58.39 -35.59 72.25 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.024 0.93 . . . . 0.0 112.758 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -100.55 9.83 42.01 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.191 0.597 . . . . 0.0 112.118 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.24 29.05 74.34 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 119.1 0.864 . . . . 0.0 112.927 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mm -77.13 81.38 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.333 1.453 . . . . 0.0 109.915 -166.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.6 mmt -123.89 -0.98 8.41 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.726 1.61 . . . . 0.0 111.103 166.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.4 t -77.9 30.07 0.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.161 1.785 . . . . 0.0 113.077 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.472 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -67.96 148.44 98.4 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.384 0.538 . . . . 0.0 111.828 -172.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 62.3 Cg_endo -66.36 128.74 9.56 Favored 'Cis proline' 0 C--N 1.35 0.635 0 CA-C-N 119.73 0.939 . . . . 0.0 111.493 4.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.1 m -123.76 151.87 42.79 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 122.207 1.003 . . . . 0.0 108.838 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.9 tt -131.87 130.21 41.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 mt -130.28 141.24 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 165.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.72 119.55 39.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 175.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -117.32 161.22 19.86 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.979 2.112 . . . . 0.0 112.391 -175.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.41 157.33 19.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.65 2.38 . . . . 0.0 108.668 159.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.42 14.83 14.28 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.94 1.257 . . . . 0.0 115.394 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.87 -6.02 58.38 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.625 1.584 . . . . 0.0 113.543 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -129.01 157.44 75.84 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 119.183 1.492 . . . . 0.0 110.689 -170.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.74 166.78 24.96 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.31 2.007 . . . . 0.0 111.55 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.44 -34.8 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.734 1.214 . . . . 0.0 108.505 158.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -162.02 165.77 26.88 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.495 1.118 . . . . 0.0 109.978 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -136.45 143.26 43.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.937 2.495 . . . . 0.0 106.397 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.7 mt -132.55 153.4 51.01 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.618 1.567 . . . . 0.0 108.194 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.2 pt -143.85 143.61 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.052 1.341 . . . . 0.0 108.075 -173.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.64 161.94 26.36 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.783 0.706 . . . . 0.0 111.903 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -75.25 78.55 2.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.083 0.953 . . . . 0.0 111.526 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -69.63 140.86 89.79 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 166.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.85 160.25 49.98 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.748 1.632 . . . . 0.0 110.404 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.91 -45.88 42.13 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.93 1.292 . . . . 0.0 112.814 -171.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -74.09 -25.1 59.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.455 -172.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -73.8 -37.67 64.85 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.406 HD12 ' CE2' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -59.0 -61.26 2.78 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.165 1.386 . . . . 0.0 108.813 175.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -64.94 -25.78 68.02 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.22 -0.895 . . . . 0.0 112.229 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.21 -53.88 12.89 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.856 0.753 . . . . 0.0 110.494 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -62.19 -35.07 77.74 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.148 0.579 . . . . 0.0 112.302 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.83 1.85 56.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.645 1.178 . . . . 0.0 112.751 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.15 -31.97 54.0 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 120.082 1.31 . . . . 0.0 113.511 -174.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -65.4 -14.41 60.82 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.954 0.901 . . . . 0.0 113.295 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 66.0 t -109.06 -5.57 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.574 1.55 . . . . 0.0 110.858 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.47 -5.85 14.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.791 1.236 . . . . 0.0 112.741 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.099 0 C-N-CA 126.946 2.099 . . . . 0.0 110.552 164.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.708 ' HB2' HD23 ' A' ' 55' ' ' LEU . 58.0 mt . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.0 m -125.17 -88.53 0.59 Allowed 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -140.03 -66.25 0.45 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.858 0.863 . . . . 0.0 109.132 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.68 -30.83 45.28 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.666 -0.646 . . . . 0.0 111.912 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -72.32 -26.3 61.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.103 0.561 . . . . 0.0 110.688 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.423 ' HD2' HD21 ' A' ' 55' ' ' LEU . 50.3 t80 -58.0 -62.83 1.53 Allowed 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.021 0.929 . . . . 0.0 109.678 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.443 ' HA ' HG12 ' A' ' 14' ' ' ILE . 20.9 tt0 -60.39 -42.43 95.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.841 0.456 . . . . 0.0 110.502 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -64.12 -25.65 68.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.66 1.184 . . . . 0.0 112.962 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.08 -61.53 1.97 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.232 0.924 . . . . 0.0 110.058 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 11' ' ' GLN . 43.2 pt -59.07 -20.34 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -167.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -60.67 -19.05 57.36 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.344 1.458 . . . . 0.0 113.321 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.95 157.51 48.6 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 119.452 1.024 . . . . 0.0 111.631 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -76.94 -36.28 56.69 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.846 1.659 . . . . 0.0 111.443 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.22 161.97 47.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 123.814 0.721 . . . . 0.0 111.721 177.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.29 107.88 0.74 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.591 2.86 . . . . 0.0 110.948 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.466 HG22 ' HB ' ' A' ' 51' ' ' THR . 71.4 t -98.45 141.96 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 167.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.53 153.5 44.91 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 118.565 0.62 . . . . 0.0 111.033 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.02 126.85 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 22.4 t0 -80.12 121.2 25.26 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.953 0.783 . . . . 0.0 108.915 161.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.418 ' CD1' HG23 ' A' ' 57' ' ' VAL . 63.6 m-85 -98.26 107.16 19.56 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.045 0.938 . . . . 0.0 108.684 163.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -124.08 -177.7 3.85 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.905 1.282 . . . . 0.0 107.992 172.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.61 165.96 33.21 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.971 1.308 . . . . 0.0 108.832 170.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.66 -3.04 7.9 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -174.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.562 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -117.27 -24.58 7.39 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.81 1.187 . . . . 0.0 114.155 -175.237 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.73 93.79 2.63 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.196 0.907 . . . . 0.0 111.845 -163.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -19.32 -71.11 0.01 OUTLIER Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.538 2.018 . . . . 0.0 115.567 173.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.17 -29.46 47.48 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.16 2.574 . . . . 0.0 114.303 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.9 p -64.66 -27.7 69.11 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.513 1.051 . . . . 0.0 110.771 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -19.57 65.96 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.405 173.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -101.95 -23.89 14.07 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.935 1.294 . . . . 0.0 112.486 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.0 tpt -75.99 -47.28 25.54 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 125.917 1.687 . . . . 0.0 108.494 173.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.73 -48.15 70.43 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 120.133 1.333 . . . . 0.0 113.617 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.78 -33.02 21.88 Favored 'Trans proline' 0 C--N 1.352 0.741 0 CA-C-N 122.061 1.772 . . . . 0.0 112.53 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.49 -35.13 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.856 1.207 . . . . 0.0 110.526 173.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.3 mt -72.14 -21.7 61.42 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 125.929 1.692 . . . . 0.0 111.199 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.27 -52.68 31.11 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 170.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -71.34 -19.91 62.24 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -67.08 -60.06 2.94 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.044 1.338 . . . . 0.0 108.963 165.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.74 -49.55 65.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.821 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -53.93 -42.41 68.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.81 1.244 . . . . 0.0 111.262 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.35 -15.27 62.38 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -158.43 57.65 0.45 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.074 1.349 . . . . 0.0 109.462 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.02 -14.51 62.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.596 0.758 . . . . 0.0 112.086 -172.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -109.37 -55.22 2.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.383 3.473 . . . . 0.0 110.646 -172.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -53.72 -31.47 48.3 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 126.268 1.827 . . . . 0.0 112.444 -172.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 m -130.13 150.52 34.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.466 ' HB ' HG22 ' A' ' 20' ' ' VAL . 97.3 m -82.79 71.62 9.88 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 172.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.76 147.56 7.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 124.397 1.079 . . . . 0.0 109.936 175.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.65 163.02 40.01 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.186 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 51.3 pttt -128.26 143.14 51.0 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 123.736 0.648 . . . . 0.0 110.904 159.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.708 HD23 ' HB2' ' A' ' 5' ' ' LEU . 1.3 pp -146.29 154.34 41.58 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 124.974 1.421 . . . . 0.0 109.515 176.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -77.54 129.24 35.41 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 24' ' ' PHE . 3.3 p -68.06 -20.39 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.174 -0.953 . . . . 0.0 112.003 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.75 -17.38 55.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.593 0.757 . . . . 0.0 111.266 172.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.23 -34.5 21.99 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.3 1.84 . . . . 0.0 110.147 173.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -106.4 93.43 8.26 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 124.825 1.25 . . . . 0.0 111.264 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.18 -25.71 9.81 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.976 2.451 . . . . 0.0 113.75 164.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -58.89 119.24 6.84 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.752 1.16 . . . . 0.0 111.169 -177.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.268 16.4 m 63.58 -15.64 0.07 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.281 2.232 . . . . 0.0 113.795 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.7 m -53.03 -56.06 18.97 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.102 1.361 . . . . 0.0 108.844 167.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.6 t -72.18 0.39 9.87 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 117.821 -1.085 . . . . 0.0 112.899 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -108.3 -36.05 6.37 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.454 1.101 . . . . 0.0 111.177 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -104.06 10.0 36.21 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.033 0.833 . . . . 0.0 111.108 -175.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.62 32.11 59.84 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 123.918 0.77 . . . . 0.0 112.249 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.9 mm -75.23 83.25 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.999 0.919 . . . . 0.0 109.617 -170.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.2 ttp -128.07 -10.34 5.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.401 1.08 . . . . 0.0 111.342 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.4 t -87.22 56.62 4.06 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.428 1.091 . . . . 0.0 109.36 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.562 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 34.6 pt -81.96 148.43 60.67 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.183 -174.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.411 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 57.2 Cg_endo -66.77 125.02 6.16 Favored 'Cis proline' 0 C--N 1.35 0.62 0 CA-C-N 119.589 0.889 . . . . 0.0 110.925 -0.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.8 m -109.22 143.91 38.04 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.6 tt -129.4 132.93 47.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 171.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.1 mt -130.43 144.9 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.29 132.96 56.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.85 163.03 30.0 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.454 1.902 . . . . 0.0 111.778 -169.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.47 148.47 18.06 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 125.696 1.598 . . . . 0.0 108.554 157.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.87 19.99 38.98 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 123.904 0.764 . . . . 0.0 113.101 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.91 -7.4 51.2 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.197 1.38 . . . . 0.0 113.971 -170.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -84.3 118.9 72.33 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 119.297 1.548 . . . . 0.0 108.751 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.15 109.09 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.37 2.713 . . . . 0.0 109.853 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 m -71.1 -37.27 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.641 -0.662 . . . . 0.0 111.428 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -156.98 160.62 39.21 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.199 0.6 . . . . 0.0 111.846 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -128.8 142.55 50.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.713 2.405 . . . . 0.0 107.526 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.407 HD11 ' HG2' ' A' ' 99' ' ' GLN . 4.1 mm? -120.09 149.95 41.38 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.999 2.12 . . . . 0.0 107.044 165.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.47 132.52 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.353 1.461 . . . . 0.0 107.102 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.16 166.92 26.85 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.405 1.002 . . . . 0.0 112.135 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -76.83 74.56 3.46 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.505 1.122 . . . . 0.0 109.409 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -76.81 122.83 87.17 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 171.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.25 166.72 22.38 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.756 1.637 . . . . 0.0 110.441 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.427 ' HE3' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -47.98 -50.52 27.14 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.895 1.278 . . . . 0.0 112.412 -175.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.48 -19.71 65.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.73 -56.07 3.45 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.8 tt -55.99 -60.52 3.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.505 1.922 . . . . 0.0 109.394 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.427 ' OE1' ' HE3' ' A' ' 93' ' ' LYS . 6.3 tt0 -68.67 -17.4 64.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.493 1.117 . . . . 0.0 111.392 -176.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.84 -52.13 9.38 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 119.472 1.033 . . . . 0.0 110.069 166.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.407 ' HG2' HD11 ' A' ' 87' ' ' LEU . 18.6 tp60 -60.5 -27.52 67.65 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.966 0.907 . . . . 0.0 112.047 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.94 0.39 41.08 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.37 1.868 . . . . 0.0 112.988 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.89 -34.53 67.97 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.978 0.911 . . . . 0.0 112.746 -171.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -66.02 -11.92 51.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.508 1.523 . . . . 0.0 113.45 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.16 8.89 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.197 1.399 . . . . 0.0 111.552 171.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.2 -0.23 12.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.513 1.525 . . . . 0.0 113.529 169.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.363 1.865 . . . . 0.0 108.797 172.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.215 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.5 p -117.35 -89.0 0.59 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 158.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 8' ' ' ALA . 9.1 p-10 -142.84 -73.24 0.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.416 1.486 . . . . 0.0 108.014 -159.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.442 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . -54.14 -32.24 54.7 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.042 0.937 . . . . 0.0 111.291 170.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -81.7 -15.6 53.91 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 119.238 -0.985 . . . . 0.0 112.089 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -66.89 -54.13 25.25 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.145 0.884 . . . . 0.0 109.143 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -65.78 -23.05 66.63 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.604 0.761 . . . . 0.0 111.694 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -73.64 -49.11 27.64 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.152 0.887 . . . . 0.0 110.844 167.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.61 -39.57 91.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.962 0.801 . . . . 0.0 111.801 -171.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 14' ' ' ILE . 9.0 tt -58.26 -22.16 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.21 1.404 . . . . 0.0 113.38 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -56.06 -36.75 68.43 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.478 1.511 . . . . 0.0 113.874 -159.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.49 133.92 2.0 Allowed Glycine 0 C--N 1.334 0.428 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 -170.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -174.74 -55.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.836 1.654 . . . . 0.0 107.964 -166.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.73 -157.65 27.47 Favored Glycine 0 CA--C 1.534 1.281 0 N-CA-C 105.064 -3.214 . . . . 0.0 105.064 -158.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.17 103.66 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.205 2.604 . . . . 0.0 111.347 168.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.4 t -88.99 127.42 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 168.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 tt -132.19 122.99 26.15 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -172.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.99 119.74 62.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -172.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -97.07 94.13 6.98 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -176.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.457 ' CD1' HG23 ' A' ' 57' ' ' VAL . 29.9 m-85 -82.46 110.63 17.75 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.133 1.373 . . . . 0.0 108.871 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 16.5 p-90 -125.82 177.07 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.25 164.35 32.59 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.753 1.221 . . . . 0.0 108.953 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.58 -8.74 56.71 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -123.86 -13.88 7.3 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.7 p -70.22 39.19 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -158.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 42.87 -99.03 0.01 OUTLIER Glycine 0 CA--C 1.536 1.389 0 C-N-CA 127.572 2.51 . . . . 0.0 114.764 169.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -58.58 -19.02 42.88 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.862 3.041 . . . . 0.0 114.166 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 14.9 p -60.03 -22.68 62.95 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 119.188 0.904 . . . . 0.0 112.235 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -14.94 61.72 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.12 1.327 . . . . 0.0 112.451 173.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.2 mtm -100.43 -32.46 10.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.647 1.579 . . . . 0.0 111.054 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.2 ttt -72.91 -43.18 62.72 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-O 117.811 -1.09 . . . . 0.0 109.142 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.59 -45.97 85.41 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 116.595 -1.669 . . . . 0.0 113.213 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.5 -45.51 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.628 1.552 . . . . 0.0 111.79 167.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -30.17 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 121.71 2.05 . . . . 0.0 112.133 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 mt -68.7 -13.01 62.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 128.667 2.787 . . . . 0.0 112.252 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.88 -46.38 8.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.296 1.038 . . . . 0.0 109.851 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.89 -40.78 70.13 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.519 1.054 . . . . 0.0 110.665 165.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.456 ' CE1' HD22 ' A' ' 96' ' ' LEU . 79.0 t80 -56.14 -60.07 4.02 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.922 0.889 . . . . 0.0 110.235 171.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.69 -49.68 67.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.632 0.651 . . . . 0.0 111.861 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.1 -48.52 64.7 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.514 1.526 . . . . 0.0 110.547 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.93 -12.6 11.77 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -150.61 61.85 0.94 Allowed 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.268 1.427 . . . . 0.0 108.502 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.04 -45.41 64.67 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.634 1.574 . . . . 0.0 111.413 -169.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -136.41 9.75 3.19 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -61.94 -32.84 73.3 Favored 'General case' 0 C--N 1.345 0.403 0 O-C-N 121.413 -0.805 . . . . 0.0 110.201 163.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.0 m -119.71 143.37 31.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.341 1.1 t -82.21 73.59 9.24 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 124.259 1.981 . . . . 0.0 106.596 166.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.4 148.28 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 113.642 -1.617 . . . . 0.0 107.957 165.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.82 158.8 44.58 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.099 1.36 . . . . 0.0 107.631 170.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -133.05 124.82 28.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.76 152.13 46.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.67 1.224 . . . . 0.0 113.054 -177.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -85.22 110.17 18.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.051 1.74 . . . . 0.0 108.835 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.457 HG23 ' CD1' ' A' ' 24' ' ' PHE . 3.0 p -60.99 -26.19 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.039 0.936 . . . . 0.0 112.754 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -70.78 -22.69 62.34 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 126.547 1.939 . . . . 0.0 111.182 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.61 -38.74 13.72 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.589 1.156 . . . . 0.0 111.021 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -105.05 106.43 55.52 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.705 -169.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.89 -22.42 6.24 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.047 2.498 . . . . 0.0 114.316 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -66.41 118.55 10.22 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.325 0.966 . . . . 0.0 108.766 -173.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.272 25.9 m 67.65 -17.75 0.15 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.817 2.847 . . . . 0.0 112.659 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -54.5 -54.9 34.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.125 1.77 . . . . 0.0 108.895 160.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -57.97 -46.8 84.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.55 0.74 . . . . 0.0 110.356 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -55.06 -35.37 64.46 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.543 1.137 . . . . 0.0 112.899 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -111.09 14.75 21.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.232 0.613 . . . . 0.0 112.258 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.39 31.2 80.07 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 118.962 0.801 . . . . 0.0 113.114 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.7 mm -76.54 81.98 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.102 1.361 . . . . 0.0 110.288 -165.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.6 mmt -130.27 3.82 4.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.19 1.396 . . . . 0.0 111.424 165.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 t -78.89 37.44 0.3 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.232 1.813 . . . . 0.0 110.966 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.479 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -78.74 151.27 76.71 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 121.324 -0.86 . . . . 0.0 111.427 -169.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 61.3 Cg_endo -64.7 123.98 4.06 Favored 'Cis proline' 0 C--N 1.349 0.583 0 CA-C-N 119.861 0.986 . . . . 0.0 111.107 4.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.3 m -118.69 154.22 33.08 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 tt -146.3 122.7 10.99 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 104.673 -2.344 . . . . 0.0 104.673 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.8 mt -123.37 139.08 51.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 119.55 39.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.569 1.948 . . . . 0.0 105.822 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -122.26 169.16 11.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.797 2.439 . . . . 0.0 108.062 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.474 ' C ' ' HE3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -153.33 40.13 0.52 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.344 -0.847 . . . . 0.0 112.417 -179.718 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.92 87.41 1.91 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -167.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.69 -23.35 3.02 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 130.585 3.945 . . . . 0.0 114.422 160.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -131.94 149.3 72.95 Favored Pre-proline 0 N--CA 1.445 -0.69 0 C-N-CA 125.379 1.472 . . . . 0.0 110.182 -171.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.12 159.94 30.05 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.848 2.366 . . . . 0.0 111.043 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -38.67 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.239 1.416 . . . . 0.0 110.383 165.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -161.11 171.91 17.7 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 119.317 0.962 . . . . 0.0 111.381 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -139.05 150.38 45.7 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.24 2.216 . . . . 0.0 108.649 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.76 150.61 40.12 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.148 1.779 . . . . 0.0 107.632 161.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.9 pt -143.33 137.36 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 126.269 1.827 . . . . 0.0 108.082 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.55 167.37 18.01 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.163 0.887 . . . . 0.0 111.762 -174.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -57.01 110.72 0.87 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.906 0.883 . . . . 0.0 111.183 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -101.33 133.84 20.66 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 160.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.97 158.14 58.2 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 CA-C-N 120.287 1.138 . . . . 0.0 109.161 164.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.35 -52.52 2.7 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.149 1.78 . . . . 0.0 110.843 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.19 -31.66 69.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.017 1.727 . . . . 0.0 113.103 -175.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -85.31 -47.27 10.19 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 119.244 0.929 . . . . 0.0 109.906 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.456 HD22 ' CE1' ' A' ' 42' ' ' PHE . 1.3 tt -56.53 -61.89 2.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.305 2.642 . . . . 0.0 108.999 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -63.24 -29.26 70.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.585 1.154 . . . . 0.0 110.827 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.64 -49.15 33.75 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.39 0.995 . . . . 0.0 110.732 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -56.86 -43.24 80.99 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.479 0.712 . . . . 0.0 110.828 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.68 -0.27 55.95 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.51 1.124 . . . . 0.0 113.324 -176.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.16 -28.82 63.12 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.232 1.413 . . . . 0.0 113.4 -170.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -63.25 -22.09 66.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.15 0.98 . . . . 0.0 113.393 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.11 -15.87 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 118.862 0.756 . . . . 0.0 111.14 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -10.38 56.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.01 1.324 . . . . 0.0 112.49 169.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.249 1.042 0 C-N-CA 129.608 3.163 . . . . 0.0 111.182 161.929 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 mt . . . . . 0 C--O 1.23 0.068 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.9 p -127.01 170.13 12.62 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 163.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -53.39 -55.52 24.34 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 127.886 2.475 . . . . 0.0 111.412 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.4 81.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.226 0.611 . . . . 0.0 110.084 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -75.09 -20.23 59.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.248 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -58.36 -63.93 1.1 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.14 -46.81 89.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.017 0.527 . . . . 0.0 110.787 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.23 -20.02 65.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.094 -174.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.14 -58.13 3.09 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.4 1.0 . . . . 0.0 110.213 165.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.2 pt -62.41 -20.05 23.8 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -169.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -57.36 -24.62 56.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.137 0.975 . . . . 0.0 113.038 172.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.24 112.57 0.26 Allowed Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -157.96 -75.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.489 1.515 . . . . 0.0 109.137 -175.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.69 -166.25 30.75 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 -159.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.32 83.87 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.703 3.602 . . . . 0.0 112.226 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.7 t -94.06 124.12 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 125.743 1.617 . . . . 0.0 106.848 171.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.74 146.64 44.6 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.52 0.676 . . . . 0.0 111.964 170.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.3 t -131.54 108.41 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -161.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -83.46 100.75 10.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.345 1.058 . . . . 0.0 109.155 174.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -78.54 108.61 12.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 166.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -123.17 176.06 6.29 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.39 155.73 31.03 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 120.884 -1.135 . . . . 0.0 110.825 166.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.49 -12.81 61.21 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -173.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.69 -12.37 31.63 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.572 1.078 . . . . 0.0 112.772 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.4 p -67.24 173.72 3.7 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.436 0.636 . . . . 0.0 112.469 -164.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.35 -86.63 1.89 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 162.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.24 -20.78 55.64 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.96 2.44 . . . . 0.0 114.336 -167.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.67 -33.66 68.57 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.8 1.182 . . . . 0.0 111.128 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -74.05 -11.82 60.44 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.572 -0.727 . . . . 0.0 112.516 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.6 ptm -104.23 -21.64 13.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.923 1.289 . . . . 0.0 112.079 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.1 ttt -83.82 -44.4 14.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.89 1.676 . . . . 0.0 108.969 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.2 -47.26 82.56 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 117.541 -1.219 . . . . 0.0 113.324 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.87 -31.48 38.4 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.918 1.721 . . . . 0.0 112.445 172.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.23 -39.03 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.813 1.188 . . . . 0.0 110.511 172.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.8 mt -69.23 -20.01 63.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.227 1.411 . . . . 0.0 111.831 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -69.98 -45.57 67.07 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.673 0.789 . . . . 0.0 110.092 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -62.1 -44.28 96.99 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.529 0.331 . . . . 0.0 110.289 171.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.22 -44.9 84.17 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.772 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.72 -53.51 46.75 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.054 0.942 . . . . 0.0 110.745 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.01 -46.8 87.28 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.184 0.994 . . . . 0.0 111.069 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.8 -26.57 14.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.051 1.341 . . . . 0.0 114.414 -173.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.05 29.67 4.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.415 1.486 . . . . 0.0 111.826 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -14.26 -61.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 131.421 3.888 . . . . 0.0 116.028 -172.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -114.08 -14.53 12.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.386 1.874 . . . . 0.0 113.134 -168.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -66.42 -31.96 73.04 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.231 0.923 . . . . 0.0 110.276 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.12 171.56 17.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 122.706 0.402 . . . . 0.0 110.216 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.5 t -124.45 137.77 54.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.102 0.477 . . . . 0.0 110.005 172.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.86 154.74 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 125.255 1.422 . . . . 0.0 107.313 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.95 138.04 20.35 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -117.45 136.46 53.18 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 118.898 0.772 . . . . 0.0 109.338 170.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -144.38 146.46 32.54 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.175 0.988 . . . . 0.0 113.446 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -75.16 104.14 5.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.007 1.723 . . . . 0.0 107.826 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.534 HG11 HG21 ' A' ' 72' ' ' ILE . 4.7 p -70.15 -20.56 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -166.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.87 -43.08 90.78 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.076 1.35 . . . . 0.0 110.566 169.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -89.23 -25.36 21.78 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.636 1.974 . . . . 0.0 112.316 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -105.33 90.08 3.65 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 118.404 0.547 . . . . 0.0 111.24 164.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.9 -12.67 17.82 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.872 2.381 . . . . 0.0 114.042 166.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -72.87 129.17 37.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.667 1.121 . . . . 0.0 109.078 -176.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.5 m 64.33 -25.12 0.08 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.943 3.297 . . . . 0.0 112.466 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 62' ' ' GLU . 41.7 m -50.31 -61.59 2.08 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 128.328 2.651 . . . . 0.0 109.214 165.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.1 t -57.45 -46.49 83.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.95 0.5 . . . . 0.0 109.881 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -58.59 -38.58 78.25 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.4 1.08 . . . . 0.0 112.451 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -95.22 12.0 30.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.848 0.749 . . . . 0.0 111.461 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.36 25.64 73.65 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 118.78 0.718 . . . . 0.0 112.635 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.8 mm -73.65 94.89 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.86 1.264 . . . . 0.0 109.312 -169.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.14 -21.37 3.61 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.366 1.466 . . . . 0.0 110.861 175.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 p -81.58 47.76 1.1 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.115 2.566 . . . . 0.0 112.333 -162.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.534 HG21 HG11 ' A' ' 57' ' ' VAL . 45.6 pt -76.16 153.53 84.39 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -169.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.421 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 41.1 Cg_endo -62.85 128.27 6.06 Favored 'Cis proline' 0 C--N 1.351 0.693 0 N-CA-C 110.238 -0.716 . . . . 0.0 110.238 -7.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 m -115.41 132.64 56.56 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tt -125.43 116.82 22.44 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 mt -120.17 143.03 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 tt -118.9 119.83 35.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -111.48 166.91 10.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.577 1.951 . . . . 0.0 110.356 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -161.67 127.75 3.72 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 126.22 1.808 . . . . 0.0 106.714 158.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 47.8 42.87 22.25 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.633 0.635 . . . . 0.0 113.771 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.12 -7.05 82.63 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 117.859 -1.523 . . . . 0.0 115.146 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -101.03 104.34 31.54 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 120.094 1.947 . . . . 0.0 111.243 -173.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.88 90.25 1.09 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.799 3.0 . . . . 0.0 111.189 171.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 m -63.45 -21.35 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.04 158.03 34.04 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.896 0.878 . . . . 0.0 110.699 160.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -118.36 136.5 53.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.126 2.17 . . . . 0.0 105.958 163.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.07 147.53 41.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.182 2.193 . . . . 0.0 105.637 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.4 pt -140.9 142.67 29.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.779 1.231 . . . . 0.0 107.987 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.21 167.3 27.76 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 123.892 0.745 . . . . 0.0 111.658 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -72.22 79.09 0.97 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.892 0.877 . . . . 0.0 110.088 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -76.45 129.63 79.28 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 162.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -68.45 167.8 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.053 1.835 . . . . 0.0 109.832 175.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.36 -42.56 61.41 Favored 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 123.595 0.758 . . . . 0.0 110.245 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -75.14 -2.34 27.28 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.758 1.223 . . . . 0.0 111.505 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -112.13 -49.56 2.96 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 125.845 1.658 . . . . 0.0 109.221 172.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.0 tt -52.04 -66.44 0.38 Allowed 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 127.2 2.2 . . . . 0.0 110.418 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -63.55 -20.65 65.81 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.69 1.196 . . . . 0.0 111.952 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.67 -48.09 41.98 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.533 1.06 . . . . 0.0 110.665 172.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -59.49 -51.16 71.04 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.928 0.891 . . . . 0.0 110.223 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 mt -75.04 -5.36 43.65 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 126.129 1.771 . . . . 0.0 112.753 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.62 -26.71 34.56 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 124.541 1.136 . . . . 0.0 111.632 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -6.49 9.14 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.802 1.241 . . . . 0.0 113.657 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.62 -14.14 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 162.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.05 -7.86 59.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.211 -0.931 . . . . 0.0 112.249 170.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 C--O 1.247 0.956 0 C-N-CA 127.398 2.279 . . . . 0.0 108.154 158.858 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 N--CA 1.462 0.171 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.0 p -112.42 -105.63 0.38 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 167.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -126.06 -64.72 1.03 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.095 2.158 . . . . 0.0 108.932 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.63 -30.63 61.29 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.764 -0.585 . . . . 0.0 112.075 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.04 -22.59 59.5 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.163 -0.446 . . . . 0.0 111.254 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -64.06 -58.7 5.89 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.841 0.746 . . . . 0.0 109.829 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -59.59 -34.98 73.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.833 0.453 . . . . 0.0 110.978 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -62.82 -53.31 56.27 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.901 -0.499 . . . . 0.0 110.685 171.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.95 -43.99 97.92 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.423 0.689 . . . . 0.0 111.654 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 pt -59.95 -23.59 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -11.06 60.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.542 0.737 . . . . 0.0 111.85 177.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.06 131.19 48.28 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 174.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -87.0 35.65 0.7 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.635 0.774 . . . . 0.0 112.702 -165.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -142.13 179.93 19.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.398 1.475 . . . . 0.0 110.238 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.57 93.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.296 3.331 . . . . 0.0 111.585 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.0 t -100.34 126.42 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 127.35 2.26 . . . . 0.0 106.078 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.541 HD11 HD21 ' A' ' 75' ' ' LEU . 15.8 tp -126.77 120.92 30.51 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.866 -0.521 . . . . 0.0 110.275 -167.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -100.4 133.65 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 118.698 0.681 . . . . 0.0 109.92 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -93.2 107.86 19.59 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 159.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.472 ' CD1' HG23 ' A' ' 57' ' ' VAL . 47.5 m-85 -82.7 111.96 19.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 162.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -119.71 -174.36 2.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.506 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -147.6 161.42 41.18 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 121.394 -0.817 . . . . 0.0 111.508 168.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.83 6.38 0.24 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.433 1.493 . . . . 0.0 115.02 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.42 ' CG ' ' N ' ' A' ' 29' ' ' CYS . 3.5 p90 -124.31 -66.72 0.96 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 163.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 28' ' ' TRP . 16.4 t 36.16 -91.52 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 129.896 3.278 . . . . 0.0 114.614 175.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.66 -91.54 0.56 Allowed Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.624 1.583 . . . . 0.0 111.074 -172.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.07 -19.24 68.5 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.99 3.127 . . . . 0.0 115.066 -168.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 p -51.51 -35.21 39.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.83 0.741 . . . . 0.0 111.722 165.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -66.13 -14.26 61.5 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.547 1.067 . . . . 0.0 112.54 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.8 mtp -105.57 -15.58 14.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.295 1.838 . . . . 0.0 111.407 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.6 ttt -93.95 -34.93 12.88 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 126.322 1.849 . . . . 0.0 109.227 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.26 -50.62 63.21 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.651 1.58 . . . . 0.0 113.02 171.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.91 -35.48 55.29 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 122.127 1.796 . . . . 0.0 111.815 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -61.79 -39.82 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 118.809 0.731 . . . . 0.0 110.079 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.6 mp -68.3 -32.09 71.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.936 2.094 . . . . 0.0 112.211 174.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -68.5 -49.87 56.42 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.026 0.931 . . . . 0.0 108.957 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -56.51 -47.7 78.79 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.277 0.56 . . . . 0.0 110.274 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -58.18 -42.98 87.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.646 1.178 . . . . 0.0 111.051 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.27 59.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.367 1.067 . . . . 0.0 110.218 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -52.61 -45.87 66.76 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.503 0.592 . . . . 0.0 110.589 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.82 -10.68 58.18 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -139.09 3.72 2.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -168.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -24.32 -52.96 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 129.318 3.047 . . . . 0.0 116.258 -158.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . 0.27 2.8 m-20 -125.32 10.7 8.03 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -70.68 -26.63 63.52 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 119.556 1.071 . . . . 0.0 108.665 158.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.79 174.32 12.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 126.12 1.768 . . . . 0.0 110.023 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.262 0.7 OUTLIER -137.51 112.71 9.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 159.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.04 159.17 2.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.228 0.537 . . . . 0.0 109.897 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.2 171.86 15.77 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.57 0.748 . . . . 0.0 109.177 172.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -139.69 131.49 27.52 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -170.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.43 151.25 33.7 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -85.12 115.7 23.07 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.441 1.896 . . . . 0.0 108.494 -178.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' A' ' 26' ' ' ALA . 2.3 p -64.99 -24.14 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.254 1.022 . . . . 0.0 113.017 -172.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.08 63.7 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.396 1.478 . . . . 0.0 109.988 174.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -65.06 -32.67 74.5 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.079 1.351 . . . . 0.0 111.947 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -110.08 87.32 5.81 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.206 1.002 . . . . 0.0 111.633 -174.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.61 -25.68 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.151 2.567 . . . . 0.0 114.445 170.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -73.22 137.89 45.26 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 120.49 1.495 . . . . 0.0 109.481 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.293 49.3 m 67.53 -23.97 0.12 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 129.495 3.118 . . . . 0.0 111.751 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.432 ' H ' ' C ' ' A' ' 62' ' ' GLU . 41.2 m -63.76 -71.9 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 127.917 2.487 . . . . 0.0 110.153 169.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -64.55 -28.4 69.61 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -59.0 -24.68 62.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.334 1.854 . . . . 0.0 111.856 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -120.91 13.51 11.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.85 1.26 . . . . 0.0 111.257 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.85 25.01 71.73 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 121.341 -0.849 . . . . 0.0 113.514 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.493 HD12 HG21 ' A' ' 74' ' ' THR . 23.2 mm -68.21 93.89 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.99 1.316 . . . . 0.0 110.167 -171.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -128.37 -13.22 4.96 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.101 1.36 . . . . 0.0 112.063 171.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.7 t -81.84 53.24 2.12 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.994 1.318 . . . . 0.0 111.457 -173.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.423 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 23.7 pt -70.84 153.03 95.01 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.188 0.995 . . . . 0.0 112.343 -176.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.423 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 39.7 Cg_endo -62.92 129.92 7.82 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 CA-C-N 119.087 0.71 . . . . 0.0 110.506 -8.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.493 HG21 HD12 ' A' ' 69' ' ' ILE . 24.7 m -112.83 141.85 46.17 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.541 HD21 HD11 ' A' ' 21' ' ' LEU . 5.4 tt -133.19 105.26 6.91 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -172.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.6 mt -109.12 128.86 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.415 HD13 HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -92.1 110.83 22.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 169.236 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -103.18 156.53 17.64 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.543 1.137 . . . . 0.0 109.462 170.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 127.16 11.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 163.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.84 27.39 59.21 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 118.321 0.51 . . . . 0.0 113.523 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.38 -12.58 69.35 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.959 1.743 . . . . 0.0 113.763 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -90.6 118.36 68.64 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 119.366 1.583 . . . . 0.0 109.689 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 85.01 1.18 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.582 2.855 . . . . 0.0 109.72 171.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -64.82 -38.82 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.344 1.057 . . . . 0.0 111.995 -176.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -142.28 156.05 45.26 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.483 1.038 . . . . 0.0 110.684 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.99 135.48 32.77 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.856 1.663 . . . . 0.0 107.952 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.1 mm? -122.01 146.71 46.9 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.356 2.262 . . . . 0.0 106.797 174.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.3 pt -143.23 119.17 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 124.598 1.159 . . . . 0.0 109.233 -169.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.9 170.57 41.63 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.491 1.52 . . . . 0.0 110.798 -169.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -66.44 93.12 0.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.868 1.267 . . . . 0.0 110.43 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -74.63 131.77 79.26 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 168.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.47 166.57 21.31 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.584 1.522 . . . . 0.0 109.593 165.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -47.48 73.2 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -177.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.1 -15.11 20.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.53 2.332 . . . . 0.0 113.181 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -101.35 -56.05 2.39 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 125.418 1.487 . . . . 0.0 108.703 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.48 -58.07 8.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.593 1.957 . . . . 0.0 109.782 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -26.94 68.61 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.247 1.019 . . . . 0.0 110.946 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.34 -44.87 42.87 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.505 1.048 . . . . 0.0 110.714 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -49.73 76.57 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.255 1.022 . . . . 0.0 109.967 172.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.83 -2.52 57.85 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.18 -34.45 14.54 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 119.429 1.013 . . . . 0.0 110.42 168.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.6 29.02 0.08 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.562 2.345 . . . . 0.0 112.16 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.35 -24.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.9 2.08 . . . . 0.0 111.204 158.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.15 -10.84 59.73 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.978 0.911 . . . . 0.0 112.343 172.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.258 0 C-N-CA 127.195 2.198 . . . . 0.0 109.167 165.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 53' ' ' ALA . 1.1 tp . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 121.806 0.812 . . . . 0.0 111.403 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.5 p -130.35 178.29 6.7 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 159.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -58.4 -57.99 10.47 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.614 1.566 . . . . 0.0 110.466 169.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.01 79.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.668 -0.645 . . . . 0.0 110.699 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -84.15 -19.32 34.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.949 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.46 ' HA ' HD21 ' A' ' 5' ' ' LEU . 21.9 t80 -58.74 -56.58 20.35 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 167.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -63.18 -46.07 88.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.748 0.819 . . . . 0.0 109.715 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.597 HE21 ' NE2' ' A' ' 15' ' ' GLN . 9.5 tp60 -63.47 -30.62 71.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.945 0.793 . . . . 0.0 112.336 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.22 -60.48 2.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.422 1.01 . . . . 0.0 110.048 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.37 -10.04 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.597 ' NE2' HE21 ' A' ' 12' ' ' GLN . 20.9 pt20 -46.58 -36.1 6.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.502 1.521 . . . . 0.0 112.818 -174.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.85 113.85 1.66 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 124.131 0.872 . . . . 0.0 112.808 165.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -152.56 -102.89 0.05 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 164.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.74 -138.13 6.37 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.545 1.545 . . . . 0.0 111.742 -168.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.75 85.87 0.92 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.371 3.381 . . . . 0.0 113.05 -167.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.3 t -97.26 140.32 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 170.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.19 124.43 20.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 O-C-N 121.689 -0.632 . . . . 0.0 109.411 164.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.92 142.44 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 172.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.8 89.27 3.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.502 1.144 . . . . 0.0 108.983 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 69' ' ' ILE . 74.8 m-85 -76.19 114.58 15.02 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.614 1.166 . . . . 0.0 109.27 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 16.4 p-90 -127.93 -171.52 2.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 168.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.77 160.38 41.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.082 -1.011 . . . . 0.0 110.393 169.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.6 -29.17 64.28 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.568 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.474 ' CH2' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -93.61 -26.95 16.87 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 p -71.66 164.98 24.93 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.221 0.919 . . . . 0.0 113.438 -159.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.84 -82.36 1.4 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.279 1.418 . . . . 0.0 112.653 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -60.7 -20.96 67.84 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.466 2.778 . . . . 0.0 113.077 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 17.7 p -59.21 -27.28 65.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.148 172.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.3 mtt85 -76.61 -12.76 60.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 120.477 1.489 . . . . 0.0 112.864 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 86.7 mtp -95.09 -33.0 12.84 Favored 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 124.843 1.257 . . . . 0.0 110.296 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.6 ttt -78.0 -36.18 49.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.416 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.67 -51.8 66.55 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.198 -1.382 . . . . 0.0 112.203 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.83 -38.14 40.85 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 121.735 1.655 . . . . 0.0 111.848 171.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.78 -14.36 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 119.576 1.08 . . . . 0.0 112.163 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.38 -16.36 18.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 128.669 2.788 . . . . 0.0 111.816 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.36 -40.7 29.56 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.672 1.123 . . . . 0.0 109.449 168.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -52.41 -51.02 61.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.739 0.816 . . . . 0.0 109.034 163.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.458 ' CD1' ' HE2' ' A' ' 93' ' ' LYS . 2.3 t80 -57.93 -48.77 78.95 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-O 118.652 -0.689 . . . . 0.0 110.889 177.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.81 -59.82 3.03 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.95 1.3 . . . . 0.0 109.63 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -60.21 -44.7 94.94 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 124.806 1.316 . . . . 0.0 111.343 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.56 -15.09 2.49 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.652 1.181 . . . . 0.0 113.939 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.97 35.37 1.75 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.46 1.104 . . . . 0.0 112.713 174.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.79 -37.54 8.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.83 1.652 . . . . 0.0 115.195 -165.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.4 7.74 4.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.737 1.215 . . . . 0.0 111.362 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -83.99 -27.13 28.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.719 1.607 . . . . 0.0 110.554 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.97 171.63 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.819 1.248 . . . . 0.0 108.788 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.306 6.6 t -110.49 85.95 2.21 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 123.529 1.633 . . . . 0.0 108.631 164.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -70.02 154.95 7.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.409 163.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.494 ' HB3' HD22 ' A' ' 5' ' ' LEU . . . -157.55 120.41 3.93 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.085 169.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -94.0 146.47 23.91 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.073 0.233 . . . . 0.0 111.405 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.97 154.51 35.12 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.638 0.732 . . . . 0.0 112.082 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -86.31 96.39 9.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.597 1.959 . . . . 0.0 107.885 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.401 HG11 HG21 ' A' ' 72' ' ' ILE . 1.1 p -66.22 -20.3 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 121.371 -0.831 . . . . 0.0 113.068 -167.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.5 -28.46 63.45 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.97 1.708 . . . . 0.0 111.676 170.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -109.44 -16.83 13.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.446 2.298 . . . . 0.0 111.821 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -112.53 79.67 3.22 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.217 1.807 . . . . 0.0 110.85 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.57 -88.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.572 2.848 . . . . 0.0 109.984 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 46.74 -17.12 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 131.344 3.858 . . . . 0.0 121.206 167.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.8 m 178.2 -25.43 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 130.806 3.642 . . . . 0.0 110.782 -171.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.404 HG23 ' HB ' ' A' ' 69' ' ' ILE . 37.2 m -44.39 -61.55 1.48 Allowed 'General case' 0 N--CA 1.458 -0.075 0 C-N-CA 127.574 2.35 . . . . 0.0 110.621 173.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -57.94 -45.66 86.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.777 0.831 . . . . 0.0 109.659 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -60.44 -28.12 68.04 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.075 1.35 . . . . 0.0 112.949 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -112.45 12.08 19.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.915 0.779 . . . . 0.0 111.571 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.33 24.58 74.96 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 121.334 -0.854 . . . . 0.0 114.203 173.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.417 HG21 ' CE2' ' A' ' 24' ' ' PHE . 40.8 mm -80.82 46.54 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 126.79 2.036 . . . . 0.0 111.269 -167.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.0 ttt -83.39 -8.25 59.43 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.237 -0.914 . . . . 0.0 110.17 162.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.2 p -75.77 16.52 0.39 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.251 2.22 . . . . 0.0 115.054 -164.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.474 HD11 ' CH2' ' A' ' 28' ' ' TRP . 28.4 pt -61.31 145.49 90.35 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.001 0.92 . . . . 0.0 112.361 -165.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 74.3 Cg_endo -67.57 135.53 29.29 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 118.25 0.411 . . . . 0.0 111.544 -1.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.6 m -133.44 140.6 47.39 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.049 0.94 . . . . 0.0 110.075 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt -135.65 99.13 4.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.028 1.731 . . . . 0.0 106.757 -170.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.8 mt -95.17 130.56 43.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.449 HD12 ' HG ' ' A' ' 100' ' ' LEU . 0.8 OUTLIER -92.46 123.28 35.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 171.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -113.82 148.45 36.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 172.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.608 ' HE3' HG21 ' A' ' 84' ' ' VAL . 12.7 ptpt -152.36 154.71 36.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 163.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.53 15.47 1.25 Allowed Glycine 0 CA--C 1.541 1.713 0 N-CA-C 117.134 1.614 . . . . 0.0 117.134 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.83 15.88 38.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-N 119.69 1.745 . . . . 0.0 112.995 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -134.97 128.0 18.49 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.195 1.398 . . . . 0.0 109.555 -167.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.83 87.32 1.41 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.914 3.076 . . . . 0.0 109.646 171.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.608 HG21 ' HE3' ' A' ' 79' ' ' LYS . 2.6 m -63.75 -36.3 76.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 O-C-N 121.503 -0.748 . . . . 0.0 112.456 -174.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 167.05 31.57 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 122.905 0.482 . . . . 0.0 111.106 170.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -134.66 134.06 40.74 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.3 1.84 . . . . 0.0 107.881 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.484 HD11 ' HG2' ' A' ' 99' ' ' GLN . 4.5 mm? -106.49 149.72 26.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.801 1.64 . . . . 0.0 107.529 167.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 pt -143.32 144.18 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.398 1.479 . . . . 0.0 107.831 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.81 169.52 19.03 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.947 0.784 . . . . 0.0 112.796 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -72.74 73.82 1.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.553 1.541 . . . . 0.0 111.167 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.45 ' HG3' HD12 ' A' ' 87' ' ' LEU . 6.3 mm100 -75.28 136.03 72.51 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 165.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.36 166.01 29.76 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.202 1.935 . . . . 0.0 110.863 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.458 ' HE2' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -49.46 -50.61 40.42 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.68 1.192 . . . . 0.0 111.865 -177.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -52.63 -33.73 48.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.226 1.41 . . . . 0.0 112.964 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.456 HE22 ' NE2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -83.59 -47.83 10.87 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 tt -61.03 -56.84 16.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.433 1.493 . . . . 0.0 110.338 -175.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -55.66 -33.56 64.19 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.456 1.502 . . . . 0.0 110.337 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.86 -50.22 17.79 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 118.232 0.469 . . . . 0.0 110.268 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.484 ' HG2' HD11 ' A' ' 87' ' ' LEU . 1.9 tp-100 -59.62 -41.06 89.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.553 0.741 . . . . 0.0 110.82 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.449 ' HG ' HD12 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -85.87 -0.02 54.26 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.365 1.466 . . . . 0.0 113.108 -178.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.53 -27.5 16.78 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.236 1.015 . . . . 0.0 113.332 -174.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.38 0.16 1.6 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.372 1.442 . . . . 0.0 113.686 176.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.273 0.4 OUTLIER -129.97 4.17 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 161.262 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.81 -13.59 16.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.242 1.017 . . . . 0.0 112.13 171.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.896 2.078 . . . . 0.0 109.964 170.304 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 10' ' ' PHE . 6.3 tp . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.47 ' H ' ' HB2' ' A' ' 9' ' ' ASN . 67.2 p -130.15 -100.97 0.31 Allowed 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 170.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -133.73 -71.18 0.51 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.273 1.429 . . . . 0.0 110.123 -158.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.01 -42.28 37.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.499 0.72 . . . . 0.0 110.253 163.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.47 ' HB2' ' H ' ' A' ' 6' ' ' THR . 72.3 m-80 -69.74 -26.95 64.56 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.327 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.527 ' HA ' HD21 ' A' ' 5' ' ' LEU . 8.8 t80 -61.51 -67.06 0.44 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.051 0.841 . . . . 0.0 109.028 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -63.21 -35.8 81.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 121.482 -0.087 . . . . 0.0 110.843 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.91 -8.0 56.58 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 118.228 -0.892 . . . . 0.0 113.144 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.95 -49.21 5.9 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 120.36 1.437 . . . . 0.0 110.784 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.3 pt -59.94 -19.38 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -174.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -17.73 60.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.446 1.498 . . . . 0.0 113.686 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.59 146.19 48.18 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 119.175 0.898 . . . . 0.0 111.259 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -76.4 -23.36 54.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.321 1.048 . . . . 0.0 113.658 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.57 -174.26 40.0 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.132 0.872 . . . . 0.0 112.571 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.72 87.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.506 3.47 . . . . 0.0 111.86 172.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.68 138.1 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 162.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.47 163.0 39.02 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.742 -0.599 . . . . 0.0 110.318 168.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.41 126.87 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 123.994 0.918 . . . . 0.0 108.672 -173.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 66.3 t0 -80.13 114.88 19.37 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 158.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -100.03 108.88 21.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 25.5 p-90 -125.2 179.43 5.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.287 1.435 . . . . 0.0 107.249 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.554 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -152.25 162.73 40.71 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.496 1.118 . . . . 0.0 109.815 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.85 -9.27 50.48 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -16.38 5.6 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -174.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 26' ' ' ALA . 6.4 p -74.4 38.13 0.11 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -159.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 37.62 -102.98 0.02 OUTLIER Glycine 0 CA--C 1.54 1.614 0 C-N-CA 127.665 2.555 . . . . 0.0 114.344 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.93 -17.77 39.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.015 3.144 . . . . 0.0 115.131 -175.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.2 p -53.27 -36.7 61.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.502 1.046 . . . . 0.0 111.323 168.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.2 ttt-85 -67.36 -8.85 35.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.204 1.002 . . . . 0.0 112.545 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 64.8 mtm -107.34 -14.74 14.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.503 1.521 . . . . 0.0 112.473 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.5 ttt -96.55 -36.41 10.77 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.633 1.173 . . . . 0.0 109.428 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.15 -47.81 86.82 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.648 1.179 . . . . 0.0 112.162 174.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.81 -31.28 48.58 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 121.995 1.748 . . . . 0.0 112.699 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.8 -33.74 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 119.437 1.017 . . . . 0.0 110.567 173.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -31.04 62.14 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.184 1.794 . . . . 0.0 111.614 173.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -71.15 -40.18 71.48 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.431 1.014 . . . . 0.0 109.613 172.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -62.58 -43.29 99.17 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 171.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -56.47 -42.7 78.67 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.286 1.035 . . . . 0.0 111.633 172.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.81 -55.12 36.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.183 0.993 . . . . 0.0 110.565 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.38 -47.54 72.55 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.548 1.139 . . . . 0.0 110.097 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.26 -13.69 60.8 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -133.98 17.22 3.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.567 1.076 . . . . 0.0 113.147 -173.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.75 -31.95 5.36 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.846 2.058 . . . . 0.0 115.469 -159.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -124.06 -3.28 8.09 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.963 0.905 . . . . 0.0 113.383 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -78.63 -39.05 38.23 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.99 1.268 . . . . 0.0 110.436 166.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 m -124.45 166.45 19.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.302 5.6 t -120.63 91.59 3.57 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.415 1.102 . . . . 0.0 108.501 172.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 p -98.54 116.61 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 125.065 1.346 . . . . 0.0 110.99 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.38 98.13 5.32 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.311 -159.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' CD ' ' H ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -72.1 140.82 49.1 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.873 -173.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pp -153.67 167.69 28.72 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 124.423 1.077 . . . . 0.0 112.758 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -95.97 112.05 23.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.914 1.686 . . . . 0.0 109.388 -173.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -64.72 -23.67 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.314 0.645 . . . . 0.0 111.967 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -75.42 -3.04 31.48 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.452 1.501 . . . . 0.0 111.776 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -135.26 -38.59 0.76 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.708 2.003 . . . . 0.0 111.743 -166.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -88.33 119.03 70.13 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 118.95 0.795 . . . . 0.0 109.513 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -90.55 -21.54 0.81 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.504 2.803 . . . . 0.0 113.804 164.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 64' ' ' THR . 7.5 tp10 -61.4 111.74 1.9 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.306 1.442 . . . . 0.0 112.002 -170.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m 68.75 -30.58 0.18 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.625 2.77 . . . . 0.0 111.851 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.407 ' H ' ' C ' ' A' ' 62' ' ' GLU . 57.5 m -51.73 -51.35 56.85 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 128.49 2.716 . . . . 0.0 110.463 171.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.5 t -57.73 -50.14 74.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.355 0.662 . . . . 0.0 110.191 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.3 tp60 -56.62 -44.5 81.25 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.693 0.797 . . . . 0.0 111.9 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -88.61 11.54 17.11 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 119.138 -0.458 . . . . 0.0 112.028 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.61 29.31 71.45 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 124.413 1.006 . . . . 0.0 112.391 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.484 ' CD1' HD11 ' A' ' 76' ' ' ILE . 43.3 mm -79.97 82.0 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.138 0.975 . . . . 0.0 109.579 -162.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.0 ttm -123.42 -6.02 8.2 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.657 1.583 . . . . 0.0 111.111 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.2 t -83.16 26.17 0.65 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.679 1.192 . . . . 0.0 113.744 -167.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.454 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -63.86 151.46 89.16 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -165.222 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 59.6 Cg_endo -65.8 129.84 10.76 Favored 'Cis proline' 0 C--N 1.353 0.784 0 CA-C-N 119.379 0.814 . . . . 0.0 111.44 2.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.8 m -121.37 152.68 38.73 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.0 tt -132.37 130.32 40.54 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 171.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.484 HD11 ' CD1' ' A' ' 69' ' ' ILE . 37.3 mt -120.78 132.62 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 167.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.47 141.0 28.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.795 2.038 . . . . 0.0 105.982 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -142.52 161.89 36.89 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.993 2.117 . . . . 0.0 111.346 -175.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.448 ' CE ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -163.74 153.34 14.66 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.203 1.801 . . . . 0.0 108.776 158.143 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.68 15.69 54.47 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.676 1.131 . . . . 0.0 114.536 167.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.16 -10.36 71.72 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.24 1.4 . . . . 0.0 112.837 -175.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -97.55 159.73 30.4 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 118.729 1.265 . . . . 0.0 109.181 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -69.76 -175.46 1.16 Allowed 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 122.5 2.133 . . . . 0.0 111.193 159.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.448 HG22 ' CE ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -133.07 -46.45 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.309 1.843 . . . . 0.0 108.738 159.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.426 ' HZ1' ' CG ' ' A' ' 102' ' ' ASP . 75.9 mttt -145.57 148.01 32.71 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.665 1.186 . . . . 0.0 107.973 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -117.32 131.99 56.69 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 163.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -125.48 141.03 52.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.1 141.18 29.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 124.022 0.929 . . . . 0.0 108.799 -170.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.18 164.87 39.6 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.586 1.089 . . . . 0.0 111.42 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.58 78.58 2.58 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.3 0.571 . . . . 0.0 110.006 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -71.01 133.82 85.8 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.23 167.58 21.68 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.874 1.716 . . . . 0.0 111.367 176.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -44.78 73.9 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.081 1.352 . . . . 0.0 110.792 -172.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -51.33 -44.9 62.11 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.69 2.396 . . . . 0.0 111.063 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -42.59 53.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.1 1.76 . . . . 0.0 108.049 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -61.74 2.11 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.655 1.582 . . . . 0.0 108.827 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.78 -39.09 83.72 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.585 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.41 82.78 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.267 1.394 . . . . 0.0 111.713 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -78.0 -21.75 50.37 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.16 -1.78 13.58 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.467 1.107 . . . . 0.0 112.808 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.38 -36.19 42.16 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.776 1.63 . . . . 0.0 112.604 -175.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.426 ' CG ' ' HZ1' ' A' ' 85' ' ' LYS . 10.1 p-10 -64.31 -11.29 30.58 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.182 1.393 . . . . 0.0 114.091 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.81 -8.5 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 119.459 1.027 . . . . 0.0 112.071 168.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.27 -10.25 26.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.392 1.477 . . . . 0.0 112.899 175.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 C--O 1.246 0.899 0 C-N-CA 126.167 1.787 . . . . 0.0 110.212 172.058 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.446 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 1.6 tp . . . . . 0 CA--C 1.531 0.248 0 CA-C-O 121.842 0.83 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.3 m -166.89 170.59 12.07 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.871 3.668 . . . . 0.0 101.958 172.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -43.38 -59.85 1.95 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 128.725 2.81 . . . . 0.0 112.781 -166.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.05 91.66 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.319 0.58 . . . . 0.0 111.189 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -72.07 -21.79 61.46 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.139 -0.458 . . . . 0.0 111.777 -177.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.26 -60.02 3.98 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -60.53 -46.06 91.55 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.442 -0.789 . . . . 0.0 111.184 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -62.67 -26.31 68.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.314 0.961 . . . . 0.0 112.71 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.94 -63.47 1.25 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.066 0.848 . . . . 0.0 109.485 165.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.77 HG22 HG11 ' A' ' 20' ' ' VAL . 2.9 pt -66.95 -13.52 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -166.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -58.54 -20.74 48.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.993 1.317 . . . . 0.0 113.975 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.43 -112.14 0.26 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 107.849 -2.1 . . . . 0.0 107.849 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 t0 62.4 -12.83 0.07 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 130.039 3.336 . . . . 0.0 117.677 158.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.83 -166.85 16.89 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.512 1.053 . . . . 0.0 111.889 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -55.66 101.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.946 3.098 . . . . 0.0 111.235 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.77 HG11 HG22 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -94.77 140.83 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 108.361 -175.4 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.472 HD11 HD21 ' A' ' 100' ' ' LEU . 3.5 mm? -130.43 143.14 50.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 173.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.69 108.3 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.481 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 63.3 t0 -75.91 98.52 4.24 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 78.0 m-85 -84.3 105.53 15.21 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -124.8 -177.15 3.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.96 162.09 41.48 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.222 -0.924 . . . . 0.0 110.552 171.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.35 -5.42 2.43 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.473 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -113.66 -20.96 10.99 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.591 1.087 . . . . 0.0 113.765 178.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.9 p -73.83 161.67 29.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.912 1.233 . . . . 0.0 110.347 -173.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.78 -84.86 1.74 Allowed Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.559 -0.579 . . . . 0.0 112.552 -173.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.15 -16.55 55.52 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.339 2.693 . . . . 0.0 113.448 -171.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.0 p -49.78 -40.84 42.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.848 0.859 . . . . 0.0 111.586 166.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -12.35 61.55 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.145 0.578 . . . . 0.0 112.257 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.5 mtm -100.99 -15.73 17.38 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.322 1.449 . . . . 0.0 112.057 173.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.8 ttt -85.32 -42.62 14.43 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 125.485 1.514 . . . . 0.0 108.444 172.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.09 -50.4 36.99 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.359 -1.305 . . . . 0.0 113.419 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.14 -36.1 30.52 Favored 'Trans proline' 0 C--N 1.353 0.766 0 CA-C-N 121.845 1.695 . . . . 0.0 112.17 173.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.97 -35.48 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.306 0.957 . . . . 0.0 110.304 173.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.84 -17.55 57.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.631 1.973 . . . . 0.0 111.847 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.26 -48.86 18.73 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 167.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -61.55 -26.18 67.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.602 0.761 . . . . 0.0 111.33 173.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.447 ' CE1' HD12 ' A' ' 96' ' ' LEU . 81.2 t80 -65.25 -63.19 1.16 Allowed 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 125.182 1.393 . . . . 0.0 107.879 170.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.77 -46.16 67.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.173 -0.442 . . . . 0.0 112.046 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.93 -34.79 56.94 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.245 1.418 . . . . 0.0 111.781 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.91 -14.45 61.06 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -162.18 63.38 0.23 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.341 1.456 . . . . 0.0 108.995 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.66 71.39 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -166.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -131.74 -1.31 3.82 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -168.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -64.46 -39.63 94.19 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.928 1.24 . . . . 0.0 108.866 161.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.01 170.9 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.697 1.199 . . . . 0.0 108.094 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 t -128.41 74.81 1.58 Allowed 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 123.989 1.852 . . . . 0.0 106.556 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 p -82.78 160.34 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.787 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 5' ' ' LEU . . . -159.67 174.11 15.05 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.185 176.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 28.1 mttp -131.99 144.39 50.76 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 123.331 0.653 . . . . 0.0 110.509 176.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.97 163.4 39.77 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.788 1.305 . . . . 0.0 114.297 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -91.45 105.33 17.68 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.101 1.76 . . . . 0.0 108.716 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.484 HG21 HG22 ' A' ' 69' ' ' ILE . 2.7 p -65.94 -21.78 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.664 0.786 . . . . 0.0 112.669 -172.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -67.69 -22.43 65.28 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.303 1.041 . . . . 0.0 111.612 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -114.09 -21.64 10.43 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.744 2.017 . . . . 0.0 111.829 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -100.32 94.23 3.23 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.235 1.414 . . . . 0.0 109.924 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.19 -27.74 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.038 2.492 . . . . 0.0 113.524 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -74.84 103.76 5.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.275 0.943 . . . . 0.0 110.751 -172.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m 104.88 -32.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 130.868 3.667 . . . . 0.0 109.471 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -52.82 -52.82 55.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.888 1.275 . . . . 0.0 109.714 167.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 t -70.9 -7.43 45.7 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.228 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -87.73 -33.22 18.78 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.998 1.272 . . . . 0.0 111.12 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -120.12 2.41 10.92 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.62 38.34 51.25 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 119.134 0.879 . . . . 0.0 111.801 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.491 HG21 ' CZ ' ' A' ' 24' ' ' PHE . 39.3 mm -75.51 83.67 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.973 1.309 . . . . 0.0 110.498 -166.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -119.58 -6.55 10.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.058 1.343 . . . . 0.0 112.544 172.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 m -77.14 34.41 0.16 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.929 2.092 . . . . 0.0 113.362 -168.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.473 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 34.0 pt -74.76 151.06 86.7 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -162.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 59.3 Cg_endo -65.88 130.65 12.23 Favored 'Cis proline' 0 C--N 1.351 0.685 0 CA-C-N 119.047 0.695 . . . . 0.0 110.745 -3.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -119.07 144.12 46.76 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.6 tp -132.36 113.92 13.75 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mt -111.42 142.9 22.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.99 118.56 37.02 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.762 2.025 . . . . 0.0 106.875 -176.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.432 ' HB2' HG12 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -130.72 176.38 8.24 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.239 1.016 . . . . 0.0 110.433 175.247 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.88 145.83 17.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 158.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 37.61 41.79 0.89 Allowed Glycine 0 CA--C 1.54 1.637 0 N-CA-C 115.974 1.15 . . . . 0.0 115.974 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.29 -12.63 68.67 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.77 1.652 . . . . 0.0 115.545 177.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -95.43 120.52 63.63 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 120.601 2.2 . . . . 0.0 110.768 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.82 148.71 46.65 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.124 1.883 . . . . 0.0 109.487 163.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.94 -44.54 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.68 0.792 . . . . 0.0 111.914 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -159.56 171.62 19.31 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.72 1.145 . . . . 0.0 110.061 171.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.29 156.21 46.54 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.016 1.726 . . . . 0.0 110.133 -174.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.4 mt -137.01 139.54 41.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.04 134.23 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 -170.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.02 162.68 37.92 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.796 0.712 . . . . 0.0 111.63 -175.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -75.29 75.78 2.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.363 1.065 . . . . 0.0 110.923 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -75.31 140.43 72.72 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 167.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 170.13 19.46 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.592 2.195 . . . . 0.0 111.692 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.83 -46.39 41.98 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.006 1.323 . . . . 0.0 111.945 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -56.94 -43.75 81.84 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.913 1.285 . . . . 0.0 110.95 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.73 -36.49 70.48 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.403 0.681 . . . . 0.0 109.251 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.447 HD12 ' CE1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -64.92 -60.03 3.52 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.415 1.086 . . . . 0.0 108.552 179.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -62.35 -32.87 73.72 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.102 0.561 . . . . 0.0 110.377 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.74 -53.68 10.99 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.355 0.525 . . . . 0.0 111.009 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.5 -35.87 81.89 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 118.477 0.581 . . . . 0.0 111.089 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.472 HD21 HD11 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -87.63 -1.14 57.75 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.913 -178.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -50.32 -31.33 14.15 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 125.224 1.41 . . . . 0.0 113.588 -172.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -22.64 58.6 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.399 1.08 . . . . 0.0 112.32 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.55 -8.25 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.809 0.844 . . . . 0.0 111.444 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.89 -10.4 28.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.19 1.396 . . . . 0.0 112.487 171.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 . . . . . 0 C--O 1.249 1.069 0 C-N-CA 126.104 1.761 . . . . 0.0 110.898 171.904 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.341 0 CA-C-O 121.015 0.436 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.0 t -131.78 -50.74 0.97 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.092 0.957 . . . . 0.0 111.53 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 174.27 -68.9 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 127.9 2.48 . . . . 0.0 105.179 171.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.67 -33.5 64.16 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.881 -0.512 . . . . 0.0 111.836 177.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -17.39 61.26 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 119.105 -0.474 . . . . 0.0 111.25 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.69 -64.45 0.89 Allowed 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.88 -44.42 94.21 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.974 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.8 -28.01 65.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.468 1.031 . . . . 0.0 113.013 -177.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.9 -58.9 2.68 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.974 0.91 . . . . 0.0 110.723 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.6 pt -62.08 -23.13 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.936 -171.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -57.71 -31.99 66.94 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.393 1.077 . . . . 0.0 111.688 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.5 102.08 0.15 Allowed Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -165.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -153.36 -69.55 0.15 Allowed 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 128.294 2.638 . . . . 0.0 105.539 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.46 -114.65 0.98 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 106.957 -2.457 . . . . 0.0 106.957 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.79 76.94 3.53 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.21 3.273 . . . . 0.0 112.564 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.96 130.14 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -112.87 113.89 26.17 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 159.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.09 125.01 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.1 94.73 5.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 124.12 0.888 . . . . 0.0 110.337 -174.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -83.08 109.27 16.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.416 ' O ' HG12 ' A' ' 57' ' ' VAL . 22.7 p-90 -126.93 175.02 8.38 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -140.14 150.2 43.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.773 0.715 . . . . 0.0 110.52 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.9 -26.26 58.69 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.764 0.825 . . . . 0.0 113.023 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.11 -25.88 16.96 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.0 p -69.75 157.64 36.93 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.372 0.987 . . . . 0.0 111.467 -160.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.75 -86.11 1.16 Allowed Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.318 -172.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.87 -18.83 66.73 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.13 2.553 . . . . 0.0 113.918 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 p -53.67 -35.47 61.1 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.24 0.473 . . . . 0.0 111.23 168.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -69.31 -16.42 63.55 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.381 -0.824 . . . . 0.0 112.336 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.78 -12.32 20.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.597 1.559 . . . . 0.0 112.119 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.8 ttt -93.14 -35.13 13.34 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 126.415 1.886 . . . . 0.0 108.773 175.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.82 -50.45 43.81 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.034 1.734 . . . . 0.0 112.894 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.05 -36.76 46.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 121.81 1.682 . . . . 0.0 111.585 172.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.02 -22.84 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 119.851 1.205 . . . . 0.0 111.314 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.81 -35.06 24.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.776 2.43 . . . . 0.0 111.8 175.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.12 -42.71 93.65 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 169.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -65.79 -15.41 62.85 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.306 1.443 . . . . 0.0 112.368 170.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -82.63 -47.82 11.64 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 120.636 -1.29 . . . . 0.0 109.214 170.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.55 81.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.551 1.14 . . . . 0.0 110.573 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -58.7 -53.12 61.98 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.575 0.75 . . . . 0.0 110.959 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.7 -14.67 54.3 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -162.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 51.39 0.79 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.369 1.868 . . . . 0.0 108.428 172.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.63 -14.02 7.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.412 1.085 . . . . 0.0 113.679 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -88.87 -51.28 5.72 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.596 2.358 . . . . 0.0 111.864 174.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -73.33 -16.73 61.35 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 117.439 -1.267 . . . . 0.0 112.244 -168.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.09 166.56 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 121.128 1.785 . . . . 0.0 113.102 -170.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.1 t -119.46 122.75 42.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.75 0.786 . . . . 0.0 109.146 159.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.411 ' HA ' ' HG ' ' A' ' 21' ' ' LEU . 2.9 t -76.97 152.13 5.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 158.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.35 99.7 3.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -95.14 143.38 26.62 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 122.783 0.433 . . . . 0.0 110.714 -169.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -141.73 145.36 34.75 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.299 0.571 . . . . 0.0 110.755 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -82.22 90.0 6.57 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 173.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 72' ' ' ILE . 6.1 p -62.01 -15.04 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 125.275 1.43 . . . . 0.0 112.468 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -65.85 -20.0 66.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.809 2.444 . . . . 0.0 112.766 169.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -131.06 -23.43 2.46 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.067 2.147 . . . . 0.0 111.696 -167.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -116.28 77.85 7.71 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.402 1.881 . . . . 0.0 109.176 -169.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.92 -4.82 16.08 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.608 3.539 . . . . 0.0 116.675 -170.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.461 ' C ' ' H ' ' A' ' 64' ' ' THR . 5.6 tp10 -59.93 135.25 57.64 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.976 1.716 . . . . 0.0 109.979 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m 59.26 -14.64 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.925 3.29 . . . . 0.0 112.847 -176.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.461 ' H ' ' C ' ' A' ' 62' ' ' GLU . 96.9 m -63.44 -54.26 39.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 126.259 1.824 . . . . 0.0 109.221 -175.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -73.02 1.12 9.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.543 1.137 . . . . 0.0 112.704 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -107.01 -39.66 5.68 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.622 1.169 . . . . 0.0 110.627 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -104.27 5.24 34.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.587 1.155 . . . . 0.0 110.734 -176.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.81 38.67 49.28 Favored Glycine 0 C--N 1.343 0.941 0 C-N-CA 124.243 0.925 . . . . 0.0 112.158 174.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.9 mm -78.83 76.44 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.965 1.306 . . . . 0.0 109.734 -167.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 70.7 mtm -106.54 -14.88 14.93 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.935 1.294 . . . . 0.0 111.478 173.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.4 m -82.61 23.73 0.77 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.165 1.786 . . . . 0.0 114.022 -159.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.546 HG21 HG11 ' A' ' 57' ' ' VAL . 16.3 pt -71.31 155.79 92.47 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.317 1.047 . . . . 0.0 112.943 -158.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 56.7 Cg_endo -62.74 127.86 5.64 Favored 'Cis proline' 0 C--N 1.352 0.711 0 CA-C-N 119.666 0.916 . . . . 0.0 110.687 -3.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -114.32 136.4 53.01 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 tt -131.72 92.99 3.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -174.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.7 mt -94.52 144.37 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.5 HD11 ' HB ' ' A' ' 103' ' ' VAL . 3.3 tt -110.84 120.33 42.03 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -110.44 148.38 32.16 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -141.27 111.63 6.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 170.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 39.54 59.17 1.98 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.58 2.038 . . . . 0.0 112.942 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.66 -20.32 51.05 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.636 1.588 . . . . 0.0 114.03 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.74 109.41 59.36 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 119.452 1.626 . . . . 0.0 111.359 -166.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.31 92.78 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.855 3.037 . . . . 0.0 110.731 169.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 m -65.54 -40.78 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.582 -0.699 . . . . 0.0 112.644 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.404 ' CE ' ' HB2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -158.76 167.19 30.14 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.09 0.956 . . . . 0.0 110.248 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -136.11 133.21 37.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.905 2.082 . . . . 0.0 107.607 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.12 154.2 18.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 158.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.3 pt -141.35 143.93 27.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 106.872 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.55 172.34 20.19 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 121.983 0.768 . . . . 0.0 112.191 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -74.75 79.62 2.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.934 0.894 . . . . 0.0 110.784 -176.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -72.36 127.69 89.82 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 161.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.41 163.55 36.14 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.712 1.608 . . . . 0.0 109.779 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -45.35 12.32 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.81 1.244 . . . . 0.0 111.041 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -59.92 -24.7 64.55 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.191 1.396 . . . . 0.0 113.908 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -100.12 -46.95 5.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.707 1.203 . . . . 0.0 108.624 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 tt -52.64 -62.93 1.33 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.873 2.069 . . . . 0.0 108.892 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -59.14 -34.92 72.63 Favored 'General case' 0 C--N 1.337 0.043 0 C-N-CA 125.025 1.33 . . . . 0.0 110.469 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.62 -42.04 71.44 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.064 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -41.89 85.41 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.411 0.55 . . . . 0.0 109.798 173.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.449 ' HG ' HD12 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -71.77 -4.04 25.45 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.958 1.703 . . . . 0.0 113.337 -178.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.47 -25.07 9.16 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.842 1.257 . . . . 0.0 113.132 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -7.43 9.41 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 121.091 1.769 . . . . 0.0 113.975 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.5 ' HB ' HD11 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -127.49 -1.55 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 121.431 -0.793 . . . . 0.0 112.845 168.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -105.77 -10.98 16.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.44 1.096 . . . . 0.0 113.094 174.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 C--O 1.251 1.15 0 C-N-CA 127.017 2.127 . . . . 0.0 109.81 162.87 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.461 ' HB ' HG23 ' A' ' 51' ' ' THR . 7.2 m -60.48 175.74 0.42 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 127.517 2.327 . . . . 0.0 110.883 169.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.64 -165.44 2.06 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.895 1.678 . . . . 0.0 107.507 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.8 m -44.35 136.36 4.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.817 2.047 . . . . 0.0 112.933 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.71 172.92 12.04 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.023 1.729 . . . . 0.0 111.102 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.1 t -129.44 179.61 5.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.117 1.767 . . . . 0.0 107.33 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -52.46 -58.97 5.05 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.483 2.313 . . . . 0.0 111.735 -160.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.38 -16.32 60.13 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -102.22 -17.11 16.1 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.959 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -49.11 -55.8 11.11 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 125.203 1.401 . . . . 0.0 108.859 171.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -53.02 -54.54 33.84 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.307 1.843 . . . . 0.0 112.468 173.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -64.09 -20.93 66.31 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.125 0.57 . . . . 0.0 112.278 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.34 -64.18 1.16 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 167.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.3 pt -58.55 -25.72 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -62.53 -22.33 66.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.29 1.036 . . . . 0.0 113.406 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -67.12 149.51 51.21 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 119.12 0.873 . . . . 0.0 112.453 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -87.82 53.34 2.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.232 1.413 . . . . 0.0 110.193 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.76 165.9 35.9 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.66 101.09 0.16 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.192 3.261 . . . . 0.0 111.772 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.47 101.71 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 125.369 1.468 . . . . 0.0 107.973 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.46 HD22 HG13 ' A' ' 52' ' ' VAL . 4.9 tt -82.58 112.77 19.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 171.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.59 114.95 39.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.97 93.03 4.65 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -164.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 69' ' ' ILE . 52.8 m-85 -86.62 112.86 22.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.601 0.761 . . . . 0.0 109.758 -176.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 26.6 p-90 -124.54 -175.68 3.33 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 169.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.497 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -151.52 158.69 43.93 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.202 -0.936 . . . . 0.0 110.096 172.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.42 -1.27 0.5 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.215 1.806 . . . . 0.0 115.598 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.15 -18.96 1.75 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 26' ' ' ALA . 1.1 p -72.27 100.65 2.66 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.855 1.207 . . . . 0.0 111.519 -165.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -29.0 -61.81 0.14 Allowed Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.934 1.73 . . . . 0.0 115.067 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.31 -33.67 29.56 Favored 'Trans proline' 0 C--N 1.351 0.658 0 CA-C-N 120.273 2.036 . . . . 0.0 112.985 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.7 p -69.27 -30.35 68.44 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.795 1.179 . . . . 0.0 110.624 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -20.6 65.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.329 0.968 . . . . 0.0 111.654 172.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.1 mtp -99.85 -25.98 14.17 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.323 1.449 . . . . 0.0 111.878 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.7 ttt -81.48 -38.74 25.86 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.727 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.03 -50.73 61.17 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 120.703 1.592 . . . . 0.0 112.534 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.22 -33.25 40.22 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.598 1.532 . . . . 0.0 112.359 172.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.65 -36.63 77.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 120.13 1.332 . . . . 0.0 110.851 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 42' ' ' PHE . 54.2 mt -78.92 -6.47 56.27 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.921 2.489 . . . . 0.0 111.471 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.92 -48.52 13.29 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.738 1.215 . . . . 0.0 108.144 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -60.9 -43.41 98.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.853 0.461 . . . . 0.0 110.022 168.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.467 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 33.1 t80 -63.85 -20.13 65.58 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 118.017 -0.992 . . . . 0.0 112.543 173.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.92 -59.4 2.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 121.174 1.806 . . . . 0.0 108.668 166.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.16 -45.43 65.06 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.792 1.237 . . . . 0.0 111.838 -173.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.55 -23.91 29.35 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -169.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.32 36.69 0.83 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.037 1.335 . . . . 0.0 110.626 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.39 -23.42 3.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 -160.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.18 0.07 8.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.349 0.977 . . . . 0.0 112.841 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -76.58 -29.34 56.57 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.432 -0.792 . . . . 0.0 109.946 167.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.22 143.04 42.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 109.249 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.461 HG23 ' HB ' ' A' ' 2' ' ' THR . 1.0 OUTLIER -68.33 136.49 53.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 158.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.46 HG13 HD22 ' A' ' 21' ' ' LEU . 5.0 t -119.92 134.61 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 104.889 -2.263 . . . . 0.0 104.889 160.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.21 90.38 2.03 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -166.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -86.99 143.71 27.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.226 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.1 152.62 26.63 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.208 0.913 . . . . 0.0 113.263 171.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -76.45 107.04 8.44 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.246 1.818 . . . . 0.0 107.683 172.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' A' ' 26' ' ' ALA . 8.6 p -48.41 -43.53 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 126.738 2.015 . . . . 0.0 114.274 -165.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.45 -27.09 68.31 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 126.872 2.069 . . . . 0.0 112.492 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.4 -28.1 62.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.726 0.81 . . . . 0.0 111.406 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -115.48 83.75 11.21 Favored Pre-proline 0 N--CA 1.457 -0.125 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.53 -25.77 29.32 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 121.631 1.554 . . . . 0.0 112.207 170.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.71 118.44 7.13 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.47 1.108 . . . . 0.0 109.405 -176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.262 8.8 m 70.23 -20.01 0.2 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.606 2.362 . . . . 0.0 113.366 173.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.9 m -54.66 -55.73 26.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.58 1.952 . . . . 0.0 109.011 160.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.5 t -57.59 -41.57 81.44 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.291 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -62.75 -40.81 98.41 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.665 0.786 . . . . 0.0 112.949 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -96.27 16.56 17.98 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.713 0.688 . . . . 0.0 112.773 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.21 25.81 72.24 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 124.129 0.871 . . . . 0.0 112.523 172.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.542 HD12 HG21 ' A' ' 74' ' ' THR . 30.6 mm -82.14 70.02 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 122.576 1.179 . . . . 0.0 109.558 -165.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 53.3 ttp -120.37 0.78 10.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.739 1.616 . . . . 0.0 109.974 166.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.3 t -88.83 21.94 2.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.102 1.361 . . . . 0.0 112.985 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.451 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -59.45 144.61 83.95 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.529 0.732 . . . . 0.0 112.528 -168.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 62.6 Cg_endo -69.06 130.64 16.41 Favored 'Cis proline' 0 C--N 1.35 0.606 0 CA-C-N 119.01 0.682 . . . . 0.0 112.734 7.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.542 HG21 HD12 ' A' ' 69' ' ' ILE . 40.9 m -125.26 151.71 45.58 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.862 1.265 . . . . 0.0 108.82 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.2 tt -143.63 105.34 4.32 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -173.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.42 HD11 HD11 ' A' ' 69' ' ' ILE . 23.9 mt -101.1 143.82 13.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 171.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.25 115.89 28.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -113.63 163.39 15.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.827 1.651 . . . . 0.0 111.873 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.456 ' HE3' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -162.41 149.91 13.89 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.466 1.907 . . . . 0.0 107.337 158.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.03 14.67 47.0 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 119.155 0.889 . . . . 0.0 113.496 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.87 -5.99 82.24 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.436 1.494 . . . . 0.0 113.35 -170.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -98.86 121.14 56.93 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 119.174 1.487 . . . . 0.0 110.189 -173.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.09 103.79 1.8 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 123.75 2.967 . . . . 0.0 110.048 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.456 HG21 ' HE3' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -71.29 -35.94 59.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 121.815 -0.553 . . . . 0.0 112.071 178.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -153.54 158.27 41.0 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.592 0.757 . . . . 0.0 110.669 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -147.44 125.22 11.88 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.744 2.018 . . . . 0.0 106.741 -172.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.8 mp -121.83 150.5 41.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.473 1.909 . . . . 0.0 106.802 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.9 pt -145.43 151.97 14.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.613 1.165 . . . . 0.0 109.344 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.12 167.63 24.65 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.404 1.002 . . . . 0.0 111.908 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -75.33 73.94 2.42 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.077 0.951 . . . . 0.0 110.855 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -70.06 138.3 87.33 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.62 163.53 38.63 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.403 2.069 . . . . 0.0 110.634 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.12 -44.8 61.4 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.982 1.313 . . . . 0.0 111.225 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -66.67 -15.32 63.41 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.093 0.957 . . . . 0.0 112.67 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -102.0 -44.57 5.44 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.208 0.913 . . . . 0.0 109.17 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.51 -59.32 5.63 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.106 1.762 . . . . 0.0 109.636 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -63.55 -24.73 67.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.054 0.843 . . . . 0.0 110.968 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.92 -51.52 15.85 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.854 0.752 . . . . 0.0 110.682 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -62.27 -43.3 99.15 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.7 0.8 . . . . 0.0 110.481 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 tp -78.77 -7.03 57.41 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.725 1.21 . . . . 0.0 112.744 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.07 -33.05 37.46 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.689 1.196 . . . . 0.0 111.085 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.16 11.87 0.1 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.803 2.041 . . . . 0.0 112.711 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.54 -11.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 119.451 -2.031 . . . . 0.0 113.187 158.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.07 -22.57 20.67 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.043 1.337 . . . . 0.0 112.047 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 . . . . . 0 C--O 1.251 1.134 0 C-N-CA 128.591 2.757 . . . . 0.0 110.202 175.613 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 117.371 -1.299 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.8 m 82.69 140.54 0.07 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.436 2.695 . . . . 0.0 113.092 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.4 ttm -157.55 171.81 19.68 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.326 1.85 . . . . 0.0 109.082 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 m -70.99 162.41 29.45 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.889 -1.132 . . . . 0.0 109.264 162.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 10' ' ' PHE . 4.2 tp -136.79 165.08 26.77 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.964 0.906 . . . . 0.0 110.629 175.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.4 p -146.03 172.27 13.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 128.703 2.801 . . . . 0.0 104.988 170.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -45.45 -61.2 1.78 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.517 2.327 . . . . 0.0 110.855 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.0 -31.95 71.54 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.692 -0.63 . . . . 0.0 112.182 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -78.03 -19.25 54.71 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.287 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.504 ' HA ' HD21 ' A' ' 5' ' ' LEU . 2.2 t80 -55.51 -60.44 3.43 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.442 1.497 . . . . 0.0 107.572 173.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -58.81 -45.46 89.88 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 111.793 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -56.85 -36.01 69.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.568 0.622 . . . . 0.0 111.516 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.46 -60.72 2.11 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.873 0.869 . . . . 0.0 110.69 172.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.2 pt -68.98 -2.42 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -168.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -42.76 -39.69 2.55 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.593 1.957 . . . . 0.0 114.91 -172.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 159.25 -176.55 36.04 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 119.322 0.965 . . . . 0.0 113.899 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 65.25 -57.44 0.29 Allowed 'General case' 0 N--CA 1.463 0.196 1 C-N-CA 132.056 4.143 . . . . 0.0 112.543 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.53 150.86 20.61 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.645 -160.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.16 88.5 0.7 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.113 3.209 . . . . 0.0 110.24 170.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.59 149.57 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 170.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.03 167.77 21.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.932 -0.48 . . . . 0.0 110.595 161.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.31 134.46 66.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 124.48 1.112 . . . . 0.0 108.382 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 45.4 t0 -95.7 99.72 11.53 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 167.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.484 ' CD1' HG23 ' A' ' 57' ' ' VAL . 37.1 m-85 -86.68 112.73 21.92 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.8 p-90 -128.28 176.65 7.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.163 1.385 . . . . 0.0 108.162 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -147.5 149.03 31.86 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.723 1.147 . . . . 0.0 110.789 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.07 -24.46 66.24 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -102.51 -6.99 22.26 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.252 0.933 . . . . 0.0 113.25 -174.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.1 p -66.19 169.94 6.44 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.638 0.732 . . . . 0.0 112.676 -164.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.89 -90.22 1.54 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 165.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.39 -23.16 71.7 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.003 2.469 . . . . 0.0 114.117 -168.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.86 -25.92 68.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.161 0.891 . . . . 0.0 111.682 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -71.8 -17.16 62.18 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.0 0.92 . . . . 0.0 111.632 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 41.5 mtp -97.39 -39.87 8.98 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.689 1.596 . . . . 0.0 110.211 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.8 tpt -66.84 -44.87 79.94 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-O 117.657 -1.163 . . . . 0.0 109.931 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.86 99.91 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.309 1.413 . . . . 0.0 112.725 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -69.19 -38.63 8.75 Favored 'Trans proline' 0 C--N 1.352 0.747 0 CA-C-N 121.78 1.671 . . . . 0.0 112.837 169.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.97 -34.09 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 120.935 1.698 . . . . 0.0 111.531 177.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.0 -13.23 61.19 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.877 2.471 . . . . 0.0 111.701 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.3 -36.63 34.06 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.564 1.074 . . . . 0.0 110.308 176.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.95 -43.24 99.33 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 169.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -58.57 -45.98 87.89 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 123.669 0.788 . . . . 0.0 110.479 171.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.06 -49.04 72.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.173 0.897 . . . . 0.0 110.893 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -53.19 60.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.74 1.216 . . . . 0.0 111.087 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.72 48.56 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -164.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -141.98 38.88 1.62 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.748 1.219 . . . . 0.0 110.552 172.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.47 -8.67 2.89 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.009 1.324 . . . . 0.0 113.964 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -92.29 -53.96 4.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.94 2.496 . . . . 0.0 111.425 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -68.34 -26.08 65.42 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 118.719 -0.658 . . . . 0.0 111.248 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.2 m -141.73 171.0 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.436 0.695 . . . . 0.0 110.111 -174.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.9 t -127.48 130.43 49.21 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 160.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.0 p -90.98 173.08 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 158.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.07 153.35 34.91 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 159.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 17.8 mtpp -113.26 137.65 51.17 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 119.29 -0.386 . . . . 0.0 109.992 -169.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pp -149.86 146.88 27.36 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 122.686 1.232 . . . . 0.0 114.288 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -78.64 110.16 13.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.127 2.171 . . . . 0.0 108.025 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.484 HG23 ' CD1' ' A' ' 24' ' ' PHE . 7.6 p -63.01 -37.1 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.861 1.665 . . . . 0.0 112.929 -166.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.86 -38.62 83.36 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.097 1.359 . . . . 0.0 110.601 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -76.34 -27.31 56.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.629 2.372 . . . . 0.0 112.048 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -116.65 78.21 8.7 Favored Pre-proline 0 N--CA 1.445 -0.703 0 C-N-CA 124.817 1.247 . . . . 0.0 110.461 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.36 -88.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 123.875 3.05 . . . . 0.0 112.313 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 30.96 -39.45 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.893 1 C-N-CA 132.912 4.485 . . . . 0.0 120.367 -159.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -159.52 -7.32 0.06 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 129.466 3.106 . . . . 0.0 112.376 -177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.1 m -39.93 -60.4 1.03 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.168 2.187 . . . . 0.0 110.547 164.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.0 t -68.79 -17.39 64.02 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.789 -1.1 . . . . 0.0 113.041 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -77.61 -30.97 52.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.69 1.132 . . . . 0.0 110.112 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -93.51 9.65 35.76 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.438 0.695 . . . . 0.0 111.122 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.52 22.85 75.23 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.846 0.736 . . . . 0.0 112.784 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.443 HG21 ' CZ ' ' A' ' 24' ' ' PHE . 40.8 mm -78.23 77.36 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.753 1.221 . . . . 0.0 109.151 -169.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.81 -2.54 8.77 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.088 1.355 . . . . 0.0 110.363 167.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 p -82.87 43.64 0.86 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.177 2.591 . . . . 0.0 111.485 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.11 145.84 94.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 O-C-N 121.7 -0.625 . . . . 0.0 111.697 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.21 127.0 8.89 Favored 'Cis proline' 0 N--CA 1.459 -0.512 0 CA-C-N 119.153 0.733 . . . . 0.0 110.797 0.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.0 m -116.84 148.07 41.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 tt -136.96 126.64 25.42 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.9 mt -128.85 141.56 46.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.466 HD11 HD21 ' A' ' 100' ' ' LEU . 1.3 mp -106.94 142.7 36.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.843 1.657 . . . . 0.0 109.474 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -134.68 150.09 50.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.357 1.463 . . . . 0.0 109.309 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.66 163.88 32.19 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 159.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.02 8.55 8.55 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 118.453 -1.193 . . . . 0.0 115.287 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.34 2.49 60.39 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 119.134 1.467 . . . . 0.0 113.156 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -126.57 135.91 27.93 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 119.346 1.573 . . . . 0.0 110.813 -168.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.44 117.2 5.02 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.48 2.786 . . . . 0.0 110.376 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.2 m -84.03 -46.01 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -156.55 164.5 38.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.867 0.758 . . . . 0.0 111.365 -173.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -136.28 147.98 47.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.483 1.913 . . . . 0.0 109.414 -171.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -122.14 154.05 37.92 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.833 1.653 . . . . 0.0 107.845 158.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 pt -141.32 137.74 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.671 1.988 . . . . 0.0 106.129 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.42 168.31 35.61 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.922 0.772 . . . . 0.0 112.921 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -80.4 83.64 6.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.529 1.131 . . . . 0.0 108.952 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -88.66 134.68 33.5 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.53 160.41 48.1 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.28 1.32 . . . . 0.0 109.793 174.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -41.67 80.79 Favored 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 123.803 0.841 . . . . 0.0 111.512 -175.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.79 -19.99 60.54 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -95.39 -49.75 5.31 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.888 1.222 . . . . 0.0 109.364 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.31 -59.17 5.74 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 124.499 1.12 . . . . 0.0 110.62 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -65.9 -18.44 65.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.075 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.25 -51.6 12.89 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.148 0.885 . . . . 0.0 110.307 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -53.32 -43.17 67.4 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.852 0.861 . . . . 0.0 110.831 175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.466 HD21 HD11 ' A' ' 77' ' ' LEU . 1.4 mp -86.85 -0.77 57.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.597 1.559 . . . . 0.0 113.167 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.04 -34.29 69.91 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 119.431 1.014 . . . . 0.0 111.622 -172.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -63.26 -12.56 30.0 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.195 1.398 . . . . 0.0 113.96 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.4 m -128.59 9.73 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 126.245 1.818 . . . . 0.0 111.633 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -124.95 -4.55 7.51 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.924 1.689 . . . . 0.0 113.122 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.25 1.105 0 C-N-CA 126.895 2.078 . . . . 0.0 108.708 164.761 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.662 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -65.96 -9.08 26.71 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.047 1.339 . . . . 0.0 113.698 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.51 -146.33 0.43 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.833 1.653 . . . . 0.0 110.633 167.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.0 m -67.85 122.17 17.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.31 1.044 . . . . 0.0 108.848 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 tt -134.17 161.67 34.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.956 1.702 . . . . 0.0 109.136 -163.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.1 p -142.86 163.97 31.35 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 129.145 2.978 . . . . 0.0 104.998 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 10' ' ' PHE . 21.5 t70 -58.41 -40.14 81.63 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.601 1.16 . . . . 0.0 113.124 -168.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.52 65.84 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.633 -0.667 . . . . 0.0 112.358 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -94.49 -34.75 12.58 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.201 1.4 . . . . 0.0 110.549 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' A' ' 7' ' ' ASP . 51.8 t80 -50.6 -62.39 1.63 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 126.847 2.059 . . . . 0.0 109.201 173.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -57.29 -46.03 83.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.277 0.489 . . . . 0.0 110.781 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -70.62 -21.53 62.63 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.4 -62.01 1.71 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.212 0.915 . . . . 0.0 109.538 165.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.1 pt -62.46 -21.71 27.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.514 1.126 . . . . 0.0 113.776 -167.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -64.37 -23.92 67.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.93 0.892 . . . . 0.0 112.807 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.35 170.16 54.52 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 118.864 0.756 . . . . 0.0 112.058 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -82.83 -22.62 34.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.601 1.56 . . . . 0.0 112.798 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.92 157.46 48.73 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 123.408 0.528 . . . . 0.0 112.219 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HA ' HD21 ' A' ' 77' ' ' LEU . 34.7 Cg_endo -65.3 91.3 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 124.186 3.257 . . . . 0.0 111.317 173.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.67 131.43 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 mp -118.57 136.94 53.58 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.55 116.63 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 26.0 t0 -72.72 107.52 5.22 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 124.105 0.878 . . . . 0.0 109.025 163.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -89.03 108.15 19.43 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 164.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -126.44 -177.92 4.16 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.31 159.84 40.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.376 -0.827 . . . . 0.0 108.876 168.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.77 -15.67 22.01 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.535 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -89.63 -31.25 17.62 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.458 1.026 . . . . 0.0 113.354 177.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.9 p -72.8 160.67 31.81 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.684 1.129 . . . . 0.0 111.151 -168.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.43 -79.55 1.47 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.018 0.818 . . . . 0.0 112.515 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.15 -15.89 51.93 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.621 2.881 . . . . 0.0 113.701 -172.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.1 p -52.81 -35.97 57.75 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.248 0.619 . . . . 0.0 111.786 167.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -70.38 -13.94 62.35 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.753 0.706 . . . . 0.0 112.563 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.2 mtm -95.91 -20.08 19.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.078 1.351 . . . . 0.0 111.63 170.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.5 ttt -79.85 -39.27 30.99 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 108.913 174.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.01 -52.48 46.94 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.742 1.217 . . . . 0.0 113.326 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.65 -30.88 34.14 Favored 'Trans proline' 0 C--N 1.352 0.711 0 CA-C-N 121.987 1.745 . . . . 0.0 112.26 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.17 -38.3 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.636 1.107 . . . . 0.0 109.887 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 mp -69.99 -26.93 64.31 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.6 1.96 . . . . 0.0 112.196 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -69.52 -46.76 65.79 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.252 0.933 . . . . 0.0 109.156 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -61.93 -41.23 97.7 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.069 0.548 . . . . 0.0 110.591 173.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.29 -50.53 73.29 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.286 1.035 . . . . 0.0 110.915 172.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.25 -48.24 79.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.725 0.81 . . . . 0.0 110.16 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -58.27 -50.03 75.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.254 0.621 . . . . 0.0 110.941 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.7 -23.14 50.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -153.96 52.86 0.69 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.348 1.459 . . . . 0.0 109.876 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.26 -17.63 54.43 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -173.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -95.43 -49.6 5.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.595 2.358 . . . . 0.0 111.549 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -67.11 -24.62 65.95 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 118.49 -0.767 . . . . 0.0 112.151 -170.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.22 149.43 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 119.139 0.881 . . . . 0.0 111.074 -172.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.344 2.9 t -110.57 84.9 2.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 123.11 1.433 . . . . 0.0 109.3 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.14 139.14 19.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.967 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.52 166.56 22.91 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.201 2.2 . . . . 0.0 107.976 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 23.5 pttp -136.22 144.57 44.96 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 122.406 0.282 . . . . 0.0 111.377 173.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -145.86 142.7 29.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.368 0.604 . . . . 0.0 111.539 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -83.13 98.51 9.37 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.98 -27.73 43.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.613 -163.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -65.01 -24.87 67.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.867 2.467 . . . . 0.0 112.306 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -91.89 -32.26 15.36 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.069 1.347 . . . . 0.0 110.238 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -116.94 74.87 7.12 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.643 1.177 . . . . 0.0 109.839 -170.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.15 -12.65 14.3 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.152 3.235 . . . . 0.0 113.514 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.9 142.6 47.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.131 0.878 . . . . 0.0 109.315 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m 60.07 -29.36 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 131.46 3.904 . . . . 0.0 113.458 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.2 m -50.11 -59.6 3.76 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.018 2.927 . . . . 0.0 108.737 161.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -70.93 -10.14 59.12 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 117.725 -1.131 . . . . 0.0 112.674 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -85.87 -39.21 17.26 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 119.852 1.205 . . . . 0.0 111.266 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -92.99 6.85 46.44 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.538 0.608 . . . . 0.0 112.242 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.89 34.5 77.28 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 118.861 0.755 . . . . 0.0 111.926 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.7 mm -72.17 85.31 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.078 1.751 . . . . 0.0 109.259 -171.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.8 tpp -143.11 51.85 1.38 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.557 1.543 . . . . 0.0 109.654 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.2 m -156.81 42.41 0.36 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.145 -1.597 . . . . 0.0 111.812 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.535 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 43.2 pt -70.73 151.93 95.24 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 121.767 -0.583 . . . . 0.0 112.564 -174.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 37.8 Cg_endo -62.49 129.2 6.64 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 119.379 0.814 . . . . 0.0 110.755 -5.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.1 m -121.44 140.93 51.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -123.53 120.39 32.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 171.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.6 mt -121.24 142.77 35.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 19' ' ' PRO . 4.4 tt -108.11 121.54 45.05 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.409 ' N ' HD23 ' A' ' 77' ' ' LEU . 80.8 m-85 -118.37 156.77 28.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.151 0.98 . . . . 0.0 111.221 -176.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -163.14 158.97 22.48 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 125.535 1.534 . . . . 0.0 108.745 161.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.26 16.05 25.61 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 123.919 0.771 . . . . 0.0 113.984 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.22 -5.82 83.95 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.122 -1.377 . . . . 0.0 114.017 -173.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.97 149.97 44.24 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 120.186 1.993 . . . . 0.0 111.617 -174.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.17 128.03 6.23 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.352 2.702 . . . . 0.0 110.296 170.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.3 -41.86 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 O-C-N 121.579 -0.701 . . . . 0.0 110.34 168.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -164.91 169.85 16.02 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.827 0.851 . . . . 0.0 111.22 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -136.31 146.93 47.17 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.729 2.411 . . . . 0.0 108.941 -170.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.8 151.52 37.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.651 1.981 . . . . 0.0 106.897 159.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.06 147.9 26.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.005 1.722 . . . . 0.0 107.298 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.31 169.4 21.14 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 122.022 0.79 . . . . 0.0 112.081 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -74.01 89.05 1.91 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -86.87 137.38 33.52 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 159.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.4 165.95 30.85 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.322 2.015 . . . . 0.0 111.451 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -46.27 -48.67 18.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.724 1.61 . . . . 0.0 112.144 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -52.78 -47.09 67.77 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.113 1.365 . . . . 0.0 111.644 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -38.51 72.3 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 124.341 1.056 . . . . 0.0 108.578 -178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 -54.53 30.2 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.218 1.007 . . . . 0.0 109.514 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.22 -40.23 85.18 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.66 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.78 -51.96 65.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.524 1.056 . . . . 0.0 111.414 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -62.81 -27.69 69.49 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.77 0.828 . . . . 0.0 112.419 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 mp -106.66 3.36 26.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.716 1.207 . . . . 0.0 111.905 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.58 -29.97 60.0 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.543 1.137 . . . . 0.0 112.567 -174.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -62.53 -14.86 46.71 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.422 HG11 ' CD1' ' A' ' 77' ' ' LEU . 2.1 p -117.55 -7.03 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 119.651 1.114 . . . . 0.0 111.686 172.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.52 -11.87 26.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.548 1.139 . . . . 0.0 112.068 172.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.739 2.016 . . . . 0.0 110.135 165.875 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.4 p -50.86 144.44 8.5 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -159.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.4 ttm -139.33 159.93 41.0 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.686 1.595 . . . . 0.0 107.533 168.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.4 m -76.03 146.09 39.73 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 163.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.3 mt -120.74 173.08 7.43 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 122.364 1.078 . . . . 0.0 109.541 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.5 m -150.2 -129.4 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 102.581 -3.118 . . . . 0.0 102.581 172.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -86.61 -67.42 0.82 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.117 1.767 . . . . 0.0 111.248 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.6 -35.87 77.19 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.271 -0.893 . . . . 0.0 111.359 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -67.01 -31.33 71.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.728 0.811 . . . . 0.0 109.671 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -58.88 -57.25 13.86 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.819 0.736 . . . . 0.0 109.623 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -59.74 -46.52 88.9 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-O 118.852 -0.594 . . . . 0.0 110.54 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -63.29 -17.21 62.27 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.71 -59.28 2.48 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.807 0.843 . . . . 0.0 110.585 166.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.6 pt -67.59 -18.84 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -169.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -49.08 -34.45 13.76 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.157 1.783 . . . . 0.0 112.996 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.61 138.56 2.88 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 112.042 -0.423 . . . . 0.0 112.042 168.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.54 -102.97 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.9 -130.54 2.76 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 127.691 2.567 . . . . 0.0 106.752 165.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.95 93.45 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.272 2.648 . . . . 0.0 111.703 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.2 141.17 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 167.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.2 mt -137.33 158.99 43.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.04 141.31 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.41 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 54.9 t0 -96.06 110.39 22.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 158.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -93.71 109.68 21.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 167.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -134.25 -176.52 4.23 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.072 1.749 . . . . 0.0 108.098 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.37 166.3 33.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.643 1.577 . . . . 0.0 107.386 168.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.5 -29.08 69.76 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -31.86 17.75 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -169.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 p -71.51 102.4 2.69 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.713 0.688 . . . . 0.0 111.999 -162.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -34.14 -61.01 0.54 Allowed Glycine 0 CA--C 1.539 1.534 0 C-N-CA 126.017 1.77 . . . . 0.0 114.912 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -67.82 -32.86 28.6 Favored 'Trans proline' 0 C--N 1.35 0.646 0 CA-C-N 120.241 2.02 . . . . 0.0 112.512 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.4 p -67.73 -35.59 79.03 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 119.315 0.961 . . . . 0.0 110.258 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -62.35 -15.92 51.34 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.855 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 75.9 mtm -104.11 -14.2 15.97 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.564 1.145 . . . . 0.0 112.876 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.417 ' SD ' ' HA ' ' A' ' 90' ' ' TYR . 14.9 ttt -94.11 -40.67 9.93 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.284 1.434 . . . . 0.0 109.547 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.82 -49.42 86.85 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 117.738 -1.125 . . . . 0.0 112.466 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.76 -33.6 53.34 Favored 'Trans proline' 0 C--N 1.354 0.841 0 CA-C-N 121.888 1.71 . . . . 0.0 112.086 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -63.88 -42.27 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 118.447 0.567 . . . . 0.0 109.513 174.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.47 -24.58 64.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.014 1.725 . . . . 0.0 112.319 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -68.88 -48.25 63.85 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.418 1.008 . . . . 0.0 109.624 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -62.88 -45.23 93.53 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -55.16 -48.17 74.11 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 122.931 0.492 . . . . 0.0 110.439 175.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.07 -55.04 37.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.385 1.074 . . . . 0.0 110.73 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -52.82 -46.75 67.86 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.848 0.859 . . . . 0.0 110.602 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.53 -16.53 10.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -150.13 48.82 0.91 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.535 1.134 . . . . 0.0 110.559 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -25.64 66.58 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -97.68 -54.1 3.22 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.233 1.413 . . . . 0.0 112.465 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -53.79 -29.7 41.5 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.603 0.761 . . . . 0.0 112.378 -171.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 m -134.29 141.56 43.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.319 1.9 t -92.56 73.45 5.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 123.191 1.472 . . . . 0.0 107.723 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.79 164.26 3.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.307 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.6 179.9 8.75 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.806 0.843 . . . . 0.0 110.119 170.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 7.6 ttpm? -139.63 134.44 32.06 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.53 159.79 43.28 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.999 0.812 . . . . 0.0 112.351 177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -82.38 123.38 29.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.314 0.646 . . . . 0.0 109.408 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.6 p -62.34 -29.59 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.182 0.993 . . . . 0.0 112.824 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.62 -36.34 70.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.642 0.777 . . . . 0.0 110.8 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.54 -34.85 74.83 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.178 2.191 . . . . 0.0 112.181 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -111.1 85.15 5.04 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 123.953 0.901 . . . . 0.0 109.393 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.3 -24.12 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.086 2.524 . . . . 0.0 112.816 172.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.07 117.66 11.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.021 1.328 . . . . 0.0 109.978 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 89.36 -40.71 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 129.784 3.233 . . . . 0.0 109.906 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.2 m -52.16 -60.54 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.163 2.185 . . . . 0.0 110.353 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.3 t -57.94 -44.26 86.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.709 0.404 . . . . 0.0 109.938 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -60.15 -27.92 67.49 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.965 1.306 . . . . 0.0 112.913 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.33 14.65 22.62 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.8 0.727 . . . . 0.0 111.465 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.07 26.5 73.32 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 121.55 -0.719 . . . . 0.0 113.135 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.3 mm -75.86 79.16 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.346 1.458 . . . . 0.0 109.014 -171.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.6 ttm -128.24 3.39 5.77 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.305 1.442 . . . . 0.0 110.962 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 t -90.82 23.88 2.95 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.088 1.355 . . . . 0.0 113.121 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.492 HD13 ' H ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -57.95 145.06 73.54 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 123.782 0.833 . . . . 0.0 113.161 -168.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 55.7 Cg_endo -69.09 132.24 20.78 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.034 0.691 . . . . 0.0 112.19 8.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.5 m -122.22 153.28 39.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 tt -144.44 104.44 4.07 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.734 2.014 . . . . 0.0 106.22 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.9 mt -102.19 133.17 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.66 109.68 21.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.095 2.158 . . . . 0.0 105.652 171.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -105.04 156.96 17.57 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -152.87 146.28 24.89 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 159.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.81 35.84 4.55 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.874 1.226 . . . . 0.0 115.215 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.77 -3.22 62.67 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 118.701 1.251 . . . . 0.0 114.791 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -123.61 130.88 24.32 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 119.652 1.726 . . . . 0.0 110.977 -168.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.48 101.69 1.39 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.778 2.986 . . . . 0.0 109.803 169.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -42.42 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.859 0.864 . . . . 0.0 111.094 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.37 168.41 26.4 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.74 163.45 30.14 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.352 0.596 . . . . 0.0 111.489 160.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 99' ' ' GLN . 2.8 mm? -117.88 148.31 42.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.838 2.055 . . . . 0.0 105.784 170.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.6 pt -139.56 140.26 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 125.151 1.38 . . . . 0.0 107.885 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.68 161.63 8.57 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.76 0.695 . . . . 0.0 111.781 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.417 ' HA ' ' SD ' ' A' ' 35' ' ' MET . 10.6 t80 -66.73 98.88 0.56 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.574 1.55 . . . . 0.0 112.385 -170.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -93.01 140.6 23.43 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 168.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.15 163.5 38.53 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.487 2.125 . . . . 0.0 110.308 168.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.67 -46.04 70.5 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 123.843 0.857 . . . . 0.0 111.879 -174.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -49.63 -43.36 46.66 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.801 1.24 . . . . 0.0 111.159 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -88.35 -42.61 12.09 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.442 1.097 . . . . 0.0 109.061 -166.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.83 -62.46 1.85 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.99 1.316 . . . . 0.0 109.31 173.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -57.3 -38.13 73.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.608 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.29 82.06 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.615 1.098 . . . . 0.0 110.574 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.439 ' HG2' HD11 ' A' ' 87' ' ' LEU . 4.9 tp60 -66.99 -21.88 65.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.77 -7.24 27.9 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.204 1.802 . . . . 0.0 113.287 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.71 -29.46 66.7 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.088 1.755 . . . . 0.0 112.532 -167.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.48 -5.54 3.88 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.073 1.749 . . . . 0.0 113.886 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.4 -1.07 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-N 119.124 0.874 . . . . 0.0 112.687 167.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.19 -12.51 15.71 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.247 1.419 . . . . 0.0 113.316 174.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 . . . . . 0 C--O 1.248 1.003 0 C-N-CA 126.461 1.904 . . . . 0.0 107.395 159.126 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 119.73 -0.176 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.3 m -64.79 153.75 39.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.838 0.855 . . . . 0.0 112.074 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.4 ttp -142.5 172.66 12.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.827 1.251 . . . . 0.0 107.837 159.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -77.19 154.73 32.81 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 159.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tp -113.96 164.94 13.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.625 0.726 . . . . 0.0 109.845 173.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.48 171.04 15.16 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 103.999 -2.593 . . . . 0.0 103.999 -173.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -45.38 -58.89 3.0 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 127.562 2.345 . . . . 0.0 112.758 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.66 96.89 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.531 -0.731 . . . . 0.0 111.341 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -68.05 -26.97 66.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.395 1.078 . . . . 0.0 110.314 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -65.18 -6.44 9.34 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 125.128 1.371 . . . . 0.0 112.431 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -121.19 -56.15 1.93 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 162.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -67.89 -12.6 61.01 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -168.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.26 -3.87 13.79 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.593 1.157 . . . . 0.0 113.044 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 11.7 pt -91.83 -105.95 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 158.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 47.95 -10.26 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.77 1 C-N-CA 131.859 4.064 . . . . 0.0 118.881 174.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.27 179.94 17.48 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.144 1.831 . . . . 0.0 112.29 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.14 -11.43 57.94 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.087 1.755 . . . . 0.0 112.869 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.4 150.02 51.7 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.72 97.42 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.036 2.491 . . . . 0.0 110.34 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.1 t -105.33 140.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.95 136.44 46.11 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.793 0.806 . . . . 0.0 110.206 172.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.87 120.99 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 126.707 2.003 . . . . 0.0 105.965 -170.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.02 92.06 4.22 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -77.97 113.77 16.19 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.028 0.931 . . . . 0.0 108.9 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -131.97 -174.21 3.36 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 170.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.46 167.67 26.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.642 1.577 . . . . 0.0 107.584 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.9 -8.89 32.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.357 1.244 . . . . 0.0 114.357 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.538 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -110.53 -21.49 12.12 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -172.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.437 ' SG ' HD12 ' A' ' 72' ' ' ILE . 3.7 p -77.87 45.55 0.52 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 -158.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 29.3 -95.17 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 C-N-CA 128.782 3.086 . . . . 0.0 114.213 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -59.07 -21.68 60.2 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.41 2.74 . . . . 0.0 114.538 -176.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.1 p -56.97 -32.37 65.99 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.448 1.476 . . . . 0.0 111.436 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -72.25 -18.91 61.78 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.751 1.22 . . . . 0.0 112.182 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -98.73 -18.11 18.18 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.086 1.354 . . . . 0.0 111.251 173.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.8 ttt -74.2 -37.62 63.84 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.602 1.561 . . . . 0.0 109.377 168.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.77 -51.56 45.3 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 117.495 -1.241 . . . . 0.0 113.171 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.68 -33.4 13.15 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 121.739 1.657 . . . . 0.0 113.051 171.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -28.89 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 121.258 1.844 . . . . 0.0 110.777 175.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.43 -13.1 61.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.765 2.026 . . . . 0.0 112.711 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -79.42 -40.7 29.37 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.682 1.128 . . . . 0.0 108.982 171.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -66.44 -16.89 64.45 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.733 0.813 . . . . 0.0 111.383 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -83.13 -43.89 15.72 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.426 1.09 . . . . 0.0 111.43 169.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.68 -48.66 49.47 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.938 0.895 . . . . 0.0 110.871 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -54.95 -43.0 73.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.458 1.103 . . . . 0.0 111.765 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.21 -12.49 28.71 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.551 1.141 . . . . 0.0 113.369 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -156.01 49.88 0.52 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.544 1.137 . . . . 0.0 110.056 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.07 -47.45 53.6 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.959 0.904 . . . . 0.0 112.459 -170.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -124.65 -6.2 7.5 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 171.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -55.07 -31.15 60.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.177 1.391 . . . . 0.0 111.765 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.26 177.26 6.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.676 1.19 . . . . 0.0 109.321 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 m -117.18 96.92 5.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.817 1.247 . . . . 0.0 107.741 164.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.77 149.25 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 160.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.58 109.03 3.98 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.432 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -88.32 145.5 25.8 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.767 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -154.38 157.29 38.33 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.659 0.784 . . . . 0.0 112.374 173.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -76.81 106.19 8.33 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.688 1.595 . . . . 0.0 109.187 174.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 p -64.1 -28.9 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.015 0.926 . . . . 0.0 112.685 -173.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -64.54 -30.25 71.28 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.341 1.056 . . . . 0.0 110.891 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -98.44 -20.45 17.11 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.578 1.951 . . . . 0.0 112.062 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -104.76 92.52 5.19 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.115 167.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.69 -17.95 22.69 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.062 1.841 . . . . 0.0 113.533 167.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 113.63 3.89 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.568 1.147 . . . . 0.0 109.282 -173.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.303 17.6 m 66.13 -14.69 0.14 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.329 2.651 . . . . 0.0 113.63 176.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.4 m -50.41 -55.24 16.64 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.321 1.848 . . . . 0.0 108.486 158.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -72.01 -6.79 44.75 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 117.847 -1.073 . . . . 0.0 113.103 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.77 -52.84 4.79 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.403 1.001 . . . . 0.0 109.364 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -81.2 16.87 1.42 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.159 0.89 . . . . 0.0 112.43 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.32 32.02 80.75 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 121.558 -0.714 . . . . 0.0 111.775 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.3 mm -77.43 81.3 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.538 1.135 . . . . 0.0 108.083 -172.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -117.88 14.4 14.21 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.783 1.633 . . . . 0.0 112.472 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.1 m -154.78 158.98 40.31 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.74 -1.225 . . . . 0.0 109.802 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.538 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 15.8 pt -155.05 162.51 27.07 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 129.28 3.032 . . . . 0.0 107.568 -171.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.2 127.59 7.24 Favored 'Cis proline' 0 C--N 1.349 0.565 0 CA-C-N 119.952 1.018 . . . . 0.0 110.653 -6.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.3 m -124.56 136.34 53.89 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.325 1.05 . . . . 0.0 108.797 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 tt -130.01 117.56 20.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.9 mt -126.38 129.65 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 tt -96.67 126.32 41.75 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -122.62 153.44 39.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.594 1.157 . . . . 0.0 110.613 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -158.56 153.37 24.89 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 124.757 1.223 . . . . 0.0 108.434 158.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.86 11.47 24.26 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 119.424 -0.653 . . . . 0.0 113.355 -169.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.65 0.58 89.95 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 118.345 1.072 . . . . 0.0 113.717 -170.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -107.82 136.16 19.74 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 119.34 1.57 . . . . 0.0 109.691 -173.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.99 110.31 3.02 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.361 2.707 . . . . 0.0 110.965 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 42.0 t -71.79 -37.19 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.629 1.572 . . . . 0.0 110.981 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -154.68 157.32 37.93 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.865 0.866 . . . . 0.0 109.108 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -141.24 127.73 20.03 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 126.937 2.095 . . . . 0.0 105.989 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mp -122.58 139.77 53.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.429 1.891 . . . . 0.0 106.03 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.09 121.86 29.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.207 1.403 . . . . 0.0 108.248 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.02 172.7 23.46 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.128 1.347 . . . . 0.0 112.507 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -69.7 85.22 0.46 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.285 1.034 . . . . 0.0 108.473 171.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.98 120.99 77.11 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 169.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -65.96 160.6 43.52 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.288 1.325 . . . . 0.0 109.92 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.44 -52.46 13.05 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 125.264 1.426 . . . . 0.0 112.558 -172.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -59.77 -25.95 65.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.911 1.284 . . . . 0.0 112.673 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -88.12 -42.18 12.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.033 0.933 . . . . 0.0 109.849 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.32 -60.83 3.0 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.658 1.983 . . . . 0.0 110.384 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -57.8 -33.45 68.59 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.189 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.05 -48.7 62.17 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 119.616 1.098 . . . . 0.0 111.119 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.0 tp-100 -63.25 -38.26 90.47 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.243 0.617 . . . . 0.0 111.33 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.86 -1.4 56.48 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.034 0.933 . . . . 0.0 112.912 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.46 -38.95 66.97 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 124.235 1.014 . . . . 0.0 112.798 -165.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -69.83 -6.47 32.67 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.647 1.112 . . . . 0.0 113.305 -176.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.28 1.29 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.654 1.182 . . . . 0.0 111.934 170.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -124.78 -4.03 7.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.005 1.722 . . . . 0.0 113.384 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.119 0 C-N-CA 126.792 2.037 . . . . 0.0 110.38 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.1 m -147.68 144.29 28.24 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 120.732 -1.23 . . . . 0.0 109.093 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.9 mtt -145.97 177.39 8.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.678 1.591 . . . . 0.0 109.256 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.4 m -93.85 160.84 14.56 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 161.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.8 mt -133.27 165.37 24.97 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.654 0.781 . . . . 0.0 109.444 171.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -138.15 -178.65 5.37 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 164.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.31 -60.37 3.2 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.989 2.115 . . . . 0.0 112.777 -161.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.94 -34.53 77.67 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -77.04 -19.14 57.56 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.914 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -57.18 -59.73 4.66 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.529 1.059 . . . . 0.0 109.759 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -42.6 99.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.589 0.356 . . . . 0.0 110.48 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.64 -26.7 61.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.159 0.584 . . . . 0.0 112.149 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.74 -26.94 19.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.828 -1.082 . . . . 0.0 112.655 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.472 HG13 ' H ' ' A' ' 15' ' ' GLN 0.279 11.3 pt -75.22 -91.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.95 0.795 . . . . 0.0 109.517 171.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.472 ' H ' HG13 ' A' ' 14' ' ' ILE . 13.9 pt20 45.85 -17.77 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.758 1 C-N-CA 133.207 4.603 . . . . 0.0 119.632 174.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.02 -179.06 25.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.757 1.162 . . . . 0.0 112.887 -159.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -81.46 -13.57 58.04 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.85 2.06 . . . . 0.0 114.207 -167.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.93 156.04 41.28 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 118.577 0.626 . . . . 0.0 112.036 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.15 81.96 1.11 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.778 2.985 . . . . 0.0 110.466 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.4 t -87.81 138.11 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.8 tt -133.75 141.27 47.44 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.91 125.63 58.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -170.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.71 96.85 6.2 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.747 1.219 . . . . 0.0 108.218 175.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -75.11 115.78 15.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -117.49 176.76 5.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 168.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.62 161.22 40.99 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 121.294 -0.879 . . . . 0.0 110.392 174.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.31 15.06 0.48 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.321 1.049 . . . . 0.0 113.579 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.411 ' CG ' ' N ' ' A' ' 29' ' ' CYS . 2.2 p90 -136.82 -61.72 0.66 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.215 1.006 . . . . 0.0 108.553 168.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.411 ' N ' ' CG ' ' A' ' 28' ' ' TRP . 16.3 p 44.16 -62.95 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 1 C-N-CA 132.024 4.13 . . . . 0.0 117.525 178.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.76 -103.83 3.06 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.951 1.739 . . . . 0.0 109.802 -161.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -60.19 -21.12 64.96 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.451 2.767 . . . . 0.0 115.15 -171.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -60.75 -25.3 66.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.947 1.248 . . . . 0.0 111.466 173.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -22.3 65.93 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.394 0.997 . . . . 0.0 111.932 174.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 84.0 mtp -98.54 -25.0 14.9 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 125.946 1.698 . . . . 0.0 111.429 176.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.2 ttt -83.38 -36.37 24.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 117.521 -1.228 . . . . 0.0 109.109 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.87 -51.13 57.24 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.871 1.669 . . . . 0.0 112.482 175.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -62.41 -39.43 46.28 Favored 'Trans proline' 0 C--N 1.352 0.744 0 CA-C-N 121.444 1.551 . . . . 0.0 112.422 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.25 -20.67 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 119.981 1.264 . . . . 0.0 112.071 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.84 -17.39 24.15 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.242 1.817 . . . . 0.0 111.612 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.04 -45.84 69.41 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 167.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -53.83 -50.14 66.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.954 1.301 . . . . 0.0 110.151 167.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.86 -51.39 67.72 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.095 0.558 . . . . 0.0 110.974 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.57 -55.85 19.4 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.881 0.872 . . . . 0.0 110.532 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -57.68 -43.6 85.18 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.672 0.608 . . . . 0.0 111.217 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.79 -21.31 10.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -147.63 40.94 1.02 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.481 1.112 . . . . 0.0 111.003 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.52 -37.17 16.91 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.951 1.7 . . . . 0.0 115.275 -162.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -132.26 6.27 4.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -66.24 -34.58 78.33 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.527 -0.733 . . . . 0.0 109.825 166.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.65 171.64 5.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.338 0.6 OUTLIER -118.62 97.81 5.92 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 159.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 p -84.89 159.76 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.2 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.38 156.92 44.07 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 162.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -123.03 138.09 54.77 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 172.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pp -150.87 150.83 31.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.867 0.467 . . . . 0.0 110.956 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -82.79 116.57 22.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.81 -27.86 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 123.8 0.84 . . . . 0.0 112.142 -175.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -67.63 -31.45 71.47 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 123.683 0.793 . . . . 0.0 111.0 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -83.97 -24.82 30.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.034 0.934 . . . . 0.0 111.907 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -113.84 86.63 11.23 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.309 1.043 . . . . 0.0 109.856 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.03 -24.51 12.7 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.124 2.55 . . . . 0.0 113.752 171.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.23 131.16 44.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.788 1.176 . . . . 0.0 109.808 -177.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.9 m 69.68 -31.8 0.22 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.42 2.688 . . . . 0.0 112.453 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.1 m -53.51 -54.74 32.93 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.471 1.909 . . . . 0.0 109.721 170.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.6 t -70.03 -1.94 11.28 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.766 -1.111 . . . . 0.0 113.157 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -106.69 -35.09 7.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.663 1.12 . . . . 0.0 111.339 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -99.1 14.93 27.55 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.794 0.725 . . . . 0.0 112.119 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.99 33.53 85.81 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 123.486 0.565 . . . . 0.0 111.899 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 42.7 mm -74.3 80.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.416 1.486 . . . . 0.0 108.312 -171.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 21.7 ttt -138.89 40.12 2.15 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.255 1.422 . . . . 0.0 109.642 -176.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.2 m -155.11 61.41 0.64 Allowed 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.468 -1.395 . . . . 0.0 109.565 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.48 153.79 81.54 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.686 173.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -67.32 126.08 7.45 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 CA-C-N 119.206 0.752 . . . . 0.0 110.544 -5.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -114.53 130.49 56.76 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.99 119.6 30.02 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -173.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.52 148.7 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -121.98 132.97 54.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -121.35 155.1 35.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.064 1.346 . . . . 0.0 110.842 -173.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -164.62 151.39 11.04 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.333 1.453 . . . . 0.0 109.229 158.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.03 15.81 50.88 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.652 0.644 . . . . 0.0 112.353 -165.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.02 -3.59 28.26 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.843 -0.976 . . . . 0.0 113.862 -166.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -86.74 133.56 39.41 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 119.522 1.661 . . . . 0.0 108.821 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.45 95.82 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.272 2.648 . . . . 0.0 109.299 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 m -61.14 -35.56 66.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 O-C-N 121.656 -0.653 . . . . 0.0 111.917 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.88 159.85 43.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.012 0.434 . . . . 0.0 111.636 159.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.13 140.92 48.93 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 127.538 2.335 . . . . 0.0 107.303 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.462 HD11 ' HG2' ' A' ' 99' ' ' GLN . 3.6 mm? -123.39 152.59 41.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 127.702 2.401 . . . . 0.0 107.625 168.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.73 126.18 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.82 163.75 39.14 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.607 1.099 . . . . 0.0 113.101 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -61.82 134.05 56.23 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.057 1.343 . . . . 0.0 110.535 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -137.91 144.01 42.24 Favored Pre-proline 0 C--O 1.242 0.671 0 C-N-CA 124.89 1.276 . . . . 0.0 107.608 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.94 157.27 57.76 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.192 1.928 . . . . 0.0 109.155 169.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.54 -38.47 87.57 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.149 -0.97 . . . . 0.0 110.779 -175.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.22 -21.37 13.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.059 0.944 . . . . 0.0 113.02 174.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -97.92 -50.91 4.24 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 119.49 1.041 . . . . 0.0 110.454 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.74 -58.9 6.32 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.837 1.655 . . . . 0.0 109.527 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -59.52 -30.77 68.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.931 1.292 . . . . 0.0 110.657 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.71 -46.25 32.14 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.547 0.612 . . . . 0.0 110.965 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.462 ' HG2' HD11 ' A' ' 87' ' ' LEU . 12.7 tp-100 -64.75 -31.22 72.35 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.424 1.09 . . . . 0.0 111.19 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.24 2.17 56.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.345 1.058 . . . . 0.0 112.511 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.18 -19.04 61.13 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -19.79 62.88 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.066 1.757 . . . . 0.0 111.672 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.31 -7.23 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 125.779 1.632 . . . . 0.0 111.783 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.05 5.96 28.52 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.557 1.543 . . . . 0.0 112.78 167.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.962 0 C-N-CA 126.157 1.783 . . . . 0.0 109.618 165.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 110.793 -0.077 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.0 m -122.03 140.15 52.84 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 171.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.9 tpt -148.07 176.12 10.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.968 1.307 . . . . 0.0 109.131 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.2 m -99.8 141.32 32.77 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 168.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.658 HD13 ' CB ' ' A' ' 53' ' ' ALA . 1.6 tp -113.85 163.1 15.52 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.339 0.59 . . . . 0.0 110.307 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 t -142.64 -127.67 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -98.79 -62.22 1.27 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.982 1.313 . . . . 0.0 109.49 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.97 -44.94 79.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.62 1.168 . . . . 0.0 111.008 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -72.24 -24.54 61.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.335 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -71.45 -48.83 46.94 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.07 -32.98 74.74 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.949 -0.548 . . . . 0.0 112.3 176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -64.85 -50.32 67.1 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.166 0.894 . . . . 0.0 110.2 167.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.402 ' O ' HG21 ' A' ' 20' ' ' VAL . . . -54.74 -48.21 72.86 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.143 0.883 . . . . 0.0 111.372 -175.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.1 pt -63.01 -1.98 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -52.23 -31.6 32.83 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.233 1.379 . . . . 0.0 111.909 171.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.99 -133.28 13.98 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 116.531 1.372 . . . . 0.0 116.531 158.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.6 t70 64.29 -50.16 0.29 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 130.221 3.408 . . . . 0.0 111.303 -158.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.4 160.68 46.0 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -62.68 107.04 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.19 2.593 . . . . 0.0 110.956 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 13' ' ' ALA . 50.3 t -94.52 107.02 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.97 153.59 22.06 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 164.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.26 150.88 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 164.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -110.7 104.62 13.31 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.43 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 79.0 m-85 -89.31 108.2 19.49 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 164.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -131.49 -176.39 4.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.528 1.531 . . . . 0.0 107.019 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.18 171.25 20.25 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.692 1.197 . . . . 0.0 108.132 164.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.24 -35.52 80.61 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.52 -23.91 18.94 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -163.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.9 p -75.6 40.19 0.18 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.298 1.839 . . . . 0.0 115.256 -159.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 42.48 -99.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 127.718 2.58 . . . . 0.0 113.974 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -57.52 -23.48 56.51 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.528 2.819 . . . . 0.0 114.396 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 18.9 p -56.91 -34.63 68.13 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.511 1.05 . . . . 0.0 111.417 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -71.12 -8.0 50.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.357 1.063 . . . . 0.0 112.359 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.7 mtm -106.88 -12.3 15.51 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.81 1.644 . . . . 0.0 112.222 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -40.42 11.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.813 2.045 . . . . 0.0 108.851 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.34 -56.23 19.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.233 1.413 . . . . 0.0 112.177 170.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.57 -25.01 69.79 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 122.143 1.801 . . . . 0.0 113.017 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.1 t -68.78 -46.35 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.365 0.984 . . . . 0.0 109.677 170.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.47 ' HA ' ' HB3' ' A' ' 42' ' ' PHE . 3.7 mp -61.15 -36.2 79.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.698 1.599 . . . . 0.0 111.901 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.18 -7.64 38.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.218 2.207 . . . . 0.0 112.099 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -109.81 -50.72 2.95 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.368 1.467 . . . . 0.0 109.47 168.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 47.4 t80 -45.45 -51.76 11.07 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 125.811 1.645 . . . . 0.0 112.22 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.15 -63.09 1.24 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.601 1.161 . . . . 0.0 110.369 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.88 -33.77 74.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.61 1.564 . . . . 0.0 111.993 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.77 -19.4 27.79 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -140.7 48.5 1.72 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.142 1.377 . . . . 0.0 109.028 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.24 -37.44 16.1 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.077 1.351 . . . . 0.0 114.259 -164.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -130.32 3.22 4.69 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -65.46 -36.78 84.9 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.679 1.127 . . . . 0.0 109.094 159.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.6 m -111.09 174.27 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.248 1.019 . . . . 0.0 108.696 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.4 134.72 48.87 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 158.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.6 p -137.01 161.06 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.552 1.141 . . . . 0.0 109.827 -175.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.658 ' CB ' HD13 ' A' ' 5' ' ' LEU . . . -165.09 166.35 19.23 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.275 171.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.15 148.1 42.67 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.52 137.05 36.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 125.812 1.945 . . . . 0.0 111.403 169.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -75.21 101.11 4.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.439 HG11 HG21 ' A' ' 72' ' ' ILE . 2.8 p -61.56 -25.3 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.373 1.069 . . . . 0.0 112.374 -166.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -73.01 -18.79 61.31 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.367 1.867 . . . . 0.0 112.649 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -114.97 -43.62 3.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 127.68 2.392 . . . . 0.0 109.887 -171.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -114.93 81.88 7.92 Favored Pre-proline 0 N--CA 1.443 -0.795 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.2 -68.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.235 2.623 . . . . 0.0 111.828 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 29.32 99.34 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.357 2.663 . . . . 0.0 115.586 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.263 38.6 m 67.71 -8.39 0.52 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.748 1.219 . . . . 0.0 113.165 174.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.0 m -49.36 -50.14 41.3 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 120.488 -1.382 . . . . 0.0 111.173 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.9 t -71.75 -3.68 23.37 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 117.657 -1.163 . . . . 0.0 112.778 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -95.6 -32.05 12.99 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.731 1.15 . . . . 0.0 111.68 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -110.48 0.74 17.89 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.82 35.91 43.89 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.263 0.935 . . . . 0.0 112.399 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.43 HG21 ' CZ ' ' A' ' 24' ' ' PHE . 42.8 mm -82.17 48.88 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.376 1.47 . . . . 0.0 111.778 -163.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 18.0 ttt -88.32 2.35 52.66 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.754 1.222 . . . . 0.0 110.348 163.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 p -72.77 13.97 0.32 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.202 2.201 . . . . 0.0 114.907 -176.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.462 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -65.16 144.75 99.1 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 123.907 0.883 . . . . 0.0 112.014 -165.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.462 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 57.5 Cg_endo -65.94 132.09 15.42 Favored 'Cis proline' 0 C--N 1.35 0.622 0 CA-C-N 119.268 0.774 . . . . 0.0 111.398 2.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.5 m -131.44 141.1 49.75 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.563 0.745 . . . . 0.0 109.144 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -135.87 98.92 4.02 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.1 mt -88.29 145.99 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.35 99.21 7.04 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -96.47 160.83 14.2 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.552 1.941 . . . . 0.0 109.685 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -157.78 39.02 0.27 Allowed 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 158.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 82' ' ' GLU . . . 159.39 52.38 0.01 OUTLIER Glycine 0 N--CA 1.463 0.468 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 169.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.4 -25.53 0.58 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.31 1.91 . . . . 0.0 112.677 -168.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 80' ' ' GLY . 42.0 tt0 -91.72 131.71 35.04 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 126.43 1.892 . . . . 0.0 110.028 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.85 126.55 7.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.988 3.125 . . . . 0.0 110.78 170.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.8 -38.4 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 121.661 -0.65 . . . . 0.0 110.448 165.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -154.1 172.07 18.11 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 118.623 0.647 . . . . 0.0 111.233 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -138.35 136.15 36.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.196 1.799 . . . . 0.0 108.032 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.25 141.29 43.43 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.19 2.196 . . . . 0.0 105.851 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 pt -139.78 152.32 22.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.575 1.15 . . . . 0.0 108.838 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.19 168.1 6.86 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.838 0.732 . . . . 0.0 111.65 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -81.61 75.08 8.57 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.723 -0.869 . . . . 0.0 110.563 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -75.42 122.9 88.19 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 158.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -71.84 173.75 12.24 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.089 1.859 . . . . 0.0 110.7 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HE2' ' OE1' ' A' ' 97' ' ' GLU . 22.8 tptm -31.8 -59.12 0.27 Allowed 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 127.561 2.344 . . . . 0.0 112.483 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.72 -49.81 64.64 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.802 1.313 . . . . 0.0 111.643 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -74.22 -42.01 60.44 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.496 1.118 . . . . 0.0 110.033 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 tt -59.78 -62.46 1.86 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.594 1.558 . . . . 0.0 108.983 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.46 ' OE1' ' HE2' ' A' ' 93' ' ' LYS . 11.3 tt0 -66.09 -25.92 67.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.224 1.41 . . . . 0.0 111.102 -177.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.93 -52.48 24.18 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.212 0.915 . . . . 0.0 110.412 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -59.7 -40.0 86.47 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.391 0.541 . . . . 0.0 111.367 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.27 -0.66 50.57 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.797 1.239 . . . . 0.0 112.764 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.6 -28.97 66.09 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.363 0.983 . . . . 0.0 112.142 -176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -69.67 -3.71 16.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.626 1.17 . . . . 0.0 113.488 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.88 -15.58 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.156 0.889 . . . . 0.0 112.416 164.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.37 -9.98 50.88 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.015 0.926 . . . . 0.0 113.204 173.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 C-N-CA 125.641 1.576 . . . . 0.0 110.622 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 m 87.35 168.71 0.06 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.078 1.351 . . . . 0.0 113.657 152.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.5 ttt 72.92 -21.14 0.25 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 129.57 3.148 . . . . 0.0 116.001 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.8 m -155.33 156.97 36.42 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.759 1.624 . . . . 0.0 109.215 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.446 HD21 ' HA ' ' A' ' 10' ' ' PHE . 6.0 tp -146.01 170.32 16.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 127.728 2.411 . . . . 0.0 106.934 175.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.5 m -150.02 157.2 42.9 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -46.51 -53.4 11.34 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 127.172 2.189 . . . . 0.0 113.207 -168.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.03 93.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.051 0.929 . . . . 0.0 111.746 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -69.91 -18.47 63.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.124 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.446 ' HA ' HD21 ' A' ' 5' ' ' LEU . 2.3 t80 -58.12 -60.9 3.03 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.252 0.621 . . . . 0.0 110.242 172.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -63.47 -39.64 95.0 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 119.322 -0.37 . . . . 0.0 110.56 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -63.65 -27.99 69.61 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.609 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.64 -60.39 2.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.659 1.118 . . . . 0.0 109.517 168.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.8 pt -64.89 -23.28 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -167.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -59.53 -30.09 68.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 164.16 104.39 0.18 Allowed Glycine 0 C--N 1.34 0.77 0 CA-C-N 119.316 0.962 . . . . 0.0 110.734 -168.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -160.93 -65.03 0.06 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.614 1.566 . . . . 0.0 109.778 -169.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.22 -161.39 32.48 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 -164.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.44 112.48 1.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.491 2.127 . . . . 0.0 108.855 167.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.7 t -110.3 141.16 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 C-N-CA 125.501 1.521 . . . . 0.0 107.199 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.1 tp -145.2 111.33 5.59 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 118.028 0.377 . . . . 0.0 110.469 -167.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.4 t -112.83 121.99 66.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 118.957 0.799 . . . . 0.0 109.436 -163.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 11.4 t0 -82.36 106.76 14.5 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 169.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.49 105.3 16.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 162.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.3 p-90 -117.95 -179.44 3.76 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 166.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.76 152.04 32.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 120.505 -1.372 . . . . 0.0 110.336 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.95 -23.9 66.7 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.93 -13.27 29.09 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.8 p -71.55 178.25 3.61 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.214 0.605 . . . . 0.0 112.386 -164.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.97 -93.5 1.87 Allowed Glycine 0 CA--C 1.538 1.489 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 164.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -66.85 -21.27 50.87 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.381 2.721 . . . . 0.0 114.133 -166.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -30.37 68.81 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.521 0.6 . . . . 0.0 111.225 174.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 -71.8 -13.16 61.61 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.501 1.12 . . . . 0.0 111.981 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 76.4 mtm -98.6 -37.2 9.62 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.105 1.362 . . . . 0.0 111.089 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.8 ttt -67.44 -43.02 82.13 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.874 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.22 -50.64 74.58 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 119.956 1.253 . . . . 0.0 113.284 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.93 -33.43 26.35 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.849 1.696 . . . . 0.0 112.684 170.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -29.56 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 120.093 1.315 . . . . 0.0 112.018 173.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.7 mt -82.98 -23.9 33.17 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.667 2.387 . . . . 0.0 110.904 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -70.05 -35.93 74.62 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.824 0.738 . . . . 0.0 110.6 171.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.03 -35.43 61.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.134 0.879 . . . . 0.0 111.107 174.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -55.02 -46.06 75.21 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.326 0.65 . . . . 0.0 109.549 166.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.473 ' HA ' HG11 ' A' ' 52' ' ' VAL . . . -61.12 -51.68 68.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 118.427 -0.796 . . . . 0.0 111.274 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.93 -46.46 74.93 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.445 0.698 . . . . 0.0 110.311 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.4 -16.07 59.42 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -138.89 28.55 2.35 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.058 1.343 . . . . 0.0 112.271 -173.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.46 65.79 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -164.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -95.38 -45.61 7.05 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.304 2.642 . . . . 0.0 111.316 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -66.51 -19.61 65.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.785 1.634 . . . . 0.0 113.029 -171.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.35 143.16 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 119.14 0.882 . . . . 0.0 110.058 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.8 m -78.01 60.07 2.3 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.724 1.61 . . . . 0.0 107.743 168.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 43' ' ' ALA . 2.5 p -71.3 151.09 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.03 169.51 24.4 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 16.4 ttpp -144.32 125.7 14.81 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -168.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.39 154.51 43.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.838 1.304 . . . . 0.0 114.112 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -87.57 105.22 17.18 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.26 -14.65 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 121.382 -0.824 . . . . 0.0 112.207 -172.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.93 -35.79 82.3 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.197 1.399 . . . . 0.0 111.643 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -74.47 -33.1 62.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.287 1.035 . . . . 0.0 110.638 172.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -111.43 87.43 7.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.115 0.966 . . . . 0.0 111.985 -164.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -80.95 -19.82 8.02 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.64 2.893 . . . . 0.0 113.951 168.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.61 128.88 37.26 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.645 1.111 . . . . 0.0 109.649 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 55.0 m 68.54 -28.79 0.16 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.807 2.443 . . . . 0.0 112.696 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.2 m -53.14 -55.71 21.97 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.03 1.732 . . . . 0.0 109.649 167.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -70.6 -4.01 21.08 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 117.917 -1.04 . . . . 0.0 112.855 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -94.39 -34.25 12.84 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.563 1.074 . . . . 0.0 110.714 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -106.06 11.36 31.57 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.64 0.655 . . . . 0.0 112.117 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.22 35.23 90.1 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 123.939 0.78 . . . . 0.0 111.553 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.58 87.98 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.993 0.901 . . . . 0.0 109.979 -168.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.2 ttt -125.81 -1.35 7.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.514 1.525 . . . . 0.0 110.74 167.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.1 p -72.95 23.27 0.06 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.706 2.402 . . . . 0.0 114.824 -169.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.412 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 46.4 pt -68.61 150.87 97.53 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -159.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.412 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 36.8 Cg_endo -63.86 130.19 9.15 Favored 'Cis proline' 0 C--N 1.353 0.766 0 CA-C-N 118.89 0.639 . . . . 0.0 110.682 -7.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.1 m -114.14 130.56 56.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.9 tt -120.12 109.95 16.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.8 mt -119.08 132.88 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tt -102.56 137.95 40.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -135.18 163.99 28.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.386 1.874 . . . . 0.0 108.757 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -153.86 140.92 19.36 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 158.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 39.13 53.46 2.64 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 126.219 1.866 . . . . 0.0 114.49 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.1 -7.24 78.85 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.842 1.21 . . . . 0.0 114.338 176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.19 123.7 36.09 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 119.453 1.626 . . . . 0.0 110.049 -173.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -71.65 135.38 25.98 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.099 2.532 . . . . 0.0 109.89 169.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.9 t -100.4 -56.14 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.625 1.17 . . . . 0.0 110.033 -173.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -155.56 163.9 39.37 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.743 0.701 . . . . 0.0 109.975 170.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -120.86 132.27 54.89 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.811 2.044 . . . . 0.0 107.267 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.53 144.93 38.63 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.97 2.508 . . . . 0.0 106.411 169.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.8 pt -139.64 120.11 14.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.497 1.119 . . . . 0.0 109.622 -170.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.83 168.86 42.34 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.073 0.844 . . . . 0.0 111.905 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.74 81.08 1.57 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.792 1.637 . . . . 0.0 110.501 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -68.63 133.73 90.64 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.31 159.73 52.02 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.496 1.464 . . . . 0.0 109.532 165.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.51 -41.03 72.54 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 123.446 0.699 . . . . 0.0 112.748 -170.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.83 -29.72 68.45 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.012 0.925 . . . . 0.0 112.667 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.5 -47.28 11.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.345 1.858 . . . . 0.0 107.496 178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.34 -62.48 1.81 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.139 2.176 . . . . 0.0 109.846 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -30.19 71.33 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 117.607 -1.187 . . . . 0.0 110.602 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.49 -26.41 64.54 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 122.044 2.202 . . . . 0.0 111.679 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.03 -17.26 61.0 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 167.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 tp -128.42 -9.0 5.19 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -159.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.88 -15.88 24.87 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.136 2.174 . . . . 0.0 112.702 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -72.81 -20.26 61.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.494 1.118 . . . . 0.0 113.261 170.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.0 m -126.51 -6.69 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.149 1.78 . . . . 0.0 112.746 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.6 6.09 49.82 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.196 1.798 . . . . 0.0 109.808 158.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 . . . . . 0 C--O 1.25 1.082 0 C-N-CA 124.653 1.181 . . . . 0.0 109.717 163.679 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 51' ' ' THR . . . . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 118.94 -0.552 . . . . 0.0 112.279 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 t -155.04 12.97 0.38 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.771 0.829 . . . . 0.0 112.166 -166.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.6 ttt -121.68 161.09 23.14 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -158.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -67.16 143.67 56.45 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.062 1.745 . . . . 0.0 109.735 161.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.66 HD13 ' HB1' ' A' ' 53' ' ' ALA . 1.8 mp -131.27 160.82 33.79 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.219 1.008 . . . . 0.0 110.267 -170.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.0 p -134.96 -62.01 0.74 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.778 0.799 . . . . 0.0 110.528 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 8' ' ' ALA . 39.0 p-10 -179.3 -78.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.468 1.907 . . . . 0.0 108.807 -159.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.412 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . -61.69 -38.44 87.84 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.984 0.913 . . . . 0.0 109.66 172.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -75.82 -21.53 57.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.362 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -67.58 -55.87 11.69 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 173.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -63.02 -35.63 80.85 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.634 -0.698 . . . . 0.0 111.39 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -58.11 -46.3 85.79 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.801 0.728 . . . . 0.0 110.638 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.34 -40.7 96.39 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.026 -0.988 . . . . 0.0 112.567 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . 0.257 11.8 pt -72.22 -67.31 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 118.851 0.75 . . . . 0.0 111.613 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 37.78 -13.39 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.601 1 C-N-CA 134.905 5.282 . . . . 0.0 120.359 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 174.1 -159.93 29.47 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 120.78 1.627 . . . . 0.0 116.049 -166.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.586 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 4.0 m-20 -70.52 -9.37 56.49 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.211 3.004 . . . . 0.0 115.835 -161.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.52 164.2 54.03 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 119.093 0.86 . . . . 0.0 112.967 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.33 110.25 1.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.293 2.662 . . . . 0.0 107.775 166.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.499 ' HA ' ' HB ' ' A' ' 51' ' ' THR . 60.1 t -122.2 142.54 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.454 HD11 HG13 ' A' ' 52' ' ' VAL . 1.3 pp -133.5 155.85 48.82 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.161 0.505 . . . . 0.0 110.156 168.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.666 HG13 HD11 ' A' ' 55' ' ' LEU . 2.1 t -128.55 124.2 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.605 1.562 . . . . 0.0 107.612 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.01 100.9 13.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.676 1.59 . . . . 0.0 107.967 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.578 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 61.1 m-85 -89.71 109.77 20.72 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.915 0.886 . . . . 0.0 108.979 174.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -137.4 -171.86 3.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.97 170.19 21.08 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.196 1.398 . . . . 0.0 107.454 169.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.38 -14.65 62.42 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CH2' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -113.53 -24.11 9.43 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -166.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.6 p -70.94 34.59 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 127.275 2.23 . . . . 0.0 116.51 -160.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 52.3 -110.21 1.11 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.523 1.535 . . . . 0.0 113.372 171.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.11 -14.94 31.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 124.085 3.19 . . . . 0.0 114.921 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 17.5 p -54.54 -30.96 55.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.988 0.813 . . . . 0.0 111.856 165.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -71.69 -6.21 39.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.161 0.984 . . . . 0.0 112.923 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.6 mtm -108.82 -30.41 8.16 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.974 1.709 . . . . 0.0 111.371 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.3 tpt -75.07 -43.91 50.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.227 1.811 . . . . 0.0 109.406 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.0 95.41 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 116.806 -1.569 . . . . 0.0 112.09 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HA ' ' HB2' ' A' ' 40' ' ' GLU . 26.6 Cg_endo -63.7 -34.68 61.66 Favored 'Trans proline' 0 C--N 1.352 0.728 0 CA-C-N 122.432 1.904 . . . . 0.0 112.54 173.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.29 -33.39 63.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 119.728 1.149 . . . . 0.0 110.983 174.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mp -75.92 -23.08 55.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.715 1.606 . . . . 0.0 111.672 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -66.04 -44.8 83.54 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 124.331 1.052 . . . . 0.0 109.425 169.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.469 ' OE2' ' HE3' ' A' ' 93' ' ' LYS . 19.0 tt0 -59.22 -48.88 79.99 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 172.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -52.33 -49.48 64.18 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 122.665 0.386 . . . . 0.0 110.748 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.1 -51.93 58.45 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.971 0.908 . . . . 0.0 111.33 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.15 -47.51 75.0 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.366 0.667 . . . . 0.0 109.992 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.14 -17.09 64.19 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -136.0 14.42 3.33 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -168.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -42.5 -46.03 4.67 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.912 1.685 . . . . 0.0 113.366 -174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -86.0 -13.46 47.47 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -94.29 -21.93 18.7 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.69 -0.631 . . . . 0.0 111.483 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.47 137.45 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 122.207 1.003 . . . . 0.0 109.803 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 20' ' ' VAL . 3.5 m -77.75 86.84 4.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.319 1.848 . . . . 0.0 107.16 -175.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.454 HG13 HD11 ' A' ' 21' ' ' LEU . 45.4 t -80.44 159.72 4.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.66 ' HB1' HD13 ' A' ' 5' ' ' LEU . . . -162.01 158.85 25.64 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 162.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -135.92 129.38 32.15 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -166.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.666 HD11 HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -149.67 151.72 34.17 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 122.525 1.155 . . . . 0.0 113.227 -174.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -87.17 103.96 15.91 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.286 1.835 . . . . 0.0 107.503 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.443 HG21 HG22 ' A' ' 69' ' ' ILE . 4.5 p -61.21 -24.29 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.279 1.032 . . . . 0.0 113.513 -165.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.43 -42.89 78.24 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.881 0.872 . . . . 0.0 110.708 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -81.81 -18.22 44.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.364 2.266 . . . . 0.0 111.914 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -109.59 78.68 1.2 Allowed Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.849 1.66 . . . . 0.0 109.805 173.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.08 -18.06 14.73 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.269 2.646 . . . . 0.0 112.481 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -64.71 125.75 25.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.143 1.377 . . . . 0.0 109.619 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.2 m 66.53 -29.56 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.932 3.293 . . . . 0.0 112.492 -174.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -52.36 -54.05 36.82 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.815 2.046 . . . . 0.0 110.587 172.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.8 t -62.03 -41.92 98.62 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.166 0.292 . . . . 0.0 110.508 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -60.91 -42.4 97.99 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.993 0.917 . . . . 0.0 111.87 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -96.63 5.52 50.56 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.4 33.48 72.83 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 119.224 0.92 . . . . 0.0 112.125 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.578 HG21 ' CZ ' ' A' ' 24' ' ' PHE . 35.5 mm -75.75 82.37 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.599 1.56 . . . . 0.0 110.118 -166.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 93.4 mtp -122.47 -3.29 8.87 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.625 1.17 . . . . 0.0 111.688 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.1 t -84.69 21.93 1.43 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.733 1.213 . . . . 0.0 113.998 -166.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.497 HD11 ' CH2' ' A' ' 28' ' ' TRP . 26.2 pt -56.05 144.1 60.29 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.108 1.363 . . . . 0.0 112.935 -170.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 57.1 Cg_endo -65.74 139.25 40.79 Favored 'Cis proline' 0 C--N 1.35 0.637 0 CA-C-O 121.99 0.746 . . . . 0.0 111.085 -1.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -138.09 149.19 45.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.6 tt -135.03 123.41 23.24 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.267 -2.124 . . . . 0.0 105.267 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.456 HD12 ' CE2' ' A' ' 24' ' ' PHE . 21.1 mt -124.84 147.67 29.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.44 HD12 HD21 ' A' ' 100' ' ' LEU . 6.5 tt -129.35 124.04 33.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.044 0.937 . . . . 0.0 108.897 -168.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -116.31 152.11 34.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 126.242 1.817 . . . . 0.0 110.398 -171.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 148.94 26.33 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 125.34 1.456 . . . . 0.0 107.38 158.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.586 ' H ' ' HA ' ' A' ' 17' ' ' ASP . . . 67.15 20.78 71.4 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -168.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.95 3.3 55.42 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.478 -1.179 . . . . 0.0 114.044 -171.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -120.39 139.34 28.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 119.589 1.694 . . . . 0.0 109.454 -170.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.63 125.91 9.21 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.011 2.474 . . . . 0.0 111.775 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -78.33 -43.48 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 123.78 0.832 . . . . 0.0 110.781 175.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -158.77 169.97 23.19 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.022 0.929 . . . . 0.0 109.864 -174.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.401 ' CB ' HG12 ' A' ' 76' ' ' ILE . 1.7 pm0 -137.02 157.22 47.21 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.84 1.256 . . . . 0.0 111.13 173.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.43 HD11 ' HG2' ' A' ' 99' ' ' GLN . 4.2 mm? -123.36 145.26 48.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 127.947 2.499 . . . . 0.0 106.087 169.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.6 pt -138.79 156.14 28.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 124.756 1.223 . . . . 0.0 109.058 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.07 179.08 11.17 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -71.4 126.15 28.89 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -126.23 134.5 26.03 Favored Pre-proline 0 N--CA 1.449 -0.525 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 165.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.99 159.15 47.82 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.167 1.245 . . . . 0.0 110.011 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.469 ' HE3' ' OE2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -49.51 -36.96 24.78 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 125.293 1.437 . . . . 0.0 112.686 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -58.7 -50.11 75.11 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.649 1.58 . . . . 0.0 110.973 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -74.39 -36.73 63.51 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.874 1.269 . . . . 0.0 109.378 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.79 -63.28 1.25 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.471 1.108 . . . . 0.0 108.04 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.36 -31.69 73.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 118.379 -0.82 . . . . 0.0 110.754 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.76 -44.03 78.44 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.694 0.679 . . . . 0.0 110.75 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.43 ' HG2' HD11 ' A' ' 87' ' ' LEU . 9.5 tp-100 -67.15 -38.26 85.19 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 118.24 0.473 . . . . 0.0 111.493 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.44 HD21 HD12 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -86.15 -6.43 59.0 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.958 0.903 . . . . 0.0 112.997 -173.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.66 -33.2 15.0 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.954 1.701 . . . . 0.0 114.201 -175.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.16 -6.56 9.55 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.64 1.564 . . . . 0.0 114.17 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.36 2.92 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.261 0.937 . . . . 0.0 113.108 166.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.32 -13.5 13.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.469 1.107 . . . . 0.0 112.403 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 . . . . . 0 C--O 1.249 1.066 0 C-N-CA 127.777 2.431 . . . . 0.0 109.478 165.497 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 121.4 0.619 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 61.3 m -144.06 149.46 36.66 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 120.938 -1.101 . . . . 0.0 108.05 165.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.29 -178.61 6.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.99 1.316 . . . . 0.0 109.835 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.0 m -108.47 144.17 36.44 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 161.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.416 HD13 ' CB ' ' A' ' 53' ' ' ALA . 1.0 OUTLIER -110.85 161.93 15.31 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.5 t -149.3 -128.82 0.05 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.457 ' HA ' HD22 ' A' ' 60' ' ' ASN . 18.0 p-10 -84.65 -70.72 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 120.224 1.375 . . . . 0.0 110.937 164.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.1 -43.55 82.34 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.349 0.977 . . . . 0.0 111.433 -171.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -76.0 -14.42 60.23 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.898 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -67.3 -68.28 0.39 Allowed 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 172.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.7 -48.79 69.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.463 0.705 . . . . 0.0 110.411 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -68.29 -19.48 64.7 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 118.183 -0.913 . . . . 0.0 113.145 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.38 -58.78 3.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.157 1.344 . . . . 0.0 110.669 164.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.9 pt -62.11 -21.8 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -168.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -64.94 -20.34 66.42 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.462 1.105 . . . . 0.0 113.589 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.04 166.54 48.58 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 119.662 1.119 . . . . 0.0 111.606 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.59 -4.18 57.95 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.14 148.53 50.95 Favored Glycine 0 CA--C 1.538 1.514 0 O-C-N 120.707 -1.246 . . . . 0.0 110.03 171.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -62.76 96.6 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.78 2.32 . . . . 0.0 109.137 167.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.2 t -99.03 115.5 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 125.187 1.395 . . . . 0.0 107.85 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 tt -113.43 119.82 38.91 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 126.052 1.741 . . . . 0.0 108.475 -168.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.9 t -109.3 110.73 33.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 126.218 1.807 . . . . 0.0 109.034 -168.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.445 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 28.2 t0 -82.2 98.77 8.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.924 0.784 . . . . 0.0 109.832 167.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -81.32 112.91 19.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 164.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -134.3 -174.04 3.44 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.64 166.3 32.37 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.886 1.275 . . . . 0.0 108.603 167.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.76 65.85 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -173.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.6 -30.26 11.87 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -170.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -75.02 98.97 3.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.613 0.642 . . . . 0.0 111.113 -164.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -25.47 -66.17 0.05 OUTLIER Glycine 0 CA--C 1.541 1.714 0 C-N-CA 126.385 1.945 . . . . 0.0 115.255 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.26 -30.98 23.69 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.311 2.008 . . . . 0.0 113.181 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 p -67.71 -34.6 77.19 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-N 119.34 0.973 . . . . 0.0 110.158 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -66.67 -12.13 56.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.49 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 70.9 mtp -97.97 -37.95 9.58 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.88 1.272 . . . . 0.0 111.526 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.1 ttt -74.17 -39.01 63.52 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.009 0.923 . . . . 0.0 110.781 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.58 -52.16 75.61 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 117.826 -1.083 . . . . 0.0 111.349 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.41 -34.61 65.22 Favored 'Trans proline' 0 C--N 1.352 0.72 0 CA-C-N 121.844 1.694 . . . . 0.0 112.113 172.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.32 -31.38 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 119.65 1.113 . . . . 0.0 111.606 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 mp -79.48 -26.17 41.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.196 2.198 . . . . 0.0 111.96 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.82 -44.37 93.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.79 1.177 . . . . 0.0 108.983 171.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -63.09 -45.62 91.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.854 0.462 . . . . 0.0 110.254 172.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -58.68 -38.29 77.89 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 122.017 -0.427 . . . . 0.0 111.158 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.37 -54.39 47.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.213 1.005 . . . . 0.0 109.445 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -51.57 62.11 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.597 0.759 . . . . 0.0 109.841 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.18 -11.94 10.99 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -174.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -136.09 17.42 3.23 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.449 1.099 . . . . 0.0 113.021 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.55 -20.63 1.23 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -158.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -133.74 8.22 3.84 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 173.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -80.94 -23.38 38.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.517 1.053 . . . . 0.0 110.51 161.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.56 176.07 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.226 1.01 . . . . 0.0 110.529 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 73.4 m -115.02 88.06 2.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.2 2.2 . . . . 0.0 107.157 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 t -80.81 149.28 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.416 ' CB ' HD13 ' A' ' 5' ' ' LEU . . . -154.06 167.52 29.54 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 121.289 -0.882 . . . . 0.0 109.352 162.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 39.9 pttt -134.09 150.11 51.15 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.027 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -154.87 157.85 38.46 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 125.196 1.56 . . . . 0.0 112.863 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -86.16 104.89 16.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.018 1.327 . . . . 0.0 107.661 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.8 p -49.27 -35.56 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.011 1.324 . . . . 0.0 113.488 -166.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -55.12 -37.21 66.61 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.684 1.594 . . . . 0.0 112.718 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.72 -22.12 65.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.649 1.58 . . . . 0.0 113.393 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.457 HD22 ' HA ' ' A' ' 7' ' ' ASP . 26.1 t-20 -117.06 82.71 14.08 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 125.912 1.685 . . . . 0.0 108.594 -172.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.71 -31.19 3.38 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.037 1.825 . . . . 0.0 111.978 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -63.68 140.79 58.91 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.54 0.736 . . . . 0.0 110.073 177.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.9 m 66.79 -33.3 0.2 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 128.253 2.621 . . . . 0.0 113.079 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.4 m -64.81 -56.33 14.15 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 128.559 2.744 . . . . 0.0 109.305 172.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -69.08 -11.79 61.11 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.115 -0.945 . . . . 0.0 112.667 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.97 -55.18 5.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.226 0.921 . . . . 0.0 109.166 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -87.66 10.72 17.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.533 0.606 . . . . 0.0 112.308 -167.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.42 24.96 62.07 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.044 1.307 . . . . 0.0 113.163 173.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.1 mm -83.4 79.08 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 122.489 1.138 . . . . 0.0 110.205 -162.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -115.69 -6.37 12.15 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.475 166.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.1 p -84.71 24.48 1.02 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.255 1.822 . . . . 0.0 113.742 -164.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.457 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -69.74 155.44 93.5 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 122.844 0.457 . . . . 0.0 111.483 -163.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 55.7 Cg_endo -66.44 130.19 12.11 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 119.859 0.985 . . . . 0.0 111.38 6.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 36.0 m -118.85 143.13 47.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -124.18 100.52 6.75 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.3 mt -97.72 144.26 11.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 tt -111.89 125.77 54.39 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 164.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -118.99 161.66 19.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.213 1.805 . . . . 0.0 110.542 -173.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -162.57 147.3 12.04 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 124.837 1.255 . . . . 0.0 109.035 158.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.42 20.34 44.49 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.521 -0.6 . . . . 0.0 113.66 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.82 -10.27 57.47 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.401 1.476 . . . . 0.0 113.854 -171.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -83.87 125.21 73.64 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 119.26 1.53 . . . . 0.0 109.277 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.49 94.5 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.167 2.578 . . . . 0.0 108.782 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 m -60.73 -37.32 75.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.565 -0.709 . . . . 0.0 111.697 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.565 ' HE3' ' HA ' ' A' ' 100' ' ' LEU . 18.9 pttm -166.26 165.02 17.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.162 1.385 . . . . 0.0 109.019 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.16 158.37 43.76 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.54 0.736 . . . . 0.0 112.214 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.11 153.42 23.17 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 160.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.1 140.35 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 126.101 1.76 . . . . 0.0 106.684 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.65 165.62 5.93 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.778 0.704 . . . . 0.0 111.782 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.34 96.97 0.12 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.56 1.144 . . . . 0.0 110.298 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -93.3 131.82 31.91 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 167.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.59 161.83 41.81 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.011 1.808 . . . . 0.0 109.863 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -40.15 66.7 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.342 0.657 . . . . 0.0 112.372 -174.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -59.84 -24.75 64.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.428 1.091 . . . . 0.0 113.192 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.4 tp-100 -95.98 -44.09 7.51 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.835 1.254 . . . . 0.0 109.12 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -67.57 0.25 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.909 2.484 . . . . 0.0 108.671 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.58 -37.89 85.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 117.963 -1.018 . . . . 0.0 108.703 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.88 99.77 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.69 1.132 . . . . 0.0 111.906 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -69.67 -20.54 63.57 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.876 0.471 . . . . 0.0 112.177 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.565 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 1.1 tp -105.88 -10.22 16.76 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.118 1.367 . . . . 0.0 112.693 -171.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.23 -7.33 5.81 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 128.776 2.831 . . . . 0.0 114.48 -173.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -84.6 -13.34 51.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.089 1.756 . . . . 0.0 112.457 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.23 -16.17 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 119.092 0.86 . . . . 0.0 111.097 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -82.14 -6.07 58.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 121.626 -0.672 . . . . 0.0 112.226 162.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 . . . . . 0 C--O 1.245 0.836 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 158.721 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 121.462 0.648 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.1 m -153.55 139.42 18.1 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 119.396 -2.065 . . . . 0.0 106.404 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 52.5 ttm -149.12 119.31 7.25 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -65.76 92.97 0.16 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.114 0.966 . . . . 0.0 110.525 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.52 ' HB2' HD23 ' A' ' 55' ' ' LEU . 32.4 mt -53.43 146.98 11.45 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 161.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.1 m -152.66 -32.72 0.13 Allowed 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.387 -1.445 . . . . 0.0 113.187 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -171.6 -79.9 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 125.989 1.716 . . . . 0.0 106.654 160.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.84 -27.28 63.05 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 121.013 -1.054 . . . . 0.0 112.303 173.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 12' ' ' GLN . 12.7 t-20 -72.99 -21.63 60.81 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.97 -0.538 . . . . 0.0 111.063 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.28 1.71 0.71 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.638 1.975 . . . . 0.0 112.264 168.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -126.9 -50.15 1.46 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.039 1.335 . . . . 0.0 109.783 168.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 9' ' ' ASN . 45.6 tt0 -53.71 -35.64 61.36 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.163 0.985 . . . . 0.0 112.284 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.35 -45.86 24.7 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.982 0.81 . . . . 0.0 110.024 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -67.53 -23.61 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 117.732 -1.128 . . . . 0.0 112.236 -170.62 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -50.17 -35.11 24.85 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.813 1.245 . . . . 0.0 113.728 -164.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.78 122.69 0.97 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 166.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -156.25 -71.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.883 0.873 . . . . 0.0 110.081 -170.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 149.21 -166.67 29.51 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -161.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -65.86 89.44 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.649 2.899 . . . . 0.0 110.958 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t -70.45 146.22 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 126.89 2.076 . . . . 0.0 108.479 169.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -144.8 123.58 12.63 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.835 1.654 . . . . 0.0 107.685 -170.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.49 140.88 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 119.508 1.049 . . . . 0.0 111.43 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.408 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 53.6 t0 -98.95 104.16 16.18 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.933 0.893 . . . . 0.0 109.356 159.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -85.15 108.33 17.65 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 166.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -130.82 -172.47 2.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.224 1.41 . . . . 0.0 107.92 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.62 165.97 29.74 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 125.749 1.619 . . . . 0.0 107.878 168.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.42 -14.29 55.9 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -174.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.64 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -108.04 -23.85 11.83 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.508 ' SG ' HD12 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -74.31 93.35 2.37 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.195 0.907 . . . . 0.0 111.449 -165.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -24.49 -63.98 0.05 OUTLIER Glycine 0 CA--C 1.542 1.723 0 C-N-CA 126.377 1.941 . . . . 0.0 115.495 173.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.99 -36.3 22.87 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.562 2.174 . . . . 0.0 113.382 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 p -63.32 -37.14 86.09 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.792 1.178 . . . . 0.0 110.103 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.53 -20.28 64.48 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.647 0.779 . . . . 0.0 112.043 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 74.4 mtm -101.27 -14.05 17.82 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.968 1.307 . . . . 0.0 112.749 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.9 ttt -93.28 -39.21 11.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.668 1.587 . . . . 0.0 109.776 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.15 -48.44 92.17 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 117.413 -1.279 . . . . 0.0 112.025 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.64 -33.48 45.01 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 121.862 1.701 . . . . 0.0 112.411 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -40.66 89.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.457 1.026 . . . . 0.0 109.873 174.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 42' ' ' PHE . 4.9 mp -66.46 -20.23 65.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.085 1.754 . . . . 0.0 112.166 176.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.62 -51.33 28.78 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.222 0.919 . . . . 0.0 109.888 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.69 -43.03 97.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.271 0.628 . . . . 0.0 110.438 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 39' ' ' LEU . 67.0 t80 -51.55 -57.36 9.31 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.633 1.173 . . . . 0.0 110.317 169.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.91 -52.06 65.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.65 -0.691 . . . . 0.0 111.156 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -55.22 -42.88 73.91 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.042 0.937 . . . . 0.0 110.804 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.0 -15.67 24.41 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -146.88 56.22 1.13 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.193 1.397 . . . . 0.0 109.819 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.07 64.57 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -169.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -134.98 -2.11 2.61 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -63.7 -32.19 73.61 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.884 -1.135 . . . . 0.0 109.464 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.02 165.11 24.51 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 124.336 1.054 . . . . 0.0 110.252 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.6 m -107.96 88.8 2.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.778 2.031 . . . . 0.0 108.681 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 t -71.73 158.17 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.668 0.787 . . . . 0.0 110.291 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -154.13 155.04 34.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.903 1.681 . . . . 0.0 106.801 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 14.8 mtpt -139.62 128.91 24.01 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 173.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 5' ' ' LEU . 0.6 OUTLIER -147.42 150.69 35.13 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.198 0.936 . . . . 0.0 111.825 -175.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.97 128.12 34.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 167.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.34 -34.06 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.04 -42.94 75.67 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.265 1.426 . . . . 0.0 110.717 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.32 -35.78 67.97 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.361 2.265 . . . . 0.0 112.487 176.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.39 80.49 4.59 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.271 1.029 . . . . 0.0 110.769 -172.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.12 -28.54 23.39 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.734 2.29 . . . . 0.0 114.185 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -52.49 117.22 2.71 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.027 1.331 . . . . 0.0 110.944 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.256 21.7 m 68.13 -21.35 0.13 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 129.202 3.001 . . . . 0.0 113.336 174.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.9 m -53.28 -52.47 58.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.003 1.721 . . . . 0.0 108.833 162.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -69.96 -3.33 15.65 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 117.722 -1.133 . . . . 0.0 113.266 176.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -100.94 -38.44 8.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.769 1.168 . . . . 0.0 110.595 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -92.63 7.67 42.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.702 0.683 . . . . 0.0 111.831 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.86 34.2 81.87 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 123.714 0.673 . . . . 0.0 111.739 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 26.2 mm -77.92 71.31 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.3 1.44 . . . . 0.0 109.002 -170.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 53.6 ttm -95.05 -18.48 20.97 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.431 1.092 . . . . 0.0 110.292 161.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.3 t -62.22 128.01 34.06 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.588 1.155 . . . . 0.0 108.67 167.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.64 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 14.8 pt -146.44 156.11 49.51 Favored Pre-proline 0 N--CA 1.443 -0.818 0 C-N-CA 126.829 2.052 . . . . 0.0 107.531 159.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.36 130.1 9.57 Favored 'Cis proline' 0 N--CA 1.453 -0.91 0 CA-C-N 119.733 0.94 . . . . 0.0 110.467 -9.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.7 m -123.78 149.3 45.82 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 tt -135.12 134.58 40.38 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 13.3 mt -131.67 144.12 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.19 136.75 48.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 168.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -133.26 169.48 16.84 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.334 1.854 . . . . 0.0 110.909 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.457 ' HE3' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -153.69 155.81 36.68 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 126.376 1.871 . . . . 0.0 106.204 158.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.02 37.58 4.34 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 124.579 1.085 . . . . 0.0 115.795 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.457 ' H ' HG22 ' A' ' 14' ' ' ILE . . . 75.24 17.81 80.14 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.735 1.16 . . . . 0.0 115.1 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -139.64 135.5 16.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.052 1.341 . . . . 0.0 108.9 -168.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.09 170.84 16.01 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.066 2.511 . . . . 0.0 113.097 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.13 -7.53 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.848 1.659 . . . . 0.0 112.081 173.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 161.15 170.75 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 1 C-N-CA 132.088 4.155 . . . . 0.0 108.763 164.15 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -129.5 142.87 50.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.492 1.917 . . . . 0.0 107.639 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.77 145.41 48.07 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 128.926 2.89 . . . . 0.0 106.299 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.69 135.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -173.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.68 165.18 41.03 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 123.772 0.701 . . . . 0.0 112.311 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -77.48 69.33 3.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.917 1.287 . . . . 0.0 111.486 -174.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -76.86 131.81 72.68 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.79 168.09 19.53 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.086 2.524 . . . . 0.0 110.988 173.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -45.59 76.01 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 123.846 0.858 . . . . 0.0 110.45 -174.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -67.76 -12.09 59.83 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.323 1.049 . . . . 0.0 112.386 -174.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.13 -55.76 2.68 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.476 1.511 . . . . 0.0 108.155 172.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 tt -54.38 -60.73 2.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.844 2.058 . . . . 0.0 110.315 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -65.51 -20.99 66.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.565 1.146 . . . . 0.0 111.845 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.16 -48.1 31.52 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.487 1.04 . . . . 0.0 109.623 170.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -59.41 -32.08 69.85 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.846 1.258 . . . . 0.0 112.104 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tp -97.71 0.52 47.17 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.669 1.988 . . . . 0.0 112.379 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.07 -29.42 68.55 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.992 0.917 . . . . 0.0 112.529 -169.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -65.85 -12.82 57.38 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.99 4.53 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.814 0.846 . . . . 0.0 112.226 173.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -112.28 -6.42 14.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.528 1.131 . . . . 0.0 112.853 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.539 1.936 . . . . 0.0 108.966 159.24 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.252 0.549 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.0 m -149.42 153.47 37.38 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 164.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.29 -178.29 7.03 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.568 1.147 . . . . 0.0 108.404 166.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.3 m -81.14 159.49 24.64 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 163.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.3 tp -132.08 162.13 31.56 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.881 1.272 . . . . 0.0 107.961 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.1 m -149.43 163.12 38.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -42.79 -55.28 3.72 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.437 3.095 . . . . 0.0 113.624 -164.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.32 91.95 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.369 0.604 . . . . 0.0 111.792 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.71 -18.1 58.71 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.059 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.34 -61.92 2.14 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.749 1.159 . . . . 0.0 108.745 174.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.417 ' HA ' HG12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -59.39 -39.74 84.35 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.577 0.351 . . . . 0.0 110.781 -177.376 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -74.84 -16.44 60.69 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.62 0.768 . . . . 0.0 112.701 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.22 -57.36 3.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.352 0.978 . . . . 0.0 109.321 168.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 11' ' ' GLN . 41.2 pt -59.32 -24.35 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -170.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -67.4 -17.62 64.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.615 1.166 . . . . 0.0 113.198 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.42 165.01 47.5 Favored Glycine 0 C--N 1.342 0.909 0 C-N-CA 124.127 0.87 . . . . 0.0 112.124 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -80.29 -42.48 23.01 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.382 1.473 . . . . 0.0 111.956 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.27 164.06 54.88 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 123.371 0.51 . . . . 0.0 112.681 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.2 100.63 0.46 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.775 2.984 . . . . 0.0 112.006 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.1 t -90.18 121.99 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 C-N-CA 125.986 1.714 . . . . 0.0 108.116 177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 tt -118.95 112.16 19.26 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.132 0.973 . . . . 0.0 109.312 -174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -91.49 127.85 43.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 62.1 t0 -92.08 101.93 14.47 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 164.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -87.19 111.69 21.23 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 14.5 p-90 -135.29 178.49 6.99 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.772 1.229 . . . . 0.0 110.491 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.73 167.49 30.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.982 1.313 . . . . 0.0 110.798 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.77 -4.65 41.73 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.11 -16.0 7.6 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -174.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.8 p -75.45 36.93 0.13 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.836 1.654 . . . . 0.0 114.287 -165.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 33.39 -97.94 0.01 OUTLIER Glycine 0 CA--C 1.536 1.381 0 C-N-CA 128.913 3.149 . . . . 0.0 114.464 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.67 -15.76 33.14 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.751 2.967 . . . . 0.0 115.053 -175.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.3 p -54.4 -32.33 56.95 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.347 0.976 . . . . 0.0 111.96 167.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttp85 -67.03 -12.03 58.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.771 0.828 . . . . 0.0 112.66 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.5 mtp -110.09 -20.4 12.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.716 1.606 . . . . 0.0 111.846 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.4 ttt -80.61 -44.31 19.12 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 124.52 1.128 . . . . 0.0 109.412 170.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.66 -47.6 78.43 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 116.802 -1.571 . . . . 0.0 113.528 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.25 -29.9 25.55 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.098 1.865 . . . . 0.0 112.719 171.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.8 -30.12 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 120.216 1.371 . . . . 0.0 111.007 171.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.3 mt -80.02 -18.04 51.24 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.959 1.704 . . . . 0.0 111.212 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.83 -41.92 58.99 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.057 0.943 . . . . 0.0 110.299 162.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.87 -15.51 62.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.676 1.19 . . . . 0.0 111.498 171.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.406 ' CE2' HD12 ' A' ' 96' ' ' LEU . 31.9 t80 -85.29 -49.0 8.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.221 1.808 . . . . 0.0 109.025 167.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.29 -32.22 66.42 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 118.17 -0.919 . . . . 0.0 113.363 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.29 -57.35 5.43 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.03 1.286 . . . . 0.0 110.919 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.68 -22.47 35.04 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -159.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.9 30.21 1.18 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.886 1.275 . . . . 0.0 111.114 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -20.29 -63.4 0.02 OUTLIER 'General case' 0 C--N 1.341 0.196 0 C-N-CA 128.94 2.896 . . . . 0.0 115.314 -170.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -108.12 8.1 27.94 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -169.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -70.88 -26.06 63.07 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.982 0.81 . . . . 0.0 109.682 158.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.79 170.26 15.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 124.192 0.997 . . . . 0.0 110.9 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.267 10.7 t -124.91 103.64 8.16 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 158.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.6 t -70.08 155.75 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.09 111.42 3.91 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 6.0 tttp -89.19 130.72 35.57 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -172.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.37 143.15 24.66 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.927 0.87 . . . . 0.0 112.77 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -81.14 117.69 21.91 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.1 p -51.8 -32.2 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.503 1.121 . . . . 0.0 113.801 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -67.79 -29.76 69.03 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.191 1.797 . . . . 0.0 112.488 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -23.77 60.69 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.979 1.312 . . . . 0.0 112.462 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -126.21 87.36 56.32 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 125.237 1.415 . . . . 0.0 109.735 -163.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.55 -29.87 15.72 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.875 2.383 . . . . 0.0 113.712 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 64' ' ' THR . 8.3 tp10 -73.8 137.55 43.93 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.741 1.155 . . . . 0.0 110.73 -173.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.7 m 64.09 -31.01 0.11 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 130.123 3.369 . . . . 0.0 112.822 -169.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 62' ' ' GLU . 52.2 m -58.08 -57.35 13.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.572 1.949 . . . . 0.0 109.45 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -57.78 -46.25 84.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.053 0.541 . . . . 0.0 109.874 178.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -58.39 -35.59 72.25 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.024 0.93 . . . . 0.0 112.758 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -100.55 9.83 42.01 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.191 0.597 . . . . 0.0 112.118 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.24 29.05 74.34 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 119.1 0.864 . . . . 0.0 112.927 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mm -77.13 81.38 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.333 1.453 . . . . 0.0 109.915 -166.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.6 mmt -123.89 -0.98 8.41 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.726 1.61 . . . . 0.0 111.103 166.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.4 t -77.9 30.07 0.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.161 1.785 . . . . 0.0 113.077 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.472 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -67.96 148.44 98.4 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.384 0.538 . . . . 0.0 111.828 -172.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 62.3 Cg_endo -66.36 128.74 9.56 Favored 'Cis proline' 0 C--N 1.35 0.635 0 CA-C-N 119.73 0.939 . . . . 0.0 111.493 4.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.1 m -123.76 151.87 42.79 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 122.207 1.003 . . . . 0.0 108.838 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.9 tt -131.87 130.21 41.38 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 mt -130.28 141.24 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 165.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.72 119.55 39.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.428 -1.694 . . . . 0.0 106.428 175.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -117.32 161.22 19.86 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.979 2.112 . . . . 0.0 112.391 -175.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.41 157.33 19.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.65 2.38 . . . . 0.0 108.668 159.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.42 14.83 14.28 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.94 1.257 . . . . 0.0 115.394 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.87 -6.02 58.38 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.625 1.584 . . . . 0.0 113.543 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -129.01 157.44 75.84 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 119.183 1.492 . . . . 0.0 110.689 -170.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.74 166.78 24.96 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.31 2.007 . . . . 0.0 111.55 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.44 -34.8 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.734 1.214 . . . . 0.0 108.505 158.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -162.02 165.77 26.88 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.495 1.118 . . . . 0.0 109.978 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -136.45 143.26 43.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.937 2.495 . . . . 0.0 106.397 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.7 mt -132.55 153.4 51.01 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.618 1.567 . . . . 0.0 108.194 174.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.2 pt -143.85 143.61 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.052 1.341 . . . . 0.0 108.075 -173.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.64 161.94 26.36 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.783 0.706 . . . . 0.0 111.903 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -75.25 78.55 2.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.083 0.953 . . . . 0.0 111.526 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -69.63 140.86 89.79 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 166.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.85 160.25 49.98 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.748 1.632 . . . . 0.0 110.404 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.91 -45.88 42.13 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.93 1.292 . . . . 0.0 112.814 -171.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -74.09 -25.1 59.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.455 -172.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -73.8 -37.67 64.85 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.406 HD12 ' CE2' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -59.0 -61.26 2.78 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.165 1.386 . . . . 0.0 108.813 175.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -64.94 -25.78 68.02 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.22 -0.895 . . . . 0.0 112.229 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.21 -53.88 12.89 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.856 0.753 . . . . 0.0 110.494 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -62.19 -35.07 77.74 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.148 0.579 . . . . 0.0 112.302 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.83 1.85 56.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.645 1.178 . . . . 0.0 112.751 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.15 -31.97 54.0 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 120.082 1.31 . . . . 0.0 113.511 -174.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -65.4 -14.41 60.82 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.954 0.901 . . . . 0.0 113.295 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 66.0 t -109.06 -5.57 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.574 1.55 . . . . 0.0 110.858 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -112.47 -5.85 14.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.791 1.236 . . . . 0.0 112.741 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.099 0 C-N-CA 126.946 2.099 . . . . 0.0 110.552 164.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.3 m -114.09 125.2 53.71 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -173.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.8 ttp -149.58 -0.46 0.47 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.319 0.7 OUTLIER 57.18 176.0 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.934 1.294 . . . . 0.0 112.569 -170.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.708 ' HB2' HD23 ' A' ' 55' ' ' LEU . 58.0 mt -142.75 172.25 12.94 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.664 1.985 . . . . 0.0 107.938 -167.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.0 m -125.17 -88.53 0.59 Allowed 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -140.03 -66.25 0.45 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.858 0.863 . . . . 0.0 109.132 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.68 -30.83 45.28 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.666 -0.646 . . . . 0.0 111.912 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -72.32 -26.3 61.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.103 0.561 . . . . 0.0 110.688 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.423 ' HD2' HD21 ' A' ' 55' ' ' LEU . 50.3 t80 -58.0 -62.83 1.53 Allowed 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.021 0.929 . . . . 0.0 109.678 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.443 ' HA ' HG12 ' A' ' 14' ' ' ILE . 20.9 tt0 -60.39 -42.43 95.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.841 0.456 . . . . 0.0 110.502 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -64.12 -25.65 68.19 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.66 1.184 . . . . 0.0 112.962 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.08 -61.53 1.97 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.232 0.924 . . . . 0.0 110.058 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 11' ' ' GLN . 43.2 pt -59.07 -20.34 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -167.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -60.67 -19.05 57.36 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.344 1.458 . . . . 0.0 113.321 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.95 157.51 48.6 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 119.452 1.024 . . . . 0.0 111.631 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -76.94 -36.28 56.69 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.846 1.659 . . . . 0.0 111.443 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.22 161.97 47.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 123.814 0.721 . . . . 0.0 111.721 177.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.29 107.88 0.74 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.591 2.86 . . . . 0.0 110.948 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.466 HG22 ' HB ' ' A' ' 51' ' ' THR . 71.4 t -98.45 141.96 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 167.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.53 153.5 44.91 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 118.565 0.62 . . . . 0.0 111.033 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.02 126.85 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 22.4 t0 -80.12 121.2 25.26 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.953 0.783 . . . . 0.0 108.915 161.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.418 ' CD1' HG23 ' A' ' 57' ' ' VAL . 63.6 m-85 -98.26 107.16 19.56 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.045 0.938 . . . . 0.0 108.684 163.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 -124.08 -177.7 3.85 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.905 1.282 . . . . 0.0 107.992 172.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.61 165.96 33.21 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.971 1.308 . . . . 0.0 108.832 170.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.66 -3.04 7.9 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -174.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.562 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -117.27 -24.58 7.39 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.81 1.187 . . . . 0.0 114.155 -175.237 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.73 93.79 2.63 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.196 0.907 . . . . 0.0 111.845 -163.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -19.32 -71.11 0.01 OUTLIER Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.538 2.018 . . . . 0.0 115.567 173.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.17 -29.46 47.48 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.16 2.574 . . . . 0.0 114.303 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.9 p -64.66 -27.7 69.11 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.513 1.051 . . . . 0.0 110.771 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -19.57 65.96 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.405 173.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -101.95 -23.89 14.07 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.935 1.294 . . . . 0.0 112.486 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.0 tpt -75.99 -47.28 25.54 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 125.917 1.687 . . . . 0.0 108.494 173.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.73 -48.15 70.43 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 120.133 1.333 . . . . 0.0 113.617 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.78 -33.02 21.88 Favored 'Trans proline' 0 C--N 1.352 0.741 0 CA-C-N 122.061 1.772 . . . . 0.0 112.53 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.49 -35.13 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.856 1.207 . . . . 0.0 110.526 173.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.3 mt -72.14 -21.7 61.42 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 125.929 1.692 . . . . 0.0 111.199 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.27 -52.68 31.11 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 170.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -71.34 -19.91 62.24 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -67.08 -60.06 2.94 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.044 1.338 . . . . 0.0 108.963 165.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.74 -49.55 65.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.821 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -53.93 -42.41 68.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.81 1.244 . . . . 0.0 111.262 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.35 -15.27 62.38 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -158.43 57.65 0.45 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.074 1.349 . . . . 0.0 109.462 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.02 -14.51 62.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.596 0.758 . . . . 0.0 112.086 -172.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -109.37 -55.22 2.45 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.383 3.473 . . . . 0.0 110.646 -172.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -53.72 -31.47 48.3 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 126.268 1.827 . . . . 0.0 112.444 -172.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 m -130.13 150.52 34.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.466 ' HB ' HG22 ' A' ' 20' ' ' VAL . 97.3 m -82.79 71.62 9.88 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 172.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.76 147.56 7.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 124.397 1.079 . . . . 0.0 109.936 175.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.65 163.02 40.01 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.186 175.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 51.3 pttt -128.26 143.14 51.0 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 123.736 0.648 . . . . 0.0 110.904 159.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.708 HD23 ' HB2' ' A' ' 5' ' ' LEU . 1.3 pp -146.29 154.34 41.58 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 124.974 1.421 . . . . 0.0 109.515 176.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -77.54 129.24 35.41 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.418 HG23 ' CD1' ' A' ' 24' ' ' PHE . 3.3 p -68.06 -20.39 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 121.174 -0.953 . . . . 0.0 112.003 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.75 -17.38 55.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.593 0.757 . . . . 0.0 111.266 172.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.23 -34.5 21.99 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.3 1.84 . . . . 0.0 110.147 173.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -106.4 93.43 8.26 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 124.825 1.25 . . . . 0.0 111.264 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.18 -25.71 9.81 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.976 2.451 . . . . 0.0 113.75 164.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -58.89 119.24 6.84 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.752 1.16 . . . . 0.0 111.169 -177.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.268 16.4 m 63.58 -15.64 0.07 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 127.281 2.232 . . . . 0.0 113.795 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.7 m -53.03 -56.06 18.97 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.102 1.361 . . . . 0.0 108.844 167.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.6 t -72.18 0.39 9.87 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 117.821 -1.085 . . . . 0.0 112.899 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -108.3 -36.05 6.37 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.454 1.101 . . . . 0.0 111.177 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -104.06 10.0 36.21 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.033 0.833 . . . . 0.0 111.108 -175.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.62 32.11 59.84 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 123.918 0.77 . . . . 0.0 112.249 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.9 mm -75.23 83.25 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.999 0.919 . . . . 0.0 109.617 -170.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.2 ttp -128.07 -10.34 5.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.401 1.08 . . . . 0.0 111.342 171.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.4 t -87.22 56.62 4.06 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.428 1.091 . . . . 0.0 109.36 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.562 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 34.6 pt -81.96 148.43 60.67 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.183 -174.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.411 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 57.2 Cg_endo -66.77 125.02 6.16 Favored 'Cis proline' 0 C--N 1.35 0.62 0 CA-C-N 119.589 0.889 . . . . 0.0 110.925 -0.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.8 m -109.22 143.91 38.04 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.6 tt -129.4 132.93 47.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 171.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.1 mt -130.43 144.9 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 tt -115.29 132.96 56.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -132.85 163.03 30.0 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.454 1.902 . . . . 0.0 111.778 -169.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.47 148.47 18.06 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 125.696 1.598 . . . . 0.0 108.554 157.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.87 19.99 38.98 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 123.904 0.764 . . . . 0.0 113.101 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.91 -7.4 51.2 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.197 1.38 . . . . 0.0 113.971 -170.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -84.3 118.9 72.33 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 119.297 1.548 . . . . 0.0 108.751 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.15 109.09 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.37 2.713 . . . . 0.0 109.853 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 m -71.1 -37.27 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.641 -0.662 . . . . 0.0 111.428 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -156.98 160.62 39.21 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.199 0.6 . . . . 0.0 111.846 171.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -128.8 142.55 50.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.713 2.405 . . . . 0.0 107.526 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.407 HD11 ' HG2' ' A' ' 99' ' ' GLN . 4.1 mm? -120.09 149.95 41.38 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.999 2.12 . . . . 0.0 107.044 165.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.47 132.52 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 125.353 1.461 . . . . 0.0 107.102 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.16 166.92 26.85 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.405 1.002 . . . . 0.0 112.135 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -76.83 74.56 3.46 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.505 1.122 . . . . 0.0 109.409 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -76.81 122.83 87.17 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 171.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.25 166.72 22.38 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.756 1.637 . . . . 0.0 110.441 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.427 ' HE3' ' OE1' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -47.98 -50.52 27.14 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.895 1.278 . . . . 0.0 112.412 -175.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.48 -19.71 65.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.73 -56.07 3.45 Favored 'General case' 0 C--O 1.223 -0.326 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 175.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.8 tt -55.99 -60.52 3.36 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.505 1.922 . . . . 0.0 109.394 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.427 ' OE1' ' HE3' ' A' ' 93' ' ' LYS . 6.3 tt0 -68.67 -17.4 64.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.493 1.117 . . . . 0.0 111.392 -176.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.84 -52.13 9.38 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 119.472 1.033 . . . . 0.0 110.069 166.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.407 ' HG2' HD11 ' A' ' 87' ' ' LEU . 18.6 tp60 -60.5 -27.52 67.65 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.966 0.907 . . . . 0.0 112.047 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.94 0.39 41.08 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.37 1.868 . . . . 0.0 112.988 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.89 -34.53 67.97 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.978 0.911 . . . . 0.0 112.746 -171.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -66.02 -11.92 51.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.508 1.523 . . . . 0.0 113.45 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.16 8.89 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.197 1.399 . . . . 0.0 111.552 171.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.2 -0.23 12.12 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.513 1.525 . . . . 0.0 113.529 169.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.363 1.865 . . . . 0.0 108.797 172.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.2 m 114.19 60.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 1 C-N-CA 133.372 4.669 . . . . 0.0 106.563 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.5 mtt -74.36 137.03 42.52 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.1 m -72.14 81.5 0.98 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 165.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.23 159.04 31.97 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.613 0.765 . . . . 0.0 109.635 175.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.5 p -117.35 -89.0 0.59 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 158.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 8' ' ' ALA . 9.1 p-10 -142.84 -73.24 0.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.416 1.486 . . . . 0.0 108.014 -159.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.442 ' H ' ' CG ' ' A' ' 7' ' ' ASP . . . -54.14 -32.24 54.7 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.042 0.937 . . . . 0.0 111.291 170.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -81.7 -15.6 53.91 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 119.238 -0.985 . . . . 0.0 112.089 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -66.89 -54.13 25.25 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 119.145 0.884 . . . . 0.0 109.143 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -65.78 -23.05 66.63 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.604 0.761 . . . . 0.0 111.694 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -73.64 -49.11 27.64 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.152 0.887 . . . . 0.0 110.844 167.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.61 -39.57 91.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.962 0.801 . . . . 0.0 111.801 -171.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 14' ' ' ILE . 9.0 tt -58.26 -22.16 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.21 1.404 . . . . 0.0 113.38 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -56.06 -36.75 68.43 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.478 1.511 . . . . 0.0 113.874 -159.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.49 133.92 2.0 Allowed Glycine 0 C--N 1.334 0.428 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 -170.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -174.74 -55.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.836 1.654 . . . . 0.0 107.964 -166.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.73 -157.65 27.47 Favored Glycine 0 CA--C 1.534 1.281 0 N-CA-C 105.064 -3.214 . . . . 0.0 105.064 -158.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.17 103.66 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.205 2.604 . . . . 0.0 111.347 168.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.4 t -88.99 127.42 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 168.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 tt -132.19 122.99 26.15 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -172.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.99 119.74 62.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -172.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -97.07 94.13 6.98 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -176.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.457 ' CD1' HG23 ' A' ' 57' ' ' VAL . 29.9 m-85 -82.46 110.63 17.75 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.133 1.373 . . . . 0.0 108.871 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 16.5 p-90 -125.82 177.07 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.25 164.35 32.59 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.753 1.221 . . . . 0.0 108.953 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.58 -8.74 56.71 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -123.86 -13.88 7.3 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.7 p -70.22 39.19 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 117.518 2.414 . . . . 0.0 117.518 -158.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 42.87 -99.03 0.01 OUTLIER Glycine 0 CA--C 1.536 1.389 0 C-N-CA 127.572 2.51 . . . . 0.0 114.764 169.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -58.58 -19.02 42.88 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.862 3.041 . . . . 0.0 114.166 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 14.9 p -60.03 -22.68 62.95 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 119.188 0.904 . . . . 0.0 112.235 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -14.94 61.72 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.12 1.327 . . . . 0.0 112.451 173.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 79.2 mtm -100.43 -32.46 10.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.647 1.579 . . . . 0.0 111.054 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.2 ttt -72.91 -43.18 62.72 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-O 117.811 -1.09 . . . . 0.0 109.142 173.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.59 -45.97 85.41 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 116.595 -1.669 . . . . 0.0 113.213 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.5 -45.51 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.628 1.552 . . . . 0.0 111.79 167.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -30.17 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 121.71 2.05 . . . . 0.0 112.133 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.4 mt -68.7 -13.01 62.1 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 128.667 2.787 . . . . 0.0 112.252 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.88 -46.38 8.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.296 1.038 . . . . 0.0 109.851 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -54.89 -40.78 70.13 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.519 1.054 . . . . 0.0 110.665 165.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.456 ' CE1' HD22 ' A' ' 96' ' ' LEU . 79.0 t80 -56.14 -60.07 4.02 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.922 0.889 . . . . 0.0 110.235 171.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.69 -49.68 67.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.632 0.651 . . . . 0.0 111.861 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.1 -48.52 64.7 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.514 1.526 . . . . 0.0 110.547 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.93 -12.6 11.77 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -150.61 61.85 0.94 Allowed 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.268 1.427 . . . . 0.0 108.502 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.04 -45.41 64.67 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.634 1.574 . . . . 0.0 111.413 -169.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -136.41 9.75 3.19 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -61.94 -32.84 73.3 Favored 'General case' 0 C--N 1.345 0.403 0 O-C-N 121.413 -0.805 . . . . 0.0 110.201 163.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.0 m -119.71 143.37 31.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.341 1.1 t -82.21 73.59 9.24 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 124.259 1.981 . . . . 0.0 106.596 166.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.4 148.28 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 113.642 -1.617 . . . . 0.0 107.957 165.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.82 158.8 44.58 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.099 1.36 . . . . 0.0 107.631 170.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -133.05 124.82 28.34 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.76 152.13 46.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.67 1.224 . . . . 0.0 113.054 -177.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -85.22 110.17 18.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.051 1.74 . . . . 0.0 108.835 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.457 HG23 ' CD1' ' A' ' 24' ' ' PHE . 3.0 p -60.99 -26.19 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.039 0.936 . . . . 0.0 112.754 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -70.78 -22.69 62.34 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 126.547 1.939 . . . . 0.0 111.182 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.61 -38.74 13.72 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.589 1.156 . . . . 0.0 111.021 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -105.05 106.43 55.52 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.277 -0.868 . . . . 0.0 112.705 -169.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.89 -22.42 6.24 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.047 2.498 . . . . 0.0 114.316 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -66.41 118.55 10.22 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.325 0.966 . . . . 0.0 108.766 -173.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.272 25.9 m 67.65 -17.75 0.15 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.817 2.847 . . . . 0.0 112.659 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -54.5 -54.9 34.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.125 1.77 . . . . 0.0 108.895 160.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -57.97 -46.8 84.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.55 0.74 . . . . 0.0 110.356 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -55.06 -35.37 64.46 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 124.543 1.137 . . . . 0.0 112.899 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -111.09 14.75 21.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.232 0.613 . . . . 0.0 112.258 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.39 31.2 80.07 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 118.962 0.801 . . . . 0.0 113.114 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.7 mm -76.54 81.98 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.102 1.361 . . . . 0.0 110.288 -165.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.6 mmt -130.27 3.82 4.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.19 1.396 . . . . 0.0 111.424 165.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 t -78.89 37.44 0.3 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.232 1.813 . . . . 0.0 110.966 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.479 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -78.74 151.27 76.71 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 121.324 -0.86 . . . . 0.0 111.427 -169.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 61.3 Cg_endo -64.7 123.98 4.06 Favored 'Cis proline' 0 C--N 1.349 0.583 0 CA-C-N 119.861 0.986 . . . . 0.0 111.107 4.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.3 m -118.69 154.22 33.08 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 tt -146.3 122.7 10.99 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 104.673 -2.344 . . . . 0.0 104.673 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.8 mt -123.37 139.08 51.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 119.55 39.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 126.569 1.948 . . . . 0.0 105.822 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -122.26 169.16 11.19 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.797 2.439 . . . . 0.0 108.062 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.474 ' C ' ' HE3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -153.33 40.13 0.52 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.344 -0.847 . . . . 0.0 112.417 -179.718 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.92 87.41 1.91 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -167.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.69 -23.35 3.02 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 130.585 3.945 . . . . 0.0 114.422 160.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -131.94 149.3 72.95 Favored Pre-proline 0 N--CA 1.445 -0.69 0 C-N-CA 125.379 1.472 . . . . 0.0 110.182 -171.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.12 159.94 30.05 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.848 2.366 . . . . 0.0 111.043 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -38.67 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.239 1.416 . . . . 0.0 110.383 165.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -161.11 171.91 17.7 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 119.317 0.962 . . . . 0.0 111.381 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -139.05 150.38 45.7 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.24 2.216 . . . . 0.0 108.649 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.76 150.61 40.12 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.148 1.779 . . . . 0.0 107.632 161.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.9 pt -143.33 137.36 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 126.269 1.827 . . . . 0.0 108.082 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.55 167.37 18.01 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.163 0.887 . . . . 0.0 111.762 -174.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -57.01 110.72 0.87 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.906 0.883 . . . . 0.0 111.183 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -101.33 133.84 20.66 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 160.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.97 158.14 58.2 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 CA-C-N 120.287 1.138 . . . . 0.0 109.161 164.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.35 -52.52 2.7 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.149 1.78 . . . . 0.0 110.843 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.19 -31.66 69.22 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.017 1.727 . . . . 0.0 113.103 -175.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -85.31 -47.27 10.19 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 119.244 0.929 . . . . 0.0 109.906 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.456 HD22 ' CE1' ' A' ' 42' ' ' PHE . 1.3 tt -56.53 -61.89 2.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.305 2.642 . . . . 0.0 108.999 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -63.24 -29.26 70.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.585 1.154 . . . . 0.0 110.827 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.64 -49.15 33.75 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.39 0.995 . . . . 0.0 110.732 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -56.86 -43.24 80.99 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.479 0.712 . . . . 0.0 110.828 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.68 -0.27 55.95 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.51 1.124 . . . . 0.0 113.324 -176.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.16 -28.82 63.12 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.232 1.413 . . . . 0.0 113.4 -170.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -63.25 -22.09 66.65 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.15 0.98 . . . . 0.0 113.393 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.11 -15.87 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 118.862 0.756 . . . . 0.0 111.14 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -10.38 56.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.01 1.324 . . . . 0.0 112.49 169.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.249 1.042 0 C-N-CA 129.608 3.163 . . . . 0.0 111.182 161.929 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 51' ' ' THR . . . . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.2 t -79.18 -165.92 0.84 Allowed 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 153.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.63 5.63 0.61 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 174.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -134.75 158.88 43.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.423 1.089 . . . . 0.0 108.899 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 mt -140.34 170.39 15.89 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 125.335 1.454 . . . . 0.0 109.621 170.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.9 p -127.01 170.13 12.62 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 163.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -53.39 -55.52 24.34 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 127.886 2.475 . . . . 0.0 111.412 172.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.4 81.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.226 0.611 . . . . 0.0 110.084 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -75.09 -20.23 59.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.248 -172.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -58.36 -63.93 1.1 Allowed 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.14 -46.81 89.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.017 0.527 . . . . 0.0 110.787 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.23 -20.02 65.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.094 -174.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.14 -58.13 3.09 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.4 1.0 . . . . 0.0 110.213 165.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.2 pt -62.41 -20.05 23.8 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -169.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -57.36 -24.62 56.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.137 0.975 . . . . 0.0 113.038 172.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.24 112.57 0.26 Allowed Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -157.96 -75.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.489 1.515 . . . . 0.0 109.137 -175.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.69 -166.25 30.75 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 -159.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.32 83.87 0.2 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.703 3.602 . . . . 0.0 112.226 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.7 t -94.06 124.12 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 125.743 1.617 . . . . 0.0 106.848 171.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.74 146.64 44.6 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.52 0.676 . . . . 0.0 111.964 170.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.3 t -131.54 108.41 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -161.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -83.46 100.75 10.93 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.345 1.058 . . . . 0.0 109.155 174.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -78.54 108.61 12.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 166.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -123.17 176.06 6.29 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.39 155.73 31.03 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 120.884 -1.135 . . . . 0.0 110.825 166.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.49 -12.81 61.21 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -173.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.69 -12.37 31.63 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.572 1.078 . . . . 0.0 112.772 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.4 p -67.24 173.72 3.7 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.436 0.636 . . . . 0.0 112.469 -164.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.35 -86.63 1.89 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 162.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.24 -20.78 55.64 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.96 2.44 . . . . 0.0 114.336 -167.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.67 -33.66 68.57 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.8 1.182 . . . . 0.0 111.128 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -74.05 -11.82 60.44 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.572 -0.727 . . . . 0.0 112.516 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.6 ptm -104.23 -21.64 13.5 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.923 1.289 . . . . 0.0 112.079 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 26.1 ttt -83.82 -44.4 14.38 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.89 1.676 . . . . 0.0 108.969 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.2 -47.26 82.56 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 117.541 -1.219 . . . . 0.0 113.324 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.87 -31.48 38.4 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.918 1.721 . . . . 0.0 112.445 172.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.23 -39.03 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.813 1.188 . . . . 0.0 110.511 172.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.8 mt -69.23 -20.01 63.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.227 1.411 . . . . 0.0 111.831 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -69.98 -45.57 67.07 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.673 0.789 . . . . 0.0 110.092 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -62.1 -44.28 96.99 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.529 0.331 . . . . 0.0 110.289 171.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.22 -44.9 84.17 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.772 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.72 -53.51 46.75 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.054 0.942 . . . . 0.0 110.745 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.01 -46.8 87.28 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.184 0.994 . . . . 0.0 111.069 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.8 -26.57 14.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.051 1.341 . . . . 0.0 114.414 -173.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.05 29.67 4.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.415 1.486 . . . . 0.0 111.826 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -14.26 -61.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 131.421 3.888 . . . . 0.0 116.028 -172.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -114.08 -14.53 12.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.386 1.874 . . . . 0.0 113.134 -168.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -66.42 -31.96 73.04 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 119.231 0.923 . . . . 0.0 110.276 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.12 171.56 17.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 122.706 0.402 . . . . 0.0 110.216 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 1' ' ' ALA . 3.5 t -124.45 137.77 54.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.102 0.477 . . . . 0.0 110.005 172.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.86 154.74 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 125.255 1.422 . . . . 0.0 107.313 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.95 138.04 20.35 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -117.45 136.46 53.18 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 118.898 0.772 . . . . 0.0 109.338 170.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -144.38 146.46 32.54 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.175 0.988 . . . . 0.0 113.446 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -75.16 104.14 5.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.007 1.723 . . . . 0.0 107.826 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.534 HG11 HG21 ' A' ' 72' ' ' ILE . 4.7 p -70.15 -20.56 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -166.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.87 -43.08 90.78 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.076 1.35 . . . . 0.0 110.566 169.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -89.23 -25.36 21.78 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.636 1.974 . . . . 0.0 112.316 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -105.33 90.08 3.65 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 118.404 0.547 . . . . 0.0 111.24 164.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.9 -12.67 17.82 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.872 2.381 . . . . 0.0 114.042 166.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -72.87 129.17 37.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.667 1.121 . . . . 0.0 109.078 -176.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.5 m 64.33 -25.12 0.08 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 129.943 3.297 . . . . 0.0 112.466 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 62' ' ' GLU . 41.7 m -50.31 -61.59 2.08 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 128.328 2.651 . . . . 0.0 109.214 165.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.1 t -57.45 -46.49 83.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.95 0.5 . . . . 0.0 109.881 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -58.59 -38.58 78.25 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.4 1.08 . . . . 0.0 112.451 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -95.22 12.0 30.43 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.848 0.749 . . . . 0.0 111.461 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.36 25.64 73.65 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 118.78 0.718 . . . . 0.0 112.635 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.8 mm -73.65 94.89 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.86 1.264 . . . . 0.0 109.312 -169.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.14 -21.37 3.61 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.366 1.466 . . . . 0.0 110.861 175.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 p -81.58 47.76 1.1 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.115 2.566 . . . . 0.0 112.333 -162.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.534 HG21 HG11 ' A' ' 57' ' ' VAL . 45.6 pt -76.16 153.53 84.39 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -169.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.421 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 41.1 Cg_endo -62.85 128.27 6.06 Favored 'Cis proline' 0 C--N 1.351 0.693 0 N-CA-C 110.238 -0.716 . . . . 0.0 110.238 -7.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 m -115.41 132.64 56.56 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tt -125.43 116.82 22.44 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 mt -120.17 143.03 33.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.0 tt -118.9 119.83 35.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -111.48 166.91 10.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.577 1.951 . . . . 0.0 110.356 -172.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -161.67 127.75 3.72 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 126.22 1.808 . . . . 0.0 106.714 158.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 47.8 42.87 22.25 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.633 0.635 . . . . 0.0 113.771 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.12 -7.05 82.63 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 117.859 -1.523 . . . . 0.0 115.146 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -101.03 104.34 31.54 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 120.094 1.947 . . . . 0.0 111.243 -173.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.88 90.25 1.09 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.799 3.0 . . . . 0.0 111.189 171.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 m -63.45 -21.35 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.04 158.03 34.04 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.896 0.878 . . . . 0.0 110.699 160.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -118.36 136.5 53.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.126 2.17 . . . . 0.0 105.958 163.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.07 147.53 41.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.182 2.193 . . . . 0.0 105.637 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.4 pt -140.9 142.67 29.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.779 1.231 . . . . 0.0 107.987 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.21 167.3 27.76 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 123.892 0.745 . . . . 0.0 111.658 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -72.22 79.09 0.97 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.892 0.877 . . . . 0.0 110.088 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -76.45 129.63 79.28 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 162.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -68.45 167.8 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.053 1.835 . . . . 0.0 109.832 175.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.36 -42.56 61.41 Favored 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 123.595 0.758 . . . . 0.0 110.245 -177.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -75.14 -2.34 27.28 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.758 1.223 . . . . 0.0 111.505 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -112.13 -49.56 2.96 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 125.845 1.658 . . . . 0.0 109.221 172.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.0 tt -52.04 -66.44 0.38 Allowed 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 127.2 2.2 . . . . 0.0 110.418 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -63.55 -20.65 65.81 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.69 1.196 . . . . 0.0 111.952 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.67 -48.09 41.98 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.533 1.06 . . . . 0.0 110.665 172.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -59.49 -51.16 71.04 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.928 0.891 . . . . 0.0 110.223 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 mt -75.04 -5.36 43.65 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 126.129 1.771 . . . . 0.0 112.753 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.62 -26.71 34.56 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 124.541 1.136 . . . . 0.0 111.632 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -6.49 9.14 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.802 1.241 . . . . 0.0 113.657 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.62 -14.14 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 162.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.05 -7.86 59.65 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.211 -0.931 . . . . 0.0 112.249 170.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 C--O 1.247 0.956 0 C-N-CA 127.398 2.279 . . . . 0.0 108.154 158.858 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.2 m -149.78 153.03 36.17 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 120.018 -1.677 . . . . 0.0 107.743 168.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.3 mtt -138.19 -175.2 4.02 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.588 1.955 . . . . 0.0 109.44 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.7 m -151.83 154.54 36.38 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 171.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.7 mt -140.33 169.53 17.5 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.029 0.932 . . . . 0.0 109.652 -159.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.0 p -112.42 -105.63 0.38 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 167.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -126.06 -64.72 1.03 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.095 2.158 . . . . 0.0 108.932 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.63 -30.63 61.29 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.764 -0.585 . . . . 0.0 112.075 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.04 -22.59 59.5 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 119.163 -0.446 . . . . 0.0 111.254 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -64.06 -58.7 5.89 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 118.841 0.746 . . . . 0.0 109.829 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -59.59 -34.98 73.42 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.833 0.453 . . . . 0.0 110.978 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -62.82 -53.31 56.27 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.901 -0.499 . . . . 0.0 110.685 171.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.95 -43.99 97.92 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.423 0.689 . . . . 0.0 111.654 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 pt -59.95 -23.59 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -11.06 60.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.542 0.737 . . . . 0.0 111.85 177.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.06 131.19 48.28 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 174.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -87.0 35.65 0.7 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.635 0.774 . . . . 0.0 112.702 -165.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -142.13 179.93 19.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.398 1.475 . . . . 0.0 110.238 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.57 93.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.296 3.331 . . . . 0.0 111.585 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.0 t -100.34 126.42 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 127.35 2.26 . . . . 0.0 106.078 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.541 HD11 HD21 ' A' ' 75' ' ' LEU . 15.8 tp -126.77 120.92 30.51 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.866 -0.521 . . . . 0.0 110.275 -167.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -100.4 133.65 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 118.698 0.681 . . . . 0.0 109.92 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -93.2 107.86 19.59 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 159.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.472 ' CD1' HG23 ' A' ' 57' ' ' VAL . 47.5 m-85 -82.7 111.96 19.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 162.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -119.71 -174.36 2.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.506 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -147.6 161.42 41.18 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 121.394 -0.817 . . . . 0.0 111.508 168.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.83 6.38 0.24 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.433 1.493 . . . . 0.0 115.02 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.42 ' CG ' ' N ' ' A' ' 29' ' ' CYS . 3.5 p90 -124.31 -66.72 0.96 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 163.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 28' ' ' TRP . 16.4 t 36.16 -91.52 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 129.896 3.278 . . . . 0.0 114.614 175.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.66 -91.54 0.56 Allowed Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.624 1.583 . . . . 0.0 111.074 -172.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.07 -19.24 68.5 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.99 3.127 . . . . 0.0 115.066 -168.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 p -51.51 -35.21 39.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.83 0.741 . . . . 0.0 111.722 165.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -66.13 -14.26 61.5 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.547 1.067 . . . . 0.0 112.54 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.8 mtp -105.57 -15.58 14.95 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.295 1.838 . . . . 0.0 111.407 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.6 ttt -93.95 -34.93 12.88 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 126.322 1.849 . . . . 0.0 109.227 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.26 -50.62 63.21 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.651 1.58 . . . . 0.0 113.02 171.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.91 -35.48 55.29 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 122.127 1.796 . . . . 0.0 111.815 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -61.79 -39.82 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 118.809 0.731 . . . . 0.0 110.079 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.6 mp -68.3 -32.09 71.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.936 2.094 . . . . 0.0 112.211 174.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -68.5 -49.87 56.42 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.026 0.931 . . . . 0.0 108.957 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -56.51 -47.7 78.79 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.277 0.56 . . . . 0.0 110.274 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -58.18 -42.98 87.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.646 1.178 . . . . 0.0 111.051 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.86 -53.27 59.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.367 1.067 . . . . 0.0 110.218 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -52.61 -45.87 66.76 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.503 0.592 . . . . 0.0 110.589 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.82 -10.68 58.18 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -139.09 3.72 2.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -168.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -24.32 -52.96 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 129.318 3.047 . . . . 0.0 116.258 -158.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . 0.27 2.8 m-20 -125.32 10.7 8.03 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -70.68 -26.63 63.52 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 119.556 1.071 . . . . 0.0 108.665 158.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.79 174.32 12.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 126.12 1.768 . . . . 0.0 110.023 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.262 0.7 OUTLIER -137.51 112.71 9.19 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 159.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.04 159.17 2.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 121.228 0.537 . . . . 0.0 109.897 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.2 171.86 15.77 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.57 0.748 . . . . 0.0 109.177 172.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -139.69 131.49 27.52 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -170.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.43 151.25 33.7 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -85.12 115.7 23.07 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.441 1.896 . . . . 0.0 108.494 -178.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' A' ' 26' ' ' ALA . 2.3 p -64.99 -24.14 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.254 1.022 . . . . 0.0 113.017 -172.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.08 63.7 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.396 1.478 . . . . 0.0 109.988 174.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -65.06 -32.67 74.5 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.079 1.351 . . . . 0.0 111.947 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -110.08 87.32 5.81 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.206 1.002 . . . . 0.0 111.633 -174.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.61 -25.68 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.151 2.567 . . . . 0.0 114.445 170.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -73.22 137.89 45.26 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 120.49 1.495 . . . . 0.0 109.481 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.293 49.3 m 67.53 -23.97 0.12 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 129.495 3.118 . . . . 0.0 111.751 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.432 ' H ' ' C ' ' A' ' 62' ' ' GLU . 41.2 m -63.76 -71.9 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 127.917 2.487 . . . . 0.0 110.153 169.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -64.55 -28.4 69.61 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -59.0 -24.68 62.99 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.334 1.854 . . . . 0.0 111.856 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -120.91 13.51 11.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.85 1.26 . . . . 0.0 111.257 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.85 25.01 71.73 Favored Glycine 0 CA--C 1.534 1.227 0 O-C-N 121.341 -0.849 . . . . 0.0 113.514 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.493 HD12 HG21 ' A' ' 74' ' ' THR . 23.2 mm -68.21 93.89 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.99 1.316 . . . . 0.0 110.167 -171.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -128.37 -13.22 4.96 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.101 1.36 . . . . 0.0 112.063 171.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.7 t -81.84 53.24 2.12 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.994 1.318 . . . . 0.0 111.457 -173.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.423 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 23.7 pt -70.84 153.03 95.01 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.188 0.995 . . . . 0.0 112.343 -176.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.423 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 39.7 Cg_endo -62.92 129.92 7.82 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 CA-C-N 119.087 0.71 . . . . 0.0 110.506 -8.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.493 HG21 HD12 ' A' ' 69' ' ' ILE . 24.7 m -112.83 141.85 46.17 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.541 HD21 HD11 ' A' ' 21' ' ' LEU . 5.4 tt -133.19 105.26 6.91 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -172.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.6 mt -109.12 128.86 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.415 HD13 HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -92.1 110.83 22.21 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 169.236 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -103.18 156.53 17.64 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.543 1.137 . . . . 0.0 109.462 170.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.19 127.16 11.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 163.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.84 27.39 59.21 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-N 118.321 0.51 . . . . 0.0 113.523 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.38 -12.58 69.35 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.959 1.743 . . . . 0.0 113.763 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -90.6 118.36 68.64 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 119.366 1.583 . . . . 0.0 109.689 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 85.01 1.18 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.582 2.855 . . . . 0.0 109.72 171.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -64.82 -38.82 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.344 1.057 . . . . 0.0 111.995 -176.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -142.28 156.05 45.26 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.483 1.038 . . . . 0.0 110.684 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.99 135.48 32.77 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.856 1.663 . . . . 0.0 107.952 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.1 mm? -122.01 146.71 46.9 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.356 2.262 . . . . 0.0 106.797 174.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.3 pt -143.23 119.17 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 124.598 1.159 . . . . 0.0 109.233 -169.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.9 170.57 41.63 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.491 1.52 . . . . 0.0 110.798 -169.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -66.44 93.12 0.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.868 1.267 . . . . 0.0 110.43 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -74.63 131.77 79.26 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 168.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.47 166.57 21.31 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.584 1.522 . . . . 0.0 109.593 165.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -47.48 73.2 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -177.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.1 -15.11 20.54 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.53 2.332 . . . . 0.0 113.181 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -101.35 -56.05 2.39 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 125.418 1.487 . . . . 0.0 108.703 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.48 -58.07 8.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.593 1.957 . . . . 0.0 109.782 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -26.94 68.61 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.247 1.019 . . . . 0.0 110.946 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.34 -44.87 42.87 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.505 1.048 . . . . 0.0 110.714 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -49.73 76.57 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.255 1.022 . . . . 0.0 109.967 172.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.83 -2.52 57.85 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.18 -34.45 14.54 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 119.429 1.013 . . . . 0.0 110.42 168.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.6 29.02 0.08 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.562 2.345 . . . . 0.0 112.16 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.35 -24.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.9 2.08 . . . . 0.0 111.204 158.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.15 -10.84 59.73 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.978 0.911 . . . . 0.0 112.343 172.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.258 0 C-N-CA 127.195 2.198 . . . . 0.0 109.167 165.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 118.844 -0.598 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . 0.268 6.1 t 54.91 -162.8 0.14 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.548 1.939 . . . . 0.0 115.059 159.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . 0.289 13.2 ttt 137.24 -136.54 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 1 C-N-CA 135.283 5.433 . . . . 0.0 106.673 179.075 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.4 m -56.43 137.24 53.31 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.682 1.593 . . . . 0.0 112.672 -168.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 53' ' ' ALA . 1.1 tp -90.63 175.23 7.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.153 1.781 . . . . 0.0 111.403 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.5 p -130.35 178.29 6.7 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 159.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -58.4 -57.99 10.47 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.614 1.566 . . . . 0.0 110.466 169.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.01 79.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.668 -0.645 . . . . 0.0 110.699 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -84.15 -19.32 34.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.949 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.46 ' HA ' HD21 ' A' ' 5' ' ' LEU . 21.9 t80 -58.74 -56.58 20.35 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 167.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -63.18 -46.07 88.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.748 0.819 . . . . 0.0 109.715 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.597 HE21 ' NE2' ' A' ' 15' ' ' GLN . 9.5 tp60 -63.47 -30.62 71.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.945 0.793 . . . . 0.0 112.336 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.22 -60.48 2.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.422 1.01 . . . . 0.0 110.048 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.37 -10.04 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.597 ' NE2' HE21 ' A' ' 12' ' ' GLN . 20.9 pt20 -46.58 -36.1 6.53 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.502 1.521 . . . . 0.0 112.818 -174.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.85 113.85 1.66 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 124.131 0.872 . . . . 0.0 112.808 165.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -152.56 -102.89 0.05 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 164.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.74 -138.13 6.37 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.545 1.545 . . . . 0.0 111.742 -168.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.75 85.87 0.92 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.371 3.381 . . . . 0.0 113.05 -167.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.3 t -97.26 140.32 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 170.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.19 124.43 20.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 O-C-N 121.689 -0.632 . . . . 0.0 109.411 164.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.92 142.44 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 172.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.8 89.27 3.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.502 1.144 . . . . 0.0 108.983 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 69' ' ' ILE . 74.8 m-85 -76.19 114.58 15.02 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.614 1.166 . . . . 0.0 109.27 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 16.4 p-90 -127.93 -171.52 2.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 168.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.77 160.38 41.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.082 -1.011 . . . . 0.0 110.393 169.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.6 -29.17 64.28 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.568 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.474 ' CH2' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -93.61 -26.95 16.87 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.1 p -71.66 164.98 24.93 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.221 0.919 . . . . 0.0 113.438 -159.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.84 -82.36 1.4 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.279 1.418 . . . . 0.0 112.653 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -60.7 -20.96 67.84 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.466 2.778 . . . . 0.0 113.077 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 17.7 p -59.21 -27.28 65.59 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.148 172.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.3 mtt85 -76.61 -12.76 60.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 120.477 1.489 . . . . 0.0 112.864 175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 86.7 mtp -95.09 -33.0 12.84 Favored 'General case' 0 C--O 1.227 -0.114 0 C-N-CA 124.843 1.257 . . . . 0.0 110.296 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.6 ttt -78.0 -36.18 49.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.416 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.67 -51.8 66.55 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.198 -1.382 . . . . 0.0 112.203 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.83 -38.14 40.85 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 121.735 1.655 . . . . 0.0 111.848 171.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.78 -14.36 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 119.576 1.08 . . . . 0.0 112.163 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.38 -16.36 18.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 128.669 2.788 . . . . 0.0 111.816 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -79.36 -40.7 29.56 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.672 1.123 . . . . 0.0 109.449 168.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -52.41 -51.02 61.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.739 0.816 . . . . 0.0 109.034 163.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.458 ' CD1' ' HE2' ' A' ' 93' ' ' LYS . 2.3 t80 -57.93 -48.77 78.95 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-O 118.652 -0.689 . . . . 0.0 110.889 177.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.81 -59.82 3.03 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.95 1.3 . . . . 0.0 109.63 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -60.21 -44.7 94.94 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 124.806 1.316 . . . . 0.0 111.343 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.56 -15.09 2.49 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.652 1.181 . . . . 0.0 113.939 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.97 35.37 1.75 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.46 1.104 . . . . 0.0 112.713 174.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.79 -37.54 8.76 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.83 1.652 . . . . 0.0 115.195 -165.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.4 7.74 4.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.737 1.215 . . . . 0.0 111.362 175.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -83.99 -27.13 28.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.719 1.607 . . . . 0.0 110.554 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 m -138.97 171.63 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.819 1.248 . . . . 0.0 108.788 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.306 6.6 t -110.49 85.95 2.21 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 123.529 1.633 . . . . 0.0 108.631 164.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -70.02 154.95 7.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.409 163.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.494 ' HB3' HD22 ' A' ' 5' ' ' LEU . . . -157.55 120.41 3.93 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.085 169.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -94.0 146.47 23.91 Favored 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.073 0.233 . . . . 0.0 111.405 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.97 154.51 35.12 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.638 0.732 . . . . 0.0 112.082 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -86.31 96.39 9.96 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.597 1.959 . . . . 0.0 107.885 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.401 HG11 HG21 ' A' ' 72' ' ' ILE . 1.1 p -66.22 -20.3 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 121.371 -0.831 . . . . 0.0 113.068 -167.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.5 -28.46 63.45 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.97 1.708 . . . . 0.0 111.676 170.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -109.44 -16.83 13.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.446 2.298 . . . . 0.0 111.821 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -112.53 79.67 3.22 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.217 1.807 . . . . 0.0 110.85 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.57 -88.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.572 2.848 . . . . 0.0 109.984 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 46.74 -17.12 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 131.344 3.858 . . . . 0.0 121.206 167.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.8 m 178.2 -25.43 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 130.806 3.642 . . . . 0.0 110.782 -171.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.404 HG23 ' HB ' ' A' ' 69' ' ' ILE . 37.2 m -44.39 -61.55 1.48 Allowed 'General case' 0 N--CA 1.458 -0.075 0 C-N-CA 127.574 2.35 . . . . 0.0 110.621 173.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -57.94 -45.66 86.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.777 0.831 . . . . 0.0 109.659 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -60.44 -28.12 68.04 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.075 1.35 . . . . 0.0 112.949 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -112.45 12.08 19.98 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.915 0.779 . . . . 0.0 111.571 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.33 24.58 74.96 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 121.334 -0.854 . . . . 0.0 114.203 173.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.417 HG21 ' CE2' ' A' ' 24' ' ' PHE . 40.8 mm -80.82 46.54 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 126.79 2.036 . . . . 0.0 111.269 -167.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.0 ttt -83.39 -8.25 59.43 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.237 -0.914 . . . . 0.0 110.17 162.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.2 p -75.77 16.52 0.39 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.251 2.22 . . . . 0.0 115.054 -164.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.474 HD11 ' CH2' ' A' ' 28' ' ' TRP . 28.4 pt -61.31 145.49 90.35 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.001 0.92 . . . . 0.0 112.361 -165.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 74.3 Cg_endo -67.57 135.53 29.29 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 118.25 0.411 . . . . 0.0 111.544 -1.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 54.6 m -133.44 140.6 47.39 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.049 0.94 . . . . 0.0 110.075 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt -135.65 99.13 4.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.028 1.731 . . . . 0.0 106.757 -170.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.8 mt -95.17 130.56 43.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.449 HD12 ' HG ' ' A' ' 100' ' ' LEU . 0.8 OUTLIER -92.46 123.28 35.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 171.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -113.82 148.45 36.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 172.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.608 ' HE3' HG21 ' A' ' 84' ' ' VAL . 12.7 ptpt -152.36 154.71 36.19 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 163.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.53 15.47 1.25 Allowed Glycine 0 CA--C 1.541 1.713 0 N-CA-C 117.134 1.614 . . . . 0.0 117.134 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.83 15.88 38.08 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-N 119.69 1.745 . . . . 0.0 112.995 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -134.97 128.0 18.49 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.195 1.398 . . . . 0.0 109.555 -167.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.83 87.32 1.41 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.914 3.076 . . . . 0.0 109.646 171.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.608 HG21 ' HE3' ' A' ' 79' ' ' LYS . 2.6 m -63.75 -36.3 76.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 O-C-N 121.503 -0.748 . . . . 0.0 112.456 -174.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.88 167.05 31.57 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 122.905 0.482 . . . . 0.0 111.106 170.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -134.66 134.06 40.74 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.3 1.84 . . . . 0.0 107.881 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.484 HD11 ' HG2' ' A' ' 99' ' ' GLN . 4.5 mm? -106.49 149.72 26.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.801 1.64 . . . . 0.0 107.529 167.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 pt -143.32 144.18 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.398 1.479 . . . . 0.0 107.831 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.81 169.52 19.03 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.947 0.784 . . . . 0.0 112.796 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -72.74 73.82 1.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.553 1.541 . . . . 0.0 111.167 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.45 ' HG3' HD12 ' A' ' 87' ' ' LEU . 6.3 mm100 -75.28 136.03 72.51 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 165.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.36 166.01 29.76 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.202 1.935 . . . . 0.0 110.863 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.458 ' HE2' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -49.46 -50.61 40.42 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.68 1.192 . . . . 0.0 111.865 -177.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -52.63 -33.73 48.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.226 1.41 . . . . 0.0 112.964 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.456 HE22 ' NE2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -83.59 -47.83 10.87 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 tt -61.03 -56.84 16.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.433 1.493 . . . . 0.0 110.338 -175.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -55.66 -33.56 64.19 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.456 1.502 . . . . 0.0 110.337 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.86 -50.22 17.79 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 118.232 0.469 . . . . 0.0 110.268 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.484 ' HG2' HD11 ' A' ' 87' ' ' LEU . 1.9 tp-100 -59.62 -41.06 89.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.553 0.741 . . . . 0.0 110.82 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.449 ' HG ' HD12 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -85.87 -0.02 54.26 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.365 1.466 . . . . 0.0 113.108 -178.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.53 -27.5 16.78 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.236 1.015 . . . . 0.0 113.332 -174.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.38 0.16 1.6 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.372 1.442 . . . . 0.0 113.686 176.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.273 0.4 OUTLIER -129.97 4.17 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 161.262 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.81 -13.59 16.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.242 1.017 . . . . 0.0 112.13 171.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.896 2.078 . . . . 0.0 109.964 170.304 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -156.37 174.36 15.52 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 120.225 -1.547 . . . . 0.0 111.436 -175.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.4 mtp -148.84 169.92 19.42 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.607 1.963 . . . . 0.0 108.885 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.1 m -62.46 148.97 43.99 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 159.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 10' ' ' PHE . 6.3 tp -119.62 162.99 18.04 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.118 0.967 . . . . 0.0 110.276 -173.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.47 ' H ' ' HB2' ' A' ' 9' ' ' ASN . 67.2 p -130.15 -100.97 0.31 Allowed 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 170.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -133.73 -71.18 0.51 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.273 1.429 . . . . 0.0 110.123 -158.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.01 -42.28 37.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.499 0.72 . . . . 0.0 110.253 163.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.47 ' HB2' ' H ' ' A' ' 6' ' ' THR . 72.3 m-80 -69.74 -26.95 64.56 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.327 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.527 ' HA ' HD21 ' A' ' 5' ' ' LEU . 8.8 t80 -61.51 -67.06 0.44 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.051 0.841 . . . . 0.0 109.028 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -63.21 -35.8 81.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 121.482 -0.087 . . . . 0.0 110.843 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.91 -8.0 56.58 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 118.228 -0.892 . . . . 0.0 113.144 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.95 -49.21 5.9 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 120.36 1.437 . . . . 0.0 110.784 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.3 pt -59.94 -19.38 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -174.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -17.73 60.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.446 1.498 . . . . 0.0 113.686 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.59 146.19 48.18 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 119.175 0.898 . . . . 0.0 111.259 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -76.4 -23.36 54.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.321 1.048 . . . . 0.0 113.658 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -93.57 -174.26 40.0 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.132 0.872 . . . . 0.0 112.571 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.72 87.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.506 3.47 . . . . 0.0 111.86 172.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.9 t -83.68 138.1 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 162.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.47 163.0 39.02 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.742 -0.599 . . . . 0.0 110.318 168.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.41 126.87 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 123.994 0.918 . . . . 0.0 108.672 -173.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 66.3 t0 -80.13 114.88 19.37 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 158.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -100.03 108.88 21.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 25.5 p-90 -125.2 179.43 5.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.287 1.435 . . . . 0.0 107.249 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.554 ' HB2' HG12 ' A' ' 57' ' ' VAL . . . -152.25 162.73 40.71 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.496 1.118 . . . . 0.0 109.815 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.85 -9.27 50.48 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -16.38 5.6 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -174.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 26' ' ' ALA . 6.4 p -74.4 38.13 0.11 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 -159.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 37.62 -102.98 0.02 OUTLIER Glycine 0 CA--C 1.54 1.614 0 C-N-CA 127.665 2.555 . . . . 0.0 114.344 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.93 -17.77 39.01 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.015 3.144 . . . . 0.0 115.131 -175.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.2 p -53.27 -36.7 61.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.502 1.046 . . . . 0.0 111.323 168.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.2 ttt-85 -67.36 -8.85 35.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.204 1.002 . . . . 0.0 112.545 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 64.8 mtm -107.34 -14.74 14.8 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.503 1.521 . . . . 0.0 112.473 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.5 ttt -96.55 -36.41 10.77 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.633 1.173 . . . . 0.0 109.428 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.15 -47.81 86.82 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.648 1.179 . . . . 0.0 112.162 174.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.81 -31.28 48.58 Favored 'Trans proline' 0 C--N 1.351 0.702 0 CA-C-N 121.995 1.748 . . . . 0.0 112.699 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.8 -33.74 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 119.437 1.017 . . . . 0.0 110.567 173.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -31.04 62.14 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.184 1.794 . . . . 0.0 111.614 173.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -71.15 -40.18 71.48 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.431 1.014 . . . . 0.0 109.613 172.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -62.58 -43.29 99.17 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 171.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -56.47 -42.7 78.67 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.286 1.035 . . . . 0.0 111.633 172.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.81 -55.12 36.87 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.183 0.993 . . . . 0.0 110.565 174.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.38 -47.54 72.55 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.548 1.139 . . . . 0.0 110.097 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.26 -13.69 60.8 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -133.98 17.22 3.83 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.567 1.076 . . . . 0.0 113.147 -173.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.75 -31.95 5.36 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.846 2.058 . . . . 0.0 115.469 -159.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -124.06 -3.28 8.09 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.963 0.905 . . . . 0.0 113.383 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -78.63 -39.05 38.23 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.99 1.268 . . . . 0.0 110.436 166.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 m -124.45 166.45 19.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . 0.302 5.6 t -120.63 91.59 3.57 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 122.415 1.102 . . . . 0.0 108.501 172.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 p -98.54 116.61 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 125.065 1.346 . . . . 0.0 110.99 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.38 98.13 5.32 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 113.17 -1.832 . . . . 0.0 109.311 -159.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' CD ' ' H ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -72.1 140.82 49.1 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.873 -173.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pp -153.67 167.69 28.72 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 124.423 1.077 . . . . 0.0 112.758 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -95.97 112.05 23.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.914 1.686 . . . . 0.0 109.388 -173.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -64.72 -23.67 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.314 0.645 . . . . 0.0 111.967 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -75.42 -3.04 31.48 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.452 1.501 . . . . 0.0 111.776 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -135.26 -38.59 0.76 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.708 2.003 . . . . 0.0 111.743 -166.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -88.33 119.03 70.13 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 118.95 0.795 . . . . 0.0 109.513 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -90.55 -21.54 0.81 Allowed 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.504 2.803 . . . . 0.0 113.804 164.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 64' ' ' THR . 7.5 tp10 -61.4 111.74 1.9 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.306 1.442 . . . . 0.0 112.002 -170.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m 68.75 -30.58 0.18 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.625 2.77 . . . . 0.0 111.851 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.407 ' H ' ' C ' ' A' ' 62' ' ' GLU . 57.5 m -51.73 -51.35 56.85 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 128.49 2.716 . . . . 0.0 110.463 171.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.5 t -57.73 -50.14 74.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.355 0.662 . . . . 0.0 110.191 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.3 tp60 -56.62 -44.5 81.25 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 123.693 0.797 . . . . 0.0 111.9 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -88.61 11.54 17.11 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 119.138 -0.458 . . . . 0.0 112.028 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 69.61 29.31 71.45 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 124.413 1.006 . . . . 0.0 112.391 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.484 ' CD1' HD11 ' A' ' 76' ' ' ILE . 43.3 mm -79.97 82.0 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.138 0.975 . . . . 0.0 109.579 -162.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 48.0 ttm -123.42 -6.02 8.2 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.657 1.583 . . . . 0.0 111.111 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.2 t -83.16 26.17 0.65 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.679 1.192 . . . . 0.0 113.744 -167.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.454 ' HA ' ' C ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -63.86 151.46 89.16 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -165.222 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 59.6 Cg_endo -65.8 129.84 10.76 Favored 'Cis proline' 0 C--N 1.353 0.784 0 CA-C-N 119.379 0.814 . . . . 0.0 111.44 2.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.8 m -121.37 152.68 38.73 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.0 tt -132.37 130.32 40.54 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 171.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.484 HD11 ' CD1' ' A' ' 69' ' ' ILE . 37.3 mt -120.78 132.62 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 167.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.47 141.0 28.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.795 2.038 . . . . 0.0 105.982 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -142.52 161.89 36.89 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.993 2.117 . . . . 0.0 111.346 -175.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.448 ' CE ' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -163.74 153.34 14.66 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.203 1.801 . . . . 0.0 108.776 158.143 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.68 15.69 54.47 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.676 1.131 . . . . 0.0 114.536 167.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.16 -10.36 71.72 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.24 1.4 . . . . 0.0 112.837 -175.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -97.55 159.73 30.4 Favored Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 118.729 1.265 . . . . 0.0 109.181 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -69.76 -175.46 1.16 Allowed 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 122.5 2.133 . . . . 0.0 111.193 159.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.448 HG22 ' CE ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -133.07 -46.45 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.309 1.843 . . . . 0.0 108.738 159.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.426 ' HZ1' ' CG ' ' A' ' 102' ' ' ASP . 75.9 mttt -145.57 148.01 32.71 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 124.665 1.186 . . . . 0.0 107.973 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -117.32 131.99 56.69 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 163.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -125.48 141.03 52.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.1 141.18 29.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 124.022 0.929 . . . . 0.0 108.799 -170.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.18 164.87 39.6 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.586 1.089 . . . . 0.0 111.42 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.58 78.58 2.58 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.3 0.571 . . . . 0.0 110.006 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -71.01 133.82 85.8 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 165.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.23 167.58 21.68 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.874 1.716 . . . . 0.0 111.367 176.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -44.78 73.9 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.081 1.352 . . . . 0.0 110.792 -172.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -51.33 -44.9 62.11 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.69 2.396 . . . . 0.0 111.063 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -42.59 53.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.1 1.76 . . . . 0.0 108.049 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -61.74 2.11 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.655 1.582 . . . . 0.0 108.827 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.78 -39.09 83.72 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.585 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.41 82.78 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 120.267 1.394 . . . . 0.0 111.713 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -78.0 -21.75 50.37 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.16 -1.78 13.58 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.467 1.107 . . . . 0.0 112.808 -174.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.38 -36.19 42.16 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.776 1.63 . . . . 0.0 112.604 -175.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.426 ' CG ' ' HZ1' ' A' ' 85' ' ' LYS . 10.1 p-10 -64.31 -11.29 30.58 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.182 1.393 . . . . 0.0 114.091 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.81 -8.5 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 119.459 1.027 . . . . 0.0 112.071 168.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.27 -10.25 26.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.392 1.477 . . . . 0.0 112.899 175.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 C--O 1.246 0.899 0 C-N-CA 126.167 1.787 . . . . 0.0 110.212 172.058 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 51' ' ' THR . . . . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.0 m -51.93 127.06 20.07 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.139 1.376 . . . . 0.0 112.846 -170.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.1 ptm -164.45 -179.89 6.3 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.516 1.526 . . . . 0.0 109.613 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -69.4 154.56 41.84 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.179 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.446 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 1.6 tp -123.84 159.68 29.07 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.842 0.83 . . . . 0.0 111.226 -177.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.3 m -166.89 170.59 12.07 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.871 3.668 . . . . 0.0 101.958 172.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -43.38 -59.85 1.95 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 128.725 2.81 . . . . 0.0 112.781 -166.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.05 91.66 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.319 0.58 . . . . 0.0 111.189 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -72.07 -21.79 61.46 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.139 -0.458 . . . . 0.0 111.777 -177.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.26 -60.02 3.98 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -60.53 -46.06 91.55 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.442 -0.789 . . . . 0.0 111.184 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -62.67 -26.31 68.58 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.314 0.961 . . . . 0.0 112.71 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.94 -63.47 1.25 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 119.066 0.848 . . . . 0.0 109.485 165.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.77 HG22 HG11 ' A' ' 20' ' ' VAL . 2.9 pt -66.95 -13.52 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -166.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -58.54 -20.74 48.95 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.993 1.317 . . . . 0.0 113.975 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.43 -112.14 0.26 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 107.849 -2.1 . . . . 0.0 107.849 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 t0 62.4 -12.83 0.07 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 130.039 3.336 . . . . 0.0 117.677 158.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.83 -166.85 16.89 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.512 1.053 . . . . 0.0 111.889 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -55.66 101.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.946 3.098 . . . . 0.0 111.235 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.77 HG11 HG22 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -94.77 140.83 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 108.361 -175.4 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.472 HD11 HD21 ' A' ' 100' ' ' LEU . 3.5 mm? -130.43 143.14 50.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 173.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.69 108.3 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.481 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 63.3 t0 -75.91 98.52 4.24 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 69' ' ' ILE . 78.0 m-85 -84.3 105.53 15.21 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -124.8 -177.15 3.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -153.96 162.09 41.48 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.222 -0.924 . . . . 0.0 110.552 171.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.35 -5.42 2.43 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.473 ' CZ3' HD11 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -113.66 -20.96 10.99 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.591 1.087 . . . . 0.0 113.765 178.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.9 p -73.83 161.67 29.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.912 1.233 . . . . 0.0 110.347 -173.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.78 -84.86 1.74 Allowed Glycine 0 CA--C 1.531 1.089 0 CA-C-O 119.559 -0.579 . . . . 0.0 112.552 -173.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.15 -16.55 55.52 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.339 2.693 . . . . 0.0 113.448 -171.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.0 p -49.78 -40.84 42.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.848 0.859 . . . . 0.0 111.586 166.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -12.35 61.55 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.145 0.578 . . . . 0.0 112.257 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 73.5 mtm -100.99 -15.73 17.38 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.322 1.449 . . . . 0.0 112.057 173.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.8 ttt -85.32 -42.62 14.43 Favored 'General case' 0 C--O 1.217 -0.648 0 C-N-CA 125.485 1.514 . . . . 0.0 108.444 172.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.09 -50.4 36.99 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.359 -1.305 . . . . 0.0 113.419 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.14 -36.1 30.52 Favored 'Trans proline' 0 C--N 1.353 0.766 0 CA-C-N 121.845 1.695 . . . . 0.0 112.17 173.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -60.97 -35.48 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.306 0.957 . . . . 0.0 110.304 173.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.84 -17.55 57.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.631 1.973 . . . . 0.0 111.847 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.26 -48.86 18.73 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 167.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -61.55 -26.18 67.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.602 0.761 . . . . 0.0 111.33 173.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.447 ' CE1' HD12 ' A' ' 96' ' ' LEU . 81.2 t80 -65.25 -63.19 1.16 Allowed 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 125.182 1.393 . . . . 0.0 107.879 170.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.77 -46.16 67.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 119.173 -0.442 . . . . 0.0 112.046 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.93 -34.79 56.94 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.245 1.418 . . . . 0.0 111.781 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.91 -14.45 61.06 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -162.18 63.38 0.23 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.341 1.456 . . . . 0.0 108.995 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.66 71.39 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -166.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -131.74 -1.31 3.82 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -168.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -64.46 -39.63 94.19 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.928 1.24 . . . . 0.0 108.866 161.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.01 170.9 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.697 1.199 . . . . 0.0 108.094 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.463 ' HB ' ' HA ' ' A' ' 1' ' ' ALA . 2.6 t -128.41 74.81 1.58 Allowed 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 123.989 1.852 . . . . 0.0 106.556 177.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 p -82.78 160.34 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.787 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 5' ' ' LEU . . . -159.67 174.11 15.05 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.185 176.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 23' ' ' ASP . 28.1 mttp -131.99 144.39 50.76 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 123.331 0.653 . . . . 0.0 110.509 176.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.97 163.4 39.77 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.788 1.305 . . . . 0.0 114.297 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -91.45 105.33 17.68 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.101 1.76 . . . . 0.0 108.716 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.484 HG21 HG22 ' A' ' 69' ' ' ILE . 2.7 p -65.94 -21.78 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.664 0.786 . . . . 0.0 112.669 -172.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -67.69 -22.43 65.28 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.303 1.041 . . . . 0.0 111.612 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -114.09 -21.64 10.43 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.744 2.017 . . . . 0.0 111.829 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -100.32 94.23 3.23 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.235 1.414 . . . . 0.0 109.924 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.19 -27.74 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.038 2.492 . . . . 0.0 113.524 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -74.84 103.76 5.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.275 0.943 . . . . 0.0 110.751 -172.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m 104.88 -32.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 130.868 3.667 . . . . 0.0 109.471 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -52.82 -52.82 55.57 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.888 1.275 . . . . 0.0 109.714 167.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.4 t -70.9 -7.43 45.7 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.228 178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -87.73 -33.22 18.78 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.998 1.272 . . . . 0.0 111.12 177.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -120.12 2.41 10.92 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.62 38.34 51.25 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 119.134 0.879 . . . . 0.0 111.801 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.491 HG21 ' CZ ' ' A' ' 24' ' ' PHE . 39.3 mm -75.51 83.67 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.973 1.309 . . . . 0.0 110.498 -166.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -119.58 -6.55 10.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.058 1.343 . . . . 0.0 112.544 172.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 m -77.14 34.41 0.16 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.929 2.092 . . . . 0.0 113.362 -168.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.473 HD11 ' CZ3' ' A' ' 28' ' ' TRP . 34.0 pt -74.76 151.06 86.7 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -162.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 59.3 Cg_endo -65.88 130.65 12.23 Favored 'Cis proline' 0 C--N 1.351 0.685 0 CA-C-N 119.047 0.695 . . . . 0.0 110.745 -3.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.5 m -119.07 144.12 46.76 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.6 tp -132.36 113.92 13.75 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mt -111.42 142.9 22.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.99 118.56 37.02 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.762 2.025 . . . . 0.0 106.875 -176.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.432 ' HB2' HG12 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -130.72 176.38 8.24 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.239 1.016 . . . . 0.0 110.433 175.247 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.88 145.83 17.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 158.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 37.61 41.79 0.89 Allowed Glycine 0 CA--C 1.54 1.637 0 N-CA-C 115.974 1.15 . . . . 0.0 115.974 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.29 -12.63 68.67 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.77 1.652 . . . . 0.0 115.545 177.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -95.43 120.52 63.63 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 120.601 2.2 . . . . 0.0 110.768 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.82 148.71 46.65 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.124 1.883 . . . . 0.0 109.487 163.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.94 -44.54 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.68 0.792 . . . . 0.0 111.914 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -159.56 171.62 19.31 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.72 1.145 . . . . 0.0 110.061 171.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.29 156.21 46.54 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.016 1.726 . . . . 0.0 110.133 -174.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.4 mt -137.01 139.54 41.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.04 134.23 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 -170.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.02 162.68 37.92 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.796 0.712 . . . . 0.0 111.63 -175.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -75.29 75.78 2.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.363 1.065 . . . . 0.0 110.923 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -75.31 140.43 72.72 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 167.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 170.13 19.46 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.592 2.195 . . . . 0.0 111.692 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.83 -46.39 41.98 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.006 1.323 . . . . 0.0 111.945 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -56.94 -43.75 81.84 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.913 1.285 . . . . 0.0 110.95 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.73 -36.49 70.48 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.403 0.681 . . . . 0.0 109.251 -177.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.447 HD12 ' CE1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -64.92 -60.03 3.52 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.415 1.086 . . . . 0.0 108.552 179.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -62.35 -32.87 73.72 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.102 0.561 . . . . 0.0 110.377 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.74 -53.68 10.99 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.355 0.525 . . . . 0.0 111.009 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.5 -35.87 81.89 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 118.477 0.581 . . . . 0.0 111.089 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.472 HD21 HD11 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -87.63 -1.14 57.75 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.913 -178.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -50.32 -31.33 14.15 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 125.224 1.41 . . . . 0.0 113.588 -172.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -22.64 58.6 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.399 1.08 . . . . 0.0 112.32 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -111.55 -8.25 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.809 0.844 . . . . 0.0 111.444 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.89 -10.4 28.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.19 1.396 . . . . 0.0 112.487 171.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 . . . . . 0 C--O 1.249 1.069 0 C-N-CA 126.104 1.761 . . . . 0.0 110.898 171.904 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 117.002 -1.475 . . . . 0.0 107.8 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.3 m -62.65 -61.09 2.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.311 1.414 . . . . 0.0 112.789 -168.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.4 ttp 48.56 -137.66 0.9 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.785 1.634 . . . . 0.0 110.22 -166.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.4 m -59.01 126.48 27.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.653 1.581 . . . . 0.0 113.34 -159.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.95 171.22 8.9 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.814 2.046 . . . . 0.0 111.207 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.0 t -131.78 -50.74 0.97 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.092 0.957 . . . . 0.0 111.53 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 174.27 -68.9 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 127.9 2.48 . . . . 0.0 105.179 171.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.67 -33.5 64.16 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.881 -0.512 . . . . 0.0 111.836 177.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.42 -17.39 61.26 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 119.105 -0.474 . . . . 0.0 111.25 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -63.69 -64.45 0.89 Allowed 'General case' 0 C--N 1.343 0.284 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 176.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.88 -44.42 94.21 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.974 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -58.8 -28.01 65.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.468 1.031 . . . . 0.0 113.013 -177.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.9 -58.9 2.68 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.974 0.91 . . . . 0.0 110.723 171.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.6 pt -62.08 -23.13 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.936 -171.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -57.71 -31.99 66.94 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.393 1.077 . . . . 0.0 111.688 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.5 102.08 0.15 Allowed Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -165.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -153.36 -69.55 0.15 Allowed 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 128.294 2.638 . . . . 0.0 105.539 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.46 -114.65 0.98 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 106.957 -2.457 . . . . 0.0 106.957 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.79 76.94 3.53 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.21 3.273 . . . . 0.0 112.564 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.96 130.14 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.411 ' HG ' ' HA ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -112.87 113.89 26.17 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 159.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.09 125.01 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.1 94.73 5.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 124.12 0.888 . . . . 0.0 110.337 -174.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -83.08 109.27 16.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.416 ' O ' HG12 ' A' ' 57' ' ' VAL . 22.7 p-90 -126.93 175.02 8.38 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 169.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -140.14 150.2 43.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.773 0.715 . . . . 0.0 110.52 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.9 -26.26 58.69 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.764 0.825 . . . . 0.0 113.023 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.11 -25.88 16.96 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.0 p -69.75 157.64 36.93 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.372 0.987 . . . . 0.0 111.467 -160.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.75 -86.11 1.16 Allowed Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.318 -172.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.87 -18.83 66.73 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.13 2.553 . . . . 0.0 113.918 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 20.4 p -53.67 -35.47 61.1 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.24 0.473 . . . . 0.0 111.23 168.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -69.31 -16.42 63.55 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.381 -0.824 . . . . 0.0 112.336 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.78 -12.32 20.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.597 1.559 . . . . 0.0 112.119 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.8 ttt -93.14 -35.13 13.34 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 126.415 1.886 . . . . 0.0 108.773 175.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.82 -50.45 43.81 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.034 1.734 . . . . 0.0 112.894 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.05 -36.76 46.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 121.81 1.682 . . . . 0.0 111.585 172.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.02 -22.84 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 119.851 1.205 . . . . 0.0 111.314 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.81 -35.06 24.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.776 2.43 . . . . 0.0 111.8 175.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.12 -42.71 93.65 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 169.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -65.79 -15.41 62.85 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.306 1.443 . . . . 0.0 112.368 170.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -82.63 -47.82 11.64 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 120.636 -1.29 . . . . 0.0 109.214 170.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.63 -47.55 81.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.551 1.14 . . . . 0.0 110.573 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -58.7 -53.12 61.98 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.575 0.75 . . . . 0.0 110.959 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.7 -14.67 54.3 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -162.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.15 51.39 0.79 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.369 1.868 . . . . 0.0 108.428 172.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.63 -14.02 7.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.412 1.085 . . . . 0.0 113.679 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -88.87 -51.28 5.72 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.596 2.358 . . . . 0.0 111.864 174.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -73.33 -16.73 61.35 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 117.439 -1.267 . . . . 0.0 112.244 -168.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.4 m -140.09 166.56 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 121.128 1.785 . . . . 0.0 113.102 -170.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.1 t -119.46 122.75 42.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.75 0.786 . . . . 0.0 109.146 159.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.411 ' HA ' ' HG ' ' A' ' 21' ' ' LEU . 2.9 t -76.97 152.13 5.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 158.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.35 99.7 3.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -95.14 143.38 26.62 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 122.783 0.433 . . . . 0.0 110.714 -169.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -141.73 145.36 34.75 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.299 0.571 . . . . 0.0 110.755 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -82.22 90.0 6.57 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 173.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 72' ' ' ILE . 6.1 p -62.01 -15.04 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 125.275 1.43 . . . . 0.0 112.468 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -65.85 -20.0 66.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.809 2.444 . . . . 0.0 112.766 169.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -131.06 -23.43 2.46 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.067 2.147 . . . . 0.0 111.696 -167.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -116.28 77.85 7.71 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.402 1.881 . . . . 0.0 109.176 -169.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.92 -4.82 16.08 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.608 3.539 . . . . 0.0 116.675 -170.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.461 ' C ' ' H ' ' A' ' 64' ' ' THR . 5.6 tp10 -59.93 135.25 57.64 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.976 1.716 . . . . 0.0 109.979 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m 59.26 -14.64 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.925 3.29 . . . . 0.0 112.847 -176.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.461 ' H ' ' C ' ' A' ' 62' ' ' GLU . 96.9 m -63.44 -54.26 39.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 126.259 1.824 . . . . 0.0 109.221 -175.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.9 t -73.02 1.12 9.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.543 1.137 . . . . 0.0 112.704 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -107.01 -39.66 5.68 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.622 1.169 . . . . 0.0 110.627 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -104.27 5.24 34.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.587 1.155 . . . . 0.0 110.734 -176.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.81 38.67 49.28 Favored Glycine 0 C--N 1.343 0.941 0 C-N-CA 124.243 0.925 . . . . 0.0 112.158 174.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.9 mm -78.83 76.44 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.965 1.306 . . . . 0.0 109.734 -167.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 70.7 mtm -106.54 -14.88 14.93 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.935 1.294 . . . . 0.0 111.478 173.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.4 m -82.61 23.73 0.77 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.165 1.786 . . . . 0.0 114.022 -159.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.546 HG21 HG11 ' A' ' 57' ' ' VAL . 16.3 pt -71.31 155.79 92.47 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.317 1.047 . . . . 0.0 112.943 -158.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 72' ' ' ILE . 56.7 Cg_endo -62.74 127.86 5.64 Favored 'Cis proline' 0 C--N 1.352 0.711 0 CA-C-N 119.666 0.916 . . . . 0.0 110.687 -3.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 39.3 m -114.32 136.4 53.01 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 tt -131.72 92.99 3.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -174.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.7 mt -94.52 144.37 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.5 HD11 ' HB ' ' A' ' 103' ' ' VAL . 3.3 tt -110.84 120.33 42.03 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 173.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -110.44 148.38 32.16 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -141.27 111.63 6.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 170.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 39.54 59.17 1.98 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.58 2.038 . . . . 0.0 112.942 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.66 -20.32 51.05 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.636 1.588 . . . . 0.0 114.03 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.74 109.41 59.36 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 119.452 1.626 . . . . 0.0 111.359 -166.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.31 92.78 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.855 3.037 . . . . 0.0 110.731 169.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 m -65.54 -40.78 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.582 -0.699 . . . . 0.0 112.644 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.404 ' CE ' ' HB2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -158.76 167.19 30.14 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.09 0.956 . . . . 0.0 110.248 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -136.11 133.21 37.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.905 2.082 . . . . 0.0 107.607 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -101.12 154.2 18.93 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 158.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.3 pt -141.35 143.93 27.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 106.872 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.55 172.34 20.19 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 121.983 0.768 . . . . 0.0 112.191 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -74.75 79.62 2.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.934 0.894 . . . . 0.0 110.784 -176.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -72.36 127.69 89.82 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 161.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.41 163.55 36.14 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.712 1.608 . . . . 0.0 109.779 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.34 -45.35 12.32 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.81 1.244 . . . . 0.0 111.041 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -59.92 -24.7 64.55 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.191 1.396 . . . . 0.0 113.908 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -100.12 -46.95 5.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.707 1.203 . . . . 0.0 108.624 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 tt -52.64 -62.93 1.33 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.873 2.069 . . . . 0.0 108.892 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -59.14 -34.92 72.63 Favored 'General case' 0 C--N 1.337 0.043 0 C-N-CA 125.025 1.33 . . . . 0.0 110.469 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.62 -42.04 71.44 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.064 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -41.89 85.41 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.411 0.55 . . . . 0.0 109.798 173.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.449 ' HG ' HD12 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -71.77 -4.04 25.45 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.958 1.703 . . . . 0.0 113.337 -178.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.47 -25.07 9.16 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.842 1.257 . . . . 0.0 113.132 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -7.43 9.41 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 121.091 1.769 . . . . 0.0 113.975 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.5 ' HB ' HD11 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -127.49 -1.55 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 121.431 -0.793 . . . . 0.0 112.845 168.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -105.77 -10.98 16.44 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.44 1.096 . . . . 0.0 113.094 174.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 C--O 1.251 1.15 0 C-N-CA 127.017 2.127 . . . . 0.0 109.81 162.87 . . . . . . . . 0 0 . 1 stop_ save_